data_2kxt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -80.24 115.88 20.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.89 -23.15 18.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -146.31 152.33 38.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.301 -0.874 . . . . 0.0 109.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 t -146.16 158.52 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 tp -147.69 107.65 4.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.851 . . . . 0.0 109.022 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.11 150.77 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.92 116.93 1.39 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -110.88 126.83 55.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -142.21 145.48 15.73 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -158.49 151.24 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 110.031 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -91.2 128.23 36.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 109.712 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.314 0.578 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 150.12 20.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.95 104.48 4.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.912 . . . . 0.0 109.64 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.36 151.38 25.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 108.783 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.36 106.56 17.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 109.879 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.5 125.68 45.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 108.757 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 5.7 t -149.43 167.62 25.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.941 -1.099 . . . . 0.0 109.913 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.38 136.53 49.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.4 m-85 -104.02 127.96 51.58 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.621 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.77 142.0 30.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.373 -0.83 . . . . 0.0 109.998 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.57 131.62 20.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -0.935 . . . . 0.0 109.835 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.36 175.11 10.06 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 1.56 43.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.289 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -83.09 -9.84 59.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 109.504 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.7 -5.05 69.52 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -109.71 150.37 28.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.9 m -65.97 136.53 26.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -71.02 5.35 2.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ALA . . . -158.77 118.59 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -47.68 -10.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -1.113 . . . . 0.0 110.338 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLY . . . -95.7 -40.21 9.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.5 t0 47.57 14.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 109.294 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 62.6 t80 -137.2 100.39 4.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 109.654 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.9 pt -103.48 139.57 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.558 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.2 p90 -153.22 -153.98 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -0.879 . . . . 0.0 109.686 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.573 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.0 OUTLIER -43.43 -36.24 1.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.064 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.45 -1.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 108.946 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.573 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.3 t30 -149.57 103.97 3.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.137 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.21 -28.57 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttm -165.18 160.12 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 t -69.86 147.92 49.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.264 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.81 -48.52 14.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -116.2 1.64 13.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.661 -0.649 . . . . 0.0 109.587 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 -12.71 69.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 60.78 11.99 3.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.36 -1.082 . . . . 0.0 109.42 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.07 150.27 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.249 -0.907 . . . . 0.0 108.93 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.9 m -148.77 138.08 21.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.12 -0.987 . . . . 0.0 110.0 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -90.06 127.91 36.17 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -67.12 -56.91 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.57 111.11 0.47 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.2 p-10 -77.4 110.88 12.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -81.92 -164.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -156.15 16.48 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -154.64 -37.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 109.325 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.63 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -1.169 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -73.28 -63.86 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.22 171.68 9.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.4 132.26 6.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.326 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.37 119.41 35.59 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -95.69 135.88 36.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 108.736 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.51 146.93 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 110.358 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.28 87.62 2.35 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 79' ' ' ALA . 21.9 mt -67.94 -34.52 76.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.869 . . . . 0.0 109.751 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -55.28 -5.71 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.582 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -119.27 20.65 12.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' PRO . 48.0 t -105.41 104.98 50.6 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.327 -0.858 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.25 -171.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.055 1.837 . . . . 0.0 112.353 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 1.08 89.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.02 -55.95 15.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -1.105 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 83.5 t -84.39 148.59 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 0.0 108.977 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 45.3 m-20 -136.61 -5.27 2.0 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.359 -0.838 . . . . 0.0 110.136 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -145.25 131.17 19.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.949 -1.094 . . . . 0.0 109.423 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -141.49 108.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.23 154.86 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 109.627 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -96.45 159.1 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 109.202 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.3 t -147.23 152.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.746 0.784 . . . . 0.0 110.651 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.6 t -148.01 115.84 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 p -132.85 174.45 10.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 mm -86.53 143.25 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -100.4 -68.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.327 -0.858 . . . . 0.0 110.044 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -18.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.248 -0.908 . . . . 0.0 110.06 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -46.43 -26.96 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -53.98 -50.41 66.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 109.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.12 -39.48 12.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.42 -0.8 . . . . 0.0 110.984 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -96.99 -19.49 18.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.057 -1.027 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.6 mmt180 50.94 58.2 5.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.637 -1.289 . . . . 0.0 109.169 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.37 148.45 25.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.3 p -98.15 159.39 14.97 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.743 . . . . 0.0 109.605 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -45.88 -33.94 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -59.16 -36.84 90.42 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -47.53 -19.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -1.21 . . . . 0.0 109.328 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 104' ' ' GLY . 18.6 t -85.93 168.12 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.131 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -69.3 -23.91 63.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.21 79.98 0.03 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.75 25.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 109.817 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.8 p90 -153.33 143.51 22.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.099 -1.0 . . . . 0.0 110.257 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.8 mt -107.02 154.7 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.39 159.83 41.24 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 2.7 tt -154.23 116.54 4.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.097 -1.002 . . . . 0.0 109.482 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.65 143.3 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 117' ' ' ASP . 78.8 m-20 -75.33 102.12 4.98 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -64.73 -1.85 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.561 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.1 t0 -82.1 -53.7 5.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 109.72 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.71 6.55 8.8 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.67 -0.644 . . . . 0.0 109.724 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 59.03 59.7 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -111.21 -69.91 0.84 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.866 -0.521 . . . . 0.0 110.309 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 51.0 mm-40 -45.26 157.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.0 109.893 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.58 72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.0 152.22 51.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.067 -1.021 . . . . 0.0 109.992 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 30.3 ptt180 -140.79 144.36 35.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -91.32 147.63 22.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 103.39 16.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 131' ' ' ALA . 46.3 mt -80.44 -40.7 25.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.298 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.85 -29.58 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -95.26 -54.66 3.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.434 -0.791 . . . . 0.0 109.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.11 -1.35 25.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.85 -44.71 66.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.294 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -72.7 3.09 5.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.56 -0.713 . . . . 0.0 109.984 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.4 m -83.02 -34.39 26.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 0.0 110.283 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.75 -164.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.952 -1.093 . . . . 0.0 109.729 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -124.81 -5.71 7.46 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.76 135.31 23.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.36 150.67 9.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.55 136.0 33.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.79 -49.4 46.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 109.938 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.35 -155.56 7.21 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.293 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -150.64 157.73 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -1.024 . . . . 0.0 109.347 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.74 135.74 28.23 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -150.82 166.8 29.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.931 -1.106 . . . . 0.0 110.275 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 11.5 ptm180 -86.95 147.07 25.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.779 . . . . 0.0 109.503 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.5 OUTLIER -129.54 -114.88 0.25 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.693 . . . . 0.0 109.259 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.584 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.2 m120 -72.67 58.42 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.963 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.44 7.25 63.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -127.92 154.18 45.84 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.668 -0.901 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -75.74 151.49 37.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -145.35 127.83 16.0 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -89.99 148.25 23.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -157.32 107.37 2.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.78 153.72 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.04 -32.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.78 85.92 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -139.14 104.48 5.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.559 -0.965 . . . . 0.0 109.548 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.0 154.79 35.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -150.08 124.17 9.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.404 -1.056 . . . . 0.0 109.123 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.69 15.09 6.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.32 -0.862 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.06 -76.56 0.15 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.21 126.18 0.82 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.01 -29.21 1.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -1.126 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.97 -32.6 21.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 166' ' ' CYS . 19.9 m -80.28 -50.35 10.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.73 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 m -45.76 -19.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.341 -0.849 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 78.0 m -70.94 -62.0 1.55 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.25 -15.38 38.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.108 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.68 -34.99 71.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.003 -1.06 . . . . 0.0 110.365 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -70.75 -19.59 62.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.153 . . . . 0.0 109.206 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.684 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 16.3 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.286 0.565 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.6 mtt -80.91 -173.67 4.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -153.15 -34.67 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.71 HD21 ' H ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -140.57 139.39 34.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.0 109.279 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.71 ' H ' HD21 ' A' ' 4' ' ' ASN . 3.8 t -144.46 130.64 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.21 109.76 17.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.71 144.73 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.145 -0.972 . . . . 0.0 108.727 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -129.98 129.94 6.11 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 tt -134.87 126.81 29.49 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.01 151.11 23.12 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 27.5 p90 -155.73 154.7 31.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.367 -1.079 . . . . 0.0 109.738 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.8 99.62 11.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.28 134.43 39.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -141.11 100.06 3.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.0 109.712 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 136.48 34.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.888 . . . . 0.0 108.633 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.66 110.58 22.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.186 -0.947 . . . . 0.0 110.005 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 128.83 44.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.252 -0.905 . . . . 0.0 108.859 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.5 m -150.25 167.8 25.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.046 -1.034 . . . . 0.0 110.37 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 136.62 48.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.8 m-85 -103.48 145.34 30.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.9 153.83 31.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.75 143.31 36.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -81.4 176.59 9.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.43 -13.24 52.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -0.906 . . . . 0.0 109.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -84.42 7.95 17.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 109.867 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 -14.8 61.88 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' ALA . 37.6 mmtm -102.81 176.18 5.24 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' C ' ' H ' ' A' ' 38' ' ' GLY . 21.4 t -101.11 137.07 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -62.76 1.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -151.04 124.38 1.69 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.51 3.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.156 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -97.78 -41.97 7.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.04 -1.037 . . . . 0.0 109.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 10.6 t0 46.92 14.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 109.442 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 14.0 t80 -136.9 99.07 3.92 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 0.0 109.368 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 pt -101.97 133.17 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.437 -0.79 . . . . 0.0 108.942 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.7 p90 -142.14 -161.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.259 -0.9 . . . . 0.0 109.278 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.44 ' C ' ' H ' ' A' ' 47' ' ' ASN . 21.7 p90 -44.65 -27.51 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.224 -0.923 . . . . 0.0 110.372 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.4 t30 -57.93 -8.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.999 -1.063 . . . . 0.0 108.96 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 45.0 t-20 -139.06 109.42 6.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.798 . . . . 0.0 108.966 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -47.37 -31.51 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.89 . . . . 0.0 109.183 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.8 pttt -168.52 155.01 7.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.442 -0.786 . . . . 0.0 109.39 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -60.82 147.88 41.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.38 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.36 -47.88 16.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -116.16 0.91 13.07 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.736 -0.602 . . . . 0.0 109.516 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.66 -12.01 65.1 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t 58.44 14.92 3.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.232 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.97 151.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.1 m -148.84 134.62 18.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.0 109.811 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -90.57 139.57 30.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.393 -0.817 . . . . 0.0 109.072 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 m -76.84 -55.55 5.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.44 117.28 0.66 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.91 113.62 18.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -1.148 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 132.95 35.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -81.75 7.97 11.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.69 -35.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.4 111.36 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -1.149 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.55 -63.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -87.92 159.29 18.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.6 m -152.51 132.4 13.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.214 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.15 123.95 47.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -95.87 136.19 36.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.275 -0.89 . . . . 0.0 108.853 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.52 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 87.4 mt -133.39 146.99 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.086 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.25 90.36 2.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 79' ' ' ALA . 13.8 mt -72.41 -25.27 61.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -66.4 4.74 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -137.08 24.91 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 81' ' ' PRO . 38.1 t -103.93 105.54 48.8 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.451 -0.78 . . . . 0.0 109.198 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . 73.2 Cg_exo -48.06 -175.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.026 1.817 . . . . 0.0 112.335 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.84 85.92 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.27 -50.81 72.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -1.204 . . . . 0.0 109.243 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 m -95.55 139.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 109.076 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -116.86 2.41 12.82 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.57 -0.706 . . . . 0.0 109.819 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -158.14 132.68 8.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.041 . . . . 0.0 109.777 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.7 mt -141.17 117.79 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.2 157.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -105.9 137.41 43.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 1.2 p -147.01 157.46 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.521 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 3.5 p -129.26 147.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 p -140.15 140.71 36.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mm -73.82 132.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.826 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 97' ' ' GLN . 83.8 t60 -89.95 -63.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.22 -18.22 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.92 -18.26 43.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 38.1 mt-30 -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.734 -1.229 . . . . 0.0 109.412 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.46 -44.42 9.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 0.0 111.047 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -81.72 -17.79 46.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.05 -1.031 . . . . 0.0 111.402 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 52.34 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.854 -1.154 . . . . 0.0 109.077 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -148.13 143.5 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.328 -0.857 . . . . 0.0 109.132 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -99.85 165.38 11.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.284 -0.885 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -46.22 -32.22 2.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.321 -0.862 . . . . 0.0 109.785 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -61.61 -38.69 96.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -49.87 -17.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.3 . . . . 0.0 109.296 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' N ' ' C ' ' A' ' 104' ' ' GLY . 15.9 t -84.92 163.82 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 109.127 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 -26.79 68.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.597 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.1 79.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 164.37 25.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -1.146 . . . . 0.0 109.74 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 37.0 p90 -151.29 170.02 20.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.301 -0.875 . . . . 0.0 110.018 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 24.7 mt -132.66 154.93 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 72.6 ttt180 -143.38 162.48 35.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.968 -1.083 . . . . 0.0 109.718 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 4.3 tt -157.67 117.97 3.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 0.0 109.771 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.03 142.81 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.359 -0.838 . . . . 0.0 109.586 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 117' ' ' ASP . 1.5 m120 -78.84 102.27 8.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 5.5 t70 -68.03 -1.78 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 115' ' ' ASN . 24.9 t70 -76.5 -52.12 10.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 4.5 t-20 -122.02 -14.12 8.07 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.677 -0.639 . . . . 0.0 109.608 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 5.0 tt0 71.67 69.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.6 m -134.39 -43.71 0.77 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.722 -0.611 . . . . 0.0 109.807 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 5.7 mp0 -65.79 158.25 28.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 108.781 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 174.21 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.92 51.73 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.751 . . . . 0.0 109.201 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.0 ptt180 -134.08 142.07 47.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.607 -0.683 . . . . 0.0 109.474 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.8 t80 -91.43 147.35 23.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.371 -0.831 . . . . 0.0 108.916 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.77 102.83 15.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 109.394 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 50.5 mt -79.65 -39.19 31.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.6 p -47.56 -30.51 3.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.018 -1.051 . . . . 0.0 109.286 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -95.23 -54.59 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -0.825 . . . . 0.0 109.75 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 53.9 m-20 -74.77 -0.73 19.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -54.7 -46.5 74.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.085 -1.01 . . . . 0.0 109.321 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.2 t -69.23 2.99 2.42 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.548 -0.72 . . . . 0.0 109.882 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 131' ' ' ALA . 11.6 m -82.96 -34.57 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.9 -162.91 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.001 -1.062 . . . . 0.0 109.582 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -15.25 7.56 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.35 137.37 35.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.6 ttp -164.89 152.05 11.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.872 -1.142 . . . . 0.0 110.144 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.451 ' CD2' ' H ' ' A' ' 138' ' ' LEU . 1.7 pt? -87.96 135.43 33.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -77.81 -26.4 49.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.922 -1.111 . . . . 0.0 109.304 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.69 -164.23 21.91 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -150.53 154.22 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.988 . . . . 0.0 108.74 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 134.81 24.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.038 -1.039 . . . . 0.0 108.86 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -147.47 166.01 28.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 109.717 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.57 148.48 24.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -152.3 123.73 7.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER 55.72 24.8 7.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.18 80.05 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -127.82 137.48 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -1.015 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 69.7 m95 -67.69 151.19 47.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.369 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -148.61 121.98 9.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.148 -0.97 . . . . 0.0 109.726 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 17.6 t80 -89.94 143.77 26.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.497 -0.752 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.32 107.43 3.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 109.026 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.36 154.79 10.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.776 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -139.42 -34.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.373 -0.829 . . . . 0.0 109.05 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.41 81.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.428 ' H ' ' CD2' ' A' ' 138' ' ' LEU . 34.7 tt0 -141.35 104.14 4.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.057 . . . . 0.0 109.041 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.0 150.5 27.73 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.7 137.77 38.69 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.606 -0.937 . . . . 0.0 108.782 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.51 13.86 24.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.217 -0.927 . . . . 0.0 109.519 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.88 -68.35 1.34 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.06 131.59 1.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.23 -30.27 1.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -1.116 . . . . 0.0 109.87 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.7 -25.18 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' GLY . 53.6 p -77.34 -55.4 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.471 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.6 m -46.97 -20.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 80.0 m -71.47 -60.91 1.98 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.03 -19.64 28.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.28 -0.888 . . . . 0.0 110.141 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -55.21 -42.19 73.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 109.726 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -71.47 -19.86 62.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.355 -0.841 . . . . 0.0 109.178 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 149' ' ' TRP . 73.2 m . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -74.19 -169.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -153.9 -34.58 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 31.4 t30 -143.63 128.22 18.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 109.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.64 158.54 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.626 -0.671 . . . . 0.0 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 tt -146.21 112.95 6.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -89.94 150.55 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 108.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.35 116.76 1.34 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.61 135.46 42.02 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.92 138.07 8.09 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -160.33 153.7 22.08 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.4 111.24 23.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.548 -0.72 . . . . 0.0 109.347 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 68.4 m-85 -96.31 150.9 20.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.07 99.67 3.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.865 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.63 132.78 35.56 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -95.85 111.06 23.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.096 -1.002 . . . . 0.0 110.092 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.36 125.34 43.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.414 -0.804 . . . . 0.0 108.893 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -149.81 167.77 25.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.844 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.0 142.25 41.66 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.5 m-85 -103.9 148.28 26.35 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' H ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -120.18 154.11 35.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.568 -0.708 . . . . 0.0 109.987 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 139.54 27.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.102 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -74.86 176.42 7.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.097 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.38 -9.44 58.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.179 -0.95 . . . . 0.0 109.763 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.39 8.29 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.136 -0.977 . . . . 0.0 109.919 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.18 70.1 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 31' ' ' ALA . 66.7 mmtt -104.18 170.1 8.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.624 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.8 t -98.42 137.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.12 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.3 ttt-85 -64.69 1.94 0.76 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.93 125.21 1.7 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 4.42 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -1.148 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.59 -41.5 8.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.97 -1.081 . . . . 0.0 110.028 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 12.2 t0 47.72 13.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.857 -1.152 . . . . 0.0 109.43 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 72.4 t80 -136.89 99.39 4.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -0.8 . . . . 0.0 109.642 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 43' ' ' ILE . 6.3 pt -99.7 139.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.6 p90 -154.22 -155.93 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 109.596 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.552 ' C ' ' H ' ' A' ' 47' ' ' ASN . 3.8 m-85 -43.54 -34.29 1.35 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.544 -0.723 . . . . 0.0 110.138 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -58.28 -2.16 0.17 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.096 -1.002 . . . . 0.0 108.827 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 45' ' ' TYR . 43.5 t-20 -148.72 113.76 5.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 109.27 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.64 -38.49 46.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 108.945 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 36.0 pttt -161.87 157.67 24.31 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.372 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 t -63.21 144.57 56.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -47.12 17.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -116.31 2.02 13.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.715 -0.615 . . . . 0.0 109.67 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -87.7 -17.97 57.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 2.9 p 67.22 7.97 5.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -93.11 149.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 m -148.86 138.98 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.227 -0.92 . . . . 0.0 109.496 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -89.88 139.83 30.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -142.61 40.57 1.56 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 109.343 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.38 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.2 124.28 34.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -1.058 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.7 m120 -153.53 93.03 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -73.88 14.52 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 61' ' ' ASN . 52.6 p -147.59 -35.29 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.887 . . . . 0.0 109.303 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.73 122.01 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -82.01 -70.43 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.33 177.0 7.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.2 m -159.98 132.44 6.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.44 125.15 48.26 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -95.9 139.35 32.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 108.837 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 69.3 mt -132.22 146.61 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.5 mttm -141.22 101.32 3.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.68 -5.41 53.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.13 -20.46 32.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.569 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.74 7.99 43.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.15 123.95 84.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.203 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.923 1.749 . . . . 0.0 112.054 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.82 2.24 76.1 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -69.94 -60.63 2.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -1.199 . . . . 0.0 109.219 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.97 148.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.003 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.7 15.99 3.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.245 -0.909 . . . . 0.0 109.693 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' A' ' 141' ' ' GLU . 50.6 tttp -158.37 135.21 9.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.589 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.2 mt -133.65 154.14 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.93 173.47 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 108.913 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.7 m-85 -142.1 123.38 14.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.71 157.9 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 110.352 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.24 115.53 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -107.11 153.24 22.93 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.39 -0.819 . . . . 0.0 110.242 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 94' ' ' HIS . 5.7 mm -73.84 167.41 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.464 ' N ' ' CG2' ' A' ' 93' ' ' ILE . 46.7 t-80 -133.69 -60.81 0.82 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.385 -0.822 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -49.28 -18.27 0.34 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.972 . . . . 0.0 109.586 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.74 -40.02 90.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.81 -32.6 44.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.776 -1.202 . . . . 0.0 109.698 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.91 -54.03 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.124 -0.985 . . . . 0.0 111.352 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.49 4.09 17.21 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.294 -0.879 . . . . 0.0 111.16 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 96' ' ' ALA . 51.7 ttt180 57.56 106.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 109.301 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.421 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 34.7 mt-30 -151.34 145.34 25.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 109.671 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.8 p -104.95 163.59 12.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.447 -0.783 . . . . 0.0 109.55 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -46.15 -36.38 5.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 109.859 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -58.92 -41.43 96.23 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 57.8 mm-40 -49.43 -14.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.28 . . . . 0.0 109.267 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 104' ' ' GLY . 21.9 t -83.59 165.4 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.049 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 t -69.0 -20.15 64.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 0.0 109.554 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.11 79.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.37 163.46 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.129 . . . . 0.0 109.821 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 18.3 p90 -157.85 158.75 35.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.8 mt -118.88 157.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -138.11 159.35 42.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.059 -1.026 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.407 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 2.9 tt -152.9 115.31 4.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.86 142.11 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.395 -0.816 . . . . 0.0 109.857 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 119' ' ' GLN . 57.9 t30 -79.49 101.82 8.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.53 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.7 t70 -69.34 -4.89 20.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.728 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.516 ' C ' HD21 ' A' ' 118' ' ' ASN . 13.7 t0 -70.91 -53.2 15.89 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.813 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.516 HD21 ' C ' ' A' ' 117' ' ' ASP . 1.4 m-80 -123.38 0.78 8.95 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' ASN . 26.1 tt0 62.93 64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.4 m -118.06 -69.9 0.82 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.924 -0.485 . . . . 0.0 110.304 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 14.9 mm-40 -45.29 157.04 0.09 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.311 -0.868 . . . . 0.0 109.876 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.84 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.19 154.47 50.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.012 -1.055 . . . . 0.0 110.025 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.2 ptm180 -139.32 149.24 43.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 109.193 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.05 147.32 22.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.188 -0.945 . . . . 0.0 109.135 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.4 103.13 15.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 0.0 109.399 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 64.3 mt -80.94 -40.49 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -47.84 -31.06 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 109.189 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -95.2 -54.62 3.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -0.783 . . . . 0.0 109.753 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.96 -4.76 34.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.77 -45.95 67.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.132 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.5 p -69.14 3.01 2.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.647 -0.658 . . . . 0.0 109.845 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 131' ' ' ALA . 14.1 m -83.18 -34.58 25.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 0.0 110.2 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 179.52 -163.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.93 -1.106 . . . . 0.0 109.592 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 -9.74 9.57 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.71 139.53 34.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.46 157.6 15.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.176 -0.953 . . . . 0.0 109.512 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.36 138.41 37.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 109.718 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 29.2 t80 -81.06 -43.98 18.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 109.611 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.82 -168.69 20.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 86' ' ' LYS . 29.2 tt0 -151.32 163.53 38.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -1.1 . . . . 0.0 109.408 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.92 140.73 29.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 0.0 108.661 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.45 ' OH ' ' CZ ' ' A' ' 152' ' ' ARG . 4.7 p90 -150.59 166.02 31.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.116 -0.99 . . . . 0.0 109.703 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -85.3 151.48 24.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.563 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -157.72 123.95 4.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 0.4 OUTLIER 55.97 24.15 7.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.366 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.12 10.55 83.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -127.8 138.98 52.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.598 -0.943 . . . . 0.0 109.339 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.461 ' O ' ' N ' ' A' ' 1' ' ' SER . 83.5 m95 -67.67 151.6 47.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.504 ' NZ ' HH21 ' A' ' 152' ' ' ARG . 80.3 tttt -150.72 123.2 8.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -89.47 138.87 31.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.504 HH21 ' NZ ' ' A' ' 150' ' ' LYS . 86.0 mtt180 -143.67 107.35 4.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.26 154.68 39.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -139.8 -33.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.78 86.15 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -137.95 104.76 5.35 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.982 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 152.94 39.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -147.45 125.27 11.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -1.178 . . . . 0.0 109.33 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.36 11.7 25.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -65.75 2.23 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.37 126.99 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.8 pt? -46.77 -33.03 4.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 109.82 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.65 -26.03 26.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.335 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.9 t -74.37 -54.31 7.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.5 m -47.94 -20.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.9 m -71.44 -60.65 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.142 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -15.46 38.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.188 -0.945 . . . . 0.0 110.393 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.64 -44.23 87.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.941 -1.099 . . . . 0.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -71.49 -0.2 9.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.545 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.99 174.81 11.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -153.23 -34.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.437 HD21 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -145.94 143.49 29.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.093 -1.004 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -145.94 133.09 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.381 -0.824 . . . . 0.0 109.226 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.79 109.78 17.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.88 151.0 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.04 117.08 1.33 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -108.12 133.24 52.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.9 140.71 8.61 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -158.04 152.96 25.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -1.112 . . . . 0.0 109.984 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.72 130.55 39.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.0 109.597 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.314 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.14 151.17 19.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.325 -0.859 . . . . 0.0 109.282 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -141.02 99.77 3.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.285 -0.884 . . . . 0.0 109.676 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.28 142.64 30.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 108.625 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.52 112.71 25.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.376 -0.827 . . . . 0.0 109.563 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 130.12 44.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.1 m -149.58 163.06 38.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.089 -1.007 . . . . 0.0 109.937 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 146.08 36.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.5 m-85 -104.24 161.55 13.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.894 . . . . 0.0 109.415 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.06 139.16 52.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.661 -0.65 . . . . 0.0 109.478 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 133.46 22.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.05 176.41 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.21 -8.94 59.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.652 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.8 OUTLIER -83.27 1.6 40.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.157 -0.965 . . . . 0.0 109.736 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.17 58.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -98.29 144.57 27.56 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 38' ' ' GLY . 22.4 t -66.39 136.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.067 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.02 13.44 0.68 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -159.89 173.15 36.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -94.52 -1.74 52.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.052 -1.264 . . . . 0.0 110.289 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.08 -42.08 5.89 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.196 -0.94 . . . . 0.0 110.059 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 26.9 t0 61.47 -1.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 110.094 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.59 124.31 19.74 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.166 -0.959 . . . . 0.0 110.009 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 pt -102.58 139.57 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.62 ' CE1' ' CZ ' ' A' ' 42' ' ' PHE . 1.3 p90 -138.11 -161.67 1.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 22.8 p90 -44.23 -30.49 0.8 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.162 -0.961 . . . . 0.0 110.437 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 2.4 t30 -51.1 -16.95 0.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 109.081 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.5 t-20 -135.03 104.06 5.8 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.525 -0.735 . . . . 0.0 109.071 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.98 -24.69 1.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.6 pttt -167.45 155.07 8.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -77.23 122.46 25.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.521 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.06 62.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.962 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -112.91 -19.0 12.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.57 -13.55 75.62 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.5 p 62.85 10.27 4.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -1.118 . . . . 0.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -92.79 151.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 109.089 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -148.72 142.49 25.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.154 -0.966 . . . . 0.0 110.046 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -91.83 126.41 36.9 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 25.5 m -74.48 -29.54 61.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.38 110.82 0.25 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.86 110.98 18.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -81.67 -163.56 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -152.16 14.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 109.268 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.4 p -154.87 -37.73 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.99 101.97 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -1.155 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -55.25 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -89.27 167.5 13.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.346 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.418 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.5 p -160.48 132.86 6.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.18 128.29 56.44 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.504 -0.747 . . . . 0.0 109.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -96.36 110.51 22.83 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.93 146.88 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.596 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -136.49 94.42 3.01 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.52 -11.57 59.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.93 . . . . 0.0 109.616 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.41 4.7 23.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.35 10.73 7.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.449 -0.782 . . . . 0.0 109.322 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.4 t -81.3 125.77 78.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.022 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.14 -162.23 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.841 1.694 . . . . 0.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.38 -0.12 82.75 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.86 -60.69 2.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -1.172 . . . . 0.0 109.44 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.6 t -89.93 148.65 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 41.3 m-20 -139.35 1.96 2.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 109.659 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -150.92 131.48 13.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.186 -0.946 . . . . 0.0 109.006 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.99 154.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.503 -0.748 . . . . 0.0 109.31 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -139.86 173.93 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 17.1 m-85 -141.55 122.06 14.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.63 157.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.14 114.31 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -107.82 151.95 25.05 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.331 -0.855 . . . . 0.0 109.924 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.36 140.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 108.799 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -62.34 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.076 -1.015 . . . . 0.0 109.877 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -47.6 -20.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 109.569 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.6 -18.28 28.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 109.777 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -64.75 -60.79 2.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.687 -1.258 . . . . 0.0 109.255 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.44 11.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 111.024 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -86.16 -19.58 29.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.944 -1.097 . . . . 0.0 111.379 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 55.33 96.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.759 -1.213 . . . . 0.0 109.275 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -158.74 152.54 23.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.491 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 m -105.15 154.65 19.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.457 -0.777 . . . . 0.0 109.241 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.6 -29.89 0.81 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.429 -0.794 . . . . 0.0 109.727 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.67 -37.39 50.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -58.96 -14.18 8.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 109.345 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.9 t -80.32 165.81 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.131 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 t -68.15 -25.89 65.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.94 . . . . 0.0 109.691 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.12 79.89 0.03 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.45 26.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 13.5 p90 -152.69 142.92 22.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.07 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 48.0 mt -107.49 156.73 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -140.46 161.1 38.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.966 -1.083 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -157.35 117.52 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.055 -1.028 . . . . 0.0 109.756 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -129.54 143.98 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.366 -0.833 . . . . 0.0 109.522 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 117' ' ' ASP . 79.4 m-20 -74.78 101.69 4.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.93 -1.83 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.056 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' CB ' HD21 ' A' ' 4' ' ' ASN . 29.0 t0 -82.57 -52.74 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -122.52 -5.97 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.652 . . . . 0.0 109.851 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 65.81 65.77 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.5 p -123.81 -49.1 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.931 -0.481 . . . . 0.0 109.998 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 54.6 mm-40 -62.94 159.05 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.288 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 177.53 75.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.92 52.28 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.424 -0.798 . . . . 0.0 109.508 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 32.4 ptt180 -136.16 141.16 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.693 . . . . 0.0 109.226 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -92.1 143.61 26.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.0 109.163 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -87.64 103.64 15.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.5 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.6 mt -80.57 -38.31 29.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.4 m -48.25 -33.62 8.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.863 -1.148 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -95.21 -51.12 4.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.406 -0.809 . . . . 0.0 109.747 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.444 ' O ' ' OG1' ' A' ' 133' ' ' THR . 4.9 m-20 -72.55 -7.44 50.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.251 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -60.22 -49.99 75.45 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.009 -1.057 . . . . 0.0 109.825 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 p -55.88 0.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.78 . . . . 0.0 110.509 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 131' ' ' ALA . 38.0 p -87.42 -33.12 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.746 -1.221 . . . . 0.0 110.081 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -172.34 -145.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.785 -1.197 . . . . 0.0 109.712 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 21.1 m -126.61 -40.23 1.94 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.18 155.97 26.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 ttt -166.81 157.59 12.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.16 -0.963 . . . . 0.0 109.829 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.81 126.8 50.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.328 -0.857 . . . . 0.0 109.337 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -70.07 -37.13 75.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.932 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.1 -163.39 24.06 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.851 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -151.54 164.09 37.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -1.069 . . . . 0.0 109.519 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.72 140.04 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.244 -0.91 . . . . 0.0 108.571 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.447 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.8 p90 -150.61 166.31 30.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.913 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 17.4 ptm180 -85.34 152.7 23.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.514 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 2.1 t60 -153.9 119.9 5.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.267 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 29.0 m-20 52.46 29.39 6.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 109.501 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.52 81.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -127.87 134.91 49.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.48 -1.012 . . . . 0.0 109.396 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.43 149.34 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -148.86 125.98 11.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.208 -0.932 . . . . 0.0 109.538 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -93.37 140.99 28.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 109.971 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -144.06 107.54 4.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.422 -0.799 . . . . 0.0 109.09 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.13 154.65 41.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.098 -1.001 . . . . 0.0 109.72 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.24 -33.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.81 85.82 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.308 -1.113 . . . . 0.0 109.572 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.56 154.03 46.75 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 12.7 p90 -137.88 124.04 20.39 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.377 -1.072 . . . . 0.0 109.436 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.63 3.08 34.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.45 -75.09 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 156.39 136.59 2.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.7 pp -47.38 -36.97 10.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -1.172 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.86 -16.83 37.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.3 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 161' ' ' GLY . 34.5 m -78.82 -56.0 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 m -51.62 -19.94 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 109.11 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.594 ' SG ' ' CG ' ' A' ' 42' ' ' PHE . 70.8 m -73.67 -63.02 1.29 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.469 -0.769 . . . . 0.0 110.352 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.28 35.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.849 . . . . 0.0 110.583 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -61.37 -48.74 79.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.064 -1.022 . . . . 0.0 110.26 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -71.74 -20.33 61.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 109.464 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' TRP . 26.0 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.448 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 20.3 mmt -79.95 -176.29 5.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 82.7 mttt -151.73 -35.77 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 51.8 m-20 -145.09 143.77 30.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.81 158.14 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 tp -145.34 109.75 4.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.03 145.7 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.36 117.21 2.89 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.93 124.92 50.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.15 150.47 22.68 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.535 -1.317 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -157.04 153.98 28.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.412 -1.052 . . . . 0.0 109.804 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.69 130.05 34.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.762 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.288 0.566 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 60.9 m-85 -96.41 146.79 24.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 12.1 m-20 -141.03 99.62 3.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 8.7 mp -85.28 140.64 30.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 108.524 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -103.17 119.7 39.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.29 131.71 43.73 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.292 -0.88 . . . . 0.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 13.5 t -150.19 168.18 24.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.63 147.47 45.19 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -103.6 123.15 46.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.614 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.02 135.72 37.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 108.725 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.01 128.33 17.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.964 -1.085 . . . . 0.0 110.388 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 176.26 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.71 1.13 44.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -84.62 -7.44 59.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 -10.78 73.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -105.07 148.09 27.17 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 38' ' ' GLY . 44.3 t -66.39 137.25 25.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.91 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -70.79 7.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -154.04 172.66 32.7 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.94 -2.88 49.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.842 -1.387 . . . . 0.0 110.321 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.19 -40.85 6.27 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.09 -1.006 . . . . 0.0 110.982 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.44 10.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.74 -1.225 . . . . 0.0 109.329 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.8 t80 -138.12 100.22 4.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.0 109.533 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.8 pt -101.41 137.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.22 -0.925 . . . . 0.0 109.086 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.8 p90 -142.81 -162.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.3 p90 -45.23 -32.37 1.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -0.942 . . . . 0.0 110.512 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 17.9 t-20 -51.83 -11.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.886 -1.134 . . . . 0.0 109.036 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.0 t-20 -135.6 107.8 7.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.9 tp -47.52 -29.71 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 35.3 pttt -168.85 156.96 7.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -65.95 144.25 56.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.92 -46.98 32.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -116.07 -2.78 12.17 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -81.05 -15.68 76.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.8 p 62.46 9.41 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.426 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.07 149.82 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.154 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.51 137.75 25.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.164 -0.96 . . . . 0.0 109.869 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -89.42 135.25 33.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.773 . . . . 0.0 108.931 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -73.38 -44.44 58.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.09 110.11 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.59 110.89 12.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -1.142 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.96 -164.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -158.18 17.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -155.71 -40.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.332 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.81 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 42.8 p-10 -48.66 98.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -1.153 . . . . 0.0 109.564 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 68' ' ' GLY . 68.0 m-20 -74.8 -46.18 38.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.46 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' CG ' ' N ' ' A' ' 72' ' ' SER . 68.0 tt0 -115.82 162.7 16.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.685 . . . . 0.0 109.176 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 m -153.53 143.09 21.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.73 123.1 41.05 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.603 -0.685 . . . . 0.0 109.24 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -95.61 138.63 33.01 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.27 146.82 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.434 -0.791 . . . . 0.0 110.182 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -139.12 106.42 5.51 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 79' ' ' ALA . 9.0 mt -78.98 -42.52 26.49 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -52.55 -8.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.977 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.68 19.5 16.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.55 -0.719 . . . . 0.0 109.67 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 81' ' ' PRO . 47.2 t -104.63 105.17 49.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.319 -0.863 . . . . 0.0 109.246 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.2 Cg_exo -48.97 -173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.039 1.826 . . . . 0.0 112.355 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.25 0.33 87.22 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.77 -58.51 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -1.198 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.35 145.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -135.93 -5.74 2.15 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.082 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -142.46 130.67 22.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.997 -1.064 . . . . 0.0 109.214 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.1 mt -139.99 113.99 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.67 173.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.316 -0.865 . . . . 0.0 109.121 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.94 142.2 51.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.7 t -146.9 156.53 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.857 -1.152 . . . . 0.0 111.713 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.58 113.65 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -120.57 161.67 20.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.295 -0.878 . . . . 0.0 110.828 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -77.56 161.87 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.428 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.3 t60 -111.19 -76.05 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.344 -0.848 . . . . 0.0 109.934 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' GLN . 1.4 m-20 -47.82 -18.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.772 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -47.77 -19.07 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 49.7 tt0 -71.45 -62.22 1.49 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.95 -1.094 . . . . 0.0 109.319 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.52 -43.82 9.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.339 -0.85 . . . . 0.0 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HE ' ' CD ' ' A' ' 101' ' ' GLN . 40.9 ttt85 -79.23 -20.18 48.87 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 99' ' ' ARG . 59.5 ttt-85 54.59 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.745 -1.222 . . . . 0.0 109.474 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.449 ' CD ' ' HE ' ' A' ' 99' ' ' ARG . 18.8 mt-30 -157.8 141.47 15.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -102.2 163.89 11.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -46.73 -33.01 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.844 . . . . 0.0 109.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 106' ' ' VAL . . . -63.5 -42.28 98.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 66.1 mm-40 -51.21 -12.04 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.156 -1.202 . . . . 0.0 109.225 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 104' ' ' GLY . 21.4 t -82.74 165.29 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.852 . . . . 0.0 109.204 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.2 m -69.39 -18.51 63.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.195 -0.941 . . . . 0.0 109.657 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.76 79.46 0.03 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.19 157.51 22.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -1.18 . . . . 0.0 109.706 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 26.5 p90 -150.24 169.71 20.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 109.969 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -135.87 151.56 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -138.17 161.59 36.43 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.022 -1.049 . . . . 0.0 109.984 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.1 tt -154.14 116.32 4.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.177 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.69 144.94 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.317 -0.864 . . . . 0.0 109.957 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.448 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 57.8 t30 -76.13 102.03 5.58 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.91 -1.57 3.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.668 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 115' ' ' ASN . 17.5 t70 -82.64 -53.78 5.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.42 ' OD1' ' OG1' ' A' ' 120' ' ' THR . 13.7 p30 -123.82 6.81 8.73 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.737 -0.602 . . . . 0.0 109.638 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' ASN . 8.1 mt-30 59.55 60.52 2.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 118' ' ' ASN . 86.0 m -110.82 -70.41 0.81 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.896 -0.502 . . . . 0.0 110.342 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 22.9 mm-40 -45.3 157.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.18 156.01 48.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.168 -0.958 . . . . 0.0 109.923 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptp180 -142.49 143.31 32.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.545 -0.722 . . . . 0.0 109.243 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.429 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.4 t80 -91.22 142.04 28.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 108.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -85.26 102.86 13.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.065 -1.022 . . . . 0.0 109.432 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 54.1 mt -79.0 -39.21 34.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.166 -0.959 . . . . 0.0 109.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.2 t -47.79 -31.07 4.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.992 -1.067 . . . . 0.0 109.209 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.18 -54.6 3.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.773 . . . . 0.0 109.711 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.429 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 46.8 m-20 -73.23 -2.68 22.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.283 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -54.1 -47.15 72.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.087 -1.008 . . . . 0.0 109.238 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 t -68.1 3.12 1.73 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.549 -0.719 . . . . 0.0 109.819 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 131' ' ' ALA . 10.4 m -84.3 -34.93 23.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.985 . . . . 0.0 110.169 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -177.53 -166.31 0.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.931 -1.105 . . . . 0.0 109.66 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.69 -10.72 9.14 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.79 26.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.68 158.14 15.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.41 134.16 37.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.1 t80 -73.33 -45.44 55.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.892 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.74 -162.5 11.26 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 22.2 tt0 -151.97 164.29 37.47 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.106 -1.232 . . . . 0.0 109.839 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 13.3 tp -144.16 133.35 23.0 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -148.64 166.22 28.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.0 109.639 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 14.5 ptm180 -94.47 141.24 28.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.377 -0.827 . . . . 0.0 110.095 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 10.2 t-160 -100.03 -132.88 0.26 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.616 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.3 m120 -51.85 -51.45 56.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.887 -1.133 . . . . 0.0 108.322 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.48 16.93 0.14 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.83 159.51 36.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.5 m95 -77.73 151.81 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -148.21 124.99 11.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -89.69 147.65 23.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.377 -0.827 . . . . 0.0 109.391 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -153.9 109.35 3.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.69 154.68 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.526 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.58 -34.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.14 84.22 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.32 104.41 7.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.68 -0.894 . . . . 0.0 109.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 149.96 29.32 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.63 127.47 19.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.46 12.15 21.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.6 -67.18 1.76 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.77 126.89 1.13 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -44.68 -32.5 1.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.363 -1.08 . . . . 0.0 110.099 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.74 -27.19 25.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 161' ' ' GLY . 23.3 t -77.71 -50.51 12.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.426 -0.796 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -48.68 -20.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.483 ' SG ' ' CB ' ' A' ' 42' ' ' PHE . 56.7 m -72.35 -61.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.57 -15.36 37.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.165 -0.959 . . . . 0.0 110.537 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.88 -42.14 99.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.033 . . . . 0.0 110.476 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.62 -20.62 61.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.513 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.567 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.1 mpt? -73.06 171.46 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -153.98 -34.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.06 128.31 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.245 -0.91 . . . . 0.0 109.233 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.673 ' N ' HD21 ' A' ' 4' ' ' ASN . 5.2 t -127.69 156.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.613 -0.679 . . . . 0.0 109.178 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -142.4 107.18 4.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.067 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.78 150.6 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.83 116.94 1.32 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.71 135.18 45.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.9 135.46 5.9 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -157.04 153.2 27.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -1.103 . . . . 0.0 109.816 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.09 108.02 20.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.262 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.34 141.66 29.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.239 -0.913 . . . . 0.0 109.402 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.4 p30 -141.07 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.155 -0.966 . . . . 0.0 109.595 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.69 134.87 34.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 108.877 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -92.4 107.13 18.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.034 -1.042 . . . . 0.0 109.83 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.41 123.46 42.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.74 167.59 26.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.101 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.49 46.2 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.6 m-85 -104.37 128.37 52.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.338 -0.851 . . . . 0.0 108.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.623 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.76 155.62 17.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 110.088 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.53 137.28 25.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.349 -0.845 . . . . 0.0 109.362 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -80.16 176.67 9.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.16 -8.56 59.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.966 . . . . 0.0 109.805 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -85.67 2.91 43.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.139 -0.975 . . . . 0.0 109.808 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.03 -18.31 57.6 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 31' ' ' ALA . 84.6 mttt -106.61 173.23 6.41 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.584 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -101.3 142.18 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.405 -0.809 . . . . 0.0 109.675 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -60.11 -5.55 1.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -144.33 102.32 0.27 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 31.8 p-10 -45.28 -25.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -1.101 . . . . 0.0 110.356 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -58.76 -42.06 88.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.067 -1.02 . . . . 0.0 109.822 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 38.8 t0 46.27 15.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 81.5 t80 -137.35 99.58 4.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 109.419 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.0 pt -102.86 137.92 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.7 p90 -140.85 -160.78 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.18 -0.95 . . . . 0.0 109.344 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.4 p90 -44.68 -31.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 0.0 110.495 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.6 t-20 -51.05 -14.27 0.22 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.903 -1.123 . . . . 0.0 109.01 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.4 t-20 -135.77 107.38 6.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -47.78 -26.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.372 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 14.4 pttm -170.52 159.14 6.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.626 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t -73.22 129.99 39.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.388 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.24 -30.36 54.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.66 -15.97 11.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.626 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -84.46 -12.58 75.28 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 60.68 10.75 2.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.75 151.9 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 108.963 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -145.37 145.0 31.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -90.94 119.59 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 m -67.24 -46.98 72.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.27 117.61 0.77 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -78.46 158.9 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -1.178 . . . . 0.0 109.543 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -157.55 109.98 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.59 17.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.897 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -152.56 -35.05 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.255 -0.903 . . . . 0.0 109.372 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.16 99.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -1.135 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -69.11 -73.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -98.67 164.45 12.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 139.33 10.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.338 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.94 127.32 53.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.524 -0.735 . . . . 0.0 109.382 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 52.4 tttp -96.19 114.79 26.52 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.531 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 64.5 mt -104.18 147.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.388 -0.82 . . . . 0.0 110.571 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HZ1' ' CD ' ' A' ' 74' ' ' LYS . 64.4 mttp -138.71 105.65 5.42 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.27 -38.61 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.15 -22.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.71 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.06 -24.03 17.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.279 -0.888 . . . . 0.0 109.75 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.99 124.24 79.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 109.334 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.23 -160.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.939 1.759 . . . . 0.0 111.826 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.25 0.89 88.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -66.98 -56.37 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.15 148.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 11.7 t0 -125.53 -19.58 4.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.572 -0.705 . . . . 0.0 109.567 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -149.43 143.42 25.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.118 -0.989 . . . . 0.0 109.784 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 89.6 mt -135.21 154.35 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -145.21 172.77 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 2.9 m-85 -142.47 118.76 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.16 158.01 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.308 -0.87 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.41 113.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 p -110.44 156.29 21.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 0.0 110.347 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.16 144.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.405 ' C ' ' N ' ' A' ' 96' ' ' ALA . 74.6 t60 -99.46 -69.1 0.78 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' NE2' ' A' ' 101' ' ' GLN . 2.9 p30 -49.14 -18.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.849 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.48 -50.37 59.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.712 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 -30.25 41.38 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.799 -1.188 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.85 -53.71 4.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.066 -1.021 . . . . 0.0 111.471 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 100' ' ' ARG . 5.1 ptp180 -112.14 3.5 17.3 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.153 -0.967 . . . . 0.0 111.101 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 85.9 mtt-85 53.42 104.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OD1' ' A' ' 95' ' ' ASP . 25.3 mt-30 -147.93 137.85 22.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.4 p -94.71 160.54 14.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -46.66 -37.03 7.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -58.25 -37.73 87.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -47.7 -16.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -1.226 . . . . 0.0 109.322 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 104' ' ' GLY . 33.6 t -87.58 166.75 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 109.121 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 t -67.92 -21.68 65.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 109.707 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.96 79.4 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.03 162.17 25.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 109.75 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 17.8 p90 -155.8 161.44 40.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.8 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 49.7 mt -123.25 157.97 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -141.18 159.71 41.63 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.045 -1.034 . . . . 0.0 109.614 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.403 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.3 tt -154.67 117.42 4.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.953 -1.092 . . . . 0.0 109.499 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.5 144.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 119' ' ' GLN . 55.7 t30 -76.76 102.06 6.09 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 4' ' ' ASN . 23.0 t70 -67.2 -1.61 4.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.318 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -80.65 -53.35 6.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.223 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -123.33 3.97 9.13 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 115' ' ' ASN . 11.9 mt-30 59.75 61.18 2.0 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.8 m -113.54 -68.49 0.92 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.956 -0.465 . . . . 0.0 110.363 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 36.4 mm-40 -45.25 157.65 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.907 . . . . 0.0 109.907 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.83 73.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.84 150.3 52.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.044 -1.035 . . . . 0.0 110.084 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.3 ptm180 -140.28 142.66 35.7 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.27 146.39 23.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.062 -1.024 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.39 103.4 16.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 109.389 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.6 mt -79.55 -36.52 38.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m -48.08 -32.4 6.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.048 . . . . 0.0 109.213 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.23 -53.88 3.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.76 -4.15 32.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -51.96 -42.91 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.0 t -74.38 2.95 8.22 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.979 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -83.39 -34.2 25.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.167 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -176.43 -167.41 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.928 -1.107 . . . . 0.0 109.654 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.09 -15.75 8.68 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.22 140.48 41.73 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 45.7 ttp -165.8 158.0 14.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 109.749 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -99.91 135.71 40.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.388 -0.82 . . . . 0.0 109.152 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.99 -43.75 33.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 0.0 109.628 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.29 -172.48 31.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.56 166.65 29.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.238 . . . . 0.0 109.943 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.89 143.56 45.07 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -148.1 166.05 28.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.045 . . . . 0.0 109.667 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -95.02 146.05 24.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.682 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -122.49 -120.63 0.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.466 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.4 m-80 -73.61 52.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.24 9.61 86.38 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.82 138.22 52.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.526 -0.985 . . . . 0.0 109.387 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -67.42 151.67 47.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -149.78 128.61 12.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.456 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -89.8 151.01 22.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 109.779 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -156.12 107.19 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.68 39.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.686 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.33 -34.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.66 87.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -132.37 104.45 6.73 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.62 150.88 35.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -144.32 126.36 15.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -1.099 . . . . 0.0 109.268 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.5 11.91 20.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.25 -77.74 0.11 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 158.3 138.29 2.45 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.71 -34.94 20.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.187 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -81.64 -15.56 54.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.6 m -90.15 -53.99 4.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.8 m -54.5 -21.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 15.0 p -75.85 -51.96 11.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.041 -1.037 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.625 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.82 -25.39 23.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.905 -1.122 . . . . 0.0 110.492 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -57.59 -39.56 77.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.046 -1.034 . . . . 0.0 110.469 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -71.0 -19.53 62.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 149' ' ' TRP . 21.0 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.275 0.559 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 46.5 mtt -152.55 90.98 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.21 -21.97 49.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 6.7 m120 -146.36 139.58 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -145.67 129.62 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 109.196 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.9 113.71 25.9 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.11 150.68 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -134.7 116.85 1.66 Allowed Glycine 0 N--CA 1.499 2.851 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -115.57 126.22 53.95 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.52 151.99 24.18 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.563 -1.303 . . . . 0.0 109.964 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -161.58 152.45 18.06 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.369 -1.077 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.27 127.54 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 109.591 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.895 . . . . 0.0 109.382 179.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.298 0.571 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -96.28 143.45 27.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -141.09 100.33 3.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 109.863 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.09 138.55 33.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' CE2' ' A' ' 44' ' ' PHE . 58.7 t0 -98.81 119.78 38.14 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.161 -0.962 . . . . 0.0 110.383 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -100.53 133.79 44.45 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.2 t -150.0 167.7 25.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.051 -1.03 . . . . 0.0 109.801 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.77 148.82 39.41 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.19 162.11 13.24 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.17 148.91 43.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.87 . . . . 0.0 109.683 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.03 141.05 28.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.925 . . . . 0.0 109.076 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 176.33 7.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.6 -1.0 52.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.9 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.509 ' ND2' ' HZ3' ' A' ' 35' ' ' LYS . 18.7 t30 -95.95 4.17 52.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.181 -0.949 . . . . 0.0 109.959 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.02 -13.4 66.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HZ3' ' ND2' ' A' ' 33' ' ' ASN . 41.7 mttp -105.03 163.83 12.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.602 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.5 t -90.06 136.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.229 -0.92 . . . . 0.0 109.045 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -66.46 4.09 0.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.14 127.1 1.82 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.6 5.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -1.185 . . . . 0.0 110.523 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -92.14 -42.57 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.847 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 48.0 12.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.653 -1.28 . . . . 0.0 109.468 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ALA . 13.0 t80 -137.68 99.48 3.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.456 -0.778 . . . . 0.0 109.094 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 4.0 pt -97.08 120.96 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.269 -0.894 . . . . 0.0 109.367 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 25' ' ' ALA . 27.0 t80 -171.48 -166.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 67.9 m-85 54.2 -112.89 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.825 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.17 -21.53 65.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 24.0 t-20 -81.39 68.9 7.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -54.29 -19.61 5.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.152 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 14.8 pttm -163.37 156.65 19.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.474 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 69.5 m -74.54 148.11 41.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.87 -46.41 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.197 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -116.47 -0.4 12.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.725 -0.609 . . . . 0.0 109.647 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.02 -9.74 76.59 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 t 60.52 12.31 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -1.082 . . . . 0.0 109.633 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -93.01 147.97 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -149.2 137.61 20.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.047 -1.033 . . . . 0.0 109.887 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -91.7 132.11 36.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.375 -0.828 . . . . 0.0 108.906 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 72' ' ' SER . 24.4 m -68.54 -57.57 5.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.94 124.25 1.11 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.5 112.24 19.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.146 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.11 121.38 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -79.49 13.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.441 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -153.76 -35.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -49.8 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -1.21 . . . . 0.0 109.435 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' GLY . 28.5 m-20 -69.81 -67.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -93.09 102.8 15.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 58' ' ' THR . 55.1 m -91.88 133.4 35.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.17 126.52 55.3 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.49 140.16 30.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.269 -0.894 . . . . 0.0 109.33 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 54.3 mt -133.79 146.74 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -145.42 99.86 3.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 79' ' ' ALA . 6.4 mt -81.62 -25.23 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.97 . . . . 0.0 109.865 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.27 4.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.91 22.72 3.56 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 81' ' ' PRO . 55.3 t -104.01 105.7 49.78 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.261 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' VAL . 71.4 Cg_exo -48.39 -174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.02 1.813 . . . . 0.0 112.275 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 1.54 88.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -55.11 20.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -1.112 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.86 121.45 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.381 -0.824 . . . . 0.0 109.121 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.73 -1.6 32.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.325 -0.859 . . . . 0.0 110.289 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -158.17 144.64 17.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.123 . . . . 0.0 110.106 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mt -146.11 118.56 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 173.34 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 0.0 109.737 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 96.5 m-85 -140.3 118.13 11.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.11 158.01 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.471 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.42 117.56 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -112.69 149.91 32.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.15 149.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.755 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 96' ' ' ALA . 66.9 t60 -103.91 -68.85 0.82 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -46.9 -19.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 109.614 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 94' ' ' HIS . . . -57.91 -18.5 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.82 -60.6 2.89 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.716 -1.24 . . . . 0.0 109.315 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.53 -33.3 15.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 111.127 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt-85 -95.57 -18.88 20.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.895 -1.128 . . . . 0.0 111.503 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttt85 56.9 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.796 -1.19 . . . . 0.0 108.984 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -146.09 138.45 25.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.37 -0.831 . . . . 0.0 109.246 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.6 p -96.08 164.27 12.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 135' ' ' THR . 46.8 m-85 -48.17 -35.71 12.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -60.75 -37.84 94.24 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -47.27 -16.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -1.189 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 104' ' ' GLY . 21.6 t -86.74 168.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.044 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 m -68.19 -20.96 64.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.77 80.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.26 164.11 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.9 p90 -154.23 155.32 35.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 50.0 mt -120.08 153.66 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -140.18 159.57 41.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.966 -1.084 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 3.3 tt -153.57 116.34 4.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 109.467 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -129.38 143.12 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.467 -0.771 . . . . 0.0 109.749 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 119' ' ' GLN . 60.7 t-20 -78.24 101.88 7.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.48 -1.96 4.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 0.0 109.301 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 115' ' ' ASN . 21.1 t0 -77.56 -53.34 7.71 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.032 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.44 3.12 9.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 115' ' ' ASN . 24.6 mt-30 60.01 61.74 1.8 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.6 p -115.17 -67.93 0.96 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.903 -0.498 . . . . 0.0 110.379 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 47.9 mm-40 -45.37 157.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 109.973 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.98 73.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.54 152.55 51.54 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.123 -0.985 . . . . 0.0 109.841 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.5 ptt180 -140.16 145.82 37.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.552 -0.718 . . . . 0.0 109.377 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -91.32 147.82 22.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 108.975 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.73 101.94 14.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.243 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' ALA . 26.5 mt -81.43 -31.66 33.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.524 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.7 m -48.48 -36.82 15.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 108.82 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -95.4 -49.94 5.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.477 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.62 -11.63 58.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -51.35 -43.8 61.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 109.246 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.0 m -74.46 2.89 8.51 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.639 -0.663 . . . . 0.0 109.978 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -89.74 -33.94 16.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.056 . . . . 0.0 110.376 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -175.48 -176.48 0.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.772 -1.205 . . . . 0.0 109.844 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -112.84 -16.37 12.74 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.01 138.65 40.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.8 ttp -164.99 157.78 16.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 109.703 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.61 139.23 33.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.253 -0.904 . . . . 0.0 109.636 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.7 t80 -82.51 -44.07 16.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.082 -1.011 . . . . 0.0 109.605 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.31 -171.41 29.52 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -150.82 166.77 29.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.293 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mt -138.94 131.8 29.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.2 p90 -138.86 166.15 25.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.302 -0.873 . . . . 0.0 109.707 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.7 ptm180 -85.79 149.37 25.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.827 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.524 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 80.4 t60 -155.01 124.54 6.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 0.0 109.217 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.524 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 6.2 m120 54.11 26.04 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.55 11.62 82.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.88 140.4 52.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.508 -0.995 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' SER . 78.2 m95 -68.11 151.51 46.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.221 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -150.73 135.65 17.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 17.5 t80 -93.81 150.46 20.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.741 . . . . 0.0 109.701 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 15.2 tpt85 -156.16 107.1 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.099 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.19 154.6 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.704 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.28 -32.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.497 -0.752 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.79 83.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -139.18 104.28 4.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.981 . . . . 0.0 109.377 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.76 151.07 31.76 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -143.78 123.26 13.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.391 -1.064 . . . . 0.0 109.245 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.93 10.45 21.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 109.503 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -73.94 0.29 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.1 135.21 1.89 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -46.95 -24.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -1.177 . . . . 0.0 109.807 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.85 -33.86 21.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.9 t -75.19 -51.93 12.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.701 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 33.3 m -46.6 -19.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 85.0 m -73.32 -61.23 1.9 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.063 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.99 -15.39 38.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.244 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -59.38 -40.62 87.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.65 -15.83 62.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.21 -0.932 . . . . 0.0 109.398 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.86 173.39 12.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -153.41 -35.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 3.9 m120 -146.14 140.18 26.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.9 t -141.74 146.0 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.35 -0.844 . . . . 0.0 109.245 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 tp -130.7 109.39 10.59 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.63 147.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 108.514 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.89 116.8 1.38 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.48 136.64 41.94 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.49 137.35 6.74 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -157.37 152.52 25.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -1.137 . . . . 0.0 109.759 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.46 109.59 22.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.678 -0.639 . . . . 0.0 109.544 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.305 179.857 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.0 m-85 -96.26 145.29 25.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.416 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.92 140.74 34.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 mt -128.52 128.61 44.64 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -91.97 108.55 20.01 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.168 -0.957 . . . . 0.0 110.176 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 44' ' ' PHE . . . -100.6 125.97 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.284 -0.885 . . . . 0.0 108.936 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p -149.46 168.04 24.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 0.0 109.937 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.44 139.75 44.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.46 125.75 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.2 152.97 18.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.343 -0.848 . . . . 0.0 109.605 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.42 138.25 27.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.1 176.41 8.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.563 -0.711 . . . . 0.0 109.232 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.48 -8.41 58.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.784 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 3.51 39.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.927 . . . . 0.0 109.947 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.47 61.53 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -104.2 168.56 9.03 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.611 ' C ' ' H ' ' A' ' 38' ' ' GLY . 18.9 t -93.18 137.05 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.173 -0.955 . . . . 0.0 108.993 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 32.3 ttp180 -63.84 2.09 0.55 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.36 128.22 2.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -65.07 4.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -1.189 . . . . 0.0 110.234 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -94.35 -41.87 9.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.0 -1.062 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 t0 45.78 17.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.0 109.477 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 40' ' ' ALA . 31.8 t80 -136.97 106.59 6.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 109.627 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.64 139.69 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.581 -0.699 . . . . 0.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -161.01 -145.23 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 47' ' ' ASN . 46.8 p90 -43.76 -31.1 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 109.944 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.09 3.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.3 t-20 -158.65 116.28 2.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.154 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -50.66 -36.04 33.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttp -165.78 157.43 14.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 109.361 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.496 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 3.4 t -70.54 120.1 15.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.58 87.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.178 -0.951 . . . . 0.0 109.547 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 43.4 p-10 -103.27 -17.61 15.24 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.516 -0.74 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.496 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -84.36 -15.34 69.18 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.1 p 61.86 11.19 3.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -1.104 . . . . 0.0 109.491 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -93.02 151.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.311 -0.868 . . . . 0.0 109.175 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 m -148.05 136.26 21.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 0.0 110.078 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.41 129.75 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -68.59 -56.62 7.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 109.335 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.17 123.41 1.22 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -81.72 110.89 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -81.72 -169.63 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -150.82 12.28 0.68 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.8 p -156.64 -35.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -50.04 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.174 . . . . 0.0 109.456 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -70.8 -68.93 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -86.9 175.64 8.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 109.533 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -159.25 132.43 7.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.314 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.41 123.43 44.09 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.704 ' HZ3' ' HZ2' ' A' ' 76' ' ' LYS . 33.0 tttm -95.18 137.61 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 52.1 mt -128.75 147.07 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.547 -0.721 . . . . 0.0 110.348 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HZ2' ' HZ3' ' A' ' 74' ' ' LYS . 65.8 mttm -140.51 97.16 3.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.54 -5.31 49.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.99 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.98 -22.97 31.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.095 -1.003 . . . . 0.0 109.777 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.34 -11.61 27.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.183 -0.948 . . . . 0.0 109.891 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.98 123.99 77.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.22 -161.33 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.795 1.663 . . . . 0.0 112.098 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.05 -0.17 83.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.2 m-20 -70.06 -60.35 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.11 144.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.66 10.95 5.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.393 -0.817 . . . . 0.0 109.532 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 141' ' ' GLU . 81.7 tttt -158.48 144.13 16.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.225 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.39 115.75 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.081 -1.012 . . . . 0.0 109.369 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.1 173.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 95.0 m-85 -142.29 129.55 21.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.55 157.76 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 0.0 110.649 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.42 113.62 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.401 ' HG1' ' CB ' ' A' ' 162' ' ' LEU . 4.3 p -110.22 154.64 23.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.393 -0.817 . . . . 0.0 110.778 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.22 151.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 96' ' ' ALA . 9.3 t60 -101.93 -74.23 0.63 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.372 -0.83 . . . . 0.0 110.271 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.09 -17.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 109.798 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -49.98 -19.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.448 -0.782 . . . . 0.0 109.504 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -71.61 -62.58 1.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.971 -1.08 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -39.27 12.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.33 -0.856 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.613 ' NE ' ' NE2' ' A' ' 101' ' ' GLN . 49.4 ttt180 -83.89 -20.2 33.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.934 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 ttp85 53.33 96.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.766 -1.209 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.613 ' NE2' ' NE ' ' A' ' 99' ' ' ARG . 60.7 mt-30 -155.85 143.5 19.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.453 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -100.7 166.27 10.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.468 -0.77 . . . . 0.0 109.627 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -49.12 -29.7 5.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 106' ' ' VAL . . . -65.03 -40.34 97.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 29.5 mm-40 -51.03 -11.7 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.315 . . . . 0.0 109.326 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 104' ' ' GLY . 11.3 t -86.7 162.63 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.845 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 t -64.29 -23.35 67.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.83 79.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.37 162.28 25.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 109.686 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 20.5 p90 -156.21 158.39 37.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 110.004 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 32.0 mt -120.55 156.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -143.42 159.09 43.02 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.926 -1.109 . . . . 0.0 109.912 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 tt -152.43 124.39 8.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.209 -0.932 . . . . 0.0 109.185 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.07 144.87 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.429 -0.795 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -74.45 101.83 4.26 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.84 -1.84 2.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.677 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.6 t0 -84.37 -53.85 5.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.912 . . . . 0.0 109.919 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -123.75 7.6 8.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.628 -0.67 . . . . 0.0 109.996 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 59.66 60.2 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 m -109.98 -70.52 0.81 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.825 -0.547 . . . . 0.0 110.3 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -45.27 157.43 0.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.49 72.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.05 150.54 52.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.088 -1.007 . . . . 0.0 110.13 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.2 ptt180 -143.27 140.21 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.707 . . . . 0.0 109.136 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -91.26 147.86 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 109.016 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.56 102.04 14.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.075 -1.016 . . . . 0.0 108.942 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 131' ' ' ALA . 21.5 mt -76.37 -26.57 55.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.6 m -49.57 -33.61 15.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.969 -1.082 . . . . 0.0 108.385 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.44 -52.05 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 109.286 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.458 ' OD2' ' SD ' ' A' ' 137' ' ' MET . 15.7 t70 -67.1 -10.71 52.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.199 -0.938 . . . . 0.0 109.987 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -51.41 -46.33 62.88 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.8 t -71.46 3.47 3.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.761 -0.587 . . . . 0.0 110.022 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.2 m -92.12 -34.23 14.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.949 -1.094 . . . . 0.0 110.49 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -175.51 -174.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.676 -1.265 . . . . 0.0 110.011 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.29 -8.94 12.27 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.81 137.2 26.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.458 ' SD ' ' OD2' ' A' ' 130' ' ' ASP . 12.4 ptp -165.41 158.21 15.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.86 141.92 27.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.196 -0.94 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -85.5 -44.61 12.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.99 -176.02 24.27 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 86' ' ' LYS . 29.4 tt0 -151.22 122.2 7.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 9.7 mp -99.34 142.74 30.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 109.001 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.48 166.23 31.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.017 -1.052 . . . . 0.0 109.695 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.54 142.83 26.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.256 -0.902 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.647 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 17.6 t-160 -115.63 -120.16 0.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.647 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.1 m120 -73.56 52.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.84 9.39 85.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.79 142.89 51.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.593 -0.946 . . . . 0.0 109.365 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -67.86 151.66 46.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -153.66 133.12 12.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.978 . . . . 0.0 109.434 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 21.8 t80 -89.58 153.7 20.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 109.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.534 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 17.5 tpt180 -160.42 107.26 1.55 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.126 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.08 149.11 50.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.56 -30.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.553 -0.717 . . . . 0.0 109.068 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.2 83.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -139.37 104.44 4.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.959 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.07 152.84 35.19 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.37 127.67 14.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.27 -1.136 . . . . 0.0 109.244 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.3 9.05 33.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.41 -69.0 0.99 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 154.45 129.29 1.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.48 -28.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 109.8 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.69 -26.41 25.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' GLY . 43.9 t -78.06 -54.65 6.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.1 m -46.98 -20.49 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 73.2 m -70.53 -60.72 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.393 -0.817 . . . . 0.0 110.103 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -17.34 33.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.38 -45.51 91.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.959 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -71.85 -19.93 61.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.638 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 149' ' ' TRP . 7.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.48 ' SD ' ' OD1' ' A' ' 115' ' ' ASN . 62.7 mtm -147.55 -170.89 3.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.934 . . . . 0.0 109.332 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -152.46 -33.52 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.278 -0.889 . . . . 0.0 109.7 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -142.66 128.3 19.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -130.82 150.88 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.69 115.34 9.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -86.22 151.03 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.14 117.29 1.51 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.02 133.98 49.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -150.33 145.22 13.02 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.054 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -158.13 151.55 23.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.493 -1.004 . . . . 0.0 109.674 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -80.24 121.73 25.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.388 179.773 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.34 0.59 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -96.21 150.6 20.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 109.3 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -140.95 99.93 3.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.0 109.726 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.39 138.55 33.46 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' ' CE2' ' A' ' 44' ' ' PHE . 8.2 t70 -92.17 117.24 29.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 109.829 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.63 48.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.421 -0.8 . . . . 0.0 109.016 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.34 167.66 25.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.092 -1.005 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.93 137.04 52.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -104.22 159.46 15.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.399 -0.813 . . . . 0.0 109.282 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -127.54 144.93 51.01 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.546 -0.721 . . . . 0.0 109.765 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.47 134.84 24.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.082 -1.011 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.96 176.59 3.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.5 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.89 -8.24 59.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -83.28 1.31 41.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.05 -13.42 59.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -101.03 153.4 19.58 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 38' ' ' GLY . 35.6 t -73.7 137.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.893 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.83 7.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -156.95 172.83 34.57 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.39 2.69 55.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.287 . . . . 0.0 109.969 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.04 -41.84 5.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.269 -0.895 . . . . 0.0 109.834 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.0 t0 53.25 6.46 0.07 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.945 -1.097 . . . . 0.0 109.71 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 40' ' ' ALA . 1.5 p90 -138.45 123.49 19.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.289 -0.882 . . . . 0.0 110.264 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 pt -110.17 122.68 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 33.3 t80 -170.56 -170.95 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.933 -1.104 . . . . 0.0 109.722 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 53.4 m-85 51.03 -112.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.949 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -55.42 -16.78 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.562 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -95.14 82.37 3.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.561 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.83 -22.1 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -166.54 156.97 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' SER . 4.5 p -84.93 113.49 21.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.48 69.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.268 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -104.64 -19.2 14.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.556 -0.715 . . . . 0.0 109.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.28 -13.98 75.36 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 1.8 p 70.16 2.05 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.92 146.85 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 p -147.0 152.59 38.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.077 -1.014 . . . . 0.0 110.567 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -92.03 130.23 37.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -78.33 -38.91 41.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.15 100.94 0.15 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.07 110.89 14.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.462 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.95 -164.37 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -156.02 16.12 0.35 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.4 p -154.71 -35.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.873 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -48.41 111.32 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -1.146 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -80.85 -67.18 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -105.22 162.92 12.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.815 . . . . 0.0 109.394 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.4 p -162.31 138.52 7.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.2 131.41 55.49 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.15 120.67 36.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 46.7 mt -108.36 146.57 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 110.58 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HZ1' ' CB ' ' A' ' 76' ' ' LYS . 10.0 mtpm? -143.77 97.65 3.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.4 mt -82.32 -15.98 50.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.982 -1.074 . . . . 0.0 109.48 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.81 -0.87 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -131.82 15.99 4.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.55 -0.718 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.34 134.75 91.13 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.855 . . . . 0.0 109.193 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.26 -161.78 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.902 1.734 . . . . 0.0 111.736 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.95 5.06 53.09 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -90.57 -72.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.163 -1.198 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.3 p -70.14 149.06 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.55 -30.02 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 109.451 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -114.88 157.54 23.18 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.7 mt -142.38 150.37 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -141.34 162.03 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.369 -0.832 . . . . 0.0 108.882 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 88' ' ' ILE . 57.4 m-85 -141.69 125.31 16.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.22 157.92 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.386 -0.822 . . . . 0.0 110.191 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.0 121.6 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 p -117.44 153.47 33.04 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.45 -0.782 . . . . 0.0 110.438 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.2 145.0 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.416 ' C ' ' N ' ' A' ' 96' ' ' ALA . 24.5 t60 -100.64 -69.67 0.76 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLN . 5.4 m-20 -48.25 -18.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.416 ' N ' ' C ' ' A' ' 94' ' ' HIS . . . -45.9 -18.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' ASP . 65.2 mt-30 -69.58 -58.24 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.917 -1.114 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.66 -52.68 4.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.169 -0.957 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -75.43 -20.74 58.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.967 -1.083 . . . . 0.0 110.917 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 53.94 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.01 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -150.69 149.85 30.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 m -104.42 167.28 9.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' ' CE ' ' A' ' 137' ' ' MET . 57.9 m-85 -46.12 -38.19 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.441 -0.787 . . . . 0.0 109.881 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -58.1 -38.02 88.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -47.14 -18.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.237 . . . . 0.0 109.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.3 t -84.35 168.63 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.079 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 t -71.46 -19.56 62.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.77 79.52 0.03 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.6 164.59 22.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.127 . . . . 0.0 109.735 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.8 p90 -156.74 161.15 39.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.054 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 59.1 mt -120.95 156.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -140.94 160.42 40.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.998 -1.064 . . . . 0.0 109.915 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 tt -154.37 117.62 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.122 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.2 142.97 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.305 -0.872 . . . . 0.0 110.322 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' OD1' ' SD ' ' A' ' 2' ' ' MET . 76.8 m-20 -74.97 102.13 4.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.21 -1.53 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.474 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 115' ' ' ASN . 16.7 t70 -81.58 -53.47 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -123.49 7.0 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.783 -0.573 . . . . 0.0 109.676 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 115' ' ' ASN . 22.0 mt-30 58.61 59.69 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.8 m -109.74 -71.02 0.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.927 -0.483 . . . . 0.0 110.386 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 32.3 mt-10 -45.38 157.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.0 109.803 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.18 73.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.67 155.02 49.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.196 -0.94 . . . . 0.0 109.836 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.8 ptm180 -142.59 147.34 35.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 109.18 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -91.32 146.95 23.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -87.97 103.18 15.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.14 -0.975 . . . . 0.0 109.421 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 57.6 mt -81.03 -42.11 21.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.429 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.8 p -47.56 -30.18 3.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 109.245 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -95.31 -54.6 3.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.341 -0.849 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -74.87 -3.44 31.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.965 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.87 -45.85 71.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 109.26 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.2 p -70.83 3.17 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.541 -0.725 . . . . 0.0 109.976 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -82.77 -35.1 26.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.979 -1.075 . . . . 0.0 110.353 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -177.29 -161.94 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.661 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.56 -1.71 8.5 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.61 137.63 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.42 ' CE ' ' CE1' ' A' ' 103' ' ' PHE . 10.6 ptp -165.04 157.56 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.342 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -97.87 128.9 44.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.219 -0.925 . . . . 0.0 109.737 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 24.6 t80 -65.57 -43.82 88.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.153 -0.967 . . . . 0.0 109.342 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.57 31.22 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.213 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 167.01 29.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.264 -1.139 . . . . 0.0 110.667 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.9 mt -132.31 136.95 47.25 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 6.4 p90 -140.36 160.91 38.95 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.003 -1.061 . . . . 0.0 109.733 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 9.0 ptm180 -84.96 148.66 26.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.042 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.523 ' NE2' ' OD1' ' A' ' 146' ' ' ASN . 29.8 t-80 -148.92 121.58 8.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.062 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.523 ' OD1' ' NE2' ' A' ' 145' ' ' HIS . 3.6 m120 52.32 27.18 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.26 75.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.9 136.22 51.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.981 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.513 ' O ' ' N ' ' A' ' 1' ' ' SER . 70.4 m95 -67.31 151.47 47.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.549 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -150.9 143.89 24.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -99.58 142.08 31.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.363 -0.835 . . . . 0.0 110.154 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -134.47 114.82 13.26 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.6 150.03 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 109.639 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.0 t -147.41 -36.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 109.084 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.75 79.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -122.45 106.03 10.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.782 -0.834 . . . . 0.0 109.537 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.01 149.08 32.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -149.99 139.85 21.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -1.173 . . . . 0.0 109.465 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.18 6.87 47.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.35 -37.45 25.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 82.88 150.59 9.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.07 -13.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.51 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -72.55 -56.89 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.086 -1.009 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.0 t -90.57 -37.87 13.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.16 -0.963 . . . . 0.0 109.73 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.39 -20.68 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.522 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.698 ' HG ' ' H ' ' A' ' 167' ' ' ALA . 29.9 p -83.41 -55.77 4.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.111 -0.993 . . . . 0.0 110.823 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.698 ' H ' ' HG ' ' A' ' 166' ' ' CYS . . . -87.91 -24.63 23.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 110.531 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' SER . 51.4 tt0 -51.68 -37.59 51.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.974 . . . . 0.0 109.74 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.66 -20.35 58.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.661 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.7 mmt -78.77 178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -154.39 -35.32 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.665 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.25 128.14 15.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 109.135 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.665 ' N ' HD21 ' A' ' 4' ' ' ASN . 6.2 t -127.78 158.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 tp -144.46 106.7 4.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.958 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.425 ' O ' ' OG ' ' A' ' 72' ' ' SER . 14.7 t -85.29 150.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.11 116.98 1.24 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.85 129.53 54.68 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.95 142.78 11.16 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.45 ' CE2' ' CA ' ' A' ' 64' ' ' GLY . 25.1 p90 -157.22 153.43 27.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.405 -1.056 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -77.51 128.81 34.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.505 -0.747 . . . . 0.0 109.809 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.27 179.78 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.363 0.601 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.32 150.43 20.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 15.3 p-10 -141.04 99.74 3.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.258 -0.901 . . . . 0.0 109.712 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.62 130.91 34.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 108.631 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -87.24 111.44 21.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.966 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.32 125.86 46.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 108.803 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 m -149.76 168.06 24.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 109.769 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 136.09 49.48 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -103.79 119.59 39.23 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.19 152.63 21.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.525 -0.735 . . . . 0.0 109.906 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 134.94 22.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -75.67 176.32 7.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 108.979 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.69 -10.85 59.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.681 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 33' ' ' ASN . 3.0 m120 -84.32 4.55 30.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.29 56.75 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 31' ' ' ALA . 48.9 mtpt -104.45 171.95 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.8 t -103.45 143.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -61.83 -4.09 1.39 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.75 101.22 0.23 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -45.12 -20.97 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.401 -1.058 . . . . 0.0 110.601 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.26 -41.81 80.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.597 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 0.6 OUTLIER 48.12 12.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.978 -1.076 . . . . 0.0 109.517 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 23.8 t80 -137.46 105.8 5.77 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.842 . . . . 0.0 110.214 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 pt -110.52 134.92 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.3 p90 -151.99 -152.89 0.45 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.04 . . . . 0.0 109.766 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.56 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.7 m-85 -43.81 -36.0 2.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.576 -0.703 . . . . 0.0 110.028 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -58.65 -1.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 108.73 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 45' ' ' TYR . 51.1 t-20 -148.11 108.71 4.16 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.23 -27.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 109.407 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.5 pttt -172.8 160.55 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.287 -0.883 . . . . 0.0 109.322 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 54' ' ' SER . 10.2 p -65.12 135.24 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.286 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.39 -45.35 55.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.1 1.49 13.23 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.657 -0.652 . . . . 0.0 109.604 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -88.78 -14.33 61.3 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.4 m 64.13 4.17 1.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -1.054 . . . . 0.0 109.314 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' GLY . 72.7 t -93.14 146.75 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.919 . . . . 0.0 109.105 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -149.21 152.11 35.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -91.75 132.58 36.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 109.392 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 m -82.94 -38.85 22.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.55 107.55 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 33.2 p-10 -80.58 159.15 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.49 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -155.29 -173.01 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 109.418 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -161.82 30.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -151.81 -34.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.497 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' CA ' ' CE2' ' A' ' 11' ' ' TRP . . . . . . . . 0 N--CA 1.497 2.761 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.6 p-10 -48.68 111.14 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.599 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.12 -67.45 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.405 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -98.4 158.27 15.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.266 -0.896 . . . . 0.0 109.134 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -159.69 138.89 11.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mp -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.518 -0.739 . . . . 0.0 109.548 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -96.39 112.68 24.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.1 mp -100.66 146.87 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 110.898 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -135.54 88.92 2.45 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.38 -13.54 61.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.306 -0.871 . . . . 0.0 109.794 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -78.29 4.82 11.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.66 10.99 6.15 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.435 -0.791 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -82.01 125.86 76.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.947 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.52 -161.76 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.74 -0.17 84.1 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -69.44 -59.73 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -1.178 . . . . 0.0 109.321 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.89 148.78 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.89 . . . . 0.0 109.252 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -135.98 0.82 2.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 141' ' ' GLU . 43.3 tttp -150.09 131.5 14.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.877 . . . . 0.0 109.055 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 90.4 mt -136.35 132.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 0.0 109.003 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.95 154.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.814 . . . . 0.0 109.671 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -107.1 137.95 44.2 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 2.7 p -146.73 158.16 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.115 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.407 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 7.5 p -132.36 147.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -143.09 145.26 32.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.125 -0.985 . . . . 0.0 109.727 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.35 137.5 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 50.9 t-80 -95.49 -63.44 1.16 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.161 -0.962 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 12.0 m-20 -47.4 -18.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 0.0 109.578 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.24 -18.18 34.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.835 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -65.94 -60.82 2.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.85 -1.156 . . . . 0.0 109.437 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.14 -41.22 11.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.082 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' NH1' ' OD2' ' A' ' 95' ' ' ASP . 54.5 mtt180 -85.66 -19.58 30.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.973 -1.079 . . . . 0.0 111.352 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 55.19 92.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.687 -1.258 . . . . 0.0 109.035 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -148.46 142.54 25.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 109.256 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -98.75 165.15 11.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -47.37 -35.48 8.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 109.624 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -55.89 -38.38 74.09 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -47.42 -19.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.361 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.3 t -83.97 167.03 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.005 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.1 t -72.61 -24.51 61.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.38 78.1 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.13 164.8 24.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.36 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.4 p90 -154.0 143.7 21.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.0 110.573 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.6 mt -106.94 153.86 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.38 160.21 40.36 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.987 -1.07 . . . . 0.0 109.84 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 3.1 tt -154.31 116.07 4.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 0.0 109.386 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -129.3 143.75 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.298 -0.876 . . . . 0.0 109.95 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.54 102.04 5.9 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -67.26 -1.36 4.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.539 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 115' ' ' ASN . 27.8 t70 -81.04 -52.97 6.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -123.1 3.59 9.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.721 -0.612 . . . . 0.0 109.479 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ASN . 21.0 tp60 60.41 61.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.9 m -113.27 -69.15 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.883 -0.51 . . . . 0.0 110.256 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 33.1 mm-40 -45.24 157.55 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.344 -0.848 . . . . 0.0 109.984 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.73 72.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.53 52.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 110.038 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.4 ptm180 -138.5 145.65 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -91.33 145.16 24.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.994 . . . . 0.0 109.082 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.28 103.16 15.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.023 . . . . 0.0 109.51 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 131' ' ' ALA . 92.1 mt -82.11 -37.84 25.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.3 p -48.35 -35.06 11.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.906 -1.121 . . . . 0.0 109.091 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -95.39 -49.24 5.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' OG1' ' A' ' 133' ' ' THR . 72.9 m-20 -76.45 -4.16 41.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.33 -43.71 67.87 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.954 -1.091 . . . . 0.0 109.695 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.3 p -68.97 3.17 2.15 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 110.978 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 130' ' ' ASP . 66.0 p -86.15 -34.51 20.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.544 -1.348 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.2 -161.44 0.08 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.766 -1.209 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.91 -12.98 7.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.48 133.78 24.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.8 ptp -165.41 141.44 5.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.47 141.11 41.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -0.952 . . . . 0.0 109.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.5 t80 -79.41 -46.2 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.411 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.88 -163.52 11.37 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.466 ' CD ' ' NZ ' ' A' ' 86' ' ' LYS . 11.5 tt0 -150.7 158.29 43.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.382 -1.069 . . . . 0.0 109.061 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 136.19 25.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -150.73 166.51 30.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.882 -1.136 . . . . 0.0 110.122 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -90.59 143.43 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -117.95 -120.12 0.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.613 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 34.9 m120 -73.56 51.25 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.05 -1.031 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 9.1 85.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.77 142.13 51.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.997 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -68.53 151.48 46.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -148.91 131.8 16.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.112 -0.993 . . . . 0.0 109.69 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -89.76 150.61 22.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -149.75 124.19 9.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 0.0 109.065 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.75 147.91 27.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.1 t -150.15 -36.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 109.09 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.26 76.54 0.15 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -108.6 104.38 13.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.754 -0.85 . . . . 0.0 109.125 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.03 143.35 20.39 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.15 141.7 32.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.299 -1.118 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.14 9.55 43.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.32 -0.863 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -68.01 1.33 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.51 132.5 1.51 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.9 -30.55 2.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -1.123 . . . . 0.0 109.607 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.74 24.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 69.2 m -73.4 -53.28 11.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.74 -20.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 57.7 m -71.55 -60.84 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 110.163 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.4 38.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 110.402 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -65.78 -43.79 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.95 -1.094 . . . . 0.0 110.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -71.34 -19.62 62.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.5 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.5 mtt -86.8 147.43 25.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 94.0 mttt -116.9 -21.8 8.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.565 -0.709 . . . . 0.0 109.274 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 51.3 m-20 -146.23 142.34 28.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.8 158.52 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -0.77 . . . . 0.0 109.211 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -146.29 107.32 4.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.937 . . . . 0.0 109.09 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.78 150.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.25 116.84 1.15 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.0 137.05 42.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.82 139.19 7.81 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -156.49 152.35 27.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.201 -1.176 . . . . 0.0 109.971 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -90.74 126.99 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.608 -0.682 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.356 179.865 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.251 0.548 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.8 m-85 -96.25 142.8 27.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 14.6 m-20 -141.03 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.26 -0.9 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.77 149.69 25.1 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -108.11 118.17 36.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.322 -0.861 . . . . 0.0 109.633 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.91 133.11 42.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.388 -0.82 . . . . 0.0 108.993 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -149.95 167.85 25.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 110.201 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.3 137.65 54.6 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 9.0 m-85 -104.15 126.66 51.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.628 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.96 153.69 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.345 -0.847 . . . . 0.0 109.918 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.3 135.74 24.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 109.111 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.67 176.54 8.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.094 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.59 -7.51 59.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -85.24 1.82 46.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 109.906 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.66 -17.99 58.25 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -107.48 171.02 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 38' ' ' GLY . 5.7 t -99.64 137.36 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -62.31 -0.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -136.61 114.42 1.15 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.52 3.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -1.177 . . . . 0.0 110.6 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -99.34 -42.07 7.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.917 -1.114 . . . . 0.0 109.82 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 46.5 t0 46.81 14.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.994 -1.066 . . . . 0.0 109.594 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 36.2 t80 -137.3 99.44 3.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.815 . . . . 0.0 109.724 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.0 pt -105.2 135.13 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.1 p90 -139.3 -163.05 1.41 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.0 109.368 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 26.6 p90 -43.79 -36.92 2.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 110.551 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.586 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.8 t-20 -50.5 -11.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 109.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.1 t30 -135.29 104.7 5.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.468 -0.77 . . . . 0.0 109.067 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 mt -49.13 -28.92 4.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.473 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.1 pttp -164.85 157.67 16.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.331 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.479 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 3.6 m -68.7 143.5 54.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.458 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 -48.16 36.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.165 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.29 1.73 13.13 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.747 -0.596 . . . . 0.0 109.548 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.42 -14.15 74.57 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t 62.42 6.29 1.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -1.107 . . . . 0.0 109.799 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.15 151.62 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.115 -0.99 . . . . 0.0 108.986 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 p -145.21 139.74 27.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.075 -1.016 . . . . 0.0 110.251 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -90.27 132.87 35.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -72.25 -40.4 67.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.348 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.93 111.44 0.33 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.27 110.95 13.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.87 -164.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 12.7 ptt-85 -156.23 16.34 0.34 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -155.84 -36.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.278 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.92 108.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -1.153 . . . . 0.0 109.433 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -61.37 -69.62 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.41 173.11 10.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -159.51 132.6 6.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.258 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.21 122.14 42.24 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -96.01 137.3 35.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 0.0 109.067 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.7 mt -129.33 143.35 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.634 -0.666 . . . . 0.0 110.018 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -141.22 98.84 3.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -80.79 -17.78 49.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -51.04 -36.73 41.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.27 27.28 7.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 81' ' ' PRO . 6.2 p -60.56 115.34 13.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 81.4 Cg_exo -46.55 -178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.812 1.674 . . . . 0.0 112.264 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.18 59.71 0.63 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -154.71 -54.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -1.177 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.45 148.53 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 1.0 OUTLIER -143.43 11.95 1.72 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.179 -0.951 . . . . 0.0 109.858 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -157.02 133.52 9.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 87.9 mt -129.39 154.24 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.548 -0.72 . . . . 0.0 109.447 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.413 HG21 ' H ' ' A' ' 89' ' ' PHE . 1.2 mt -144.68 173.44 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 108.904 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' H ' HG21 ' A' ' 88' ' ' ILE . 6.3 m-85 -131.62 141.95 49.76 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.1 t -147.23 151.94 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.942 -1.099 . . . . 0.0 110.953 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -147.53 113.92 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -122.28 174.6 6.89 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.741 0.781 . . . . 0.0 110.222 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -83.86 166.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.432 ' C ' ' N ' ' A' ' 96' ' ' ALA . 53.6 t60 -133.26 -66.58 0.65 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -48.12 -18.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.25 -38.42 52.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -54.53 -31.95 57.25 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 109.214 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -52.83 4.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -0.83 . . . . 0.0 111.008 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 10.9 ptp180 -110.51 -4.71 15.37 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.282 -0.886 . . . . 0.0 111.166 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.1 ttm180 57.07 102.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.858 -1.151 . . . . 0.0 109.205 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -147.69 148.97 31.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 m -104.2 161.93 13.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.43 -0.794 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -47.15 -35.31 7.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -61.61 -42.38 99.75 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 23.4 mm100 -48.5 -14.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 109.403 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.4 t -83.76 164.59 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t -64.87 -23.73 67.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.06 -1.025 . . . . 0.0 109.552 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.89 79.94 0.03 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.7 164.54 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 109.958 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.4 p90 -154.81 152.35 29.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.889 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -115.53 157.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.27 160.73 39.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.897 -1.127 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.03 144.25 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 4.2 t-20 -76.07 102.14 5.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -65.79 -1.69 3.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 115' ' ' ASN . 23.5 t0 -82.29 -53.72 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.58 6.33 8.89 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' ASN . 19.5 tt0 59.61 60.52 2.22 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.2 p -111.07 -69.8 0.85 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.879 -0.513 . . . . 0.0 110.334 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 45.1 mt-10 -45.26 157.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.77 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.52 52.15 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.134 -0.979 . . . . 0.0 110.218 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.5 ptt180 -140.18 142.4 35.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -91.34 147.65 22.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.089 -1.007 . . . . 0.0 109.12 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 18.5 p-10 -91.54 103.29 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.145 -0.972 . . . . 0.0 109.358 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -80.89 -32.75 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.295 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 m -48.98 -37.52 20.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.909 -1.119 . . . . 0.0 108.963 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.37 -45.78 6.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.695 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 133' ' ' THR . 3.0 m-20 -76.32 -4.54 42.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 110.535 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -55.4 -46.12 76.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.798 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -65.33 3.29 0.68 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 111.013 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 130' ' ' ASP . 71.7 p -86.14 -34.93 20.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.596 -1.315 . . . . 0.0 110.458 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.9 -161.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.907 -1.12 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.05 -3.83 6.94 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -146.79 135.4 22.07 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.4 ttp -165.83 158.08 14.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.941 -1.1 . . . . 0.0 110.335 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.69 139.41 31.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.341 -0.849 . . . . 0.0 109.471 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -78.62 -47.62 16.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 109.782 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.72 -164.29 14.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -151.45 163.19 39.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.168 -1.195 . . . . 0.0 109.739 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.65 134.75 24.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -146.05 165.84 27.86 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 109.781 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.507 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.1 ptm180 -90.34 143.7 26.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.859 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.656 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-80 -119.81 -116.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.656 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 18.8 m-20 -76.02 53.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.45 8.02 87.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -127.88 145.39 50.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.989 . . . . 0.0 109.314 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.51 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.1 m95 -70.58 151.59 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.424 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -145.97 126.85 14.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -89.72 147.92 23.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -153.03 107.37 3.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.305 -0.872 . . . . 0.0 109.046 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.91 154.64 40.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.6 t -143.41 -33.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.72 83.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -132.26 104.32 6.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.647 -0.913 . . . . 0.0 109.31 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.38 152.7 38.14 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.2 124.4 14.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.355 -1.085 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.06 6.22 37.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.44 -68.58 1.13 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.41 129.08 1.18 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -46.62 -26.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.165 . . . . 0.0 109.891 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.32 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.897 . . . . 0.0 109.457 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -50.98 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.3 m -47.83 -20.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 39.9 m -69.33 -59.93 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.817 . . . . 0.0 110.191 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -18.89 29.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.17 -43.74 87.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.017 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -71.48 -19.81 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -67.66 -170.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 58.6 mttp -153.78 -34.64 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 59.7 m-20 -145.96 152.57 39.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.62 155.8 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 109.291 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -143.79 108.53 4.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 108.949 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.28 148.76 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 108.661 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.23 116.85 1.28 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.87 136.25 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.74 141.19 9.02 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.556 -1.307 . . . . 0.0 109.856 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -158.42 156.59 30.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.421 -1.047 . . . . 0.0 109.707 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -81.36 126.19 31.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.856 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.828 . . . . 0.0 109.118 179.655 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.19 138.31 33.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.85 99.81 3.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 109.677 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -83.37 141.01 32.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -98.97 109.97 22.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.23 125.61 43.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.212 -0.93 . . . . 0.0 108.9 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 11.1 t -149.76 168.13 24.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 109.993 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.53 138.87 45.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -104.02 127.72 51.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.622 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.39 155.99 16.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.28 -0.888 . . . . 0.0 110.055 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.77 139.99 32.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.084 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.84 176.59 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.34 -5.46 59.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.75 4.04 50.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.0 109.905 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.96 -11.02 73.23 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -109.89 169.12 8.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.621 ' C ' ' H ' ' A' ' 38' ' ' GLY . 20.2 t -93.09 136.57 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 109.171 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -64.01 1.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -150.01 122.07 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -61.96 3.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 110.076 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -95.05 -42.24 8.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.889 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 31.8 t0 46.17 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 109.599 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 75.7 t80 -137.49 99.59 3.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.456 -0.777 . . . . 0.0 109.52 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.2 pt -103.69 137.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.4 p90 -143.52 -160.76 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 p90 -45.17 -31.89 1.63 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 7.9 t-20 -52.59 -11.22 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.873 -1.142 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.0 t30 -135.75 108.25 7.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -47.43 -28.93 2.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.835 . . . . 0.0 109.266 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.2 pttt -171.81 157.51 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 67.3 m -62.69 149.57 43.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.65 -48.75 14.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -116.45 0.84 12.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.651 -0.656 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.94 -12.84 67.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m 58.71 13.92 2.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 109.401 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.5 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.304 -0.872 . . . . 0.0 109.027 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.454 ' HG1' ' CB ' ' A' ' 49' ' ' LYS . 58.6 m -148.6 135.06 19.58 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.019 -1.051 . . . . 0.0 110.212 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -90.17 129.06 36.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -69.8 -43.84 71.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.3 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.11 115.18 0.44 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.08 110.95 17.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -1.133 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.92 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.381 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -150.69 12.38 0.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -156.28 -38.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.868 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 p-10 -48.73 115.7 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 109.595 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.32 -64.9 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -88.39 173.43 8.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.95 132.24 6.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.362 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.79 121.66 41.36 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -95.4 138.16 33.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 108.533 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.04 146.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.484 -0.76 . . . . 0.0 110.502 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 9.5 mtpm? -138.55 94.1 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.69 -5.36 40.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.47 -29.67 37.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 0.0 109.791 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.74 10.37 37.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.0 109.905 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.24 125.59 69.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.984 . . . . 0.0 109.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.95 -161.11 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.894 1.729 . . . . 0.0 111.868 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.84 4.52 78.76 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 2.5 m-20 -64.41 -54.52 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -1.189 . . . . 0.0 109.44 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.99 149.07 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 9.3 t0 -123.91 -9.05 7.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.767 . . . . 0.0 109.46 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -158.06 131.34 7.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 110.029 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.9 mt -121.13 154.18 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -142.57 173.16 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.093 -1.004 . . . . 0.0 109.304 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 11.0 m-85 -142.31 118.56 10.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.89 157.73 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -130.92 114.35 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -110.21 148.16 32.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.3 138.97 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 21.3 t-160 -96.27 -65.11 0.99 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.005 . . . . 0.0 109.805 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -47.31 -18.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.08 -18.23 23.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 109.734 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.25 -61.49 1.82 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.85 -1.156 . . . . 0.0 109.545 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.18 -40.47 11.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -0.84 . . . . 0.0 111.086 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.4 mpt_? -85.19 -19.13 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.897 -1.127 . . . . 0.0 110.955 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 99' ' ' ARG . 50.1 ttp85 55.62 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.806 -1.184 . . . . 0.0 109.255 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.9 144.67 14.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -102.03 166.82 10.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.52 -32.14 3.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.847 . . . . 0.0 109.76 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -61.5 -37.05 93.51 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -46.88 -19.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -1.192 . . . . 0.0 109.244 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.2 t -86.48 166.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 0.0 108.986 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -66.99 -26.6 66.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.639 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.2 78.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.03 164.67 25.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 22.6 p90 -152.37 151.98 31.5 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 110.263 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.0 mt -114.49 154.46 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -144.13 157.5 44.27 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 tt -150.63 125.77 9.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 0.0 109.266 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.25 143.57 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.699 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 119' ' ' GLN . 61.4 m-20 -75.19 102.08 4.85 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 35.5 t0 -66.1 -1.67 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 109.851 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 1.1 p30 -83.53 -52.65 6.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -0.928 . . . . 0.0 109.494 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 22.1 m120 -122.87 5.69 9.37 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 0.0 109.819 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.1 mt-30 58.97 60.06 2.58 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.0 m -112.03 -69.72 0.85 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.946 -0.471 . . . . 0.0 110.471 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 53.6 mm-40 -45.25 157.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.97 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.95 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.78 151.21 52.05 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -140.74 143.54 35.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.708 . . . . 0.0 109.143 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.73 147.82 22.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.6 103.31 15.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.971 . . . . 0.0 109.326 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.2 mt -81.03 -38.19 27.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.5 m -47.61 -32.1 5.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.147 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.47 -54.23 3.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.533 -0.729 . . . . 0.0 109.94 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.49 -2.95 27.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.99 . . . . 0.0 110.612 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.05 -45.99 68.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 109.193 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -69.36 3.19 2.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.0 109.873 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 131' ' ' ALA . 15.2 m -82.78 -34.5 27.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 110.346 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -176.76 -162.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.958 -1.089 . . . . 0.0 109.729 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.47 -7.92 6.91 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.48 136.04 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 ptm -165.46 157.75 15.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.564 ' CD2' ' H ' ' A' ' 138' ' ' LEU . 1.5 pt? -92.27 141.43 28.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -86.54 -22.42 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.19 -171.29 40.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.31 163.41 38.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -1.156 . . . . 0.0 109.496 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.67 138.88 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.55 166.15 31.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.145 -0.972 . . . . 0.0 109.718 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -93.35 143.9 25.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.671 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.66 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.3 t60 -118.79 -118.55 0.31 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.66 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 30.8 t30 -75.41 51.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.05 8.84 86.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -127.81 139.99 52.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.987 . . . . 0.0 109.353 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -68.05 151.79 46.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -148.69 125.74 11.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -89.3 146.82 24.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.442 -0.786 . . . . 0.0 109.459 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -151.22 111.23 4.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.041 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.99 154.68 40.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.766 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.17 -33.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.39 0.04 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -143.72 104.31 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.443 -1.034 . . . . 0.0 109.157 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.73 34.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.6 138.44 44.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.618 -0.931 . . . . 0.0 108.919 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.39 9.06 39.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.76 -73.88 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 164' ' ' SER . . . 155.53 129.84 1.26 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -46.27 -24.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 109.879 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.0 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 166' ' ' CYS . 52.8 p -78.99 -54.43 6.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.652 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 29.6 m -45.37 -19.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.328 -0.857 . . . . 0.0 109.565 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 164' ' ' SER . 89.3 m -72.54 -62.15 1.55 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.1 -14.88 40.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.381 -0.825 . . . . 0.0 110.133 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -56.33 -45.65 80.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -78.79 -19.71 51.54 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.529 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.4 mpt? -79.63 175.98 10.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.428 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -154.09 -34.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 4.4 m120 -146.13 128.44 15.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -127.0 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.63 110.84 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.446 -0.783 . . . . 0.0 109.057 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.99 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 108.699 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.83 117.15 1.61 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -112.44 127.23 55.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.28 150.0 22.2 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -159.42 151.45 20.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.355 -1.085 . . . . 0.0 109.944 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -90.51 122.87 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.677 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.839 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 62.9 m-85 -96.21 136.39 36.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.8 p-10 -140.92 99.79 3.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 7.5 mp -83.45 130.49 35.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -90.67 123.36 34.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.76 131.03 44.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 p -150.1 168.24 24.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.021 -1.049 . . . . 0.0 109.939 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.75 136.81 34.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -103.32 138.26 40.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.149 -0.969 . . . . 0.0 109.796 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.588 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -90.36 163.22 14.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.92 141.7 29.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.059 -1.026 . . . . 0.0 109.867 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.12 176.71 9.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.583 -0.698 . . . . 0.0 109.219 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.04 -3.78 55.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.29 2.45 55.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -22.36 40.1 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -104.97 173.15 6.43 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -93.99 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -68.9 4.07 1.69 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -127.88 150.16 18.26 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.37 1.2 57.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.254 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.41 -42.34 5.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.221 -0.924 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 45.43 21.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.311 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 66.6 t80 -136.2 99.64 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.554 -0.716 . . . . 0.0 110.275 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 pt -103.34 134.85 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.0 p90 -146.11 -161.18 1.26 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.03 -1.044 . . . . 0.0 109.735 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.3 p90 -45.92 -30.67 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.116 -0.99 . . . . 0.0 110.434 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 8.3 t30 -61.97 -1.17 0.61 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.895 -1.128 . . . . 0.0 108.972 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.3 t30 -141.48 100.12 3.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.448 -0.783 . . . . 0.0 109.039 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -48.12 -24.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.305 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.3 pttt -166.78 154.87 9.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -62.67 137.85 58.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.51 92.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -116.13 -17.14 10.92 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.648 -0.658 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.67 76.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m 54.47 20.72 2.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 109.288 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -92.85 151.54 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.886 . . . . 0.0 109.076 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -133.91 125.48 28.38 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.512 -0.742 . . . . 0.0 109.515 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -92.46 124.19 36.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.339 -0.851 . . . . 0.0 109.367 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.8 m -58.58 -46.59 86.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.92 143.72 3.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.3 112.51 24.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -1.119 . . . . 0.0 109.395 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.08 128.78 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.63 5.65 17.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.9 p -153.55 -35.03 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.908 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 38.4 p-10 -52.65 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.106 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -57.95 -64.45 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . 60.0 mt-10 -102.69 170.97 7.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.363 -0.835 . . . . 0.0 108.989 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.1 m -165.85 164.65 18.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -135.06 124.04 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -95.69 109.68 21.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.729 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.29 146.81 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -142.29 92.7 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' ALA . 10.5 mt -71.09 -41.95 69.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.111 -0.993 . . . . 0.0 110.322 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -48.15 -13.96 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.544 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -104.97 -19.3 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.459 -0.776 . . . . 0.0 109.858 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.81 126.37 85.26 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.268 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 -160.11 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.983 1.789 . . . . 0.0 111.895 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.49 3.7 63.66 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.64 -60.95 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -1.218 . . . . 0.0 109.347 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.46 148.06 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.451 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.1 m-20 -125.71 -3.14 7.22 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.378 -0.826 . . . . 0.0 110.046 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.48 136.67 15.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.952 -1.093 . . . . 0.0 109.436 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.41 154.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.402 HG21 ' H ' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -138.38 172.89 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.146 -0.971 . . . . 0.0 110.103 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.402 ' H ' HG21 ' A' ' 88' ' ' ILE . 17.8 m-85 -137.53 129.2 28.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.1 t -140.57 151.32 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.953 . . . . 0.0 111.344 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.7 131.63 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -132.4 155.37 48.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -73.9 162.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.34 -60.24 1.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.522 -0.736 . . . . 0.0 109.465 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -49.88 -18.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.25 -42.4 86.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -54.13 -32.07 54.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.739 -1.226 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.86 -53.23 4.48 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.256 -0.903 . . . . 0.0 111.311 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' ARG . 3.1 ptp85 -111.85 1.72 16.69 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.181 -0.949 . . . . 0.0 111.237 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' ALA . 46.2 ttp180 56.19 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.788 -1.195 . . . . 0.0 109.24 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 102' ' ' SER . 1.3 pp0? -153.16 147.77 26.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.154 -0.966 . . . . 0.0 109.437 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 101' ' ' GLN . 20.8 m -105.01 163.41 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.831 . . . . 0.0 110.01 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -43.85 -28.61 0.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 0.0 110.161 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -64.1 -44.1 96.26 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.409 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 7.5 tp-100 -47.64 -17.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' GLY . 16.1 t -82.25 165.88 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 t -67.86 -21.72 65.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.671 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.41 79.98 0.03 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.23 162.48 27.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 109.623 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.5 p90 -155.38 151.69 28.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 45.9 mt -117.02 153.61 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -139.98 154.72 47.25 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.058 -1.026 . . . . 0.0 109.739 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.8 tt -148.59 117.51 6.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.16 145.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.38 -0.825 . . . . 0.0 109.838 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.12 101.87 5.51 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.46 -1.58 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.847 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.2 t0 -83.62 -52.99 5.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 109.661 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -122.97 4.37 9.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 60.29 60.61 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.8 m -113.07 -69.09 0.88 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.817 -0.552 . . . . 0.0 110.227 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 57.2 mt-10 -45.29 157.83 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.91 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.57 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.53 148.86 52.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 109.902 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.7 ptm180 -138.61 145.2 40.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -91.32 147.59 22.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.235 -0.916 . . . . 0.0 109.061 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -91.05 103.37 16.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 131' ' ' ALA . 83.9 mt -80.77 -37.71 29.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.482 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -47.8 -32.37 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.151 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.29 -53.89 3.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 -2.2 23.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.224 -0.922 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.25 -46.8 69.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.2 t -69.49 3.2 2.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.603 -0.686 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -83.4 -34.7 25.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 110.354 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -176.61 -161.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.4 -2.49 5.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.65 134.09 13.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.5 ptm -165.49 152.58 10.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.058 -1.026 . . . . 0.0 109.911 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -87.47 138.43 31.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 27.6 t80 -80.25 -43.57 21.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.31 -173.85 35.11 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.858 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -150.77 166.59 30.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.143 -1.21 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 139.8 44.14 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -144.88 166.2 25.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.03 -1.044 . . . . 0.0 109.84 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.451 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.3 ptm180 -90.15 145.77 24.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.517 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.1 t60 -123.57 -120.29 0.28 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.598 -0.689 . . . . 0.0 109.166 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.517 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 10.1 m120 -73.37 52.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.64 88.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.84 142.0 51.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.582 -0.952 . . . . 0.0 109.406 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -67.48 151.64 47.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.358 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -149.96 132.82 16.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.076 -1.015 . . . . 0.0 109.632 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -89.91 153.16 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 107.32 1.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.1 154.74 41.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.724 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.69 -33.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.859 . . . . 0.0 109.268 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.57 86.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -134.8 104.36 5.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.574 -0.956 . . . . 0.0 109.214 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.64 146.09 18.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.4 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -1.08 . . . . 0.0 108.971 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.88 40.6 3.24 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.539 -0.726 . . . . 0.0 109.471 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.95 -54.45 3.4 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.0 122.13 0.71 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -45.53 -35.74 4.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.12 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.45 -28.36 23.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 109.59 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.8 p -80.88 -50.68 9.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.989 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.542 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.8 m -49.15 -21.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.008 . . . . 0.0 109.533 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 28' ' ' PHE . 57.9 m -79.39 -59.98 2.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.912 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.5 63.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.465 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -71.05 -28.41 64.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.969 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.85 -19.57 61.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.4 mtt -81.31 162.51 23.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -130.95 -31.3 1.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.499 -0.75 . . . . 0.0 109.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.23 128.17 15.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 109.089 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.668 ' N ' HD21 ' A' ' 4' ' ' ASN . 94.3 t -128.13 144.45 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 tp -130.64 114.29 15.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.0 151.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 108.777 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.43 121.65 2.34 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.49 126.17 32.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.32 152.99 25.04 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -155.04 154.57 32.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -1.044 . . . . 0.0 109.7 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -90.45 120.97 32.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.171 -0.955 . . . . 0.0 109.303 179.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -96.32 145.73 25.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 25.1 p-10 -140.97 99.68 3.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.371 -0.831 . . . . 0.0 109.574 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -85.51 130.53 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 108.758 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.72 106.0 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -98.28 124.93 43.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 29.4 t -149.47 168.23 24.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.973 -1.079 . . . . 0.0 110.115 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.58 137.38 46.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m-85 -102.99 130.55 50.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.0 109.178 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' H ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.66 145.54 28.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.86 136.46 25.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.026 . . . . 0.0 110.109 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.16 176.48 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.699 . . . . 0.0 109.519 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -7.47 59.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.2 m-80 -83.03 -0.16 47.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.31 -12.01 61.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.74 148.68 24.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' A' ' 38' ' ' GLY . 29.0 t -66.39 136.89 25.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.934 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.94 9.25 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.0 170.09 34.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.14 3.83 54.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.986 -1.302 . . . . 0.0 109.902 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.16 -41.78 5.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.243 -0.91 . . . . 0.0 110.309 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 23.2 t0 51.04 9.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 0.0 109.313 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.2 p90 -138.29 118.75 13.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.316 -0.865 . . . . 0.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.3 pt -114.22 134.14 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -154.74 -148.21 0.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.959 . . . . 0.0 108.888 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 47' ' ' ASN . 37.3 p90 -44.89 -32.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.826 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 18.2 p-10 -65.4 4.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.177 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.1 t30 -155.53 100.29 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.804 . . . . 0.0 109.155 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -48.09 -18.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 28.4 pttt -175.38 155.23 1.81 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.398 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 54' ' ' SER . 53.2 p -66.71 130.51 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.83 -48.72 44.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.826 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -116.39 23.36 12.14 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 109.929 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.33 -15.11 7.24 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.6 t 63.48 4.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -1.116 . . . . 0.0 109.458 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 50' ' ' SER . 69.7 t -92.9 146.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.914 . . . . 0.0 108.916 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.9 m -149.78 153.78 37.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.057 . . . . 0.0 110.35 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -90.58 131.74 36.12 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.2 m -81.78 -34.71 30.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.506 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 113.76 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.74 159.09 25.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -1.122 . . . . 0.0 109.492 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.82 118.59 7.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -84.17 10.77 9.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.7 p -154.41 -35.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.85 99.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -1.198 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.53 -68.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.33 146.73 23.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.267 -0.896 . . . . 0.0 109.279 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -159.84 141.56 12.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.37 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.4 130.36 56.87 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.0 109.554 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -96.73 109.94 22.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.408 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.3 mp -98.8 146.75 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.204 -0.935 . . . . 0.0 110.465 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' O ' ' OG ' ' A' ' 54' ' ' SER . 9.8 mtpm? -141.98 90.62 2.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 79' ' ' ALA . 11.3 mt -78.86 -10.76 59.9 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.13 -0.84 0.82 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.009 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -135.83 18.12 3.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.2 134.99 90.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.329 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.5 -161.36 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.939 1.759 . . . . 0.0 111.682 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.08 39.7 2.79 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -126.19 -59.16 1.33 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.477 -1.014 . . . . 0.0 109.688 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.82 145.67 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.11 -0.994 . . . . 0.0 109.686 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -138.97 1.5 2.06 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.399 -0.813 . . . . 0.0 109.581 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 141' ' ' GLU . 60.2 tttm -149.06 131.35 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 108.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -137.38 130.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' CG2' ' HZ2' ' A' ' 86' ' ' LYS . 9.3 pt -137.22 152.89 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.933 . . . . 0.0 109.619 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.59 141.18 34.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.377 -0.827 . . . . 0.0 109.08 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.89 153.02 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.922 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -133.15 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -138.29 145.17 40.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.904 . . . . 0.0 109.861 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.26 148.01 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -0.862 . . . . 0.0 108.822 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' ALA . 56.6 t-80 -101.32 -70.66 0.74 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -47.51 -18.1 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 109.694 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -53.5 -18.76 3.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.81 -62.19 1.49 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.905 -1.122 . . . . 0.0 109.244 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.45 -38.45 12.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 110.813 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.517 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 6.2 mpt_? -85.14 -18.0 35.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.042 -1.036 . . . . 0.0 111.109 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 99' ' ' ARG . 16.1 tpt180 52.1 94.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.811 -1.18 . . . . 0.0 108.763 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -152.46 140.68 20.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 109.435 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 t -99.62 164.14 12.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.44 -30.9 2.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.397 -0.814 . . . . 0.0 109.934 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.442 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -63.39 -39.73 98.08 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -49.78 -15.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.502 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.442 ' N ' ' C ' ' A' ' 104' ' ' GLY . 17.7 t -83.13 163.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 109.088 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 t -62.66 -22.7 66.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.74 80.02 0.03 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.3 164.33 24.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.129 . . . . 0.0 109.667 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.0 p90 -150.04 169.82 20.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.194 -0.942 . . . . 0.0 110.185 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 18.1 mt -136.13 152.11 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 67.0 ttt-85 -143.55 163.62 32.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 tt -156.58 117.19 3.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.13 145.32 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.309 -0.87 . . . . 0.0 110.212 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 119' ' ' GLN . 2.2 m120 -78.6 102.35 7.91 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -68.0 -1.76 6.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.104 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.7 t0 -79.15 -53.13 7.29 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.993 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -123.27 3.03 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.2 mt-30 59.95 61.28 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 m -114.33 -66.31 1.1 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.901 -0.499 . . . . 0.0 110.247 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 1.4 mp0 -45.3 156.91 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.563 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.4 73.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.23 143.83 50.2 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.087 -1.008 . . . . 0.0 110.154 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.1 ptp180 -138.0 139.33 39.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.508 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 6.4 t80 -91.02 142.78 27.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 108.97 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -85.72 102.85 13.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.438 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.0 mt -79.42 -36.71 38.61 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 0.0 109.308 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -48.06 -33.2 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.139 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -95.3 -53.59 3.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.487 -0.758 . . . . 0.0 109.721 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 65.8 m-20 -71.9 -5.46 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.96 -46.06 68.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.18 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 65.4 p -68.84 3.18 2.08 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.916 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.0 m -83.32 -34.78 25.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.252 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -177.06 -162.77 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.971 -1.081 . . . . 0.0 109.677 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.52 -13.29 7.59 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.39 135.36 32.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.2 ttp -165.33 151.34 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.024 -1.047 . . . . 0.0 110.189 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.36 137.21 32.53 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.429 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -75.84 -47.43 25.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.902 -1.124 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.96 -158.91 9.06 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 86' ' ' LYS . 13.2 tt0 -150.98 158.65 44.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -1.085 . . . . 0.0 109.266 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 tt -143.28 131.92 22.49 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.66 166.34 30.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.5 ptm180 -94.68 142.53 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.449 -0.782 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -114.15 -120.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.61 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 20.0 t-20 -73.66 51.35 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.129 -0.982 . . . . 0.0 109.146 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.64 82.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -127.67 140.12 52.28 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.562 -0.963 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.515 ' O ' ' N ' ' A' ' 1' ' ' SER . 58.0 m95 -67.3 151.75 46.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -151.4 121.6 7.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -91.81 145.21 24.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.243 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -152.18 107.28 3.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.106 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.506 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -64.16 154.54 34.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.725 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.7 t -138.76 -33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.83 83.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -134.61 104.13 5.94 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.61 -0.936 . . . . 0.0 109.007 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.91 149.22 21.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.34 132.61 26.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -1.016 . . . . 0.0 108.99 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -87.14 19.64 3.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.53 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -57.66 -107.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.1 129.43 1.96 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.55 -30.3 2.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -30.86 22.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.3 t -79.54 -53.93 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 18.1 m -47.2 -19.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 164' ' ' SER . 65.9 m -74.49 -61.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.03 -15.13 45.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -57.19 -43.69 82.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 45.8 m-85 -71.84 -20.07 61.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.541 ' N ' ' SD ' ' A' ' 2' ' ' MET . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -156.53 156.38 33.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 57.0 mttp -126.98 -14.53 5.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.519 -0.738 . . . . 0.0 109.382 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 43.0 m-20 -146.31 128.63 15.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.208 -0.932 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.17 158.56 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.567 -0.708 . . . . 0.0 109.307 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.0 tp -145.64 109.45 4.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 109.061 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.78 150.84 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.905 . . . . 0.0 108.747 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.24 117.25 1.68 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -115.36 124.21 50.67 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -144.03 150.56 22.59 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -159.95 152.12 20.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.396 -1.061 . . . . 0.0 109.893 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.18 129.61 34.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.575 -0.703 . . . . 0.0 109.643 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.386 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 12.3 p-10 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.211 0.529 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.26 143.37 27.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -141.06 100.25 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.269 -0.894 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.28 135.51 34.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 108.748 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.51 117.59 30.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.51 130.98 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.66 167.75 25.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 109.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.27 144.98 42.91 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -101.94 151.81 21.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.87 143.34 47.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.562 -0.711 . . . . 0.0 109.282 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 133.2 22.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.069 -1.019 . . . . 0.0 110.136 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.5 176.5 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.741 -0.6 . . . . 0.0 109.487 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.93 -2.49 55.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 46.7 t30 -87.67 -1.43 57.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.741 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.54 -13.02 65.09 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -101.61 150.99 22.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.536 -0.979 . . . . 0.0 108.402 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLY . 27.4 t -69.05 137.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.24 -0.913 . . . . 0.0 109.121 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -71.62 8.68 1.04 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.74 170.95 35.35 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.1 m-20 -94.81 3.46 54.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.939 -1.33 . . . . 0.0 110.21 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.17 -42.13 5.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.056 -1.028 . . . . 0.0 110.584 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t0 49.63 9.93 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.955 -1.09 . . . . 0.0 109.496 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 8.2 t80 -138.13 100.22 4.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.323 -0.861 . . . . 0.0 109.803 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 43' ' ' ILE . 8.0 pt -96.75 139.6 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.208 -0.932 . . . . 0.0 108.608 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 35.4 p90 -151.23 -152.3 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 109.568 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.549 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.5 m-85 -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.644 -0.66 . . . . 0.0 110.013 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -57.27 -4.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -0.965 . . . . 0.0 108.639 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.0 t30 -151.32 102.03 2.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -48.72 -26.34 2.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.6 pttp -163.93 157.28 18.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.6 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 7.1 t -76.97 125.86 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.241 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.77 -45.81 67.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.922 . . . . 0.0 109.758 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.75 -12.23 19.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.494 -0.754 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.6 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -86.19 -13.51 68.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.1 p 60.45 12.19 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -1.212 . . . . 0.0 109.104 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -92.97 151.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.413 -0.804 . . . . 0.0 109.214 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.2 m -148.52 139.13 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.01 . . . . 0.0 109.921 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -90.3 129.01 36.58 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -66.63 -53.02 38.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.4 114.09 0.54 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -79.37 110.98 15.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.94 -163.93 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.41 15.86 0.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -155.85 -39.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.332 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.28 98.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -1.122 . . . . 0.0 109.486 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.21 -57.38 13.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.22 170.82 8.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 132.21 5.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.201 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.23 119.44 36.34 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.05 137.32 35.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 109.081 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -127.8 144.75 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.588 -0.695 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.35 97.27 3.34 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.7 mt -82.98 -14.96 53.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.087 -1.008 . . . . 0.0 109.557 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.43 -1.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.462 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.37 16.32 3.73 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.342 -0.849 . . . . 0.0 109.101 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.68 134.96 92.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.217 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.24 -177.95 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.814 1.676 . . . . 0.0 111.495 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.41 13.57 64.92 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -96.89 -59.78 1.73 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -1.14 . . . . 0.0 109.828 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.22 148.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.734 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -144.06 7.37 1.39 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.31 -0.869 . . . . 0.0 109.635 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -152.0 140.23 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 109.051 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.1 mt -145.55 122.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.161 -0.962 . . . . 0.0 109.709 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.09 174.15 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.339 -0.851 . . . . 0.0 108.747 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -141.08 119.53 12.29 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.07 157.67 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.332 -0.855 . . . . 0.0 110.651 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.61 136.72 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 p -131.12 148.54 52.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.5 mm -75.57 147.87 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' ALA . 4.0 t60 -102.36 -68.48 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.249 -0.907 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.27 -18.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -54.25 -17.89 3.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -69.86 -59.63 2.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.939 -1.101 . . . . 0.0 109.964 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.77 -51.33 5.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.181 -0.949 . . . . 0.0 111.354 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -78.09 -16.84 57.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.96 -1.088 . . . . 0.0 110.991 -178.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' ARG . 35.6 ttp180 55.89 101.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.746 -1.221 . . . . 0.0 109.308 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -159.16 143.06 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 131' ' ' ALA . 23.3 t -100.96 167.25 10.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -45.87 -35.35 4.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -58.15 -39.31 92.08 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -46.98 -16.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -1.174 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 104' ' ' GLY . 23.0 t -86.08 168.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.149 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.2 m -70.86 -22.23 62.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.819 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.61 79.39 0.03 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.5 23.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 109.748 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 42.8 p90 -152.34 163.32 39.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 54.3 mt -126.2 154.3 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -141.22 159.85 41.34 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.983 -1.073 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.2 tt -154.22 116.99 4.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 109.28 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.98 143.51 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 117' ' ' ASP . 55.9 t30 -75.14 102.07 4.8 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.62 -1.32 2.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t70 -83.01 -53.55 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.652 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.6 6.2 8.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.587 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 59.52 60.33 2.31 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.1 p -110.62 -70.12 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.925 -0.485 . . . . 0.0 110.298 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 66.8 mt-10 -45.33 157.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.324 -0.86 . . . . 0.0 109.774 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 150.17 52.15 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.091 -1.006 . . . . 0.0 110.02 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -139.78 142.26 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.645 -0.659 . . . . 0.0 109.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.35 147.77 22.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.234 -0.916 . . . . 0.0 109.147 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -91.17 103.16 15.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.407 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 131' ' ' ALA . 82.3 mt -79.24 -39.3 33.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.4 m -47.51 -30.29 3.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.971 -1.081 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.3 -54.74 3.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.403 -0.811 . . . . 0.0 109.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.5 -2.35 28.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.14 -0.975 . . . . 0.0 110.418 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.46 -45.27 69.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.217 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 t -70.91 3.08 3.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.491 -0.756 . . . . 0.0 109.868 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.1 m -83.11 -34.72 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.035 -1.04 . . . . 0.0 110.226 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -176.74 -162.42 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.022 . . . . 0.0 109.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.56 -15.31 7.58 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.41 138.67 36.71 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.409 ' C ' ' HH ' ' A' ' 158' ' ' TYR . 13.3 ptm -165.45 157.99 15.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 0.0 109.916 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.07 134.64 37.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.347 -0.846 . . . . 0.0 109.664 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -76.71 -42.42 41.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.05 . . . . 0.0 109.431 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.44 -163.13 13.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.28 163.05 39.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -1.098 . . . . 0.0 109.015 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.5 tp -144.82 137.22 26.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.068 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -150.68 166.04 31.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 109.275 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -95.7 141.45 29.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 9.5 t-160 -99.18 -133.95 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.641 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 5.6 m120 -52.22 -50.48 61.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.984 -1.072 . . . . 0.0 108.269 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.04 16.94 0.13 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -129.87 154.43 47.3 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.228 -1.16 . . . . 0.0 109.683 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.52 ' O ' ' N ' ' A' ' 1' ' ' SER . 71.9 m95 -72.35 151.86 42.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.395 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -147.28 121.63 9.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.233 -0.917 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -90.32 146.26 24.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -150.81 107.78 3.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.4 -0.812 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.44 154.7 40.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.835 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 -33.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.4 85.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.16 104.3 5.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.531 -0.982 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.89 150.66 26.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.409 ' HH ' ' C ' ' A' ' 137' ' ' MET . 0.1 OUTLIER -134.67 135.07 41.79 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.604 -0.939 . . . . 0.0 108.837 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.51 2.7 54.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 109.519 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -58.68 -110.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.97 140.27 6.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.49 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -47.75 -35.22 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.848 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.49 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.79 -19.81 30.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.1 m -89.02 -52.44 5.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 12.7 m -54.54 -28.29 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.617 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 32.1 p -78.54 -54.59 5.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -71.98 -15.12 62.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.976 -1.077 . . . . 0.0 109.33 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -28.99 63.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 51.1 m-85 -71.78 -19.83 61.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 109.473 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.439 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.774 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 149' ' ' TRP . 20.9 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.08 -170.99 2.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -153.25 -34.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 15.5 m120 -145.99 141.26 27.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -141.0 154.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.0 109.226 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.79 121.82 12.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 109.288 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -91.8 150.74 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 108.988 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.3 116.85 1.8 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -112.59 127.81 56.19 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.86 146.95 17.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -157.63 152.74 25.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -1.134 . . . . 0.0 109.872 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -92.53 126.51 37.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.737 . . . . 0.0 109.649 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.473 179.789 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 95.2 m-85 -96.17 153.09 17.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -140.93 111.15 6.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.92 163.61 13.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -106.68 154.57 20.74 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 0.0 109.479 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -144.67 109.7 5.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.185 -0.947 . . . . 0.0 108.764 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.427 ' HG ' ' N ' ' A' ' 27' ' ' ALA . 22.8 t -149.43 163.3 38.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 109.974 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' N ' ' HG ' ' A' ' 26' ' ' SER . . . -109.88 144.69 37.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 8.0 m-85 -104.04 129.07 51.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.447 -0.783 . . . . 0.0 108.909 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.622 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.53 155.56 17.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.41 -0.806 . . . . 0.0 109.204 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.23 137.3 25.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -76.69 176.35 8.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.445 -0.785 . . . . 0.0 109.266 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.5 -2.55 53.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.642 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -93.18 3.55 55.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.174 -0.954 . . . . 0.0 109.821 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 -19.6 53.83 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 31' ' ' ALA . 40.3 mttp -106.26 172.45 6.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.8 t -101.27 141.81 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -59.69 -5.55 0.93 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -148.6 101.11 0.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 18.6 p-10 -45.23 -18.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.376 -1.073 . . . . 0.0 110.28 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.44 79.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 0.0 109.561 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD1' ' CG2' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 45.45 17.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' ALA . 52.5 t80 -137.8 100.02 4.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.533 -0.729 . . . . 0.0 109.858 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.419 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.2 pt -106.3 139.65 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.315 -0.866 . . . . 0.0 109.072 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -152.92 -148.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 109.039 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 47' ' ' ASN . 25.9 p90 -44.46 -34.33 2.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.971 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.69 -5.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.166 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' A' ' 45' ' ' TYR . 54.0 t-20 -148.0 110.09 4.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -0.834 . . . . 0.0 108.956 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.24 -29.1 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 12.8 pttm -169.17 155.6 6.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.432 -0.793 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -73.51 117.51 15.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.22 78.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.663 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -93.42 -16.41 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.29 -0.881 . . . . 0.0 109.786 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.17 -13.69 61.58 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t 58.39 14.04 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.91 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.329 -0.857 . . . . 0.0 109.168 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.496 ' HG1' ' CB ' ' A' ' 49' ' ' LYS . 76.5 m -145.75 136.12 24.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -89.97 133.49 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.347 -0.846 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -71.75 -60.79 2.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.506 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.43 114.92 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 32.6 p-10 -82.21 110.94 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.0 t-20 -80.84 -163.48 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.358 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 36.1 ttp180 -151.91 14.23 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 109.243 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -154.11 -38.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.945 . . . . 0.0 109.25 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.24 124.13 9.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -1.165 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.93 -73.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -90.84 99.66 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 t -91.38 132.15 36.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.217 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.27 125.08 53.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -96.3 142.51 28.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 108.949 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -133.68 146.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.332 -0.855 . . . . 0.0 109.927 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -142.2 102.23 4.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 79' ' ' ALA . 5.6 mt -82.59 -27.69 31.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.862 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -63.63 4.65 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.29 19.08 4.01 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.81 125.81 45.19 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.117 -0.99 . . . . 0.0 108.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.06 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.818 1.679 . . . . 0.0 111.88 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.56 4.71 83.95 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -53.27 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -1.181 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.29 149.07 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.0 109.347 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 10.4 t0 -120.71 -13.79 8.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 109.482 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -158.02 134.18 9.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.013 . . . . 0.0 109.949 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -122.88 154.42 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.12 173.57 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.193 -0.942 . . . . 0.0 109.291 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -141.84 128.91 20.83 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.61 158.33 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 8.7 m -135.63 114.06 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -106.15 161.06 14.85 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.407 HG23 ' H ' ' A' ' 96' ' ' ALA . 4.9 mm -73.01 140.58 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.12 -69.88 0.73 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.056 -1.028 . . . . 0.0 110.441 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -50.39 -17.92 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.146 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -47.35 -50.51 21.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -55.24 -28.02 50.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.904 -1.123 . . . . 0.0 109.801 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -54.14 4.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.114 -0.991 . . . . 0.0 111.173 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.45 -0.43 15.29 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.187 -0.945 . . . . 0.0 111.058 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.0 ttm-85 56.23 101.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.889 -1.132 . . . . 0.0 109.046 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -146.93 149.48 33.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.7 p -101.03 158.22 16.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.341 -0.849 . . . . 0.0 109.652 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -45.62 -34.46 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.397 -0.815 . . . . 0.0 109.743 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -60.7 -42.22 99.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 87.4 mm-40 -47.66 -15.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.251 . . . . 0.0 109.371 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' GLY . 23.1 t -83.57 166.16 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -69.83 -20.48 63.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.725 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.83 79.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.06 162.76 26.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 109.734 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 20.7 p90 -156.3 149.96 24.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 56.7 mt -115.83 154.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -139.59 159.4 42.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.03 -1.043 . . . . 0.0 109.923 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.3 tt -151.94 117.23 5.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.16 145.82 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.2 t-20 -76.42 102.05 5.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.93 -1.56 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.88 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 115' ' ' ASN . 24.4 t0 -84.08 -53.17 5.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.713 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -123.11 4.67 9.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' ASN . 10.7 tt0 60.39 61.12 1.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.3 p -112.34 -68.97 0.89 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.903 -0.498 . . . . 0.0 110.221 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 22.3 mm-40 -45.4 157.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.851 . . . . 0.0 109.956 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.74 150.83 52.11 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.149 -0.969 . . . . 0.0 109.935 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptm180 -138.81 146.26 41.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.507 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.0 t80 -91.34 147.3 23.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.61 103.06 15.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.516 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 131' ' ' ALA . 46.8 mt -81.38 -39.16 25.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.3 m -48.16 -31.87 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 0.0 109.152 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.18 -54.53 3.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.47 -0.769 . . . . 0.0 109.771 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 58.6 m-20 -72.75 -2.99 22.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.274 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.72 -44.35 66.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.244 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.5 p -72.39 3.17 5.03 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -82.79 -34.57 26.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.74 -162.6 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -127.37 -1.58 6.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.07 13.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.8 ptm -165.35 157.97 15.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.843 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -94.68 139.66 30.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 109.795 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 26.5 t80 -81.14 -42.82 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.629 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.62 -169.45 22.95 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.8 164.86 35.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.251 -1.147 . . . . 0.0 109.46 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 136.52 26.23 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 152' ' ' ARG . 9.5 p90 -146.95 166.27 27.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.019 -1.05 . . . . 0.0 110.25 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.98 145.32 24.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 4.7 t60 -122.77 -118.81 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.641 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 73.6 m-20 -73.53 53.3 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.23 8.13 87.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.76 148.61 50.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.99 . . . . 0.0 109.312 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.515 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.4 m95 -75.08 151.79 38.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -147.74 127.11 13.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.112 -0.993 . . . . 0.0 109.603 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -89.63 148.23 23.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.484 -0.76 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 143' ' ' TYR . 2.6 ptp180 -153.87 107.52 2.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.06 154.55 37.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.44 -34.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.0 109.389 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 86.26 0.04 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -131.67 104.19 6.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.634 -0.921 . . . . 0.0 109.389 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.36 148.08 24.94 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -139.43 128.66 23.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -1.073 . . . . 0.0 109.321 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.8 12.16 13.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.06 -80.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 152.77 131.24 1.63 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.1 pt? -47.15 -13.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.56 -50.32 7.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.2 p -81.12 -37.72 28.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.92 -24.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.434 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 93.4 m -79.55 -55.28 5.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.168 -0.957 . . . . 0.0 110.959 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.09 -15.21 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.957 -1.089 . . . . 0.0 110.355 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -66.3 -39.96 89.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.58 -19.62 62.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.683 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.734 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 25.2 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.255 0.55 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -80.21 -174.64 4.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -153.21 -34.98 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -138.0 142.65 40.41 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.362 -0.837 . . . . 0.0 109.321 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 5.2 t -140.08 146.01 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tt -136.25 111.9 9.37 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.42 150.97 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.26 117.08 1.56 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tt -115.98 132.42 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -149.0 143.96 11.55 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.52 158.8 41.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -1.023 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -76.73 131.35 38.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.911 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 0.0 109.261 179.692 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 p30 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.17 140.03 31.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.83 99.79 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.304 -0.872 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.69 153.29 24.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -108.44 109.06 20.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -0.761 . . . . 0.0 109.543 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.25 128.0 44.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.307 -0.87 . . . . 0.0 108.924 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.417 ' OG ' ' CE1' ' A' ' 42' ' ' PHE . 84.0 p -149.44 167.81 25.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.068 . . . . 0.0 109.984 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.68 140.7 43.22 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -103.91 129.83 51.46 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.406 -0.809 . . . . 0.0 108.922 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.97 146.72 27.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 109.681 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.64 134.69 23.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.188 -0.945 . . . . 0.0 110.005 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.74 176.53 3.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.65 -6.4 58.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.711 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -86.57 1.49 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.86 59.16 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -99.48 152.26 20.2 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.2 t -72.26 136.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.054 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -70.96 8.17 0.99 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.2 168.36 34.61 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.33 4.05 54.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.997 -1.296 . . . . 0.0 110.13 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -102.77 -42.05 6.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.158 -0.964 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 47.71 13.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.742 -1.224 . . . . 0.0 109.454 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ALA . 68.7 t80 -137.5 102.86 4.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.444 -0.785 . . . . 0.0 109.911 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 pt -103.08 131.04 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.813 . . . . 0.0 108.855 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -150.06 -146.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -50.65 -16.27 0.37 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 10.0 p-10 -78.92 4.88 12.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 108.799 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.1 t-20 -156.71 106.44 2.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -48.05 -25.57 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 11.9 pttm -172.86 158.53 3.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 t -69.64 141.38 53.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.66 -43.55 25.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.31 -1.58 12.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.694 -0.629 . . . . 0.0 109.553 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.8 -13.68 60.6 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 t 60.45 10.28 2.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -1.077 . . . . 0.0 109.426 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.13 147.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.99 138.2 25.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 109.721 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -89.82 130.17 36.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -69.49 -42.76 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.332 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.27 111.08 0.39 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -72.84 110.79 7.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.1 t-20 -86.3 -167.04 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.945 . . . . 0.0 109.341 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.51 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 15.5 ptt-85 -162.37 20.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -153.9 -43.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 109.352 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -56.42 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -52.96 -61.07 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.65 165.31 13.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -154.89 132.15 11.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.15 124.48 50.43 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -95.91 139.83 31.55 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.51 146.8 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -139.57 99.35 3.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.18 -5.53 52.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -83.26 -26.89 30.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.93 5.87 50.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.42 124.44 85.53 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.13 -161.35 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.828 1.686 . . . . 0.0 112.057 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.32 1.38 79.5 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -68.9 -59.83 2.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 109.246 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 50.4 t -91.39 148.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.408 -0.807 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 2.4 m-20 -138.26 9.03 2.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -155.04 131.3 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 109.327 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.38 154.3 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.46 173.66 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.307 -0.87 . . . . 0.0 109.001 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.9 m-85 -140.95 120.48 13.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.21 158.11 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.714 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.63 136.34 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -125.55 143.88 50.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 109.695 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.22 132.05 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 108.863 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -93.8 -60.14 1.83 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.33 -19.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.56 -43.88 72.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -55.79 -27.6 51.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.762 -1.212 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.67 -53.74 4.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.137 -0.977 . . . . 0.0 111.076 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' CZ ' HE22 ' A' ' 101' ' ' GLN . 12.3 ptm180 -112.42 -3.9 14.37 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.244 -0.91 . . . . 0.0 110.9 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 48.0 ttp180 56.74 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.071 . . . . 0.0 109.321 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.42 HE22 ' CZ ' ' A' ' 99' ' ' ARG . 3.8 pt20 -157.88 153.65 26.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -101.85 158.47 16.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.01 -31.49 0.92 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -50.06 -33.51 22.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -57.53 -26.29 61.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -1.077 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.41 166.4 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.223 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.3 m -70.69 -28.89 65.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.4 75.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.62 25.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 108.938 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.9 p90 -153.24 169.86 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.297 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 41.8 mt -132.4 156.62 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.71 162.69 34.8 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.006 -1.059 . . . . 0.0 109.731 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.6 tt -157.52 116.66 3.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.92 141.88 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.318 -0.864 . . . . 0.0 109.651 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 117' ' ' ASP . 1.4 m120 -77.79 102.1 7.03 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 6.1 p-10 -68.29 -3.67 11.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.9 t70 -72.96 -52.69 13.58 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.138 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -122.67 -12.02 8.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.766 -0.584 . . . . 0.0 109.617 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 115' ' ' ASN . 6.0 tt0 70.86 69.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 121' ' ' GLU . 16.8 p -130.48 -45.71 1.09 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.738 -0.601 . . . . 0.0 109.979 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 5.0 mp0 -65.13 158.23 26.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 108.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 176.67 76.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.28 148.67 52.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.495 -0.753 . . . . 0.0 109.407 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 27.8 ptt180 -136.49 141.72 43.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.53 140.04 30.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 0.0 108.946 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -83.85 103.02 12.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 0.0 109.402 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.7 mt -78.22 -41.72 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 84.7 m -47.88 -29.58 3.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.933 -1.104 . . . . 0.0 109.274 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.05 -54.74 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 109.878 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.28 -4.74 37.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 110.355 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -60.21 -49.29 78.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.961 -1.087 . . . . 0.0 109.783 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.3 p -60.41 2.8 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.5 m -89.68 -33.31 16.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 110.4 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.405 ' CG ' ' H ' ' A' ' 135' ' ' THR . 3.3 tp10 -172.68 -145.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.18 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.521 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -135.82 -52.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.77 143.64 30.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.2 ttt -166.2 158.08 13.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.043 . . . . 0.0 109.802 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -101.04 136.48 40.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.373 -0.83 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 25.9 t80 -81.65 -40.74 22.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.74 -170.79 26.95 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -150.96 163.62 38.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -1.12 . . . . 0.0 109.602 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.03 140.39 32.61 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -150.57 166.5 30.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.099 -1.001 . . . . 0.0 109.857 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -88.15 148.96 24.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.79 . . . . 0.0 109.709 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -152.5 123.78 7.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 55.67 24.77 7.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.81 80.33 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -127.8 138.37 52.71 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.488 -1.007 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 76.8 m95 -67.69 150.7 48.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -151.35 126.19 9.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -89.23 147.02 24.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.465 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -152.76 108.09 3.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.048 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.54 154.74 41.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.0 t -139.31 -33.65 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -0.843 . . . . 0.0 109.293 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.09 86.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -138.25 104.46 5.2 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.928 . . . . 0.0 109.485 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.64 150.59 33.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -147.88 134.4 19.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.221 -1.164 . . . . 0.0 109.396 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.3 16.94 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.339 -0.851 . . . . 0.0 109.43 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.1 -64.55 2.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.64 127.04 0.97 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.8 pt? -47.22 -35.58 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.792 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.0 -22.2 27.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.423 ' C ' ' N ' ' A' ' 166' ' ' CYS . 26.0 m -79.18 -57.53 3.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.0 m -47.58 -20.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 96.2 m -72.63 -61.94 1.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.68 -17.52 31.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.35 -43.51 88.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.24 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.92 -20.31 61.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 149' ' ' TRP . 11.8 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt -67.67 -178.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.436 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 81.8 mttt -153.62 -33.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.911 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 26.7 m-20 -140.3 129.11 23.18 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.69 156.09 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -142.02 110.0 5.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 108.896 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.22 150.5 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.209 -0.932 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.54 116.5 1.22 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.56 134.55 49.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.57 142.32 10.58 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -160.39 152.98 20.94 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -1.151 . . . . 0.0 109.914 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.08 99.32 11.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 109.403 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.428 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.24 131.19 42.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 p-10 -141.03 100.8 3.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.18 146.3 28.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.78 121.4 44.3 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.33 -0.856 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.6 134.37 40.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.262 -0.899 . . . . 0.0 108.912 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 27.9 t -149.85 167.92 25.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.08 138.33 54.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.8 m-85 -104.06 128.03 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.317 -0.865 . . . . 0.0 109.332 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.634 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -103.03 155.84 18.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.42 137.49 25.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 109.35 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -79.14 176.78 9.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 109.501 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.35 59.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.98 4.66 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.119 -0.988 . . . . 0.0 109.839 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.89 -20.68 45.91 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 31' ' ' ALA . 43.6 mtpt -103.32 172.49 6.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.6 t -101.29 142.63 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.406 -0.809 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 39.1 mmm-85 -59.74 -6.03 1.09 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -146.1 100.16 0.22 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -44.94 -21.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -1.091 . . . . 0.0 110.414 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.35 79.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 109.62 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER 47.77 13.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 109.369 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 84.9 t80 -138.28 99.46 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.366 -0.834 . . . . 0.0 109.654 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.422 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.1 pt -101.83 136.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.8 p90 -144.94 -160.85 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.139 -0.976 . . . . 0.0 109.502 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.8 p90 -45.64 -29.96 1.39 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.433 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.8 t30 -57.42 -6.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.855 -1.153 . . . . 0.0 108.989 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 48.6 t30 -140.17 110.07 6.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.458 -0.776 . . . . 0.0 109.022 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.03 -31.65 5.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 109.278 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 16.9 pttp -169.87 160.01 8.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -65.01 142.29 58.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.327 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.92 43.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.631 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -115.21 -3.79 12.49 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.643 -0.661 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -82.07 -15.64 74.23 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.0 p 61.48 11.45 3.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.0 109.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.9 m -147.68 133.85 19.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 109.746 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -91.42 139.17 30.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 72' ' ' SER . 7.2 m -74.43 -61.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.67 121.63 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 23.6 p-10 -81.28 112.11 18.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.146 . . . . 0.0 109.543 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.35 132.1 35.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -79.82 6.24 11.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.532 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 p -153.3 -34.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -49.2 106.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.04 -63.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -90.99 -179.69 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.562 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.9 m -161.85 135.43 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.18 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 120.5 35.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.13 138.8 33.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.096 -1.002 . . . . 0.0 109.304 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.38 147.02 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.583 -0.698 . . . . 0.0 109.763 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 54' ' ' SER . 53.8 mttp -142.85 102.1 3.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.857 . . . . 0.0 108.722 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 79' ' ' ALA . 9.3 mt -77.11 -39.01 51.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.999 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -49.42 -17.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -100.17 -15.95 17.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.78 123.89 88.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.398 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.56 -160.74 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.967 1.778 . . . . 0.0 111.941 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.01 1.73 87.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' NH1' ' A' ' 37' ' ' ARG . 59.4 t0 -67.28 -55.64 13.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -1.143 . . . . 0.0 109.57 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -79.02 148.53 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 8.9 t0 -128.25 -7.13 5.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 109.564 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -158.21 135.84 10.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 109.614 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.75 154.12 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.51 173.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.262 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -133.32 139.28 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.94 155.62 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.99 . . . . 0.0 111.212 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.57 113.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -121.14 171.62 8.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.449 -0.782 . . . . 0.0 110.606 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.8 mm -81.68 168.3 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -132.75 -64.8 0.74 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -49.91 -18.23 0.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.28 -39.44 79.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.579 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' NE2' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -52.9 -32.21 44.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.77 -1.206 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.84 4.22 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.135 -0.978 . . . . 0.0 111.296 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.23 1.75 16.31 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.127 -0.983 . . . . 0.0 111.091 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.4 ttm180 59.08 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.998 -1.064 . . . . 0.0 109.339 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.402 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 83.4 mt-30 -150.05 139.35 21.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 109.555 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 m -99.13 158.98 15.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.37 -0.831 . . . . 0.0 109.461 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -46.31 -30.21 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.325 -0.86 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -68.19 -37.53 86.91 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -47.71 -17.06 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.167 . . . . 0.0 109.138 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' GLY . 23.0 t -85.0 167.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 108.969 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.0 m -67.26 -20.47 65.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.0 80.48 0.03 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.76 164.68 23.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 109.832 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.8 p90 -154.07 150.45 28.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.129 -0.982 . . . . 0.0 110.024 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 36.2 mt -114.17 155.84 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -141.96 162.82 34.51 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.995 -1.065 . . . . 0.0 109.919 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.7 tt -157.07 118.14 3.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.77 144.56 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.331 -0.856 . . . . 0.0 110.049 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -75.24 101.97 4.85 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.92 -1.71 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.479 ' CB ' HD22 ' A' ' 115' ' ' ASN . 22.3 t0 -84.75 -52.18 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.306 -0.871 . . . . 0.0 109.627 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -122.24 -0.48 9.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.65 -0.656 . . . . 0.0 109.988 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 60.67 63.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -118.13 -53.93 2.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.002 -0.436 . . . . 0.0 110.099 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER -60.16 158.55 11.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 109.389 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER 178.31 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 148.01 52.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 109.791 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 41.1 ptt85 -134.82 145.68 48.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.408 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.8 t80 -91.36 147.59 22.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.15 -0.969 . . . . 0.0 109.186 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -86.11 102.99 14.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 109.285 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 131' ' ' ALA . 66.9 mt -83.07 -40.66 19.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.9 p -48.13 -31.74 6.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.118 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -95.32 -54.62 3.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.823 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 47.1 m-20 -73.47 -3.82 29.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.161 -0.962 . . . . 0.0 110.416 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.27 -45.15 65.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.997 -1.065 . . . . 0.0 109.125 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.1 m -70.91 3.01 3.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.643 -0.66 . . . . 0.0 109.92 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -84.47 -34.26 23.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 110.17 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.64 -167.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -123.4 -8.05 8.1 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.05 135.52 24.26 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.94 157.65 14.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.014 -1.054 . . . . 0.0 110.048 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -92.6 138.37 31.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -81.51 -41.96 20.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.29 -169.95 20.97 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.406 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.9 tt0 -151.5 161.25 43.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -144.51 136.39 25.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.2 -0.937 . . . . 0.0 108.523 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.2 p90 -144.04 165.87 26.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.188 -0.945 . . . . 0.0 109.685 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.5 ptm180 -84.98 152.52 23.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -155.29 116.47 3.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.411 ' O ' ' OE1' ' A' ' 148' ' ' GLU . 14.6 t-20 56.25 24.99 8.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 -3.89 86.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 3.4 mp0 -109.64 135.09 51.16 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.51 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.7 m95 -69.14 151.64 46.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.192 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.85 129.42 15.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.119 -0.988 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 19.4 t80 -96.72 137.73 35.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.457 -0.777 . . . . 0.0 109.912 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -143.61 107.29 4.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.48 154.56 39.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -143.08 -34.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.264 -0.898 . . . . 0.0 109.322 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.04 85.24 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -132.65 104.23 6.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.663 -0.904 . . . . 0.0 109.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.76 149.71 25.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.24 133.44 29.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.468 -1.019 . . . . 0.0 109.117 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.16 7.66 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 0.0 109.439 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -69.6 0.91 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.89 125.39 0.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.21 -28.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.137 . . . . 0.0 109.928 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.75 -31.0 22.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.9 p -75.6 -50.48 15.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.13 -20.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.486 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.4 m -69.97 -58.94 3.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 110.326 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.71 -15.24 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.35 -44.2 92.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.293 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -71.23 -20.01 62.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 149' ' ' TRP . 53.0 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -77.61 148.8 34.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -129.64 -9.88 4.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.453 ' ND2' ' OD1' ' A' ' 117' ' ' ASP . 11.7 m-80 -146.41 129.18 16.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.219 -0.926 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -135.88 147.98 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.066 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tt -135.28 109.92 8.59 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.16 143.87 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.47 117.15 2.18 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.46 131.82 56.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -145.24 143.46 11.86 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' THR . 19.0 p90 -154.97 153.69 31.43 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.44 -1.035 . . . . 0.0 109.695 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.04 117.51 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -140.9 99.65 3.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.39 -0.819 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.66 130.63 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -91.43 112.54 24.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 109.959 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 128.74 44.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.276 -0.89 . . . . 0.0 108.6 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -149.26 165.73 31.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.102 -0.999 . . . . 0.0 110.171 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 138.69 45.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.3 m-85 -104.45 129.41 52.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.472 -0.768 . . . . 0.0 109.007 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.02 153.42 19.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.377 -0.827 . . . . 0.0 109.949 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.02 135.36 22.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.822 . . . . 0.0 109.415 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -76.25 176.46 8.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.47 -10.49 59.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.973 . . . . 0.0 109.718 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -84.78 4.81 31.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.18 -19.61 51.21 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 31' ' ' ALA . 85.0 mttt -103.71 172.05 7.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -103.03 140.94 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.458 -0.776 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' NH1' ' OD1' ' A' ' 83' ' ' ASP . 34.3 ttp180 -62.06 -3.54 1.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -143.54 101.29 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -45.54 -27.29 0.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 110.47 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.4 -42.34 82.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.912 -1.118 . . . . 0.0 109.623 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.8 t0 46.03 15.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 13.8 t80 -137.77 100.22 4.13 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.653 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 pt -101.55 137.92 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.3 p90 -141.14 -160.08 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 25.7 p90 -42.5 -36.06 1.23 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.607 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 9.1 t30 -49.27 -14.61 0.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.912 -1.118 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 45' ' ' TYR . 40.7 t30 -153.88 112.85 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.94 -64.63 0.97 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.202 -0.937 . . . . 0.0 109.542 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -89.92 117.77 28.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.478 -0.764 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.588 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 6.9 t -57.21 134.77 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.89 75.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.826 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -116.39 -5.96 11.76 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.615 -0.678 . . . . 0.0 109.892 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.588 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -82.42 -19.27 64.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t 62.78 6.57 2.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -1.17 . . . . 0.0 109.238 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -92.97 152.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 108.932 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -143.45 142.13 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.111 -0.993 . . . . 0.0 110.468 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -92.12 121.44 33.67 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 72' ' ' SER . 19.0 m -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.381 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 109.77 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -79.77 110.77 15.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -1.18 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -86.34 132.6 33.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -78.89 2.8 18.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 40.1 p -153.52 -35.01 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.2 94.69 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 109.557 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.17 -53.05 42.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.22 160.08 14.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 108.998 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.424 ' O ' ' OG1' ' A' ' 58' ' ' THR . 10.4 m -157.86 132.32 8.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.077 -1.014 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mp -117.88 126.4 52.31 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -96.27 122.74 39.45 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.434 -0.791 . . . . 0.0 110.199 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 103.52 4.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.12 -24.33 40.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.909 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.4 -21.99 66.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.67 -9.19 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.953 . . . . 0.0 109.773 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.13 125.06 90.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.98 -160.28 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.909 1.739 . . . . 0.0 111.909 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.26 3.22 75.91 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 16.4 t70 -69.12 -60.1 2.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.304 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.36 148.75 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.494 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.7 m-20 -133.1 10.48 4.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.343 -0.848 . . . . 0.0 109.831 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -158.14 131.73 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 109.235 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.9 mt -129.36 154.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.515 -0.741 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.03 173.17 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.426 -0.796 . . . . 0.0 109.014 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 6.9 m-85 -142.4 118.4 10.64 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.02 157.71 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.248 -0.907 . . . . 0.0 110.625 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -120.98 148.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -141.81 140.08 32.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -73.92 137.4 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 108.867 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.8 t-80 -94.17 -64.9 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -47.45 -18.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.852 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.94 -18.13 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.0 109.94 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -66.14 -60.44 2.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.889 -1.132 . . . . 0.0 109.484 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -43.6 9.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.364 -0.835 . . . . 0.0 111.151 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -83.88 -18.02 38.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 111.225 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 54.19 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.652 -1.28 . . . . 0.0 109.162 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -148.39 142.28 25.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.25 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -99.63 165.27 11.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.217 -0.927 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -46.29 -34.19 4.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.285 -0.885 . . . . 0.0 109.871 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -58.26 -38.49 90.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -49.1 -18.85 0.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.981 -1.305 . . . . 0.0 109.338 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.424 ' N ' ' C ' ' A' ' 104' ' ' GLY . 23.2 t -82.54 166.22 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 109.161 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.3 m -70.28 -23.4 62.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.988 . . . . 0.0 109.758 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.35 77.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.2 163.48 23.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -1.176 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 30.6 p90 -154.23 169.88 22.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.5 mt -132.08 156.55 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -143.85 162.12 36.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -157.77 118.1 3.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.079 -1.013 . . . . 0.0 109.658 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.91 143.8 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 117' ' ' ASP . 82.9 m-20 -79.85 102.01 8.87 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.01 -1.49 7.61 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 31.7 t0 -76.76 -52.44 9.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 5.4 m-80 -122.48 -14.74 7.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.73 -0.606 . . . . 0.0 109.583 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 15.9 tt0 73.83 71.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.546 ' HG1' ' N ' ' A' ' 121' ' ' GLU . 71.9 p -135.9 -45.13 0.65 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.644 -0.66 . . . . 0.0 109.975 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.546 ' N ' ' HG1' ' A' ' 120' ' ' THR . 49.9 mm-40 -65.37 158.44 26.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 108.931 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 173.4 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.79 149.45 52.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.501 -0.75 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.7 ptp180 -135.12 142.9 46.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.618 -0.676 . . . . 0.0 109.461 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -91.32 143.09 27.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.905 . . . . 0.0 108.925 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.16 102.87 14.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.585 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 38.3 mt -78.7 -41.0 32.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.204 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.9 p -47.78 -29.68 3.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 109.295 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -95.22 -54.68 3.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 109.804 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.93 -0.83 22.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.968 . . . . 0.0 110.275 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.0 -44.62 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 109.275 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 t -72.57 3.01 5.4 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.539 -0.725 . . . . 0.0 109.851 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.1 m -82.32 -34.35 28.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 110.124 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.76 -164.06 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 0.0 109.612 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.06 -14.34 8.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.6 140.12 36.94 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.8 ptm -165.47 158.05 15.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.008 -1.057 . . . . 0.0 109.871 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.19 137.58 35.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -82.87 -41.06 19.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.627 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.93 -170.1 25.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -151.21 164.24 37.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.216 -1.167 . . . . 0.0 109.558 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 139.02 29.04 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.16 166.45 29.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.065 -1.022 . . . . 0.0 109.894 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.494 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -89.19 146.18 24.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 109.506 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 19.9 t-160 -128.23 -115.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.619 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 21.9 m120 -72.66 58.71 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.068 -1.02 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.73 8.09 62.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.02 149.47 50.35 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.963 . . . . 0.0 109.315 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.8 m95 -72.8 151.63 41.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.356 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -146.58 129.42 16.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -89.89 149.28 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.405 -0.81 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -155.46 113.52 3.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.195 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.96 154.53 31.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.56 -33.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -0.871 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.91 84.58 0.03 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -136.96 104.28 5.41 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.966 . . . . 0.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.36 152.12 37.38 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.95 129.46 21.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.24 9.31 31.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 109.444 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.36 -70.97 0.61 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.83 132.44 1.48 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.8 pt? -46.33 -33.33 3.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.63 -26.39 26.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 166' ' ' CYS . 12.6 t -74.69 -54.39 7.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 35.5 m -47.41 -20.71 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.504 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 60.0 m -71.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -15.4 39.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.35 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.28 -43.31 98.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.108 -0.995 . . . . 0.0 110.076 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -71.43 -19.7 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' TRP . 75.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 34.2 mtt -81.69 162.84 22.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -141.45 -33.73 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 13.1 m120 -146.11 128.46 15.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.84 149.0 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -132.63 108.24 8.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 108.985 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.55 150.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.94 117.0 1.25 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -106.05 132.45 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.07 138.41 7.26 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.946 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -156.46 155.19 31.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -75.5 125.53 29.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.263 179.686 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.281 0.562 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.32 104.9 16.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.184 -0.948 . . . . 0.0 109.338 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' ND1' ' A' ' 94' ' ' HIS . 24.4 p-10 -92.87 102.71 15.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 mt -83.4 138.04 33.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 109.15 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.07 106.69 18.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.05 119.05 38.08 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -149.04 168.37 23.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.04 . . . . 0.0 109.804 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.03 138.42 45.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.597 -0.689 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.0 m-85 -104.35 131.83 51.26 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.611 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.62 154.39 19.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.382 -0.823 . . . . 0.0 110.132 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 136.62 24.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -77.04 176.68 8.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.247 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.86 -11.23 59.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.5 m120 -86.55 5.65 34.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.069 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.46 52.16 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' ALA . 40.7 mmtm -102.61 172.03 7.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -102.18 143.23 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 109.784 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -62.5 -3.24 1.34 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.82 102.57 0.25 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -45.18 -25.8 0.4 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -1.085 . . . . 0.0 110.751 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.819 -1.175 . . . . 0.0 109.687 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.554 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 0.4 OUTLIER 48.4 12.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 109.444 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 40' ' ' ALA . 79.3 t80 -135.11 100.25 4.5 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CD1' ' HG ' ' A' ' 50' ' ' SER . 4.6 pt -103.5 130.52 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.487 ' CZ ' ' OD2' ' A' ' 60' ' ' ASP . 33.4 t80 -170.99 -168.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.985 -1.072 . . . . 0.0 109.179 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.473 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 52.4 m-85 48.46 -113.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' LEU . 23.0 t30 -56.84 -7.65 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 45' ' ' TYR . 8.3 t-20 -67.49 68.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.945 -1.097 . . . . 0.0 109.648 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 46' ' ' ASN . 13.3 mt -52.98 -30.97 38.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 108.898 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 127.15 0.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.744 . . . . 0.0 109.124 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.438 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 1.5 m -55.86 111.9 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.67 -25.4 63.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.08 -16.12 11.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.545 -0.722 . . . . 0.0 109.658 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.53 -20.27 35.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m 69.14 2.67 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.451 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.77 146.56 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.229 -0.92 . . . . 0.0 108.663 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -149.12 150.56 32.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.961 -1.087 . . . . 0.0 110.348 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -91.37 136.15 33.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.65 -0.657 . . . . 0.0 109.756 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 p -85.78 -30.35 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.27 104.1 0.24 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' CZ ' ' A' ' 44' ' ' PHE . 12.6 t70 -80.77 110.82 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.636 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -95.36 -167.85 1.69 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -161.47 19.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.8 p -154.29 -42.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.856 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.87 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -71.93 -69.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.32 156.1 17.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.314 -0.866 . . . . 0.0 109.132 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -159.68 141.33 12.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.19 131.81 55.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.067 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.47 110.16 22.26 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.405 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 26.6 mt -97.94 146.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 111.075 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -140.21 84.35 1.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 -5.19 11.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.9 -20.23 49.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.648 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.49 -13.89 21.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.217 -0.927 . . . . 0.0 109.781 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.99 124.91 82.23 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 109.269 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.01 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.74 1.627 . . . . 0.0 111.866 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.56 1.86 79.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -71.41 -60.52 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.544 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 t -87.12 133.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -113.32 4.43 16.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.697 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -156.36 137.86 14.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.528 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.4 mt -145.44 107.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -109.18 171.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.405 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 4.7 m-85 -129.84 134.4 47.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.1 158.16 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -131.28 134.75 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -138.04 164.62 28.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mm -77.64 142.01 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 22' ' ' ASP . 20.6 t-160 -98.1 -68.35 0.81 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -51.33 -18.11 0.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.104 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -48.94 -42.93 38.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 109.772 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.19 -30.07 48.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.918 -1.114 . . . . 0.0 109.753 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.518 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -90.73 -54.01 4.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 111.297 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.518 ' HE ' ' CB ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -112.52 -0.31 15.27 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.256 -0.903 . . . . 0.0 111.1 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 96' ' ' ALA . 43.1 ttt85 57.08 103.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.949 -1.095 . . . . 0.0 108.991 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.435 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 70.1 mt-30 -137.38 134.04 35.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.277 -0.889 . . . . 0.0 109.708 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -90.64 152.77 20.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -46.76 -30.89 2.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.197 -0.94 . . . . 0.0 109.583 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -57.96 -40.31 93.09 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.435 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 51.0 mt-30 -48.17 -17.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.241 . . . . 0.0 109.359 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.2 t -82.78 163.97 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 108.949 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 m -72.13 -25.55 61.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.14 78.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.11 164.71 25.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -1.109 . . . . 0.0 109.145 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 22.7 p90 -154.4 143.82 21.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.92 -1.113 . . . . 0.0 110.477 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 43.1 mt -108.43 154.16 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -139.94 160.8 39.1 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.999 -1.063 . . . . 0.0 109.731 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.412 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 3.9 tt -155.11 116.69 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.529 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.46 144.51 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 109.755 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 119' ' ' GLN . 53.8 t30 -76.37 102.12 5.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.22 -1.87 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.383 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 115' ' ' ASN . 18.2 t70 -81.66 -53.23 6.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.22 4.22 9.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.771 -0.58 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 115' ' ' ASN . 20.0 tp60 59.5 60.41 2.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 53.9 m -113.46 -68.64 0.91 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.951 -0.468 . . . . 0.0 110.299 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 57.8 mm-40 -45.2 157.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 110.029 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -179.28 73.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.85 151.55 52.0 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.3 ptp180 -139.21 142.48 37.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -91.4 147.77 22.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.167 -0.958 . . . . 0.0 109.314 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -85.96 106.19 16.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.6 mm? -80.33 -46.78 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.5 m -47.83 -27.96 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.264 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -91.81 -54.57 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.59 0.84 9.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -56.96 -47.18 81.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 p -73.26 3.09 6.19 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.502 -0.749 . . . . 0.0 109.976 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.2 m -87.96 -34.61 18.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 0.0 110.478 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -175.65 -163.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.789 -1.194 . . . . 0.0 109.857 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.5 p -125.58 -8.73 6.82 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.14 27.81 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.5 ptm -165.46 157.9 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.04 -1.037 . . . . 0.0 109.951 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -96.76 137.29 36.07 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 109.436 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.0 t80 -79.69 -42.12 25.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.077 -1.015 . . . . 0.0 109.958 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.57 -166.29 15.48 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.532 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 10.1 tt0 -150.82 160.66 43.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -1.012 . . . . 0.0 109.292 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.422 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.0 mt -142.81 137.52 29.73 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.44 165.75 29.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -95.6 144.41 26.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.465 -0.772 . . . . 0.0 109.687 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 20.0 t-80 -125.49 -117.16 0.28 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.654 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 53.0 t30 -72.54 58.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.968 . . . . 0.0 109.407 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.31 10.49 66.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -127.74 141.46 51.59 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.933 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.0 m95 -71.37 152.03 43.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -148.52 131.39 16.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.561 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.1 t80 -89.7 149.64 22.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.509 -0.744 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 21.6 tpt85 -154.39 107.26 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 109.025 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.508 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -63.75 154.75 32.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.42 -33.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.435 -0.791 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.24 82.14 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -135.74 104.37 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.588 -0.948 . . . . 0.0 109.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.47 151.34 36.13 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -145.78 133.77 21.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.358 -1.084 . . . . 0.0 109.213 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.28 11.65 29.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.98 -27.47 6.68 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 83.6 139.5 3.86 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.63 -12.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -1.132 . . . . 0.0 109.719 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -77.81 -57.59 3.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 109.515 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 m -80.72 -41.83 22.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.01 -21.32 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 40' ' ' ALA . 13.5 t -73.97 -60.37 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.616 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -26.42 23.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.195 -0.94 . . . . 0.0 110.443 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 169' ' ' TYR . 1.3 tm0? -51.32 -35.34 37.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 109.813 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 24.6 m-85 -85.73 13.26 7.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.504 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -80.24 115.88 20.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.89 -23.15 18.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -146.31 152.33 38.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.301 -0.874 . . . . 0.0 109.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 t -146.16 158.52 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 tp -147.69 107.65 4.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.851 . . . . 0.0 109.022 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.11 150.77 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.92 116.93 1.39 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -110.88 126.83 55.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -142.21 145.48 15.73 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -158.49 151.24 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 110.031 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -91.2 128.23 36.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 109.712 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.18 31.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -79.65 106.96 12.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 p -84.91 124.62 31.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -155.93 -39.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.265 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.51 25.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.0 109.073 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.65 6.69 63.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -77.54 163.99 25.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -170.31 146.82 2.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 150.12 20.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.95 104.48 4.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.912 . . . . 0.0 109.64 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.36 151.38 25.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 108.783 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.36 106.56 17.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 109.879 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.5 125.68 45.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 108.757 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 5.7 t -149.43 167.62 25.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.941 -1.099 . . . . 0.0 109.913 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.38 136.53 49.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.4 m-85 -104.02 127.96 51.58 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.621 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.77 142.0 30.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.373 -0.83 . . . . 0.0 109.998 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.57 131.62 20.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -0.935 . . . . 0.0 109.835 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.36 175.11 10.06 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 1.56 43.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.289 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -83.09 -9.84 59.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 109.504 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.7 -5.05 69.52 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -109.71 150.37 28.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.9 m -65.97 136.53 26.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -71.02 5.35 2.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ALA . . . -158.77 118.59 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -47.68 -10.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -1.113 . . . . 0.0 110.338 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLY . . . -95.7 -40.21 9.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.5 t0 47.57 14.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 109.294 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 62.6 t80 -137.2 100.39 4.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 109.654 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.9 pt -103.48 139.57 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.558 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.2 p90 -153.22 -153.98 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -0.879 . . . . 0.0 109.686 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.573 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.0 OUTLIER -43.43 -36.24 1.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.064 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.45 -1.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 108.946 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.573 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.3 t30 -149.57 103.97 3.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.137 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.21 -28.57 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttm -165.18 160.12 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 t -69.86 147.92 49.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.264 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.81 -48.52 14.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -116.2 1.64 13.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.661 -0.649 . . . . 0.0 109.587 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 -12.71 69.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 60.78 11.99 3.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.36 -1.082 . . . . 0.0 109.42 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.07 150.27 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.249 -0.907 . . . . 0.0 108.93 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.9 m -148.77 138.08 21.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.12 -0.987 . . . . 0.0 110.0 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -90.06 127.91 36.17 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -67.12 -56.91 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.57 111.11 0.47 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.2 p-10 -77.4 110.88 12.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -81.92 -164.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -156.15 16.48 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -154.64 -37.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 109.325 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 16.43 79.41 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -58.47 111.14 1.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.21 -145.19 10.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -160.01 57.56 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -1.142 . . . . 0.0 109.391 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.12 -176.3 48.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.63 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -1.169 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -73.28 -63.86 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.22 171.68 9.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.4 132.26 6.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.326 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.37 119.41 35.59 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -95.69 135.88 36.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 108.736 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.51 146.93 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 110.358 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.28 87.62 2.35 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 79' ' ' ALA . 21.9 mt -67.94 -34.52 76.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.869 . . . . 0.0 109.751 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -55.28 -5.71 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.582 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -119.27 20.65 12.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' PRO . 48.0 t -105.41 104.98 50.6 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.327 -0.858 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.25 -171.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.055 1.837 . . . . 0.0 112.353 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 1.08 89.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.02 -55.95 15.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -1.105 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 83.5 t -84.39 148.59 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 0.0 108.977 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 45.3 m-20 -136.61 -5.27 2.0 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.359 -0.838 . . . . 0.0 110.136 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -145.25 131.17 19.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.949 -1.094 . . . . 0.0 109.423 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -141.49 108.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.23 154.86 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 109.627 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -96.45 159.1 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 109.202 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.3 t -147.23 152.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.746 0.784 . . . . 0.0 110.651 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.6 t -148.01 115.84 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 p -132.85 174.45 10.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 mm -86.53 143.25 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -100.4 -68.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.327 -0.858 . . . . 0.0 110.044 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -18.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.248 -0.908 . . . . 0.0 110.06 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -46.43 -26.96 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -53.98 -50.41 66.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 109.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.12 -39.48 12.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.42 -0.8 . . . . 0.0 110.984 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -96.99 -19.49 18.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.057 -1.027 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.6 mmt180 50.94 58.2 5.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.637 -1.289 . . . . 0.0 109.169 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.37 148.45 25.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.3 p -98.15 159.39 14.97 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.743 . . . . 0.0 109.605 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -45.88 -33.94 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -59.16 -36.84 90.42 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -47.53 -19.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -1.21 . . . . 0.0 109.328 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 104' ' ' GLY . 18.6 t -85.93 168.12 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.131 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -69.3 -23.91 63.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.21 79.98 0.03 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.75 25.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 109.817 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.8 p90 -153.33 143.51 22.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.099 -1.0 . . . . 0.0 110.257 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.8 mt -107.02 154.7 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.39 159.83 41.24 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 2.7 tt -154.23 116.54 4.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.097 -1.002 . . . . 0.0 109.482 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.65 143.3 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 117' ' ' ASP . 78.8 m-20 -75.33 102.12 4.98 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -64.73 -1.85 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.561 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.1 t0 -82.1 -53.7 5.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 109.72 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.71 6.55 8.8 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.67 -0.644 . . . . 0.0 109.724 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 59.03 59.7 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -111.21 -69.91 0.84 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.866 -0.521 . . . . 0.0 110.309 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 51.0 mm-40 -45.26 157.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.0 109.893 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.58 72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.0 152.22 51.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.067 -1.021 . . . . 0.0 109.992 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 30.3 ptt180 -140.79 144.36 35.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -91.32 147.63 22.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 103.39 16.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 131' ' ' ALA . 46.3 mt -80.44 -40.7 25.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.298 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.85 -29.58 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -95.26 -54.66 3.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.434 -0.791 . . . . 0.0 109.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.11 -1.35 25.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.85 -44.71 66.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.294 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -72.7 3.09 5.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.56 -0.713 . . . . 0.0 109.984 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.4 m -83.02 -34.39 26.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 0.0 110.283 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.75 -164.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.952 -1.093 . . . . 0.0 109.729 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -124.81 -5.71 7.46 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.76 135.31 23.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.36 150.67 9.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.55 136.0 33.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.79 -49.4 46.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 109.938 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.35 -155.56 7.21 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.293 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -150.64 157.73 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -1.024 . . . . 0.0 109.347 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.74 135.74 28.23 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -150.82 166.8 29.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.931 -1.106 . . . . 0.0 110.275 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 11.5 ptm180 -86.95 147.07 25.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.779 . . . . 0.0 109.503 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.5 OUTLIER -129.54 -114.88 0.25 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.693 . . . . 0.0 109.259 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.584 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.2 m120 -72.67 58.42 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.963 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.44 7.25 63.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -127.92 154.18 45.84 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.668 -0.901 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -75.74 151.49 37.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -145.35 127.83 16.0 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -89.99 148.25 23.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -157.32 107.37 2.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.78 153.72 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.04 -32.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.78 85.92 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -139.14 104.48 5.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.559 -0.965 . . . . 0.0 109.548 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.0 154.79 35.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -150.08 124.17 9.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.404 -1.056 . . . . 0.0 109.123 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.69 15.09 6.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.32 -0.862 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.06 -76.56 0.15 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.21 126.18 0.82 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.01 -29.21 1.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -1.126 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.97 -32.6 21.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 166' ' ' CYS . 19.9 m -80.28 -50.35 10.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.73 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 m -45.76 -19.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.341 -0.849 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 78.0 m -70.94 -62.0 1.55 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.25 -15.38 38.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.108 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.68 -34.99 71.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.003 -1.06 . . . . 0.0 110.365 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -70.75 -19.59 62.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.153 . . . . 0.0 109.206 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -92.49 -47.94 3.12 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.88 94.47 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.414 HD21 ' H ' ' A' ' 172' ' ' ASN . 2.4 p30 -78.11 116.24 18.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.39 110.25 15.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.459 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 16.3 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.286 0.565 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.6 mtt -80.91 -173.67 4.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -153.15 -34.67 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.71 HD21 ' H ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -140.57 139.39 34.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.0 109.279 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.71 ' H ' HD21 ' A' ' 4' ' ' ASN . 3.8 t -144.46 130.64 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.21 109.76 17.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.71 144.73 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.145 -0.972 . . . . 0.0 108.727 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -129.98 129.94 6.11 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 tt -134.87 126.81 29.49 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.01 151.11 23.12 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 27.5 p90 -155.73 154.7 31.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.367 -1.079 . . . . 0.0 109.738 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.8 99.62 11.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 165.96 24.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -132.88 106.85 7.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.442 -0.786 . . . . 0.0 109.217 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -86.96 105.61 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 p -88.16 -61.74 1.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 109.179 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -158.12 17.74 0.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 109.476 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.73 -26.55 0.94 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -82.31 142.65 31.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 109.601 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -157.71 153.66 26.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 109.353 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.28 134.43 39.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -141.11 100.06 3.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.0 109.712 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 136.48 34.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.888 . . . . 0.0 108.633 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.66 110.58 22.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.186 -0.947 . . . . 0.0 110.005 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 128.83 44.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.252 -0.905 . . . . 0.0 108.859 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.5 m -150.25 167.8 25.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.046 -1.034 . . . . 0.0 110.37 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 136.62 48.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.8 m-85 -103.48 145.34 30.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.9 153.83 31.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.75 143.31 36.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -81.4 176.59 9.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.43 -13.24 52.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -0.906 . . . . 0.0 109.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -84.42 7.95 17.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 109.867 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 -14.8 61.88 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' ALA . 37.6 mmtm -102.81 176.18 5.24 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' C ' ' H ' ' A' ' 38' ' ' GLY . 21.4 t -101.11 137.07 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -62.76 1.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -151.04 124.38 1.69 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.51 3.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.156 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -97.78 -41.97 7.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.04 -1.037 . . . . 0.0 109.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 10.6 t0 46.92 14.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 109.442 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 14.0 t80 -136.9 99.07 3.92 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 0.0 109.368 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 pt -101.97 133.17 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.437 -0.79 . . . . 0.0 108.942 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.7 p90 -142.14 -161.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.259 -0.9 . . . . 0.0 109.278 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.44 ' C ' ' H ' ' A' ' 47' ' ' ASN . 21.7 p90 -44.65 -27.51 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.224 -0.923 . . . . 0.0 110.372 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.4 t30 -57.93 -8.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.999 -1.063 . . . . 0.0 108.96 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 45.0 t-20 -139.06 109.42 6.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.798 . . . . 0.0 108.966 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -47.37 -31.51 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.89 . . . . 0.0 109.183 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.8 pttt -168.52 155.01 7.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.442 -0.786 . . . . 0.0 109.39 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -60.82 147.88 41.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.38 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.36 -47.88 16.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -116.16 0.91 13.07 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.736 -0.602 . . . . 0.0 109.516 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.66 -12.01 65.1 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t 58.44 14.92 3.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.232 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.97 151.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.1 m -148.84 134.62 18.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.0 109.811 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -90.57 139.57 30.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.393 -0.817 . . . . 0.0 109.072 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 m -76.84 -55.55 5.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.44 117.28 0.66 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.91 113.62 18.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -1.148 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 132.95 35.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -81.75 7.97 11.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.69 -35.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.17 16.16 57.44 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.5 110.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -1.124 . . . . 0.0 109.344 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.21 156.78 7.22 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.6 p30 -85.14 -171.97 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.14 -175.44 19.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.4 111.36 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -1.149 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.55 -63.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -87.92 159.29 18.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.6 m -152.51 132.4 13.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.214 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.15 123.95 47.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -95.87 136.19 36.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.275 -0.89 . . . . 0.0 108.853 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.52 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 87.4 mt -133.39 146.99 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.086 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.25 90.36 2.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 79' ' ' ALA . 13.8 mt -72.41 -25.27 61.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -66.4 4.74 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -137.08 24.91 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 81' ' ' PRO . 38.1 t -103.93 105.54 48.8 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.451 -0.78 . . . . 0.0 109.198 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . 73.2 Cg_exo -48.06 -175.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.026 1.817 . . . . 0.0 112.335 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.84 85.92 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.27 -50.81 72.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -1.204 . . . . 0.0 109.243 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 m -95.55 139.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 109.076 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -116.86 2.41 12.82 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.57 -0.706 . . . . 0.0 109.819 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -158.14 132.68 8.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.041 . . . . 0.0 109.777 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.7 mt -141.17 117.79 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.2 157.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -105.9 137.41 43.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 1.2 p -147.01 157.46 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.521 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 3.5 p -129.26 147.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 p -140.15 140.71 36.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mm -73.82 132.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.826 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 97' ' ' GLN . 83.8 t60 -89.95 -63.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.22 -18.22 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.92 -18.26 43.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 38.1 mt-30 -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.734 -1.229 . . . . 0.0 109.412 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.46 -44.42 9.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 0.0 111.047 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -81.72 -17.79 46.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.05 -1.031 . . . . 0.0 111.402 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 52.34 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.854 -1.154 . . . . 0.0 109.077 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -148.13 143.5 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.328 -0.857 . . . . 0.0 109.132 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -99.85 165.38 11.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.284 -0.885 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -46.22 -32.22 2.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.321 -0.862 . . . . 0.0 109.785 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -61.61 -38.69 96.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -49.87 -17.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.3 . . . . 0.0 109.296 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' N ' ' C ' ' A' ' 104' ' ' GLY . 15.9 t -84.92 163.82 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 109.127 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -62.08 -26.79 68.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.597 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.1 79.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 164.37 25.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -1.146 . . . . 0.0 109.74 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 37.0 p90 -151.29 170.02 20.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.301 -0.875 . . . . 0.0 110.018 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 24.7 mt -132.66 154.93 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 72.6 ttt180 -143.38 162.48 35.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.968 -1.083 . . . . 0.0 109.718 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 4.3 tt -157.67 117.97 3.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 0.0 109.771 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.03 142.81 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.359 -0.838 . . . . 0.0 109.586 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 117' ' ' ASP . 1.5 m120 -78.84 102.27 8.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 5.5 t70 -68.03 -1.78 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 115' ' ' ASN . 24.9 t70 -76.5 -52.12 10.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 4.5 t-20 -122.02 -14.12 8.07 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.677 -0.639 . . . . 0.0 109.608 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 5.0 tt0 71.67 69.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.6 m -134.39 -43.71 0.77 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.722 -0.611 . . . . 0.0 109.807 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 5.7 mp0 -65.79 158.25 28.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 108.781 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 174.21 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.92 51.73 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.751 . . . . 0.0 109.201 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.0 ptt180 -134.08 142.07 47.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.607 -0.683 . . . . 0.0 109.474 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.8 t80 -91.43 147.35 23.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.371 -0.831 . . . . 0.0 108.916 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.77 102.83 15.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 109.394 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 50.5 mt -79.65 -39.19 31.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.6 p -47.56 -30.51 3.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.018 -1.051 . . . . 0.0 109.286 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -95.23 -54.59 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -0.825 . . . . 0.0 109.75 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 53.9 m-20 -74.77 -0.73 19.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -54.7 -46.5 74.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.085 -1.01 . . . . 0.0 109.321 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.2 t -69.23 2.99 2.42 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.548 -0.72 . . . . 0.0 109.882 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 131' ' ' ALA . 11.6 m -82.96 -34.57 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.9 -162.91 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.001 -1.062 . . . . 0.0 109.582 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -15.25 7.56 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.35 137.37 35.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.6 ttp -164.89 152.05 11.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.872 -1.142 . . . . 0.0 110.144 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.451 ' CD2' ' H ' ' A' ' 138' ' ' LEU . 1.7 pt? -87.96 135.43 33.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -77.81 -26.4 49.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.922 -1.111 . . . . 0.0 109.304 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.69 -164.23 21.91 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -150.53 154.22 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.988 . . . . 0.0 108.74 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 134.81 24.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.038 -1.039 . . . . 0.0 108.86 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -147.47 166.01 28.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 109.717 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.57 148.48 24.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -152.3 123.73 7.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER 55.72 24.8 7.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.18 80.05 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -127.82 137.48 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -1.015 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 69.7 m95 -67.69 151.19 47.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.369 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -148.61 121.98 9.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.148 -0.97 . . . . 0.0 109.726 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 17.6 t80 -89.94 143.77 26.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.497 -0.752 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.32 107.43 3.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 109.026 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.36 154.79 10.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.776 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -139.42 -34.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.373 -0.829 . . . . 0.0 109.05 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.41 81.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.428 ' H ' ' CD2' ' A' ' 138' ' ' LEU . 34.7 tt0 -141.35 104.14 4.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.057 . . . . 0.0 109.041 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.0 150.5 27.73 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.7 137.77 38.69 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.606 -0.937 . . . . 0.0 108.782 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.51 13.86 24.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.217 -0.927 . . . . 0.0 109.519 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.88 -68.35 1.34 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.06 131.59 1.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.23 -30.27 1.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -1.116 . . . . 0.0 109.87 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.7 -25.18 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' GLY . 53.6 p -77.34 -55.4 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.471 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.6 m -46.97 -20.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 80.0 m -71.47 -60.91 1.98 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.03 -19.64 28.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.28 -0.888 . . . . 0.0 110.141 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -55.21 -42.19 73.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 109.726 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -71.47 -19.86 62.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.355 -0.841 . . . . 0.0 109.178 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.31 -53.71 3.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.08 90.34 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -1.154 . . . . 0.0 109.281 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.24 106.12 8.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 109.455 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 10.02 5.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.51 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 149' ' ' TRP . 73.2 m . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -74.19 -169.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -153.9 -34.58 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 31.4 t30 -143.63 128.22 18.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 109.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.64 158.54 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.626 -0.671 . . . . 0.0 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 tt -146.21 112.95 6.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -89.94 150.55 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 108.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.35 116.76 1.34 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.61 135.46 42.02 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.92 138.07 8.09 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -160.33 153.7 22.08 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.4 111.24 23.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.548 -0.72 . . . . 0.0 109.347 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.07 43.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.33 106.81 17.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 p -93.9 128.96 40.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -156.2 -76.19 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 108.855 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.8 21.5 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.04 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.19 0.67 80.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -84.85 178.37 7.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.14 165.44 2.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 68.4 m-85 -96.31 150.9 20.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.07 99.67 3.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.865 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.63 132.78 35.56 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -95.85 111.06 23.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.096 -1.002 . . . . 0.0 110.092 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.36 125.34 43.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.414 -0.804 . . . . 0.0 108.893 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -149.81 167.77 25.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.844 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.0 142.25 41.66 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.5 m-85 -103.9 148.28 26.35 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' H ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -120.18 154.11 35.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.568 -0.708 . . . . 0.0 109.987 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 139.54 27.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.102 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -74.86 176.42 7.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.097 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.38 -9.44 58.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.179 -0.95 . . . . 0.0 109.763 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.39 8.29 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.136 -0.977 . . . . 0.0 109.919 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.18 70.1 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 31' ' ' ALA . 66.7 mmtt -104.18 170.1 8.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.624 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.8 t -98.42 137.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.12 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.3 ttt-85 -64.69 1.94 0.76 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.93 125.21 1.7 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 4.42 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -1.148 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.59 -41.5 8.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.97 -1.081 . . . . 0.0 110.028 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 12.2 t0 47.72 13.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.857 -1.152 . . . . 0.0 109.43 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 72.4 t80 -136.89 99.39 4.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -0.8 . . . . 0.0 109.642 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 43' ' ' ILE . 6.3 pt -99.7 139.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.6 p90 -154.22 -155.93 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 109.596 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.552 ' C ' ' H ' ' A' ' 47' ' ' ASN . 3.8 m-85 -43.54 -34.29 1.35 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.544 -0.723 . . . . 0.0 110.138 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -58.28 -2.16 0.17 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.096 -1.002 . . . . 0.0 108.827 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 45' ' ' TYR . 43.5 t-20 -148.72 113.76 5.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 109.27 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.64 -38.49 46.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 108.945 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 36.0 pttt -161.87 157.67 24.31 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.372 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 t -63.21 144.57 56.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -47.12 17.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -116.31 2.02 13.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.715 -0.615 . . . . 0.0 109.67 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -87.7 -17.97 57.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 2.9 p 67.22 7.97 5.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -93.11 149.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 m -148.86 138.98 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.227 -0.92 . . . . 0.0 109.496 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -89.88 139.83 30.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -142.61 40.57 1.56 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 109.343 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.38 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.2 124.28 34.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -1.058 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.7 m120 -153.53 93.03 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -73.88 14.52 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 61' ' ' ASN . 52.6 p -147.59 -35.29 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.887 . . . . 0.0 109.303 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.45 13.25 29.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.46 110.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -1.113 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.07 -126.35 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -159.29 170.57 21.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.48 172.29 2.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.73 122.01 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -82.01 -70.43 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.33 177.0 7.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.2 m -159.98 132.44 6.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.44 125.15 48.26 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -95.9 139.35 32.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 108.837 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 69.3 mt -132.22 146.61 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.5 mttm -141.22 101.32 3.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.68 -5.41 53.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.13 -20.46 32.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.569 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.74 7.99 43.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.15 123.95 84.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.203 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.923 1.749 . . . . 0.0 112.054 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.82 2.24 76.1 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -69.94 -60.63 2.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -1.199 . . . . 0.0 109.219 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.97 148.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.003 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.7 15.99 3.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.245 -0.909 . . . . 0.0 109.693 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' A' ' 141' ' ' GLU . 50.6 tttp -158.37 135.21 9.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.589 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.2 mt -133.65 154.14 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.93 173.47 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 108.913 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.7 m-85 -142.1 123.38 14.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.71 157.9 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 110.352 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.24 115.53 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -107.11 153.24 22.93 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.39 -0.819 . . . . 0.0 110.242 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 94' ' ' HIS . 5.7 mm -73.84 167.41 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.464 ' N ' ' CG2' ' A' ' 93' ' ' ILE . 46.7 t-80 -133.69 -60.81 0.82 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.385 -0.822 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -49.28 -18.27 0.34 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.972 . . . . 0.0 109.586 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.74 -40.02 90.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.81 -32.6 44.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.776 -1.202 . . . . 0.0 109.698 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.91 -54.03 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.124 -0.985 . . . . 0.0 111.352 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.49 4.09 17.21 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.294 -0.879 . . . . 0.0 111.16 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 96' ' ' ALA . 51.7 ttt180 57.56 106.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 109.301 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.421 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 34.7 mt-30 -151.34 145.34 25.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 109.671 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.8 p -104.95 163.59 12.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.447 -0.783 . . . . 0.0 109.55 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -46.15 -36.38 5.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 109.859 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -58.92 -41.43 96.23 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 57.8 mm-40 -49.43 -14.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.28 . . . . 0.0 109.267 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 104' ' ' GLY . 21.9 t -83.59 165.4 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.049 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 t -69.0 -20.15 64.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 0.0 109.554 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.11 79.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.37 163.46 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.129 . . . . 0.0 109.821 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 18.3 p90 -157.85 158.75 35.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.8 mt -118.88 157.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -138.11 159.35 42.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.059 -1.026 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.407 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 2.9 tt -152.9 115.31 4.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.86 142.11 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.395 -0.816 . . . . 0.0 109.857 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 119' ' ' GLN . 57.9 t30 -79.49 101.82 8.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.53 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.7 t70 -69.34 -4.89 20.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.728 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.516 ' C ' HD21 ' A' ' 118' ' ' ASN . 13.7 t0 -70.91 -53.2 15.89 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.813 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.516 HD21 ' C ' ' A' ' 117' ' ' ASP . 1.4 m-80 -123.38 0.78 8.95 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' ASN . 26.1 tt0 62.93 64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.4 m -118.06 -69.9 0.82 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.924 -0.485 . . . . 0.0 110.304 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 14.9 mm-40 -45.29 157.04 0.09 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.311 -0.868 . . . . 0.0 109.876 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.84 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.19 154.47 50.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.012 -1.055 . . . . 0.0 110.025 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.2 ptm180 -139.32 149.24 43.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 109.193 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.05 147.32 22.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.188 -0.945 . . . . 0.0 109.135 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.4 103.13 15.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 0.0 109.399 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 64.3 mt -80.94 -40.49 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.1 p -47.84 -31.06 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 109.189 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -95.2 -54.62 3.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -0.783 . . . . 0.0 109.753 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.96 -4.76 34.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.77 -45.95 67.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.132 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.5 p -69.14 3.01 2.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.647 -0.658 . . . . 0.0 109.845 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 131' ' ' ALA . 14.1 m -83.18 -34.58 25.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 0.0 110.2 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 179.52 -163.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.93 -1.106 . . . . 0.0 109.592 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 -9.74 9.57 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.71 139.53 34.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.46 157.6 15.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.176 -0.953 . . . . 0.0 109.512 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.36 138.41 37.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 109.718 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 29.2 t80 -81.06 -43.98 18.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 109.611 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.82 -168.69 20.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 86' ' ' LYS . 29.2 tt0 -151.32 163.53 38.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -1.1 . . . . 0.0 109.408 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.92 140.73 29.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 0.0 108.661 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.45 ' OH ' ' CZ ' ' A' ' 152' ' ' ARG . 4.7 p90 -150.59 166.02 31.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.116 -0.99 . . . . 0.0 109.703 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -85.3 151.48 24.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.563 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -157.72 123.95 4.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 0.4 OUTLIER 55.97 24.15 7.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.366 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.12 10.55 83.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -127.8 138.98 52.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.598 -0.943 . . . . 0.0 109.339 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.461 ' O ' ' N ' ' A' ' 1' ' ' SER . 83.5 m95 -67.67 151.6 47.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.504 ' NZ ' HH21 ' A' ' 152' ' ' ARG . 80.3 tttt -150.72 123.2 8.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -89.47 138.87 31.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.504 HH21 ' NZ ' ' A' ' 150' ' ' LYS . 86.0 mtt180 -143.67 107.35 4.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.26 154.68 39.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -139.8 -33.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.78 86.15 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -137.95 104.76 5.35 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.982 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 152.94 39.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -147.45 125.27 11.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -1.178 . . . . 0.0 109.33 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.36 11.7 25.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -65.75 2.23 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.37 126.99 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.8 pt? -46.77 -33.03 4.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 109.82 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.65 -26.03 26.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.335 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.9 t -74.37 -54.31 7.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.5 m -47.94 -20.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.9 m -71.44 -60.65 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.142 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -15.46 38.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.188 -0.945 . . . . 0.0 110.393 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.64 -44.23 87.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.941 -1.099 . . . . 0.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -71.49 -0.2 9.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -149.41 34.09 1.08 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 tt -75.17 159.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.47 127.88 33.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 74.27 7.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.482 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.6 p . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.484 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.99 174.81 11.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -153.23 -34.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.437 HD21 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -145.94 143.49 29.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.093 -1.004 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -145.94 133.09 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.381 -0.824 . . . . 0.0 109.226 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.79 109.78 17.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.88 151.0 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.04 117.08 1.33 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -108.12 133.24 52.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.9 140.71 8.61 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -158.04 152.96 25.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -1.112 . . . . 0.0 109.984 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.72 130.55 39.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.0 109.597 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.29 133.88 35.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.314 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -79.12 106.85 11.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -90.34 127.57 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -156.24 -36.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.07 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -149.85 22.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 108.977 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.93 2.76 62.46 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -80.63 151.81 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -1.144 . . . . 0.0 109.384 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -157.45 151.65 24.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.14 151.17 19.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.325 -0.859 . . . . 0.0 109.282 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -141.02 99.77 3.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.285 -0.884 . . . . 0.0 109.676 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.28 142.64 30.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 108.625 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.52 112.71 25.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.376 -0.827 . . . . 0.0 109.563 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 130.12 44.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.1 m -149.58 163.06 38.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.089 -1.007 . . . . 0.0 109.937 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 146.08 36.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.5 m-85 -104.24 161.55 13.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.894 . . . . 0.0 109.415 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.06 139.16 52.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.661 -0.65 . . . . 0.0 109.478 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 133.46 22.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.05 176.41 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.21 -8.94 59.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.652 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.8 OUTLIER -83.27 1.6 40.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.157 -0.965 . . . . 0.0 109.736 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.17 58.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -98.29 144.57 27.56 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 38' ' ' GLY . 22.4 t -66.39 136.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.067 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.02 13.44 0.68 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -159.89 173.15 36.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -94.52 -1.74 52.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.052 -1.264 . . . . 0.0 110.289 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.08 -42.08 5.89 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.196 -0.94 . . . . 0.0 110.059 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 26.9 t0 61.47 -1.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 110.094 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.59 124.31 19.74 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.166 -0.959 . . . . 0.0 110.009 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 pt -102.58 139.57 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.62 ' CE1' ' CZ ' ' A' ' 42' ' ' PHE . 1.3 p90 -138.11 -161.67 1.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 22.8 p90 -44.23 -30.49 0.8 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.162 -0.961 . . . . 0.0 110.437 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 2.4 t30 -51.1 -16.95 0.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 109.081 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.5 t-20 -135.03 104.06 5.8 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.525 -0.735 . . . . 0.0 109.071 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.98 -24.69 1.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.6 pttt -167.45 155.07 8.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -77.23 122.46 25.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.521 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.06 62.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.962 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -112.91 -19.0 12.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.57 -13.55 75.62 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.5 p 62.85 10.27 4.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -1.118 . . . . 0.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -92.79 151.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 109.089 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -148.72 142.49 25.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.154 -0.966 . . . . 0.0 110.046 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -91.83 126.41 36.9 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 25.5 m -74.48 -29.54 61.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.38 110.82 0.25 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.86 110.98 18.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -81.67 -163.56 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -152.16 14.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 109.268 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.4 p -154.87 -37.73 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 4.1 65.79 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.57 110.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.421 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.15 -125.63 1.57 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -165.48 160.6 18.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.05 177.59 47.91 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.99 101.97 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -1.155 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -55.25 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -89.27 167.5 13.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.346 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.418 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.5 p -160.48 132.86 6.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.18 128.29 56.44 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.504 -0.747 . . . . 0.0 109.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -96.36 110.51 22.83 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.93 146.88 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.596 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -136.49 94.42 3.01 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.52 -11.57 59.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.93 . . . . 0.0 109.616 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.41 4.7 23.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.35 10.73 7.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.449 -0.782 . . . . 0.0 109.322 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.4 t -81.3 125.77 78.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.022 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.14 -162.23 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.841 1.694 . . . . 0.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.38 -0.12 82.75 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.86 -60.69 2.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -1.172 . . . . 0.0 109.44 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.6 t -89.93 148.65 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 41.3 m-20 -139.35 1.96 2.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 109.659 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -150.92 131.48 13.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.186 -0.946 . . . . 0.0 109.006 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.99 154.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.503 -0.748 . . . . 0.0 109.31 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -139.86 173.93 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 17.1 m-85 -141.55 122.06 14.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.63 157.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.14 114.31 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -107.82 151.95 25.05 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.331 -0.855 . . . . 0.0 109.924 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.36 140.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 108.799 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -62.34 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.076 -1.015 . . . . 0.0 109.877 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -47.6 -20.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 109.569 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.6 -18.28 28.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 109.777 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -64.75 -60.79 2.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.687 -1.258 . . . . 0.0 109.255 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.44 11.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 111.024 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -86.16 -19.58 29.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.944 -1.097 . . . . 0.0 111.379 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 55.33 96.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.759 -1.213 . . . . 0.0 109.275 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -158.74 152.54 23.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.491 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 m -105.15 154.65 19.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.457 -0.777 . . . . 0.0 109.241 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.6 -29.89 0.81 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.429 -0.794 . . . . 0.0 109.727 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.67 -37.39 50.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -58.96 -14.18 8.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 109.345 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.9 t -80.32 165.81 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.131 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 t -68.15 -25.89 65.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.94 . . . . 0.0 109.691 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.12 79.89 0.03 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.45 26.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 13.5 p90 -152.69 142.92 22.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.07 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 48.0 mt -107.49 156.73 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -140.46 161.1 38.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.966 -1.083 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -157.35 117.52 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.055 -1.028 . . . . 0.0 109.756 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -129.54 143.98 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.366 -0.833 . . . . 0.0 109.522 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 117' ' ' ASP . 79.4 m-20 -74.78 101.69 4.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.93 -1.83 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.056 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' CB ' HD21 ' A' ' 4' ' ' ASN . 29.0 t0 -82.57 -52.74 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -122.52 -5.97 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.652 . . . . 0.0 109.851 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 65.81 65.77 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.5 p -123.81 -49.1 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.931 -0.481 . . . . 0.0 109.998 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 54.6 mm-40 -62.94 159.05 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.288 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 177.53 75.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.92 52.28 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.424 -0.798 . . . . 0.0 109.508 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 32.4 ptt180 -136.16 141.16 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.693 . . . . 0.0 109.226 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -92.1 143.61 26.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.0 109.163 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -87.64 103.64 15.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.5 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.6 mt -80.57 -38.31 29.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.4 m -48.25 -33.62 8.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.863 -1.148 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -95.21 -51.12 4.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.406 -0.809 . . . . 0.0 109.747 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.444 ' O ' ' OG1' ' A' ' 133' ' ' THR . 4.9 m-20 -72.55 -7.44 50.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.251 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -60.22 -49.99 75.45 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.009 -1.057 . . . . 0.0 109.825 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 p -55.88 0.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.78 . . . . 0.0 110.509 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 131' ' ' ALA . 38.0 p -87.42 -33.12 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.746 -1.221 . . . . 0.0 110.081 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -172.34 -145.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.785 -1.197 . . . . 0.0 109.712 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 21.1 m -126.61 -40.23 1.94 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.18 155.97 26.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 ttt -166.81 157.59 12.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.16 -0.963 . . . . 0.0 109.829 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.81 126.8 50.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.328 -0.857 . . . . 0.0 109.337 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -70.07 -37.13 75.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.932 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.1 -163.39 24.06 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.851 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -151.54 164.09 37.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -1.069 . . . . 0.0 109.519 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.72 140.04 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.244 -0.91 . . . . 0.0 108.571 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.447 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.8 p90 -150.61 166.31 30.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.913 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 17.4 ptm180 -85.34 152.7 23.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.514 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 2.1 t60 -153.9 119.9 5.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.267 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 29.0 m-20 52.46 29.39 6.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 109.501 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.52 81.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -127.87 134.91 49.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.48 -1.012 . . . . 0.0 109.396 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.43 149.34 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -148.86 125.98 11.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.208 -0.932 . . . . 0.0 109.538 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -93.37 140.99 28.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 109.971 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -144.06 107.54 4.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.422 -0.799 . . . . 0.0 109.09 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.13 154.65 41.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.098 -1.001 . . . . 0.0 109.72 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.24 -33.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.81 85.82 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.308 -1.113 . . . . 0.0 109.572 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.56 154.03 46.75 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 12.7 p90 -137.88 124.04 20.39 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.377 -1.072 . . . . 0.0 109.436 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.63 3.08 34.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.45 -75.09 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 156.39 136.59 2.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.7 pp -47.38 -36.97 10.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -1.172 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.86 -16.83 37.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.3 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 161' ' ' GLY . 34.5 m -78.82 -56.0 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 m -51.62 -19.94 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 109.11 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.594 ' SG ' ' CG ' ' A' ' 42' ' ' PHE . 70.8 m -73.67 -63.02 1.29 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.469 -0.769 . . . . 0.0 110.352 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.28 35.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.849 . . . . 0.0 110.583 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -61.37 -48.74 79.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.064 -1.022 . . . . 0.0 110.26 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -71.74 -20.33 61.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 109.464 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.62 -46.46 5.74 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.95 139.3 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -72.6 112.92 9.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.41 50.23 1.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.425 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' TRP . 26.0 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.448 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 20.3 mmt -79.95 -176.29 5.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 82.7 mttt -151.73 -35.77 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 51.8 m-20 -145.09 143.77 30.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.81 158.14 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 tp -145.34 109.75 4.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.03 145.7 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.36 117.21 2.89 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.93 124.92 50.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.15 150.47 22.68 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.535 -1.317 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -157.04 153.98 28.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.412 -1.052 . . . . 0.0 109.804 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.69 130.05 34.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.762 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.85 133.38 33.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -86.33 109.26 18.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.532 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -82.85 124.46 30.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.456 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -154.19 -41.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -149.44 28.13 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 109.047 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.2 -30.32 5.61 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.98 158.4 19.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.407 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -165.91 176.09 8.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.558 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 60.9 m-85 -96.41 146.79 24.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 12.1 m-20 -141.03 99.62 3.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 8.7 mp -85.28 140.64 30.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 108.524 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -103.17 119.7 39.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.29 131.71 43.73 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.292 -0.88 . . . . 0.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 13.5 t -150.19 168.18 24.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.63 147.47 45.19 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -103.6 123.15 46.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.614 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.02 135.72 37.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 108.725 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.01 128.33 17.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.964 -1.085 . . . . 0.0 110.388 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 176.26 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.71 1.13 44.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -84.62 -7.44 59.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 -10.78 73.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -105.07 148.09 27.17 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 38' ' ' GLY . 44.3 t -66.39 137.25 25.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.91 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -70.79 7.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -154.04 172.66 32.7 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.94 -2.88 49.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.842 -1.387 . . . . 0.0 110.321 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.19 -40.85 6.27 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.09 -1.006 . . . . 0.0 110.982 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.44 10.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.74 -1.225 . . . . 0.0 109.329 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.8 t80 -138.12 100.22 4.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.0 109.533 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.8 pt -101.41 137.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.22 -0.925 . . . . 0.0 109.086 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.8 p90 -142.81 -162.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.3 p90 -45.23 -32.37 1.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -0.942 . . . . 0.0 110.512 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 17.9 t-20 -51.83 -11.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.886 -1.134 . . . . 0.0 109.036 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.0 t-20 -135.6 107.8 7.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.9 tp -47.52 -29.71 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 35.3 pttt -168.85 156.96 7.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -65.95 144.25 56.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.92 -46.98 32.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -116.07 -2.78 12.17 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -81.05 -15.68 76.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.8 p 62.46 9.41 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.426 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.07 149.82 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.154 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.51 137.75 25.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.164 -0.96 . . . . 0.0 109.869 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -89.42 135.25 33.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.773 . . . . 0.0 108.931 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -73.38 -44.44 58.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.09 110.11 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.59 110.89 12.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -1.142 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.96 -164.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -158.18 17.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -155.71 -40.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.332 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.74 69.72 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.48 110.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -1.152 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.4 -140.72 6.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 68' ' ' GLY . 22.7 t0 -80.0 -169.95 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -1.109 . . . . 0.0 109.516 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 67' ' ' ASP . . . -60.8 -93.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 42.8 p-10 -48.66 98.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -1.153 . . . . 0.0 109.564 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 68' ' ' GLY . 68.0 m-20 -74.8 -46.18 38.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.46 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' CG ' ' N ' ' A' ' 72' ' ' SER . 68.0 tt0 -115.82 162.7 16.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.685 . . . . 0.0 109.176 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 m -153.53 143.09 21.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.73 123.1 41.05 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.603 -0.685 . . . . 0.0 109.24 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -95.61 138.63 33.01 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.27 146.82 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.434 -0.791 . . . . 0.0 110.182 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -139.12 106.42 5.51 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 79' ' ' ALA . 9.0 mt -78.98 -42.52 26.49 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -52.55 -8.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.977 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.68 19.5 16.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.55 -0.719 . . . . 0.0 109.67 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 81' ' ' PRO . 47.2 t -104.63 105.17 49.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.319 -0.863 . . . . 0.0 109.246 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.2 Cg_exo -48.97 -173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.039 1.826 . . . . 0.0 112.355 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.25 0.33 87.22 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.77 -58.51 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -1.198 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.35 145.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -135.93 -5.74 2.15 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.082 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -142.46 130.67 22.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.997 -1.064 . . . . 0.0 109.214 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.1 mt -139.99 113.99 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.67 173.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.316 -0.865 . . . . 0.0 109.121 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.94 142.2 51.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.7 t -146.9 156.53 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.857 -1.152 . . . . 0.0 111.713 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.58 113.65 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -120.57 161.67 20.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.295 -0.878 . . . . 0.0 110.828 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -77.56 161.87 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.428 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.3 t60 -111.19 -76.05 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.344 -0.848 . . . . 0.0 109.934 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' GLN . 1.4 m-20 -47.82 -18.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.772 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -47.77 -19.07 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 49.7 tt0 -71.45 -62.22 1.49 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.95 -1.094 . . . . 0.0 109.319 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.52 -43.82 9.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.339 -0.85 . . . . 0.0 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HE ' ' CD ' ' A' ' 101' ' ' GLN . 40.9 ttt85 -79.23 -20.18 48.87 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 99' ' ' ARG . 59.5 ttt-85 54.59 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.745 -1.222 . . . . 0.0 109.474 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.449 ' CD ' ' HE ' ' A' ' 99' ' ' ARG . 18.8 mt-30 -157.8 141.47 15.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -102.2 163.89 11.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -46.73 -33.01 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.844 . . . . 0.0 109.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 106' ' ' VAL . . . -63.5 -42.28 98.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 66.1 mm-40 -51.21 -12.04 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.156 -1.202 . . . . 0.0 109.225 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 104' ' ' GLY . 21.4 t -82.74 165.29 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.852 . . . . 0.0 109.204 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.2 m -69.39 -18.51 63.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.195 -0.941 . . . . 0.0 109.657 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.76 79.46 0.03 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.19 157.51 22.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -1.18 . . . . 0.0 109.706 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 26.5 p90 -150.24 169.71 20.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 109.969 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -135.87 151.56 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -138.17 161.59 36.43 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.022 -1.049 . . . . 0.0 109.984 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.1 tt -154.14 116.32 4.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.177 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.69 144.94 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.317 -0.864 . . . . 0.0 109.957 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.448 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 57.8 t30 -76.13 102.03 5.58 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.91 -1.57 3.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.668 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 115' ' ' ASN . 17.5 t70 -82.64 -53.78 5.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.42 ' OD1' ' OG1' ' A' ' 120' ' ' THR . 13.7 p30 -123.82 6.81 8.73 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.737 -0.602 . . . . 0.0 109.638 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' ASN . 8.1 mt-30 59.55 60.52 2.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 118' ' ' ASN . 86.0 m -110.82 -70.41 0.81 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.896 -0.502 . . . . 0.0 110.342 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 22.9 mm-40 -45.3 157.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.18 156.01 48.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.168 -0.958 . . . . 0.0 109.923 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptp180 -142.49 143.31 32.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.545 -0.722 . . . . 0.0 109.243 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.429 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.4 t80 -91.22 142.04 28.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 108.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -85.26 102.86 13.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.065 -1.022 . . . . 0.0 109.432 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 54.1 mt -79.0 -39.21 34.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.166 -0.959 . . . . 0.0 109.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.2 t -47.79 -31.07 4.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.992 -1.067 . . . . 0.0 109.209 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.18 -54.6 3.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.773 . . . . 0.0 109.711 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.429 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 46.8 m-20 -73.23 -2.68 22.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.283 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -54.1 -47.15 72.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.087 -1.008 . . . . 0.0 109.238 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 t -68.1 3.12 1.73 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.549 -0.719 . . . . 0.0 109.819 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 131' ' ' ALA . 10.4 m -84.3 -34.93 23.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.985 . . . . 0.0 110.169 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -177.53 -166.31 0.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.931 -1.105 . . . . 0.0 109.66 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.69 -10.72 9.14 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.79 26.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.68 158.14 15.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.41 134.16 37.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.1 t80 -73.33 -45.44 55.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.892 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.74 -162.5 11.26 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 22.2 tt0 -151.97 164.29 37.47 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.106 -1.232 . . . . 0.0 109.839 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 13.3 tp -144.16 133.35 23.0 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -148.64 166.22 28.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.0 109.639 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 14.5 ptm180 -94.47 141.24 28.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.377 -0.827 . . . . 0.0 110.095 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 10.2 t-160 -100.03 -132.88 0.26 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.616 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.3 m120 -51.85 -51.45 56.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.887 -1.133 . . . . 0.0 108.322 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.48 16.93 0.14 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.83 159.51 36.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.5 m95 -77.73 151.81 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -148.21 124.99 11.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -89.69 147.65 23.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.377 -0.827 . . . . 0.0 109.391 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -153.9 109.35 3.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.69 154.68 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.526 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.58 -34.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.14 84.22 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.32 104.41 7.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.68 -0.894 . . . . 0.0 109.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 149.96 29.32 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.63 127.47 19.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.46 12.15 21.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.6 -67.18 1.76 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.77 126.89 1.13 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -44.68 -32.5 1.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.363 -1.08 . . . . 0.0 110.099 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.74 -27.19 25.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 161' ' ' GLY . 23.3 t -77.71 -50.51 12.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.426 -0.796 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -48.68 -20.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.483 ' SG ' ' CB ' ' A' ' 42' ' ' PHE . 56.7 m -72.35 -61.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.57 -15.36 37.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.165 -0.959 . . . . 0.0 110.537 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.88 -42.14 99.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.033 . . . . 0.0 110.476 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.62 -20.62 61.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.513 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.04 -49.56 5.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.02 132.17 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.475 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.39 146.06 45.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 -178.45 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.536 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.1 mpt? -73.06 171.46 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -153.98 -34.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.06 128.31 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.245 -0.91 . . . . 0.0 109.233 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.673 ' N ' HD21 ' A' ' 4' ' ' ASN . 5.2 t -127.69 156.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.613 -0.679 . . . . 0.0 109.178 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -142.4 107.18 4.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.067 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.78 150.6 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.83 116.94 1.32 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.71 135.18 45.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.9 135.46 5.9 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -157.04 153.2 27.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -1.103 . . . . 0.0 109.816 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.09 108.02 20.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.09 162.36 24.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -132.84 106.77 7.92 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.452 -0.78 . . . . 0.0 109.246 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.9 p -89.97 105.71 17.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 p -85.29 -100.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.318 -0.864 . . . . 0.0 109.199 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -83.42 -10.6 58.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.285 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.37 -17.14 0.36 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.89 176.36 2.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 109.664 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -176.75 162.38 2.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.34 141.66 29.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.239 -0.913 . . . . 0.0 109.402 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.4 p30 -141.07 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.155 -0.966 . . . . 0.0 109.595 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.69 134.87 34.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 108.877 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -92.4 107.13 18.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.034 -1.042 . . . . 0.0 109.83 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.41 123.46 42.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.74 167.59 26.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.101 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.49 46.2 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.6 m-85 -104.37 128.37 52.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.338 -0.851 . . . . 0.0 108.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.623 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.76 155.62 17.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 110.088 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.53 137.28 25.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.349 -0.845 . . . . 0.0 109.362 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -80.16 176.67 9.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.16 -8.56 59.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.966 . . . . 0.0 109.805 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -85.67 2.91 43.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.139 -0.975 . . . . 0.0 109.808 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.03 -18.31 57.6 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 31' ' ' ALA . 84.6 mttt -106.61 173.23 6.41 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.584 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -101.3 142.18 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.405 -0.809 . . . . 0.0 109.675 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -60.11 -5.55 1.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -144.33 102.32 0.27 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 31.8 p-10 -45.28 -25.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -1.101 . . . . 0.0 110.356 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -58.76 -42.06 88.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.067 -1.02 . . . . 0.0 109.822 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 38.8 t0 46.27 15.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 81.5 t80 -137.35 99.58 4.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 109.419 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.0 pt -102.86 137.92 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.7 p90 -140.85 -160.78 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.18 -0.95 . . . . 0.0 109.344 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.4 p90 -44.68 -31.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 0.0 110.495 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.6 t-20 -51.05 -14.27 0.22 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.903 -1.123 . . . . 0.0 109.01 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.4 t-20 -135.77 107.38 6.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -47.78 -26.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.372 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 14.4 pttm -170.52 159.14 6.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.626 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t -73.22 129.99 39.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.388 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.24 -30.36 54.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.66 -15.97 11.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.626 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -84.46 -12.58 75.28 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 60.68 10.75 2.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.75 151.9 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 108.963 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -145.37 145.0 31.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -90.94 119.59 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 m -67.24 -46.98 72.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.27 117.61 0.77 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -78.46 158.9 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -1.178 . . . . 0.0 109.543 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -157.55 109.98 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.59 17.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.897 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -152.56 -35.05 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.255 -0.903 . . . . 0.0 109.372 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.46 18.7 59.01 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -58.44 110.4 0.97 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -1.13 . . . . 0.0 109.399 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 177.06 -134.87 2.63 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -166.04 69.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -1.144 . . . . 0.0 109.442 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.55 -166.57 33.33 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.16 99.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -1.135 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -69.11 -73.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -98.67 164.45 12.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.81 139.33 10.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.338 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.94 127.32 53.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.524 -0.735 . . . . 0.0 109.382 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 52.4 tttp -96.19 114.79 26.52 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.531 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 64.5 mt -104.18 147.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.388 -0.82 . . . . 0.0 110.571 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HZ1' ' CD ' ' A' ' 74' ' ' LYS . 64.4 mttp -138.71 105.65 5.42 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.27 -38.61 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.15 -22.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.71 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.06 -24.03 17.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.279 -0.888 . . . . 0.0 109.75 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.99 124.24 79.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 109.334 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.23 -160.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.939 1.759 . . . . 0.0 111.826 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.25 0.89 88.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -66.98 -56.37 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.15 148.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 11.7 t0 -125.53 -19.58 4.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.572 -0.705 . . . . 0.0 109.567 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -149.43 143.42 25.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.118 -0.989 . . . . 0.0 109.784 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 89.6 mt -135.21 154.35 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -145.21 172.77 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 2.9 m-85 -142.47 118.76 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.16 158.01 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.308 -0.87 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.41 113.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 p -110.44 156.29 21.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 0.0 110.347 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.16 144.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.405 ' C ' ' N ' ' A' ' 96' ' ' ALA . 74.6 t60 -99.46 -69.1 0.78 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' NE2' ' A' ' 101' ' ' GLN . 2.9 p30 -49.14 -18.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.849 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.48 -50.37 59.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.712 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 -30.25 41.38 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.799 -1.188 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.85 -53.71 4.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.066 -1.021 . . . . 0.0 111.471 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 100' ' ' ARG . 5.1 ptp180 -112.14 3.5 17.3 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.153 -0.967 . . . . 0.0 111.101 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 85.9 mtt-85 53.42 104.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OD1' ' A' ' 95' ' ' ASP . 25.3 mt-30 -147.93 137.85 22.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.4 p -94.71 160.54 14.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -46.66 -37.03 7.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -58.25 -37.73 87.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -47.7 -16.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -1.226 . . . . 0.0 109.322 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 104' ' ' GLY . 33.6 t -87.58 166.75 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 109.121 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 t -67.92 -21.68 65.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 109.707 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.96 79.4 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.03 162.17 25.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 109.75 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 17.8 p90 -155.8 161.44 40.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.8 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 49.7 mt -123.25 157.97 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -141.18 159.71 41.63 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.045 -1.034 . . . . 0.0 109.614 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.3 tt -154.67 117.42 4.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.953 -1.092 . . . . 0.0 109.499 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.5 144.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 119' ' ' GLN . 55.7 t30 -76.76 102.06 6.09 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 4' ' ' ASN . 23.0 t70 -67.2 -1.61 4.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.318 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -80.65 -53.35 6.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.223 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -123.33 3.97 9.13 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 115' ' ' ASN . 11.9 mt-30 59.75 61.18 2.0 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.8 m -113.54 -68.49 0.92 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.956 -0.465 . . . . 0.0 110.363 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 36.4 mm-40 -45.25 157.65 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.907 . . . . 0.0 109.907 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.83 73.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.84 150.3 52.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.044 -1.035 . . . . 0.0 110.084 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.3 ptm180 -140.28 142.66 35.7 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.27 146.39 23.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.062 -1.024 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.39 103.4 16.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 109.389 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.6 mt -79.55 -36.52 38.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m -48.08 -32.4 6.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.048 . . . . 0.0 109.213 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.23 -53.88 3.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.76 -4.15 32.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -51.96 -42.91 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.0 t -74.38 2.95 8.22 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.979 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -83.39 -34.2 25.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.167 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -176.43 -167.41 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.928 -1.107 . . . . 0.0 109.654 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.09 -15.75 8.68 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.22 140.48 41.73 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 45.7 ttp -165.8 158.0 14.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 109.749 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -99.91 135.71 40.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.388 -0.82 . . . . 0.0 109.152 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.99 -43.75 33.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 0.0 109.628 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.29 -172.48 31.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.56 166.65 29.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.238 . . . . 0.0 109.943 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.89 143.56 45.07 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -148.1 166.05 28.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.045 . . . . 0.0 109.667 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -95.02 146.05 24.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.682 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -122.49 -120.63 0.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.466 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.4 m-80 -73.61 52.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.24 9.61 86.38 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.82 138.22 52.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.526 -0.985 . . . . 0.0 109.387 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -67.42 151.67 47.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -149.78 128.61 12.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.456 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -89.8 151.01 22.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 109.779 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -156.12 107.19 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.68 39.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.686 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.33 -34.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.66 87.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -132.37 104.45 6.73 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.62 150.88 35.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -144.32 126.36 15.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -1.099 . . . . 0.0 109.268 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.5 11.91 20.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.25 -77.74 0.11 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 158.3 138.29 2.45 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.71 -34.94 20.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.187 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -81.64 -15.56 54.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.6 m -90.15 -53.99 4.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.8 m -54.5 -21.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 15.0 p -75.85 -51.96 11.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.041 -1.037 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.625 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.82 -25.39 23.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.905 -1.122 . . . . 0.0 110.492 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -57.59 -39.56 77.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.046 -1.034 . . . . 0.0 110.469 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -71.0 -19.53 62.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.89 -49.44 7.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 87.2 mt -80.49 157.13 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.127 . . . . 0.0 109.5 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -75.79 136.27 40.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 -178.47 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.445 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 149' ' ' TRP . 21.0 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.275 0.559 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 46.5 mtt -152.55 90.98 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.21 -21.97 49.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 6.7 m120 -146.36 139.58 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -145.67 129.62 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 109.196 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.9 113.71 25.9 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.11 150.68 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -134.7 116.85 1.66 Allowed Glycine 0 N--CA 1.499 2.851 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -115.57 126.22 53.95 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.52 151.99 24.18 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.563 -1.303 . . . . 0.0 109.964 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -161.58 152.45 18.06 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.369 -1.077 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.27 127.54 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 109.591 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.5 170.73 14.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.895 . . . . 0.0 109.382 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -128.64 126.89 41.12 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.562 -0.711 . . . . 0.0 109.297 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -84.74 127.64 34.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.3 m -149.56 -45.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.88 . . . . 0.0 109.373 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -152.69 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.21 -24.98 9.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.626 HE22 ' NH2' ' A' ' 99' ' ' ARG . 18.2 mt-30 -71.91 177.85 4.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -1.155 . . . . 0.0 109.423 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -173.2 178.31 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.578 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -96.28 143.45 27.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -141.09 100.33 3.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 109.863 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.09 138.55 33.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' CE2' ' A' ' 44' ' ' PHE . 58.7 t0 -98.81 119.78 38.14 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.161 -0.962 . . . . 0.0 110.383 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -100.53 133.79 44.45 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.2 t -150.0 167.7 25.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.051 -1.03 . . . . 0.0 109.801 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.77 148.82 39.41 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.19 162.11 13.24 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.17 148.91 43.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.87 . . . . 0.0 109.683 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.03 141.05 28.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.925 . . . . 0.0 109.076 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 176.33 7.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.6 -1.0 52.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.9 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.509 ' ND2' ' HZ3' ' A' ' 35' ' ' LYS . 18.7 t30 -95.95 4.17 52.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.181 -0.949 . . . . 0.0 109.959 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.02 -13.4 66.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HZ3' ' ND2' ' A' ' 33' ' ' ASN . 41.7 mttp -105.03 163.83 12.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.602 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.5 t -90.06 136.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.229 -0.92 . . . . 0.0 109.045 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -66.46 4.09 0.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.14 127.1 1.82 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.6 5.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -1.185 . . . . 0.0 110.523 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -92.14 -42.57 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.847 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 48.0 12.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.653 -1.28 . . . . 0.0 109.468 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ALA . 13.0 t80 -137.68 99.48 3.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.456 -0.778 . . . . 0.0 109.094 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 4.0 pt -97.08 120.96 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.269 -0.894 . . . . 0.0 109.367 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 25' ' ' ALA . 27.0 t80 -171.48 -166.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 67.9 m-85 54.2 -112.89 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.825 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.17 -21.53 65.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 24.0 t-20 -81.39 68.9 7.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -54.29 -19.61 5.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.152 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 14.8 pttm -163.37 156.65 19.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.474 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 69.5 m -74.54 148.11 41.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.87 -46.41 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.197 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -116.47 -0.4 12.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.725 -0.609 . . . . 0.0 109.647 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.02 -9.74 76.59 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 t 60.52 12.31 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -1.082 . . . . 0.0 109.633 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -93.01 147.97 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -149.2 137.61 20.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.047 -1.033 . . . . 0.0 109.887 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -91.7 132.11 36.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.375 -0.828 . . . . 0.0 108.906 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 72' ' ' SER . 24.4 m -68.54 -57.57 5.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.94 124.25 1.11 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.5 112.24 19.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.146 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.11 121.38 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -79.49 13.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.441 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -153.76 -35.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.32 12.12 57.59 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -59.92 114.92 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.2 -143.69 9.14 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -160.59 67.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . 170.96 176.46 40.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -49.8 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -1.21 . . . . 0.0 109.435 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' GLY . 28.5 m-20 -69.81 -67.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -93.09 102.8 15.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 58' ' ' THR . 55.1 m -91.88 133.4 35.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.17 126.52 55.3 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.49 140.16 30.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.269 -0.894 . . . . 0.0 109.33 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 54.3 mt -133.79 146.74 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -145.42 99.86 3.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 79' ' ' ALA . 6.4 mt -81.62 -25.23 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.97 . . . . 0.0 109.865 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.27 4.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.91 22.72 3.56 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 81' ' ' PRO . 55.3 t -104.01 105.7 49.78 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.261 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' VAL . 71.4 Cg_exo -48.39 -174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.02 1.813 . . . . 0.0 112.275 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 1.54 88.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -55.11 20.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -1.112 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.86 121.45 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.381 -0.824 . . . . 0.0 109.121 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.73 -1.6 32.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.325 -0.859 . . . . 0.0 110.289 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -158.17 144.64 17.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.123 . . . . 0.0 110.106 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mt -146.11 118.56 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 173.34 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 0.0 109.737 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 96.5 m-85 -140.3 118.13 11.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.11 158.01 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.471 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.42 117.56 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -112.69 149.91 32.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.15 149.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.755 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 96' ' ' ALA . 66.9 t60 -103.91 -68.85 0.82 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -46.9 -19.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 109.614 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 94' ' ' HIS . . . -57.91 -18.5 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.82 -60.6 2.89 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.716 -1.24 . . . . 0.0 109.315 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.53 -33.3 15.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 111.127 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.626 ' NH2' HE22 ' A' ' 19' ' ' GLN . 22.5 mtt-85 -95.57 -18.88 20.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.895 -1.128 . . . . 0.0 111.503 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttt85 56.9 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.796 -1.19 . . . . 0.0 108.984 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -146.09 138.45 25.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.37 -0.831 . . . . 0.0 109.246 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.6 p -96.08 164.27 12.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 135' ' ' THR . 46.8 m-85 -48.17 -35.71 12.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -60.75 -37.84 94.24 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -47.27 -16.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -1.189 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 104' ' ' GLY . 21.6 t -86.74 168.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.044 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 m -68.19 -20.96 64.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.77 80.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.26 164.11 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.9 p90 -154.23 155.32 35.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 50.0 mt -120.08 153.66 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -140.18 159.57 41.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.966 -1.084 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 3.3 tt -153.57 116.34 4.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 109.467 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -129.38 143.12 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.467 -0.771 . . . . 0.0 109.749 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 119' ' ' GLN . 60.7 t-20 -78.24 101.88 7.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.48 -1.96 4.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 0.0 109.301 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 115' ' ' ASN . 21.1 t0 -77.56 -53.34 7.71 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.032 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.44 3.12 9.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 115' ' ' ASN . 24.6 mt-30 60.01 61.74 1.8 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.6 p -115.17 -67.93 0.96 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.903 -0.498 . . . . 0.0 110.379 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 47.9 mm-40 -45.37 157.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 109.973 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.98 73.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.54 152.55 51.54 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.123 -0.985 . . . . 0.0 109.841 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.5 ptt180 -140.16 145.82 37.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.552 -0.718 . . . . 0.0 109.377 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -91.32 147.82 22.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 108.975 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.73 101.94 14.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.243 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' ALA . 26.5 mt -81.43 -31.66 33.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.524 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.7 m -48.48 -36.82 15.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 108.82 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -95.4 -49.94 5.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.477 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.62 -11.63 58.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -51.35 -43.8 61.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 109.246 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.0 m -74.46 2.89 8.51 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.639 -0.663 . . . . 0.0 109.978 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -89.74 -33.94 16.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.056 . . . . 0.0 110.376 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -175.48 -176.48 0.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.772 -1.205 . . . . 0.0 109.844 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -112.84 -16.37 12.74 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.01 138.65 40.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.8 ttp -164.99 157.78 16.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 109.703 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.61 139.23 33.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.253 -0.904 . . . . 0.0 109.636 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.7 t80 -82.51 -44.07 16.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.082 -1.011 . . . . 0.0 109.605 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.31 -171.41 29.52 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -150.82 166.77 29.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.293 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mt -138.94 131.8 29.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.2 p90 -138.86 166.15 25.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.302 -0.873 . . . . 0.0 109.707 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.7 ptm180 -85.79 149.37 25.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.827 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.524 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 80.4 t60 -155.01 124.54 6.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 0.0 109.217 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.524 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 6.2 m120 54.11 26.04 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.55 11.62 82.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.88 140.4 52.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.508 -0.995 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' SER . 78.2 m95 -68.11 151.51 46.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.221 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -150.73 135.65 17.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 17.5 t80 -93.81 150.46 20.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.741 . . . . 0.0 109.701 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 15.2 tpt85 -156.16 107.1 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.099 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.19 154.6 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.704 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.28 -32.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.497 -0.752 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.79 83.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -139.18 104.28 4.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.981 . . . . 0.0 109.377 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.76 151.07 31.76 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -143.78 123.26 13.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.391 -1.064 . . . . 0.0 109.245 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.93 10.45 21.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 109.503 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -73.94 0.29 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.1 135.21 1.89 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -46.95 -24.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -1.177 . . . . 0.0 109.807 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.85 -33.86 21.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.9 t -75.19 -51.93 12.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.701 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 33.3 m -46.6 -19.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 85.0 m -73.32 -61.23 1.9 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.063 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.99 -15.39 38.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.244 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -59.38 -40.62 87.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 171' ' ' ILE . 15.2 m-85 -71.65 -15.83 62.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.21 -0.932 . . . . 0.0 109.398 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -52.6 -7.73 0.45 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.513 ' H ' ' C ' ' A' ' 169' ' ' TYR . 21.3 pt -71.69 156.4 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -1.23 . . . . 0.0 109.505 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 3.0 m-20 -73.06 108.29 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.67 144.44 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 109.457 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.487 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.86 173.39 12.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -153.41 -35.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 3.9 m120 -146.14 140.18 26.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.9 t -141.74 146.0 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.35 -0.844 . . . . 0.0 109.245 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 tp -130.7 109.39 10.59 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.63 147.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 108.514 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.89 116.8 1.38 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.48 136.64 41.94 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.49 137.35 6.74 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -157.37 152.52 25.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -1.137 . . . . 0.0 109.759 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.46 109.59 22.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.678 -0.639 . . . . 0.0 109.544 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.78 168.13 18.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -132.74 106.68 7.91 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.468 -0.77 . . . . 0.0 109.29 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -92.29 105.81 17.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 p -82.54 -29.76 30.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.241 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -158.38 -34.71 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.0 109.37 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.97 -32.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 19' ' ' GLN . 1.8 mp0 -70.14 174.34 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -1.143 . . . . 0.0 109.608 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -175.84 177.12 1.72 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.42 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.0 m-85 -96.26 145.29 25.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.416 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.92 140.74 34.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 mt -128.52 128.61 44.64 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -91.97 108.55 20.01 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.168 -0.957 . . . . 0.0 110.176 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 44' ' ' PHE . . . -100.6 125.97 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.284 -0.885 . . . . 0.0 108.936 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p -149.46 168.04 24.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 0.0 109.937 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.44 139.75 44.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.46 125.75 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.2 152.97 18.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.343 -0.848 . . . . 0.0 109.605 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.42 138.25 27.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.1 176.41 8.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.563 -0.711 . . . . 0.0 109.232 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.48 -8.41 58.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.784 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 3.51 39.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.927 . . . . 0.0 109.947 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.47 61.53 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -104.2 168.56 9.03 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.611 ' C ' ' H ' ' A' ' 38' ' ' GLY . 18.9 t -93.18 137.05 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.173 -0.955 . . . . 0.0 108.993 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 32.3 ttp180 -63.84 2.09 0.55 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.36 128.22 2.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -65.07 4.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -1.189 . . . . 0.0 110.234 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -94.35 -41.87 9.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.0 -1.062 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 t0 45.78 17.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.0 109.477 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 40' ' ' ALA . 31.8 t80 -136.97 106.59 6.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 109.627 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.9 pt -112.64 139.69 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.581 -0.699 . . . . 0.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -161.01 -145.23 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 47' ' ' ASN . 46.8 p90 -43.76 -31.1 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 109.944 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.09 3.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.3 t-20 -158.65 116.28 2.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.154 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -50.66 -36.04 33.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttp -165.78 157.43 14.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 109.361 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.496 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 3.4 t -70.54 120.1 15.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.58 87.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.178 -0.951 . . . . 0.0 109.547 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 43.4 p-10 -103.27 -17.61 15.24 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.516 -0.74 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.496 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -84.36 -15.34 69.18 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.1 p 61.86 11.19 3.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -1.104 . . . . 0.0 109.491 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -93.02 151.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.311 -0.868 . . . . 0.0 109.175 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 m -148.05 136.26 21.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 0.0 110.078 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.41 129.75 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -68.59 -56.62 7.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 109.335 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.17 123.41 1.22 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -81.72 110.89 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -81.72 -169.63 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -150.82 12.28 0.68 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 109.544 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.8 p -156.64 -35.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.94 11.71 25.91 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.42 110.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -1.118 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.05 -130.35 2.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -170.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -1.168 . . . . 0.0 109.542 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.63 178.1 33.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -50.04 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.174 . . . . 0.0 109.456 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -70.8 -68.93 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -86.9 175.64 8.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 109.533 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -159.25 132.43 7.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.314 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.41 123.43 44.09 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.704 ' HZ3' ' HZ2' ' A' ' 76' ' ' LYS . 33.0 tttm -95.18 137.61 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 52.1 mt -128.75 147.07 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.547 -0.721 . . . . 0.0 110.348 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HZ2' ' HZ3' ' A' ' 74' ' ' LYS . 65.8 mttm -140.51 97.16 3.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.54 -5.31 49.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.99 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.98 -22.97 31.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.095 -1.003 . . . . 0.0 109.777 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.34 -11.61 27.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.183 -0.948 . . . . 0.0 109.891 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.98 123.99 77.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.22 -161.33 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.795 1.663 . . . . 0.0 112.098 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.05 -0.17 83.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.2 m-20 -70.06 -60.35 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.11 144.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.66 10.95 5.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.393 -0.817 . . . . 0.0 109.532 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 141' ' ' GLU . 81.7 tttt -158.48 144.13 16.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.225 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.39 115.75 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.081 -1.012 . . . . 0.0 109.369 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.1 173.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 95.0 m-85 -142.29 129.55 21.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.55 157.76 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 0.0 110.649 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.42 113.62 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.401 ' HG1' ' CB ' ' A' ' 162' ' ' LEU . 4.3 p -110.22 154.64 23.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.393 -0.817 . . . . 0.0 110.778 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.22 151.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 96' ' ' ALA . 9.3 t60 -101.93 -74.23 0.63 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.372 -0.83 . . . . 0.0 110.271 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.09 -17.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 109.798 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -49.98 -19.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.448 -0.782 . . . . 0.0 109.504 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -71.61 -62.58 1.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.971 -1.08 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -39.27 12.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.33 -0.856 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.613 ' NE ' ' NE2' ' A' ' 101' ' ' GLN . 49.4 ttt180 -83.89 -20.2 33.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.934 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 ttp85 53.33 96.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.766 -1.209 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.613 ' NE2' ' NE ' ' A' ' 99' ' ' ARG . 60.7 mt-30 -155.85 143.5 19.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.453 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -100.7 166.27 10.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.468 -0.77 . . . . 0.0 109.627 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -49.12 -29.7 5.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 106' ' ' VAL . . . -65.03 -40.34 97.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 29.5 mm-40 -51.03 -11.7 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.315 . . . . 0.0 109.326 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 104' ' ' GLY . 11.3 t -86.7 162.63 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.845 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 t -64.29 -23.35 67.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.83 79.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.37 162.28 25.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 109.686 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 20.5 p90 -156.21 158.39 37.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 110.004 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 32.0 mt -120.55 156.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -143.42 159.09 43.02 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.926 -1.109 . . . . 0.0 109.912 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 tt -152.43 124.39 8.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.209 -0.932 . . . . 0.0 109.185 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.07 144.87 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.429 -0.795 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -74.45 101.83 4.26 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.84 -1.84 2.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.677 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.6 t0 -84.37 -53.85 5.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.912 . . . . 0.0 109.919 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -123.75 7.6 8.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.628 -0.67 . . . . 0.0 109.996 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 59.66 60.2 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 m -109.98 -70.52 0.81 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.825 -0.547 . . . . 0.0 110.3 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -45.27 157.43 0.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.49 72.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.05 150.54 52.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.088 -1.007 . . . . 0.0 110.13 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.2 ptt180 -143.27 140.21 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.707 . . . . 0.0 109.136 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -91.26 147.86 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 109.016 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.56 102.04 14.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.075 -1.016 . . . . 0.0 108.942 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 131' ' ' ALA . 21.5 mt -76.37 -26.57 55.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.6 m -49.57 -33.61 15.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.969 -1.082 . . . . 0.0 108.385 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.44 -52.05 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 109.286 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.458 ' OD2' ' SD ' ' A' ' 137' ' ' MET . 15.7 t70 -67.1 -10.71 52.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.199 -0.938 . . . . 0.0 109.987 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -51.41 -46.33 62.88 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.8 t -71.46 3.47 3.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.761 -0.587 . . . . 0.0 110.022 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.2 m -92.12 -34.23 14.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.949 -1.094 . . . . 0.0 110.49 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -175.51 -174.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.676 -1.265 . . . . 0.0 110.011 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.29 -8.94 12.27 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.81 137.2 26.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.458 ' SD ' ' OD2' ' A' ' 130' ' ' ASP . 12.4 ptp -165.41 158.21 15.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.86 141.92 27.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.196 -0.94 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -85.5 -44.61 12.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.99 -176.02 24.27 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 86' ' ' LYS . 29.4 tt0 -151.22 122.2 7.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 9.7 mp -99.34 142.74 30.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 109.001 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.48 166.23 31.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.017 -1.052 . . . . 0.0 109.695 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.54 142.83 26.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.256 -0.902 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.647 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 17.6 t-160 -115.63 -120.16 0.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.647 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.1 m120 -73.56 52.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.84 9.39 85.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.79 142.89 51.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.593 -0.946 . . . . 0.0 109.365 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -67.86 151.66 46.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -153.66 133.12 12.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.978 . . . . 0.0 109.434 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 21.8 t80 -89.58 153.7 20.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 109.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.534 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 17.5 tpt180 -160.42 107.26 1.55 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.126 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.08 149.11 50.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.56 -30.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.553 -0.717 . . . . 0.0 109.068 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.2 83.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -139.37 104.44 4.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.959 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.07 152.84 35.19 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.37 127.67 14.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.27 -1.136 . . . . 0.0 109.244 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.3 9.05 33.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.41 -69.0 0.99 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 154.45 129.29 1.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.48 -28.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 109.8 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.69 -26.41 25.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' GLY . 43.9 t -78.06 -54.65 6.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.1 m -46.98 -20.49 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 73.2 m -70.53 -60.72 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.393 -0.817 . . . . 0.0 110.103 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -17.34 33.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.38 -45.51 91.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.959 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -71.85 -19.93 61.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.4 -40.29 19.73 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.33 155.82 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -1.106 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.96 134.07 41.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 134.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.451 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 149' ' ' TRP . 7.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.48 ' SD ' ' OD1' ' A' ' 115' ' ' ASN . 62.7 mtm -147.55 -170.89 3.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.934 . . . . 0.0 109.332 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -152.46 -33.52 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.278 -0.889 . . . . 0.0 109.7 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -142.66 128.3 19.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -130.82 150.88 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.69 115.34 9.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -86.22 151.03 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.14 117.29 1.51 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.02 133.98 49.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -150.33 145.22 13.02 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.054 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -158.13 151.55 23.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.493 -1.004 . . . . 0.0 109.674 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -80.24 121.73 25.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.28 123.37 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.388 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -75.66 106.83 7.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.539 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -91.28 127.4 36.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' ' OD1' ' A' ' 17' ' ' ASP . 6.6 t -157.93 -35.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.282 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 16' ' ' THR . 26.4 m-20 -157.24 37.24 0.29 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -10.86 49.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -79.11 139.93 37.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -1.135 . . . . 0.0 109.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -157.16 169.08 25.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -96.21 150.6 20.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 109.3 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -140.95 99.93 3.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.0 109.726 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.39 138.55 33.46 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' ' CE2' ' A' ' 44' ' ' PHE . 8.2 t70 -92.17 117.24 29.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 109.829 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.63 48.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.421 -0.8 . . . . 0.0 109.016 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.34 167.66 25.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.092 -1.005 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.93 137.04 52.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -104.22 159.46 15.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.399 -0.813 . . . . 0.0 109.282 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -127.54 144.93 51.01 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.546 -0.721 . . . . 0.0 109.765 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.47 134.84 24.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.082 -1.011 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.96 176.59 3.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.5 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.89 -8.24 59.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -83.28 1.31 41.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.05 -13.42 59.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -101.03 153.4 19.58 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 38' ' ' GLY . 35.6 t -73.7 137.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.893 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.83 7.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -156.95 172.83 34.57 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.39 2.69 55.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.287 . . . . 0.0 109.969 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.04 -41.84 5.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.269 -0.895 . . . . 0.0 109.834 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.0 t0 53.25 6.46 0.07 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.945 -1.097 . . . . 0.0 109.71 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 40' ' ' ALA . 1.5 p90 -138.45 123.49 19.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.289 -0.882 . . . . 0.0 110.264 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 pt -110.17 122.68 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 33.3 t80 -170.56 -170.95 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.933 -1.104 . . . . 0.0 109.722 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 53.4 m-85 51.03 -112.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.949 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -55.42 -16.78 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.562 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -95.14 82.37 3.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.561 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.83 -22.1 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -166.54 156.97 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' SER . 4.5 p -84.93 113.49 21.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.48 69.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.268 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -104.64 -19.2 14.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.556 -0.715 . . . . 0.0 109.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.28 -13.98 75.36 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 1.8 p 70.16 2.05 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.92 146.85 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 p -147.0 152.59 38.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.077 -1.014 . . . . 0.0 110.567 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -92.03 130.23 37.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -78.33 -38.91 41.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.15 100.94 0.15 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.07 110.89 14.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.462 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.95 -164.37 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -156.02 16.12 0.35 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HG1' ' H ' ' A' ' 65' ' ' GLU . 35.4 p -154.71 -35.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.51 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.58 -0.08 26.18 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' H ' ' HG1' ' A' ' 63' ' ' THR . 89.8 mt-10 -68.63 110.27 4.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.32 -1.106 . . . . 0.0 109.324 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 178.69 173.94 44.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.8 OUTLIER -82.24 96.96 8.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 109.537 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 -108.32 1.45 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -48.41 111.32 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -1.146 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -80.85 -67.18 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -105.22 162.92 12.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.815 . . . . 0.0 109.394 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.4 p -162.31 138.52 7.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.2 131.41 55.49 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.15 120.67 36.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 46.7 mt -108.36 146.57 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 110.58 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HZ1' ' CB ' ' A' ' 76' ' ' LYS . 10.0 mtpm? -143.77 97.65 3.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.4 mt -82.32 -15.98 50.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.982 -1.074 . . . . 0.0 109.48 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.81 -0.87 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -131.82 15.99 4.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.55 -0.718 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.34 134.75 91.13 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.855 . . . . 0.0 109.193 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.26 -161.78 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.902 1.734 . . . . 0.0 111.736 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.95 5.06 53.09 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -90.57 -72.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.163 -1.198 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.3 p -70.14 149.06 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.55 -30.02 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 109.451 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -114.88 157.54 23.18 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.7 mt -142.38 150.37 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -141.34 162.03 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.369 -0.832 . . . . 0.0 108.882 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 88' ' ' ILE . 57.4 m-85 -141.69 125.31 16.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.22 157.92 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.386 -0.822 . . . . 0.0 110.191 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.0 121.6 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 p -117.44 153.47 33.04 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.45 -0.782 . . . . 0.0 110.438 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.2 145.0 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.416 ' C ' ' N ' ' A' ' 96' ' ' ALA . 24.5 t60 -100.64 -69.67 0.76 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLN . 5.4 m-20 -48.25 -18.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.416 ' N ' ' C ' ' A' ' 94' ' ' HIS . . . -45.9 -18.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' ASP . 65.2 mt-30 -69.58 -58.24 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.917 -1.114 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.66 -52.68 4.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.169 -0.957 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -75.43 -20.74 58.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.967 -1.083 . . . . 0.0 110.917 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 53.94 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.01 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -150.69 149.85 30.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 m -104.42 167.28 9.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 109.531 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' ' CE ' ' A' ' 137' ' ' MET . 57.9 m-85 -46.12 -38.19 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.441 -0.787 . . . . 0.0 109.881 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -58.1 -38.02 88.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -47.14 -18.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.237 . . . . 0.0 109.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.3 t -84.35 168.63 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.079 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 t -71.46 -19.56 62.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.77 79.52 0.03 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.6 164.59 22.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.127 . . . . 0.0 109.735 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.8 p90 -156.74 161.15 39.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.054 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 59.1 mt -120.95 156.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -140.94 160.42 40.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.998 -1.064 . . . . 0.0 109.915 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 tt -154.37 117.62 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.122 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.2 142.97 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.305 -0.872 . . . . 0.0 110.322 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' OD1' ' SD ' ' A' ' 2' ' ' MET . 76.8 m-20 -74.97 102.13 4.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.21 -1.53 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.474 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 115' ' ' ASN . 16.7 t70 -81.58 -53.47 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -123.49 7.0 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.783 -0.573 . . . . 0.0 109.676 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 115' ' ' ASN . 22.0 mt-30 58.61 59.69 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.8 m -109.74 -71.02 0.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.927 -0.483 . . . . 0.0 110.386 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 32.3 mt-10 -45.38 157.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.0 109.803 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.18 73.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.67 155.02 49.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.196 -0.94 . . . . 0.0 109.836 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.8 ptm180 -142.59 147.34 35.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 109.18 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -91.32 146.95 23.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -87.97 103.18 15.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.14 -0.975 . . . . 0.0 109.421 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' ALA . 57.6 mt -81.03 -42.11 21.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.429 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.8 p -47.56 -30.18 3.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 109.245 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -95.31 -54.6 3.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.341 -0.849 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -74.87 -3.44 31.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.965 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.87 -45.85 71.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 109.26 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.2 p -70.83 3.17 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.541 -0.725 . . . . 0.0 109.976 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -82.77 -35.1 26.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.979 -1.075 . . . . 0.0 110.353 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -177.29 -161.94 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.661 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.56 -1.71 8.5 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.61 137.63 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.42 ' CE ' ' CE1' ' A' ' 103' ' ' PHE . 10.6 ptp -165.04 157.56 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.342 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -97.87 128.9 44.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.219 -0.925 . . . . 0.0 109.737 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 24.6 t80 -65.57 -43.82 88.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.153 -0.967 . . . . 0.0 109.342 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.57 31.22 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.213 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 167.01 29.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.264 -1.139 . . . . 0.0 110.667 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.9 mt -132.31 136.95 47.25 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 6.4 p90 -140.36 160.91 38.95 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.003 -1.061 . . . . 0.0 109.733 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 9.0 ptm180 -84.96 148.66 26.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.042 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.523 ' NE2' ' OD1' ' A' ' 146' ' ' ASN . 29.8 t-80 -148.92 121.58 8.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.062 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.523 ' OD1' ' NE2' ' A' ' 145' ' ' HIS . 3.6 m120 52.32 27.18 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.26 75.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.9 136.22 51.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.981 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.513 ' O ' ' N ' ' A' ' 1' ' ' SER . 70.4 m95 -67.31 151.47 47.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.549 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -150.9 143.89 24.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -99.58 142.08 31.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.363 -0.835 . . . . 0.0 110.154 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -134.47 114.82 13.26 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.6 150.03 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 109.639 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.0 t -147.41 -36.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 109.084 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.75 79.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -122.45 106.03 10.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.782 -0.834 . . . . 0.0 109.537 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.01 149.08 32.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -149.99 139.85 21.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -1.173 . . . . 0.0 109.465 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.18 6.87 47.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.35 -37.45 25.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 82.88 150.59 9.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.07 -13.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.51 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -72.55 -56.89 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.086 -1.009 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.0 t -90.57 -37.87 13.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.16 -0.963 . . . . 0.0 109.73 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.39 -20.68 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.522 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.698 ' HG ' ' H ' ' A' ' 167' ' ' ALA . 29.9 p -83.41 -55.77 4.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.111 -0.993 . . . . 0.0 110.823 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.698 ' H ' ' HG ' ' A' ' 166' ' ' CYS . . . -87.91 -24.63 23.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 110.531 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' SER . 51.4 tt0 -51.68 -37.59 51.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.974 . . . . 0.0 109.74 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.66 -20.35 58.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.17 -27.83 47.52 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.28 129.9 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -1.153 . . . . 0.0 109.473 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -65.85 104.51 1.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 109.509 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.42 -74.2 0.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.471 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.7 mmt -78.77 178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -154.39 -35.32 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.665 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.25 128.14 15.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 109.135 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.665 ' N ' HD21 ' A' ' 4' ' ' ASN . 6.2 t -127.78 158.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 tp -144.46 106.7 4.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.958 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.425 ' O ' ' OG ' ' A' ' 72' ' ' SER . 14.7 t -85.29 150.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.11 116.98 1.24 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.85 129.53 54.68 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.95 142.78 11.16 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.45 ' CE2' ' CA ' ' A' ' 64' ' ' GLY . 25.1 p90 -157.22 153.43 27.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.405 -1.056 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -77.51 128.81 34.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.505 -0.747 . . . . 0.0 109.809 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.36 30.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.27 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -132.92 119.34 20.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 20' ' ' ASP . 8.0 m -90.2 128.67 36.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.4 m -150.29 -80.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.915 . . . . 0.0 109.386 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -3.55 7.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.86 -124.57 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.605 ' H ' HH22 ' A' ' 99' ' ' ARG . 98.3 mm-40 -74.03 163.55 27.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -1.189 . . . . 0.0 109.268 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' OD1' ' OG ' ' A' ' 15' ' ' SER . 24.8 m-20 -65.44 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.32 150.43 20.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 15.3 p-10 -141.04 99.74 3.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.258 -0.901 . . . . 0.0 109.712 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.62 130.91 34.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 108.631 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -87.24 111.44 21.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.966 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.32 125.86 46.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 108.803 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 m -149.76 168.06 24.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 109.769 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 136.09 49.48 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -103.79 119.59 39.23 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.19 152.63 21.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.525 -0.735 . . . . 0.0 109.906 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 134.94 22.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -75.67 176.32 7.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 108.979 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.69 -10.85 59.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.681 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 33' ' ' ASN . 3.0 m120 -84.32 4.55 30.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.29 56.75 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 31' ' ' ALA . 48.9 mtpt -104.45 171.95 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.8 t -103.45 143.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -61.83 -4.09 1.39 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.75 101.22 0.23 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -45.12 -20.97 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.401 -1.058 . . . . 0.0 110.601 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.26 -41.81 80.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.597 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 0.6 OUTLIER 48.12 12.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.978 -1.076 . . . . 0.0 109.517 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 23.8 t80 -137.46 105.8 5.77 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.842 . . . . 0.0 110.214 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 pt -110.52 134.92 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.3 p90 -151.99 -152.89 0.45 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.04 . . . . 0.0 109.766 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.56 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.7 m-85 -43.81 -36.0 2.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.576 -0.703 . . . . 0.0 110.028 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -58.65 -1.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 108.73 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 45' ' ' TYR . 51.1 t-20 -148.11 108.71 4.16 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.23 -27.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 109.407 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.5 pttt -172.8 160.55 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.287 -0.883 . . . . 0.0 109.322 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 54' ' ' SER . 10.2 p -65.12 135.24 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.286 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.39 -45.35 55.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.1 1.49 13.23 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.657 -0.652 . . . . 0.0 109.604 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -88.78 -14.33 61.3 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.4 m 64.13 4.17 1.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -1.054 . . . . 0.0 109.314 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' GLY . 72.7 t -93.14 146.75 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.919 . . . . 0.0 109.105 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -149.21 152.11 35.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -91.75 132.58 36.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 109.392 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 m -82.94 -38.85 22.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.55 107.55 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 33.2 p-10 -80.58 159.15 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.49 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -155.29 -173.01 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 109.418 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -161.82 30.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -151.81 -34.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.497 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' CA ' ' CE2' ' A' ' 11' ' ' TRP . . . 106.45 3.79 37.75 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -67.37 110.25 3.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -1.085 . . . . 0.0 109.368 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 173.36 154.01 10.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.57 102.62 13.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.6 -140.82 21.43 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.6 p-10 -48.68 111.14 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.599 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.12 -67.45 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.405 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -98.4 158.27 15.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.266 -0.896 . . . . 0.0 109.134 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -159.69 138.89 11.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mp -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.518 -0.739 . . . . 0.0 109.548 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -96.39 112.68 24.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.1 mp -100.66 146.87 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 110.898 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -135.54 88.92 2.45 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.38 -13.54 61.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.306 -0.871 . . . . 0.0 109.794 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -78.29 4.82 11.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.66 10.99 6.15 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.435 -0.791 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -82.01 125.86 76.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.947 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.52 -161.76 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.74 -0.17 84.1 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -69.44 -59.73 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -1.178 . . . . 0.0 109.321 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.89 148.78 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.89 . . . . 0.0 109.252 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -135.98 0.82 2.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 141' ' ' GLU . 43.3 tttp -150.09 131.5 14.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.877 . . . . 0.0 109.055 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 90.4 mt -136.35 132.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 0.0 109.003 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.95 154.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.814 . . . . 0.0 109.671 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -107.1 137.95 44.2 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 2.7 p -146.73 158.16 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.115 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.407 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 7.5 p -132.36 147.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -143.09 145.26 32.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.125 -0.985 . . . . 0.0 109.727 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.35 137.5 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 50.9 t-80 -95.49 -63.44 1.16 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.161 -0.962 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 12.0 m-20 -47.4 -18.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 0.0 109.578 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.24 -18.18 34.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.835 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -65.94 -60.82 2.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.85 -1.156 . . . . 0.0 109.437 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.14 -41.22 11.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.082 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.605 HH22 ' H ' ' A' ' 19' ' ' GLN . 54.5 mtt180 -85.66 -19.58 30.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.973 -1.079 . . . . 0.0 111.352 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 55.19 92.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.687 -1.258 . . . . 0.0 109.035 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -148.46 142.54 25.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 109.256 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -98.75 165.15 11.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -47.37 -35.48 8.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 109.624 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -55.89 -38.38 74.09 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -47.42 -19.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.361 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.3 t -83.97 167.03 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.005 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.1 t -72.61 -24.51 61.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.38 78.1 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.13 164.8 24.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.36 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.4 p90 -154.0 143.7 21.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.0 110.573 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.6 mt -106.94 153.86 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.38 160.21 40.36 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.987 -1.07 . . . . 0.0 109.84 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 3.1 tt -154.31 116.07 4.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 0.0 109.386 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -129.3 143.75 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.298 -0.876 . . . . 0.0 109.95 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.54 102.04 5.9 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -67.26 -1.36 4.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.539 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 115' ' ' ASN . 27.8 t70 -81.04 -52.97 6.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -123.1 3.59 9.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.721 -0.612 . . . . 0.0 109.479 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ASN . 21.0 tp60 60.41 61.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.9 m -113.27 -69.15 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.883 -0.51 . . . . 0.0 110.256 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 33.1 mm-40 -45.24 157.55 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.344 -0.848 . . . . 0.0 109.984 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.73 72.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.53 52.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 110.038 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.4 ptm180 -138.5 145.65 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -91.33 145.16 24.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.994 . . . . 0.0 109.082 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.28 103.16 15.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.023 . . . . 0.0 109.51 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 131' ' ' ALA . 92.1 mt -82.11 -37.84 25.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.3 p -48.35 -35.06 11.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.906 -1.121 . . . . 0.0 109.091 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -95.39 -49.24 5.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' OG1' ' A' ' 133' ' ' THR . 72.9 m-20 -76.45 -4.16 41.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.33 -43.71 67.87 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.954 -1.091 . . . . 0.0 109.695 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.3 p -68.97 3.17 2.15 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 110.978 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 130' ' ' ASP . 66.0 p -86.15 -34.51 20.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.544 -1.348 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.2 -161.44 0.08 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.766 -1.209 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.91 -12.98 7.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.48 133.78 24.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.8 ptp -165.41 141.44 5.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.47 141.11 41.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -0.952 . . . . 0.0 109.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.5 t80 -79.41 -46.2 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.411 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.88 -163.52 11.37 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.466 ' CD ' ' NZ ' ' A' ' 86' ' ' LYS . 11.5 tt0 -150.7 158.29 43.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.382 -1.069 . . . . 0.0 109.061 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 136.19 25.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -150.73 166.51 30.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.882 -1.136 . . . . 0.0 110.122 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -90.59 143.43 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -117.95 -120.12 0.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.613 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 34.9 m120 -73.56 51.25 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.05 -1.031 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 9.1 85.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.77 142.13 51.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.997 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -68.53 151.48 46.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -148.91 131.8 16.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.112 -0.993 . . . . 0.0 109.69 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -89.76 150.61 22.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -149.75 124.19 9.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 0.0 109.065 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.75 147.91 27.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.1 t -150.15 -36.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 109.09 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.26 76.54 0.15 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -108.6 104.38 13.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.754 -0.85 . . . . 0.0 109.125 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.03 143.35 20.39 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.15 141.7 32.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.299 -1.118 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.14 9.55 43.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.32 -0.863 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -68.01 1.33 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.51 132.5 1.51 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.9 -30.55 2.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -1.123 . . . . 0.0 109.607 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.74 24.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 69.2 m -73.4 -53.28 11.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.74 -20.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 57.7 m -71.55 -60.84 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 110.163 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.4 38.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 110.402 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -65.78 -43.79 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.95 -1.094 . . . . 0.0 110.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -71.34 -19.62 62.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.89 -44.57 36.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 22.7 pt -72.04 158.35 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -77.06 146.85 37.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 45.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.467 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.5 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.5 mtt -86.8 147.43 25.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 94.0 mttt -116.9 -21.8 8.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.565 -0.709 . . . . 0.0 109.274 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 51.3 m-20 -146.23 142.34 28.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.8 158.52 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -0.77 . . . . 0.0 109.211 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -146.29 107.32 4.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.937 . . . . 0.0 109.09 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.78 150.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.25 116.84 1.15 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.0 137.05 42.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.82 139.19 7.81 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -156.49 152.35 27.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.201 -1.176 . . . . 0.0 109.971 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -90.74 126.99 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.608 -0.682 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.73 138.31 34.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.356 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -132.76 106.85 8.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 109.29 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 19' ' ' GLN . 27.1 m -86.16 106.1 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 p -59.36 -30.48 68.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -160.91 -34.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.431 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.61 60.62 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.514 ' CB ' HH22 ' A' ' 99' ' ' ARG . 3.1 pt20 -163.4 -165.97 1.16 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -1.189 . . . . 0.0 109.521 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -173.23 165.05 4.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.8 m-85 -96.25 142.8 27.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 14.6 m-20 -141.03 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.26 -0.9 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.77 149.69 25.1 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -108.11 118.17 36.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.322 -0.861 . . . . 0.0 109.633 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.91 133.11 42.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.388 -0.82 . . . . 0.0 108.993 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -149.95 167.85 25.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 110.201 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.3 137.65 54.6 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 9.0 m-85 -104.15 126.66 51.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.628 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.96 153.69 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.345 -0.847 . . . . 0.0 109.918 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.3 135.74 24.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 109.111 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.67 176.54 8.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.094 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.59 -7.51 59.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -85.24 1.82 46.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 109.906 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.66 -17.99 58.25 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -107.48 171.02 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 38' ' ' GLY . 5.7 t -99.64 137.36 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -62.31 -0.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -136.61 114.42 1.15 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.52 3.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -1.177 . . . . 0.0 110.6 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -99.34 -42.07 7.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.917 -1.114 . . . . 0.0 109.82 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 46.5 t0 46.81 14.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.994 -1.066 . . . . 0.0 109.594 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 36.2 t80 -137.3 99.44 3.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.815 . . . . 0.0 109.724 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.0 pt -105.2 135.13 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.1 p90 -139.3 -163.05 1.41 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.0 109.368 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 26.6 p90 -43.79 -36.92 2.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 110.551 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.586 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.8 t-20 -50.5 -11.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 109.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.1 t30 -135.29 104.7 5.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.468 -0.77 . . . . 0.0 109.067 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 mt -49.13 -28.92 4.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.473 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.1 pttp -164.85 157.67 16.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.331 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.479 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 3.6 m -68.7 143.5 54.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.458 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 -48.16 36.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.165 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.29 1.73 13.13 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.747 -0.596 . . . . 0.0 109.548 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.42 -14.15 74.57 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t 62.42 6.29 1.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -1.107 . . . . 0.0 109.799 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.15 151.62 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.115 -0.99 . . . . 0.0 108.986 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 p -145.21 139.74 27.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.075 -1.016 . . . . 0.0 110.251 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -90.27 132.87 35.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -72.25 -40.4 67.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.348 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.93 111.44 0.33 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.27 110.95 13.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.87 -164.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 12.7 ptt-85 -156.23 16.34 0.34 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -155.84 -36.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.278 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.19 7.49 88.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.11 110.54 1.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.86 -127.1 1.79 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -164.96 163.3 20.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -1.092 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.24 -172.12 34.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.92 108.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -1.153 . . . . 0.0 109.433 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -61.37 -69.62 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.41 173.11 10.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -159.51 132.6 6.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.258 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.21 122.14 42.24 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -96.01 137.3 35.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 0.0 109.067 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.7 mt -129.33 143.35 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.634 -0.666 . . . . 0.0 110.018 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -141.22 98.84 3.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -80.79 -17.78 49.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -51.04 -36.73 41.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.27 27.28 7.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 81' ' ' PRO . 6.2 p -60.56 115.34 13.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 81.4 Cg_exo -46.55 -178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.812 1.674 . . . . 0.0 112.264 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.18 59.71 0.63 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -154.71 -54.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -1.177 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.45 148.53 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 1.0 OUTLIER -143.43 11.95 1.72 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.179 -0.951 . . . . 0.0 109.858 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -157.02 133.52 9.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 87.9 mt -129.39 154.24 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.548 -0.72 . . . . 0.0 109.447 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.413 HG21 ' H ' ' A' ' 89' ' ' PHE . 1.2 mt -144.68 173.44 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 108.904 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' H ' HG21 ' A' ' 88' ' ' ILE . 6.3 m-85 -131.62 141.95 49.76 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.1 t -147.23 151.94 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.942 -1.099 . . . . 0.0 110.953 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -147.53 113.92 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -122.28 174.6 6.89 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.741 0.781 . . . . 0.0 110.222 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -83.86 166.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.432 ' C ' ' N ' ' A' ' 96' ' ' ALA . 53.6 t60 -133.26 -66.58 0.65 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -48.12 -18.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.25 -38.42 52.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -54.53 -31.95 57.25 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 109.214 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -52.83 4.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -0.83 . . . . 0.0 111.008 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.514 HH22 ' CB ' ' A' ' 19' ' ' GLN . 10.9 ptp180 -110.51 -4.71 15.37 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.282 -0.886 . . . . 0.0 111.166 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.1 ttm180 57.07 102.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.858 -1.151 . . . . 0.0 109.205 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -147.69 148.97 31.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 m -104.2 161.93 13.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.43 -0.794 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -47.15 -35.31 7.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -61.61 -42.38 99.75 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 23.4 mm100 -48.5 -14.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 109.403 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.4 t -83.76 164.59 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 t -64.87 -23.73 67.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.06 -1.025 . . . . 0.0 109.552 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.89 79.94 0.03 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.7 164.54 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 109.958 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.4 p90 -154.81 152.35 29.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.889 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -115.53 157.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.27 160.73 39.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.897 -1.127 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.03 144.25 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 4.2 t-20 -76.07 102.14 5.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -65.79 -1.69 3.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 115' ' ' ASN . 23.5 t0 -82.29 -53.72 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.58 6.33 8.89 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' ASN . 19.5 tt0 59.61 60.52 2.22 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.2 p -111.07 -69.8 0.85 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.879 -0.513 . . . . 0.0 110.334 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 45.1 mt-10 -45.26 157.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.77 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.52 52.15 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.134 -0.979 . . . . 0.0 110.218 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.5 ptt180 -140.18 142.4 35.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -91.34 147.65 22.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.089 -1.007 . . . . 0.0 109.12 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 18.5 p-10 -91.54 103.29 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.145 -0.972 . . . . 0.0 109.358 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -80.89 -32.75 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.295 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 m -48.98 -37.52 20.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.909 -1.119 . . . . 0.0 108.963 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.37 -45.78 6.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.695 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 133' ' ' THR . 3.0 m-20 -76.32 -4.54 42.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 110.535 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -55.4 -46.12 76.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.798 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -65.33 3.29 0.68 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 111.013 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 130' ' ' ASP . 71.7 p -86.14 -34.93 20.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.596 -1.315 . . . . 0.0 110.458 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.9 -161.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.907 -1.12 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.05 -3.83 6.94 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -146.79 135.4 22.07 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.4 ttp -165.83 158.08 14.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.941 -1.1 . . . . 0.0 110.335 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.69 139.41 31.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.341 -0.849 . . . . 0.0 109.471 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -78.62 -47.62 16.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 109.782 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.72 -164.29 14.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -151.45 163.19 39.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.168 -1.195 . . . . 0.0 109.739 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.65 134.75 24.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -146.05 165.84 27.86 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 109.781 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.1 ptm180 -90.34 143.7 26.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.859 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.656 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-80 -119.81 -116.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.656 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 18.8 m-20 -76.02 53.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.45 8.02 87.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -127.88 145.39 50.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.989 . . . . 0.0 109.314 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.51 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.1 m95 -70.58 151.59 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.424 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -145.97 126.85 14.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -89.72 147.92 23.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -153.03 107.37 3.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.305 -0.872 . . . . 0.0 109.046 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.91 154.64 40.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.6 t -143.41 -33.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.72 83.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -132.26 104.32 6.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.647 -0.913 . . . . 0.0 109.31 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.38 152.7 38.14 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.2 124.4 14.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.355 -1.085 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.06 6.22 37.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.44 -68.58 1.13 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.41 129.08 1.18 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -46.62 -26.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.165 . . . . 0.0 109.891 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.32 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.897 . . . . 0.0 109.457 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -50.98 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.3 m -47.83 -20.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 39.9 m -69.33 -59.93 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.817 . . . . 0.0 110.191 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -18.89 29.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.17 -43.74 87.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.017 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -71.48 -19.81 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.56 -2.37 89.62 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.41 159.42 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -79.03 135.59 36.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.42 81.84 6.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.446 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -67.66 -170.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 58.6 mttp -153.78 -34.64 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 59.7 m-20 -145.96 152.57 39.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.62 155.8 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 109.291 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -143.79 108.53 4.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 108.949 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.28 148.76 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 108.661 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.23 116.85 1.28 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.87 136.25 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.74 141.19 9.02 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.556 -1.307 . . . . 0.0 109.856 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -158.42 156.59 30.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.421 -1.047 . . . . 0.0 109.707 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -81.36 126.19 31.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.856 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.74 136.32 33.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.828 . . . . 0.0 109.118 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -132.99 116.44 16.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -120.7 106.53 11.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 m -65.27 -61.23 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.392 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.18 18.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.78 51.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -166.77 165.3 16.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -177.92 156.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.256 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.19 138.31 33.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.85 99.81 3.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 109.677 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -83.37 141.01 32.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -98.97 109.97 22.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.23 125.61 43.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.212 -0.93 . . . . 0.0 108.9 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 11.1 t -149.76 168.13 24.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 109.993 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.53 138.87 45.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -104.02 127.72 51.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.622 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.39 155.99 16.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.28 -0.888 . . . . 0.0 110.055 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.77 139.99 32.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.084 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.84 176.59 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.34 -5.46 59.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.75 4.04 50.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.0 109.905 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.96 -11.02 73.23 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -109.89 169.12 8.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.621 ' C ' ' H ' ' A' ' 38' ' ' GLY . 20.2 t -93.09 136.57 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 109.171 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -64.01 1.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -150.01 122.07 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -61.96 3.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 110.076 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -95.05 -42.24 8.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.889 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 31.8 t0 46.17 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 109.599 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 75.7 t80 -137.49 99.59 3.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.456 -0.777 . . . . 0.0 109.52 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.2 pt -103.69 137.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.4 p90 -143.52 -160.76 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 47' ' ' ASN . 18.0 p90 -45.17 -31.89 1.63 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 7.9 t-20 -52.59 -11.22 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.873 -1.142 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.0 t30 -135.75 108.25 7.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -47.43 -28.93 2.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.835 . . . . 0.0 109.266 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.2 pttt -171.81 157.51 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 67.3 m -62.69 149.57 43.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.65 -48.75 14.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -116.45 0.84 12.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.651 -0.656 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.94 -12.84 67.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m 58.71 13.92 2.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 109.401 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.5 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.304 -0.872 . . . . 0.0 109.027 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.454 ' HG1' ' CB ' ' A' ' 49' ' ' LYS . 58.6 m -148.6 135.06 19.58 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.019 -1.051 . . . . 0.0 110.212 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -90.17 129.06 36.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -69.8 -43.84 71.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.3 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.11 115.18 0.44 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.08 110.95 17.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -1.133 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.92 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.381 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -150.69 12.38 0.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -156.28 -38.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.63 -1.28 13.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.54 110.26 0.95 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.276 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 172.93 150.42 7.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.3 120.3 25.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.23 -138.41 41.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 p-10 -48.73 115.7 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 109.595 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.32 -64.9 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -88.39 173.43 8.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.95 132.24 6.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.362 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.79 121.66 41.36 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -95.4 138.16 33.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 108.533 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.04 146.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.484 -0.76 . . . . 0.0 110.502 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 9.5 mtpm? -138.55 94.1 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.69 -5.36 40.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.47 -29.67 37.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 0.0 109.791 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.74 10.37 37.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.0 109.905 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.24 125.59 69.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.984 . . . . 0.0 109.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.95 -161.11 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.894 1.729 . . . . 0.0 111.868 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.84 4.52 78.76 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 2.5 m-20 -64.41 -54.52 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -1.189 . . . . 0.0 109.44 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.99 149.07 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 9.3 t0 -123.91 -9.05 7.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.767 . . . . 0.0 109.46 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -158.06 131.34 7.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 110.029 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.9 mt -121.13 154.18 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -142.57 173.16 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.093 -1.004 . . . . 0.0 109.304 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 11.0 m-85 -142.31 118.56 10.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.89 157.73 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -130.92 114.35 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -110.21 148.16 32.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.3 138.97 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 21.3 t-160 -96.27 -65.11 0.99 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.005 . . . . 0.0 109.805 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -47.31 -18.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.08 -18.23 23.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 109.734 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.25 -61.49 1.82 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.85 -1.156 . . . . 0.0 109.545 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.18 -40.47 11.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -0.84 . . . . 0.0 111.086 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.4 mpt_? -85.19 -19.13 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.897 -1.127 . . . . 0.0 110.955 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 99' ' ' ARG . 50.1 ttp85 55.62 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.806 -1.184 . . . . 0.0 109.255 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.9 144.67 14.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -102.03 166.82 10.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.52 -32.14 3.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.847 . . . . 0.0 109.76 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -61.5 -37.05 93.51 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -46.88 -19.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -1.192 . . . . 0.0 109.244 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.2 t -86.48 166.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 0.0 108.986 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -66.99 -26.6 66.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.639 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.2 78.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.03 164.67 25.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 22.6 p90 -152.37 151.98 31.5 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 110.263 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.0 mt -114.49 154.46 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -144.13 157.5 44.27 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 tt -150.63 125.77 9.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 0.0 109.266 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.25 143.57 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.699 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 119' ' ' GLN . 61.4 m-20 -75.19 102.08 4.85 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 35.5 t0 -66.1 -1.67 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 109.851 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 1.1 p30 -83.53 -52.65 6.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -0.928 . . . . 0.0 109.494 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 22.1 m120 -122.87 5.69 9.37 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 0.0 109.819 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.1 mt-30 58.97 60.06 2.58 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.0 m -112.03 -69.72 0.85 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.946 -0.471 . . . . 0.0 110.471 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 53.6 mm-40 -45.25 157.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.97 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.95 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.78 151.21 52.05 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -140.74 143.54 35.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.708 . . . . 0.0 109.143 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.73 147.82 22.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.6 103.31 15.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.971 . . . . 0.0 109.326 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.2 mt -81.03 -38.19 27.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.5 m -47.61 -32.1 5.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.147 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.47 -54.23 3.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.533 -0.729 . . . . 0.0 109.94 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.49 -2.95 27.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.99 . . . . 0.0 110.612 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.05 -45.99 68.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 109.193 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -69.36 3.19 2.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.0 109.873 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 131' ' ' ALA . 15.2 m -82.78 -34.5 27.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 110.346 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -176.76 -162.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.958 -1.089 . . . . 0.0 109.729 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.47 -7.92 6.91 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.48 136.04 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 ptm -165.46 157.75 15.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.564 ' CD2' ' H ' ' A' ' 138' ' ' LEU . 1.5 pt? -92.27 141.43 28.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -86.54 -22.42 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.19 -171.29 40.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.31 163.41 38.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -1.156 . . . . 0.0 109.496 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.67 138.88 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.55 166.15 31.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.145 -0.972 . . . . 0.0 109.718 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -93.35 143.9 25.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.671 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.66 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.3 t60 -118.79 -118.55 0.31 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.66 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 30.8 t30 -75.41 51.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.05 8.84 86.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -127.81 139.99 52.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.987 . . . . 0.0 109.353 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -68.05 151.79 46.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -148.69 125.74 11.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -89.3 146.82 24.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.442 -0.786 . . . . 0.0 109.459 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -151.22 111.23 4.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.041 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.99 154.68 40.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.766 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.17 -33.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.39 0.04 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -143.72 104.31 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.443 -1.034 . . . . 0.0 109.157 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.73 34.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.6 138.44 44.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.618 -0.931 . . . . 0.0 108.919 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.39 9.06 39.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.76 -73.88 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 164' ' ' SER . . . 155.53 129.84 1.26 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -46.27 -24.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 109.879 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.0 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 166' ' ' CYS . 52.8 p -78.99 -54.43 6.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.652 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 29.6 m -45.37 -19.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.328 -0.857 . . . . 0.0 109.565 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 164' ' ' SER . 89.3 m -72.54 -62.15 1.55 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.1 -14.88 40.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.381 -0.825 . . . . 0.0 110.133 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -56.33 -45.65 80.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -78.79 -19.71 51.54 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.529 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.04 -41.24 32.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.9 pt -78.9 159.53 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.13 147.06 53.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.933 . . . . 0.0 109.421 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.4 98.69 7.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.446 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.4 mpt? -79.63 175.98 10.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.428 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -154.09 -34.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 4.4 m120 -146.13 128.44 15.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -127.0 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.63 110.84 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.446 -0.783 . . . . 0.0 109.057 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.99 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 108.699 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.83 117.15 1.61 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -112.44 127.23 55.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.28 150.0 22.2 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -159.42 151.45 20.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.355 -1.085 . . . . 0.0 109.944 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -90.51 122.87 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.677 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.67 167.08 17.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -132.85 106.99 8.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.437 -0.789 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 m -87.99 125.4 34.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 109.279 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -157.93 -36.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.42 26.67 2.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.395 -0.815 . . . . 0.0 109.002 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.7 -23.93 6.24 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -64.0 155.72 30.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.361 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -157.67 156.1 31.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 62.9 m-85 -96.21 136.39 36.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.8 p-10 -140.92 99.79 3.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 7.5 mp -83.45 130.49 35.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -90.67 123.36 34.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.76 131.03 44.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 p -150.1 168.24 24.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.021 -1.049 . . . . 0.0 109.939 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.75 136.81 34.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -103.32 138.26 40.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.149 -0.969 . . . . 0.0 109.796 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.588 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -90.36 163.22 14.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.92 141.7 29.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.059 -1.026 . . . . 0.0 109.867 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.12 176.71 9.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.583 -0.698 . . . . 0.0 109.219 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.04 -3.78 55.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.29 2.45 55.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -22.36 40.1 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -104.97 173.15 6.43 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -93.99 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -68.9 4.07 1.69 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -127.88 150.16 18.26 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.37 1.2 57.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.254 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.41 -42.34 5.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.221 -0.924 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 45.43 21.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.311 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 66.6 t80 -136.2 99.64 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.554 -0.716 . . . . 0.0 110.275 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 pt -103.34 134.85 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.0 p90 -146.11 -161.18 1.26 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.03 -1.044 . . . . 0.0 109.735 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.3 p90 -45.92 -30.67 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.116 -0.99 . . . . 0.0 110.434 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 8.3 t30 -61.97 -1.17 0.61 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.895 -1.128 . . . . 0.0 108.972 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.3 t30 -141.48 100.12 3.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.448 -0.783 . . . . 0.0 109.039 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -48.12 -24.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.305 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.3 pttt -166.78 154.87 9.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -62.67 137.85 58.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.51 92.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -116.13 -17.14 10.92 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.648 -0.658 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.67 76.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m 54.47 20.72 2.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 109.288 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -92.85 151.54 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.886 . . . . 0.0 109.076 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -133.91 125.48 28.38 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.512 -0.742 . . . . 0.0 109.515 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -92.46 124.19 36.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.339 -0.851 . . . . 0.0 109.367 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.8 m -58.58 -46.59 86.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.92 143.72 3.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.3 112.51 24.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -1.119 . . . . 0.0 109.395 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.08 128.78 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.63 5.65 17.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.9 p -153.55 -35.03 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.39 16.63 58.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -58.34 110.42 0.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -1.145 . . . . 0.0 109.532 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.35 -126.26 1.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -170.33 69.41 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -1.139 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.74 -176.03 37.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 38.4 p-10 -52.65 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.106 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -57.95 -64.45 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . 60.0 mt-10 -102.69 170.97 7.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.363 -0.835 . . . . 0.0 108.989 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.1 m -165.85 164.65 18.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -135.06 124.04 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -95.69 109.68 21.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.729 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.29 146.81 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -142.29 92.7 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' ALA . 10.5 mt -71.09 -41.95 69.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.111 -0.993 . . . . 0.0 110.322 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -48.15 -13.96 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.544 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -104.97 -19.3 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.459 -0.776 . . . . 0.0 109.858 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.81 126.37 85.26 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.268 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 -160.11 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.983 1.789 . . . . 0.0 111.895 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.49 3.7 63.66 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.64 -60.95 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -1.218 . . . . 0.0 109.347 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.46 148.06 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.451 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.1 m-20 -125.71 -3.14 7.22 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.378 -0.826 . . . . 0.0 110.046 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.48 136.67 15.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.952 -1.093 . . . . 0.0 109.436 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.41 154.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.402 HG21 ' H ' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -138.38 172.89 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.146 -0.971 . . . . 0.0 110.103 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.402 ' H ' HG21 ' A' ' 88' ' ' ILE . 17.8 m-85 -137.53 129.2 28.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.1 t -140.57 151.32 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.953 . . . . 0.0 111.344 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.7 131.63 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -132.4 155.37 48.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -73.9 162.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.34 -60.24 1.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.522 -0.736 . . . . 0.0 109.465 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -49.88 -18.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.25 -42.4 86.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -54.13 -32.07 54.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.739 -1.226 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.86 -53.23 4.48 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.256 -0.903 . . . . 0.0 111.311 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' ARG . 3.1 ptp85 -111.85 1.72 16.69 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.181 -0.949 . . . . 0.0 111.237 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' ALA . 46.2 ttp180 56.19 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.788 -1.195 . . . . 0.0 109.24 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 102' ' ' SER . 1.3 pp0? -153.16 147.77 26.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.154 -0.966 . . . . 0.0 109.437 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 101' ' ' GLN . 20.8 m -105.01 163.41 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.831 . . . . 0.0 110.01 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -43.85 -28.61 0.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 0.0 110.161 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -64.1 -44.1 96.26 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 7.5 tp-100 -47.64 -17.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' GLY . 16.1 t -82.25 165.88 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 t -67.86 -21.72 65.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.671 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.41 79.98 0.03 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.23 162.48 27.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 109.623 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.5 p90 -155.38 151.69 28.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 45.9 mt -117.02 153.61 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -139.98 154.72 47.25 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.058 -1.026 . . . . 0.0 109.739 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.8 tt -148.59 117.51 6.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.16 145.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.38 -0.825 . . . . 0.0 109.838 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.12 101.87 5.51 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.46 -1.58 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.847 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.2 t0 -83.62 -52.99 5.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 109.661 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -122.97 4.37 9.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 60.29 60.61 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.8 m -113.07 -69.09 0.88 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.817 -0.552 . . . . 0.0 110.227 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 57.2 mt-10 -45.29 157.83 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.91 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.57 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.53 148.86 52.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 109.902 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.7 ptm180 -138.61 145.2 40.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -91.32 147.59 22.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.235 -0.916 . . . . 0.0 109.061 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -91.05 103.37 16.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 131' ' ' ALA . 83.9 mt -80.77 -37.71 29.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.482 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.5 p -47.8 -32.37 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.151 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.29 -53.89 3.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 -2.2 23.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.224 -0.922 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.25 -46.8 69.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.2 t -69.49 3.2 2.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.603 -0.686 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -83.4 -34.7 25.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 110.354 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -176.61 -161.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.4 -2.49 5.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.65 134.09 13.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.5 ptm -165.49 152.58 10.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.058 -1.026 . . . . 0.0 109.911 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -87.47 138.43 31.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 27.6 t80 -80.25 -43.57 21.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.31 -173.85 35.11 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.858 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -150.77 166.59 30.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.143 -1.21 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 139.8 44.14 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -144.88 166.2 25.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.03 -1.044 . . . . 0.0 109.84 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.451 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.3 ptm180 -90.15 145.77 24.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.517 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.1 t60 -123.57 -120.29 0.28 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.598 -0.689 . . . . 0.0 109.166 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.517 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 10.1 m120 -73.37 52.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.64 88.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.84 142.0 51.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.582 -0.952 . . . . 0.0 109.406 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -67.48 151.64 47.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.358 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -149.96 132.82 16.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.076 -1.015 . . . . 0.0 109.632 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -89.91 153.16 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 107.32 1.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.1 154.74 41.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.724 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.69 -33.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.859 . . . . 0.0 109.268 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.57 86.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -134.8 104.36 5.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.574 -0.956 . . . . 0.0 109.214 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.64 146.09 18.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.4 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -1.08 . . . . 0.0 108.971 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.88 40.6 3.24 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.539 -0.726 . . . . 0.0 109.471 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.95 -54.45 3.4 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.0 122.13 0.71 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -45.53 -35.74 4.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.12 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.45 -28.36 23.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 109.59 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.8 p -80.88 -50.68 9.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.989 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.542 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.8 m -49.15 -21.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.008 . . . . 0.0 109.533 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 28' ' ' PHE . 57.9 m -79.39 -59.98 2.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.912 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.5 63.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.465 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -71.05 -28.41 64.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.969 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.85 -19.57 61.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 -51.71 4.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.85 159.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -1.1 . . . . 0.0 109.403 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -69.59 140.02 53.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 -160.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.48 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.4 mtt -81.31 162.51 23.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -130.95 -31.3 1.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.499 -0.75 . . . . 0.0 109.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.23 128.17 15.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 109.089 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.668 ' N ' HD21 ' A' ' 4' ' ' ASN . 94.3 t -128.13 144.45 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 tp -130.64 114.29 15.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.0 151.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 108.777 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.43 121.65 2.34 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.49 126.17 32.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.32 152.99 25.04 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -155.04 154.57 32.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -1.044 . . . . 0.0 109.7 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -90.45 120.97 32.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 137.31 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.171 -0.955 . . . . 0.0 109.303 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -87.1 113.26 22.69 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.447 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -84.44 123.42 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -145.46 -41.75 0.22 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.308 -0.87 . . . . 0.0 109.274 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.28 37.72 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.25 -20.71 24.72 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -74.65 149.77 39.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.313 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -160.14 175.31 13.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.521 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -96.32 145.73 25.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 25.1 p-10 -140.97 99.68 3.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.371 -0.831 . . . . 0.0 109.574 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -85.51 130.53 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 108.758 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.72 106.0 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -98.28 124.93 43.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 29.4 t -149.47 168.23 24.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.973 -1.079 . . . . 0.0 110.115 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.58 137.38 46.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m-85 -102.99 130.55 50.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.0 109.178 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' H ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.66 145.54 28.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.86 136.46 25.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.026 . . . . 0.0 110.109 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.16 176.48 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.699 . . . . 0.0 109.519 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -7.47 59.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.2 m-80 -83.03 -0.16 47.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.31 -12.01 61.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.74 148.68 24.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' A' ' 38' ' ' GLY . 29.0 t -66.39 136.89 25.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.934 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.94 9.25 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.0 170.09 34.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.14 3.83 54.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.986 -1.302 . . . . 0.0 109.902 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.16 -41.78 5.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.243 -0.91 . . . . 0.0 110.309 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 23.2 t0 51.04 9.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 0.0 109.313 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.2 p90 -138.29 118.75 13.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.316 -0.865 . . . . 0.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.3 pt -114.22 134.14 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -154.74 -148.21 0.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.959 . . . . 0.0 108.888 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 47' ' ' ASN . 37.3 p90 -44.89 -32.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.826 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 18.2 p-10 -65.4 4.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.177 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.1 t30 -155.53 100.29 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.804 . . . . 0.0 109.155 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -48.09 -18.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 28.4 pttt -175.38 155.23 1.81 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.398 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 54' ' ' SER . 53.2 p -66.71 130.51 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.83 -48.72 44.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.826 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -116.39 23.36 12.14 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 109.929 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.33 -15.11 7.24 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.6 t 63.48 4.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -1.116 . . . . 0.0 109.458 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 50' ' ' SER . 69.7 t -92.9 146.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.914 . . . . 0.0 108.916 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.9 m -149.78 153.78 37.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.057 . . . . 0.0 110.35 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -90.58 131.74 36.12 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.2 m -81.78 -34.71 30.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.506 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 113.76 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.74 159.09 25.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -1.122 . . . . 0.0 109.492 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.82 118.59 7.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -84.17 10.77 9.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.7 p -154.41 -35.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.62 13.03 58.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.57 110.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.478 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.25 -115.61 0.67 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.03 166.12 4.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.63 177.98 49.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.85 99.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -1.198 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.53 -68.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.33 146.73 23.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.267 -0.896 . . . . 0.0 109.279 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -159.84 141.56 12.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.37 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.4 130.36 56.87 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.0 109.554 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -96.73 109.94 22.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.408 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.3 mp -98.8 146.75 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.204 -0.935 . . . . 0.0 110.465 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' O ' ' OG ' ' A' ' 54' ' ' SER . 9.8 mtpm? -141.98 90.62 2.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 79' ' ' ALA . 11.3 mt -78.86 -10.76 59.9 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.13 -0.84 0.82 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.009 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -135.83 18.12 3.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.2 134.99 90.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.329 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.5 -161.36 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.939 1.759 . . . . 0.0 111.682 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.08 39.7 2.79 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -126.19 -59.16 1.33 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.477 -1.014 . . . . 0.0 109.688 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.82 145.67 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.11 -0.994 . . . . 0.0 109.686 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.458 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -138.97 1.5 2.06 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.399 -0.813 . . . . 0.0 109.581 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 141' ' ' GLU . 60.2 tttm -149.06 131.35 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 108.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -137.38 130.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' CG2' ' HZ2' ' A' ' 86' ' ' LYS . 9.3 pt -137.22 152.89 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.933 . . . . 0.0 109.619 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.59 141.18 34.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.377 -0.827 . . . . 0.0 109.08 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.89 153.02 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.922 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -133.15 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -138.29 145.17 40.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.904 . . . . 0.0 109.861 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.26 148.01 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -0.862 . . . . 0.0 108.822 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' ALA . 56.6 t-80 -101.32 -70.66 0.74 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -47.51 -18.1 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 109.694 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -53.5 -18.76 3.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.81 -62.19 1.49 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.905 -1.122 . . . . 0.0 109.244 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.45 -38.45 12.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 110.813 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.517 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 6.2 mpt_? -85.14 -18.0 35.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.042 -1.036 . . . . 0.0 111.109 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 99' ' ' ARG . 16.1 tpt180 52.1 94.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.811 -1.18 . . . . 0.0 108.763 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -152.46 140.68 20.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 109.435 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 t -99.62 164.14 12.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.44 -30.9 2.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.397 -0.814 . . . . 0.0 109.934 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.442 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -63.39 -39.73 98.08 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -49.78 -15.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.502 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.442 ' N ' ' C ' ' A' ' 104' ' ' GLY . 17.7 t -83.13 163.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 109.088 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.6 t -62.66 -22.7 66.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.74 80.02 0.03 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.3 164.33 24.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.129 . . . . 0.0 109.667 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.0 p90 -150.04 169.82 20.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.194 -0.942 . . . . 0.0 110.185 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 18.1 mt -136.13 152.11 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 67.0 ttt-85 -143.55 163.62 32.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 tt -156.58 117.19 3.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -132.13 145.32 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.309 -0.87 . . . . 0.0 110.212 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 119' ' ' GLN . 2.2 m120 -78.6 102.35 7.91 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -68.0 -1.76 6.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.104 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.7 t0 -79.15 -53.13 7.29 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.993 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -123.27 3.03 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.2 mt-30 59.95 61.28 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 m -114.33 -66.31 1.1 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.901 -0.499 . . . . 0.0 110.247 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 1.4 mp0 -45.3 156.91 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.563 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.4 73.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.23 143.83 50.2 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.087 -1.008 . . . . 0.0 110.154 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.1 ptp180 -138.0 139.33 39.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.508 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 6.4 t80 -91.02 142.78 27.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 108.97 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -85.72 102.85 13.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.438 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.0 mt -79.42 -36.71 38.61 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 0.0 109.308 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.9 p -48.06 -33.2 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.139 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -95.3 -53.59 3.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.487 -0.758 . . . . 0.0 109.721 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 65.8 m-20 -71.9 -5.46 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.96 -46.06 68.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.18 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 65.4 p -68.84 3.18 2.08 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.916 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.0 m -83.32 -34.78 25.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.252 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -177.06 -162.77 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.971 -1.081 . . . . 0.0 109.677 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.52 -13.29 7.59 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.39 135.36 32.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.2 ttp -165.33 151.34 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.024 -1.047 . . . . 0.0 110.189 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.36 137.21 32.53 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.429 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -75.84 -47.43 25.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.902 -1.124 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.96 -158.91 9.06 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 86' ' ' LYS . 13.2 tt0 -150.98 158.65 44.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -1.085 . . . . 0.0 109.266 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 tt -143.28 131.92 22.49 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.66 166.34 30.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.5 ptm180 -94.68 142.53 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.449 -0.782 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -114.15 -120.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.61 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 20.0 t-20 -73.66 51.35 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.129 -0.982 . . . . 0.0 109.146 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.64 82.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -127.67 140.12 52.28 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.562 -0.963 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.515 ' O ' ' N ' ' A' ' 1' ' ' SER . 58.0 m95 -67.3 151.75 46.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -151.4 121.6 7.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -91.81 145.21 24.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.243 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -152.18 107.28 3.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.106 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.506 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -64.16 154.54 34.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.725 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.7 t -138.76 -33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.83 83.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -134.61 104.13 5.94 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.61 -0.936 . . . . 0.0 109.007 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.91 149.22 21.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.34 132.61 26.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -1.016 . . . . 0.0 108.99 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -87.14 19.64 3.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.53 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -57.66 -107.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.1 129.43 1.96 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.55 -30.3 2.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -30.86 22.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.3 t -79.54 -53.93 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 18.1 m -47.2 -19.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 164' ' ' SER . 65.9 m -74.49 -61.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.03 -15.13 45.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -57.19 -43.69 82.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 45.8 m-85 -71.84 -20.07 61.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.35 -34.38 29.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 93.1 mt -71.91 136.17 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -1.217 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -65.96 126.21 27.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.51 -12.25 59.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.408 -179.93 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.541 ' N ' ' SD ' ' A' ' 2' ' ' MET . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -156.53 156.38 33.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 57.0 mttp -126.98 -14.53 5.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.519 -0.738 . . . . 0.0 109.382 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 43.0 m-20 -146.31 128.63 15.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.208 -0.932 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.17 158.56 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.567 -0.708 . . . . 0.0 109.307 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.0 tp -145.64 109.45 4.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 109.061 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.78 150.84 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.905 . . . . 0.0 108.747 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.24 117.25 1.68 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -115.36 124.21 50.67 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -144.03 150.56 22.59 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -159.95 152.12 20.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.396 -1.061 . . . . 0.0 109.893 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.18 129.61 34.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.575 -0.703 . . . . 0.0 109.643 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.4 170.18 16.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.386 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -132.72 107.07 8.15 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.522 -0.736 . . . . 0.0 109.314 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -85.35 123.91 31.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -145.74 -36.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.388 -0.82 . . . . 0.0 109.205 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -158.23 33.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.315 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.61 -0.28 84.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -78.28 165.89 23.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -1.18 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 12.3 p-10 -172.4 149.15 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.574 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.26 143.37 27.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -141.06 100.25 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.269 -0.894 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.28 135.51 34.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 108.748 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.51 117.59 30.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.51 130.98 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.66 167.75 25.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 109.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.27 144.98 42.91 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -101.94 151.81 21.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.87 143.34 47.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.562 -0.711 . . . . 0.0 109.282 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 133.2 22.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.069 -1.019 . . . . 0.0 110.136 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.5 176.5 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.741 -0.6 . . . . 0.0 109.487 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.93 -2.49 55.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 46.7 t30 -87.67 -1.43 57.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.741 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.54 -13.02 65.09 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -101.61 150.99 22.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.536 -0.979 . . . . 0.0 108.402 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLY . 27.4 t -69.05 137.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.24 -0.913 . . . . 0.0 109.121 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -71.62 8.68 1.04 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.74 170.95 35.35 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.1 m-20 -94.81 3.46 54.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.939 -1.33 . . . . 0.0 110.21 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.17 -42.13 5.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.056 -1.028 . . . . 0.0 110.584 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t0 49.63 9.93 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.955 -1.09 . . . . 0.0 109.496 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 8.2 t80 -138.13 100.22 4.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.323 -0.861 . . . . 0.0 109.803 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 43' ' ' ILE . 8.0 pt -96.75 139.6 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.208 -0.932 . . . . 0.0 108.608 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 35.4 p90 -151.23 -152.3 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 109.568 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.549 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.5 m-85 -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.644 -0.66 . . . . 0.0 110.013 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -57.27 -4.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -0.965 . . . . 0.0 108.639 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.0 t30 -151.32 102.03 2.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -48.72 -26.34 2.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.6 pttp -163.93 157.28 18.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.6 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 7.1 t -76.97 125.86 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.241 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.77 -45.81 67.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.922 . . . . 0.0 109.758 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.75 -12.23 19.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.494 -0.754 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.6 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -86.19 -13.51 68.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.1 p 60.45 12.19 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -1.212 . . . . 0.0 109.104 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -92.97 151.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.413 -0.804 . . . . 0.0 109.214 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.2 m -148.52 139.13 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.01 . . . . 0.0 109.921 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -90.3 129.01 36.58 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -66.63 -53.02 38.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.4 114.09 0.54 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -79.37 110.98 15.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.94 -163.93 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.41 15.86 0.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -155.85 -39.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.332 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.22 24.79 46.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -58.34 135.78 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -1.15 . . . . 0.0 109.326 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.22 124.29 0.79 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.38 -163.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -1.145 . . . . 0.0 109.579 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 165.17 33.75 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.28 98.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -1.122 . . . . 0.0 109.486 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.21 -57.38 13.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.22 170.82 8.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 132.21 5.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.201 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.23 119.44 36.34 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.05 137.32 35.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 109.081 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -127.8 144.75 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.588 -0.695 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.35 97.27 3.34 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.7 mt -82.98 -14.96 53.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.087 -1.008 . . . . 0.0 109.557 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.43 -1.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.462 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.37 16.32 3.73 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.342 -0.849 . . . . 0.0 109.101 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.68 134.96 92.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.217 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.24 -177.95 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.814 1.676 . . . . 0.0 111.495 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.41 13.57 64.92 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -96.89 -59.78 1.73 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -1.14 . . . . 0.0 109.828 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.22 148.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.734 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -144.06 7.37 1.39 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.31 -0.869 . . . . 0.0 109.635 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -152.0 140.23 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 109.051 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.1 mt -145.55 122.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.161 -0.962 . . . . 0.0 109.709 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.09 174.15 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.339 -0.851 . . . . 0.0 108.747 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -141.08 119.53 12.29 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.07 157.67 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.332 -0.855 . . . . 0.0 110.651 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.61 136.72 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 p -131.12 148.54 52.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.5 mm -75.57 147.87 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' ALA . 4.0 t60 -102.36 -68.48 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.249 -0.907 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.27 -18.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -54.25 -17.89 3.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -69.86 -59.63 2.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.939 -1.101 . . . . 0.0 109.964 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.77 -51.33 5.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.181 -0.949 . . . . 0.0 111.354 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -78.09 -16.84 57.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.96 -1.088 . . . . 0.0 110.991 -178.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' ARG . 35.6 ttp180 55.89 101.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.746 -1.221 . . . . 0.0 109.308 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -159.16 143.06 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 131' ' ' ALA . 23.3 t -100.96 167.25 10.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 109.456 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -45.87 -35.35 4.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -58.15 -39.31 92.08 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -46.98 -16.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -1.174 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 104' ' ' GLY . 23.0 t -86.08 168.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.149 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.2 m -70.86 -22.23 62.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.819 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.61 79.39 0.03 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.5 23.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 109.748 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 42.8 p90 -152.34 163.32 39.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 54.3 mt -126.2 154.3 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -141.22 159.85 41.34 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.983 -1.073 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.2 tt -154.22 116.99 4.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 109.28 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.98 143.51 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 117' ' ' ASP . 55.9 t30 -75.14 102.07 4.8 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.62 -1.32 2.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t70 -83.01 -53.55 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.652 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.6 6.2 8.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.587 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 59.52 60.33 2.31 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.1 p -110.62 -70.12 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.925 -0.485 . . . . 0.0 110.298 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 66.8 mt-10 -45.33 157.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.324 -0.86 . . . . 0.0 109.774 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 150.17 52.15 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.091 -1.006 . . . . 0.0 110.02 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -139.78 142.26 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.645 -0.659 . . . . 0.0 109.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.35 147.77 22.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.234 -0.916 . . . . 0.0 109.147 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -91.17 103.16 15.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.407 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 131' ' ' ALA . 82.3 mt -79.24 -39.3 33.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.4 m -47.51 -30.29 3.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.971 -1.081 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.3 -54.74 3.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.403 -0.811 . . . . 0.0 109.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.5 -2.35 28.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.14 -0.975 . . . . 0.0 110.418 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.46 -45.27 69.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.217 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 t -70.91 3.08 3.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.491 -0.756 . . . . 0.0 109.868 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.1 m -83.11 -34.72 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.035 -1.04 . . . . 0.0 110.226 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -176.74 -162.42 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.022 . . . . 0.0 109.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.56 -15.31 7.58 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.41 138.67 36.71 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.409 ' C ' ' HH ' ' A' ' 158' ' ' TYR . 13.3 ptm -165.45 157.99 15.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 0.0 109.916 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.07 134.64 37.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.347 -0.846 . . . . 0.0 109.664 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -76.71 -42.42 41.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.05 . . . . 0.0 109.431 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.44 -163.13 13.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.28 163.05 39.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -1.098 . . . . 0.0 109.015 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.5 tp -144.82 137.22 26.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.068 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -150.68 166.04 31.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 109.275 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -95.7 141.45 29.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 9.5 t-160 -99.18 -133.95 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.641 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 5.6 m120 -52.22 -50.48 61.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.984 -1.072 . . . . 0.0 108.269 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.04 16.94 0.13 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -129.87 154.43 47.3 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.228 -1.16 . . . . 0.0 109.683 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.52 ' O ' ' N ' ' A' ' 1' ' ' SER . 71.9 m95 -72.35 151.86 42.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.395 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -147.28 121.63 9.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.233 -0.917 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -90.32 146.26 24.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -150.81 107.78 3.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.4 -0.812 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.44 154.7 40.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.835 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 -33.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.4 85.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.16 104.3 5.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.531 -0.982 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.89 150.66 26.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.409 ' HH ' ' C ' ' A' ' 137' ' ' MET . 0.1 OUTLIER -134.67 135.07 41.79 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.604 -0.939 . . . . 0.0 108.837 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.51 2.7 54.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 109.519 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -58.68 -110.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.97 140.27 6.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.49 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -47.75 -35.22 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.848 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.49 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.79 -19.81 30.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.1 m -89.02 -52.44 5.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 12.7 m -54.54 -28.29 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.617 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 32.1 p -78.54 -54.59 5.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -71.98 -15.12 62.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.976 -1.077 . . . . 0.0 109.33 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -28.99 63.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 51.1 m-85 -71.78 -19.83 61.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 109.473 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.56 -49.0 4.29 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.3 158.87 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -1.136 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -69.51 122.69 19.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.459 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 91.21 5.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 149' ' ' TRP . 20.9 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.08 -170.99 2.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -153.25 -34.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 15.5 m120 -145.99 141.26 27.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 t -141.0 154.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.0 109.226 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.79 121.82 12.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 109.288 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -91.8 150.74 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 108.988 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.3 116.85 1.8 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -112.59 127.81 56.19 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.86 146.95 17.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -157.63 152.74 25.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -1.134 . . . . 0.0 109.872 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -92.53 126.51 37.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.737 . . . . 0.0 109.649 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.22 138.29 32.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.473 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -82.24 109.52 16.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -82.61 124.96 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -152.96 -34.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -157.98 40.57 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.53 -22.14 4.88 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.59 171.46 7.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -1.167 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -176.03 173.39 2.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.474 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 95.2 m-85 -96.17 153.09 17.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -140.93 111.15 6.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.92 163.61 13.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -106.68 154.57 20.74 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 0.0 109.479 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -144.67 109.7 5.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.185 -0.947 . . . . 0.0 108.764 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.427 ' HG ' ' N ' ' A' ' 27' ' ' ALA . 22.8 t -149.43 163.3 38.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 109.974 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' N ' ' HG ' ' A' ' 26' ' ' SER . . . -109.88 144.69 37.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 8.0 m-85 -104.04 129.07 51.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.447 -0.783 . . . . 0.0 108.909 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.622 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.53 155.56 17.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.41 -0.806 . . . . 0.0 109.204 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.23 137.3 25.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -76.69 176.35 8.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.445 -0.785 . . . . 0.0 109.266 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.5 -2.55 53.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.642 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -93.18 3.55 55.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.174 -0.954 . . . . 0.0 109.821 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 -19.6 53.83 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 31' ' ' ALA . 40.3 mttp -106.26 172.45 6.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.8 t -101.27 141.81 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -59.69 -5.55 0.93 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -148.6 101.11 0.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 18.6 p-10 -45.23 -18.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.376 -1.073 . . . . 0.0 110.28 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.44 79.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 0.0 109.561 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD1' ' CG2' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 45.45 17.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' ALA . 52.5 t80 -137.8 100.02 4.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.533 -0.729 . . . . 0.0 109.858 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.419 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.2 pt -106.3 139.65 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.315 -0.866 . . . . 0.0 109.072 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -152.92 -148.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 109.039 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 47' ' ' ASN . 25.9 p90 -44.46 -34.33 2.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.971 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.69 -5.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.166 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' A' ' 45' ' ' TYR . 54.0 t-20 -148.0 110.09 4.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -0.834 . . . . 0.0 108.956 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.24 -29.1 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 12.8 pttm -169.17 155.6 6.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.432 -0.793 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -73.51 117.51 15.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.22 78.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.663 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -93.42 -16.41 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.29 -0.881 . . . . 0.0 109.786 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.17 -13.69 61.58 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t 58.39 14.04 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.91 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.329 -0.857 . . . . 0.0 109.168 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.496 ' HG1' ' CB ' ' A' ' 49' ' ' LYS . 76.5 m -145.75 136.12 24.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -89.97 133.49 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.347 -0.846 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -71.75 -60.79 2.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.506 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.43 114.92 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 32.6 p-10 -82.21 110.94 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.0 t-20 -80.84 -163.48 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.358 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 36.1 ttp180 -151.91 14.23 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 109.243 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -154.11 -38.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.945 . . . . 0.0 109.25 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.83 -3.7 63.66 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.49 110.4 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -1.156 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.71 -122.11 1.13 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -169.85 160.02 8.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -1.11 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 166.58 31.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.24 124.13 9.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -1.165 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.93 -73.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -90.84 99.66 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 t -91.38 132.15 36.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.217 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.27 125.08 53.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -96.3 142.51 28.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 108.949 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -133.68 146.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.332 -0.855 . . . . 0.0 109.927 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -142.2 102.23 4.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 79' ' ' ALA . 5.6 mt -82.59 -27.69 31.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.862 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -63.63 4.65 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.29 19.08 4.01 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.81 125.81 45.19 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.117 -0.99 . . . . 0.0 108.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.06 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.818 1.679 . . . . 0.0 111.88 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.56 4.71 83.95 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -53.27 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -1.181 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.29 149.07 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.0 109.347 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 10.4 t0 -120.71 -13.79 8.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 109.482 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -158.02 134.18 9.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.013 . . . . 0.0 109.949 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -122.88 154.42 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.12 173.57 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.193 -0.942 . . . . 0.0 109.291 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -141.84 128.91 20.83 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.61 158.33 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 8.7 m -135.63 114.06 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -106.15 161.06 14.85 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.407 HG23 ' H ' ' A' ' 96' ' ' ALA . 4.9 mm -73.01 140.58 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.12 -69.88 0.73 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.056 -1.028 . . . . 0.0 110.441 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -50.39 -17.92 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.146 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -47.35 -50.51 21.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -55.24 -28.02 50.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.904 -1.123 . . . . 0.0 109.801 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -54.14 4.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.114 -0.991 . . . . 0.0 111.173 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.45 -0.43 15.29 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.187 -0.945 . . . . 0.0 111.058 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.0 ttm-85 56.23 101.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.889 -1.132 . . . . 0.0 109.046 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -146.93 149.48 33.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.7 p -101.03 158.22 16.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.341 -0.849 . . . . 0.0 109.652 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -45.62 -34.46 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.397 -0.815 . . . . 0.0 109.743 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -60.7 -42.22 99.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 87.4 mm-40 -47.66 -15.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.251 . . . . 0.0 109.371 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' GLY . 23.1 t -83.57 166.16 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -69.83 -20.48 63.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.725 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.83 79.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.06 162.76 26.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 109.734 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 20.7 p90 -156.3 149.96 24.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 56.7 mt -115.83 154.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -139.59 159.4 42.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.03 -1.043 . . . . 0.0 109.923 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.3 tt -151.94 117.23 5.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.16 145.82 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.2 t-20 -76.42 102.05 5.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.93 -1.56 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.88 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 115' ' ' ASN . 24.4 t0 -84.08 -53.17 5.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.713 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -123.11 4.67 9.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' ASN . 10.7 tt0 60.39 61.12 1.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.3 p -112.34 -68.97 0.89 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.903 -0.498 . . . . 0.0 110.221 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 22.3 mm-40 -45.4 157.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.851 . . . . 0.0 109.956 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.74 150.83 52.11 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.149 -0.969 . . . . 0.0 109.935 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptm180 -138.81 146.26 41.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.507 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.0 t80 -91.34 147.3 23.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.61 103.06 15.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.516 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 131' ' ' ALA . 46.8 mt -81.38 -39.16 25.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.3 m -48.16 -31.87 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 0.0 109.152 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.18 -54.53 3.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.47 -0.769 . . . . 0.0 109.771 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 58.6 m-20 -72.75 -2.99 22.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.274 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.72 -44.35 66.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.244 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.5 p -72.39 3.17 5.03 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -82.79 -34.57 26.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.74 -162.6 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -127.37 -1.58 6.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.07 13.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.8 ptm -165.35 157.97 15.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.843 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -94.68 139.66 30.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 109.795 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 26.5 t80 -81.14 -42.82 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.629 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.62 -169.45 22.95 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.8 164.86 35.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.251 -1.147 . . . . 0.0 109.46 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 136.52 26.23 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 152' ' ' ARG . 9.5 p90 -146.95 166.27 27.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.019 -1.05 . . . . 0.0 110.25 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.98 145.32 24.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 4.7 t60 -122.77 -118.81 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.641 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 73.6 m-20 -73.53 53.3 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.23 8.13 87.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.76 148.61 50.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.99 . . . . 0.0 109.312 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.515 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.4 m95 -75.08 151.79 38.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -147.74 127.11 13.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.112 -0.993 . . . . 0.0 109.603 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -89.63 148.23 23.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.484 -0.76 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 143' ' ' TYR . 2.6 ptp180 -153.87 107.52 2.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.06 154.55 37.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.44 -34.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.0 109.389 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 86.26 0.04 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -131.67 104.19 6.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.634 -0.921 . . . . 0.0 109.389 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.36 148.08 24.94 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -139.43 128.66 23.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -1.073 . . . . 0.0 109.321 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.8 12.16 13.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.06 -80.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 152.77 131.24 1.63 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.1 pt? -47.15 -13.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.56 -50.32 7.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.2 p -81.12 -37.72 28.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.92 -24.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.434 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 93.4 m -79.55 -55.28 5.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.168 -0.957 . . . . 0.0 110.959 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.09 -15.21 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.957 -1.089 . . . . 0.0 110.355 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -66.3 -39.96 89.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.58 -19.62 62.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.683 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.96 -29.23 42.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 171' ' ' ILE . 96.5 mt -80.13 139.56 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.412 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 172' ' ' ASN . 35.8 p-10 -66.03 112.58 3.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.41 -163.87 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.418 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 25.2 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.255 0.55 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -80.21 -174.64 4.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -153.21 -34.98 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -138.0 142.65 40.41 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.362 -0.837 . . . . 0.0 109.321 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 5.2 t -140.08 146.01 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tt -136.25 111.9 9.37 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.42 150.97 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.26 117.08 1.56 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 tt -115.98 132.42 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -149.0 143.96 11.55 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.52 158.8 41.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -1.023 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -76.73 131.35 38.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.911 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 119.21 29.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 0.0 109.261 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -81.08 106.72 13.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -103.02 134.5 46.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -162.98 -34.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 26.5 t70 -159.68 41.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.97 -17.44 22.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.554 ' NE2' ' N ' ' A' ' 19' ' ' GLN . 1.4 mp0 -81.73 151.63 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.522 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -175.04 174.21 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.434 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.17 140.03 31.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.83 99.79 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.304 -0.872 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.69 153.29 24.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -108.44 109.06 20.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -0.761 . . . . 0.0 109.543 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.25 128.0 44.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.307 -0.87 . . . . 0.0 108.924 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.417 ' OG ' ' CE1' ' A' ' 42' ' ' PHE . 84.0 p -149.44 167.81 25.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.068 . . . . 0.0 109.984 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.68 140.7 43.22 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -103.91 129.83 51.46 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.406 -0.809 . . . . 0.0 108.922 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.97 146.72 27.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 109.681 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.64 134.69 23.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.188 -0.945 . . . . 0.0 110.005 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.74 176.53 3.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.65 -6.4 58.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.711 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -86.57 1.49 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.86 59.16 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.563 ' HZ1' ' ND2' ' A' ' 172' ' ' ASN . 45.0 mttm -99.48 152.26 20.2 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.2 t -72.26 136.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.054 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -70.96 8.17 0.99 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.2 168.36 34.61 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.33 4.05 54.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.997 -1.296 . . . . 0.0 110.13 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -102.77 -42.05 6.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.158 -0.964 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 47.71 13.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.742 -1.224 . . . . 0.0 109.454 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ALA . 68.7 t80 -137.5 102.86 4.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.444 -0.785 . . . . 0.0 109.911 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 pt -103.08 131.04 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.813 . . . . 0.0 108.855 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -150.06 -146.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -50.65 -16.27 0.37 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 10.0 p-10 -78.92 4.88 12.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 108.799 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.1 t-20 -156.71 106.44 2.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -48.05 -25.57 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 11.9 pttm -172.86 158.53 3.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 t -69.64 141.38 53.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.66 -43.55 25.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.31 -1.58 12.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.694 -0.629 . . . . 0.0 109.553 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.8 -13.68 60.6 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 t 60.45 10.28 2.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -1.077 . . . . 0.0 109.426 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.13 147.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.99 138.2 25.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 109.721 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -89.82 130.17 36.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 108.785 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -69.49 -42.76 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.332 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.27 111.08 0.39 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -72.84 110.79 7.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.1 t-20 -86.3 -167.04 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.945 . . . . 0.0 109.341 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.51 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 15.5 ptt-85 -162.37 20.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -153.9 -43.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 109.352 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.57 30.35 12.06 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.23 150.49 48.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -1.172 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.02 144.33 2.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -79.73 -169.84 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.479 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.15 169.08 19.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -56.42 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -52.96 -61.07 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.65 165.31 13.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -154.89 132.15 11.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.15 124.48 50.43 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -95.91 139.83 31.55 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.51 146.8 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -139.57 99.35 3.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.18 -5.53 52.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -83.26 -26.89 30.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.93 5.87 50.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.42 124.44 85.53 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.13 -161.35 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.828 1.686 . . . . 0.0 112.057 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.32 1.38 79.5 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -68.9 -59.83 2.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 109.246 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 50.4 t -91.39 148.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.408 -0.807 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 2.4 m-20 -138.26 9.03 2.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -155.04 131.3 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 109.327 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.38 154.3 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.46 173.66 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.307 -0.87 . . . . 0.0 109.001 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.9 m-85 -140.95 120.48 13.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.21 158.11 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.714 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.63 136.34 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -125.55 143.88 50.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 109.695 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.22 132.05 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 108.863 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -93.8 -60.14 1.83 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.33 -19.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.56 -43.88 72.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -55.79 -27.6 51.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.762 -1.212 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.67 -53.74 4.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.137 -0.977 . . . . 0.0 111.076 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' CZ ' HE22 ' A' ' 101' ' ' GLN . 12.3 ptm180 -112.42 -3.9 14.37 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.244 -0.91 . . . . 0.0 110.9 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 48.0 ttp180 56.74 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.071 . . . . 0.0 109.321 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.42 HE22 ' CZ ' ' A' ' 99' ' ' ARG . 3.8 pt20 -157.88 153.65 26.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -101.85 158.47 16.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.01 -31.49 0.92 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -50.06 -33.51 22.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -57.53 -26.29 61.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -1.077 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.41 166.4 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.223 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.3 m -70.69 -28.89 65.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.4 75.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.62 25.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 108.938 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.9 p90 -153.24 169.86 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.297 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 41.8 mt -132.4 156.62 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.71 162.69 34.8 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.006 -1.059 . . . . 0.0 109.731 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.6 tt -157.52 116.66 3.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.92 141.88 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.318 -0.864 . . . . 0.0 109.651 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 117' ' ' ASP . 1.4 m120 -77.79 102.1 7.03 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 6.1 p-10 -68.29 -3.67 11.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.9 t70 -72.96 -52.69 13.58 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.138 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -122.67 -12.02 8.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.766 -0.584 . . . . 0.0 109.617 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 115' ' ' ASN . 6.0 tt0 70.86 69.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 121' ' ' GLU . 16.8 p -130.48 -45.71 1.09 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.738 -0.601 . . . . 0.0 109.979 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 5.0 mp0 -65.13 158.23 26.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 108.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 176.67 76.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.28 148.67 52.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.495 -0.753 . . . . 0.0 109.407 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 27.8 ptt180 -136.49 141.72 43.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.53 140.04 30.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 0.0 108.946 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -83.85 103.02 12.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 0.0 109.402 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.7 mt -78.22 -41.72 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 84.7 m -47.88 -29.58 3.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.933 -1.104 . . . . 0.0 109.274 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.05 -54.74 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 109.878 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.28 -4.74 37.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 110.355 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -60.21 -49.29 78.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.961 -1.087 . . . . 0.0 109.783 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.3 p -60.41 2.8 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.5 m -89.68 -33.31 16.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 110.4 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' CG ' ' H ' ' A' ' 135' ' ' THR . 3.3 tp10 -172.68 -145.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.18 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.521 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -135.82 -52.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.77 143.64 30.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.2 ttt -166.2 158.08 13.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.043 . . . . 0.0 109.802 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -101.04 136.48 40.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.373 -0.83 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 25.9 t80 -81.65 -40.74 22.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.74 -170.79 26.95 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -150.96 163.62 38.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -1.12 . . . . 0.0 109.602 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.03 140.39 32.61 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -150.57 166.5 30.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.099 -1.001 . . . . 0.0 109.857 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -88.15 148.96 24.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.79 . . . . 0.0 109.709 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -152.5 123.78 7.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 55.67 24.77 7.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.81 80.33 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -127.8 138.37 52.71 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.488 -1.007 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 76.8 m95 -67.69 150.7 48.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -151.35 126.19 9.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -89.23 147.02 24.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.465 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -152.76 108.09 3.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.048 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.54 154.74 41.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.0 t -139.31 -33.65 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -0.843 . . . . 0.0 109.293 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.09 86.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -138.25 104.46 5.2 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.928 . . . . 0.0 109.485 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.64 150.59 33.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -147.88 134.4 19.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.221 -1.164 . . . . 0.0 109.396 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.3 16.94 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.339 -0.851 . . . . 0.0 109.43 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.1 -64.55 2.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.64 127.04 0.97 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.8 pt? -47.22 -35.58 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.792 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.0 -22.2 27.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.423 ' C ' ' N ' ' A' ' 166' ' ' CYS . 26.0 m -79.18 -57.53 3.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.0 m -47.58 -20.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 96.2 m -72.63 -61.94 1.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.68 -17.52 31.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.35 -43.51 88.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.24 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.92 -20.31 61.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.04 -53.28 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.9 mm -76.7 107.58 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -1.174 . . . . 0.0 109.373 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.563 ' ND2' ' HZ1' ' A' ' 35' ' ' LYS . 4.7 m120 -80.52 114.17 19.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.57 24.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 172' ' ' ASN . 15.9 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.461 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 149' ' ' TRP . 11.8 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt -67.67 -178.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.436 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 81.8 mttt -153.62 -33.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.911 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 26.7 m-20 -140.3 129.11 23.18 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.69 156.09 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -142.02 110.0 5.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 108.896 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.22 150.5 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.209 -0.932 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.54 116.5 1.22 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.56 134.55 49.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.57 142.32 10.58 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -160.39 152.98 20.94 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -1.151 . . . . 0.0 109.914 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.08 99.32 11.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 109.403 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.31 163.37 24.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.428 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -132.81 106.86 7.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.487 -0.758 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 m -86.64 105.93 17.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.572 ' HG1' ' N ' ' A' ' 17' ' ' ASP . 72.9 p -79.53 -59.17 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.572 ' N ' ' HG1' ' A' ' 16' ' ' THR . 24.9 p-10 -158.51 18.01 0.21 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.68 -34.67 0.69 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -82.08 162.78 22.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -1.077 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -176.25 165.88 2.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.24 131.19 42.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 p-10 -141.03 100.8 3.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.18 146.3 28.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.78 121.4 44.3 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.33 -0.856 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.6 134.37 40.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.262 -0.899 . . . . 0.0 108.912 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 27.9 t -149.85 167.92 25.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.08 138.33 54.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.8 m-85 -104.06 128.03 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.317 -0.865 . . . . 0.0 109.332 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.634 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -103.03 155.84 18.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.42 137.49 25.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 109.35 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -79.14 176.78 9.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 109.501 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.35 59.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.98 4.66 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.119 -0.988 . . . . 0.0 109.839 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.89 -20.68 45.91 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 31' ' ' ALA . 43.6 mtpt -103.32 172.49 6.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.6 t -101.29 142.63 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.406 -0.809 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 39.1 mmm-85 -59.74 -6.03 1.09 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -146.1 100.16 0.22 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -44.94 -21.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -1.091 . . . . 0.0 110.414 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.35 79.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 109.62 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER 47.77 13.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 109.369 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 84.9 t80 -138.28 99.46 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.366 -0.834 . . . . 0.0 109.654 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.422 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.1 pt -101.83 136.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.8 p90 -144.94 -160.85 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.139 -0.976 . . . . 0.0 109.502 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.8 p90 -45.64 -29.96 1.39 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.8 t30 -57.42 -6.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.855 -1.153 . . . . 0.0 108.989 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 48.6 t30 -140.17 110.07 6.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.458 -0.776 . . . . 0.0 109.022 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.03 -31.65 5.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 109.278 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 16.9 pttp -169.87 160.01 8.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -65.01 142.29 58.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.327 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.92 43.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.631 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -115.21 -3.79 12.49 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.643 -0.661 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -82.07 -15.64 74.23 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.0 p 61.48 11.45 3.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.0 109.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.9 m -147.68 133.85 19.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 109.746 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -91.42 139.17 30.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 72' ' ' SER . 7.2 m -74.43 -61.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.67 121.63 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 23.6 p-10 -81.28 112.11 18.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.146 . . . . 0.0 109.543 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.35 132.1 35.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -79.82 6.24 11.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.532 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 p -153.3 -34.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.92 15.78 10.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.51 110.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -1.068 . . . . 0.0 109.5 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.2 -135.57 2.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -160.31 69.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -1.166 . . . . 0.0 109.441 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.3 -175.67 33.17 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -49.2 106.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.04 -63.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -90.99 -179.69 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.562 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.9 m -161.85 135.43 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.18 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 120.5 35.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.13 138.8 33.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.096 -1.002 . . . . 0.0 109.304 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.38 147.02 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.583 -0.698 . . . . 0.0 109.763 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 54' ' ' SER . 53.8 mttp -142.85 102.1 3.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.857 . . . . 0.0 108.722 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 79' ' ' ALA . 9.3 mt -77.11 -39.01 51.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.999 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -49.42 -17.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -100.17 -15.95 17.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.78 123.89 88.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.398 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.56 -160.74 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.967 1.778 . . . . 0.0 111.941 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.01 1.73 87.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' NH1' ' A' ' 37' ' ' ARG . 59.4 t0 -67.28 -55.64 13.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -1.143 . . . . 0.0 109.57 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -79.02 148.53 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 8.9 t0 -128.25 -7.13 5.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 109.564 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -158.21 135.84 10.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 109.614 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.75 154.12 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.51 173.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.262 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -133.32 139.28 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.94 155.62 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.99 . . . . 0.0 111.212 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.57 113.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -121.14 171.62 8.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.449 -0.782 . . . . 0.0 110.606 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.8 mm -81.68 168.3 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -132.75 -64.8 0.74 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -49.91 -18.23 0.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.28 -39.44 79.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.579 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' NE2' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -52.9 -32.21 44.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.77 -1.206 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.84 4.22 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.135 -0.978 . . . . 0.0 111.296 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.23 1.75 16.31 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.127 -0.983 . . . . 0.0 111.091 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.4 ttm180 59.08 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.998 -1.064 . . . . 0.0 109.339 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.402 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 83.4 mt-30 -150.05 139.35 21.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 109.555 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 m -99.13 158.98 15.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.37 -0.831 . . . . 0.0 109.461 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -46.31 -30.21 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.325 -0.86 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -68.19 -37.53 86.91 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -47.71 -17.06 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.167 . . . . 0.0 109.138 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' GLY . 23.0 t -85.0 167.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 108.969 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.0 m -67.26 -20.47 65.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.0 80.48 0.03 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.76 164.68 23.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 109.832 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.8 p90 -154.07 150.45 28.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.129 -0.982 . . . . 0.0 110.024 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 36.2 mt -114.17 155.84 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -141.96 162.82 34.51 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.995 -1.065 . . . . 0.0 109.919 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 113' ' ' LEU . 3.7 tt -157.07 118.14 3.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -130.77 144.56 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.331 -0.856 . . . . 0.0 110.049 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -75.24 101.97 4.85 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.92 -1.71 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.479 ' CB ' HD22 ' A' ' 115' ' ' ASN . 22.3 t0 -84.75 -52.18 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.306 -0.871 . . . . 0.0 109.627 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -122.24 -0.48 9.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.65 -0.656 . . . . 0.0 109.988 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 60.67 63.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -118.13 -53.93 2.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.002 -0.436 . . . . 0.0 110.099 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER -60.16 158.55 11.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 109.389 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER 178.31 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 148.01 52.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 109.791 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 41.1 ptt85 -134.82 145.68 48.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.408 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.8 t80 -91.36 147.59 22.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.15 -0.969 . . . . 0.0 109.186 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -86.11 102.99 14.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 109.285 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 131' ' ' ALA . 66.9 mt -83.07 -40.66 19.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.9 p -48.13 -31.74 6.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.118 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -95.32 -54.62 3.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.823 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 47.1 m-20 -73.47 -3.82 29.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.161 -0.962 . . . . 0.0 110.416 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -52.27 -45.15 65.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.997 -1.065 . . . . 0.0 109.125 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.1 m -70.91 3.01 3.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.643 -0.66 . . . . 0.0 109.92 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -84.47 -34.26 23.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 110.17 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.64 -167.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -123.4 -8.05 8.1 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.05 135.52 24.26 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.94 157.65 14.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.014 -1.054 . . . . 0.0 110.048 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -92.6 138.37 31.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -81.51 -41.96 20.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.29 -169.95 20.97 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.406 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.9 tt0 -151.5 161.25 43.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -144.51 136.39 25.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.2 -0.937 . . . . 0.0 108.523 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.2 p90 -144.04 165.87 26.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.188 -0.945 . . . . 0.0 109.685 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.5 ptm180 -84.98 152.52 23.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -155.29 116.47 3.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.411 ' O ' ' OE1' ' A' ' 148' ' ' GLU . 14.6 t-20 56.25 24.99 8.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 -3.89 86.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 3.4 mp0 -109.64 135.09 51.16 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.51 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.7 m95 -69.14 151.64 46.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.192 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.85 129.42 15.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.119 -0.988 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 19.4 t80 -96.72 137.73 35.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.457 -0.777 . . . . 0.0 109.912 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -143.61 107.29 4.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.48 154.56 39.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -143.08 -34.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.264 -0.898 . . . . 0.0 109.322 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.04 85.24 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -132.65 104.23 6.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.663 -0.904 . . . . 0.0 109.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.76 149.71 25.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.24 133.44 29.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.468 -1.019 . . . . 0.0 109.117 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.16 7.66 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 0.0 109.439 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -69.6 0.91 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.89 125.39 0.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.21 -28.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.137 . . . . 0.0 109.928 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.75 -31.0 22.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.9 p -75.6 -50.48 15.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 35.4 m -48.13 -20.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.486 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.4 m -69.97 -58.94 3.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 110.326 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.71 -15.24 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.35 -44.2 92.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.293 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -71.23 -20.01 62.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.76 17.45 30.95 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.31 150.01 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -1.195 . . . . 0.0 109.344 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -65.87 119.23 10.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 99.78 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.447 -180.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 149' ' ' TRP . 53.0 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -77.61 148.8 34.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -129.64 -9.88 4.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.453 ' ND2' ' OD1' ' A' ' 117' ' ' ASP . 11.7 m-80 -146.41 129.18 16.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.219 -0.926 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -135.88 147.98 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.066 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tt -135.28 109.92 8.59 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.16 143.87 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.47 117.15 2.18 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.46 131.82 56.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -145.24 143.46 11.86 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' THR . 19.0 p90 -154.97 153.69 31.43 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.44 -1.035 . . . . 0.0 109.695 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.04 117.51 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.1 170.8 15.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.59 106.95 8.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -85.79 127.87 34.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -147.39 -34.64 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 17' ' ' ASP . 7.0 p30 -158.16 47.7 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 -41.11 2.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -60.49 159.28 10.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -170.12 171.91 6.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.391 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -140.9 99.65 3.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.39 -0.819 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.66 130.63 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -91.43 112.54 24.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 109.959 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 128.74 44.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.276 -0.89 . . . . 0.0 108.6 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -149.26 165.73 31.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.102 -0.999 . . . . 0.0 110.171 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 138.69 45.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.3 m-85 -104.45 129.41 52.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.472 -0.768 . . . . 0.0 109.007 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.02 153.42 19.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.377 -0.827 . . . . 0.0 109.949 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.02 135.36 22.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.822 . . . . 0.0 109.415 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -76.25 176.46 8.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.47 -10.49 59.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.973 . . . . 0.0 109.718 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -84.78 4.81 31.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.18 -19.61 51.21 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 31' ' ' ALA . 85.0 mttt -103.71 172.05 7.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -103.03 140.94 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.458 -0.776 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' NH1' ' OD1' ' A' ' 83' ' ' ASP . 34.3 ttp180 -62.06 -3.54 1.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -143.54 101.29 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -45.54 -27.29 0.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 110.47 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.4 -42.34 82.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.912 -1.118 . . . . 0.0 109.623 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.8 t0 46.03 15.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 13.8 t80 -137.77 100.22 4.13 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.653 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 pt -101.55 137.92 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.3 p90 -141.14 -160.08 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 25.7 p90 -42.5 -36.06 1.23 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.607 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 9.1 t30 -49.27 -14.61 0.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.912 -1.118 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 45' ' ' TYR . 40.7 t30 -153.88 112.85 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.94 -64.63 0.97 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.202 -0.937 . . . . 0.0 109.542 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -89.92 117.77 28.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.478 -0.764 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.588 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 6.9 t -57.21 134.77 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.89 75.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.826 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -116.39 -5.96 11.76 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.615 -0.678 . . . . 0.0 109.892 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.588 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -82.42 -19.27 64.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t 62.78 6.57 2.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -1.17 . . . . 0.0 109.238 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -92.97 152.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 108.932 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -143.45 142.13 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.111 -0.993 . . . . 0.0 110.468 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -92.12 121.44 33.67 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 72' ' ' SER . 19.0 m -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.381 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 109.77 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -79.77 110.77 15.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -1.18 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -86.34 132.6 33.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -78.89 2.8 18.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 40.1 p -153.52 -35.01 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.78 21.26 76.49 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -58.53 115.46 3.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -1.185 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.86 -121.16 1.0 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -171.52 152.66 3.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.06 -163.92 47.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.2 94.69 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 109.557 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.17 -53.05 42.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.22 160.08 14.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 108.998 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.424 ' O ' ' OG1' ' A' ' 58' ' ' THR . 10.4 m -157.86 132.32 8.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.077 -1.014 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mp -117.88 126.4 52.31 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -96.27 122.74 39.45 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.434 -0.791 . . . . 0.0 110.199 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 103.52 4.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.12 -24.33 40.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.909 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.4 -21.99 66.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.67 -9.19 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.953 . . . . 0.0 109.773 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.13 125.06 90.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.98 -160.28 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.909 1.739 . . . . 0.0 111.909 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.26 3.22 75.91 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 16.4 t70 -69.12 -60.1 2.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.304 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.36 148.75 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.494 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.7 m-20 -133.1 10.48 4.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.343 -0.848 . . . . 0.0 109.831 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -158.14 131.73 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 109.235 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.9 mt -129.36 154.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.515 -0.741 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.03 173.17 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.426 -0.796 . . . . 0.0 109.014 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 6.9 m-85 -142.4 118.4 10.64 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.02 157.71 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.248 -0.907 . . . . 0.0 110.625 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -120.98 148.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -141.81 140.08 32.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -73.92 137.4 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 108.867 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.8 t-80 -94.17 -64.9 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -47.45 -18.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.852 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.94 -18.13 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.0 109.94 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -66.14 -60.44 2.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.889 -1.132 . . . . 0.0 109.484 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -43.6 9.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.364 -0.835 . . . . 0.0 111.151 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -83.88 -18.02 38.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 111.225 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 54.19 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.652 -1.28 . . . . 0.0 109.162 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -148.39 142.28 25.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.25 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -99.63 165.27 11.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.217 -0.927 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -46.29 -34.19 4.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.285 -0.885 . . . . 0.0 109.871 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -58.26 -38.49 90.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -49.1 -18.85 0.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.981 -1.305 . . . . 0.0 109.338 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.424 ' N ' ' C ' ' A' ' 104' ' ' GLY . 23.2 t -82.54 166.22 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 109.161 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.3 m -70.28 -23.4 62.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.988 . . . . 0.0 109.758 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.35 77.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.2 163.48 23.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -1.176 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 30.6 p90 -154.23 169.88 22.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.5 mt -132.08 156.55 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -143.85 162.12 36.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -157.77 118.1 3.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.079 -1.013 . . . . 0.0 109.658 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.91 143.8 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 117' ' ' ASP . 82.9 m-20 -79.85 102.01 8.87 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.01 -1.49 7.61 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 31.7 t0 -76.76 -52.44 9.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 5.4 m-80 -122.48 -14.74 7.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.73 -0.606 . . . . 0.0 109.583 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 15.9 tt0 73.83 71.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.546 ' HG1' ' N ' ' A' ' 121' ' ' GLU . 71.9 p -135.9 -45.13 0.65 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.644 -0.66 . . . . 0.0 109.975 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.546 ' N ' ' HG1' ' A' ' 120' ' ' THR . 49.9 mm-40 -65.37 158.44 26.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 108.931 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 173.4 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.79 149.45 52.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.501 -0.75 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.7 ptp180 -135.12 142.9 46.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.618 -0.676 . . . . 0.0 109.461 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -91.32 143.09 27.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.905 . . . . 0.0 108.925 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.16 102.87 14.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.585 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 38.3 mt -78.7 -41.0 32.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.204 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.9 p -47.78 -29.68 3.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 109.295 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -95.22 -54.68 3.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 109.804 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.93 -0.83 22.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.968 . . . . 0.0 110.275 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -53.0 -44.62 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 109.275 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 t -72.57 3.01 5.4 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.539 -0.725 . . . . 0.0 109.851 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.1 m -82.32 -34.35 28.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 110.124 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.76 -164.06 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 0.0 109.612 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.06 -14.34 8.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.6 140.12 36.94 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.8 ptm -165.47 158.05 15.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.008 -1.057 . . . . 0.0 109.871 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.19 137.58 35.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -82.87 -41.06 19.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.627 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.93 -170.1 25.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -151.21 164.24 37.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.216 -1.167 . . . . 0.0 109.558 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 139.02 29.04 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.16 166.45 29.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.065 -1.022 . . . . 0.0 109.894 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.494 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -89.19 146.18 24.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 109.506 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 19.9 t-160 -128.23 -115.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.619 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 21.9 m120 -72.66 58.71 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.068 -1.02 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.73 8.09 62.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.02 149.47 50.35 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.963 . . . . 0.0 109.315 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.8 m95 -72.8 151.63 41.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.356 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -146.58 129.42 16.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -89.89 149.28 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.405 -0.81 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -155.46 113.52 3.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.195 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.96 154.53 31.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.56 -33.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -0.871 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.91 84.58 0.03 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -136.96 104.28 5.41 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.966 . . . . 0.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.36 152.12 37.38 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.95 129.46 21.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.24 9.31 31.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 109.444 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.36 -70.97 0.61 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.83 132.44 1.48 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.8 pt? -46.33 -33.33 3.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.63 -26.39 26.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 166' ' ' CYS . 12.6 t -74.69 -54.39 7.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 35.5 m -47.41 -20.71 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.504 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 60.0 m -71.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -15.4 39.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.35 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.28 -43.31 98.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.108 -0.995 . . . . 0.0 110.076 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -71.43 -19.7 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.95 -44.87 65.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 65.5 mt -80.09 129.71 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.62 111.7 16.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.66 86.49 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.504 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' TRP . 75.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 34.2 mtt -81.69 162.84 22.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -141.45 -33.73 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 13.1 m120 -146.11 128.46 15.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.84 149.0 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -132.63 108.24 8.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 108.985 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.55 150.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.94 117.0 1.25 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -106.05 132.45 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.07 138.41 7.26 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.946 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -156.46 155.19 31.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -75.5 125.53 29.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.45 121.51 29.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.263 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -132.71 123.96 27.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.458 -0.776 . . . . 0.0 109.459 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 98.5 p -95.73 132.74 40.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.865 . . . . 0.0 109.295 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -148.62 -84.25 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -71.17 3.0 3.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.22 -127.0 1.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -79.71 176.92 9.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.165 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -72.72 -164.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.32 104.9 16.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.184 -0.948 . . . . 0.0 109.338 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' ND1' ' A' ' 94' ' ' HIS . 24.4 p-10 -92.87 102.71 15.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 mt -83.4 138.04 33.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 109.15 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.07 106.69 18.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.05 119.05 38.08 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -149.04 168.37 23.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.04 . . . . 0.0 109.804 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.03 138.42 45.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.597 -0.689 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.0 m-85 -104.35 131.83 51.26 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.611 ' CD1' ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.62 154.39 19.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.382 -0.823 . . . . 0.0 110.132 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 136.62 24.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 35' ' ' LYS . . . -77.04 176.68 8.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.247 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.86 -11.23 59.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.5 m120 -86.55 5.65 34.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.069 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.46 52.16 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' ALA . 40.7 mmtm -102.61 172.03 7.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -102.18 143.23 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 109.784 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -62.5 -3.24 1.34 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.82 102.57 0.25 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -45.18 -25.8 0.4 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -1.085 . . . . 0.0 110.751 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.819 -1.175 . . . . 0.0 109.687 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.554 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 0.4 OUTLIER 48.4 12.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 109.444 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 40' ' ' ALA . 79.3 t80 -135.11 100.25 4.5 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CD1' ' HG ' ' A' ' 50' ' ' SER . 4.6 pt -103.5 130.52 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.487 ' CZ ' ' OD2' ' A' ' 60' ' ' ASP . 33.4 t80 -170.99 -168.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.985 -1.072 . . . . 0.0 109.179 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.473 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 52.4 m-85 48.46 -113.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 48' ' ' LEU . 23.0 t30 -56.84 -7.65 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 45' ' ' TYR . 8.3 t-20 -67.49 68.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.945 -1.097 . . . . 0.0 109.648 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 46' ' ' ASN . 13.3 mt -52.98 -30.97 38.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 108.898 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 127.15 0.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.744 . . . . 0.0 109.124 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.438 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 1.5 m -55.86 111.9 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.67 -25.4 63.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.08 -16.12 11.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.545 -0.722 . . . . 0.0 109.658 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.53 -20.27 35.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m 69.14 2.67 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.451 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.77 146.56 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.229 -0.92 . . . . 0.0 108.663 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -149.12 150.56 32.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.961 -1.087 . . . . 0.0 110.348 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -91.37 136.15 33.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.65 -0.657 . . . . 0.0 109.756 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 p -85.78 -30.35 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.27 104.1 0.24 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' CZ ' ' A' ' 44' ' ' PHE . 12.6 t70 -80.77 110.82 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.636 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -95.36 -167.85 1.69 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -161.47 19.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.8 p -154.29 -42.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.55 -6.65 7.5 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.48 110.43 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -1.09 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 177.54 155.41 13.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.64 88.66 3.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -1.142 . . . . 0.0 109.482 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 -116.21 5.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.87 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -71.93 -69.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.32 156.1 17.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.314 -0.866 . . . . 0.0 109.132 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -159.68 141.33 12.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.19 131.81 55.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.067 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.47 110.16 22.26 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.405 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 26.6 mt -97.94 146.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 111.075 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -140.21 84.35 1.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 -5.19 11.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.9 -20.23 49.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.648 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.49 -13.89 21.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.217 -0.927 . . . . 0.0 109.781 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.99 124.91 82.23 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 109.269 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.01 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.74 1.627 . . . . 0.0 111.866 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.56 1.86 79.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -71.41 -60.52 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.544 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 t -87.12 133.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -113.32 4.43 16.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.697 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -156.36 137.86 14.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.528 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.4 mt -145.44 107.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -109.18 171.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.405 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 4.7 m-85 -129.84 134.4 47.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.1 158.16 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -131.28 134.75 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -138.04 164.62 28.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 mm -77.64 142.01 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 22' ' ' ASP . 20.6 t-160 -98.1 -68.35 0.81 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -51.33 -18.11 0.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.104 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -48.94 -42.93 38.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 109.772 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.19 -30.07 48.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.918 -1.114 . . . . 0.0 109.753 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.518 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -90.73 -54.01 4.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 111.297 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.518 ' HE ' ' CB ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -112.52 -0.31 15.27 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.256 -0.903 . . . . 0.0 111.1 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 96' ' ' ALA . 43.1 ttt85 57.08 103.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.949 -1.095 . . . . 0.0 108.991 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.435 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 70.1 mt-30 -137.38 134.04 35.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.277 -0.889 . . . . 0.0 109.708 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -90.64 152.77 20.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -46.76 -30.89 2.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.197 -0.94 . . . . 0.0 109.583 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' VAL . . . -57.96 -40.31 93.09 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.435 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 51.0 mt-30 -48.17 -17.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.241 . . . . 0.0 109.359 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.2 t -82.78 163.97 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 108.949 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 m -72.13 -25.55 61.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.14 78.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.11 164.71 25.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -1.109 . . . . 0.0 109.145 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 22.7 p90 -154.4 143.82 21.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.92 -1.113 . . . . 0.0 110.477 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 43.1 mt -108.43 154.16 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -139.94 160.8 39.1 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.999 -1.063 . . . . 0.0 109.731 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.412 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 3.9 tt -155.11 116.69 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.529 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.46 144.51 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 109.755 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 119' ' ' GLN . 53.8 t30 -76.37 102.12 5.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.22 -1.87 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.383 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 115' ' ' ASN . 18.2 t70 -81.66 -53.23 6.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.22 4.22 9.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.771 -0.58 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 115' ' ' ASN . 20.0 tp60 59.5 60.41 2.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 53.9 m -113.46 -68.64 0.91 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.951 -0.468 . . . . 0.0 110.299 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 122' ' ' VAL . 57.8 mm-40 -45.2 157.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 110.029 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -179.28 73.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.85 151.55 52.0 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.3 ptp180 -139.21 142.48 37.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -91.4 147.77 22.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.167 -0.958 . . . . 0.0 109.314 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -85.96 106.19 16.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.6 mm? -80.33 -46.78 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.5 m -47.83 -27.96 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.264 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -91.81 -54.57 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.59 0.84 9.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -56.96 -47.18 81.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 p -73.26 3.09 6.19 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.502 -0.749 . . . . 0.0 109.976 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.2 m -87.96 -34.61 18.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 0.0 110.478 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -175.65 -163.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.789 -1.194 . . . . 0.0 109.857 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.5 p -125.58 -8.73 6.82 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.14 27.81 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.5 ptm -165.46 157.9 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.04 -1.037 . . . . 0.0 109.951 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -96.76 137.29 36.07 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 109.436 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.0 t80 -79.69 -42.12 25.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.077 -1.015 . . . . 0.0 109.958 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.57 -166.29 15.48 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.532 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 10.1 tt0 -150.82 160.66 43.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -1.012 . . . . 0.0 109.292 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.422 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.0 mt -142.81 137.52 29.73 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.44 165.75 29.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -95.6 144.41 26.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.465 -0.772 . . . . 0.0 109.687 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 20.0 t-80 -125.49 -117.16 0.28 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.654 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 53.0 t30 -72.54 58.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.968 . . . . 0.0 109.407 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.31 10.49 66.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -127.74 141.46 51.59 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.933 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.0 m95 -71.37 152.03 43.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -148.52 131.39 16.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.561 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.1 t80 -89.7 149.64 22.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.509 -0.744 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 21.6 tpt85 -154.39 107.26 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 109.025 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.508 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -63.75 154.75 32.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.42 -33.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.435 -0.791 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.24 82.14 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -135.74 104.37 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.588 -0.948 . . . . 0.0 109.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.47 151.34 36.13 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -145.78 133.77 21.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.358 -1.084 . . . . 0.0 109.213 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.28 11.65 29.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.98 -27.47 6.68 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 83.6 139.5 3.86 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.63 -12.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -1.132 . . . . 0.0 109.719 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -77.81 -57.59 3.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 109.515 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 m -80.72 -41.83 22.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.01 -21.32 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 40' ' ' ALA . 13.5 t -73.97 -60.37 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.616 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -26.42 23.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.195 -0.94 . . . . 0.0 110.443 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 169' ' ' TYR . 1.3 tm0? -51.32 -35.34 37.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 109.813 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 24.6 m-85 -85.73 13.26 7.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -150.73 27.87 1.04 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.9 pt -71.08 133.94 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.253 . . . . 0.0 109.173 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -78.37 137.04 37.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.533 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.41 36.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.479 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -80.24 115.88 20.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.89 -23.15 18.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -146.31 152.33 38.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.301 -0.874 . . . . 0.0 109.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 t -146.16 158.52 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.8 tp -147.69 107.65 4.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.851 . . . . 0.0 109.022 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.11 150.77 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.92 116.93 1.39 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -110.88 126.83 55.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -142.21 145.48 15.73 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -158.49 151.24 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 110.031 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -91.2 128.23 36.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 109.712 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.314 0.578 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 150.12 20.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.95 104.48 4.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.912 . . . . 0.0 109.64 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.36 151.38 25.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 108.783 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.36 106.56 17.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 109.879 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.5 125.68 45.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 108.757 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 5.7 t -149.43 167.62 25.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.941 -1.099 . . . . 0.0 109.913 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.38 136.53 49.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -104.02 127.96 51.58 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.77 142.0 30.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.373 -0.83 . . . . 0.0 109.998 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.57 131.62 20.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -0.935 . . . . 0.0 109.835 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.36 175.11 10.06 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.12 1.56 43.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.289 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -83.09 -9.84 59.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 109.504 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.7 -5.05 69.52 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -109.71 150.37 28.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.9 m -65.97 136.53 26.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -71.02 5.35 2.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ALA . . . -158.77 118.59 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -47.68 -10.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -1.113 . . . . 0.0 110.338 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLY . . . -95.7 -40.21 9.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.5 t0 47.57 14.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 109.294 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 62.6 t80 -137.2 100.39 4.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 109.654 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.9 pt -103.48 139.57 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.558 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.2 p90 -153.22 -153.98 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -0.879 . . . . 0.0 109.686 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.0 OUTLIER -43.43 -36.24 1.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.064 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.45 -1.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 108.946 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.3 t30 -149.57 103.97 3.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.137 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.21 -28.57 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttm -165.18 160.12 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 t -69.86 147.92 49.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.264 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.81 -48.52 14.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -116.2 1.64 13.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.661 -0.649 . . . . 0.0 109.587 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 -12.71 69.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 60.78 11.99 3.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.36 -1.082 . . . . 0.0 109.42 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.07 150.27 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.249 -0.907 . . . . 0.0 108.93 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.9 m -148.77 138.08 21.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.12 -0.987 . . . . 0.0 110.0 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.43 ' NE2' HD11 ' A' ' 73' ' ' LEU . 31.9 m80 -90.06 127.91 36.17 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -67.12 -56.91 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.57 111.11 0.47 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.4 110.88 12.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -81.92 -164.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -156.15 16.48 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -154.64 -37.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 109.325 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.63 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -1.169 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -73.28 -63.86 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.22 171.68 9.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.4 132.26 6.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.326 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -116.37 119.41 35.59 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -95.69 135.88 36.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 108.736 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.51 146.93 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 110.358 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.28 87.62 2.35 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 79' ' ' ALA . 21.9 mt -67.94 -34.52 76.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.869 . . . . 0.0 109.751 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -55.28 -5.71 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.582 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -119.27 20.65 12.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' PRO . 48.0 t -105.41 104.98 50.6 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.327 -0.858 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.25 -171.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.055 1.837 . . . . 0.0 112.353 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 1.08 89.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.02 -55.95 15.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -1.105 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 83.5 t -84.39 148.59 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 0.0 108.977 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 45.3 m-20 -136.61 -5.27 2.0 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.359 -0.838 . . . . 0.0 110.136 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -145.25 131.17 19.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.949 -1.094 . . . . 0.0 109.423 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -141.49 108.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 141' ' ' GLU . 10.8 pt -116.23 154.86 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 109.627 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -96.45 159.1 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 109.202 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 28' ' ' PHE . 60.3 t -147.23 152.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.746 0.784 . . . . 0.0 110.651 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.6 t -148.01 115.84 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 p -132.85 174.45 10.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.54 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 6.0 mm -86.53 143.25 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -100.4 -68.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.327 -0.858 . . . . 0.0 110.044 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -18.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.248 -0.908 . . . . 0.0 110.06 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.54 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -46.43 -26.96 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -53.98 -50.41 66.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 109.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.12 -39.48 12.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.42 -0.8 . . . . 0.0 110.984 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -96.99 -19.49 18.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.057 -1.027 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.6 mmt180 50.94 58.2 5.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.637 -1.289 . . . . 0.0 109.169 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.37 148.45 25.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.3 p -98.15 159.39 14.97 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.743 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -45.88 -33.94 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.658 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.16 -36.84 90.42 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -47.53 -19.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -1.21 . . . . 0.0 109.328 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 107' ' ' SER . 18.6 t -85.93 168.12 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.131 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -69.3 -23.91 63.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.21 79.98 0.03 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.75 25.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 109.817 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.8 p90 -153.33 143.51 22.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.099 -1.0 . . . . 0.0 110.257 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.8 mt -107.02 154.7 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.39 159.83 41.24 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.7 tt -154.23 116.54 4.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.097 -1.002 . . . . 0.0 109.482 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.572 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.0 p -129.65 143.3 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.436 ' HB2' ' H ' ' A' ' 120' ' ' THR . 78.8 m-20 -75.33 102.12 4.98 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -64.73 -1.85 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.561 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.1 -53.7 5.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 109.72 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.71 6.55 8.8 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.67 -0.644 . . . . 0.0 109.724 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 59.03 59.7 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 12.5 m -111.21 -69.91 0.84 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.866 -0.521 . . . . 0.0 110.309 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 51.0 mm-40 -45.26 157.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.0 109.893 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.58 72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.0 152.22 51.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.067 -1.021 . . . . 0.0 109.992 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 30.3 ptt180 -140.79 144.36 35.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -91.32 147.63 22.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 103.39 16.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.3 mt -80.44 -40.7 25.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.298 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.85 -29.58 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -95.26 -54.66 3.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.434 -0.791 . . . . 0.0 109.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.11 -1.35 25.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.85 -44.71 66.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.294 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -72.7 3.09 5.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.56 -0.713 . . . . 0.0 109.984 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.4 m -83.02 -34.39 26.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 0.0 110.283 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.75 -164.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.952 -1.093 . . . . 0.0 109.729 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 102' ' ' SER . 1.1 p -124.81 -5.71 7.46 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.76 135.31 23.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.36 150.67 9.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.8 pp -91.55 136.0 33.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.79 -49.4 46.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 109.938 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -153.35 -155.56 7.21 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.293 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 88' ' ' ILE . 14.7 tt0 -150.64 157.73 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -1.024 . . . . 0.0 109.347 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.74 135.74 28.23 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -150.82 166.8 29.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.931 -1.106 . . . . 0.0 110.275 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 11.5 ptm180 -86.95 147.07 25.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.779 . . . . 0.0 109.503 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.5 OUTLIER -129.54 -114.88 0.25 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.693 . . . . 0.0 109.259 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.537 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.2 m120 -72.67 58.42 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.963 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.44 7.25 63.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -127.92 154.18 45.84 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.668 -0.901 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -75.74 151.49 37.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -145.35 127.83 16.0 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -89.99 148.25 23.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -157.32 107.37 2.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.78 153.72 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.04 -32.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.78 85.92 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -139.14 104.48 5.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.559 -0.965 . . . . 0.0 109.548 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.0 154.79 35.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -150.08 124.17 9.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.404 -1.056 . . . . 0.0 109.123 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.69 15.09 6.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.32 -0.862 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.06 -76.56 0.15 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.21 126.18 0.82 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.481 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.01 -29.21 1.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -1.126 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.97 -32.6 21.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 166' ' ' CYS . 19.9 m -80.28 -50.35 10.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.73 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 m -45.76 -19.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.341 -0.849 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 78.0 m -70.94 -62.0 1.55 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.25 -15.38 38.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.108 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.68 -34.99 71.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.003 -1.06 . . . . 0.0 110.365 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -70.75 -19.59 62.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.153 . . . . 0.0 109.206 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.684 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.286 0.565 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.6 mtt -80.91 -173.67 4.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -153.15 -34.67 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.502 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 46.1 t-20 -140.57 139.39 34.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.0 109.279 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG1' HD21 ' A' ' 113' ' ' LEU . 3.8 t -144.46 130.64 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.21 109.76 17.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.71 144.73 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.145 -0.972 . . . . 0.0 108.727 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -129.98 129.94 6.11 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tt -134.87 126.81 29.49 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -144.01 151.11 23.12 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 27.5 p90 -155.73 154.7 31.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.367 -1.079 . . . . 0.0 109.738 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.8 99.62 11.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.28 134.43 39.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -141.11 100.06 3.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.0 109.712 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 136.48 34.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.888 . . . . 0.0 108.633 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.66 110.58 22.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.186 -0.947 . . . . 0.0 110.005 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 128.83 44.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.252 -0.905 . . . . 0.0 108.859 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 57' ' ' HIS . 58.5 m -150.25 167.8 25.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.046 -1.034 . . . . 0.0 110.37 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 136.62 48.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.8 m-85 -103.48 145.34 30.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -116.9 153.83 31.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.75 143.31 36.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -81.4 176.59 9.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.43 -13.24 52.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -0.906 . . . . 0.0 109.86 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -84.42 7.95 17.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 109.867 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 -14.8 61.88 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 37.6 mmtm -102.81 176.18 5.24 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 38' ' ' GLY . 21.4 t -101.11 137.07 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -62.76 1.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -151.04 124.38 1.69 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.51 3.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.156 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -97.78 -41.97 7.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.04 -1.037 . . . . 0.0 109.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 10.6 t0 46.92 14.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 109.442 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 14.0 t80 -136.9 99.07 3.92 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 0.0 109.368 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 pt -101.97 133.17 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.437 -0.79 . . . . 0.0 108.942 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.7 p90 -142.14 -161.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.259 -0.9 . . . . 0.0 109.278 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 21.7 p90 -44.65 -27.51 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.224 -0.923 . . . . 0.0 110.372 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.4 t30 -57.93 -8.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.999 -1.063 . . . . 0.0 108.96 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 45.0 t-20 -139.06 109.42 6.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.798 . . . . 0.0 108.966 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -47.37 -31.51 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.89 . . . . 0.0 109.183 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.8 pttt -168.52 155.01 7.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.442 -0.786 . . . . 0.0 109.39 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 33.3 t -60.82 147.88 41.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.38 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.36 -47.88 16.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -116.16 0.91 13.07 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.736 -0.602 . . . . 0.0 109.516 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.66 -12.01 65.1 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t 58.44 14.92 3.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.232 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.4 t -92.97 151.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.404 ' O ' HD23 ' A' ' 73' ' ' LEU . 76.1 m -148.84 134.62 18.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.0 109.811 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 73' ' ' LEU . 23.0 m80 -90.57 139.57 30.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.393 -0.817 . . . . 0.0 109.072 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 m -76.84 -55.55 5.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.44 117.28 0.66 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.91 113.62 18.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -1.148 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 132.95 35.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -81.75 7.97 11.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.69 -35.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.4 111.36 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -1.149 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.55 -63.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -87.92 159.29 18.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.6 m -152.51 132.4 13.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.214 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.557 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -117.15 123.95 47.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -95.87 136.19 36.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.275 -0.89 . . . . 0.0 108.853 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 89' ' ' PHE . 87.4 mt -133.39 146.99 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.086 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.25 90.36 2.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 79' ' ' ALA . 13.8 mt -72.41 -25.27 61.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -66.4 4.74 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -137.08 24.91 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 81' ' ' PRO . 38.1 t -103.93 105.54 48.8 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.451 -0.78 . . . . 0.0 109.198 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . 73.2 Cg_exo -48.06 -175.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.026 1.817 . . . . 0.0 112.335 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.84 85.92 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.27 -50.81 72.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -1.204 . . . . 0.0 109.243 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 84' ' ' VAL . 5.2 m -95.55 139.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 109.076 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' A' ' 32' ' ' ALA . 3.4 m-20 -116.86 2.41 12.82 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.57 -0.706 . . . . 0.0 109.819 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -158.14 132.68 8.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.041 . . . . 0.0 109.777 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.7 mt -141.17 117.79 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.2 157.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 75' ' ' ILE . 4.6 m-85 -105.9 137.41 43.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 1.2 p -147.01 157.46 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.521 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 3.5 p -129.26 147.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 p -140.15 140.71 36.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -73.82 132.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.826 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 96' ' ' ALA . 30.8 t-80 -89.95 -63.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.22 -18.22 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.92 -18.26 43.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.734 -1.229 . . . . 0.0 109.412 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.46 -44.42 9.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 0.0 111.047 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -81.72 -17.79 46.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.05 -1.031 . . . . 0.0 111.402 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 52.34 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.854 -1.154 . . . . 0.0 109.077 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -148.13 143.5 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.328 -0.857 . . . . 0.0 109.132 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -99.85 165.38 11.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.284 -0.885 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -46.22 -32.22 2.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.321 -0.862 . . . . 0.0 109.785 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -38.69 96.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -49.87 -17.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.3 . . . . 0.0 109.296 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 107' ' ' SER . 15.9 t -84.92 163.82 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 109.127 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -62.08 -26.79 68.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.597 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.1 79.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 164.37 25.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -1.146 . . . . 0.0 109.74 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 37.0 p90 -151.29 170.02 20.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.301 -0.875 . . . . 0.0 110.018 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 24.7 mt -132.66 154.93 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 72.6 ttt180 -143.38 162.48 35.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.968 -1.083 . . . . 0.0 109.718 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.3 tt -157.67 117.97 3.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 0.0 109.771 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.609 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.1 p -132.03 142.81 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.359 -0.838 . . . . 0.0 109.586 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.84 102.27 8.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.502 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.5 t70 -68.03 -1.78 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.5 -52.12 10.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 50.6 t30 -122.02 -14.12 8.07 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.677 -0.639 . . . . 0.0 109.608 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 20.4 tt0 71.67 69.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.6 m -134.39 -43.71 0.77 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.722 -0.611 . . . . 0.0 109.807 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.876 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.7 mp0 -65.79 158.25 28.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 108.781 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 174.21 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.92 51.73 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.751 . . . . 0.0 109.201 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.0 ptt180 -134.08 142.07 47.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.607 -0.683 . . . . 0.0 109.474 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.8 t80 -91.43 147.35 23.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.371 -0.831 . . . . 0.0 108.916 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.77 102.83 15.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 109.394 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 50.5 mt -79.65 -39.19 31.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.6 p -47.56 -30.51 3.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.018 -1.051 . . . . 0.0 109.286 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -95.23 -54.59 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -0.825 . . . . 0.0 109.75 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 53.9 m-20 -74.77 -0.73 19.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.7 -46.5 74.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.085 -1.01 . . . . 0.0 109.321 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.2 t -69.23 2.99 2.42 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.548 -0.72 . . . . 0.0 109.882 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 m -82.96 -34.57 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.9 -162.91 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.001 -1.062 . . . . 0.0 109.582 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -15.25 7.56 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.35 137.37 35.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.6 ttp -164.89 152.05 11.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.872 -1.142 . . . . 0.0 110.144 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.596 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.7 pt? -87.96 135.43 33.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -77.81 -26.4 49.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.922 -1.111 . . . . 0.0 109.304 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.69 -164.23 21.91 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -150.53 154.22 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.988 . . . . 0.0 108.74 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 134.81 24.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.038 -1.039 . . . . 0.0 108.86 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -147.47 166.01 28.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 109.717 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.57 148.48 24.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -152.3 123.73 7.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER 55.72 24.8 7.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.18 80.05 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -127.82 137.48 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -1.015 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -67.69 151.19 47.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -148.61 121.98 9.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.148 -0.97 . . . . 0.0 109.726 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 17.6 t80 -89.94 143.77 26.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.497 -0.752 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.32 107.43 3.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 109.026 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.36 154.79 10.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.776 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -139.42 -34.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.373 -0.829 . . . . 0.0 109.05 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.41 81.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.551 ' H ' HD21 ' A' ' 138' ' ' LEU . 34.7 tt0 -141.35 104.14 4.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.057 . . . . 0.0 109.041 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.0 150.5 27.73 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.7 137.77 38.69 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.606 -0.937 . . . . 0.0 108.782 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.51 13.86 24.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.217 -0.927 . . . . 0.0 109.519 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.88 -68.35 1.34 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.06 131.59 1.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.7 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.23 -30.27 1.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -1.116 . . . . 0.0 109.87 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.7 -25.18 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' GLY . 53.6 p -77.34 -55.4 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.471 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.6 m -46.97 -20.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 80.0 m -71.47 -60.91 1.98 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.03 -19.64 28.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.28 -0.888 . . . . 0.0 110.141 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -55.21 -42.19 73.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 109.726 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -71.47 -19.86 62.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.355 -0.841 . . . . 0.0 109.178 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 149' ' ' TRP . 73.2 m . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -74.19 -169.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -153.9 -34.58 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 31.4 t30 -143.63 128.22 18.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 109.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.413 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.6 t -124.64 158.54 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.626 -0.671 . . . . 0.0 109.479 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.21 112.95 6.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.516 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -89.94 150.55 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 108.981 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.35 116.76 1.34 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.61 135.46 42.02 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.92 138.07 8.09 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -160.33 153.7 22.08 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.4 111.24 23.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.548 -0.72 . . . . 0.0 109.347 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 68.4 m-85 -96.31 150.9 20.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.07 99.67 3.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.865 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.63 132.78 35.56 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -95.85 111.06 23.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.096 -1.002 . . . . 0.0 110.092 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.36 125.34 43.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.414 -0.804 . . . . 0.0 108.893 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -149.81 167.77 25.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.844 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.0 142.25 41.66 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.5 m-85 -103.9 148.28 26.35 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -120.18 154.11 35.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.568 -0.708 . . . . 0.0 109.987 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 139.54 27.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.102 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.86 176.42 7.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.097 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.38 -9.44 58.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.179 -0.95 . . . . 0.0 109.763 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.39 8.29 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.136 -0.977 . . . . 0.0 109.919 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.18 70.1 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 66.7 mmtt -104.18 170.1 8.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.8 t -98.42 137.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.12 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.3 ttt-85 -64.69 1.94 0.76 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.93 125.21 1.7 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 4.42 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -1.148 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.59 -41.5 8.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.97 -1.081 . . . . 0.0 110.028 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 12.2 t0 47.72 13.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.857 -1.152 . . . . 0.0 109.43 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 72.4 t80 -136.89 99.39 4.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -0.8 . . . . 0.0 109.642 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.3 pt -99.7 139.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.6 p90 -154.22 -155.93 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 109.596 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 3.8 m-85 -43.54 -34.29 1.35 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.544 -0.723 . . . . 0.0 110.138 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -58.28 -2.16 0.17 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.096 -1.002 . . . . 0.0 108.827 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 43.5 t-20 -148.72 113.76 5.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 109.27 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -50.64 -38.49 46.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 108.945 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 36.0 pttt -161.87 157.67 24.31 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.372 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 t -63.21 144.57 56.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -47.12 17.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -116.31 2.02 13.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.715 -0.615 . . . . 0.0 109.67 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.7 -17.97 57.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 2.9 p 67.22 7.97 5.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -93.11 149.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 m -148.86 138.98 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.227 -0.92 . . . . 0.0 109.496 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 44.1 m80 -89.88 139.83 30.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -142.61 40.57 1.56 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 109.343 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.38 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.2 124.28 34.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -1.058 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.7 m120 -153.53 93.03 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -73.88 14.52 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 61' ' ' ASN . 52.6 p -147.59 -35.29 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.887 . . . . 0.0 109.303 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.73 122.01 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -82.01 -70.43 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.33 177.0 7.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.2 m -159.98 132.44 6.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -119.44 125.15 48.26 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -95.9 139.35 32.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 108.837 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.506 HD13 ' CE1' ' A' ' 89' ' ' PHE . 69.3 mt -132.22 146.61 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.5 mttm -141.22 101.32 3.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.68 -5.41 53.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.13 -20.46 32.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.569 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.74 7.99 43.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.15 123.95 84.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.203 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.923 1.749 . . . . 0.0 112.054 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.82 2.24 76.1 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -69.94 -60.63 2.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -1.199 . . . . 0.0 109.219 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.97 148.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.003 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.7 15.99 3.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.245 -0.909 . . . . 0.0 109.693 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' NZ ' ' OE2' ' A' ' 141' ' ' GLU . 50.6 tttp -158.37 135.21 9.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.589 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.2 mt -133.65 154.14 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.93 173.47 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 108.913 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.7 m-85 -142.1 123.38 14.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.71 157.9 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 110.352 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -131.24 115.53 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -107.11 153.24 22.93 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.39 -0.819 . . . . 0.0 110.242 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.7 mm -73.84 167.41 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.625 ' N ' HG22 ' A' ' 93' ' ' ILE . 46.7 t-80 -133.69 -60.81 0.82 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.385 -0.822 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -49.28 -18.27 0.34 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.972 . . . . 0.0 109.586 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.74 -40.02 90.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.81 -32.6 44.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.776 -1.202 . . . . 0.0 109.698 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.91 -54.03 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.124 -0.985 . . . . 0.0 111.352 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.49 4.09 17.21 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.294 -0.879 . . . . 0.0 111.16 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' ALA . 51.7 ttt180 57.56 106.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 109.301 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.44 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 34.7 mt-30 -151.34 145.34 25.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 109.671 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.8 p -104.95 163.59 12.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.447 -0.783 . . . . 0.0 109.55 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -46.15 -36.38 5.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 109.859 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.655 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.92 -41.43 96.23 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 57.8 mm-40 -49.43 -14.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.28 . . . . 0.0 109.267 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 107' ' ' SER . 21.9 t -83.59 165.4 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.049 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 t -69.0 -20.15 64.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.11 79.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.37 163.46 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.129 . . . . 0.0 109.821 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 18.3 p90 -157.85 158.75 35.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.8 mt -118.88 157.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -138.11 159.35 42.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.059 -1.026 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.9 tt -152.9 115.31 4.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.573 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.86 142.11 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.395 -0.816 . . . . 0.0 109.857 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLN . 57.9 t30 -79.49 101.82 8.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.53 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.7 t70 -69.34 -4.89 20.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.728 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 13.7 t0 -70.91 -53.2 15.89 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.813 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -123.38 0.78 8.95 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 115' ' ' ASN . 26.1 tt0 62.93 64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.4 m -118.06 -69.9 0.82 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.924 -0.485 . . . . 0.0 110.304 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.854 ' O ' HG13 ' A' ' 122' ' ' VAL . 14.9 mm-40 -45.29 157.04 0.09 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.311 -0.868 . . . . 0.0 109.876 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.84 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.19 154.47 50.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.012 -1.055 . . . . 0.0 110.025 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.2 ptm180 -139.32 149.24 43.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 109.193 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.05 147.32 22.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.188 -0.945 . . . . 0.0 109.135 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.4 103.13 15.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 0.0 109.399 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 64.3 mt -80.94 -40.49 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 128' ' ' THR . 4.1 p -47.84 -31.06 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 109.189 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -95.2 -54.62 3.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -0.783 . . . . 0.0 109.753 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.96 -4.76 34.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.655 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.77 -45.95 67.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.132 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.5 p -69.14 3.01 2.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.647 -0.658 . . . . 0.0 109.845 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 m -83.18 -34.58 25.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 0.0 110.2 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 179.52 -163.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.93 -1.106 . . . . 0.0 109.592 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 -9.74 9.57 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.71 139.53 34.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.46 157.6 15.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.176 -0.953 . . . . 0.0 109.512 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.36 138.41 37.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 109.718 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 29.2 t80 -81.06 -43.98 18.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 109.611 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.82 -168.69 20.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.514 ' OE2' ' NZ ' ' A' ' 86' ' ' LYS . 29.2 tt0 -151.32 163.53 38.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -1.1 . . . . 0.0 109.408 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.92 140.73 29.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 0.0 108.661 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.45 ' OH ' ' CZ ' ' A' ' 152' ' ' ARG . 4.7 p90 -150.59 166.02 31.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.116 -0.99 . . . . 0.0 109.703 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -85.3 151.48 24.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.563 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -157.72 123.95 4.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 55.97 24.15 7.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.366 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.12 10.55 83.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -127.8 138.98 52.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.598 -0.943 . . . . 0.0 109.339 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 1' ' ' SER . 83.5 m95 -67.67 151.6 47.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.519 ' NZ ' HH21 ' A' ' 152' ' ' ARG . 80.3 tttt -150.72 123.2 8.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -89.47 138.87 31.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.519 HH21 ' NZ ' ' A' ' 150' ' ' LYS . 86.0 mtt180 -143.67 107.35 4.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.26 154.68 39.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -139.8 -33.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.78 86.15 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -137.95 104.76 5.35 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.982 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 152.94 39.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' CE1' HG11 ' A' ' 165' ' ' VAL . 2.0 p90 -147.45 125.27 11.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -1.178 . . . . 0.0 109.33 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.36 11.7 25.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -65.75 2.23 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.37 126.99 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.77 -33.03 4.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 109.82 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.65 -26.03 26.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.335 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.9 t -74.37 -54.31 7.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.5 m -47.94 -20.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 109.438 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.9 m -71.44 -60.65 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.142 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -15.46 38.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.188 -0.945 . . . . 0.0 110.393 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.64 -44.23 87.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.941 -1.099 . . . . 0.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -71.49 -0.2 9.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.545 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.99 174.81 11.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -153.23 -34.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -145.94 143.49 29.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.093 -1.004 . . . . 0.0 109.464 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -145.94 133.09 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.381 -0.824 . . . . 0.0 109.226 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 73' ' ' LEU . 13.8 tp -116.79 109.78 17.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.88 151.0 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.04 117.08 1.33 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -108.12 133.24 52.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.9 140.71 8.61 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -158.04 152.96 25.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -1.112 . . . . 0.0 109.984 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.72 130.55 39.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.0 109.597 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.314 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.14 151.17 19.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.325 -0.859 . . . . 0.0 109.282 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -141.02 99.77 3.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.285 -0.884 . . . . 0.0 109.676 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.28 142.64 30.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 108.625 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.52 112.71 25.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.376 -0.827 . . . . 0.0 109.563 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 130.12 44.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.1 m -149.58 163.06 38.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.089 -1.007 . . . . 0.0 109.937 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 146.08 36.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.5 m-85 -104.24 161.55 13.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.894 . . . . 0.0 109.415 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -129.06 139.16 52.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.661 -0.65 . . . . 0.0 109.478 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 133.46 22.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.05 176.41 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -81.21 -8.94 59.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.27 1.6 40.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.157 -0.965 . . . . 0.0 109.736 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.17 58.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -98.29 144.57 27.56 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 38' ' ' GLY . 22.4 t -66.39 136.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.067 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.02 13.44 0.68 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -159.89 173.15 36.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -94.52 -1.74 52.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.052 -1.264 . . . . 0.0 110.289 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.08 -42.08 5.89 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.196 -0.94 . . . . 0.0 110.059 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 26.9 t0 61.47 -1.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 110.094 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.59 124.31 19.74 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.166 -0.959 . . . . 0.0 110.009 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 pt -102.58 139.57 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.62 ' CE1' ' CZ ' ' A' ' 42' ' ' PHE . 1.3 p90 -138.11 -161.67 1.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 22.8 p90 -44.23 -30.49 0.8 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.162 -0.961 . . . . 0.0 110.437 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 16.7 t-20 -51.1 -16.95 0.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 109.081 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.5 t-20 -135.03 104.06 5.8 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.525 -0.735 . . . . 0.0 109.071 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.98 -24.69 1.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.6 pttt -167.45 155.07 8.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.1 t -77.23 122.46 25.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.06 62.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.962 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -112.91 -19.0 12.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.57 -13.55 75.62 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.5 p 62.85 10.27 4.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -1.118 . . . . 0.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' A' ' 50' ' ' SER . 43.2 t -92.79 151.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -148.72 142.49 25.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.154 -0.966 . . . . 0.0 110.046 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -91.83 126.41 36.9 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 25.5 m -74.48 -29.54 61.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.38 110.82 0.25 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.86 110.98 18.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -81.67 -163.56 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' THR . 28.6 ttm180 -152.16 14.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 109.268 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 62' ' ' ARG . 34.4 p -154.87 -37.73 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.99 101.97 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -1.155 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -55.25 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -89.27 167.5 13.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.346 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.418 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.5 p -160.48 132.86 6.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.6 mp -113.18 128.29 56.44 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.504 -0.747 . . . . 0.0 109.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HZ1' ' HE2' ' A' ' 76' ' ' LYS . 1.8 tmtp? -96.36 110.51 22.83 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.93 146.88 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.596 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HE2' ' HZ1' ' A' ' 74' ' ' LYS . 86.3 mttt -136.49 94.42 3.01 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.52 -11.57 59.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.93 . . . . 0.0 109.616 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.41 4.7 23.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.35 10.73 7.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.449 -0.782 . . . . 0.0 109.322 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.4 t -81.3 125.77 78.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.022 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.14 -162.23 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.841 1.694 . . . . 0.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.38 -0.12 82.75 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.86 -60.69 2.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -1.172 . . . . 0.0 109.44 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.6 t -89.93 148.65 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 41.3 m-20 -139.35 1.96 2.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 109.659 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -150.92 131.48 13.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.186 -0.946 . . . . 0.0 109.006 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.99 154.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.503 -0.748 . . . . 0.0 109.31 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -139.86 173.93 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 17.1 m-85 -141.55 122.06 14.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.63 157.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.4 p -134.14 114.31 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -107.82 151.95 25.05 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.331 -0.855 . . . . 0.0 109.924 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.36 140.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 108.799 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -62.34 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.076 -1.015 . . . . 0.0 109.877 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -47.6 -20.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 109.569 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.6 -18.28 28.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 109.777 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -64.75 -60.79 2.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.687 -1.258 . . . . 0.0 109.255 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.44 11.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 111.024 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -86.16 -19.58 29.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.944 -1.097 . . . . 0.0 111.379 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 55.33 96.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.759 -1.213 . . . . 0.0 109.275 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -158.74 152.54 23.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.491 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 m -105.15 154.65 19.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.457 -0.777 . . . . 0.0 109.241 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.6 -29.89 0.81 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.429 -0.794 . . . . 0.0 109.727 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.67 -37.39 50.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -58.96 -14.18 8.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 109.345 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 107' ' ' SER . 27.9 t -80.32 165.81 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.131 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.506 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.7 t -68.15 -25.89 65.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.94 . . . . 0.0 109.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.12 79.89 0.03 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.45 26.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 13.5 p90 -152.69 142.92 22.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.07 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 48.0 mt -107.49 156.73 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -140.46 161.1 38.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.966 -1.083 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.4 tt -157.35 117.52 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.055 -1.028 . . . . 0.0 109.756 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.605 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -129.54 143.98 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.366 -0.833 . . . . 0.0 109.522 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -74.78 101.69 4.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.93 -1.83 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.056 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -82.57 -52.74 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -122.52 -5.97 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.652 . . . . 0.0 109.851 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 65.81 65.77 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.5 p -123.81 -49.1 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.931 -0.481 . . . . 0.0 109.998 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 54.6 mm-40 -62.94 159.05 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.288 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 177.53 75.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.92 52.28 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.424 -0.798 . . . . 0.0 109.508 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 32.4 ptt180 -136.16 141.16 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.693 . . . . 0.0 109.226 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -92.1 143.61 26.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.0 109.163 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -87.64 103.64 15.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.5 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.6 mt -80.57 -38.31 29.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.4 m -48.25 -33.62 8.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.863 -1.148 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -95.21 -51.12 4.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.406 -0.809 . . . . 0.0 109.747 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.55 -7.44 50.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.251 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.22 -49.99 75.45 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.009 -1.057 . . . . 0.0 109.825 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 p -55.88 0.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.78 . . . . 0.0 110.509 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 131' ' ' ALA . 38.0 p -87.42 -33.12 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.746 -1.221 . . . . 0.0 110.081 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -172.34 -145.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.785 -1.197 . . . . 0.0 109.712 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 21.1 m -126.61 -40.23 1.94 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.18 155.97 26.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 ttt -166.81 157.59 12.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.16 -0.963 . . . . 0.0 109.829 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.81 126.8 50.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.328 -0.857 . . . . 0.0 109.337 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -70.07 -37.13 75.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.932 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.1 -163.39 24.06 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.851 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -151.54 164.09 37.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -1.069 . . . . 0.0 109.519 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.72 140.04 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.244 -0.91 . . . . 0.0 108.571 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.447 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.8 p90 -150.61 166.31 30.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.913 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 17.4 ptm180 -85.34 152.7 23.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.436 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 18.8 t-160 -153.9 119.9 5.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.267 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.436 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 29.0 m-20 52.46 29.39 6.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 109.501 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.52 81.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -127.87 134.91 49.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.48 -1.012 . . . . 0.0 109.396 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.43 149.34 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -148.86 125.98 11.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.208 -0.932 . . . . 0.0 109.538 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -93.37 140.99 28.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 109.971 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -144.06 107.54 4.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.422 -0.799 . . . . 0.0 109.09 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.13 154.65 41.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.098 -1.001 . . . . 0.0 109.72 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.24 -33.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.81 85.82 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.308 -1.113 . . . . 0.0 109.572 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.56 154.03 46.75 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 165' ' ' VAL . 12.7 p90 -137.88 124.04 20.39 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.377 -1.072 . . . . 0.0 109.436 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.63 3.08 34.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.45 -75.09 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 156.39 136.59 2.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.7 pp -47.38 -36.97 10.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -1.172 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.86 -16.83 37.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.3 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 161' ' ' GLY . 34.5 m -78.82 -56.0 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 158' ' ' TYR . 14.4 m -51.62 -19.94 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 109.11 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 70.8 m -73.67 -63.02 1.29 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.469 -0.769 . . . . 0.0 110.352 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.28 35.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.849 . . . . 0.0 110.583 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -61.37 -48.74 79.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.064 -1.022 . . . . 0.0 110.26 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -71.74 -20.33 61.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 109.464 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.448 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 20.3 mmt -79.95 -176.29 5.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 82.7 mttt -151.73 -35.77 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 51.8 m-20 -145.09 143.77 30.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -140.81 158.14 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.6 tp -145.34 109.75 4.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.03 145.7 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.36 117.21 2.89 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.93 124.92 50.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.15 150.47 22.68 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.535 -1.317 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -157.04 153.98 28.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.412 -1.052 . . . . 0.0 109.804 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.69 130.05 34.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.762 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.288 0.566 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 60.9 m-85 -96.41 146.79 24.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 12.1 m-20 -141.03 99.62 3.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -85.28 140.64 30.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 108.524 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -103.17 119.7 39.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.29 131.71 43.73 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.292 -0.88 . . . . 0.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -150.19 168.18 24.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.63 147.47 45.19 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 90' ' ' VAL . 4.3 m-85 -103.6 123.15 46.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.0 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.02 135.72 37.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 108.725 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.01 128.33 17.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.964 -1.085 . . . . 0.0 110.388 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 176.26 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.71 1.13 44.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -84.62 -7.44 59.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 -10.78 73.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -105.07 148.09 27.17 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 38' ' ' GLY . 44.3 t -66.39 137.25 25.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.91 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -70.79 7.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.691 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -154.04 172.66 32.7 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.94 -2.88 49.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.842 -1.387 . . . . 0.0 110.321 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.19 -40.85 6.27 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.09 -1.006 . . . . 0.0 110.982 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' HG11 ' A' ' 36' ' ' VAL . 35.7 t0 50.44 10.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.74 -1.225 . . . . 0.0 109.329 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ALA . 81.8 t80 -138.12 100.22 4.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.0 109.533 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.8 pt -101.41 137.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.22 -0.925 . . . . 0.0 109.086 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.8 p90 -142.81 -162.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.3 p90 -45.23 -32.37 1.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -0.942 . . . . 0.0 110.512 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 17.9 t-20 -51.83 -11.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.886 -1.134 . . . . 0.0 109.036 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.0 t-20 -135.6 107.8 7.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.9 tp -47.52 -29.71 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 35.3 pttt -168.85 156.96 7.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -65.95 144.25 56.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.92 -46.98 32.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -116.07 -2.78 12.17 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.05 -15.68 76.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.46 9.41 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.07 149.82 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.154 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.51 137.75 25.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.164 -0.96 . . . . 0.0 109.869 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -89.42 135.25 33.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.773 . . . . 0.0 108.931 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -73.38 -44.44 58.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.09 110.11 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.59 110.89 12.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -1.142 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.96 -164.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 63' ' ' THR . 10.2 ptm180 -158.18 17.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 62' ' ' ARG . 33.3 p -155.71 -40.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.332 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.81 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 42.8 p-10 -48.66 98.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -1.153 . . . . 0.0 109.564 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 68' ' ' GLY . 68.0 m-20 -74.8 -46.18 38.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.46 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' CG ' ' N ' ' A' ' 72' ' ' SER . 68.0 tt0 -115.82 162.7 16.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.685 . . . . 0.0 109.176 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 m -153.53 143.09 21.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -121.73 123.1 41.05 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.603 -0.685 . . . . 0.0 109.24 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -95.61 138.63 33.01 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.27 146.82 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.434 -0.791 . . . . 0.0 110.182 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -139.12 106.42 5.51 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 79' ' ' ALA . 9.0 mt -78.98 -42.52 26.49 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -52.55 -8.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.977 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.68 19.5 16.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.55 -0.719 . . . . 0.0 109.67 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 81' ' ' PRO . 47.2 t -104.63 105.17 49.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.319 -0.863 . . . . 0.0 109.246 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.2 Cg_exo -48.97 -173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.039 1.826 . . . . 0.0 112.355 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.25 0.33 87.22 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.77 -58.51 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -1.198 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.35 145.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -135.93 -5.74 2.15 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.082 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -142.46 130.67 22.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.997 -1.064 . . . . 0.0 109.214 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.1 mt -139.99 113.99 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.67 173.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.316 -0.865 . . . . 0.0 109.121 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.94 142.2 51.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 91' ' ' VAL . 58.7 t -146.9 156.53 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.857 -1.152 . . . . 0.0 111.713 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.3 p -146.58 113.65 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -120.57 161.67 20.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.295 -0.878 . . . . 0.0 110.828 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.542 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -77.56 161.87 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.482 ' N ' HG22 ' A' ' 93' ' ' ILE . 1.3 t60 -111.19 -76.05 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.344 -0.848 . . . . 0.0 109.934 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' GLN . 1.4 m-20 -47.82 -18.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.772 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.77 -19.07 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 49.7 tt0 -71.45 -62.22 1.49 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.95 -1.094 . . . . 0.0 109.319 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.52 -43.82 9.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.339 -0.85 . . . . 0.0 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 101' ' ' GLN . 40.9 ttt85 -79.23 -20.18 48.87 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 99' ' ' ARG . 59.5 ttt-85 54.59 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.745 -1.222 . . . . 0.0 109.474 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.475 ' CD ' ' HE ' ' A' ' 99' ' ' ARG . 18.8 mt-30 -157.8 141.47 15.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -102.2 163.89 11.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -46.73 -33.01 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.844 . . . . 0.0 109.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.5 -42.28 98.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 66.1 mm-40 -51.21 -12.04 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.156 -1.202 . . . . 0.0 109.225 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.4 t -82.74 165.29 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.852 . . . . 0.0 109.204 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.2 m -69.39 -18.51 63.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.195 -0.941 . . . . 0.0 109.657 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.76 79.46 0.03 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.19 157.51 22.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -1.18 . . . . 0.0 109.706 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 26.5 p90 -150.24 169.71 20.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 109.969 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -135.87 151.56 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -138.17 161.59 36.43 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.022 -1.049 . . . . 0.0 109.984 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.14 116.32 4.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.177 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -128.69 144.94 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.317 -0.864 . . . . 0.0 109.957 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.448 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 57.8 t30 -76.13 102.03 5.58 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.91 -1.57 3.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.668 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.64 -53.78 5.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.49 ' CG ' ' HG1' ' A' ' 120' ' ' THR . 13.7 p30 -123.82 6.81 8.73 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.737 -0.602 . . . . 0.0 109.638 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' ASN . 8.1 mt-30 59.55 60.52 2.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 118' ' ' ASN . 86.0 m -110.82 -70.41 0.81 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.896 -0.502 . . . . 0.0 110.342 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.858 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.9 mm-40 -45.3 157.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.18 156.01 48.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.168 -0.958 . . . . 0.0 109.923 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptp180 -142.49 143.31 32.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.545 -0.722 . . . . 0.0 109.243 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.429 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.4 t80 -91.22 142.04 28.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 108.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -85.26 102.86 13.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.065 -1.022 . . . . 0.0 109.432 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 54.1 mt -79.0 -39.21 34.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.166 -0.959 . . . . 0.0 109.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.2 t -47.79 -31.07 4.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.992 -1.067 . . . . 0.0 109.209 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.18 -54.6 3.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.773 . . . . 0.0 109.711 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.429 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 46.8 m-20 -73.23 -2.68 22.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.283 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.1 -47.15 72.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.087 -1.008 . . . . 0.0 109.238 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 t -68.1 3.12 1.73 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.549 -0.719 . . . . 0.0 109.819 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 m -84.3 -34.93 23.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.985 . . . . 0.0 110.169 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -177.53 -166.31 0.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.931 -1.105 . . . . 0.0 109.66 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.69 -10.72 9.14 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.79 26.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.68 158.14 15.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.41 134.16 37.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.1 t80 -73.33 -45.44 55.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.892 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.74 -162.5 11.26 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 22.2 tt0 -151.97 164.29 37.47 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.106 -1.232 . . . . 0.0 109.839 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 13.3 tp -144.16 133.35 23.0 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -148.64 166.22 28.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.0 109.639 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 14.5 ptm180 -94.47 141.24 28.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.377 -0.827 . . . . 0.0 110.095 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.575 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -100.03 -132.88 0.26 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.3 m120 -51.85 -51.45 56.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.887 -1.133 . . . . 0.0 108.322 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.48 16.93 0.14 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.83 159.51 36.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -77.73 151.81 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -148.21 124.99 11.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -89.69 147.65 23.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.377 -0.827 . . . . 0.0 109.391 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -153.9 109.35 3.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.69 154.68 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.526 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.58 -34.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.14 84.22 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -130.32 104.41 7.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.68 -0.894 . . . . 0.0 109.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 149.96 29.32 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.63 127.47 19.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.46 12.15 21.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.6 -67.18 1.76 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.77 126.89 1.13 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -44.68 -32.5 1.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.363 -1.08 . . . . 0.0 110.099 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.74 -27.19 25.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 161' ' ' GLY . 23.3 t -77.71 -50.51 12.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.426 -0.796 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -48.68 -20.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.483 ' SG ' ' CB ' ' A' ' 42' ' ' PHE . 56.7 m -72.35 -61.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.57 -15.36 37.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.165 -0.959 . . . . 0.0 110.537 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.88 -42.14 99.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.033 . . . . 0.0 110.476 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.62 -20.62 61.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.513 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.567 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.1 mpt? -73.06 171.46 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -153.98 -34.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.569 ' ND2' ' OD2' ' A' ' 116' ' ' ASP . 39.2 t-20 -146.06 128.31 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.245 -0.91 . . . . 0.0 109.233 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.2 t -127.69 156.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.613 -0.679 . . . . 0.0 109.178 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.1 tp -142.4 107.18 4.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.78 150.6 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.83 116.94 1.32 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.71 135.18 45.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.9 135.46 5.9 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -157.04 153.2 27.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -1.103 . . . . 0.0 109.816 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.09 108.02 20.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.262 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.34 141.66 29.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.239 -0.913 . . . . 0.0 109.402 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.4 p30 -141.07 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.155 -0.966 . . . . 0.0 109.595 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.69 134.87 34.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 108.877 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -92.4 107.13 18.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.034 -1.042 . . . . 0.0 109.83 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.41 123.46 42.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.74 167.59 26.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.101 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.49 46.2 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.6 m-85 -104.37 128.37 52.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.338 -0.851 . . . . 0.0 108.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.76 155.62 17.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 110.088 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.53 137.28 25.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.349 -0.845 . . . . 0.0 109.362 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -80.16 176.67 9.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.16 -8.56 59.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.966 . . . . 0.0 109.805 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -85.67 2.91 43.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.139 -0.975 . . . . 0.0 109.808 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.03 -18.31 57.6 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.6 mttt -106.61 173.23 6.41 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -101.3 142.18 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.405 -0.809 . . . . 0.0 109.675 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -60.11 -5.55 1.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -144.33 102.32 0.27 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 31.8 p-10 -45.28 -25.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -1.101 . . . . 0.0 110.356 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -58.76 -42.06 88.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.067 -1.02 . . . . 0.0 109.822 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 38.8 t0 46.27 15.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 81.5 t80 -137.35 99.58 4.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 109.419 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.0 pt -102.86 137.92 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.7 p90 -140.85 -160.78 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.18 -0.95 . . . . 0.0 109.344 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.4 p90 -44.68 -31.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 0.0 110.495 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.6 t-20 -51.05 -14.27 0.22 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.903 -1.123 . . . . 0.0 109.01 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.4 t-20 -135.77 107.38 6.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -47.78 -26.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.372 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 14.4 pttm -170.52 159.14 6.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 8.1 t -73.22 129.99 39.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.388 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.24 -30.36 54.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.66 -15.97 11.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 -12.58 75.28 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 60.68 10.75 2.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 50' ' ' SER . 59.7 t -92.75 151.9 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 108.963 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -145.37 145.0 31.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -90.94 119.59 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 m -67.24 -46.98 72.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.27 117.61 0.77 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -78.46 158.9 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -1.178 . . . . 0.0 109.543 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -157.55 109.98 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.59 17.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.897 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -152.56 -35.05 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.255 -0.903 . . . . 0.0 109.372 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.16 99.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -1.135 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -69.11 -73.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -98.67 164.45 12.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -160.81 139.33 10.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.338 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 mp -117.94 127.32 53.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.524 -0.735 . . . . 0.0 109.382 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HG2' ' HZ2' ' A' ' 76' ' ' LYS . 52.4 tttp -96.19 114.79 26.52 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.443 HD13 ' CE1' ' A' ' 89' ' ' PHE . 64.5 mt -104.18 147.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.388 -0.82 . . . . 0.0 110.571 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HZ2' ' HG2' ' A' ' 74' ' ' LYS . 64.4 mttp -138.71 105.65 5.42 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.27 -38.61 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.15 -22.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.71 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.06 -24.03 17.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.279 -0.888 . . . . 0.0 109.75 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.99 124.24 79.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 109.334 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.23 -160.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.939 1.759 . . . . 0.0 111.826 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.25 0.89 88.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -66.98 -56.37 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.15 148.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 11.7 t0 -125.53 -19.58 4.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.572 -0.705 . . . . 0.0 109.567 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -149.43 143.42 25.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.118 -0.989 . . . . 0.0 109.784 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 89.6 mt -135.21 154.35 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -145.21 172.77 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 2.9 m-85 -142.47 118.76 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.16 158.01 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.308 -0.87 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.0 p -133.41 113.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 p -110.44 156.29 21.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 0.0 110.347 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.536 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.16 144.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.405 ' C ' ' N ' ' A' ' 96' ' ' ALA . 74.6 t60 -99.46 -69.1 0.78 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -49.14 -18.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.849 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.48 -50.37 59.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.712 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 -30.25 41.38 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.799 -1.188 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.85 -53.71 4.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.066 -1.021 . . . . 0.0 111.471 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 100' ' ' ARG . 5.1 ptp180 -112.14 3.5 17.3 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.153 -0.967 . . . . 0.0 111.101 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 85.9 mtt-85 53.42 104.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -147.93 137.85 22.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 109.301 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.4 p -94.71 160.54 14.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -46.66 -37.03 7.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.739 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.25 -37.73 87.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -47.7 -16.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -1.226 . . . . 0.0 109.322 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 107' ' ' SER . 33.6 t -87.58 166.75 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 109.121 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -67.92 -21.68 65.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 109.707 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.96 79.4 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.03 162.17 25.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 109.75 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 17.8 p90 -155.8 161.44 40.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.8 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 49.7 mt -123.25 157.97 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.401 ' N ' HG22 ' A' ' 111' ' ' ILE . 73.9 ttt180 -141.18 159.71 41.63 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.045 -1.034 . . . . 0.0 109.614 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -154.67 117.42 4.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.953 -1.092 . . . . 0.0 109.499 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.3 p -129.5 144.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 119' ' ' GLN . 55.7 t30 -76.76 102.06 6.09 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.569 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 23.0 t70 -67.2 -1.61 4.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.318 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.3 t0 -80.65 -53.35 6.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.223 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -123.33 3.97 9.13 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 115' ' ' ASN . 11.9 mt-30 59.75 61.18 2.0 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 89.8 m -113.54 -68.49 0.92 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.956 -0.465 . . . . 0.0 110.363 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 36.4 mm-40 -45.25 157.65 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.907 . . . . 0.0 109.907 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.83 73.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.84 150.3 52.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.044 -1.035 . . . . 0.0 110.084 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.3 ptm180 -140.28 142.66 35.7 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.27 146.39 23.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.062 -1.024 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.39 103.4 16.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 109.389 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 97.6 mt -79.55 -36.52 38.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m -48.08 -32.4 6.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.048 . . . . 0.0 109.213 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.23 -53.88 3.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.76 -4.15 32.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.96 -42.91 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.0 t -74.38 2.95 8.22 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.979 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -83.39 -34.2 25.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.167 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -176.43 -167.41 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.928 -1.107 . . . . 0.0 109.654 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.09 -15.75 8.68 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.22 140.48 41.73 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 45.7 ttp -165.8 158.0 14.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 109.749 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -99.91 135.71 40.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.388 -0.82 . . . . 0.0 109.152 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.99 -43.75 33.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 0.0 109.628 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.29 -172.48 31.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.56 166.65 29.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.238 . . . . 0.0 109.943 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.89 143.56 45.07 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -148.1 166.05 28.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.045 . . . . 0.0 109.667 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 9.1 ptm180 -95.02 146.05 24.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.682 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.45 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -122.49 -120.63 0.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.45 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 10.7 m120 -73.61 52.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.24 9.61 86.38 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.82 138.22 52.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.526 -0.985 . . . . 0.0 109.387 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -67.42 151.67 47.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -149.78 128.61 12.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.456 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -89.8 151.01 22.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 109.779 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -156.12 107.19 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.68 39.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.686 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.33 -34.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.66 87.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.37 104.45 6.73 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.62 150.88 35.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.463 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.8 p90 -144.32 126.36 15.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -1.099 . . . . 0.0 109.268 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.5 11.91 20.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.25 -77.74 0.11 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 158.3 138.29 2.45 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.71 -34.94 20.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.187 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -81.64 -15.56 54.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.6 m -90.15 -53.99 4.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.8 m -54.5 -21.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 15.0 p -75.85 -51.96 11.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.041 -1.037 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.625 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.82 -25.39 23.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.905 -1.122 . . . . 0.0 110.492 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -57.59 -39.56 77.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.046 -1.034 . . . . 0.0 110.469 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -71.0 -19.53 62.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.726 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 149' ' ' TRP . 21.0 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.275 0.559 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 46.5 mtt -152.55 90.98 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.21 -21.97 49.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 6.7 m120 -146.36 139.58 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.7 t -145.67 129.62 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.9 113.71 25.9 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.11 150.68 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -134.7 116.85 1.66 Allowed Glycine 0 N--CA 1.499 2.851 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -115.57 126.22 53.95 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.52 151.99 24.18 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.563 -1.303 . . . . 0.0 109.964 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -161.58 152.45 18.06 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.369 -1.077 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.27 127.54 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 109.591 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.895 . . . . 0.0 109.382 179.823 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.298 0.571 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -96.28 143.45 27.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -141.09 100.33 3.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 109.863 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.09 138.55 33.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' CE2' ' A' ' 44' ' ' PHE . 58.7 t0 -98.81 119.78 38.14 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.161 -0.962 . . . . 0.0 110.383 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -100.53 133.79 44.45 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.2 t -150.0 167.7 25.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.051 -1.03 . . . . 0.0 109.801 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.77 148.82 39.41 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 87' ' ' ILE . 3.9 m-85 -103.19 162.11 13.24 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -139.17 148.91 43.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.87 . . . . 0.0 109.683 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.03 141.05 28.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.925 . . . . 0.0 109.076 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.97 176.33 7.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.6 -1.0 52.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.9 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -95.95 4.17 52.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.181 -0.949 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.02 -13.4 66.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.7 mttp -105.03 163.83 12.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.5 t -90.06 136.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.229 -0.92 . . . . 0.0 109.045 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -66.46 4.09 0.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.14 127.1 1.82 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.6 5.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -1.185 . . . . 0.0 110.523 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -92.14 -42.57 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.847 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 48.0 12.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.653 -1.28 . . . . 0.0 109.468 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ALA . 13.0 t80 -137.68 99.48 3.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.456 -0.778 . . . . 0.0 109.094 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 4.0 pt -97.08 120.96 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.269 -0.894 . . . . 0.0 109.367 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 25' ' ' ALA . 27.0 t80 -171.48 -166.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 67.9 m-85 54.2 -112.89 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.825 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.17 -21.53 65.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 24.0 t-20 -81.39 68.9 7.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.29 -19.61 5.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.152 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 14.8 pttm -163.37 156.65 19.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.474 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 69.5 m -74.54 148.11 41.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.87 -46.41 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.197 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -116.47 -0.4 12.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.725 -0.609 . . . . 0.0 109.647 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.02 -9.74 76.59 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 t 60.52 12.31 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -1.082 . . . . 0.0 109.633 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 38.5 t -93.01 147.97 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.441 ' O ' HD23 ' A' ' 73' ' ' LEU . 31.9 m -149.2 137.61 20.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.047 -1.033 . . . . 0.0 109.887 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.0 m80 -91.7 132.11 36.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.375 -0.828 . . . . 0.0 108.906 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.54 -57.57 5.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.94 124.25 1.11 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.5 112.24 19.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.146 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.11 121.38 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -79.49 13.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.441 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -153.76 -35.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -49.8 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -1.21 . . . . 0.0 109.435 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' GLY . 28.5 m-20 -69.81 -67.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -93.09 102.8 15.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.1 m -91.88 133.4 35.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -112.17 126.52 55.3 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.49 140.16 30.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.269 -0.894 . . . . 0.0 109.33 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 54.3 mt -133.79 146.74 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -145.42 99.86 3.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 79' ' ' ALA . 6.4 mt -81.62 -25.23 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.97 . . . . 0.0 109.865 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.27 4.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.91 22.72 3.56 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 81' ' ' PRO . 55.3 t -104.01 105.7 49.78 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.261 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' VAL . 71.4 Cg_exo -48.39 -174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.02 1.813 . . . . 0.0 112.275 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 1.54 88.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -55.11 20.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -1.112 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.86 121.45 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.381 -0.824 . . . . 0.0 109.121 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.73 -1.6 32.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.325 -0.859 . . . . 0.0 110.289 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -158.17 144.64 17.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.123 . . . . 0.0 110.106 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 28' ' ' PHE . 9.3 mt -146.11 118.56 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 173.34 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 0.0 109.737 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 96.5 m-85 -140.3 118.13 11.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.11 158.01 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.471 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.3 p -126.42 117.56 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -112.69 149.91 32.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.15 149.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.755 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 96' ' ' ALA . 66.9 t60 -103.91 -68.85 0.82 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -46.9 -19.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 109.614 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -57.91 -18.5 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -60.6 2.89 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.716 -1.24 . . . . 0.0 109.315 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.53 -33.3 15.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 111.127 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt-85 -95.57 -18.88 20.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.895 -1.128 . . . . 0.0 111.503 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttt85 56.9 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.796 -1.19 . . . . 0.0 108.984 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -146.09 138.45 25.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.37 -0.831 . . . . 0.0 109.246 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.6 p -96.08 164.27 12.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 135' ' ' THR . 46.8 m-85 -48.17 -35.71 12.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.766 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.75 -37.84 94.24 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -47.27 -16.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -1.189 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 21.6 t -86.74 168.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.044 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 20.8 m -68.19 -20.96 64.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.77 80.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.26 164.11 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.9 p90 -154.23 155.32 35.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 50.0 mt -120.08 153.66 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 8' ' ' GLY . 62.5 ttt180 -140.18 159.57 41.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.966 -1.084 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -153.57 116.34 4.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 109.467 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.4 p -129.38 143.12 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.467 -0.771 . . . . 0.0 109.749 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 119' ' ' GLN . 60.7 t-20 -78.24 101.88 7.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.48 -1.96 4.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 0.0 109.301 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 115' ' ' ASN . 21.1 t0 -77.56 -53.34 7.71 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.032 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -123.44 3.12 9.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 115' ' ' ASN . 24.6 mt-30 60.01 61.74 1.8 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.6 p -115.17 -67.93 0.96 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.903 -0.498 . . . . 0.0 110.379 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 47.9 mm-40 -45.37 157.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 109.973 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.98 73.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.54 152.55 51.54 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.123 -0.985 . . . . 0.0 109.841 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.5 ptt180 -140.16 145.82 37.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.552 -0.718 . . . . 0.0 109.377 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -91.32 147.82 22.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 108.975 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.73 101.94 14.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.243 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 26.5 mt -81.43 -31.66 33.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.524 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.7 m -48.48 -36.82 15.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 108.82 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -95.4 -49.94 5.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.477 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.62 -11.63 58.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.766 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.35 -43.8 61.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 109.246 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.0 m -74.46 2.89 8.51 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.639 -0.663 . . . . 0.0 109.978 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -89.74 -33.94 16.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.056 . . . . 0.0 110.376 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -175.48 -176.48 0.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.772 -1.205 . . . . 0.0 109.844 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -112.84 -16.37 12.74 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.181 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.01 138.65 40.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.8 ttp -164.99 157.78 16.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 109.703 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.61 139.23 33.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.253 -0.904 . . . . 0.0 109.636 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.7 t80 -82.51 -44.07 16.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.082 -1.011 . . . . 0.0 109.605 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.31 -171.41 29.52 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -150.82 166.77 29.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.293 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mt -138.94 131.8 29.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.2 p90 -138.86 166.15 25.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.302 -0.873 . . . . 0.0 109.707 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.7 ptm180 -85.79 149.37 25.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.827 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.513 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 56.6 t-80 -155.01 124.54 6.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 0.0 109.217 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.513 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 6.2 m120 54.11 26.04 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.55 11.62 82.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.88 140.4 52.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.508 -0.995 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' SER . 78.2 m95 -68.11 151.51 46.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.221 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -150.73 135.65 17.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 17.5 t80 -93.81 150.46 20.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.741 . . . . 0.0 109.701 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 15.2 tpt85 -156.16 107.1 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.099 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.19 154.6 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.704 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.28 -32.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.497 -0.752 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.79 83.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -139.18 104.28 4.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.981 . . . . 0.0 109.377 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.76 151.07 31.76 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -143.78 123.26 13.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.391 -1.064 . . . . 0.0 109.245 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.93 10.45 21.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 109.503 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -73.94 0.29 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.1 135.21 1.89 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.95 -24.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -1.177 . . . . 0.0 109.807 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.85 -33.86 21.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.9 t -75.19 -51.93 12.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.701 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 158' ' ' TYR . 33.3 m -46.6 -19.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 85.0 m -73.32 -61.23 1.9 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.063 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.99 -15.39 38.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.244 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -59.38 -40.62 87.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.65 -15.83 62.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.21 -0.932 . . . . 0.0 109.398 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.86 173.39 12.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -153.41 -35.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -146.14 140.18 26.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.9 t -141.74 146.0 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.35 -0.844 . . . . 0.0 109.245 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.0 tp -130.7 109.39 10.59 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.63 147.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 108.514 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.89 116.8 1.38 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.48 136.64 41.94 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.49 137.35 6.74 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -157.37 152.52 25.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -1.137 . . . . 0.0 109.759 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.46 109.59 22.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.678 -0.639 . . . . 0.0 109.544 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.0 m-85 -96.26 145.29 25.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.416 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.92 140.74 34.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CD2' HD13 ' A' ' 93' ' ' ILE . 15.2 mt -128.52 128.61 44.64 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -91.97 108.55 20.01 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.168 -0.957 . . . . 0.0 110.176 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 44' ' ' PHE . . . -100.6 125.97 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.284 -0.885 . . . . 0.0 108.936 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p -149.46 168.04 24.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 0.0 109.937 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.44 139.75 44.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.46 125.75 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.2 152.97 18.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.343 -0.848 . . . . 0.0 109.605 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.42 138.25 27.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.1 176.41 8.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.563 -0.711 . . . . 0.0 109.232 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.48 -8.41 58.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.784 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 3.51 39.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.927 . . . . 0.0 109.947 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.47 61.53 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.5 mmtp -104.2 168.56 9.03 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 38' ' ' GLY . 18.9 t -93.18 137.05 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.173 -0.955 . . . . 0.0 108.993 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 32.3 ttp180 -63.84 2.09 0.55 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -153.36 128.22 2.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -65.07 4.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -1.189 . . . . 0.0 110.234 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -94.35 -41.87 9.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.0 -1.062 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 t0 45.78 17.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.0 109.477 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 40' ' ' ALA . 31.8 t80 -136.97 106.59 6.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 109.627 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 29' ' ' LEU . 6.9 pt -112.64 139.69 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.581 -0.699 . . . . 0.0 109.132 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -161.01 -145.23 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 46.8 p90 -43.76 -31.1 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 109.944 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.09 3.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.3 t-20 -158.65 116.28 2.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.154 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -50.66 -36.04 33.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttp -165.78 157.43 14.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 109.361 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.4 t -70.54 120.1 15.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.58 87.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.178 -0.951 . . . . 0.0 109.547 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 43.4 p-10 -103.27 -17.61 15.24 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.516 -0.74 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . -84.36 -15.34 69.18 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.1 p 61.86 11.19 3.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -1.104 . . . . 0.0 109.491 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' H ' ' HB3' ' A' ' 50' ' ' SER . 55.2 t -93.02 151.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.311 -0.868 . . . . 0.0 109.175 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 m -148.05 136.26 21.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 0.0 110.078 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.409 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.8 m80 -90.41 129.75 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -68.59 -56.62 7.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 109.335 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.17 123.41 1.22 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -81.72 110.89 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -81.72 -169.63 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 63' ' ' THR . 15.6 ptt180 -150.82 12.28 0.68 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 109.544 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.8 p -156.64 -35.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -50.04 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.174 . . . . 0.0 109.456 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -70.8 -68.93 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -86.9 175.64 8.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 109.533 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -159.25 132.43 7.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.314 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -119.41 123.43 44.09 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -95.18 137.61 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 52.1 mt -128.75 147.07 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.547 -0.721 . . . . 0.0 110.348 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.8 mttm -140.51 97.16 3.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.54 -5.31 49.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.99 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.98 -22.97 31.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.095 -1.003 . . . . 0.0 109.777 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.34 -11.61 27.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.183 -0.948 . . . . 0.0 109.891 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.98 123.99 77.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.22 -161.33 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.795 1.663 . . . . 0.0 112.098 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.05 -0.17 83.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.2 m-20 -70.06 -60.35 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 86' ' ' LYS . 46.5 t -91.11 144.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.66 10.95 5.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.393 -0.817 . . . . 0.0 109.532 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 141' ' ' GLU . 81.7 tttt -158.48 144.13 16.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.225 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.39 115.75 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.081 -1.012 . . . . 0.0 109.369 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -104.1 173.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 95.0 m-85 -142.29 129.55 21.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.55 157.76 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 0.0 110.649 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -132.42 113.62 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -110.22 154.64 23.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.393 -0.817 . . . . 0.0 110.778 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.22 151.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 96' ' ' ALA . 9.3 t60 -101.93 -74.23 0.63 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.372 -0.83 . . . . 0.0 110.271 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.09 -17.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 109.798 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.589 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -49.98 -19.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.448 -0.782 . . . . 0.0 109.504 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -71.61 -62.58 1.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.971 -1.08 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -39.27 12.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.33 -0.856 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.463 ' NE ' ' OE1' ' A' ' 101' ' ' GLN . 49.4 ttt180 -83.89 -20.2 33.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.934 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 ttp85 53.33 96.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.766 -1.209 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.463 ' OE1' ' NE ' ' A' ' 99' ' ' ARG . 20.4 mt-30 -155.85 143.5 19.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.453 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -100.7 166.27 10.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.468 -0.77 . . . . 0.0 109.627 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -49.12 -29.7 5.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.705 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.03 -40.34 97.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 29.5 mm-40 -51.03 -11.7 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.315 . . . . 0.0 109.326 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.47 ' N ' ' C ' ' A' ' 104' ' ' GLY . 11.3 t -86.7 162.63 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.845 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.402 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -64.29 -23.35 67.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.83 79.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.37 162.28 25.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 109.686 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 20.5 p90 -156.21 158.39 37.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 110.004 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 32.0 mt -120.55 156.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -143.42 159.09 43.02 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.926 -1.109 . . . . 0.0 109.912 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 tt -152.43 124.39 8.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.209 -0.932 . . . . 0.0 109.185 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.07 144.87 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.429 -0.795 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 120' ' ' THR . 53.5 t30 -74.45 101.83 4.26 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.84 -1.84 2.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.677 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.37 -53.85 5.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.912 . . . . 0.0 109.919 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -123.75 7.6 8.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.628 -0.67 . . . . 0.0 109.996 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 59.66 60.2 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.449 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 28.0 m -109.98 -70.52 0.81 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.825 -0.547 . . . . 0.0 110.3 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.855 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -45.27 157.43 0.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.49 72.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.05 150.54 52.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.088 -1.007 . . . . 0.0 110.13 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.2 ptt180 -143.27 140.21 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.707 . . . . 0.0 109.136 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -91.26 147.86 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 109.016 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.56 102.04 14.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.075 -1.016 . . . . 0.0 108.942 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.5 mt -76.37 -26.57 55.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.6 m -49.57 -33.61 15.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.969 -1.082 . . . . 0.0 108.385 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.44 -52.05 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 109.286 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.458 ' OD2' ' SD ' ' A' ' 137' ' ' MET . 15.7 t70 -67.1 -10.71 52.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.199 -0.938 . . . . 0.0 109.987 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.41 -46.33 62.88 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.8 t -71.46 3.47 3.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.761 -0.587 . . . . 0.0 110.022 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.2 m -92.12 -34.23 14.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.949 -1.094 . . . . 0.0 110.49 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -175.51 -174.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.676 -1.265 . . . . 0.0 110.011 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.29 -8.94 12.27 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.81 137.2 26.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.458 ' SD ' ' OD2' ' A' ' 130' ' ' ASP . 12.4 ptp -165.41 158.21 15.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.86 141.92 27.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.196 -0.94 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -85.5 -44.61 12.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.99 -176.02 24.27 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 86' ' ' LYS . 29.4 tt0 -151.22 122.2 7.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 142' ' ' LEU . 9.7 mp -99.34 142.74 30.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 109.001 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.48 166.23 31.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.017 -1.052 . . . . 0.0 109.695 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.54 142.83 26.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.256 -0.902 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.614 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -115.63 -120.16 0.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.614 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.1 m120 -73.56 52.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.84 9.39 85.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.79 142.89 51.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.593 -0.946 . . . . 0.0 109.365 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -67.86 151.66 46.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -153.66 133.12 12.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.978 . . . . 0.0 109.434 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 21.8 t80 -89.58 153.7 20.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 109.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.534 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 17.5 tpt180 -160.42 107.26 1.55 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.126 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.08 149.11 50.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.56 -30.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.553 -0.717 . . . . 0.0 109.068 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.2 83.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -139.37 104.44 4.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.959 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.07 152.84 35.19 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.441 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -146.37 127.67 14.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.27 -1.136 . . . . 0.0 109.244 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.3 9.05 33.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.41 -69.0 0.99 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 154.45 129.29 1.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.48 -28.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 109.8 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.69 -26.41 25.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' GLY . 43.9 t -78.06 -54.65 6.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.1 m -46.98 -20.49 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 73.2 m -70.53 -60.72 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.393 -0.817 . . . . 0.0 110.103 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -17.34 33.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.38 -45.51 91.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.959 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -71.85 -19.93 61.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.638 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 149' ' ' TRP . 7.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.635 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 62.7 mtm -147.55 -170.89 3.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.934 . . . . 0.0 109.332 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -152.46 -33.52 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.278 -0.889 . . . . 0.0 109.7 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.415 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 71.5 m-80 -142.66 128.3 19.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -130.82 150.88 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.69 115.34 9.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -86.22 151.03 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.14 117.29 1.51 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.02 133.98 49.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -150.33 145.22 13.02 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.054 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -158.13 151.55 23.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.493 -1.004 . . . . 0.0 109.674 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -80.24 121.73 25.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.388 179.773 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.34 0.59 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -96.21 150.6 20.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 109.3 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -140.95 99.93 3.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.0 109.726 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.39 138.55 33.46 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' ' CE2' ' A' ' 44' ' ' PHE . 8.2 t70 -92.17 117.24 29.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 109.829 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.63 48.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.421 -0.8 . . . . 0.0 109.016 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.34 167.66 25.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.092 -1.005 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.93 137.04 52.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -104.22 159.46 15.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.399 -0.813 . . . . 0.0 109.282 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.54 144.93 51.01 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.546 -0.721 . . . . 0.0 109.765 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.47 134.84 24.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.082 -1.011 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.96 176.59 3.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.5 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.89 -8.24 59.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -83.28 1.31 41.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.05 -13.42 59.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -101.03 153.4 19.58 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.673 HG12 ' H ' ' A' ' 38' ' ' GLY . 35.6 t -73.7 137.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.893 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.83 7.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -156.95 172.83 34.57 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.39 2.69 55.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.287 . . . . 0.0 109.969 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.04 -41.84 5.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.269 -0.895 . . . . 0.0 109.834 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.0 t0 53.25 6.46 0.07 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.945 -1.097 . . . . 0.0 109.71 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.5 p90 -138.45 123.49 19.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.289 -0.882 . . . . 0.0 110.264 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 pt -110.17 122.68 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 33.3 t80 -170.56 -170.95 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.933 -1.104 . . . . 0.0 109.722 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 53.4 m-85 51.03 -112.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.949 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -55.42 -16.78 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.562 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.14 82.37 3.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.561 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.83 -22.1 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -166.54 156.97 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' SER . 4.5 p -84.93 113.49 21.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.48 69.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.268 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -104.64 -19.2 14.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.556 -0.715 . . . . 0.0 109.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.28 -13.98 75.36 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.8 p 70.16 2.05 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.92 146.85 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 p -147.0 152.59 38.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.077 -1.014 . . . . 0.0 110.567 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' CE1' HD21 ' A' ' 73' ' ' LEU . 6.1 m80 -92.03 130.23 37.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -78.33 -38.91 41.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.15 100.94 0.15 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.07 110.89 14.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.462 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.95 -164.37 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -156.02 16.12 0.35 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.4 p -154.71 -35.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.873 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -48.41 111.32 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -1.146 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -80.85 -67.18 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -105.22 162.92 12.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.815 . . . . 0.0 109.394 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.4 p -162.31 138.52 7.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.426 HD21 ' CE1' ' A' ' 57' ' ' HIS . 4.9 mp -112.2 131.41 55.49 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.15 120.67 36.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 46.7 mt -108.36 146.57 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 110.58 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -143.77 97.65 3.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.4 mt -82.32 -15.98 50.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.982 -1.074 . . . . 0.0 109.48 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.81 -0.87 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -131.82 15.99 4.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.55 -0.718 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.3 p -60.34 134.75 91.13 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.855 . . . . 0.0 109.193 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.26 -161.78 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.902 1.734 . . . . 0.0 111.736 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.95 5.06 53.09 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -90.57 -72.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.163 -1.198 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.3 p -70.14 149.06 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.55 -30.02 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 109.451 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -114.88 157.54 23.18 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 87' ' ' ILE . 14.7 mt -142.38 150.37 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -141.34 162.03 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.369 -0.832 . . . . 0.0 108.882 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 88' ' ' ILE . 57.4 m-85 -141.69 125.31 16.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.22 157.92 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.386 -0.822 . . . . 0.0 110.191 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.1 p -131.0 121.6 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 p -117.44 153.47 33.04 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.45 -0.782 . . . . 0.0 110.438 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.7 mm -74.2 145.0 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.416 ' C ' ' N ' ' A' ' 96' ' ' ALA . 24.5 t60 -100.64 -69.67 0.76 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLN . 5.4 m-20 -48.25 -18.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -45.9 -18.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' ASP . 65.2 mt-30 -69.58 -58.24 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.917 -1.114 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.66 -52.68 4.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.169 -0.957 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -75.43 -20.74 58.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.967 -1.083 . . . . 0.0 110.917 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 53.94 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.01 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -150.69 149.85 30.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 135' ' ' THR . 43.9 m -104.42 167.28 9.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' ' CE ' ' A' ' 137' ' ' MET . 57.9 m-85 -46.12 -38.19 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.441 -0.787 . . . . 0.0 109.881 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.1 -38.02 88.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -47.14 -18.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.237 . . . . 0.0 109.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 107' ' ' SER . 17.3 t -84.35 168.63 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.079 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.5 t -71.46 -19.56 62.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.77 79.52 0.03 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.6 164.59 22.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.127 . . . . 0.0 109.735 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.8 p90 -156.74 161.15 39.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.054 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 59.1 mt -120.95 156.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -140.94 160.42 40.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.998 -1.064 . . . . 0.0 109.915 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.4 tt -154.37 117.62 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.122 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.3 p -132.2 142.97 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.305 -0.872 . . . . 0.0 110.322 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.635 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 4.3 m120 -74.97 102.13 4.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.21 -1.53 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.474 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 16.7 t70 -81.58 -53.47 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -123.49 7.0 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.783 -0.573 . . . . 0.0 109.676 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 58.61 59.69 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.8 m -109.74 -71.02 0.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.927 -0.483 . . . . 0.0 110.386 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.846 ' O ' HG13 ' A' ' 122' ' ' VAL . 32.3 mt-10 -45.38 157.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.0 109.803 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.18 73.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.67 155.02 49.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.196 -0.94 . . . . 0.0 109.836 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.8 ptm180 -142.59 147.34 35.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 109.18 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -91.32 146.95 23.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -87.97 103.18 15.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.14 -0.975 . . . . 0.0 109.421 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 57.6 mt -81.03 -42.11 21.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.429 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.8 p -47.56 -30.18 3.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 109.245 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -95.31 -54.6 3.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.341 -0.849 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -74.87 -3.44 31.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.965 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.87 -45.85 71.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 109.26 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.2 p -70.83 3.17 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.541 -0.725 . . . . 0.0 109.976 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -82.77 -35.1 26.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.979 -1.075 . . . . 0.0 110.353 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -177.29 -161.94 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.661 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -123.56 -1.71 8.5 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.61 137.63 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.42 ' CE ' ' CE1' ' A' ' 103' ' ' PHE . 10.6 ptp -165.04 157.56 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.342 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -97.87 128.9 44.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.219 -0.925 . . . . 0.0 109.737 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 24.6 t80 -65.57 -43.82 88.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.153 -0.967 . . . . 0.0 109.342 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.57 31.22 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.213 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 167.01 29.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.264 -1.139 . . . . 0.0 110.667 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.9 mt -132.31 136.95 47.25 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 6.4 p90 -140.36 160.91 38.95 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.003 -1.061 . . . . 0.0 109.733 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 9.0 ptm180 -84.96 148.66 26.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.042 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.523 ' NE2' ' OD1' ' A' ' 146' ' ' ASN . 29.8 t-80 -148.92 121.58 8.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.062 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.523 ' OD1' ' NE2' ' A' ' 145' ' ' HIS . 3.6 m120 52.32 27.18 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.26 75.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.9 136.22 51.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.981 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.472 ' CD2' HD13 ' A' ' 77' ' ' LEU . 70.4 m95 -67.31 151.47 47.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.549 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -150.9 143.89 24.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -99.58 142.08 31.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.363 -0.835 . . . . 0.0 110.154 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -134.47 114.82 13.26 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.6 150.03 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 109.639 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.0 t -147.41 -36.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 109.084 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.75 79.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -122.45 106.03 10.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.782 -0.834 . . . . 0.0 109.537 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.01 149.08 32.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -149.99 139.85 21.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -1.173 . . . . 0.0 109.465 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.18 6.87 47.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.35 -37.45 25.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 82.88 150.59 9.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -48.07 -13.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 0.0 109.618 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -72.55 -56.89 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.086 -1.009 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.0 t -90.57 -37.87 13.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.16 -0.963 . . . . 0.0 109.73 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.39 -20.68 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.522 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 29.9 p -83.41 -55.77 4.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.111 -0.993 . . . . 0.0 110.823 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.91 -24.63 23.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 110.531 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' SER . 51.4 tt0 -51.68 -37.59 51.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.974 . . . . 0.0 109.74 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.66 -20.35 58.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.661 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.7 mmt -78.77 178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -154.39 -35.32 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.411 ' ND2' ' OD2' ' A' ' 116' ' ' ASP . 41.8 t-20 -146.25 128.14 15.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 109.135 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.2 t -127.78 158.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.8 tp -144.46 106.7 4.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.958 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.29 150.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.11 116.98 1.24 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.85 129.53 54.68 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.95 142.78 11.16 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.45 ' CE2' ' CA ' ' A' ' 64' ' ' GLY . 25.1 p90 -157.22 153.43 27.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.405 -1.056 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -77.51 128.81 34.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.505 -0.747 . . . . 0.0 109.809 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.27 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.363 0.601 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.32 150.43 20.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 15.3 p-10 -141.04 99.74 3.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.258 -0.901 . . . . 0.0 109.712 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.62 130.91 34.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 108.631 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -87.24 111.44 21.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.966 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.32 125.86 46.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 108.803 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 m -149.76 168.06 24.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 109.769 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 136.09 49.48 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -103.79 119.59 39.23 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.796 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.19 152.63 21.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.525 -0.735 . . . . 0.0 109.906 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 134.94 22.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -75.67 176.32 7.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 108.979 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.69 -10.85 59.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.681 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -84.32 4.55 30.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.29 56.75 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 48.9 mtpt -104.45 171.95 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.729 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -103.45 143.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -61.83 -4.09 1.39 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.75 101.22 0.23 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -45.12 -20.97 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.401 -1.058 . . . . 0.0 110.601 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.26 -41.81 80.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.597 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.729 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 48.12 12.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.978 -1.076 . . . . 0.0 109.517 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 23.8 t80 -137.46 105.8 5.77 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.842 . . . . 0.0 110.214 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 pt -110.52 134.92 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.3 p90 -151.99 -152.89 0.45 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.04 . . . . 0.0 109.766 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.7 m-85 -43.81 -36.0 2.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.576 -0.703 . . . . 0.0 110.028 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -58.65 -1.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 108.73 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 45' ' ' TYR . 51.1 t-20 -148.11 108.71 4.16 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.23 -27.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 109.407 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.5 pttt -172.8 160.55 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.287 -0.883 . . . . 0.0 109.322 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 54' ' ' SER . 10.2 p -65.12 135.24 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.286 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.39 -45.35 55.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.1 1.49 13.23 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.657 -0.652 . . . . 0.0 109.604 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 -14.33 61.3 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.4 m 64.13 4.17 1.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -1.054 . . . . 0.0 109.314 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.14 146.75 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.919 . . . . 0.0 109.105 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -149.21 152.11 35.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -91.75 132.58 36.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 109.392 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 m -82.94 -38.85 22.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.55 107.55 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 33.2 p-10 -80.58 159.15 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.49 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -155.29 -173.01 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 109.418 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -161.82 30.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.9 p -151.81 -34.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' CA ' ' CE2' ' A' ' 11' ' ' TRP . . . . . . . . 0 N--CA 1.497 2.761 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.6 p-10 -48.68 111.14 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.599 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.12 -67.45 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.405 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -98.4 158.27 15.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.266 -0.896 . . . . 0.0 109.134 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.475 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -159.69 138.89 11.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' O ' HD12 ' A' ' 6' ' ' LEU . 8.9 mp -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.518 -0.739 . . . . 0.0 109.548 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -96.39 112.68 24.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.66 146.87 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 110.898 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -135.54 88.92 2.45 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.38 -13.54 61.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.306 -0.871 . . . . 0.0 109.794 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -78.29 4.82 11.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.66 10.99 6.15 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.435 -0.791 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -82.01 125.86 76.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.947 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.52 -161.76 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.74 -0.17 84.1 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -69.44 -59.73 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -1.178 . . . . 0.0 109.321 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.89 148.78 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.89 . . . . 0.0 109.252 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -135.98 0.82 2.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 141' ' ' GLU . 43.3 tttp -150.09 131.5 14.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.877 . . . . 0.0 109.055 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 90.4 mt -136.35 132.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 0.0 109.003 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.95 154.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.814 . . . . 0.0 109.671 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -107.1 137.95 44.2 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 91' ' ' VAL . 2.7 p -146.73 158.16 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.115 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 7.5 p -132.36 147.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -143.09 145.26 32.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.125 -0.985 . . . . 0.0 109.727 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.35 137.5 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 50.9 t-80 -95.49 -63.44 1.16 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.161 -0.962 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 12.0 m-20 -47.4 -18.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 0.0 109.578 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.24 -18.18 34.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.835 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -65.94 -60.82 2.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.85 -1.156 . . . . 0.0 109.437 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.14 -41.22 11.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.082 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' NH1' ' OD2' ' A' ' 95' ' ' ASP . 54.5 mtt180 -85.66 -19.58 30.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.973 -1.079 . . . . 0.0 111.352 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 55.19 92.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.687 -1.258 . . . . 0.0 109.035 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -148.46 142.54 25.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 109.256 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -98.75 165.15 11.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -47.37 -35.48 8.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 109.624 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.737 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.89 -38.38 74.09 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -47.42 -19.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.361 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 107' ' ' SER . 19.3 t -83.97 167.03 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.005 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -72.61 -24.51 61.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 0.0 109.712 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.38 78.1 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.13 164.8 24.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.36 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.4 p90 -154.0 143.7 21.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.0 110.573 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.6 mt -106.94 153.86 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.38 160.21 40.36 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.987 -1.07 . . . . 0.0 109.84 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.31 116.07 4.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 0.0 109.386 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.559 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -129.3 143.75 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.298 -0.876 . . . . 0.0 109.95 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 119' ' ' GLN . 64.6 t30 -76.54 102.04 5.9 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.411 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 18.4 t0 -67.26 -1.36 4.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.539 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.04 -52.97 6.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -123.1 3.59 9.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.721 -0.612 . . . . 0.0 109.479 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ASN . 21.0 tp60 60.41 61.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 40.9 m -113.27 -69.15 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.883 -0.51 . . . . 0.0 110.256 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 33.1 mm-40 -45.24 157.55 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.344 -0.848 . . . . 0.0 109.984 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.73 72.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.53 52.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 110.038 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.4 ptm180 -138.5 145.65 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -91.33 145.16 24.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.994 . . . . 0.0 109.082 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.28 103.16 15.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.023 . . . . 0.0 109.51 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 92.1 mt -82.11 -37.84 25.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.3 p -48.35 -35.06 11.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.906 -1.121 . . . . 0.0 109.091 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -95.39 -49.24 5.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -76.45 -4.16 41.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.737 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.33 -43.71 67.87 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.954 -1.091 . . . . 0.0 109.695 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.3 p -68.97 3.17 2.15 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 110.978 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 p -86.15 -34.51 20.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.544 -1.348 . . . . 0.0 110.526 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.2 -161.44 0.08 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.766 -1.209 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.91 -12.98 7.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.48 133.78 24.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.8 ptp -165.41 141.44 5.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.4 pp -76.47 141.11 41.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -0.952 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.5 t80 -79.41 -46.2 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.411 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.493 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -150.88 -163.52 11.37 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.466 ' CD ' ' NZ ' ' A' ' 86' ' ' LYS . 11.5 tt0 -150.7 158.29 43.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.382 -1.069 . . . . 0.0 109.061 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 136.19 25.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -150.73 166.51 30.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.882 -1.136 . . . . 0.0 110.122 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 15.5 ptm180 -90.59 143.43 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -117.95 -120.12 0.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.605 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 34.9 m120 -73.56 51.25 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.05 -1.031 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 9.1 85.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.77 142.13 51.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.997 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -68.53 151.48 46.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -148.91 131.8 16.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.112 -0.993 . . . . 0.0 109.69 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -89.76 150.61 22.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -149.75 124.19 9.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 0.0 109.065 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.75 147.91 27.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.1 t -150.15 -36.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 109.09 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.26 76.54 0.15 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -108.6 104.38 13.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.754 -0.85 . . . . 0.0 109.125 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.03 143.35 20.39 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.484 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -142.15 141.7 32.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.299 -1.118 . . . . 0.0 109.086 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.14 9.55 43.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.32 -0.863 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -68.01 1.33 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.51 132.5 1.51 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.9 -30.55 2.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -1.123 . . . . 0.0 109.607 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.74 24.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 69.2 m -73.4 -53.28 11.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.5 m -47.74 -20.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 57.7 m -71.55 -60.84 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 110.163 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.4 38.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 110.402 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -65.78 -43.79 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.95 -1.094 . . . . 0.0 110.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -71.34 -19.62 62.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.5 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.5 mtt -86.8 147.43 25.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 94.0 mttt -116.9 -21.8 8.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.565 -0.709 . . . . 0.0 109.274 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 51.3 m-20 -146.23 142.34 28.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.3 t -140.8 158.52 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -0.77 . . . . 0.0 109.211 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.5 tp -146.29 107.32 4.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.937 . . . . 0.0 109.09 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.78 150.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.25 116.84 1.15 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.0 137.05 42.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.82 139.19 7.81 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -156.49 152.35 27.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.201 -1.176 . . . . 0.0 109.971 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -90.74 126.99 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.608 -0.682 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.356 179.865 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.251 0.548 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.8 m-85 -96.25 142.8 27.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 14.6 m-20 -141.03 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.26 -0.9 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.77 149.69 25.1 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -108.11 118.17 36.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.322 -0.861 . . . . 0.0 109.633 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.91 133.11 42.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.388 -0.82 . . . . 0.0 108.993 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -149.95 167.85 25.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 110.201 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.3 137.65 54.6 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 9.0 m-85 -104.15 126.66 51.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.967 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.96 153.69 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.345 -0.847 . . . . 0.0 109.918 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -145.3 135.74 24.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 109.111 179.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.67 176.54 8.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.094 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.59 -7.51 59.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -85.24 1.82 46.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 109.906 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.66 -17.99 58.25 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 57.5 mttm -107.48 171.02 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 38' ' ' GLY . 5.7 t -99.64 137.36 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -62.31 -0.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -136.61 114.42 1.15 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.52 3.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -1.177 . . . . 0.0 110.6 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -99.34 -42.07 7.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.917 -1.114 . . . . 0.0 109.82 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' HG21 ' A' ' 36' ' ' VAL . 46.5 t0 46.81 14.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.994 -1.066 . . . . 0.0 109.594 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 36.2 t80 -137.3 99.44 3.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.815 . . . . 0.0 109.724 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.0 pt -105.2 135.13 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.1 p90 -139.3 -163.05 1.41 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.0 109.368 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 26.6 p90 -43.79 -36.92 2.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 110.551 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.586 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.8 t-20 -50.5 -11.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 109.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.1 t30 -135.29 104.7 5.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.468 -0.77 . . . . 0.0 109.067 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 mt -49.13 -28.92 4.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.473 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.1 pttp -164.85 157.67 16.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.331 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.479 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 3.6 m -68.7 143.5 54.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.458 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 -48.16 36.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.165 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.29 1.73 13.13 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.747 -0.596 . . . . 0.0 109.548 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.42 -14.15 74.57 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t 62.42 6.29 1.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -1.107 . . . . 0.0 109.799 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.15 151.62 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.115 -0.99 . . . . 0.0 108.986 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 p -145.21 139.74 27.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.075 -1.016 . . . . 0.0 110.251 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.419 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.0 m80 -90.27 132.87 35.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -72.25 -40.4 67.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.348 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.93 111.44 0.33 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.27 110.95 13.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.87 -164.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 63' ' ' THR . 12.7 ptt-85 -156.23 16.34 0.34 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 62' ' ' ARG . 23.0 p -155.84 -36.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.278 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.92 108.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -1.153 . . . . 0.0 109.433 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -61.37 -69.62 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.41 173.11 10.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -159.51 132.6 6.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.258 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -118.21 122.14 42.24 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -96.01 137.3 35.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 0.0 109.067 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.7 mt -129.33 143.35 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.634 -0.666 . . . . 0.0 110.018 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -141.22 98.84 3.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' VAL . 7.3 mt -80.79 -17.78 49.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -51.04 -36.73 41.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.27 27.28 7.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 80' ' ' VAL . 6.2 p -60.56 115.34 13.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 81.4 Cg_exo -46.55 -178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.812 1.674 . . . . 0.0 112.264 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.18 59.71 0.63 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -154.71 -54.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -1.177 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.45 148.53 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 1.0 OUTLIER -143.43 11.95 1.72 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.179 -0.951 . . . . 0.0 109.858 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -157.02 133.52 9.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 88' ' ' ILE . 87.9 mt -129.39 154.24 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.548 -0.72 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 87' ' ' ILE . 1.2 mt -144.68 173.44 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 108.904 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.62 141.95 49.76 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.1 t -147.23 151.94 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.942 -1.099 . . . . 0.0 110.953 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.7 p -147.53 113.92 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -122.28 174.6 6.89 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.741 0.781 . . . . 0.0 110.222 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.4 mm -83.86 166.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.546 ' N ' HG22 ' A' ' 93' ' ' ILE . 53.6 t60 -133.26 -66.58 0.65 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -48.12 -18.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.25 -38.42 52.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -54.53 -31.95 57.25 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 109.214 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -52.83 4.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -0.83 . . . . 0.0 111.008 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 10.9 ptp180 -110.51 -4.71 15.37 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.282 -0.886 . . . . 0.0 111.166 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.1 ttm180 57.07 102.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.858 -1.151 . . . . 0.0 109.205 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -147.69 148.97 31.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 m -104.2 161.93 13.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.43 -0.794 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -47.15 -35.31 7.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.734 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -42.38 99.75 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 23.4 mm100 -48.5 -14.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 109.403 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.4 t -83.76 164.59 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.1 t -64.87 -23.73 67.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.06 -1.025 . . . . 0.0 109.552 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.89 79.94 0.03 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.7 164.54 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 109.958 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.4 p90 -154.81 152.35 29.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.889 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -115.53 157.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.27 160.73 39.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.897 -1.127 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.8 tt -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.6 p -129.03 144.25 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 120' ' ' THR . 58.7 t30 -76.07 102.14 5.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -65.79 -1.69 3.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HA ' HD22 ' A' ' 4' ' ' ASN . 23.5 t0 -82.29 -53.72 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.58 6.33 8.89 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' ASN . 19.5 tt0 59.61 60.52 2.22 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 42.2 p -111.07 -69.8 0.85 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.879 -0.513 . . . . 0.0 110.334 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 45.1 mt-10 -45.26 157.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.77 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.52 52.15 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.134 -0.979 . . . . 0.0 110.218 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.5 ptt180 -140.18 142.4 35.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -91.34 147.65 22.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.089 -1.007 . . . . 0.0 109.12 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 18.5 p-10 -91.54 103.29 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.145 -0.972 . . . . 0.0 109.358 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.3 mt -80.89 -32.75 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.295 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 m -48.98 -37.52 20.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.909 -1.119 . . . . 0.0 108.963 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.37 -45.78 6.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.695 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.32 -4.54 42.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 110.535 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.4 -46.12 76.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.798 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -65.33 3.29 0.68 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 111.013 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -86.14 -34.93 20.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.596 -1.315 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.9 -161.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.907 -1.12 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.05 -3.83 6.94 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -146.79 135.4 22.07 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.4 ttp -165.83 158.08 14.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.941 -1.1 . . . . 0.0 110.335 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.69 139.41 31.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.341 -0.849 . . . . 0.0 109.471 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -78.62 -47.62 16.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 109.782 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.72 -164.29 14.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -151.45 163.19 39.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.168 -1.195 . . . . 0.0 109.739 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.65 134.75 24.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -146.05 165.84 27.86 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 109.781 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.507 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.1 ptm180 -90.34 143.7 26.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.859 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-80 -119.81 -116.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.606 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 18.8 m-20 -76.02 53.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.45 8.02 87.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -127.88 145.39 50.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.989 . . . . 0.0 109.314 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.1 m95 -70.58 151.59 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.424 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -145.97 126.85 14.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -89.72 147.92 23.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -153.03 107.37 3.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.305 -0.872 . . . . 0.0 109.046 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.91 154.64 40.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.6 t -143.41 -33.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.72 83.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -132.26 104.32 6.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.647 -0.913 . . . . 0.0 109.31 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.38 152.7 38.14 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.45 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -143.2 124.4 14.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.355 -1.085 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.06 6.22 37.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.44 -68.58 1.13 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.41 129.08 1.18 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.696 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.62 -26.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.165 . . . . 0.0 109.891 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.32 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.897 . . . . 0.0 109.457 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -50.98 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.45 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.3 m -47.83 -20.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 39.9 m -69.33 -59.93 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.817 . . . . 0.0 110.191 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -18.89 29.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.17 -43.74 87.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.017 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -71.48 -19.81 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -67.66 -170.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 58.6 mttp -153.78 -34.64 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 59.7 m-20 -145.96 152.57 39.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' LEU . 77.2 t -147.62 155.8 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 109.291 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.4 tp -143.79 108.53 4.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 108.949 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.28 148.76 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 108.661 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.23 116.85 1.28 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.87 136.25 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.74 141.19 9.02 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.556 -1.307 . . . . 0.0 109.856 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -158.42 156.59 30.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.421 -1.047 . . . . 0.0 109.707 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -81.36 126.19 31.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.856 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.828 . . . . 0.0 109.118 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.19 138.31 33.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.85 99.81 3.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 109.677 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -83.37 141.01 32.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -98.97 109.97 22.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.23 125.61 43.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.212 -0.93 . . . . 0.0 108.9 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 t -149.76 168.13 24.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 109.993 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.53 138.87 45.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -104.02 127.72 51.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.958 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.39 155.99 16.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.28 -0.888 . . . . 0.0 110.055 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.77 139.99 32.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.084 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.84 176.59 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.34 -5.46 59.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.75 4.04 50.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.0 109.905 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.96 -11.02 73.23 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.4 mttt -109.89 169.12 8.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 20.2 t -93.09 136.57 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 109.171 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -64.01 1.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -150.01 122.07 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -61.96 3.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 110.076 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.05 -42.24 8.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.889 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 31.8 t0 46.17 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 109.599 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 75.7 t80 -137.49 99.59 3.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.456 -0.777 . . . . 0.0 109.52 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.2 pt -103.69 137.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.4 p90 -143.52 -160.76 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 18.0 p90 -45.17 -31.89 1.63 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 7.9 t-20 -52.59 -11.22 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.873 -1.142 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.0 t30 -135.75 108.25 7.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -47.43 -28.93 2.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.835 . . . . 0.0 109.266 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.2 pttt -171.81 157.51 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 67.3 m -62.69 149.57 43.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.65 -48.75 14.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -116.45 0.84 12.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.651 -0.656 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.94 -12.84 67.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m 58.71 13.92 2.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 109.401 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 99.5 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.304 -0.872 . . . . 0.0 109.027 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.6 m -148.6 135.06 19.58 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.019 -1.051 . . . . 0.0 110.212 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' NE2' HD11 ' A' ' 73' ' ' LEU . 26.2 m80 -90.17 129.06 36.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -69.8 -43.84 71.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.3 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.11 115.18 0.44 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.08 110.95 17.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -1.133 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.92 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.381 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 63' ' ' THR . 76.2 mtm180 -150.69 12.38 0.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 62' ' ' ARG . 28.3 p -156.28 -38.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 0.0 109.273 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.868 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 p-10 -48.73 115.7 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 109.595 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.32 -64.9 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -88.39 173.43 8.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.95 132.24 6.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.362 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 ' NE2' ' A' ' 57' ' ' HIS . 1.0 OUTLIER -117.79 121.66 41.36 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -95.4 138.16 33.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 108.533 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.04 146.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.484 -0.76 . . . . 0.0 110.502 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 9.5 mtpm? -138.55 94.1 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.69 -5.36 40.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.47 -29.67 37.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 0.0 109.791 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.74 10.37 37.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.0 109.905 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.24 125.59 69.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.984 . . . . 0.0 109.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.95 -161.11 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.894 1.729 . . . . 0.0 111.868 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.84 4.52 78.76 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 2.5 m-20 -64.41 -54.52 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -1.189 . . . . 0.0 109.44 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.99 149.07 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 9.3 t0 -123.91 -9.05 7.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.767 . . . . 0.0 109.46 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -158.06 131.34 7.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 110.029 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.9 mt -121.13 154.18 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -142.57 173.16 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.093 -1.004 . . . . 0.0 109.304 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 11.0 m-85 -142.31 118.56 10.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.89 157.73 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.7 p -130.92 114.35 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -110.21 148.16 32.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.1 mm -74.3 138.97 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.4 t60 -96.27 -65.11 0.99 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.005 . . . . 0.0 109.805 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -47.31 -18.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.08 -18.23 23.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 109.734 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.25 -61.49 1.82 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.85 -1.156 . . . . 0.0 109.545 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.18 -40.47 11.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -0.84 . . . . 0.0 111.086 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.4 mpt_? -85.19 -19.13 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.897 -1.127 . . . . 0.0 110.955 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 99' ' ' ARG . 50.1 ttp85 55.62 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.806 -1.184 . . . . 0.0 109.255 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.9 144.67 14.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -102.03 166.82 10.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.52 -32.14 3.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.847 . . . . 0.0 109.76 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.66 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.5 -37.05 93.51 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -46.88 -19.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -1.192 . . . . 0.0 109.244 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 107' ' ' SER . 19.2 t -86.48 166.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 0.0 108.986 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 p -66.99 -26.6 66.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.639 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.2 78.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.03 164.67 25.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 22.6 p90 -152.37 151.98 31.5 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 110.263 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.0 mt -114.49 154.46 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -144.13 157.5 44.27 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 tt -150.63 125.77 9.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 0.0 109.266 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.25 143.57 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.699 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 120' ' ' THR . 61.4 m-20 -75.19 102.08 4.85 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 35.5 t0 -66.1 -1.67 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 109.851 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 1.1 p30 -83.53 -52.65 6.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -0.928 . . . . 0.0 109.494 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 22.1 m120 -122.87 5.69 9.37 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 0.0 109.819 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.1 mt-30 58.97 60.06 2.58 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.456 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.0 m -112.03 -69.72 0.85 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.946 -0.471 . . . . 0.0 110.471 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 53.6 mm-40 -45.25 157.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.97 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.95 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.78 151.21 52.05 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -140.74 143.54 35.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.708 . . . . 0.0 109.143 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.73 147.82 22.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.6 103.31 15.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.971 . . . . 0.0 109.326 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.2 mt -81.03 -38.19 27.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.5 m -47.61 -32.1 5.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.147 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.47 -54.23 3.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.533 -0.729 . . . . 0.0 109.94 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.49 -2.95 27.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.99 . . . . 0.0 110.612 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.66 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.05 -45.99 68.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 109.193 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -69.36 3.19 2.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.0 109.873 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.2 m -82.78 -34.5 27.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 110.346 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -176.76 -162.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.958 -1.089 . . . . 0.0 109.729 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.47 -7.92 6.91 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.48 136.04 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 ptm -165.46 157.75 15.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -92.27 141.43 28.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -86.54 -22.42 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.19 -171.29 40.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.31 163.41 38.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -1.156 . . . . 0.0 109.496 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.67 138.88 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.55 166.15 31.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.145 -0.972 . . . . 0.0 109.718 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -93.35 143.9 25.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.671 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.3 t60 -118.79 -118.55 0.31 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.626 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 30.8 t30 -75.41 51.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.05 8.84 86.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -127.81 139.99 52.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.987 . . . . 0.0 109.353 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -68.05 151.79 46.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -148.69 125.74 11.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -89.3 146.82 24.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.442 -0.786 . . . . 0.0 109.459 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -151.22 111.23 4.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.041 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.99 154.68 40.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.766 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.17 -33.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.39 0.04 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.561 ' H ' HD21 ' A' ' 138' ' ' LEU . 32.7 tt0 -143.72 104.31 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.443 -1.034 . . . . 0.0 109.157 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.73 34.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -134.6 138.44 44.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.618 -0.931 . . . . 0.0 108.919 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.39 9.06 39.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.76 -73.88 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 155.53 129.84 1.26 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.27 -24.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 109.879 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.0 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 166' ' ' CYS . 52.8 p -78.99 -54.43 6.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.652 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.472 HG11 ' CE1' ' A' ' 158' ' ' TYR . 29.6 m -45.37 -19.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.328 -0.857 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 164' ' ' SER . 89.3 m -72.54 -62.15 1.55 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.1 -14.88 40.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.381 -0.825 . . . . 0.0 110.133 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -56.33 -45.65 80.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -78.79 -19.71 51.54 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.529 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.4 mpt? -79.63 175.98 10.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.428 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -154.09 -34.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -146.13 128.44 15.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -127.0 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.63 110.84 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.446 -0.783 . . . . 0.0 109.057 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.99 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 108.699 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.83 117.15 1.61 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -112.44 127.23 55.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.28 150.0 22.2 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -159.42 151.45 20.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.355 -1.085 . . . . 0.0 109.944 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -90.51 122.87 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.677 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.839 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 62.9 m-85 -96.21 136.39 36.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.8 p-10 -140.92 99.79 3.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 23' ' ' LEU . 7.5 mp -83.45 130.49 35.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -90.67 123.36 34.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.76 131.03 44.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 p -150.1 168.24 24.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.021 -1.049 . . . . 0.0 109.939 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -139.75 136.81 34.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -103.32 138.26 40.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.149 -0.969 . . . . 0.0 109.796 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.931 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -90.36 163.22 14.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 mt -144.92 141.7 29.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.059 -1.026 . . . . 0.0 109.867 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.12 176.71 9.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.583 -0.698 . . . . 0.0 109.219 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.04 -3.78 55.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.29 2.45 55.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -22.36 40.1 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 mttp -104.97 173.15 6.43 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -93.99 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -68.9 4.07 1.69 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -127.88 150.16 18.26 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.37 1.2 57.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.254 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.41 -42.34 5.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.221 -0.924 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 45.43 21.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.311 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 66.6 t80 -136.2 99.64 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.554 -0.716 . . . . 0.0 110.275 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 pt -103.34 134.85 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.0 p90 -146.11 -161.18 1.26 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.03 -1.044 . . . . 0.0 109.735 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.3 p90 -45.92 -30.67 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.116 -0.99 . . . . 0.0 110.434 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 8.3 t30 -61.97 -1.17 0.61 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.895 -1.128 . . . . 0.0 108.972 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.3 t30 -141.48 100.12 3.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.448 -0.783 . . . . 0.0 109.039 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.12 -24.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.305 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.3 pttt -166.78 154.87 9.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.41 ' OG ' HD21 ' A' ' 29' ' ' LEU . 23.1 t -62.67 137.85 58.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.51 92.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -116.13 -17.14 10.92 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.648 -0.658 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.67 76.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m 54.47 20.72 2.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 109.288 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB3' ' A' ' 50' ' ' SER . 89.2 t -92.85 151.54 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.886 . . . . 0.0 109.076 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -133.91 125.48 28.38 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.512 -0.742 . . . . 0.0 109.515 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -92.46 124.19 36.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.339 -0.851 . . . . 0.0 109.367 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.8 m -58.58 -46.59 86.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.92 143.72 3.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.3 112.51 24.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -1.119 . . . . 0.0 109.395 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 64' ' ' GLY . 3.1 m-20 -82.08 128.78 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.63 5.65 17.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.9 p -153.55 -35.03 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 38.4 p-10 -52.65 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.106 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.418 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.4 m-20 -57.95 -64.45 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 72' ' ' SER . 60.0 mt-10 -102.69 170.97 7.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.363 -0.835 . . . . 0.0 108.989 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.1 m -165.85 164.65 18.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -135.06 124.04 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -95.69 109.68 21.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.729 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.29 146.81 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -142.29 92.7 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' ALA . 10.5 mt -71.09 -41.95 69.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.111 -0.993 . . . . 0.0 110.322 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -48.15 -13.96 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.544 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -104.97 -19.3 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.459 -0.776 . . . . 0.0 109.858 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 77' ' ' LEU . 37.9 t -60.81 126.37 85.26 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.268 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 -160.11 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.983 1.789 . . . . 0.0 111.895 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.49 3.7 63.66 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.64 -60.95 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -1.218 . . . . 0.0 109.347 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 30' ' ' LEU . 11.7 p -84.46 148.06 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.468 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.1 m-20 -125.71 -3.14 7.22 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.378 -0.826 . . . . 0.0 110.046 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.48 136.67 15.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.952 -1.093 . . . . 0.0 109.436 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.41 154.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.602 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -138.38 172.89 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.146 -0.971 . . . . 0.0 110.103 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -137.53 129.2 28.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG21 ' CE2' ' A' ' 28' ' ' PHE . 25.1 t -140.57 151.32 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.953 . . . . 0.0 111.344 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.0 p -132.7 131.63 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -132.4 155.37 48.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.64 HD12 ' NE2' ' A' ' 101' ' ' GLN . 6.1 mm -73.9 162.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -128.34 -60.24 1.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.522 -0.736 . . . . 0.0 109.465 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -49.88 -18.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.25 -42.4 86.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -54.13 -32.07 54.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.739 -1.226 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.86 -53.23 4.48 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.256 -0.903 . . . . 0.0 111.311 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' ARG . 3.1 ptp85 -111.85 1.72 16.69 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.181 -0.949 . . . . 0.0 111.237 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 96' ' ' ALA . 46.2 ttp180 56.19 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.788 -1.195 . . . . 0.0 109.24 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.64 ' NE2' HD12 ' A' ' 93' ' ' ILE . 1.3 pp0? -153.16 147.77 26.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.154 -0.966 . . . . 0.0 109.437 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 101' ' ' GLN . 20.8 m -105.01 163.41 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.831 . . . . 0.0 110.01 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -43.85 -28.61 0.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 0.0 110.161 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.641 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.1 -44.1 96.26 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.409 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.9 tp60 -47.64 -17.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 107' ' ' SER . 16.1 t -82.25 165.88 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -67.86 -21.72 65.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.671 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.41 79.98 0.03 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.23 162.48 27.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 109.623 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.5 p90 -155.38 151.69 28.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 45.9 mt -117.02 153.61 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -139.98 154.72 47.25 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.058 -1.026 . . . . 0.0 109.739 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -148.59 117.51 6.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.7 p -129.16 145.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.38 -0.825 . . . . 0.0 109.838 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.428 ' HB3' ' H ' ' A' ' 120' ' ' THR . 64.0 t30 -76.12 101.87 5.51 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.46 -1.58 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.847 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -83.62 -52.99 5.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 109.661 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -122.97 4.37 9.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 60.29 60.61 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 35.8 m -113.07 -69.09 0.88 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.817 -0.552 . . . . 0.0 110.227 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.2 mt-10 -45.29 157.83 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.91 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.57 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.53 148.86 52.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 109.902 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.7 ptm180 -138.61 145.2 40.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.405 ' CE2' ' HE1' ' A' ' 137' ' ' MET . 8.0 t80 -91.32 147.59 22.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.235 -0.916 . . . . 0.0 109.061 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -91.05 103.37 16.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 83.9 mt -80.77 -37.71 29.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.482 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 128' ' ' THR . 2.5 p -47.8 -32.37 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.151 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.29 -53.89 3.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 -2.2 23.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.224 -0.922 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -53.25 -46.8 69.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.2 t -69.49 3.2 2.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.603 -0.686 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -83.4 -34.7 25.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 110.354 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -176.61 -161.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.4 -2.49 5.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.65 134.09 13.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.405 ' HE1' ' CE2' ' A' ' 125' ' ' TYR . 20.5 ptm -165.49 152.58 10.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.058 -1.026 . . . . 0.0 109.911 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -87.47 138.43 31.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 27.6 t80 -80.25 -43.57 21.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.31 -173.85 35.11 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.858 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -150.77 166.59 30.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.143 -1.21 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 139.8 44.14 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -144.88 166.2 25.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.03 -1.044 . . . . 0.0 109.84 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.468 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.3 ptm180 -90.15 145.77 24.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.51 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 1.1 t60 -123.57 -120.29 0.28 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.598 -0.689 . . . . 0.0 109.166 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.51 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 10.1 m120 -73.37 52.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.64 88.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.84 142.0 51.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.582 -0.952 . . . . 0.0 109.406 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.458 ' CG ' HD13 ' A' ' 77' ' ' LEU . 74.6 m95 -67.48 151.64 47.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.358 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -149.96 132.82 16.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.076 -1.015 . . . . 0.0 109.632 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -89.91 153.16 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 107.32 1.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.1 154.74 41.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.724 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.69 -33.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.859 . . . . 0.0 109.268 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.57 86.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -134.8 104.36 5.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.574 -0.956 . . . . 0.0 109.214 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.64 146.09 18.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.551 ' CD1' HG11 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -147.4 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -1.08 . . . . 0.0 108.971 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.88 40.6 3.24 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.539 -0.726 . . . . 0.0 109.471 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.95 -54.45 3.4 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.0 122.13 0.71 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -45.53 -35.74 4.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.12 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.45 -28.36 23.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 109.59 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.8 p -80.88 -50.68 9.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.989 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.551 HG11 ' CD1' ' A' ' 158' ' ' TYR . 17.8 m -49.15 -21.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.008 . . . . 0.0 109.533 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 28' ' ' PHE . 57.9 m -79.39 -59.98 2.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.912 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.5 63.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.465 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -71.05 -28.41 64.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.969 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.85 -19.57 61.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.4 mtt -81.31 162.51 23.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -130.95 -31.3 1.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.499 -0.75 . . . . 0.0 109.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -146.23 128.17 15.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 109.089 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.13 144.45 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 73' ' ' LEU . 15.5 tp -130.64 114.29 15.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 89' ' ' PHE . 61.9 t -86.0 151.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 108.777 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.43 121.65 2.34 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.7 tt -132.49 126.17 32.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.608 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -146.32 152.99 25.04 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -155.04 154.57 32.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -1.044 . . . . 0.0 109.7 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -90.45 120.97 32.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.171 -0.955 . . . . 0.0 109.303 179.717 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -96.32 145.73 25.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 25.1 p-10 -140.97 99.68 3.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.371 -0.831 . . . . 0.0 109.574 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -85.51 130.53 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 108.758 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.72 106.0 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -98.28 124.93 43.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -149.47 168.23 24.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.973 -1.079 . . . . 0.0 110.115 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.58 137.38 46.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m-85 -102.99 130.55 50.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.0 109.178 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.73 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.66 145.54 28.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.86 136.46 25.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.026 . . . . 0.0 110.109 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.16 176.48 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.699 . . . . 0.0 109.519 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -7.47 59.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 -0.16 47.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.31 -12.01 61.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.74 148.68 24.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 38' ' ' GLY . 29.0 t -66.39 136.89 25.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.934 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.94 9.25 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.0 170.09 34.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.14 3.83 54.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.986 -1.302 . . . . 0.0 109.902 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.16 -41.78 5.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.243 -0.91 . . . . 0.0 110.309 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 23.2 t0 51.04 9.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 0.0 109.313 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.2 p90 -138.29 118.75 13.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.316 -0.865 . . . . 0.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 29' ' ' LEU . 6.3 pt -114.22 134.14 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -154.74 -148.21 0.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.959 . . . . 0.0 108.888 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 47' ' ' ASN . 37.3 p90 -44.89 -32.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.826 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 18.2 p-10 -65.4 4.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.177 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.1 t30 -155.53 100.29 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.804 . . . . 0.0 109.155 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -48.09 -18.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 28.4 pttt -175.38 155.23 1.81 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.398 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 54' ' ' SER . 53.2 p -66.71 130.51 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.83 -48.72 44.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.826 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -116.39 23.36 12.14 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 109.929 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.33 -15.11 7.24 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.6 t 63.48 4.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -1.116 . . . . 0.0 109.458 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 50' ' ' SER . 69.7 t -92.9 146.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.914 . . . . 0.0 108.916 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.9 m -149.78 153.78 37.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.057 . . . . 0.0 110.35 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.6 m80 -90.58 131.74 36.12 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.2 m -81.78 -34.71 30.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.506 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 113.76 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.74 159.09 25.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -1.122 . . . . 0.0 109.492 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.82 118.59 7.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -84.17 10.77 9.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.7 p -154.41 -35.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.955 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.85 99.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -1.198 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.53 -68.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.33 146.73 23.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.267 -0.896 . . . . 0.0 109.279 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -159.84 141.56 12.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.37 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 57' ' ' HIS . 8.0 mp -115.4 130.36 56.87 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.0 109.554 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -96.73 109.94 22.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.8 146.75 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.204 -0.935 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -141.98 90.62 2.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 149' ' ' TRP . 11.3 mt -78.86 -10.76 59.9 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.13 -0.84 0.82 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.009 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -135.83 18.12 3.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.0 p -60.2 134.99 90.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.329 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.5 -161.36 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.939 1.759 . . . . 0.0 111.682 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.08 39.7 2.79 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -126.19 -59.16 1.33 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.477 -1.014 . . . . 0.0 109.688 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.82 145.67 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.11 -0.994 . . . . 0.0 109.686 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -138.97 1.5 2.06 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.399 -0.813 . . . . 0.0 109.581 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -149.06 131.35 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 108.963 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -137.38 130.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 141' ' ' GLU . 9.3 pt -137.22 152.89 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.933 . . . . 0.0 109.619 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 7' ' ' VAL . 28.3 m-85 -101.59 141.18 34.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.377 -0.827 . . . . 0.0 109.08 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.89 153.02 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.922 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -133.15 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -138.29 145.17 40.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.904 . . . . 0.0 109.861 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.26 148.01 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -0.862 . . . . 0.0 108.822 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' ALA . 56.6 t-80 -101.32 -70.66 0.74 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -47.51 -18.1 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 109.694 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -53.5 -18.76 3.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.81 -62.19 1.49 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.905 -1.122 . . . . 0.0 109.244 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.45 -38.45 12.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 110.813 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.517 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 6.2 mpt_? -85.14 -18.0 35.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.042 -1.036 . . . . 0.0 111.109 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 99' ' ' ARG . 16.1 tpt180 52.1 94.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.811 -1.18 . . . . 0.0 108.763 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -152.46 140.68 20.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 109.435 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 t -99.62 164.14 12.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.44 -30.9 2.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.397 -0.814 . . . . 0.0 109.934 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.39 -39.73 98.08 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -49.78 -15.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.502 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 107' ' ' SER . 17.7 t -83.13 163.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 109.088 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -62.66 -22.7 66.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.74 80.02 0.03 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.3 164.33 24.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.129 . . . . 0.0 109.667 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.0 p90 -150.04 169.82 20.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.194 -0.942 . . . . 0.0 110.185 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 18.1 mt -136.13 152.11 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 67.0 ttt-85 -143.55 163.62 32.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.1 tt -156.58 117.19 3.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.568 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.0 p -132.13 145.32 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.309 -0.87 . . . . 0.0 110.212 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 119' ' ' GLN . 2.2 m120 -78.6 102.35 7.91 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -68.0 -1.76 6.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.104 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.15 -53.13 7.29 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.993 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -123.27 3.03 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.2 mt-30 59.95 61.28 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 32.6 m -114.33 -66.31 1.1 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.901 -0.499 . . . . 0.0 110.247 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 122' ' ' VAL . 1.4 mp0 -45.3 156.91 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.563 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.4 73.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.23 143.83 50.2 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.087 -1.008 . . . . 0.0 110.154 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.1 ptp180 -138.0 139.33 39.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.508 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 6.4 t80 -91.02 142.78 27.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 108.97 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -85.72 102.85 13.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.438 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 95.0 mt -79.42 -36.71 38.61 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 0.0 109.308 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 128' ' ' THR . 4.9 p -48.06 -33.2 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.139 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -95.3 -53.59 3.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.487 -0.758 . . . . 0.0 109.721 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 65.8 m-20 -71.9 -5.46 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.96 -46.06 68.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.18 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 65.4 p -68.84 3.18 2.08 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.916 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.0 m -83.32 -34.78 25.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.252 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -177.06 -162.77 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.971 -1.081 . . . . 0.0 109.677 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.52 -13.29 7.59 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.39 135.36 32.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.2 ttp -165.33 151.34 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.024 -1.047 . . . . 0.0 110.189 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.36 137.21 32.53 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.429 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -75.84 -47.43 25.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.902 -1.124 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.96 -158.91 9.06 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 88' ' ' ILE . 13.2 tt0 -150.98 158.65 44.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -1.085 . . . . 0.0 109.266 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 143' ' ' TYR . 1.8 tt -143.28 131.92 22.49 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.562 ' N ' HD23 ' A' ' 142' ' ' LEU . 12.1 p90 -150.66 166.34 30.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.5 ptm180 -94.68 142.53 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.449 -0.782 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -114.15 -120.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.593 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 20.0 t-20 -73.66 51.35 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.129 -0.982 . . . . 0.0 109.146 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.64 82.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -127.67 140.12 52.28 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.562 -0.963 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.532 ' CE2' HD13 ' A' ' 77' ' ' LEU . 58.0 m95 -67.3 151.75 46.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -151.4 121.6 7.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -91.81 145.21 24.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.243 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -152.18 107.28 3.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.106 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.506 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -64.16 154.54 34.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.725 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.7 t -138.76 -33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.83 83.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -134.61 104.13 5.94 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.61 -0.936 . . . . 0.0 109.007 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.91 149.22 21.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.34 132.61 26.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -1.016 . . . . 0.0 108.99 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -87.14 19.64 3.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.53 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -57.66 -107.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.1 129.43 1.96 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.55 -30.3 2.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -30.86 22.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.3 t -79.54 -53.93 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 18.1 m -47.2 -19.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 164' ' ' SER . 65.9 m -74.49 -61.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.03 -15.13 45.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -57.19 -43.69 82.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 45.8 m-85 -71.84 -20.07 61.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.466 ' N ' ' SD ' ' A' ' 2' ' ' MET . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -156.53 156.38 33.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 57.0 mttp -126.98 -14.53 5.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.519 -0.738 . . . . 0.0 109.382 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 43.0 m-20 -146.31 128.63 15.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.208 -0.932 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 6' ' ' LEU . 69.2 t -127.17 158.56 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.567 -0.708 . . . . 0.0 109.307 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' N ' HG12 ' A' ' 5' ' ' VAL . 12.0 tp -145.64 109.45 4.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 109.061 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.78 150.84 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.905 . . . . 0.0 108.747 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.24 117.25 1.68 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.1 tp -115.36 124.21 50.67 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -144.03 150.56 22.59 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -159.95 152.12 20.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.396 -1.061 . . . . 0.0 109.893 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.18 129.61 34.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.575 -0.703 . . . . 0.0 109.643 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.386 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 12.3 p-10 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.211 0.529 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.26 143.37 27.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -141.06 100.25 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.269 -0.894 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -83.28 135.51 34.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 108.748 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.51 117.59 30.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.51 130.98 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.66 167.75 25.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 109.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.27 144.98 42.91 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -101.94 151.81 21.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -118.87 143.34 47.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.562 -0.711 . . . . 0.0 109.282 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 133.2 22.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.069 -1.019 . . . . 0.0 110.136 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.5 176.5 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.741 -0.6 . . . . 0.0 109.487 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.93 -2.49 55.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 46.7 t30 -87.67 -1.43 57.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.741 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.54 -13.02 65.09 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -101.61 150.99 22.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.536 -0.979 . . . . 0.0 108.402 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 38' ' ' GLY . 27.4 t -69.05 137.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.24 -0.913 . . . . 0.0 109.121 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -71.62 8.68 1.04 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.74 170.95 35.35 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.1 m-20 -94.81 3.46 54.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.939 -1.33 . . . . 0.0 110.21 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.17 -42.13 5.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.056 -1.028 . . . . 0.0 110.584 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t0 49.63 9.93 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.955 -1.09 . . . . 0.0 109.496 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 8.2 t80 -138.13 100.22 4.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.323 -0.861 . . . . 0.0 109.803 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 29' ' ' LEU . 8.0 pt -96.75 139.6 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.208 -0.932 . . . . 0.0 108.608 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 35.4 p90 -151.23 -152.3 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 109.568 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.5 m-85 -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.644 -0.66 . . . . 0.0 110.013 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -57.27 -4.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -0.965 . . . . 0.0 108.639 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.0 t30 -151.32 102.03 2.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -48.72 -26.34 2.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.6 pttp -163.93 157.28 18.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 7.1 t -76.97 125.86 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.241 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.77 -45.81 67.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.922 . . . . 0.0 109.758 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.75 -12.23 19.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.494 -0.754 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.19 -13.51 68.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 p 60.45 12.19 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -1.212 . . . . 0.0 109.104 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' H ' ' HB3' ' A' ' 50' ' ' SER . 69.9 t -92.97 151.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.413 -0.804 . . . . 0.0 109.214 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.2 m -148.52 139.13 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.01 . . . . 0.0 109.921 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 73' ' ' LEU . 50.7 m80 -90.3 129.01 36.58 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -66.63 -53.02 38.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.4 114.09 0.54 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -79.37 110.98 15.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.94 -163.93 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 63' ' ' THR . 18.0 ptt180 -155.41 15.86 0.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.0 p -155.85 -39.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.28 98.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -1.122 . . . . 0.0 109.486 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.21 -57.38 13.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.22 170.82 8.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 132.21 5.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.201 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -115.23 119.44 36.34 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.05 137.32 35.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 109.081 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -127.8 144.75 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.588 -0.695 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.35 97.27 3.34 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.7 mt -82.98 -14.96 53.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.087 -1.008 . . . . 0.0 109.557 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.43 -1.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.462 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.37 16.32 3.73 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.342 -0.849 . . . . 0.0 109.101 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.2 p -60.68 134.96 92.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.217 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.24 -177.95 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.814 1.676 . . . . 0.0 111.495 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.41 13.57 64.92 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -96.89 -59.78 1.73 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -1.14 . . . . 0.0 109.828 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.22 148.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.734 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -144.06 7.37 1.39 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.31 -0.869 . . . . 0.0 109.635 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -152.0 140.23 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 109.051 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 87' ' ' ILE . 6.1 mt -145.55 122.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.161 -0.962 . . . . 0.0 109.709 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.09 174.15 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.339 -0.851 . . . . 0.0 108.747 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -141.08 119.53 12.29 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.07 157.67 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.332 -0.855 . . . . 0.0 110.651 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.61 136.72 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 p -131.12 148.54 52.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.5 mm -75.57 147.87 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' ALA . 4.0 t60 -102.36 -68.48 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.249 -0.907 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.27 -18.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.48 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -54.25 -17.89 3.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -69.86 -59.63 2.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.939 -1.101 . . . . 0.0 109.964 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.77 -51.33 5.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.181 -0.949 . . . . 0.0 111.354 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -78.09 -16.84 57.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.96 -1.088 . . . . 0.0 110.991 -178.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' ARG . 35.6 ttp180 55.89 101.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.746 -1.221 . . . . 0.0 109.308 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -159.16 143.06 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -100.96 167.25 10.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -45.87 -35.35 4.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.686 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.15 -39.31 92.08 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -46.98 -16.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -1.174 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -86.08 168.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.149 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.518 ' N ' HG12 ' A' ' 106' ' ' VAL . 23.2 m -70.86 -22.23 62.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.819 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.61 79.39 0.03 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.5 23.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 109.748 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 42.8 p90 -152.34 163.32 39.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 54.3 mt -126.2 154.3 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.43 ' NH2' HG12 ' A' ' 122' ' ' VAL . 50.6 ttt85 -141.22 159.85 41.34 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.983 -1.073 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.2 tt -154.22 116.99 4.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 109.28 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.58 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -130.98 143.51 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 120' ' ' THR . 55.9 t30 -75.14 102.07 4.8 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.62 -1.32 2.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 25.3 t70 -83.01 -53.55 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.652 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.6 6.2 8.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.587 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 59.52 60.33 2.31 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 43.1 p -110.62 -70.12 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.925 -0.485 . . . . 0.0 110.298 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 122' ' ' VAL . 66.8 mt-10 -45.33 157.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.324 -0.86 . . . . 0.0 109.774 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 150.17 52.15 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.091 -1.006 . . . . 0.0 110.02 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -139.78 142.26 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.645 -0.659 . . . . 0.0 109.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.35 147.77 22.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.234 -0.916 . . . . 0.0 109.147 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -91.17 103.16 15.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.407 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 82.3 mt -79.24 -39.3 33.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.4 m -47.51 -30.29 3.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.971 -1.081 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.3 -54.74 3.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.403 -0.811 . . . . 0.0 109.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.5 -2.35 28.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.14 -0.975 . . . . 0.0 110.418 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.46 -45.27 69.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.217 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 t -70.91 3.08 3.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.491 -0.756 . . . . 0.0 109.868 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.1 m -83.11 -34.72 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.035 -1.04 . . . . 0.0 110.226 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -176.74 -162.42 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.022 . . . . 0.0 109.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.56 -15.31 7.58 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.41 138.67 36.71 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.3 ptm -165.45 157.99 15.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 0.0 109.916 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.07 134.64 37.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.347 -0.846 . . . . 0.0 109.664 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -76.71 -42.42 41.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.05 . . . . 0.0 109.431 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.44 -163.13 13.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.28 163.05 39.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -1.098 . . . . 0.0 109.015 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.5 tp -144.82 137.22 26.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.068 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -150.68 166.04 31.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 109.275 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -95.7 141.45 29.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.602 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER -99.18 -133.95 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.602 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 5.6 m120 -52.22 -50.48 61.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.984 -1.072 . . . . 0.0 108.269 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.04 16.94 0.13 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -129.87 154.43 47.3 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.228 -1.16 . . . . 0.0 109.683 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 1' ' ' SER . 71.9 m95 -72.35 151.86 42.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.395 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -147.28 121.63 9.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.233 -0.917 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -90.32 146.26 24.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -150.81 107.78 3.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.4 -0.812 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.44 154.7 40.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.835 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 -33.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.4 85.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.16 104.3 5.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.531 -0.982 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.89 150.66 26.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.67 135.07 41.79 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.604 -0.939 . . . . 0.0 108.837 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.51 2.7 54.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 109.519 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -58.68 -110.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.97 140.27 6.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.75 -35.22 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.848 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.49 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.79 -19.81 30.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.1 m -89.02 -52.44 5.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 12.7 m -54.54 -28.29 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.617 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 32.1 p -78.54 -54.59 5.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -71.98 -15.12 62.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.976 -1.077 . . . . 0.0 109.33 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -28.99 63.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 51.1 m-85 -71.78 -19.83 61.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 109.473 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.439 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.774 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 149' ' ' TRP . 20.9 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.08 -170.99 2.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -153.25 -34.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -145.99 141.26 27.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.313 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG1' HD21 ' A' ' 113' ' ' LEU . 10.9 t -141.0 154.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.0 109.226 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.79 121.82 12.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 109.288 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -91.8 150.74 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 108.988 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.3 116.85 1.8 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -112.59 127.81 56.19 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.86 146.95 17.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -157.63 152.74 25.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -1.134 . . . . 0.0 109.872 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -92.53 126.51 37.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.737 . . . . 0.0 109.649 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.473 179.789 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 95.2 m-85 -96.17 153.09 17.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -140.93 111.15 6.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.92 163.61 13.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -106.68 154.57 20.74 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 0.0 109.479 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -144.67 109.7 5.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.185 -0.947 . . . . 0.0 108.764 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 t -149.43 163.3 38.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 109.974 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 144.69 37.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 8.0 m-85 -104.04 129.07 51.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.447 -0.783 . . . . 0.0 108.909 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.004 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.53 155.56 17.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.41 -0.806 . . . . 0.0 109.204 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.23 137.3 25.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.69 176.35 8.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.445 -0.785 . . . . 0.0 109.266 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.5 -2.55 53.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.642 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -93.18 3.55 55.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.174 -0.954 . . . . 0.0 109.821 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 -19.6 53.83 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.3 mttp -106.26 172.45 6.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -101.27 141.81 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -59.69 -5.55 0.93 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -148.6 101.11 0.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 18.6 p-10 -45.23 -18.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.376 -1.073 . . . . 0.0 110.28 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.44 79.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 0.0 109.561 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.696 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 45.45 17.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' ALA . 52.5 t80 -137.8 100.02 4.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.533 -0.729 . . . . 0.0 109.858 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 29' ' ' LEU . 6.2 pt -106.3 139.65 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.315 -0.866 . . . . 0.0 109.072 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -152.92 -148.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 109.039 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' ASN . 25.9 p90 -44.46 -34.33 2.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.971 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.69 -5.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.166 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 54.0 t-20 -148.0 110.09 4.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -0.834 . . . . 0.0 108.956 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.24 -29.1 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 12.8 pttm -169.17 155.6 6.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.432 -0.793 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 5.1 t -73.51 117.51 15.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.189 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.22 78.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.663 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -93.42 -16.41 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.29 -0.881 . . . . 0.0 109.786 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.17 -13.69 61.58 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t 58.39 14.04 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.9 t -92.91 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.329 -0.857 . . . . 0.0 109.168 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.5 m -145.75 136.12 24.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 57.2 m80 -89.97 133.49 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.347 -0.846 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -71.75 -60.79 2.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.506 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.43 114.92 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 32.6 p-10 -82.21 110.94 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.0 t-20 -80.84 -163.48 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.358 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 36.1 ttp180 -151.91 14.23 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 109.243 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -154.11 -38.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.945 . . . . 0.0 109.25 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.24 124.13 9.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -1.165 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.93 -73.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -90.84 99.66 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 t -91.38 132.15 36.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.217 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -112.27 125.08 53.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -96.3 142.51 28.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 108.949 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -133.68 146.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.332 -0.855 . . . . 0.0 109.927 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -142.2 102.23 4.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 79' ' ' ALA . 5.6 mt -82.59 -27.69 31.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.862 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -63.63 4.65 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.29 19.08 4.01 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.81 125.81 45.19 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.117 -0.99 . . . . 0.0 108.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.06 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.818 1.679 . . . . 0.0 111.88 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.56 4.71 83.95 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -53.27 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -1.181 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.29 149.07 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.0 109.347 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 10.4 t0 -120.71 -13.79 8.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 109.482 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -158.02 134.18 9.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.013 . . . . 0.0 109.949 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -122.88 154.42 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -141.12 173.57 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.193 -0.942 . . . . 0.0 109.291 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -141.84 128.91 20.83 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.61 158.33 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 m -135.63 114.06 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -106.15 161.06 14.85 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.9 mm -73.01 140.58 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.12 -69.88 0.73 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.056 -1.028 . . . . 0.0 110.441 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -50.39 -17.92 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.146 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.598 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.35 -50.51 21.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -55.24 -28.02 50.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.904 -1.123 . . . . 0.0 109.801 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -54.14 4.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.114 -0.991 . . . . 0.0 111.173 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.45 -0.43 15.29 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.187 -0.945 . . . . 0.0 111.058 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.0 ttm-85 56.23 101.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.889 -1.132 . . . . 0.0 109.046 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -146.93 149.48 33.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.7 p -101.03 158.22 16.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.341 -0.849 . . . . 0.0 109.652 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -45.62 -34.46 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.397 -0.815 . . . . 0.0 109.743 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.684 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.7 -42.22 99.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 87.4 mm-40 -47.66 -15.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.251 . . . . 0.0 109.371 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -83.57 166.16 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.509 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.2 t -69.83 -20.48 63.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.725 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.83 79.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.06 162.76 26.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 109.734 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 20.7 p90 -156.3 149.96 24.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 56.7 mt -115.83 154.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -139.59 159.4 42.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.03 -1.043 . . . . 0.0 109.923 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -151.94 117.23 5.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -129.16 145.82 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HB3' ' H ' ' A' ' 120' ' ' THR . 56.9 t30 -76.42 102.05 5.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.93 -1.56 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.88 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -84.08 -53.17 5.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.713 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -123.11 4.67 9.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' ASN . 10.7 tt0 60.39 61.12 1.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.429 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 24.3 p -112.34 -68.97 0.89 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.903 -0.498 . . . . 0.0 110.221 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.3 mm-40 -45.4 157.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.851 . . . . 0.0 109.956 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.74 150.83 52.11 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.149 -0.969 . . . . 0.0 109.935 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptm180 -138.81 146.26 41.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.507 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.0 t80 -91.34 147.3 23.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.61 103.06 15.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.516 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.8 mt -81.38 -39.16 25.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.3 m -48.16 -31.87 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 0.0 109.152 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.18 -54.53 3.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.47 -0.769 . . . . 0.0 109.771 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 58.6 m-20 -72.75 -2.99 22.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.274 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.72 -44.35 66.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.244 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.5 p -72.39 3.17 5.03 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -82.79 -34.57 26.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.74 -162.6 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -127.37 -1.58 6.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.07 13.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.8 ptm -165.35 157.97 15.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.843 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -94.68 139.66 30.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 109.795 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 26.5 t80 -81.14 -42.82 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.629 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.62 -169.45 22.95 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.8 164.86 35.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.251 -1.147 . . . . 0.0 109.46 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 136.52 26.23 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 152' ' ' ARG . 9.5 p90 -146.95 166.27 27.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.019 -1.05 . . . . 0.0 110.25 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.98 145.32 24.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 4.7 t60 -122.77 -118.81 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.61 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 23.1 m120 -73.53 53.3 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.23 8.13 87.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.76 148.61 50.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.99 . . . . 0.0 109.312 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.4 m95 -75.08 151.79 38.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -147.74 127.11 13.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.112 -0.993 . . . . 0.0 109.603 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -89.63 148.23 23.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.484 -0.76 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 143' ' ' TYR . 2.6 ptp180 -153.87 107.52 2.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.06 154.55 37.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.44 -34.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.0 109.389 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 86.26 0.04 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -131.67 104.19 6.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.634 -0.921 . . . . 0.0 109.389 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.36 148.08 24.94 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -139.43 128.66 23.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -1.073 . . . . 0.0 109.321 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.8 12.16 13.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.06 -80.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 152.77 131.24 1.63 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.15 -13.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.56 -50.32 7.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.2 p -81.12 -37.72 28.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 161' ' ' GLY . 52.1 t -49.92 -24.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.434 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 93.4 m -79.55 -55.28 5.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.168 -0.957 . . . . 0.0 110.959 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.09 -15.21 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.957 -1.089 . . . . 0.0 110.355 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.3 -39.96 89.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.58 -19.62 62.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.683 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.734 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 25.2 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.255 0.55 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.438 ' CE ' HD22 ' A' ' 115' ' ' ASN . 65.0 mtt -80.21 -174.64 4.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.536 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 62.2 mttm -153.21 -34.98 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 2.4 m120 -138.0 142.65 40.41 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.362 -0.837 . . . . 0.0 109.321 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 5.2 t -140.08 146.01 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.8 tt -136.25 111.9 9.37 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -86.42 150.97 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.26 117.08 1.56 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.8 tt -115.98 132.42 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -149.0 143.96 11.55 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.52 158.8 41.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -1.023 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -76.73 131.35 38.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.911 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 0.0 109.261 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 p30 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.17 140.03 31.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.83 99.79 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.304 -0.872 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.69 153.29 24.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -108.44 109.06 20.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -0.761 . . . . 0.0 109.543 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.25 128.0 44.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.307 -0.87 . . . . 0.0 108.924 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -149.44 167.81 25.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.068 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.68 140.7 43.22 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -103.91 129.83 51.46 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.406 -0.809 . . . . 0.0 108.922 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.949 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.97 146.72 27.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 109.681 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.64 134.69 23.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.188 -0.945 . . . . 0.0 110.005 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.74 176.53 3.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.65 -6.4 58.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.711 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -86.57 1.49 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.86 59.16 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -99.48 152.26 20.2 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 38' ' ' GLY . 26.2 t -72.26 136.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.054 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -70.96 8.17 0.99 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.2 168.36 34.61 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.33 4.05 54.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.997 -1.296 . . . . 0.0 110.13 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -102.77 -42.05 6.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.158 -0.964 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 47.71 13.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.742 -1.224 . . . . 0.0 109.454 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ALA . 68.7 t80 -137.5 102.86 4.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.444 -0.785 . . . . 0.0 109.911 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 pt -103.08 131.04 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.813 . . . . 0.0 108.855 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 20.4 t80 -150.06 -146.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -50.65 -16.27 0.37 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 10.0 p-10 -78.92 4.88 12.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 108.799 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.1 t-20 -156.71 106.44 2.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.05 -25.57 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 11.9 pttm -172.86 158.53 3.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 t -69.64 141.38 53.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.66 -43.55 25.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.31 -1.58 12.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.694 -0.629 . . . . 0.0 109.553 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.8 -13.68 60.6 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 t 60.45 10.28 2.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -1.077 . . . . 0.0 109.426 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.13 147.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.99 138.2 25.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 109.721 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.438 ' NE2' HD11 ' A' ' 73' ' ' LEU . 36.0 m80 -89.82 130.17 36.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 108.785 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -69.49 -42.76 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.332 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.27 111.08 0.39 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -72.84 110.79 7.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.1 t-20 -86.3 -167.04 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.945 . . . . 0.0 109.341 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.466 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 15.5 ptt-85 -162.37 20.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 18.8 p -153.9 -43.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 109.352 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -56.42 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -52.96 -61.07 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.65 165.31 13.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -154.89 132.15 11.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -116.15 124.48 50.43 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HZ2' ' HE3' ' A' ' 76' ' ' LYS . 36.9 tttm -95.91 139.83 31.55 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.51 146.8 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HE3' ' HZ2' ' A' ' 74' ' ' LYS . 88.7 mttt -139.57 99.35 3.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.18 -5.53 52.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -83.26 -26.89 30.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.93 5.87 50.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.42 124.44 85.53 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.13 -161.35 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.828 1.686 . . . . 0.0 112.057 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.32 1.38 79.5 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -68.9 -59.83 2.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 109.246 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 50.4 t -91.39 148.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.408 -0.807 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 2.4 m-20 -138.26 9.03 2.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -155.04 131.3 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 109.327 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.38 154.3 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.46 173.66 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.307 -0.87 . . . . 0.0 109.001 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.9 m-85 -140.95 120.48 13.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.21 158.11 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.714 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.63 136.34 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -125.55 143.88 50.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 109.695 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.7 mm -74.22 132.05 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 108.863 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -93.8 -60.14 1.83 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.33 -19.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.56 -43.88 72.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -55.79 -27.6 51.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.762 -1.212 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.67 -53.74 4.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.137 -0.977 . . . . 0.0 111.076 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -112.42 -3.9 14.37 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.244 -0.91 . . . . 0.0 110.9 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 48.0 ttp180 56.74 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.071 . . . . 0.0 109.321 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -157.88 153.65 26.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 83.0 p -101.85 158.47 16.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.01 -31.49 0.92 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.564 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.06 -33.51 22.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -57.53 -26.29 61.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -1.077 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -72.41 166.4 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.223 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.3 m -70.69 -28.89 65.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.4 75.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.62 25.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 108.938 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.9 p90 -153.24 169.86 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.297 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 41.8 mt -132.4 156.62 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.71 162.69 34.8 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.006 -1.059 . . . . 0.0 109.731 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.6 tt -157.52 116.66 3.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.587 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -132.92 141.88 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.318 -0.864 . . . . 0.0 109.651 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.438 HD22 ' CE ' ' A' ' 2' ' ' MET . 16.6 m-20 -77.79 102.1 7.03 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 6.1 p-10 -68.29 -3.67 11.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.9 t70 -72.96 -52.69 13.58 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.138 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -122.67 -12.02 8.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.766 -0.584 . . . . 0.0 109.617 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 115' ' ' ASN . 6.0 tt0 70.86 69.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -130.48 -45.71 1.09 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.738 -0.601 . . . . 0.0 109.979 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.0 mp0 -65.13 158.23 26.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 108.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 176.67 76.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.28 148.67 52.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.495 -0.753 . . . . 0.0 109.407 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 27.8 ptt180 -136.49 141.72 43.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.53 140.04 30.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 0.0 108.946 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -83.85 103.02 12.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 0.0 109.402 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 60.7 mt -78.22 -41.72 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 84.7 m -47.88 -29.58 3.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.933 -1.104 . . . . 0.0 109.274 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.05 -54.74 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 109.878 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.28 -4.74 37.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 110.355 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.21 -49.29 78.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.961 -1.087 . . . . 0.0 109.783 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.3 p -60.41 2.8 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.5 m -89.68 -33.31 16.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 110.4 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -172.68 -145.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.18 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.521 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -135.82 -52.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.77 143.64 30.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.2 ttt -166.2 158.08 13.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.043 . . . . 0.0 109.802 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -101.04 136.48 40.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.373 -0.83 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 25.9 t80 -81.65 -40.74 22.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.74 -170.79 26.95 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -150.96 163.62 38.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -1.12 . . . . 0.0 109.602 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.03 140.39 32.61 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -150.57 166.5 30.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.099 -1.001 . . . . 0.0 109.857 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -88.15 148.96 24.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.79 . . . . 0.0 109.709 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -152.5 123.78 7.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.67 24.77 7.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.81 80.33 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -127.8 138.37 52.71 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.488 -1.007 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 76.8 m95 -67.69 150.7 48.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -151.35 126.19 9.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -89.23 147.02 24.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.465 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -152.76 108.09 3.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.048 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.54 154.74 41.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.0 t -139.31 -33.65 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -0.843 . . . . 0.0 109.293 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.09 86.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -138.25 104.46 5.2 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.928 . . . . 0.0 109.485 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.64 150.59 33.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -147.88 134.4 19.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.221 -1.164 . . . . 0.0 109.396 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.3 16.94 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.339 -0.851 . . . . 0.0 109.43 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.1 -64.55 2.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.64 127.04 0.97 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -47.22 -35.58 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.792 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.0 -22.2 27.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.423 ' C ' ' N ' ' A' ' 166' ' ' CYS . 26.0 m -79.18 -57.53 3.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.0 m -47.58 -20.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.423 ' N ' ' C ' ' A' ' 164' ' ' SER . 96.2 m -72.63 -61.94 1.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.68 -17.52 31.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.35 -43.51 88.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.24 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.92 -20.31 61.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt -67.67 -178.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.436 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 81.8 mttt -153.62 -33.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.911 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.2 m120 -140.3 129.11 23.18 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -129.69 156.09 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.6 tp -142.02 110.0 5.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 108.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.22 150.5 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.209 -0.932 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.54 116.5 1.22 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.56 134.55 49.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.57 142.32 10.58 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -160.39 152.98 20.94 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -1.151 . . . . 0.0 109.914 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.08 99.32 11.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 109.403 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.428 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.24 131.19 42.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 p-10 -141.03 100.8 3.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.18 146.3 28.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.78 121.4 44.3 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.33 -0.856 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.6 134.37 40.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.262 -0.899 . . . . 0.0 108.912 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.9 t -149.85 167.92 25.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.306 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.08 138.33 54.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.8 m-85 -104.06 128.03 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.317 -0.865 . . . . 0.0 109.332 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.011 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -103.03 155.84 18.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.42 137.49 25.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 109.35 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.14 176.78 9.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 109.501 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.35 59.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.98 4.66 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.119 -0.988 . . . . 0.0 109.839 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.89 -20.68 45.91 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 43.6 mtpt -103.32 172.49 6.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.689 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.6 t -101.29 142.63 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.406 -0.809 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 39.1 mmm-85 -59.74 -6.03 1.09 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -146.1 100.16 0.22 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -44.94 -21.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -1.091 . . . . 0.0 110.414 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.35 79.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 109.62 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.689 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER 47.77 13.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 109.369 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 84.9 t80 -138.28 99.46 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.366 -0.834 . . . . 0.0 109.654 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.83 136.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.8 p90 -144.94 -160.85 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.139 -0.976 . . . . 0.0 109.502 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.8 p90 -45.64 -29.96 1.39 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.433 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 15.8 t-20 -57.42 -6.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.855 -1.153 . . . . 0.0 108.989 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 48.6 t30 -140.17 110.07 6.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.458 -0.776 . . . . 0.0 109.022 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.03 -31.65 5.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 109.278 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 16.9 pttp -169.87 160.01 8.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -65.01 142.29 58.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.327 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.92 43.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.631 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -115.21 -3.79 12.49 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.643 -0.661 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -15.64 74.23 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.0 p 61.48 11.45 3.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.0 109.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 73' ' ' LEU . 54.9 m -147.68 133.85 19.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 109.746 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.55 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.8 m80 -91.42 139.17 30.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 m -74.43 -61.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.67 121.63 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 23.6 p-10 -81.28 112.11 18.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.146 . . . . 0.0 109.543 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.35 132.1 35.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -79.82 6.24 11.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.532 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.1 p -153.3 -34.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -49.2 106.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.04 -63.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -90.99 -179.69 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.562 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.9 m -161.85 135.43 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.18 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.55 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -121.41 120.5 35.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.13 138.8 33.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.096 -1.002 . . . . 0.0 109.304 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' CE1' ' A' ' 89' ' ' PHE . 79.8 mt -132.38 147.02 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.583 -0.698 . . . . 0.0 109.763 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' O ' ' OG ' ' A' ' 54' ' ' SER . 53.8 mttp -142.85 102.1 3.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.857 . . . . 0.0 108.722 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 79' ' ' ALA . 9.3 mt -77.11 -39.01 51.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.999 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -49.42 -17.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -100.17 -15.95 17.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.78 123.89 88.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.398 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.56 -160.74 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.967 1.778 . . . . 0.0 111.941 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.01 1.73 87.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' NH1' ' A' ' 37' ' ' ARG . 59.4 t0 -67.28 -55.64 13.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -1.143 . . . . 0.0 109.57 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -79.02 148.53 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 8.9 t0 -128.25 -7.13 5.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 109.564 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -158.21 135.84 10.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 109.614 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.75 154.12 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -146.51 173.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.262 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.447 ' CE1' HD13 ' A' ' 75' ' ' ILE . 9.3 m-85 -133.32 139.28 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.94 155.62 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.99 . . . . 0.0 111.212 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -147.57 113.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -121.14 171.62 8.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.449 -0.782 . . . . 0.0 110.606 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.8 mm -81.68 168.3 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.568 ' N ' HG22 ' A' ' 93' ' ' ILE . 27.0 t-80 -132.75 -64.8 0.74 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -49.91 -18.23 0.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.28 -39.44 79.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.579 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' NE2' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -52.9 -32.21 44.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.77 -1.206 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.84 4.22 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.135 -0.978 . . . . 0.0 111.296 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.23 1.75 16.31 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.127 -0.983 . . . . 0.0 111.091 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.4 ttm180 59.08 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.998 -1.064 . . . . 0.0 109.339 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.418 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 83.4 mt-30 -150.05 139.35 21.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 109.555 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 m -99.13 158.98 15.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.37 -0.831 . . . . 0.0 109.461 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -46.31 -30.21 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.325 -0.86 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.707 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -68.19 -37.53 86.91 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -47.71 -17.06 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.167 . . . . 0.0 109.138 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -85.0 167.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 108.969 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 106' ' ' VAL . 25.0 m -67.26 -20.47 65.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.0 80.48 0.03 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.76 164.68 23.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 109.832 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.8 p90 -154.07 150.45 28.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.129 -0.982 . . . . 0.0 110.024 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 36.2 mt -114.17 155.84 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -141.96 162.82 34.51 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.995 -1.065 . . . . 0.0 109.919 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.7 tt -157.07 118.14 3.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.6 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -130.77 144.56 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.331 -0.856 . . . . 0.0 110.049 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -75.24 101.97 4.85 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.92 -1.71 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 115' ' ' ASN . 22.3 t0 -84.75 -52.18 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.306 -0.871 . . . . 0.0 109.627 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -122.24 -0.48 9.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.65 -0.656 . . . . 0.0 109.988 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 60.67 63.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 21.9 p -118.13 -53.93 2.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.002 -0.436 . . . . 0.0 110.099 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.16 158.55 11.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 109.389 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER 178.31 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 148.01 52.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 109.791 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 41.1 ptt85 -134.82 145.68 48.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.408 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.8 t80 -91.36 147.59 22.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.15 -0.969 . . . . 0.0 109.186 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -86.11 102.99 14.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 109.285 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 66.9 mt -83.07 -40.66 19.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.458 ' H ' HG23 ' A' ' 128' ' ' THR . 5.9 p -48.13 -31.74 6.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.118 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -95.32 -54.62 3.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.823 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 47.1 m-20 -73.47 -3.82 29.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.161 -0.962 . . . . 0.0 110.416 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.707 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.27 -45.15 65.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.997 -1.065 . . . . 0.0 109.125 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.1 m -70.91 3.01 3.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.643 -0.66 . . . . 0.0 109.92 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -84.47 -34.26 23.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 110.17 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.64 -167.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -123.4 -8.05 8.1 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.05 135.52 24.26 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.94 157.65 14.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.014 -1.054 . . . . 0.0 110.048 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -92.6 138.37 31.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -81.51 -41.96 20.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.29 -169.95 20.97 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.406 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.9 tt0 -151.5 161.25 43.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -144.51 136.39 25.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.2 -0.937 . . . . 0.0 108.523 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.2 p90 -144.04 165.87 26.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.188 -0.945 . . . . 0.0 109.685 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.5 ptm180 -84.98 152.52 23.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -155.29 116.47 3.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 2.2 t30 56.25 24.99 8.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 -3.89 86.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 3.4 mp0 -109.64 135.09 51.16 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -69.14 151.64 46.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.192 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.85 129.42 15.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.119 -0.988 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 19.4 t80 -96.72 137.73 35.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.457 -0.777 . . . . 0.0 109.912 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -143.61 107.29 4.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.48 154.56 39.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -143.08 -34.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.264 -0.898 . . . . 0.0 109.322 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.04 85.24 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -132.65 104.23 6.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.663 -0.904 . . . . 0.0 109.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.76 149.71 25.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -140.24 133.44 29.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.468 -1.019 . . . . 0.0 109.117 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.16 7.66 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 0.0 109.439 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -69.6 0.91 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.89 125.39 0.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.21 -28.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.137 . . . . 0.0 109.928 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.75 -31.0 22.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.9 p -75.6 -50.48 15.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.4 m -48.13 -20.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.486 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.4 m -69.97 -58.94 3.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 110.326 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.71 -15.24 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.35 -44.2 92.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.293 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -71.23 -20.01 62.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 149' ' ' TRP . 53.0 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -77.61 148.8 34.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -129.64 -9.88 4.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 9.2 m120 -146.41 129.18 16.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.219 -0.926 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.462 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.9 t -135.88 147.98 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.066 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.7 tt -135.28 109.92 8.59 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.466 ' N ' HD23 ' A' ' 6' ' ' LEU . 15.4 t -86.16 143.87 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.47 117.15 2.18 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.7 tt -115.46 131.82 56.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -145.24 143.46 11.86 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' THR . 19.0 p90 -154.97 153.69 31.43 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.44 -1.035 . . . . 0.0 109.695 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.04 117.51 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -140.9 99.65 3.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.39 -0.819 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.66 130.63 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -91.43 112.54 24.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 109.959 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 128.74 44.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.276 -0.89 . . . . 0.0 108.6 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -149.26 165.73 31.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.102 -0.999 . . . . 0.0 110.171 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 138.69 45.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.3 m-85 -104.45 129.41 52.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.472 -0.768 . . . . 0.0 109.007 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.02 153.42 19.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.377 -0.827 . . . . 0.0 109.949 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.02 135.36 22.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.822 . . . . 0.0 109.415 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.25 176.46 8.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.47 -10.49 59.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.973 . . . . 0.0 109.718 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -84.78 4.81 31.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.18 -19.61 51.21 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.0 mttt -103.71 172.05 7.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -103.03 140.94 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.458 -0.776 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' NH1' ' OD1' ' A' ' 83' ' ' ASP . 34.3 ttp180 -62.06 -3.54 1.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -143.54 101.29 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -45.54 -27.29 0.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 110.47 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.4 -42.34 82.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.912 -1.118 . . . . 0.0 109.623 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.8 t0 46.03 15.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 13.8 t80 -137.77 100.22 4.13 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.653 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 pt -101.55 137.92 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.3 p90 -141.14 -160.08 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 25.7 p90 -42.5 -36.06 1.23 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.607 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 9.1 t30 -49.27 -14.61 0.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.912 -1.118 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.479 ' N ' ' C ' ' A' ' 45' ' ' TYR . 40.7 t30 -153.88 112.85 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.94 -64.63 0.97 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.202 -0.937 . . . . 0.0 109.542 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -89.92 117.77 28.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.478 -0.764 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -57.21 134.77 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.89 75.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.826 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -116.39 -5.96 11.76 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.615 -0.678 . . . . 0.0 109.892 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.42 -19.27 64.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t 62.78 6.57 2.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -1.17 . . . . 0.0 109.238 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -92.97 152.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 108.932 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -143.45 142.13 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.111 -0.993 . . . . 0.0 110.468 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CE1' HD21 ' A' ' 73' ' ' LEU . 4.6 m80 -92.12 121.44 33.67 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 m -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.381 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 109.77 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -79.77 110.77 15.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -1.18 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -86.34 132.6 33.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -78.89 2.8 18.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 40.1 p -153.52 -35.01 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.2 94.69 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 109.557 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.17 -53.05 42.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.22 160.08 14.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 108.998 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 m -157.86 132.32 8.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.077 -1.014 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD21 ' CE1' ' A' ' 57' ' ' HIS . 2.3 mp -117.88 126.4 52.31 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -96.27 122.74 39.45 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 71.2 mt -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.434 -0.791 . . . . 0.0 110.199 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 103.52 4.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.12 -24.33 40.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.909 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.4 -21.99 66.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.67 -9.19 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.953 . . . . 0.0 109.773 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.13 125.06 90.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.98 -160.28 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.909 1.739 . . . . 0.0 111.909 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.26 3.22 75.91 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 16.4 t70 -69.12 -60.1 2.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.304 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 86' ' ' LYS . 7.3 p -91.36 148.75 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.508 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.7 m-20 -133.1 10.48 4.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.343 -0.848 . . . . 0.0 109.831 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' H ' HG22 ' A' ' 84' ' ' VAL . 75.7 tttt -158.14 131.73 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 109.235 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.9 mt -129.36 154.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.515 -0.741 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.03 173.17 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.426 -0.796 . . . . 0.0 109.014 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 6.9 m-85 -142.4 118.4 10.64 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.02 157.71 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.248 -0.907 . . . . 0.0 110.625 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -120.98 148.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -141.81 140.08 32.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -73.92 137.4 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.8 t-80 -94.17 -64.9 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -47.45 -18.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.852 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.94 -18.13 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.0 109.94 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -66.14 -60.44 2.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.889 -1.132 . . . . 0.0 109.484 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -43.6 9.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.364 -0.835 . . . . 0.0 111.151 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -83.88 -18.02 38.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 111.225 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 54.19 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.652 -1.28 . . . . 0.0 109.162 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -148.39 142.28 25.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.25 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -99.63 165.27 11.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.217 -0.927 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CG ' HD22 ' A' ' 127' ' ' LEU . 12.7 m-85 -46.29 -34.19 4.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.285 -0.885 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.685 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.26 -38.49 90.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -49.1 -18.85 0.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.981 -1.305 . . . . 0.0 109.338 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 107' ' ' SER . 23.2 t -82.54 166.22 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 109.161 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.496 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.3 m -70.28 -23.4 62.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.988 . . . . 0.0 109.758 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.35 77.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.2 163.48 23.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -1.176 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 30.6 p90 -154.23 169.88 22.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.5 mt -132.08 156.55 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -143.85 162.12 36.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.5 tt -157.77 118.1 3.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.079 -1.013 . . . . 0.0 109.658 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.91 143.8 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -79.85 102.01 8.87 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.01 -1.49 7.61 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 31.7 t0 -76.76 -52.44 9.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 8.2 m120 -122.48 -14.74 7.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.73 -0.606 . . . . 0.0 109.583 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 15.9 tt0 73.83 71.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -135.9 -45.13 0.65 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.644 -0.66 . . . . 0.0 109.975 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 49.9 mm-40 -65.37 158.44 26.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 108.931 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 173.4 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.79 149.45 52.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.501 -0.75 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.7 ptp180 -135.12 142.9 46.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.618 -0.676 . . . . 0.0 109.461 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -91.32 143.09 27.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.905 . . . . 0.0 108.925 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.16 102.87 14.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.585 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.3 mt -78.7 -41.0 32.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.204 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.9 p -47.78 -29.68 3.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 109.295 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -95.22 -54.68 3.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 109.804 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.93 -0.83 22.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.968 . . . . 0.0 110.275 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.0 -44.62 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 109.275 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 t -72.57 3.01 5.4 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.539 -0.725 . . . . 0.0 109.851 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.1 m -82.32 -34.35 28.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 110.124 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.76 -164.06 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 0.0 109.612 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.06 -14.34 8.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.6 140.12 36.94 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.8 ptm -165.47 158.05 15.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.008 -1.057 . . . . 0.0 109.871 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.19 137.58 35.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -82.87 -41.06 19.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.627 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.93 -170.1 25.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -151.21 164.24 37.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.216 -1.167 . . . . 0.0 109.558 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 139.02 29.04 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.16 166.45 29.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.065 -1.022 . . . . 0.0 109.894 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.508 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -89.19 146.18 24.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 109.506 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -128.23 -115.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 145' ' ' HIS . 88.4 m-20 -72.66 58.71 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.068 -1.02 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.73 8.09 62.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.02 149.47 50.35 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.963 . . . . 0.0 109.315 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.8 m95 -72.8 151.63 41.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.356 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -146.58 129.42 16.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -89.89 149.28 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.405 -0.81 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -155.46 113.52 3.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.195 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.96 154.53 31.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.56 -33.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -0.871 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.91 84.58 0.03 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -136.96 104.28 5.41 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.966 . . . . 0.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.36 152.12 37.38 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -141.95 129.46 21.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.24 9.31 31.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 109.444 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.36 -70.97 0.61 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.83 132.44 1.48 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.33 -33.33 3.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.63 -26.39 26.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 166' ' ' CYS . 12.6 t -74.69 -54.39 7.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.5 m -47.41 -20.71 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.504 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 60.0 m -71.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -15.4 39.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.35 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.28 -43.31 98.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.108 -0.995 . . . . 0.0 110.076 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -71.43 -19.7 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' TRP . 75.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 34.2 mtt -81.69 162.84 22.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -141.45 -33.73 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 13.1 m120 -146.11 128.46 15.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.7 t -128.84 149.0 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 73' ' ' LEU . 12.2 tp -132.63 108.24 8.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 108.985 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.55 150.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.94 117.0 1.25 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -106.05 132.45 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.07 138.41 7.26 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.946 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -156.46 155.19 31.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -75.5 125.53 29.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.263 179.686 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.281 0.562 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.32 104.9 16.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.184 -0.948 . . . . 0.0 109.338 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' ND1' ' A' ' 94' ' ' HIS . 24.4 p-10 -92.87 102.71 15.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 mt -83.4 138.04 33.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 109.15 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.07 106.69 18.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.05 119.05 38.08 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -149.04 168.37 23.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.04 . . . . 0.0 109.804 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.03 138.42 45.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.597 -0.689 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.0 m-85 -104.35 131.83 51.26 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.993 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.62 154.39 19.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.382 -0.823 . . . . 0.0 110.132 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 136.62 24.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.04 176.68 8.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.247 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -79.86 -11.23 59.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -86.55 5.65 34.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.069 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.46 52.16 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.7 mmtm -102.61 172.03 7.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.673 HG21 ' OD1' ' A' ' 41' ' ' ASP . 3.5 t -102.18 143.23 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 109.784 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -62.5 -3.24 1.34 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.82 102.57 0.25 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -45.18 -25.8 0.4 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -1.085 . . . . 0.0 110.751 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.819 -1.175 . . . . 0.0 109.687 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.673 ' OD1' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 48.4 12.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 109.444 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 40' ' ' ALA . 79.3 t80 -135.11 100.25 4.5 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HD11 ' A' ' 29' ' ' LEU . 4.6 pt -103.5 130.52 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.487 ' CZ ' ' OD2' ' A' ' 60' ' ' ASP . 33.4 t80 -170.99 -168.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.985 -1.072 . . . . 0.0 109.179 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.473 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 52.4 m-85 48.46 -113.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 48' ' ' LEU . 23.0 t30 -56.84 -7.65 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -67.49 68.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.945 -1.097 . . . . 0.0 109.648 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 46' ' ' ASN . 13.3 mt -52.98 -30.97 38.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 108.898 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 127.15 0.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.744 . . . . 0.0 109.124 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -55.86 111.9 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.67 -25.4 63.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.08 -16.12 11.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.545 -0.722 . . . . 0.0 109.658 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.53 -20.27 35.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.403 ' OG ' HG22 ' A' ' 80' ' ' VAL . 1.1 m 69.14 2.67 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.451 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.77 146.56 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.229 -0.92 . . . . 0.0 108.663 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -149.12 150.56 32.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.961 -1.087 . . . . 0.0 110.348 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -91.37 136.15 33.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.65 -0.657 . . . . 0.0 109.756 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 p -85.78 -30.35 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.27 104.1 0.24 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' CZ ' ' A' ' 44' ' ' PHE . 12.6 t70 -80.77 110.82 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.636 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -95.36 -167.85 1.69 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -161.47 19.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.8 p -154.29 -42.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.856 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.927 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.87 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -71.93 -69.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.32 156.1 17.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.314 -0.866 . . . . 0.0 109.132 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -159.68 141.33 12.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 17.5 mt -112.19 131.81 55.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.067 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.47 110.16 22.26 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 26.6 mt -97.94 146.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 111.075 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -140.21 84.35 1.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 -5.19 11.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.9 -20.23 49.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.648 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.49 -13.89 21.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.217 -0.927 . . . . 0.0 109.781 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' A' ' 54' ' ' SER . 68.2 t -60.99 124.91 82.23 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 109.269 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.01 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.74 1.627 . . . . 0.0 111.866 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.56 1.86 79.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -71.41 -60.52 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.544 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 t -87.12 133.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 32' ' ' ALA . 16.6 m-20 -113.32 4.43 16.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.697 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -156.36 137.86 14.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.528 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 87' ' ' ILE . 10.4 mt -145.44 107.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -109.18 171.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 4.7 m-85 -129.84 134.4 47.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.1 158.16 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -131.28 134.75 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -138.04 164.62 28.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.8 mm -77.64 142.01 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 22' ' ' ASP . 20.6 t-160 -98.1 -68.35 0.81 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -51.33 -18.11 0.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.104 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -48.94 -42.93 38.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 109.772 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.19 -30.07 48.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.918 -1.114 . . . . 0.0 109.753 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -90.73 -54.01 4.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 111.297 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HE ' ' CB ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -112.52 -0.31 15.27 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.256 -0.903 . . . . 0.0 111.1 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 96' ' ' ALA . 43.1 ttt85 57.08 103.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.949 -1.095 . . . . 0.0 108.991 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -137.38 134.04 35.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.277 -0.889 . . . . 0.0 109.708 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -90.64 152.77 20.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -46.76 -30.89 2.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.197 -0.94 . . . . 0.0 109.583 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -57.96 -40.31 93.09 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -48.17 -17.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.241 . . . . 0.0 109.359 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.2 t -82.78 163.97 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 108.949 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 m -72.13 -25.55 61.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.14 78.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.11 164.71 25.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -1.109 . . . . 0.0 109.145 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 22.7 p90 -154.4 143.82 21.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.92 -1.113 . . . . 0.0 110.477 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 43.1 mt -108.43 154.16 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' NH2' HG12 ' A' ' 122' ' ' VAL . 52.0 ttt85 -139.94 160.8 39.1 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.999 -1.063 . . . . 0.0 109.731 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.9 tt -155.11 116.69 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.529 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.591 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -128.46 144.51 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 109.755 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 119' ' ' GLN . 53.8 t30 -76.37 102.12 5.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.22 -1.87 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.383 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 18.2 t70 -81.66 -53.23 6.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.22 4.22 9.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.771 -0.58 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 115' ' ' ASN . 20.0 tp60 59.5 60.41 2.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 53.9 m -113.46 -68.64 0.91 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.951 -0.468 . . . . 0.0 110.299 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.861 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.8 mm-40 -45.2 157.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 110.029 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -179.28 73.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.85 151.55 52.0 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.3 ptp180 -139.21 142.48 37.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -91.4 147.77 22.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.167 -0.958 . . . . 0.0 109.314 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -85.96 106.19 16.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -80.33 -46.78 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.5 m -47.83 -27.96 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.264 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -91.81 -54.57 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.59 0.84 9.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.96 -47.18 81.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 p -73.26 3.09 6.19 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.502 -0.749 . . . . 0.0 109.976 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.2 m -87.96 -34.61 18.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 0.0 110.478 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -175.65 -163.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.789 -1.194 . . . . 0.0 109.857 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.5 p -125.58 -8.73 6.82 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.14 27.81 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.5 ptm -165.46 157.9 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.04 -1.037 . . . . 0.0 109.951 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -96.76 137.29 36.07 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 109.436 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.0 t80 -79.69 -42.12 25.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.077 -1.015 . . . . 0.0 109.958 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.57 -166.29 15.48 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.532 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 10.1 tt0 -150.82 160.66 43.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -1.012 . . . . 0.0 109.292 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.422 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.0 mt -142.81 137.52 29.73 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.44 165.75 29.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -95.6 144.41 26.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.465 -0.772 . . . . 0.0 109.687 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 20.0 t-80 -125.49 -117.16 0.28 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.62 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 53.0 t30 -72.54 58.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.968 . . . . 0.0 109.407 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.31 10.49 66.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -127.74 141.46 51.59 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.933 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.0 m95 -71.37 152.03 43.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -148.52 131.39 16.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.561 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.1 t80 -89.7 149.64 22.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.509 -0.744 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 21.6 tpt85 -154.39 107.26 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 109.025 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.508 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -63.75 154.75 32.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.42 -33.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.435 -0.791 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.24 82.14 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -135.74 104.37 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.588 -0.948 . . . . 0.0 109.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.47 151.34 36.13 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -145.78 133.77 21.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.358 -1.084 . . . . 0.0 109.213 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.28 11.65 29.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.98 -27.47 6.68 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 83.6 139.5 3.86 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.63 -12.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -1.132 . . . . 0.0 109.719 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.664 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -77.81 -57.59 3.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 109.515 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 m -80.72 -41.83 22.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.01 -21.32 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -73.97 -60.37 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.616 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -26.42 23.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.195 -0.94 . . . . 0.0 110.443 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 169' ' ' TYR . 1.3 tm0? -51.32 -35.34 37.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 109.813 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 24.6 m-85 -85.73 13.26 7.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.504 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -80.24 115.88 20.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.89 -23.15 18.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -146.31 152.33 38.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.301 -0.874 . . . . 0.0 109.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 t -146.16 158.52 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.8 tp -147.69 107.65 4.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.851 . . . . 0.0 109.022 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.11 150.77 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.92 116.93 1.39 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -110.88 126.83 55.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -142.21 145.48 15.73 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -158.49 151.24 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 110.031 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -91.2 128.23 36.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 109.712 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.18 31.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -79.65 106.96 12.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 p -84.91 124.62 31.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -155.93 -39.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.265 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.51 25.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.0 109.073 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.65 6.69 63.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -77.54 163.99 25.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -170.31 146.82 2.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 150.12 20.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.95 104.48 4.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.912 . . . . 0.0 109.64 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.36 151.38 25.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 108.783 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.36 106.56 17.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 109.879 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.5 125.68 45.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 108.757 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 5.7 t -149.43 167.62 25.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.941 -1.099 . . . . 0.0 109.913 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.38 136.53 49.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -104.02 127.96 51.58 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.77 142.0 30.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.373 -0.83 . . . . 0.0 109.998 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.57 131.62 20.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -0.935 . . . . 0.0 109.835 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.36 175.11 10.06 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.12 1.56 43.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.289 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -83.09 -9.84 59.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 109.504 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.7 -5.05 69.52 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -109.71 150.37 28.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.9 m -65.97 136.53 26.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -71.02 5.35 2.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ALA . . . -158.77 118.59 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -47.68 -10.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -1.113 . . . . 0.0 110.338 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLY . . . -95.7 -40.21 9.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.5 t0 47.57 14.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 109.294 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 62.6 t80 -137.2 100.39 4.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 109.654 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.9 pt -103.48 139.57 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.558 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.2 p90 -153.22 -153.98 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -0.879 . . . . 0.0 109.686 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.0 OUTLIER -43.43 -36.24 1.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.064 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.45 -1.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 108.946 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.3 t30 -149.57 103.97 3.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.137 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.21 -28.57 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttm -165.18 160.12 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 t -69.86 147.92 49.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.264 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.81 -48.52 14.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -116.2 1.64 13.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.661 -0.649 . . . . 0.0 109.587 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 -12.71 69.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 60.78 11.99 3.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.36 -1.082 . . . . 0.0 109.42 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.07 150.27 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.249 -0.907 . . . . 0.0 108.93 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.9 m -148.77 138.08 21.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.12 -0.987 . . . . 0.0 110.0 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.43 ' NE2' HD11 ' A' ' 73' ' ' LEU . 31.9 m80 -90.06 127.91 36.17 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -67.12 -56.91 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.57 111.11 0.47 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.4 110.88 12.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -81.92 -164.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -156.15 16.48 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -154.64 -37.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 109.325 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 16.43 79.41 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -58.47 111.14 1.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.21 -145.19 10.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -160.01 57.56 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -1.142 . . . . 0.0 109.391 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.12 -176.3 48.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.63 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -1.169 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -73.28 -63.86 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.22 171.68 9.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.4 132.26 6.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.326 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -116.37 119.41 35.59 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -95.69 135.88 36.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 108.736 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.51 146.93 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 110.358 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.28 87.62 2.35 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 79' ' ' ALA . 21.9 mt -67.94 -34.52 76.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.869 . . . . 0.0 109.751 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -55.28 -5.71 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.582 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -119.27 20.65 12.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' PRO . 48.0 t -105.41 104.98 50.6 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.327 -0.858 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.25 -171.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.055 1.837 . . . . 0.0 112.353 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 1.08 89.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.02 -55.95 15.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -1.105 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 83.5 t -84.39 148.59 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 0.0 108.977 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 45.3 m-20 -136.61 -5.27 2.0 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.359 -0.838 . . . . 0.0 110.136 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -145.25 131.17 19.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.949 -1.094 . . . . 0.0 109.423 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -141.49 108.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 141' ' ' GLU . 10.8 pt -116.23 154.86 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 109.627 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -96.45 159.1 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 109.202 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 28' ' ' PHE . 60.3 t -147.23 152.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.746 0.784 . . . . 0.0 110.651 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.6 t -148.01 115.84 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 p -132.85 174.45 10.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.54 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 6.0 mm -86.53 143.25 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -100.4 -68.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.327 -0.858 . . . . 0.0 110.044 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -18.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.248 -0.908 . . . . 0.0 110.06 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.54 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -46.43 -26.96 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -53.98 -50.41 66.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 109.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.12 -39.48 12.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.42 -0.8 . . . . 0.0 110.984 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -96.99 -19.49 18.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.057 -1.027 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.6 mmt180 50.94 58.2 5.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.637 -1.289 . . . . 0.0 109.169 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.37 148.45 25.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.3 p -98.15 159.39 14.97 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.743 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -45.88 -33.94 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.658 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.16 -36.84 90.42 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -47.53 -19.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -1.21 . . . . 0.0 109.328 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 107' ' ' SER . 18.6 t -85.93 168.12 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.131 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -69.3 -23.91 63.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.21 79.98 0.03 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.75 25.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 109.817 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.8 p90 -153.33 143.51 22.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.099 -1.0 . . . . 0.0 110.257 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.8 mt -107.02 154.7 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.39 159.83 41.24 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.7 tt -154.23 116.54 4.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.097 -1.002 . . . . 0.0 109.482 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.572 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.0 p -129.65 143.3 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.436 ' HB2' ' H ' ' A' ' 120' ' ' THR . 78.8 m-20 -75.33 102.12 4.98 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -64.73 -1.85 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.561 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.1 -53.7 5.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 109.72 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.71 6.55 8.8 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.67 -0.644 . . . . 0.0 109.724 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 59.03 59.7 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 12.5 m -111.21 -69.91 0.84 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.866 -0.521 . . . . 0.0 110.309 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 51.0 mm-40 -45.26 157.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.0 109.893 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.58 72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.0 152.22 51.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.067 -1.021 . . . . 0.0 109.992 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 30.3 ptt180 -140.79 144.36 35.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -91.32 147.63 22.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 103.39 16.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.3 mt -80.44 -40.7 25.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.298 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.85 -29.58 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -95.26 -54.66 3.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.434 -0.791 . . . . 0.0 109.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.11 -1.35 25.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.85 -44.71 66.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.294 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -72.7 3.09 5.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.56 -0.713 . . . . 0.0 109.984 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.4 m -83.02 -34.39 26.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 0.0 110.283 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.75 -164.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.952 -1.093 . . . . 0.0 109.729 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 102' ' ' SER . 1.1 p -124.81 -5.71 7.46 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.76 135.31 23.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.36 150.67 9.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.8 pp -91.55 136.0 33.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.79 -49.4 46.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 109.938 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -153.35 -155.56 7.21 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.293 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 88' ' ' ILE . 14.7 tt0 -150.64 157.73 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -1.024 . . . . 0.0 109.347 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.74 135.74 28.23 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -150.82 166.8 29.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.931 -1.106 . . . . 0.0 110.275 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 11.5 ptm180 -86.95 147.07 25.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.779 . . . . 0.0 109.503 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.5 OUTLIER -129.54 -114.88 0.25 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.693 . . . . 0.0 109.259 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.537 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.2 m120 -72.67 58.42 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.963 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.44 7.25 63.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -127.92 154.18 45.84 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.668 -0.901 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -75.74 151.49 37.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -145.35 127.83 16.0 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -89.99 148.25 23.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -157.32 107.37 2.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.78 153.72 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.04 -32.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.78 85.92 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -139.14 104.48 5.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.559 -0.965 . . . . 0.0 109.548 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.0 154.79 35.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -150.08 124.17 9.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.404 -1.056 . . . . 0.0 109.123 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.69 15.09 6.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.32 -0.862 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.06 -76.56 0.15 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.21 126.18 0.82 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.481 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.01 -29.21 1.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -1.126 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.97 -32.6 21.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 166' ' ' CYS . 19.9 m -80.28 -50.35 10.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.73 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 m -45.76 -19.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.341 -0.849 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 78.0 m -70.94 -62.0 1.55 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.25 -15.38 38.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.108 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.68 -34.99 71.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.003 -1.06 . . . . 0.0 110.365 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -70.75 -19.59 62.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.153 . . . . 0.0 109.206 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -92.49 -47.94 3.12 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.88 94.47 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -78.11 116.24 18.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.39 110.25 15.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.459 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.286 0.565 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.6 mtt -80.91 -173.67 4.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -153.15 -34.67 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.502 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 46.1 t-20 -140.57 139.39 34.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.0 109.279 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' CG1' HD21 ' A' ' 113' ' ' LEU . 3.8 t -144.46 130.64 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.21 109.76 17.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.71 144.73 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.145 -0.972 . . . . 0.0 108.727 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -129.98 129.94 6.11 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tt -134.87 126.81 29.49 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -144.01 151.11 23.12 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 27.5 p90 -155.73 154.7 31.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.367 -1.079 . . . . 0.0 109.738 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.8 99.62 11.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 165.96 24.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -132.88 106.85 7.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.442 -0.786 . . . . 0.0 109.217 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -86.96 105.61 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 p -88.16 -61.74 1.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 109.179 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -158.12 17.74 0.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 109.476 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.73 -26.55 0.94 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -82.31 142.65 31.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 109.601 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -157.71 153.66 26.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 109.353 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.28 134.43 39.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -141.11 100.06 3.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.0 109.712 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 136.48 34.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.888 . . . . 0.0 108.633 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.66 110.58 22.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.186 -0.947 . . . . 0.0 110.005 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 128.83 44.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.252 -0.905 . . . . 0.0 108.859 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 57' ' ' HIS . 58.5 m -150.25 167.8 25.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.046 -1.034 . . . . 0.0 110.37 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 136.62 48.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.8 m-85 -103.48 145.34 30.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -116.9 153.83 31.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.75 143.31 36.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -81.4 176.59 9.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.43 -13.24 52.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -0.906 . . . . 0.0 109.86 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -84.42 7.95 17.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 109.867 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 -14.8 61.88 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 37.6 mmtm -102.81 176.18 5.24 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 38' ' ' GLY . 21.4 t -101.11 137.07 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -62.76 1.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -151.04 124.38 1.69 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.51 3.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.156 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -97.78 -41.97 7.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.04 -1.037 . . . . 0.0 109.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 10.6 t0 46.92 14.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 109.442 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 14.0 t80 -136.9 99.07 3.92 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 0.0 109.368 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 pt -101.97 133.17 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.437 -0.79 . . . . 0.0 108.942 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.7 p90 -142.14 -161.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.259 -0.9 . . . . 0.0 109.278 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 21.7 p90 -44.65 -27.51 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.224 -0.923 . . . . 0.0 110.372 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.4 t30 -57.93 -8.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.999 -1.063 . . . . 0.0 108.96 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 45.0 t-20 -139.06 109.42 6.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.798 . . . . 0.0 108.966 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -47.37 -31.51 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.89 . . . . 0.0 109.183 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.8 pttt -168.52 155.01 7.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.442 -0.786 . . . . 0.0 109.39 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 33.3 t -60.82 147.88 41.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.38 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.36 -47.88 16.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -116.16 0.91 13.07 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.736 -0.602 . . . . 0.0 109.516 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.66 -12.01 65.1 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t 58.44 14.92 3.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.232 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.4 t -92.97 151.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.404 ' O ' HD23 ' A' ' 73' ' ' LEU . 76.1 m -148.84 134.62 18.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.0 109.811 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 73' ' ' LEU . 23.0 m80 -90.57 139.57 30.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.393 -0.817 . . . . 0.0 109.072 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 m -76.84 -55.55 5.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.44 117.28 0.66 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.91 113.62 18.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -1.148 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 132.95 35.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -81.75 7.97 11.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.69 -35.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.17 16.16 57.44 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.5 110.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -1.124 . . . . 0.0 109.344 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.21 156.78 7.22 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.6 p30 -85.14 -171.97 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.14 -175.44 19.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.4 111.36 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -1.149 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.55 -63.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -87.92 159.29 18.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.6 m -152.51 132.4 13.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.214 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -117.15 123.95 47.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -95.87 136.19 36.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.275 -0.89 . . . . 0.0 108.853 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 89' ' ' PHE . 87.4 mt -133.39 146.99 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.086 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.25 90.36 2.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 79' ' ' ALA . 13.8 mt -72.41 -25.27 61.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -66.4 4.74 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -137.08 24.91 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 81' ' ' PRO . 38.1 t -103.93 105.54 48.8 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.451 -0.78 . . . . 0.0 109.198 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . 73.2 Cg_exo -48.06 -175.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.026 1.817 . . . . 0.0 112.335 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.84 85.92 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.27 -50.81 72.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -1.204 . . . . 0.0 109.243 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 84' ' ' VAL . 5.2 m -95.55 139.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 109.076 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' A' ' 32' ' ' ALA . 3.4 m-20 -116.86 2.41 12.82 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.57 -0.706 . . . . 0.0 109.819 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -158.14 132.68 8.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.041 . . . . 0.0 109.777 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.7 mt -141.17 117.79 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.2 157.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 75' ' ' ILE . 4.6 m-85 -105.9 137.41 43.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 1.2 p -147.01 157.46 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.521 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 3.5 p -129.26 147.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 p -140.15 140.71 36.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -73.82 132.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.826 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 96' ' ' ALA . 30.8 t-80 -89.95 -63.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.22 -18.22 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.92 -18.26 43.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.734 -1.229 . . . . 0.0 109.412 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.46 -44.42 9.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 0.0 111.047 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -81.72 -17.79 46.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.05 -1.031 . . . . 0.0 111.402 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 52.34 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.854 -1.154 . . . . 0.0 109.077 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -148.13 143.5 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.328 -0.857 . . . . 0.0 109.132 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -99.85 165.38 11.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.284 -0.885 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -46.22 -32.22 2.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.321 -0.862 . . . . 0.0 109.785 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -38.69 96.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -49.87 -17.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.3 . . . . 0.0 109.296 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 107' ' ' SER . 15.9 t -84.92 163.82 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 109.127 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -62.08 -26.79 68.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.597 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.1 79.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 164.37 25.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -1.146 . . . . 0.0 109.74 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 37.0 p90 -151.29 170.02 20.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.301 -0.875 . . . . 0.0 110.018 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 24.7 mt -132.66 154.93 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 72.6 ttt180 -143.38 162.48 35.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.968 -1.083 . . . . 0.0 109.718 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.3 tt -157.67 117.97 3.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 0.0 109.771 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.609 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.1 p -132.03 142.81 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.359 -0.838 . . . . 0.0 109.586 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.84 102.27 8.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.502 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.5 t70 -68.03 -1.78 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.5 -52.12 10.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 50.6 t30 -122.02 -14.12 8.07 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.677 -0.639 . . . . 0.0 109.608 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 20.4 tt0 71.67 69.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.6 m -134.39 -43.71 0.77 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.722 -0.611 . . . . 0.0 109.807 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.876 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.7 mp0 -65.79 158.25 28.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 108.781 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 174.21 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.92 51.73 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.751 . . . . 0.0 109.201 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.0 ptt180 -134.08 142.07 47.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.607 -0.683 . . . . 0.0 109.474 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.8 t80 -91.43 147.35 23.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.371 -0.831 . . . . 0.0 108.916 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.77 102.83 15.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 109.394 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 50.5 mt -79.65 -39.19 31.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.6 p -47.56 -30.51 3.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.018 -1.051 . . . . 0.0 109.286 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -95.23 -54.59 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -0.825 . . . . 0.0 109.75 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 53.9 m-20 -74.77 -0.73 19.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.7 -46.5 74.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.085 -1.01 . . . . 0.0 109.321 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.2 t -69.23 2.99 2.42 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.548 -0.72 . . . . 0.0 109.882 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 m -82.96 -34.57 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.9 -162.91 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.001 -1.062 . . . . 0.0 109.582 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -15.25 7.56 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.35 137.37 35.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.6 ttp -164.89 152.05 11.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.872 -1.142 . . . . 0.0 110.144 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.596 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.7 pt? -87.96 135.43 33.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -77.81 -26.4 49.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.922 -1.111 . . . . 0.0 109.304 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.69 -164.23 21.91 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -150.53 154.22 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.988 . . . . 0.0 108.74 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 134.81 24.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.038 -1.039 . . . . 0.0 108.86 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -147.47 166.01 28.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 109.717 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.57 148.48 24.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -152.3 123.73 7.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER 55.72 24.8 7.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.18 80.05 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -127.82 137.48 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -1.015 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -67.69 151.19 47.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -148.61 121.98 9.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.148 -0.97 . . . . 0.0 109.726 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 17.6 t80 -89.94 143.77 26.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.497 -0.752 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.32 107.43 3.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 109.026 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.36 154.79 10.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.776 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -139.42 -34.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.373 -0.829 . . . . 0.0 109.05 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.41 81.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.551 ' H ' HD21 ' A' ' 138' ' ' LEU . 34.7 tt0 -141.35 104.14 4.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.057 . . . . 0.0 109.041 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.0 150.5 27.73 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.7 137.77 38.69 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.606 -0.937 . . . . 0.0 108.782 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.51 13.86 24.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.217 -0.927 . . . . 0.0 109.519 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.88 -68.35 1.34 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.06 131.59 1.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.7 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.23 -30.27 1.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -1.116 . . . . 0.0 109.87 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.7 -25.18 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' GLY . 53.6 p -77.34 -55.4 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.471 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.6 m -46.97 -20.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 80.0 m -71.47 -60.91 1.98 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.03 -19.64 28.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.28 -0.888 . . . . 0.0 110.141 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -55.21 -42.19 73.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 109.726 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -71.47 -19.86 62.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.355 -0.841 . . . . 0.0 109.178 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.31 -53.71 3.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.08 90.34 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -1.154 . . . . 0.0 109.281 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.24 106.12 8.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 109.455 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 10.02 5.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.51 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 149' ' ' TRP . 73.2 m . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -74.19 -169.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -153.9 -34.58 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 31.4 t30 -143.63 128.22 18.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 109.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.413 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.6 t -124.64 158.54 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.626 -0.671 . . . . 0.0 109.479 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.21 112.95 6.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -89.94 150.55 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 108.981 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.35 116.76 1.34 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.61 135.46 42.02 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.92 138.07 8.09 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -160.33 153.7 22.08 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.4 111.24 23.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.548 -0.72 . . . . 0.0 109.347 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.07 43.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.33 106.81 17.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 p -93.9 128.96 40.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -156.2 -76.19 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 108.855 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.8 21.5 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.04 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.19 0.67 80.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -84.85 178.37 7.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.14 165.44 2.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 68.4 m-85 -96.31 150.9 20.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.07 99.67 3.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.865 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.63 132.78 35.56 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -95.85 111.06 23.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.096 -1.002 . . . . 0.0 110.092 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.36 125.34 43.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.414 -0.804 . . . . 0.0 108.893 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -149.81 167.77 25.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.844 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.0 142.25 41.66 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.5 m-85 -103.9 148.28 26.35 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -120.18 154.11 35.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.568 -0.708 . . . . 0.0 109.987 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 139.54 27.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.102 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.86 176.42 7.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.097 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.38 -9.44 58.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.179 -0.95 . . . . 0.0 109.763 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.39 8.29 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.136 -0.977 . . . . 0.0 109.919 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.18 70.1 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 66.7 mmtt -104.18 170.1 8.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.8 t -98.42 137.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.12 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.3 ttt-85 -64.69 1.94 0.76 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.93 125.21 1.7 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 4.42 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -1.148 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.59 -41.5 8.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.97 -1.081 . . . . 0.0 110.028 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 12.2 t0 47.72 13.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.857 -1.152 . . . . 0.0 109.43 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 72.4 t80 -136.89 99.39 4.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -0.8 . . . . 0.0 109.642 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.3 pt -99.7 139.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.6 p90 -154.22 -155.93 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 109.596 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 3.8 m-85 -43.54 -34.29 1.35 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.544 -0.723 . . . . 0.0 110.138 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -58.28 -2.16 0.17 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.096 -1.002 . . . . 0.0 108.827 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 43.5 t-20 -148.72 113.76 5.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 109.27 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -50.64 -38.49 46.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 108.945 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 36.0 pttt -161.87 157.67 24.31 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.372 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 t -63.21 144.57 56.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -47.12 17.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -116.31 2.02 13.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.715 -0.615 . . . . 0.0 109.67 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.7 -17.97 57.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 2.9 p 67.22 7.97 5.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -93.11 149.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 m -148.86 138.98 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.227 -0.92 . . . . 0.0 109.496 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 44.1 m80 -89.88 139.83 30.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -142.61 40.57 1.56 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 109.343 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.38 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.2 124.28 34.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -1.058 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.7 m120 -153.53 93.03 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -73.88 14.52 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 61' ' ' ASN . 52.6 p -147.59 -35.29 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.887 . . . . 0.0 109.303 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.45 13.25 29.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.46 110.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -1.113 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.07 -126.35 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -159.29 170.57 21.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.48 172.29 2.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.73 122.01 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -82.01 -70.43 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.33 177.0 7.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.2 m -159.98 132.44 6.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -119.44 125.15 48.26 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -95.9 139.35 32.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 108.837 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.506 HD13 ' CE1' ' A' ' 89' ' ' PHE . 69.3 mt -132.22 146.61 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.5 mttm -141.22 101.32 3.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.68 -5.41 53.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.13 -20.46 32.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.569 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.74 7.99 43.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.15 123.95 84.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.203 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.923 1.749 . . . . 0.0 112.054 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.82 2.24 76.1 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -69.94 -60.63 2.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -1.199 . . . . 0.0 109.219 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.97 148.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.003 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.7 15.99 3.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.245 -0.909 . . . . 0.0 109.693 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' NZ ' ' OE2' ' A' ' 141' ' ' GLU . 50.6 tttp -158.37 135.21 9.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.589 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.2 mt -133.65 154.14 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.93 173.47 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 108.913 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.7 m-85 -142.1 123.38 14.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.71 157.9 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 110.352 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -131.24 115.53 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -107.11 153.24 22.93 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.39 -0.819 . . . . 0.0 110.242 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.7 mm -73.84 167.41 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.625 ' N ' HG22 ' A' ' 93' ' ' ILE . 46.7 t-80 -133.69 -60.81 0.82 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.385 -0.822 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -49.28 -18.27 0.34 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.972 . . . . 0.0 109.586 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.74 -40.02 90.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.81 -32.6 44.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.776 -1.202 . . . . 0.0 109.698 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.91 -54.03 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.124 -0.985 . . . . 0.0 111.352 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.49 4.09 17.21 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.294 -0.879 . . . . 0.0 111.16 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' ALA . 51.7 ttt180 57.56 106.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 109.301 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.44 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 34.7 mt-30 -151.34 145.34 25.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 109.671 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.8 p -104.95 163.59 12.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.447 -0.783 . . . . 0.0 109.55 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -46.15 -36.38 5.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 109.859 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.655 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.92 -41.43 96.23 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 57.8 mm-40 -49.43 -14.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.28 . . . . 0.0 109.267 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 107' ' ' SER . 21.9 t -83.59 165.4 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.049 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 t -69.0 -20.15 64.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.11 79.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.37 163.46 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.129 . . . . 0.0 109.821 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 18.3 p90 -157.85 158.75 35.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.8 mt -118.88 157.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -138.11 159.35 42.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.059 -1.026 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.9 tt -152.9 115.31 4.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.573 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.86 142.11 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.395 -0.816 . . . . 0.0 109.857 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLN . 57.9 t30 -79.49 101.82 8.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.53 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.7 t70 -69.34 -4.89 20.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.728 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 13.7 t0 -70.91 -53.2 15.89 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.813 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -123.38 0.78 8.95 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 115' ' ' ASN . 26.1 tt0 62.93 64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.4 m -118.06 -69.9 0.82 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.924 -0.485 . . . . 0.0 110.304 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.854 ' O ' HG13 ' A' ' 122' ' ' VAL . 14.9 mm-40 -45.29 157.04 0.09 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.311 -0.868 . . . . 0.0 109.876 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.84 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.19 154.47 50.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.012 -1.055 . . . . 0.0 110.025 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.2 ptm180 -139.32 149.24 43.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 109.193 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.05 147.32 22.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.188 -0.945 . . . . 0.0 109.135 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.4 103.13 15.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 0.0 109.399 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 64.3 mt -80.94 -40.49 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 128' ' ' THR . 4.1 p -47.84 -31.06 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 109.189 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -95.2 -54.62 3.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -0.783 . . . . 0.0 109.753 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.96 -4.76 34.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.655 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.77 -45.95 67.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.132 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.5 p -69.14 3.01 2.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.647 -0.658 . . . . 0.0 109.845 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 m -83.18 -34.58 25.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 0.0 110.2 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 179.52 -163.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.93 -1.106 . . . . 0.0 109.592 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 -9.74 9.57 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.71 139.53 34.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.46 157.6 15.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.176 -0.953 . . . . 0.0 109.512 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.36 138.41 37.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 109.718 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 29.2 t80 -81.06 -43.98 18.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 109.611 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.82 -168.69 20.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.514 ' OE2' ' NZ ' ' A' ' 86' ' ' LYS . 29.2 tt0 -151.32 163.53 38.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -1.1 . . . . 0.0 109.408 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.92 140.73 29.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 0.0 108.661 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.45 ' OH ' ' CZ ' ' A' ' 152' ' ' ARG . 4.7 p90 -150.59 166.02 31.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.116 -0.99 . . . . 0.0 109.703 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -85.3 151.48 24.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.563 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -157.72 123.95 4.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 55.97 24.15 7.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.366 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.12 10.55 83.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -127.8 138.98 52.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.598 -0.943 . . . . 0.0 109.339 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 1' ' ' SER . 83.5 m95 -67.67 151.6 47.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.519 ' NZ ' HH21 ' A' ' 152' ' ' ARG . 80.3 tttt -150.72 123.2 8.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -89.47 138.87 31.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.519 HH21 ' NZ ' ' A' ' 150' ' ' LYS . 86.0 mtt180 -143.67 107.35 4.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.26 154.68 39.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -139.8 -33.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.78 86.15 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -137.95 104.76 5.35 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.982 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 152.94 39.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' CE1' HG11 ' A' ' 165' ' ' VAL . 2.0 p90 -147.45 125.27 11.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -1.178 . . . . 0.0 109.33 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.36 11.7 25.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -65.75 2.23 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.37 126.99 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.77 -33.03 4.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 109.82 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.65 -26.03 26.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.335 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.9 t -74.37 -54.31 7.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.5 m -47.94 -20.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 109.438 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.9 m -71.44 -60.65 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.142 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -15.46 38.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.188 -0.945 . . . . 0.0 110.393 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.64 -44.23 87.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.941 -1.099 . . . . 0.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -71.49 -0.2 9.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -149.41 34.09 1.08 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 tt -75.17 159.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.47 127.88 33.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 74.27 7.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.482 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.6 p . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.484 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.99 174.81 11.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -153.23 -34.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -145.94 143.49 29.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.093 -1.004 . . . . 0.0 109.464 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -145.94 133.09 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.381 -0.824 . . . . 0.0 109.226 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 73' ' ' LEU . 13.8 tp -116.79 109.78 17.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.88 151.0 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.04 117.08 1.33 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -108.12 133.24 52.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.9 140.71 8.61 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -158.04 152.96 25.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -1.112 . . . . 0.0 109.984 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.72 130.55 39.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.0 109.597 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.29 133.88 35.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.314 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -79.12 106.85 11.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -90.34 127.57 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -156.24 -36.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.07 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -149.85 22.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 108.977 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.93 2.76 62.46 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -80.63 151.81 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -1.144 . . . . 0.0 109.384 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -157.45 151.65 24.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.14 151.17 19.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.325 -0.859 . . . . 0.0 109.282 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -141.02 99.77 3.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.285 -0.884 . . . . 0.0 109.676 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.28 142.64 30.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 108.625 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.52 112.71 25.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.376 -0.827 . . . . 0.0 109.563 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 130.12 44.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.1 m -149.58 163.06 38.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.089 -1.007 . . . . 0.0 109.937 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 146.08 36.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.5 m-85 -104.24 161.55 13.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.894 . . . . 0.0 109.415 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -129.06 139.16 52.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.661 -0.65 . . . . 0.0 109.478 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 133.46 22.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.05 176.41 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -81.21 -8.94 59.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.27 1.6 40.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.157 -0.965 . . . . 0.0 109.736 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.17 58.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -98.29 144.57 27.56 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 38' ' ' GLY . 22.4 t -66.39 136.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.067 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.02 13.44 0.68 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -159.89 173.15 36.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -94.52 -1.74 52.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.052 -1.264 . . . . 0.0 110.289 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.08 -42.08 5.89 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.196 -0.94 . . . . 0.0 110.059 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 26.9 t0 61.47 -1.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 110.094 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.59 124.31 19.74 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.166 -0.959 . . . . 0.0 110.009 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 pt -102.58 139.57 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.62 ' CE1' ' CZ ' ' A' ' 42' ' ' PHE . 1.3 p90 -138.11 -161.67 1.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 22.8 p90 -44.23 -30.49 0.8 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.162 -0.961 . . . . 0.0 110.437 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 16.7 t-20 -51.1 -16.95 0.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 109.081 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.5 t-20 -135.03 104.06 5.8 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.525 -0.735 . . . . 0.0 109.071 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.98 -24.69 1.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.6 pttt -167.45 155.07 8.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.1 t -77.23 122.46 25.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.06 62.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.962 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -112.91 -19.0 12.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.57 -13.55 75.62 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.5 p 62.85 10.27 4.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -1.118 . . . . 0.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' A' ' 50' ' ' SER . 43.2 t -92.79 151.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -148.72 142.49 25.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.154 -0.966 . . . . 0.0 110.046 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -91.83 126.41 36.9 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 25.5 m -74.48 -29.54 61.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.38 110.82 0.25 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.86 110.98 18.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -81.67 -163.56 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' THR . 28.6 ttm180 -152.16 14.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 109.268 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 62' ' ' ARG . 34.4 p -154.87 -37.73 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 4.1 65.79 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.57 110.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.421 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.15 -125.63 1.57 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -165.48 160.6 18.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.05 177.59 47.91 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.99 101.97 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -1.155 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -55.25 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -89.27 167.5 13.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.346 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.418 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.5 p -160.48 132.86 6.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.6 mp -113.18 128.29 56.44 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.504 -0.747 . . . . 0.0 109.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HZ1' ' HE2' ' A' ' 76' ' ' LYS . 1.8 tmtp? -96.36 110.51 22.83 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.93 146.88 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.596 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HE2' ' HZ1' ' A' ' 74' ' ' LYS . 86.3 mttt -136.49 94.42 3.01 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.52 -11.57 59.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.93 . . . . 0.0 109.616 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.41 4.7 23.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.35 10.73 7.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.449 -0.782 . . . . 0.0 109.322 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.4 t -81.3 125.77 78.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.022 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.14 -162.23 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.841 1.694 . . . . 0.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.38 -0.12 82.75 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.86 -60.69 2.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -1.172 . . . . 0.0 109.44 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.6 t -89.93 148.65 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 41.3 m-20 -139.35 1.96 2.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 109.659 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -150.92 131.48 13.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.186 -0.946 . . . . 0.0 109.006 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.99 154.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.503 -0.748 . . . . 0.0 109.31 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -139.86 173.93 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 17.1 m-85 -141.55 122.06 14.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.63 157.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.4 p -134.14 114.31 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -107.82 151.95 25.05 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.331 -0.855 . . . . 0.0 109.924 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.36 140.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 108.799 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -62.34 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.076 -1.015 . . . . 0.0 109.877 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -47.6 -20.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 109.569 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.6 -18.28 28.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 109.777 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -64.75 -60.79 2.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.687 -1.258 . . . . 0.0 109.255 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.44 11.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 111.024 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -86.16 -19.58 29.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.944 -1.097 . . . . 0.0 111.379 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 55.33 96.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.759 -1.213 . . . . 0.0 109.275 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -158.74 152.54 23.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.491 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 m -105.15 154.65 19.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.457 -0.777 . . . . 0.0 109.241 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.6 -29.89 0.81 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.429 -0.794 . . . . 0.0 109.727 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.67 -37.39 50.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -58.96 -14.18 8.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 109.345 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 107' ' ' SER . 27.9 t -80.32 165.81 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.131 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.506 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.7 t -68.15 -25.89 65.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.94 . . . . 0.0 109.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.12 79.89 0.03 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.45 26.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 13.5 p90 -152.69 142.92 22.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.07 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 48.0 mt -107.49 156.73 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -140.46 161.1 38.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.966 -1.083 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.4 tt -157.35 117.52 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.055 -1.028 . . . . 0.0 109.756 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.605 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -129.54 143.98 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.366 -0.833 . . . . 0.0 109.522 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -74.78 101.69 4.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.93 -1.83 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.056 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -82.57 -52.74 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -122.52 -5.97 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.652 . . . . 0.0 109.851 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 65.81 65.77 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.5 p -123.81 -49.1 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.931 -0.481 . . . . 0.0 109.998 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 54.6 mm-40 -62.94 159.05 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.288 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 177.53 75.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.92 52.28 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.424 -0.798 . . . . 0.0 109.508 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 32.4 ptt180 -136.16 141.16 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.693 . . . . 0.0 109.226 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -92.1 143.61 26.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.0 109.163 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -87.64 103.64 15.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.5 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.6 mt -80.57 -38.31 29.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.4 m -48.25 -33.62 8.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.863 -1.148 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -95.21 -51.12 4.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.406 -0.809 . . . . 0.0 109.747 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.55 -7.44 50.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.251 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.22 -49.99 75.45 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.009 -1.057 . . . . 0.0 109.825 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 p -55.88 0.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.78 . . . . 0.0 110.509 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 131' ' ' ALA . 38.0 p -87.42 -33.12 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.746 -1.221 . . . . 0.0 110.081 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -172.34 -145.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.785 -1.197 . . . . 0.0 109.712 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 21.1 m -126.61 -40.23 1.94 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.18 155.97 26.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 ttt -166.81 157.59 12.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.16 -0.963 . . . . 0.0 109.829 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.81 126.8 50.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.328 -0.857 . . . . 0.0 109.337 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -70.07 -37.13 75.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.932 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.1 -163.39 24.06 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.851 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -151.54 164.09 37.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -1.069 . . . . 0.0 109.519 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.72 140.04 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.244 -0.91 . . . . 0.0 108.571 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.447 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.8 p90 -150.61 166.31 30.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.913 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 17.4 ptm180 -85.34 152.7 23.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.436 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 18.8 t-160 -153.9 119.9 5.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.267 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.436 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 29.0 m-20 52.46 29.39 6.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 109.501 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.52 81.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -127.87 134.91 49.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.48 -1.012 . . . . 0.0 109.396 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.43 149.34 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -148.86 125.98 11.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.208 -0.932 . . . . 0.0 109.538 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -93.37 140.99 28.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 109.971 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -144.06 107.54 4.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.422 -0.799 . . . . 0.0 109.09 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.13 154.65 41.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.098 -1.001 . . . . 0.0 109.72 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.24 -33.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.81 85.82 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.308 -1.113 . . . . 0.0 109.572 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.56 154.03 46.75 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 165' ' ' VAL . 12.7 p90 -137.88 124.04 20.39 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.377 -1.072 . . . . 0.0 109.436 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.63 3.08 34.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.45 -75.09 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 156.39 136.59 2.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.7 pp -47.38 -36.97 10.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -1.172 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.86 -16.83 37.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.3 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 161' ' ' GLY . 34.5 m -78.82 -56.0 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 158' ' ' TYR . 14.4 m -51.62 -19.94 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 109.11 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 70.8 m -73.67 -63.02 1.29 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.469 -0.769 . . . . 0.0 110.352 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.28 35.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.849 . . . . 0.0 110.583 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -61.37 -48.74 79.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.064 -1.022 . . . . 0.0 110.26 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -71.74 -20.33 61.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 109.464 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.62 -46.46 5.74 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.95 139.3 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -72.6 112.92 9.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.41 50.23 1.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.425 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.448 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 20.3 mmt -79.95 -176.29 5.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 82.7 mttt -151.73 -35.77 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 51.8 m-20 -145.09 143.77 30.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -140.81 158.14 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.6 tp -145.34 109.75 4.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.03 145.7 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.36 117.21 2.89 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.93 124.92 50.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.15 150.47 22.68 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.535 -1.317 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -157.04 153.98 28.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.412 -1.052 . . . . 0.0 109.804 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.69 130.05 34.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.762 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.85 133.38 33.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -86.33 109.26 18.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.532 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -82.85 124.46 30.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.456 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -154.19 -41.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -149.44 28.13 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 109.047 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.2 -30.32 5.61 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -62.98 158.4 19.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.407 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -165.91 176.09 8.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.558 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 60.9 m-85 -96.41 146.79 24.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 12.1 m-20 -141.03 99.62 3.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -85.28 140.64 30.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 108.524 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -103.17 119.7 39.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.29 131.71 43.73 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.292 -0.88 . . . . 0.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -150.19 168.18 24.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.63 147.47 45.19 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 90' ' ' VAL . 4.3 m-85 -103.6 123.15 46.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.0 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.02 135.72 37.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 108.725 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.01 128.33 17.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.964 -1.085 . . . . 0.0 110.388 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 176.26 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.71 1.13 44.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -84.62 -7.44 59.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 -10.78 73.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -105.07 148.09 27.17 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 38' ' ' GLY . 44.3 t -66.39 137.25 25.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.91 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -70.79 7.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.691 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -154.04 172.66 32.7 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.94 -2.88 49.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.842 -1.387 . . . . 0.0 110.321 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.19 -40.85 6.27 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.09 -1.006 . . . . 0.0 110.982 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' HG11 ' A' ' 36' ' ' VAL . 35.7 t0 50.44 10.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.74 -1.225 . . . . 0.0 109.329 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ALA . 81.8 t80 -138.12 100.22 4.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.0 109.533 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.8 pt -101.41 137.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.22 -0.925 . . . . 0.0 109.086 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.8 p90 -142.81 -162.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.3 p90 -45.23 -32.37 1.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -0.942 . . . . 0.0 110.512 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 17.9 t-20 -51.83 -11.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.886 -1.134 . . . . 0.0 109.036 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.0 t-20 -135.6 107.8 7.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.9 tp -47.52 -29.71 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 35.3 pttt -168.85 156.96 7.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -65.95 144.25 56.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.92 -46.98 32.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -116.07 -2.78 12.17 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.05 -15.68 76.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.46 9.41 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.07 149.82 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.154 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.51 137.75 25.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.164 -0.96 . . . . 0.0 109.869 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -89.42 135.25 33.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.773 . . . . 0.0 108.931 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -73.38 -44.44 58.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.09 110.11 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.59 110.89 12.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -1.142 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.96 -164.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 63' ' ' THR . 10.2 ptm180 -158.18 17.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 62' ' ' ARG . 33.3 p -155.71 -40.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.332 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.74 69.72 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.48 110.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -1.152 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.4 -140.72 6.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 68' ' ' GLY . 22.7 t0 -80.0 -169.95 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -1.109 . . . . 0.0 109.516 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 67' ' ' ASP . . . -60.8 -93.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 42.8 p-10 -48.66 98.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -1.153 . . . . 0.0 109.564 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 68' ' ' GLY . 68.0 m-20 -74.8 -46.18 38.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.46 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' CG ' ' N ' ' A' ' 72' ' ' SER . 68.0 tt0 -115.82 162.7 16.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.685 . . . . 0.0 109.176 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 m -153.53 143.09 21.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -121.73 123.1 41.05 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.603 -0.685 . . . . 0.0 109.24 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -95.61 138.63 33.01 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.27 146.82 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.434 -0.791 . . . . 0.0 110.182 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -139.12 106.42 5.51 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 79' ' ' ALA . 9.0 mt -78.98 -42.52 26.49 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -52.55 -8.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.977 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.68 19.5 16.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.55 -0.719 . . . . 0.0 109.67 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 81' ' ' PRO . 47.2 t -104.63 105.17 49.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.319 -0.863 . . . . 0.0 109.246 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.2 Cg_exo -48.97 -173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.039 1.826 . . . . 0.0 112.355 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.25 0.33 87.22 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.77 -58.51 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -1.198 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.35 145.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -135.93 -5.74 2.15 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.082 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -142.46 130.67 22.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.997 -1.064 . . . . 0.0 109.214 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.1 mt -139.99 113.99 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.67 173.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.316 -0.865 . . . . 0.0 109.121 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.94 142.2 51.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 91' ' ' VAL . 58.7 t -146.9 156.53 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.857 -1.152 . . . . 0.0 111.713 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.3 p -146.58 113.65 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -120.57 161.67 20.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.295 -0.878 . . . . 0.0 110.828 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.542 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -77.56 161.87 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.482 ' N ' HG22 ' A' ' 93' ' ' ILE . 1.3 t60 -111.19 -76.05 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.344 -0.848 . . . . 0.0 109.934 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' GLN . 1.4 m-20 -47.82 -18.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.772 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.77 -19.07 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 49.7 tt0 -71.45 -62.22 1.49 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.95 -1.094 . . . . 0.0 109.319 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.52 -43.82 9.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.339 -0.85 . . . . 0.0 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 101' ' ' GLN . 40.9 ttt85 -79.23 -20.18 48.87 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 99' ' ' ARG . 59.5 ttt-85 54.59 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.745 -1.222 . . . . 0.0 109.474 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.475 ' CD ' ' HE ' ' A' ' 99' ' ' ARG . 18.8 mt-30 -157.8 141.47 15.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -102.2 163.89 11.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -46.73 -33.01 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.844 . . . . 0.0 109.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.5 -42.28 98.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 66.1 mm-40 -51.21 -12.04 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.156 -1.202 . . . . 0.0 109.225 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.4 t -82.74 165.29 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.852 . . . . 0.0 109.204 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.2 m -69.39 -18.51 63.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.195 -0.941 . . . . 0.0 109.657 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.76 79.46 0.03 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.19 157.51 22.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -1.18 . . . . 0.0 109.706 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 26.5 p90 -150.24 169.71 20.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 109.969 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -135.87 151.56 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -138.17 161.59 36.43 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.022 -1.049 . . . . 0.0 109.984 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.14 116.32 4.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.177 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -128.69 144.94 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.317 -0.864 . . . . 0.0 109.957 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.448 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 57.8 t30 -76.13 102.03 5.58 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.91 -1.57 3.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.668 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.64 -53.78 5.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.49 ' CG ' ' HG1' ' A' ' 120' ' ' THR . 13.7 p30 -123.82 6.81 8.73 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.737 -0.602 . . . . 0.0 109.638 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' ASN . 8.1 mt-30 59.55 60.52 2.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 118' ' ' ASN . 86.0 m -110.82 -70.41 0.81 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.896 -0.502 . . . . 0.0 110.342 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.858 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.9 mm-40 -45.3 157.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.18 156.01 48.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.168 -0.958 . . . . 0.0 109.923 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptp180 -142.49 143.31 32.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.545 -0.722 . . . . 0.0 109.243 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.429 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.4 t80 -91.22 142.04 28.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 108.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -85.26 102.86 13.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.065 -1.022 . . . . 0.0 109.432 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 54.1 mt -79.0 -39.21 34.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.166 -0.959 . . . . 0.0 109.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.2 t -47.79 -31.07 4.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.992 -1.067 . . . . 0.0 109.209 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.18 -54.6 3.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.773 . . . . 0.0 109.711 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.429 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 46.8 m-20 -73.23 -2.68 22.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.283 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.1 -47.15 72.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.087 -1.008 . . . . 0.0 109.238 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 t -68.1 3.12 1.73 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.549 -0.719 . . . . 0.0 109.819 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 m -84.3 -34.93 23.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.985 . . . . 0.0 110.169 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -177.53 -166.31 0.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.931 -1.105 . . . . 0.0 109.66 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.69 -10.72 9.14 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.79 26.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.68 158.14 15.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.41 134.16 37.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.1 t80 -73.33 -45.44 55.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.892 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.74 -162.5 11.26 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 22.2 tt0 -151.97 164.29 37.47 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.106 -1.232 . . . . 0.0 109.839 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 13.3 tp -144.16 133.35 23.0 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -148.64 166.22 28.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.0 109.639 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 14.5 ptm180 -94.47 141.24 28.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.377 -0.827 . . . . 0.0 110.095 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.575 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -100.03 -132.88 0.26 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.3 m120 -51.85 -51.45 56.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.887 -1.133 . . . . 0.0 108.322 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.48 16.93 0.14 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.83 159.51 36.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -77.73 151.81 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -148.21 124.99 11.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -89.69 147.65 23.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.377 -0.827 . . . . 0.0 109.391 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -153.9 109.35 3.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.69 154.68 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.526 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.58 -34.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.14 84.22 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -130.32 104.41 7.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.68 -0.894 . . . . 0.0 109.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 149.96 29.32 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.63 127.47 19.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.46 12.15 21.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.6 -67.18 1.76 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.77 126.89 1.13 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -44.68 -32.5 1.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.363 -1.08 . . . . 0.0 110.099 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.74 -27.19 25.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 161' ' ' GLY . 23.3 t -77.71 -50.51 12.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.426 -0.796 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -48.68 -20.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.483 ' SG ' ' CB ' ' A' ' 42' ' ' PHE . 56.7 m -72.35 -61.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.57 -15.36 37.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.165 -0.959 . . . . 0.0 110.537 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.88 -42.14 99.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.033 . . . . 0.0 110.476 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.62 -20.62 61.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.513 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.04 -49.56 5.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.02 132.17 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.475 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -73.39 146.06 45.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 -178.45 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.536 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.1 mpt? -73.06 171.46 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -153.98 -34.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.569 ' ND2' ' OD2' ' A' ' 116' ' ' ASP . 39.2 t-20 -146.06 128.31 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.245 -0.91 . . . . 0.0 109.233 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.2 t -127.69 156.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.613 -0.679 . . . . 0.0 109.178 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.1 tp -142.4 107.18 4.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.78 150.6 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.83 116.94 1.32 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.71 135.18 45.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.9 135.46 5.9 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -157.04 153.2 27.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -1.103 . . . . 0.0 109.816 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.09 108.02 20.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.09 162.36 24.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -132.84 106.77 7.92 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.452 -0.78 . . . . 0.0 109.246 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.9 p -89.97 105.71 17.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 p -85.29 -100.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.318 -0.864 . . . . 0.0 109.199 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -83.42 -10.6 58.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.285 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.37 -17.14 0.36 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.89 176.36 2.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 109.664 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -176.75 162.38 2.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.34 141.66 29.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.239 -0.913 . . . . 0.0 109.402 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.4 p30 -141.07 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.155 -0.966 . . . . 0.0 109.595 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.69 134.87 34.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 108.877 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -92.4 107.13 18.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.034 -1.042 . . . . 0.0 109.83 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.41 123.46 42.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.74 167.59 26.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.101 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.49 46.2 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.6 m-85 -104.37 128.37 52.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.338 -0.851 . . . . 0.0 108.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.76 155.62 17.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 110.088 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.53 137.28 25.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.349 -0.845 . . . . 0.0 109.362 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -80.16 176.67 9.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.16 -8.56 59.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.966 . . . . 0.0 109.805 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -85.67 2.91 43.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.139 -0.975 . . . . 0.0 109.808 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.03 -18.31 57.6 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.6 mttt -106.61 173.23 6.41 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -101.3 142.18 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.405 -0.809 . . . . 0.0 109.675 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -60.11 -5.55 1.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -144.33 102.32 0.27 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 31.8 p-10 -45.28 -25.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -1.101 . . . . 0.0 110.356 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -58.76 -42.06 88.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.067 -1.02 . . . . 0.0 109.822 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 38.8 t0 46.27 15.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 81.5 t80 -137.35 99.58 4.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 109.419 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.0 pt -102.86 137.92 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.7 p90 -140.85 -160.78 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.18 -0.95 . . . . 0.0 109.344 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.4 p90 -44.68 -31.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 0.0 110.495 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.6 t-20 -51.05 -14.27 0.22 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.903 -1.123 . . . . 0.0 109.01 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.4 t-20 -135.77 107.38 6.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -47.78 -26.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.372 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 14.4 pttm -170.52 159.14 6.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 8.1 t -73.22 129.99 39.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.388 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.24 -30.36 54.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.66 -15.97 11.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 -12.58 75.28 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 60.68 10.75 2.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 50' ' ' SER . 59.7 t -92.75 151.9 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 108.963 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -145.37 145.0 31.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -90.94 119.59 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 m -67.24 -46.98 72.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.27 117.61 0.77 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -78.46 158.9 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -1.178 . . . . 0.0 109.543 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -157.55 109.98 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.59 17.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.897 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -152.56 -35.05 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.255 -0.903 . . . . 0.0 109.372 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.46 18.7 59.01 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -58.44 110.4 0.97 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -1.13 . . . . 0.0 109.399 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 177.06 -134.87 2.63 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -166.04 69.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -1.144 . . . . 0.0 109.442 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.55 -166.57 33.33 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.16 99.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -1.135 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -69.11 -73.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -98.67 164.45 12.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -160.81 139.33 10.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.338 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 mp -117.94 127.32 53.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.524 -0.735 . . . . 0.0 109.382 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HG2' ' HZ2' ' A' ' 76' ' ' LYS . 52.4 tttp -96.19 114.79 26.52 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.443 HD13 ' CE1' ' A' ' 89' ' ' PHE . 64.5 mt -104.18 147.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.388 -0.82 . . . . 0.0 110.571 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HZ2' ' HG2' ' A' ' 74' ' ' LYS . 64.4 mttp -138.71 105.65 5.42 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.27 -38.61 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.15 -22.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.71 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.06 -24.03 17.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.279 -0.888 . . . . 0.0 109.75 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.99 124.24 79.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 109.334 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.23 -160.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.939 1.759 . . . . 0.0 111.826 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.25 0.89 88.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -66.98 -56.37 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.15 148.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 11.7 t0 -125.53 -19.58 4.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.572 -0.705 . . . . 0.0 109.567 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -149.43 143.42 25.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.118 -0.989 . . . . 0.0 109.784 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 89.6 mt -135.21 154.35 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -145.21 172.77 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 2.9 m-85 -142.47 118.76 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.16 158.01 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.308 -0.87 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.0 p -133.41 113.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 p -110.44 156.29 21.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 0.0 110.347 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.536 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.16 144.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.405 ' C ' ' N ' ' A' ' 96' ' ' ALA . 74.6 t60 -99.46 -69.1 0.78 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -49.14 -18.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.849 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.48 -50.37 59.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.712 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 -30.25 41.38 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.799 -1.188 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.85 -53.71 4.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.066 -1.021 . . . . 0.0 111.471 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 100' ' ' ARG . 5.1 ptp180 -112.14 3.5 17.3 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.153 -0.967 . . . . 0.0 111.101 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 85.9 mtt-85 53.42 104.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -147.93 137.85 22.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 109.301 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.4 p -94.71 160.54 14.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -46.66 -37.03 7.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.739 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.25 -37.73 87.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -47.7 -16.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -1.226 . . . . 0.0 109.322 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 107' ' ' SER . 33.6 t -87.58 166.75 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 109.121 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -67.92 -21.68 65.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 109.707 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.96 79.4 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.03 162.17 25.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 109.75 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 17.8 p90 -155.8 161.44 40.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.8 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 49.7 mt -123.25 157.97 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.401 ' N ' HG22 ' A' ' 111' ' ' ILE . 73.9 ttt180 -141.18 159.71 41.63 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.045 -1.034 . . . . 0.0 109.614 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -154.67 117.42 4.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.953 -1.092 . . . . 0.0 109.499 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.3 p -129.5 144.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 119' ' ' GLN . 55.7 t30 -76.76 102.06 6.09 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.569 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 23.0 t70 -67.2 -1.61 4.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.318 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.3 t0 -80.65 -53.35 6.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.223 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -123.33 3.97 9.13 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 115' ' ' ASN . 11.9 mt-30 59.75 61.18 2.0 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 89.8 m -113.54 -68.49 0.92 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.956 -0.465 . . . . 0.0 110.363 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 36.4 mm-40 -45.25 157.65 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.907 . . . . 0.0 109.907 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.83 73.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.84 150.3 52.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.044 -1.035 . . . . 0.0 110.084 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.3 ptm180 -140.28 142.66 35.7 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.27 146.39 23.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.062 -1.024 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.39 103.4 16.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 109.389 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 97.6 mt -79.55 -36.52 38.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m -48.08 -32.4 6.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.048 . . . . 0.0 109.213 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.23 -53.88 3.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.76 -4.15 32.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.96 -42.91 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.0 t -74.38 2.95 8.22 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.979 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -83.39 -34.2 25.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.167 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -176.43 -167.41 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.928 -1.107 . . . . 0.0 109.654 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.09 -15.75 8.68 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.22 140.48 41.73 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 45.7 ttp -165.8 158.0 14.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 109.749 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -99.91 135.71 40.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.388 -0.82 . . . . 0.0 109.152 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.99 -43.75 33.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 0.0 109.628 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.29 -172.48 31.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.56 166.65 29.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.238 . . . . 0.0 109.943 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.89 143.56 45.07 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -148.1 166.05 28.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.045 . . . . 0.0 109.667 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 9.1 ptm180 -95.02 146.05 24.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.682 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.45 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -122.49 -120.63 0.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.45 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 10.7 m120 -73.61 52.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.24 9.61 86.38 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.82 138.22 52.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.526 -0.985 . . . . 0.0 109.387 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -67.42 151.67 47.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -149.78 128.61 12.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.456 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -89.8 151.01 22.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 109.779 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -156.12 107.19 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.68 39.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.686 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.33 -34.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.66 87.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.37 104.45 6.73 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.62 150.88 35.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.463 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.8 p90 -144.32 126.36 15.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -1.099 . . . . 0.0 109.268 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.5 11.91 20.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.25 -77.74 0.11 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 158.3 138.29 2.45 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.71 -34.94 20.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.187 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -81.64 -15.56 54.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.6 m -90.15 -53.99 4.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.8 m -54.5 -21.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 15.0 p -75.85 -51.96 11.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.041 -1.037 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.625 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.82 -25.39 23.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.905 -1.122 . . . . 0.0 110.492 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -57.59 -39.56 77.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.046 -1.034 . . . . 0.0 110.469 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -71.0 -19.53 62.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.89 -49.44 7.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 172' ' ' ASN . 87.2 mt -80.49 157.13 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.127 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.433 ' N ' HG22 ' A' ' 171' ' ' ILE . 79.2 m-20 -75.79 136.27 40.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 -178.47 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.445 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 149' ' ' TRP . 21.0 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.275 0.559 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 46.5 mtt -152.55 90.98 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.21 -21.97 49.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 6.7 m120 -146.36 139.58 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.7 t -145.67 129.62 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.9 113.71 25.9 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.11 150.68 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -134.7 116.85 1.66 Allowed Glycine 0 N--CA 1.499 2.851 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -115.57 126.22 53.95 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.52 151.99 24.18 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.563 -1.303 . . . . 0.0 109.964 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -161.58 152.45 18.06 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.369 -1.077 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.27 127.54 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 109.591 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.5 170.73 14.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.895 . . . . 0.0 109.382 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -128.64 126.89 41.12 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.562 -0.711 . . . . 0.0 109.297 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -84.74 127.64 34.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.3 m -149.56 -45.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.88 . . . . 0.0 109.373 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -152.69 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.21 -24.98 9.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.638 HE22 ' NH2' ' A' ' 99' ' ' ARG . 18.2 mt-30 -71.91 177.85 4.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -1.155 . . . . 0.0 109.423 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -173.2 178.31 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.578 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -96.28 143.45 27.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -141.09 100.33 3.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 109.863 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.09 138.55 33.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' CE2' ' A' ' 44' ' ' PHE . 58.7 t0 -98.81 119.78 38.14 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.161 -0.962 . . . . 0.0 110.383 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -100.53 133.79 44.45 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.2 t -150.0 167.7 25.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.051 -1.03 . . . . 0.0 109.801 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.77 148.82 39.41 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 87' ' ' ILE . 3.9 m-85 -103.19 162.11 13.24 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -139.17 148.91 43.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.87 . . . . 0.0 109.683 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.03 141.05 28.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.925 . . . . 0.0 109.076 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.97 176.33 7.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.6 -1.0 52.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.9 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -95.95 4.17 52.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.181 -0.949 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.02 -13.4 66.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.7 mttp -105.03 163.83 12.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.5 t -90.06 136.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.229 -0.92 . . . . 0.0 109.045 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -66.46 4.09 0.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.14 127.1 1.82 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.6 5.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -1.185 . . . . 0.0 110.523 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -92.14 -42.57 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.847 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 48.0 12.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.653 -1.28 . . . . 0.0 109.468 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ALA . 13.0 t80 -137.68 99.48 3.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.456 -0.778 . . . . 0.0 109.094 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 4.0 pt -97.08 120.96 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.269 -0.894 . . . . 0.0 109.367 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 25' ' ' ALA . 27.0 t80 -171.48 -166.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 67.9 m-85 54.2 -112.89 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.825 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.17 -21.53 65.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 24.0 t-20 -81.39 68.9 7.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.29 -19.61 5.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.152 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 14.8 pttm -163.37 156.65 19.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.474 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 69.5 m -74.54 148.11 41.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.87 -46.41 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.197 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -116.47 -0.4 12.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.725 -0.609 . . . . 0.0 109.647 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.02 -9.74 76.59 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 t 60.52 12.31 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -1.082 . . . . 0.0 109.633 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 38.5 t -93.01 147.97 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.441 ' O ' HD23 ' A' ' 73' ' ' LEU . 31.9 m -149.2 137.61 20.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.047 -1.033 . . . . 0.0 109.887 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.0 m80 -91.7 132.11 36.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.375 -0.828 . . . . 0.0 108.906 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.54 -57.57 5.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.94 124.25 1.11 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.5 112.24 19.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.146 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.11 121.38 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -79.49 13.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.441 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -153.76 -35.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.32 12.12 57.59 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -59.92 114.92 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.2 -143.69 9.14 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -160.59 67.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . 170.96 176.46 40.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -49.8 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -1.21 . . . . 0.0 109.435 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' GLY . 28.5 m-20 -69.81 -67.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -93.09 102.8 15.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.1 m -91.88 133.4 35.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -112.17 126.52 55.3 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.49 140.16 30.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.269 -0.894 . . . . 0.0 109.33 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 54.3 mt -133.79 146.74 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -145.42 99.86 3.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 79' ' ' ALA . 6.4 mt -81.62 -25.23 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.97 . . . . 0.0 109.865 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.27 4.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.91 22.72 3.56 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 81' ' ' PRO . 55.3 t -104.01 105.7 49.78 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.261 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' VAL . 71.4 Cg_exo -48.39 -174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.02 1.813 . . . . 0.0 112.275 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 1.54 88.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -55.11 20.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -1.112 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.86 121.45 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.381 -0.824 . . . . 0.0 109.121 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.73 -1.6 32.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.325 -0.859 . . . . 0.0 110.289 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -158.17 144.64 17.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.123 . . . . 0.0 110.106 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 28' ' ' PHE . 9.3 mt -146.11 118.56 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 173.34 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 0.0 109.737 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 96.5 m-85 -140.3 118.13 11.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.11 158.01 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.471 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.3 p -126.42 117.56 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -112.69 149.91 32.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.15 149.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.755 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 96' ' ' ALA . 66.9 t60 -103.91 -68.85 0.82 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -46.9 -19.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 109.614 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -57.91 -18.5 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -60.6 2.89 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.716 -1.24 . . . . 0.0 109.315 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.53 -33.3 15.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 111.127 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.638 ' NH2' HE22 ' A' ' 19' ' ' GLN . 22.5 mtt-85 -95.57 -18.88 20.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.895 -1.128 . . . . 0.0 111.503 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttt85 56.9 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.796 -1.19 . . . . 0.0 108.984 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -146.09 138.45 25.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.37 -0.831 . . . . 0.0 109.246 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.6 p -96.08 164.27 12.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 135' ' ' THR . 46.8 m-85 -48.17 -35.71 12.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.766 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.75 -37.84 94.24 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -47.27 -16.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -1.189 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 21.6 t -86.74 168.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.044 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 20.8 m -68.19 -20.96 64.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.77 80.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.26 164.11 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.9 p90 -154.23 155.32 35.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 50.0 mt -120.08 153.66 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 8' ' ' GLY . 62.5 ttt180 -140.18 159.57 41.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.966 -1.084 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -153.57 116.34 4.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 109.467 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.4 p -129.38 143.12 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.467 -0.771 . . . . 0.0 109.749 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 119' ' ' GLN . 60.7 t-20 -78.24 101.88 7.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.48 -1.96 4.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 0.0 109.301 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 115' ' ' ASN . 21.1 t0 -77.56 -53.34 7.71 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.032 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -123.44 3.12 9.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 115' ' ' ASN . 24.6 mt-30 60.01 61.74 1.8 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.6 p -115.17 -67.93 0.96 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.903 -0.498 . . . . 0.0 110.379 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 47.9 mm-40 -45.37 157.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 109.973 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.98 73.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.54 152.55 51.54 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.123 -0.985 . . . . 0.0 109.841 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.5 ptt180 -140.16 145.82 37.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.552 -0.718 . . . . 0.0 109.377 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -91.32 147.82 22.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 108.975 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.73 101.94 14.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.243 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 26.5 mt -81.43 -31.66 33.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.524 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.7 m -48.48 -36.82 15.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 108.82 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -95.4 -49.94 5.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.477 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.62 -11.63 58.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.766 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.35 -43.8 61.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 109.246 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.0 m -74.46 2.89 8.51 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.639 -0.663 . . . . 0.0 109.978 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -89.74 -33.94 16.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.056 . . . . 0.0 110.376 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -175.48 -176.48 0.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.772 -1.205 . . . . 0.0 109.844 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -112.84 -16.37 12.74 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.181 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.01 138.65 40.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.8 ttp -164.99 157.78 16.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 109.703 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.61 139.23 33.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.253 -0.904 . . . . 0.0 109.636 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.7 t80 -82.51 -44.07 16.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.082 -1.011 . . . . 0.0 109.605 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.31 -171.41 29.52 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -150.82 166.77 29.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.293 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mt -138.94 131.8 29.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.2 p90 -138.86 166.15 25.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.302 -0.873 . . . . 0.0 109.707 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.7 ptm180 -85.79 149.37 25.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.827 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.513 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 56.6 t-80 -155.01 124.54 6.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 0.0 109.217 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 6.2 m120 54.11 26.04 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.55 11.62 82.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.88 140.4 52.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.508 -0.995 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' SER . 78.2 m95 -68.11 151.51 46.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.221 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -150.73 135.65 17.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 17.5 t80 -93.81 150.46 20.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.741 . . . . 0.0 109.701 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 15.2 tpt85 -156.16 107.1 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.099 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.19 154.6 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.704 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.28 -32.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.497 -0.752 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.79 83.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -139.18 104.28 4.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.981 . . . . 0.0 109.377 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.76 151.07 31.76 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -143.78 123.26 13.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.391 -1.064 . . . . 0.0 109.245 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.93 10.45 21.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 109.503 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -73.94 0.29 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.1 135.21 1.89 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.95 -24.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -1.177 . . . . 0.0 109.807 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.85 -33.86 21.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.9 t -75.19 -51.93 12.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.701 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 158' ' ' TYR . 33.3 m -46.6 -19.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 85.0 m -73.32 -61.23 1.9 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.063 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.99 -15.39 38.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.244 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -59.38 -40.62 87.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 171' ' ' ILE . 15.2 m-85 -71.65 -15.83 62.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.21 -0.932 . . . . 0.0 109.398 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -52.6 -7.73 0.45 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 169' ' ' TYR . 21.3 pt -71.69 156.4 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -1.23 . . . . 0.0 109.505 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 3.0 m-20 -73.06 108.29 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.67 144.44 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 109.457 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.487 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.86 173.39 12.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -153.41 -35.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -146.14 140.18 26.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.9 t -141.74 146.0 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.35 -0.844 . . . . 0.0 109.245 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.0 tp -130.7 109.39 10.59 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.63 147.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 108.514 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.89 116.8 1.38 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.48 136.64 41.94 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.49 137.35 6.74 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -157.37 152.52 25.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -1.137 . . . . 0.0 109.759 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.46 109.59 22.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.678 -0.639 . . . . 0.0 109.544 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -81.78 168.13 18.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -132.74 106.68 7.91 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.468 -0.77 . . . . 0.0 109.29 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -92.29 105.81 17.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 p -82.54 -29.76 30.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.241 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -158.38 -34.71 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.0 109.37 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.97 -32.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.579 ' CD ' ' H ' ' A' ' 19' ' ' GLN . 1.8 mp0 -70.14 174.34 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -1.143 . . . . 0.0 109.608 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -175.84 177.12 1.72 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.42 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.0 m-85 -96.26 145.29 25.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.416 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.92 140.74 34.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CD2' HD13 ' A' ' 93' ' ' ILE . 15.2 mt -128.52 128.61 44.64 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -91.97 108.55 20.01 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.168 -0.957 . . . . 0.0 110.176 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 44' ' ' PHE . . . -100.6 125.97 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.284 -0.885 . . . . 0.0 108.936 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p -149.46 168.04 24.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 0.0 109.937 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.44 139.75 44.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.46 125.75 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.2 152.97 18.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.343 -0.848 . . . . 0.0 109.605 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.42 138.25 27.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.1 176.41 8.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.563 -0.711 . . . . 0.0 109.232 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.48 -8.41 58.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.784 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 3.51 39.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.927 . . . . 0.0 109.947 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.47 61.53 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.5 mmtp -104.2 168.56 9.03 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 38' ' ' GLY . 18.9 t -93.18 137.05 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.173 -0.955 . . . . 0.0 108.993 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 32.3 ttp180 -63.84 2.09 0.55 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -153.36 128.22 2.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -65.07 4.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -1.189 . . . . 0.0 110.234 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -94.35 -41.87 9.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.0 -1.062 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 t0 45.78 17.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.0 109.477 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 40' ' ' ALA . 31.8 t80 -136.97 106.59 6.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 109.627 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 29' ' ' LEU . 6.9 pt -112.64 139.69 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.581 -0.699 . . . . 0.0 109.132 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -161.01 -145.23 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 46.8 p90 -43.76 -31.1 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 109.944 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.09 3.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.3 t-20 -158.65 116.28 2.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.154 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -50.66 -36.04 33.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttp -165.78 157.43 14.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 109.361 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.4 t -70.54 120.1 15.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.58 87.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.178 -0.951 . . . . 0.0 109.547 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 43.4 p-10 -103.27 -17.61 15.24 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.516 -0.74 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . -84.36 -15.34 69.18 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.1 p 61.86 11.19 3.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -1.104 . . . . 0.0 109.491 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' H ' ' HB3' ' A' ' 50' ' ' SER . 55.2 t -93.02 151.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.311 -0.868 . . . . 0.0 109.175 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 m -148.05 136.26 21.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 0.0 110.078 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.409 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.8 m80 -90.41 129.75 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -68.59 -56.62 7.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 109.335 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.17 123.41 1.22 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -81.72 110.89 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -81.72 -169.63 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 63' ' ' THR . 15.6 ptt180 -150.82 12.28 0.68 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 109.544 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.8 p -156.64 -35.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.94 11.71 25.91 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.42 110.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -1.118 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.05 -130.35 2.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -170.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -1.168 . . . . 0.0 109.542 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.63 178.1 33.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -50.04 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.174 . . . . 0.0 109.456 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -70.8 -68.93 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -86.9 175.64 8.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 109.533 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -159.25 132.43 7.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.314 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -119.41 123.43 44.09 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -95.18 137.61 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 52.1 mt -128.75 147.07 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.547 -0.721 . . . . 0.0 110.348 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.8 mttm -140.51 97.16 3.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.54 -5.31 49.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.99 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.98 -22.97 31.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.095 -1.003 . . . . 0.0 109.777 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.34 -11.61 27.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.183 -0.948 . . . . 0.0 109.891 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.98 123.99 77.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.22 -161.33 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.795 1.663 . . . . 0.0 112.098 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.05 -0.17 83.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.2 m-20 -70.06 -60.35 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 86' ' ' LYS . 46.5 t -91.11 144.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.66 10.95 5.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.393 -0.817 . . . . 0.0 109.532 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 141' ' ' GLU . 81.7 tttt -158.48 144.13 16.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.225 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.39 115.75 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.081 -1.012 . . . . 0.0 109.369 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -104.1 173.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 95.0 m-85 -142.29 129.55 21.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.55 157.76 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 0.0 110.649 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -132.42 113.62 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -110.22 154.64 23.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.393 -0.817 . . . . 0.0 110.778 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.22 151.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 96' ' ' ALA . 9.3 t60 -101.93 -74.23 0.63 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.372 -0.83 . . . . 0.0 110.271 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.09 -17.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 109.798 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.589 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -49.98 -19.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.448 -0.782 . . . . 0.0 109.504 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -71.61 -62.58 1.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.971 -1.08 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -39.27 12.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.33 -0.856 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.463 ' NE ' ' OE1' ' A' ' 101' ' ' GLN . 49.4 ttt180 -83.89 -20.2 33.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.934 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 ttp85 53.33 96.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.766 -1.209 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.463 ' OE1' ' NE ' ' A' ' 99' ' ' ARG . 20.4 mt-30 -155.85 143.5 19.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.453 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -100.7 166.27 10.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.468 -0.77 . . . . 0.0 109.627 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -49.12 -29.7 5.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.705 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.03 -40.34 97.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 29.5 mm-40 -51.03 -11.7 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.315 . . . . 0.0 109.326 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.47 ' N ' ' C ' ' A' ' 104' ' ' GLY . 11.3 t -86.7 162.63 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.845 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.402 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -64.29 -23.35 67.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.83 79.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.37 162.28 25.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 109.686 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 20.5 p90 -156.21 158.39 37.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 110.004 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 32.0 mt -120.55 156.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -143.42 159.09 43.02 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.926 -1.109 . . . . 0.0 109.912 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 tt -152.43 124.39 8.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.209 -0.932 . . . . 0.0 109.185 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.07 144.87 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.429 -0.795 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 120' ' ' THR . 53.5 t30 -74.45 101.83 4.26 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.84 -1.84 2.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.677 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.37 -53.85 5.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.912 . . . . 0.0 109.919 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -123.75 7.6 8.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.628 -0.67 . . . . 0.0 109.996 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 59.66 60.2 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.449 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 28.0 m -109.98 -70.52 0.81 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.825 -0.547 . . . . 0.0 110.3 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.855 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -45.27 157.43 0.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.49 72.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.05 150.54 52.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.088 -1.007 . . . . 0.0 110.13 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.2 ptt180 -143.27 140.21 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.707 . . . . 0.0 109.136 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -91.26 147.86 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 109.016 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.56 102.04 14.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.075 -1.016 . . . . 0.0 108.942 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.5 mt -76.37 -26.57 55.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.6 m -49.57 -33.61 15.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.969 -1.082 . . . . 0.0 108.385 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.44 -52.05 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 109.286 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.458 ' OD2' ' SD ' ' A' ' 137' ' ' MET . 15.7 t70 -67.1 -10.71 52.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.199 -0.938 . . . . 0.0 109.987 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.41 -46.33 62.88 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.8 t -71.46 3.47 3.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.761 -0.587 . . . . 0.0 110.022 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.2 m -92.12 -34.23 14.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.949 -1.094 . . . . 0.0 110.49 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -175.51 -174.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.676 -1.265 . . . . 0.0 110.011 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.29 -8.94 12.27 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.81 137.2 26.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.458 ' SD ' ' OD2' ' A' ' 130' ' ' ASP . 12.4 ptp -165.41 158.21 15.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.86 141.92 27.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.196 -0.94 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -85.5 -44.61 12.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.99 -176.02 24.27 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 86' ' ' LYS . 29.4 tt0 -151.22 122.2 7.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 142' ' ' LEU . 9.7 mp -99.34 142.74 30.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 109.001 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.48 166.23 31.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.017 -1.052 . . . . 0.0 109.695 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.54 142.83 26.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.256 -0.902 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.614 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -115.63 -120.16 0.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.614 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.1 m120 -73.56 52.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.84 9.39 85.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.79 142.89 51.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.593 -0.946 . . . . 0.0 109.365 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -67.86 151.66 46.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -153.66 133.12 12.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.978 . . . . 0.0 109.434 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 21.8 t80 -89.58 153.7 20.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 109.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.534 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 17.5 tpt180 -160.42 107.26 1.55 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.126 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.08 149.11 50.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.56 -30.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.553 -0.717 . . . . 0.0 109.068 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.2 83.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -139.37 104.44 4.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.959 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.07 152.84 35.19 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.441 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -146.37 127.67 14.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.27 -1.136 . . . . 0.0 109.244 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.3 9.05 33.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.41 -69.0 0.99 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 154.45 129.29 1.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.48 -28.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 109.8 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.69 -26.41 25.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' GLY . 43.9 t -78.06 -54.65 6.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.1 m -46.98 -20.49 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 73.2 m -70.53 -60.72 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.393 -0.817 . . . . 0.0 110.103 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -17.34 33.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.38 -45.51 91.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.959 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -71.85 -19.93 61.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.4 -40.29 19.73 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.33 155.82 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -1.106 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -74.96 134.07 41.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 134.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.451 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 149' ' ' TRP . 7.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.635 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 62.7 mtm -147.55 -170.89 3.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.934 . . . . 0.0 109.332 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -152.46 -33.52 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.278 -0.889 . . . . 0.0 109.7 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.415 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 71.5 m-80 -142.66 128.3 19.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -130.82 150.88 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.69 115.34 9.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -86.22 151.03 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.14 117.29 1.51 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.02 133.98 49.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -150.33 145.22 13.02 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.054 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -158.13 151.55 23.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.493 -1.004 . . . . 0.0 109.674 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -80.24 121.73 25.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.28 123.37 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.388 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -75.66 106.83 7.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.539 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -91.28 127.4 36.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' ' OD1' ' A' ' 17' ' ' ASP . 6.6 t -157.93 -35.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.282 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 16' ' ' THR . 26.4 m-20 -157.24 37.24 0.29 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -10.86 49.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -79.11 139.93 37.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -1.135 . . . . 0.0 109.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -157.16 169.08 25.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -96.21 150.6 20.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 109.3 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -140.95 99.93 3.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.0 109.726 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.39 138.55 33.46 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' ' CE2' ' A' ' 44' ' ' PHE . 8.2 t70 -92.17 117.24 29.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 109.829 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.63 48.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.421 -0.8 . . . . 0.0 109.016 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.34 167.66 25.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.092 -1.005 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.93 137.04 52.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -104.22 159.46 15.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.399 -0.813 . . . . 0.0 109.282 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.54 144.93 51.01 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.546 -0.721 . . . . 0.0 109.765 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.47 134.84 24.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.082 -1.011 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.96 176.59 3.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.5 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.89 -8.24 59.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -83.28 1.31 41.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.05 -13.42 59.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -101.03 153.4 19.58 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.673 HG12 ' H ' ' A' ' 38' ' ' GLY . 35.6 t -73.7 137.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.893 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.83 7.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -156.95 172.83 34.57 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.39 2.69 55.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.287 . . . . 0.0 109.969 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.04 -41.84 5.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.269 -0.895 . . . . 0.0 109.834 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.0 t0 53.25 6.46 0.07 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.945 -1.097 . . . . 0.0 109.71 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.5 p90 -138.45 123.49 19.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.289 -0.882 . . . . 0.0 110.264 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 pt -110.17 122.68 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 33.3 t80 -170.56 -170.95 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.933 -1.104 . . . . 0.0 109.722 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 53.4 m-85 51.03 -112.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.949 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -55.42 -16.78 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.562 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.14 82.37 3.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.561 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.83 -22.1 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -166.54 156.97 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' SER . 4.5 p -84.93 113.49 21.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.48 69.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.268 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -104.64 -19.2 14.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.556 -0.715 . . . . 0.0 109.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.28 -13.98 75.36 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.8 p 70.16 2.05 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.92 146.85 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 p -147.0 152.59 38.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.077 -1.014 . . . . 0.0 110.567 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' CE1' HD21 ' A' ' 73' ' ' LEU . 6.1 m80 -92.03 130.23 37.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -78.33 -38.91 41.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.15 100.94 0.15 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.07 110.89 14.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.462 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.95 -164.37 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -156.02 16.12 0.35 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.4 p -154.71 -35.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.58 -0.08 26.18 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -68.63 110.27 4.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.32 -1.106 . . . . 0.0 109.324 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 178.69 173.94 44.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.8 OUTLIER -82.24 96.96 8.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 109.537 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 -108.32 1.45 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -48.41 111.32 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -1.146 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -80.85 -67.18 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -105.22 162.92 12.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.815 . . . . 0.0 109.394 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.4 p -162.31 138.52 7.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD21 ' CE1' ' A' ' 57' ' ' HIS . 4.9 mp -112.2 131.41 55.49 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.15 120.67 36.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 46.7 mt -108.36 146.57 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 110.58 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -143.77 97.65 3.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.4 mt -82.32 -15.98 50.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.982 -1.074 . . . . 0.0 109.48 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.81 -0.87 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -131.82 15.99 4.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.55 -0.718 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.3 p -60.34 134.75 91.13 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.855 . . . . 0.0 109.193 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.26 -161.78 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.902 1.734 . . . . 0.0 111.736 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.95 5.06 53.09 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -90.57 -72.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.163 -1.198 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.3 p -70.14 149.06 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.55 -30.02 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 109.451 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -114.88 157.54 23.18 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 87' ' ' ILE . 14.7 mt -142.38 150.37 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -141.34 162.03 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.369 -0.832 . . . . 0.0 108.882 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 88' ' ' ILE . 57.4 m-85 -141.69 125.31 16.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.22 157.92 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.386 -0.822 . . . . 0.0 110.191 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.1 p -131.0 121.6 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 p -117.44 153.47 33.04 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.45 -0.782 . . . . 0.0 110.438 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.7 mm -74.2 145.0 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.416 ' C ' ' N ' ' A' ' 96' ' ' ALA . 24.5 t60 -100.64 -69.67 0.76 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLN . 5.4 m-20 -48.25 -18.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -45.9 -18.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' ASP . 65.2 mt-30 -69.58 -58.24 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.917 -1.114 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.66 -52.68 4.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.169 -0.957 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -75.43 -20.74 58.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.967 -1.083 . . . . 0.0 110.917 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 53.94 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.01 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -150.69 149.85 30.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 135' ' ' THR . 43.9 m -104.42 167.28 9.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' ' CE ' ' A' ' 137' ' ' MET . 57.9 m-85 -46.12 -38.19 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.441 -0.787 . . . . 0.0 109.881 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.1 -38.02 88.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -47.14 -18.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.237 . . . . 0.0 109.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 107' ' ' SER . 17.3 t -84.35 168.63 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.079 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.5 t -71.46 -19.56 62.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.77 79.52 0.03 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.6 164.59 22.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.127 . . . . 0.0 109.735 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.8 p90 -156.74 161.15 39.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.054 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 59.1 mt -120.95 156.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -140.94 160.42 40.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.998 -1.064 . . . . 0.0 109.915 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.4 tt -154.37 117.62 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.122 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.3 p -132.2 142.97 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.305 -0.872 . . . . 0.0 110.322 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.635 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 4.3 m120 -74.97 102.13 4.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.21 -1.53 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.474 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 16.7 t70 -81.58 -53.47 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -123.49 7.0 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.783 -0.573 . . . . 0.0 109.676 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 58.61 59.69 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.8 m -109.74 -71.02 0.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.927 -0.483 . . . . 0.0 110.386 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.846 ' O ' HG13 ' A' ' 122' ' ' VAL . 32.3 mt-10 -45.38 157.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.0 109.803 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.18 73.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.67 155.02 49.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.196 -0.94 . . . . 0.0 109.836 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.8 ptm180 -142.59 147.34 35.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 109.18 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -91.32 146.95 23.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -87.97 103.18 15.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.14 -0.975 . . . . 0.0 109.421 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 57.6 mt -81.03 -42.11 21.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.429 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.8 p -47.56 -30.18 3.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 109.245 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -95.31 -54.6 3.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.341 -0.849 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -74.87 -3.44 31.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.965 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.87 -45.85 71.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 109.26 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.2 p -70.83 3.17 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.541 -0.725 . . . . 0.0 109.976 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -82.77 -35.1 26.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.979 -1.075 . . . . 0.0 110.353 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -177.29 -161.94 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.661 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -123.56 -1.71 8.5 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.61 137.63 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.42 ' CE ' ' CE1' ' A' ' 103' ' ' PHE . 10.6 ptp -165.04 157.56 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.342 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -97.87 128.9 44.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.219 -0.925 . . . . 0.0 109.737 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 24.6 t80 -65.57 -43.82 88.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.153 -0.967 . . . . 0.0 109.342 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.57 31.22 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.213 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 167.01 29.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.264 -1.139 . . . . 0.0 110.667 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.9 mt -132.31 136.95 47.25 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 6.4 p90 -140.36 160.91 38.95 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.003 -1.061 . . . . 0.0 109.733 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 9.0 ptm180 -84.96 148.66 26.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.042 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.523 ' NE2' ' OD1' ' A' ' 146' ' ' ASN . 29.8 t-80 -148.92 121.58 8.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.062 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.523 ' OD1' ' NE2' ' A' ' 145' ' ' HIS . 3.6 m120 52.32 27.18 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.26 75.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.9 136.22 51.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.981 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.472 ' CD2' HD13 ' A' ' 77' ' ' LEU . 70.4 m95 -67.31 151.47 47.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.549 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -150.9 143.89 24.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -99.58 142.08 31.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.363 -0.835 . . . . 0.0 110.154 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -134.47 114.82 13.26 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.6 150.03 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 109.639 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.0 t -147.41 -36.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 109.084 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.75 79.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -122.45 106.03 10.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.782 -0.834 . . . . 0.0 109.537 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.01 149.08 32.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -149.99 139.85 21.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -1.173 . . . . 0.0 109.465 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.18 6.87 47.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.35 -37.45 25.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 82.88 150.59 9.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -48.07 -13.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 0.0 109.618 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -72.55 -56.89 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.086 -1.009 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.0 t -90.57 -37.87 13.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.16 -0.963 . . . . 0.0 109.73 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.39 -20.68 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.522 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 29.9 p -83.41 -55.77 4.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.111 -0.993 . . . . 0.0 110.823 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.91 -24.63 23.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 110.531 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' SER . 51.4 tt0 -51.68 -37.59 51.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.974 . . . . 0.0 109.74 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.66 -20.35 58.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.17 -27.83 47.52 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.28 129.9 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -1.153 . . . . 0.0 109.473 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -65.85 104.51 1.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 109.509 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.42 -74.2 0.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.471 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.7 mmt -78.77 178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -154.39 -35.32 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' ND2' ' OD2' ' A' ' 116' ' ' ASP . 41.8 t-20 -146.25 128.14 15.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 109.135 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.2 t -127.78 158.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.8 tp -144.46 106.7 4.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.958 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.29 150.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.11 116.98 1.24 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.85 129.53 54.68 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.95 142.78 11.16 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.45 ' CE2' ' CA ' ' A' ' 64' ' ' GLY . 25.1 p90 -157.22 153.43 27.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.405 -1.056 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -77.51 128.81 34.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.505 -0.747 . . . . 0.0 109.809 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -85.53 123.36 30.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -132.92 119.34 20.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.0 m -90.2 128.67 36.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.4 m -150.29 -80.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.915 . . . . 0.0 109.386 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -3.55 7.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.86 -124.57 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.657 ' H ' HH22 ' A' ' 99' ' ' ARG . 98.3 mm-40 -74.03 163.55 27.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -1.189 . . . . 0.0 109.268 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.44 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.32 150.43 20.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 15.3 p-10 -141.04 99.74 3.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.258 -0.901 . . . . 0.0 109.712 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.62 130.91 34.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 108.631 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -87.24 111.44 21.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.966 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.32 125.86 46.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 108.803 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 m -149.76 168.06 24.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 109.769 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 136.09 49.48 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -103.79 119.59 39.23 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.796 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.19 152.63 21.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.525 -0.735 . . . . 0.0 109.906 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 134.94 22.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -75.67 176.32 7.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 108.979 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.69 -10.85 59.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.681 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -84.32 4.55 30.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.29 56.75 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 48.9 mtpt -104.45 171.95 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.729 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -103.45 143.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -61.83 -4.09 1.39 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.75 101.22 0.23 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -45.12 -20.97 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.401 -1.058 . . . . 0.0 110.601 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.26 -41.81 80.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.597 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.729 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 48.12 12.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.978 -1.076 . . . . 0.0 109.517 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 23.8 t80 -137.46 105.8 5.77 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.842 . . . . 0.0 110.214 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 pt -110.52 134.92 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.3 p90 -151.99 -152.89 0.45 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.04 . . . . 0.0 109.766 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.7 m-85 -43.81 -36.0 2.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.576 -0.703 . . . . 0.0 110.028 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -58.65 -1.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 108.73 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 45' ' ' TYR . 51.1 t-20 -148.11 108.71 4.16 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.23 -27.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 109.407 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.5 pttt -172.8 160.55 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.287 -0.883 . . . . 0.0 109.322 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 54' ' ' SER . 10.2 p -65.12 135.24 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.286 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.39 -45.35 55.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.1 1.49 13.23 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.657 -0.652 . . . . 0.0 109.604 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 -14.33 61.3 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.4 m 64.13 4.17 1.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -1.054 . . . . 0.0 109.314 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.14 146.75 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.919 . . . . 0.0 109.105 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -149.21 152.11 35.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -91.75 132.58 36.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 109.392 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 m -82.94 -38.85 22.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.55 107.55 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 33.2 p-10 -80.58 159.15 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.49 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -155.29 -173.01 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 109.418 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -161.82 30.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.9 p -151.81 -34.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' CA ' ' CE2' ' A' ' 11' ' ' TRP . . . 106.45 3.79 37.75 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -67.37 110.25 3.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -1.085 . . . . 0.0 109.368 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 173.36 154.01 10.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.57 102.62 13.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.6 -140.82 21.43 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.6 p-10 -48.68 111.14 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.599 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.12 -67.45 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.405 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -98.4 158.27 15.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.266 -0.896 . . . . 0.0 109.134 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.475 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -159.69 138.89 11.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' O ' HD12 ' A' ' 6' ' ' LEU . 8.9 mp -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.518 -0.739 . . . . 0.0 109.548 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -96.39 112.68 24.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.66 146.87 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 110.898 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -135.54 88.92 2.45 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.38 -13.54 61.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.306 -0.871 . . . . 0.0 109.794 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -78.29 4.82 11.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.66 10.99 6.15 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.435 -0.791 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -82.01 125.86 76.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.947 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.52 -161.76 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.74 -0.17 84.1 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -69.44 -59.73 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -1.178 . . . . 0.0 109.321 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.89 148.78 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.89 . . . . 0.0 109.252 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -135.98 0.82 2.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 141' ' ' GLU . 43.3 tttp -150.09 131.5 14.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.877 . . . . 0.0 109.055 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 90.4 mt -136.35 132.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 0.0 109.003 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.95 154.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.814 . . . . 0.0 109.671 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -107.1 137.95 44.2 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 91' ' ' VAL . 2.7 p -146.73 158.16 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.115 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 7.5 p -132.36 147.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -143.09 145.26 32.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.125 -0.985 . . . . 0.0 109.727 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.35 137.5 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 50.9 t-80 -95.49 -63.44 1.16 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.161 -0.962 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 12.0 m-20 -47.4 -18.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 0.0 109.578 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.24 -18.18 34.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.835 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -65.94 -60.82 2.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.85 -1.156 . . . . 0.0 109.437 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.14 -41.22 11.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.082 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.657 HH22 ' H ' ' A' ' 19' ' ' GLN . 54.5 mtt180 -85.66 -19.58 30.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.973 -1.079 . . . . 0.0 111.352 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 55.19 92.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.687 -1.258 . . . . 0.0 109.035 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -148.46 142.54 25.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 109.256 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -98.75 165.15 11.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -47.37 -35.48 8.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 109.624 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.737 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.89 -38.38 74.09 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -47.42 -19.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.361 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 107' ' ' SER . 19.3 t -83.97 167.03 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.005 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -72.61 -24.51 61.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 0.0 109.712 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.38 78.1 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.13 164.8 24.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.36 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.4 p90 -154.0 143.7 21.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.0 110.573 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.6 mt -106.94 153.86 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.38 160.21 40.36 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.987 -1.07 . . . . 0.0 109.84 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.31 116.07 4.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 0.0 109.386 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.559 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -129.3 143.75 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.298 -0.876 . . . . 0.0 109.95 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 119' ' ' GLN . 64.6 t30 -76.54 102.04 5.9 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.411 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 18.4 t0 -67.26 -1.36 4.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.539 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.04 -52.97 6.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -123.1 3.59 9.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.721 -0.612 . . . . 0.0 109.479 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ASN . 21.0 tp60 60.41 61.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 40.9 m -113.27 -69.15 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.883 -0.51 . . . . 0.0 110.256 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 33.1 mm-40 -45.24 157.55 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.344 -0.848 . . . . 0.0 109.984 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.73 72.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.53 52.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 110.038 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.4 ptm180 -138.5 145.65 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -91.33 145.16 24.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.994 . . . . 0.0 109.082 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.28 103.16 15.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.023 . . . . 0.0 109.51 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 92.1 mt -82.11 -37.84 25.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.3 p -48.35 -35.06 11.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.906 -1.121 . . . . 0.0 109.091 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -95.39 -49.24 5.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -76.45 -4.16 41.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.737 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.33 -43.71 67.87 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.954 -1.091 . . . . 0.0 109.695 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.3 p -68.97 3.17 2.15 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 110.978 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 p -86.15 -34.51 20.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.544 -1.348 . . . . 0.0 110.526 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.2 -161.44 0.08 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.766 -1.209 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.91 -12.98 7.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.48 133.78 24.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.8 ptp -165.41 141.44 5.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.4 pp -76.47 141.11 41.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -0.952 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.5 t80 -79.41 -46.2 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.411 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.493 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -150.88 -163.52 11.37 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.466 ' CD ' ' NZ ' ' A' ' 86' ' ' LYS . 11.5 tt0 -150.7 158.29 43.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.382 -1.069 . . . . 0.0 109.061 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 136.19 25.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -150.73 166.51 30.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.882 -1.136 . . . . 0.0 110.122 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 15.5 ptm180 -90.59 143.43 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -117.95 -120.12 0.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.605 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 34.9 m120 -73.56 51.25 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.05 -1.031 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 9.1 85.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.77 142.13 51.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.997 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -68.53 151.48 46.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -148.91 131.8 16.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.112 -0.993 . . . . 0.0 109.69 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -89.76 150.61 22.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -149.75 124.19 9.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 0.0 109.065 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.75 147.91 27.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.1 t -150.15 -36.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 109.09 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.26 76.54 0.15 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -108.6 104.38 13.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.754 -0.85 . . . . 0.0 109.125 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.03 143.35 20.39 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.484 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -142.15 141.7 32.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.299 -1.118 . . . . 0.0 109.086 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.14 9.55 43.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.32 -0.863 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -68.01 1.33 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.51 132.5 1.51 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.9 -30.55 2.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -1.123 . . . . 0.0 109.607 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.74 24.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 69.2 m -73.4 -53.28 11.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.5 m -47.74 -20.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 57.7 m -71.55 -60.84 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 110.163 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.4 38.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 110.402 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -65.78 -43.79 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.95 -1.094 . . . . 0.0 110.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -71.34 -19.62 62.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.89 -44.57 36.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 22.7 pt -72.04 158.35 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -77.06 146.85 37.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 45.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.467 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.5 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.5 mtt -86.8 147.43 25.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 94.0 mttt -116.9 -21.8 8.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.565 -0.709 . . . . 0.0 109.274 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 51.3 m-20 -146.23 142.34 28.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.3 t -140.8 158.52 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -0.77 . . . . 0.0 109.211 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.5 tp -146.29 107.32 4.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.937 . . . . 0.0 109.09 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.78 150.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.25 116.84 1.15 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.0 137.05 42.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.82 139.19 7.81 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -156.49 152.35 27.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.201 -1.176 . . . . 0.0 109.971 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -90.74 126.99 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.608 -0.682 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.73 138.31 34.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.356 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -132.76 106.85 8.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 109.29 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.1 m -86.16 106.1 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 p -59.36 -30.48 68.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -160.91 -34.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.431 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.61 60.62 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.533 ' CB ' HH22 ' A' ' 99' ' ' ARG . 3.1 pt20 -163.4 -165.97 1.16 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -1.189 . . . . 0.0 109.521 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -173.23 165.05 4.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.8 m-85 -96.25 142.8 27.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 14.6 m-20 -141.03 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.26 -0.9 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.77 149.69 25.1 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -108.11 118.17 36.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.322 -0.861 . . . . 0.0 109.633 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.91 133.11 42.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.388 -0.82 . . . . 0.0 108.993 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -149.95 167.85 25.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 110.201 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.3 137.65 54.6 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 9.0 m-85 -104.15 126.66 51.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.967 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.96 153.69 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.345 -0.847 . . . . 0.0 109.918 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -145.3 135.74 24.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 109.111 179.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.67 176.54 8.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.094 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.59 -7.51 59.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -85.24 1.82 46.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 109.906 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.66 -17.99 58.25 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 57.5 mttm -107.48 171.02 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 38' ' ' GLY . 5.7 t -99.64 137.36 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -62.31 -0.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -136.61 114.42 1.15 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.52 3.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -1.177 . . . . 0.0 110.6 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -99.34 -42.07 7.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.917 -1.114 . . . . 0.0 109.82 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' HG21 ' A' ' 36' ' ' VAL . 46.5 t0 46.81 14.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.994 -1.066 . . . . 0.0 109.594 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 36.2 t80 -137.3 99.44 3.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.815 . . . . 0.0 109.724 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.0 pt -105.2 135.13 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.1 p90 -139.3 -163.05 1.41 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.0 109.368 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 26.6 p90 -43.79 -36.92 2.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 110.551 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.586 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.8 t-20 -50.5 -11.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 109.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.1 t30 -135.29 104.7 5.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.468 -0.77 . . . . 0.0 109.067 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 mt -49.13 -28.92 4.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.473 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.1 pttp -164.85 157.67 16.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.331 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.479 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 3.6 m -68.7 143.5 54.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.458 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 -48.16 36.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.165 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.29 1.73 13.13 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.747 -0.596 . . . . 0.0 109.548 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.42 -14.15 74.57 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t 62.42 6.29 1.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -1.107 . . . . 0.0 109.799 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.15 151.62 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.115 -0.99 . . . . 0.0 108.986 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 p -145.21 139.74 27.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.075 -1.016 . . . . 0.0 110.251 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.419 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.0 m80 -90.27 132.87 35.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -72.25 -40.4 67.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.348 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.93 111.44 0.33 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.27 110.95 13.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.87 -164.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 63' ' ' THR . 12.7 ptt-85 -156.23 16.34 0.34 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 62' ' ' ARG . 23.0 p -155.84 -36.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.278 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.19 7.49 88.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.11 110.54 1.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.86 -127.1 1.79 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -164.96 163.3 20.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -1.092 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.24 -172.12 34.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.92 108.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -1.153 . . . . 0.0 109.433 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -61.37 -69.62 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.41 173.11 10.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -159.51 132.6 6.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.258 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -118.21 122.14 42.24 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -96.01 137.3 35.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 0.0 109.067 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.7 mt -129.33 143.35 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.634 -0.666 . . . . 0.0 110.018 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -141.22 98.84 3.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' VAL . 7.3 mt -80.79 -17.78 49.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -51.04 -36.73 41.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.27 27.28 7.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 80' ' ' VAL . 6.2 p -60.56 115.34 13.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 81.4 Cg_exo -46.55 -178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.812 1.674 . . . . 0.0 112.264 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.18 59.71 0.63 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -154.71 -54.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -1.177 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.45 148.53 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 1.0 OUTLIER -143.43 11.95 1.72 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.179 -0.951 . . . . 0.0 109.858 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -157.02 133.52 9.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 88' ' ' ILE . 87.9 mt -129.39 154.24 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.548 -0.72 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 87' ' ' ILE . 1.2 mt -144.68 173.44 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 108.904 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.62 141.95 49.76 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.1 t -147.23 151.94 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.942 -1.099 . . . . 0.0 110.953 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.7 p -147.53 113.92 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -122.28 174.6 6.89 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.741 0.781 . . . . 0.0 110.222 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.4 mm -83.86 166.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.546 ' N ' HG22 ' A' ' 93' ' ' ILE . 53.6 t60 -133.26 -66.58 0.65 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -48.12 -18.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.25 -38.42 52.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -54.53 -31.95 57.25 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 109.214 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -52.83 4.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -0.83 . . . . 0.0 111.008 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.533 HH22 ' CB ' ' A' ' 19' ' ' GLN . 10.9 ptp180 -110.51 -4.71 15.37 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.282 -0.886 . . . . 0.0 111.166 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.1 ttm180 57.07 102.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.858 -1.151 . . . . 0.0 109.205 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -147.69 148.97 31.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 m -104.2 161.93 13.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.43 -0.794 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -47.15 -35.31 7.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.734 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -42.38 99.75 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 23.4 mm100 -48.5 -14.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 109.403 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.4 t -83.76 164.59 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.1 t -64.87 -23.73 67.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.06 -1.025 . . . . 0.0 109.552 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.89 79.94 0.03 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.7 164.54 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 109.958 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.4 p90 -154.81 152.35 29.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.889 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -115.53 157.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.27 160.73 39.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.897 -1.127 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.8 tt -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.6 p -129.03 144.25 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 120' ' ' THR . 58.7 t30 -76.07 102.14 5.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -65.79 -1.69 3.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HA ' HD22 ' A' ' 4' ' ' ASN . 23.5 t0 -82.29 -53.72 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.58 6.33 8.89 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' ASN . 19.5 tt0 59.61 60.52 2.22 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 42.2 p -111.07 -69.8 0.85 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.879 -0.513 . . . . 0.0 110.334 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 45.1 mt-10 -45.26 157.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.77 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.52 52.15 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.134 -0.979 . . . . 0.0 110.218 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.5 ptt180 -140.18 142.4 35.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -91.34 147.65 22.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.089 -1.007 . . . . 0.0 109.12 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 18.5 p-10 -91.54 103.29 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.145 -0.972 . . . . 0.0 109.358 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.3 mt -80.89 -32.75 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.295 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 m -48.98 -37.52 20.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.909 -1.119 . . . . 0.0 108.963 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.37 -45.78 6.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.695 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.32 -4.54 42.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 110.535 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.4 -46.12 76.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.798 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -65.33 3.29 0.68 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 111.013 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -86.14 -34.93 20.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.596 -1.315 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.9 -161.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.907 -1.12 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.05 -3.83 6.94 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -146.79 135.4 22.07 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.4 ttp -165.83 158.08 14.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.941 -1.1 . . . . 0.0 110.335 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.69 139.41 31.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.341 -0.849 . . . . 0.0 109.471 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -78.62 -47.62 16.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 109.782 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.72 -164.29 14.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -151.45 163.19 39.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.168 -1.195 . . . . 0.0 109.739 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.65 134.75 24.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -146.05 165.84 27.86 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 109.781 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.1 ptm180 -90.34 143.7 26.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.859 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-80 -119.81 -116.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.606 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 18.8 m-20 -76.02 53.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.45 8.02 87.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -127.88 145.39 50.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.989 . . . . 0.0 109.314 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.1 m95 -70.58 151.59 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.424 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -145.97 126.85 14.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -89.72 147.92 23.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -153.03 107.37 3.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.305 -0.872 . . . . 0.0 109.046 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.91 154.64 40.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.6 t -143.41 -33.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.72 83.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -132.26 104.32 6.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.647 -0.913 . . . . 0.0 109.31 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.38 152.7 38.14 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.45 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -143.2 124.4 14.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.355 -1.085 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.06 6.22 37.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.44 -68.58 1.13 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.41 129.08 1.18 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.696 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.62 -26.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.165 . . . . 0.0 109.891 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.32 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.897 . . . . 0.0 109.457 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -50.98 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.45 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.3 m -47.83 -20.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 39.9 m -69.33 -59.93 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.817 . . . . 0.0 110.191 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -18.89 29.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.17 -43.74 87.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.017 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -71.48 -19.81 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.56 -2.37 89.62 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.41 159.42 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -79.03 135.59 36.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.42 81.84 6.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.446 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -67.66 -170.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 58.6 mttp -153.78 -34.64 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 59.7 m-20 -145.96 152.57 39.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' LEU . 77.2 t -147.62 155.8 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 109.291 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.4 tp -143.79 108.53 4.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 108.949 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.28 148.76 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 108.661 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.23 116.85 1.28 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.87 136.25 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.74 141.19 9.02 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.556 -1.307 . . . . 0.0 109.856 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -158.42 156.59 30.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.421 -1.047 . . . . 0.0 109.707 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -81.36 126.19 31.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.856 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.74 136.32 33.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.828 . . . . 0.0 109.118 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -132.99 116.44 16.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -120.7 106.53 11.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 m -65.27 -61.23 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.392 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.18 18.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.78 51.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -166.77 165.3 16.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -177.92 156.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.256 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.19 138.31 33.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.85 99.81 3.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 109.677 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -83.37 141.01 32.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -98.97 109.97 22.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.23 125.61 43.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.212 -0.93 . . . . 0.0 108.9 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 t -149.76 168.13 24.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 109.993 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.53 138.87 45.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -104.02 127.72 51.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.958 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.39 155.99 16.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.28 -0.888 . . . . 0.0 110.055 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.77 139.99 32.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.084 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.84 176.59 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.34 -5.46 59.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -89.75 4.04 50.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.0 109.905 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.96 -11.02 73.23 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.4 mttt -109.89 169.12 8.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 20.2 t -93.09 136.57 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 109.171 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -64.01 1.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -150.01 122.07 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -61.96 3.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 110.076 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.05 -42.24 8.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.889 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 31.8 t0 46.17 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 109.599 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 75.7 t80 -137.49 99.59 3.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.456 -0.777 . . . . 0.0 109.52 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.2 pt -103.69 137.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.4 p90 -143.52 -160.76 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 18.0 p90 -45.17 -31.89 1.63 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 7.9 t-20 -52.59 -11.22 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.873 -1.142 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.0 t30 -135.75 108.25 7.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -47.43 -28.93 2.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.835 . . . . 0.0 109.266 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.2 pttt -171.81 157.51 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 67.3 m -62.69 149.57 43.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.65 -48.75 14.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -116.45 0.84 12.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.651 -0.656 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.94 -12.84 67.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m 58.71 13.92 2.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 109.401 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 99.5 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.304 -0.872 . . . . 0.0 109.027 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.6 m -148.6 135.06 19.58 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.019 -1.051 . . . . 0.0 110.212 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' NE2' HD11 ' A' ' 73' ' ' LEU . 26.2 m80 -90.17 129.06 36.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -69.8 -43.84 71.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.3 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.11 115.18 0.44 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.08 110.95 17.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -1.133 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.92 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.381 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 63' ' ' THR . 76.2 mtm180 -150.69 12.38 0.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 62' ' ' ARG . 28.3 p -156.28 -38.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 0.0 109.273 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.63 -1.28 13.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.54 110.26 0.95 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.276 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 172.93 150.42 7.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.3 120.3 25.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.23 -138.41 41.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 p-10 -48.73 115.7 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 109.595 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.32 -64.9 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -88.39 173.43 8.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.95 132.24 6.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.362 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 ' NE2' ' A' ' 57' ' ' HIS . 1.0 OUTLIER -117.79 121.66 41.36 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -95.4 138.16 33.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 108.533 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.04 146.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.484 -0.76 . . . . 0.0 110.502 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 9.5 mtpm? -138.55 94.1 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.69 -5.36 40.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.47 -29.67 37.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 0.0 109.791 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.74 10.37 37.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.0 109.905 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.24 125.59 69.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.984 . . . . 0.0 109.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.95 -161.11 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.894 1.729 . . . . 0.0 111.868 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.84 4.52 78.76 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 2.5 m-20 -64.41 -54.52 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -1.189 . . . . 0.0 109.44 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.99 149.07 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 9.3 t0 -123.91 -9.05 7.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.767 . . . . 0.0 109.46 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -158.06 131.34 7.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 110.029 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.9 mt -121.13 154.18 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -142.57 173.16 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.093 -1.004 . . . . 0.0 109.304 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 11.0 m-85 -142.31 118.56 10.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.89 157.73 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.7 p -130.92 114.35 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -110.21 148.16 32.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.1 mm -74.3 138.97 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.4 t60 -96.27 -65.11 0.99 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.005 . . . . 0.0 109.805 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -47.31 -18.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.08 -18.23 23.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 109.734 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.25 -61.49 1.82 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.85 -1.156 . . . . 0.0 109.545 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.18 -40.47 11.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -0.84 . . . . 0.0 111.086 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.4 mpt_? -85.19 -19.13 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.897 -1.127 . . . . 0.0 110.955 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 99' ' ' ARG . 50.1 ttp85 55.62 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.806 -1.184 . . . . 0.0 109.255 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.9 144.67 14.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -102.03 166.82 10.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.52 -32.14 3.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.847 . . . . 0.0 109.76 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.66 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.5 -37.05 93.51 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -46.88 -19.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -1.192 . . . . 0.0 109.244 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 107' ' ' SER . 19.2 t -86.48 166.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 0.0 108.986 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 p -66.99 -26.6 66.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.639 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.2 78.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.03 164.67 25.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 22.6 p90 -152.37 151.98 31.5 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 110.263 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.0 mt -114.49 154.46 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -144.13 157.5 44.27 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 tt -150.63 125.77 9.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 0.0 109.266 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.25 143.57 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.699 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 120' ' ' THR . 61.4 m-20 -75.19 102.08 4.85 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 35.5 t0 -66.1 -1.67 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 109.851 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 1.1 p30 -83.53 -52.65 6.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -0.928 . . . . 0.0 109.494 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 22.1 m120 -122.87 5.69 9.37 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 0.0 109.819 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.1 mt-30 58.97 60.06 2.58 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.456 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.0 m -112.03 -69.72 0.85 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.946 -0.471 . . . . 0.0 110.471 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 53.6 mm-40 -45.25 157.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.97 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.95 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.78 151.21 52.05 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -140.74 143.54 35.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.708 . . . . 0.0 109.143 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.73 147.82 22.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.6 103.31 15.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.971 . . . . 0.0 109.326 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.2 mt -81.03 -38.19 27.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.5 m -47.61 -32.1 5.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.147 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.47 -54.23 3.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.533 -0.729 . . . . 0.0 109.94 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.49 -2.95 27.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.99 . . . . 0.0 110.612 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.66 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.05 -45.99 68.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 109.193 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -69.36 3.19 2.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.0 109.873 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.2 m -82.78 -34.5 27.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 110.346 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -176.76 -162.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.958 -1.089 . . . . 0.0 109.729 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.47 -7.92 6.91 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.48 136.04 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 ptm -165.46 157.75 15.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -92.27 141.43 28.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -86.54 -22.42 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.19 -171.29 40.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.31 163.41 38.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -1.156 . . . . 0.0 109.496 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.67 138.88 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.55 166.15 31.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.145 -0.972 . . . . 0.0 109.718 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -93.35 143.9 25.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.671 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.3 t60 -118.79 -118.55 0.31 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.626 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 30.8 t30 -75.41 51.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.05 8.84 86.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -127.81 139.99 52.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.987 . . . . 0.0 109.353 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -68.05 151.79 46.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -148.69 125.74 11.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -89.3 146.82 24.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.442 -0.786 . . . . 0.0 109.459 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -151.22 111.23 4.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.041 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.99 154.68 40.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.766 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.17 -33.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.39 0.04 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.561 ' H ' HD21 ' A' ' 138' ' ' LEU . 32.7 tt0 -143.72 104.31 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.443 -1.034 . . . . 0.0 109.157 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.73 34.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -134.6 138.44 44.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.618 -0.931 . . . . 0.0 108.919 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.39 9.06 39.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.76 -73.88 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 155.53 129.84 1.26 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.27 -24.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 109.879 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.0 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 166' ' ' CYS . 52.8 p -78.99 -54.43 6.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.652 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.472 HG11 ' CE1' ' A' ' 158' ' ' TYR . 29.6 m -45.37 -19.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.328 -0.857 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 164' ' ' SER . 89.3 m -72.54 -62.15 1.55 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.1 -14.88 40.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.381 -0.825 . . . . 0.0 110.133 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -56.33 -45.65 80.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -78.79 -19.71 51.54 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.529 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . -75.04 -41.24 32.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.9 pt -78.9 159.53 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.13 147.06 53.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.933 . . . . 0.0 109.421 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.4 98.69 7.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.446 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.4 mpt? -79.63 175.98 10.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.428 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -154.09 -34.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -146.13 128.44 15.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -127.0 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.63 110.84 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.446 -0.783 . . . . 0.0 109.057 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.99 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 108.699 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.83 117.15 1.61 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -112.44 127.23 55.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.28 150.0 22.2 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -159.42 151.45 20.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.355 -1.085 . . . . 0.0 109.944 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -90.51 122.87 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.677 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.67 167.08 17.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -132.85 106.99 8.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.437 -0.789 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 m -87.99 125.4 34.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 109.279 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -157.93 -36.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.42 26.67 2.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.395 -0.815 . . . . 0.0 109.002 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.7 -23.93 6.24 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -64.0 155.72 30.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.361 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -157.67 156.1 31.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 62.9 m-85 -96.21 136.39 36.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.8 p-10 -140.92 99.79 3.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 23' ' ' LEU . 7.5 mp -83.45 130.49 35.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -90.67 123.36 34.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.76 131.03 44.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 p -150.1 168.24 24.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.021 -1.049 . . . . 0.0 109.939 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -139.75 136.81 34.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -103.32 138.26 40.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.149 -0.969 . . . . 0.0 109.796 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.931 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -90.36 163.22 14.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 mt -144.92 141.7 29.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.059 -1.026 . . . . 0.0 109.867 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.12 176.71 9.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.583 -0.698 . . . . 0.0 109.219 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.04 -3.78 55.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.29 2.45 55.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -22.36 40.1 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 mttp -104.97 173.15 6.43 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -93.99 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -68.9 4.07 1.69 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -127.88 150.16 18.26 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.37 1.2 57.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.254 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.41 -42.34 5.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.221 -0.924 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 45.43 21.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.311 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 66.6 t80 -136.2 99.64 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.554 -0.716 . . . . 0.0 110.275 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 pt -103.34 134.85 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.0 p90 -146.11 -161.18 1.26 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.03 -1.044 . . . . 0.0 109.735 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.3 p90 -45.92 -30.67 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.116 -0.99 . . . . 0.0 110.434 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 8.3 t30 -61.97 -1.17 0.61 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.895 -1.128 . . . . 0.0 108.972 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.3 t30 -141.48 100.12 3.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.448 -0.783 . . . . 0.0 109.039 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.12 -24.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.305 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.3 pttt -166.78 154.87 9.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.41 ' OG ' HD21 ' A' ' 29' ' ' LEU . 23.1 t -62.67 137.85 58.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.51 92.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -116.13 -17.14 10.92 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.648 -0.658 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.67 76.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m 54.47 20.72 2.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 109.288 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB3' ' A' ' 50' ' ' SER . 89.2 t -92.85 151.54 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.886 . . . . 0.0 109.076 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -133.91 125.48 28.38 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.512 -0.742 . . . . 0.0 109.515 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -92.46 124.19 36.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.339 -0.851 . . . . 0.0 109.367 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.8 m -58.58 -46.59 86.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.92 143.72 3.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.3 112.51 24.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -1.119 . . . . 0.0 109.395 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 64' ' ' GLY . 3.1 m-20 -82.08 128.78 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.63 5.65 17.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.9 p -153.55 -35.03 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . 63.39 16.63 58.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -58.34 110.42 0.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -1.145 . . . . 0.0 109.532 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.35 -126.26 1.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -170.33 69.41 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -1.139 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.74 -176.03 37.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 38.4 p-10 -52.65 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.106 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.418 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.4 m-20 -57.95 -64.45 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 72' ' ' SER . 60.0 mt-10 -102.69 170.97 7.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.363 -0.835 . . . . 0.0 108.989 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.1 m -165.85 164.65 18.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -135.06 124.04 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -95.69 109.68 21.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.729 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.29 146.81 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -142.29 92.7 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' ALA . 10.5 mt -71.09 -41.95 69.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.111 -0.993 . . . . 0.0 110.322 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -48.15 -13.96 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.544 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -104.97 -19.3 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.459 -0.776 . . . . 0.0 109.858 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 77' ' ' LEU . 37.9 t -60.81 126.37 85.26 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.268 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 -160.11 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.983 1.789 . . . . 0.0 111.895 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.49 3.7 63.66 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.64 -60.95 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -1.218 . . . . 0.0 109.347 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 30' ' ' LEU . 11.7 p -84.46 148.06 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.468 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.1 m-20 -125.71 -3.14 7.22 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.378 -0.826 . . . . 0.0 110.046 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.48 136.67 15.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.952 -1.093 . . . . 0.0 109.436 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.41 154.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.602 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -138.38 172.89 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.146 -0.971 . . . . 0.0 110.103 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -137.53 129.2 28.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG21 ' CE2' ' A' ' 28' ' ' PHE . 25.1 t -140.57 151.32 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.953 . . . . 0.0 111.344 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.0 p -132.7 131.63 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -132.4 155.37 48.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.64 HD12 ' NE2' ' A' ' 101' ' ' GLN . 6.1 mm -73.9 162.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -128.34 -60.24 1.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.522 -0.736 . . . . 0.0 109.465 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -49.88 -18.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.25 -42.4 86.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -54.13 -32.07 54.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.739 -1.226 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.86 -53.23 4.48 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.256 -0.903 . . . . 0.0 111.311 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' ARG . 3.1 ptp85 -111.85 1.72 16.69 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.181 -0.949 . . . . 0.0 111.237 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 96' ' ' ALA . 46.2 ttp180 56.19 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.788 -1.195 . . . . 0.0 109.24 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.64 ' NE2' HD12 ' A' ' 93' ' ' ILE . 1.3 pp0? -153.16 147.77 26.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.154 -0.966 . . . . 0.0 109.437 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 101' ' ' GLN . 20.8 m -105.01 163.41 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.831 . . . . 0.0 110.01 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -43.85 -28.61 0.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 0.0 110.161 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.641 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.1 -44.1 96.26 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.9 tp60 -47.64 -17.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 107' ' ' SER . 16.1 t -82.25 165.88 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -67.86 -21.72 65.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.671 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.41 79.98 0.03 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.23 162.48 27.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 109.623 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.5 p90 -155.38 151.69 28.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 45.9 mt -117.02 153.61 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -139.98 154.72 47.25 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.058 -1.026 . . . . 0.0 109.739 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -148.59 117.51 6.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.7 p -129.16 145.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.38 -0.825 . . . . 0.0 109.838 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.428 ' HB3' ' H ' ' A' ' 120' ' ' THR . 64.0 t30 -76.12 101.87 5.51 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.46 -1.58 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.847 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -83.62 -52.99 5.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 109.661 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -122.97 4.37 9.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 60.29 60.61 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 35.8 m -113.07 -69.09 0.88 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.817 -0.552 . . . . 0.0 110.227 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.2 mt-10 -45.29 157.83 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.91 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.57 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.53 148.86 52.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 109.902 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.7 ptm180 -138.61 145.2 40.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.405 ' CE2' ' HE1' ' A' ' 137' ' ' MET . 8.0 t80 -91.32 147.59 22.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.235 -0.916 . . . . 0.0 109.061 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -91.05 103.37 16.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 83.9 mt -80.77 -37.71 29.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.482 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 128' ' ' THR . 2.5 p -47.8 -32.37 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.151 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.29 -53.89 3.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 -2.2 23.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.224 -0.922 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -53.25 -46.8 69.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.2 t -69.49 3.2 2.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.603 -0.686 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -83.4 -34.7 25.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 110.354 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -176.61 -161.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.4 -2.49 5.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.65 134.09 13.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.405 ' HE1' ' CE2' ' A' ' 125' ' ' TYR . 20.5 ptm -165.49 152.58 10.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.058 -1.026 . . . . 0.0 109.911 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -87.47 138.43 31.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 27.6 t80 -80.25 -43.57 21.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.31 -173.85 35.11 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.858 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -150.77 166.59 30.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.143 -1.21 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 139.8 44.14 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -144.88 166.2 25.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.03 -1.044 . . . . 0.0 109.84 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.468 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.3 ptm180 -90.15 145.77 24.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.51 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 1.1 t60 -123.57 -120.29 0.28 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.598 -0.689 . . . . 0.0 109.166 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.51 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 10.1 m120 -73.37 52.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.64 88.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.84 142.0 51.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.582 -0.952 . . . . 0.0 109.406 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.458 ' CG ' HD13 ' A' ' 77' ' ' LEU . 74.6 m95 -67.48 151.64 47.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.358 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -149.96 132.82 16.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.076 -1.015 . . . . 0.0 109.632 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -89.91 153.16 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 107.32 1.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.1 154.74 41.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.724 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.69 -33.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.859 . . . . 0.0 109.268 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.57 86.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -134.8 104.36 5.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.574 -0.956 . . . . 0.0 109.214 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.64 146.09 18.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.551 ' CD1' HG11 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -147.4 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -1.08 . . . . 0.0 108.971 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.88 40.6 3.24 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.539 -0.726 . . . . 0.0 109.471 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.95 -54.45 3.4 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.0 122.13 0.71 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -45.53 -35.74 4.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.12 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.45 -28.36 23.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 109.59 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.8 p -80.88 -50.68 9.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.989 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.551 HG11 ' CD1' ' A' ' 158' ' ' TYR . 17.8 m -49.15 -21.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.008 . . . . 0.0 109.533 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 28' ' ' PHE . 57.9 m -79.39 -59.98 2.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.912 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.5 63.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.465 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -71.05 -28.41 64.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.969 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.85 -19.57 61.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . -80.55 -51.71 4.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.85 159.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -1.1 . . . . 0.0 109.403 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -69.59 140.02 53.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 -160.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.48 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.4 mtt -81.31 162.51 23.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -130.95 -31.3 1.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.499 -0.75 . . . . 0.0 109.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -146.23 128.17 15.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 109.089 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.13 144.45 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 73' ' ' LEU . 15.5 tp -130.64 114.29 15.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 89' ' ' PHE . 61.9 t -86.0 151.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 108.777 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.43 121.65 2.34 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.7 tt -132.49 126.17 32.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.608 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -146.32 152.99 25.04 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -155.04 154.57 32.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -1.044 . . . . 0.0 109.7 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -90.45 120.97 32.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 137.31 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.171 -0.955 . . . . 0.0 109.303 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -87.1 113.26 22.69 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.447 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -84.44 123.42 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -145.46 -41.75 0.22 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.308 -0.87 . . . . 0.0 109.274 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.28 37.72 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.25 -20.71 24.72 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -74.65 149.77 39.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.313 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -160.14 175.31 13.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.521 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -96.32 145.73 25.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 25.1 p-10 -140.97 99.68 3.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.371 -0.831 . . . . 0.0 109.574 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -85.51 130.53 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 108.758 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.72 106.0 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -98.28 124.93 43.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -149.47 168.23 24.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.973 -1.079 . . . . 0.0 110.115 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.58 137.38 46.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m-85 -102.99 130.55 50.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.0 109.178 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.73 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.66 145.54 28.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.86 136.46 25.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.026 . . . . 0.0 110.109 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.16 176.48 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.699 . . . . 0.0 109.519 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -7.47 59.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 -0.16 47.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.31 -12.01 61.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.74 148.68 24.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 38' ' ' GLY . 29.0 t -66.39 136.89 25.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.934 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.94 9.25 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.0 170.09 34.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.14 3.83 54.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.986 -1.302 . . . . 0.0 109.902 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.16 -41.78 5.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.243 -0.91 . . . . 0.0 110.309 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 23.2 t0 51.04 9.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 0.0 109.313 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.2 p90 -138.29 118.75 13.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.316 -0.865 . . . . 0.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 29' ' ' LEU . 6.3 pt -114.22 134.14 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -154.74 -148.21 0.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.959 . . . . 0.0 108.888 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 47' ' ' ASN . 37.3 p90 -44.89 -32.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.826 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 18.2 p-10 -65.4 4.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.177 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.1 t30 -155.53 100.29 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.804 . . . . 0.0 109.155 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -48.09 -18.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 28.4 pttt -175.38 155.23 1.81 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.398 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 54' ' ' SER . 53.2 p -66.71 130.51 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.83 -48.72 44.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.826 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -116.39 23.36 12.14 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 109.929 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.33 -15.11 7.24 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.6 t 63.48 4.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -1.116 . . . . 0.0 109.458 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 50' ' ' SER . 69.7 t -92.9 146.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.914 . . . . 0.0 108.916 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.9 m -149.78 153.78 37.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.057 . . . . 0.0 110.35 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.6 m80 -90.58 131.74 36.12 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.2 m -81.78 -34.71 30.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.506 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 113.76 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.74 159.09 25.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -1.122 . . . . 0.0 109.492 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.82 118.59 7.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -84.17 10.77 9.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.7 p -154.41 -35.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.62 13.03 58.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.57 110.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.478 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.25 -115.61 0.67 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.03 166.12 4.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.63 177.98 49.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.85 99.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -1.198 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.53 -68.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.33 146.73 23.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.267 -0.896 . . . . 0.0 109.279 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -159.84 141.56 12.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.37 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 57' ' ' HIS . 8.0 mp -115.4 130.36 56.87 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.0 109.554 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -96.73 109.94 22.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.8 146.75 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.204 -0.935 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -141.98 90.62 2.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 149' ' ' TRP . 11.3 mt -78.86 -10.76 59.9 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.13 -0.84 0.82 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.009 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -135.83 18.12 3.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.0 p -60.2 134.99 90.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.329 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.5 -161.36 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.939 1.759 . . . . 0.0 111.682 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.08 39.7 2.79 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -126.19 -59.16 1.33 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.477 -1.014 . . . . 0.0 109.688 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.82 145.67 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.11 -0.994 . . . . 0.0 109.686 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.458 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -138.97 1.5 2.06 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.399 -0.813 . . . . 0.0 109.581 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -149.06 131.35 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 108.963 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -137.38 130.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 141' ' ' GLU . 9.3 pt -137.22 152.89 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.933 . . . . 0.0 109.619 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 7' ' ' VAL . 28.3 m-85 -101.59 141.18 34.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.377 -0.827 . . . . 0.0 109.08 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.89 153.02 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.922 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -133.15 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -138.29 145.17 40.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.904 . . . . 0.0 109.861 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.26 148.01 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -0.862 . . . . 0.0 108.822 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' ALA . 56.6 t-80 -101.32 -70.66 0.74 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -47.51 -18.1 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 109.694 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -53.5 -18.76 3.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.81 -62.19 1.49 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.905 -1.122 . . . . 0.0 109.244 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.45 -38.45 12.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 110.813 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.517 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 6.2 mpt_? -85.14 -18.0 35.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.042 -1.036 . . . . 0.0 111.109 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 99' ' ' ARG . 16.1 tpt180 52.1 94.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.811 -1.18 . . . . 0.0 108.763 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -152.46 140.68 20.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 109.435 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 t -99.62 164.14 12.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.44 -30.9 2.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.397 -0.814 . . . . 0.0 109.934 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.39 -39.73 98.08 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -49.78 -15.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.502 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 107' ' ' SER . 17.7 t -83.13 163.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 109.088 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -62.66 -22.7 66.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.74 80.02 0.03 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.3 164.33 24.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.129 . . . . 0.0 109.667 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.0 p90 -150.04 169.82 20.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.194 -0.942 . . . . 0.0 110.185 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 18.1 mt -136.13 152.11 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 67.0 ttt-85 -143.55 163.62 32.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.1 tt -156.58 117.19 3.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.568 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.0 p -132.13 145.32 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.309 -0.87 . . . . 0.0 110.212 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 119' ' ' GLN . 2.2 m120 -78.6 102.35 7.91 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -68.0 -1.76 6.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.104 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.15 -53.13 7.29 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.993 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -123.27 3.03 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.2 mt-30 59.95 61.28 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 32.6 m -114.33 -66.31 1.1 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.901 -0.499 . . . . 0.0 110.247 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 122' ' ' VAL . 1.4 mp0 -45.3 156.91 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.563 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.4 73.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.23 143.83 50.2 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.087 -1.008 . . . . 0.0 110.154 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.1 ptp180 -138.0 139.33 39.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.508 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 6.4 t80 -91.02 142.78 27.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 108.97 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -85.72 102.85 13.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.438 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 95.0 mt -79.42 -36.71 38.61 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 0.0 109.308 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 128' ' ' THR . 4.9 p -48.06 -33.2 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.139 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -95.3 -53.59 3.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.487 -0.758 . . . . 0.0 109.721 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 65.8 m-20 -71.9 -5.46 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.96 -46.06 68.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.18 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 65.4 p -68.84 3.18 2.08 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.916 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.0 m -83.32 -34.78 25.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.252 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -177.06 -162.77 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.971 -1.081 . . . . 0.0 109.677 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.52 -13.29 7.59 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.39 135.36 32.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.2 ttp -165.33 151.34 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.024 -1.047 . . . . 0.0 110.189 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.36 137.21 32.53 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.429 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -75.84 -47.43 25.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.902 -1.124 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.96 -158.91 9.06 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 88' ' ' ILE . 13.2 tt0 -150.98 158.65 44.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -1.085 . . . . 0.0 109.266 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 143' ' ' TYR . 1.8 tt -143.28 131.92 22.49 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.562 ' N ' HD23 ' A' ' 142' ' ' LEU . 12.1 p90 -150.66 166.34 30.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.5 ptm180 -94.68 142.53 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.449 -0.782 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -114.15 -120.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.593 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 20.0 t-20 -73.66 51.35 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.129 -0.982 . . . . 0.0 109.146 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.64 82.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -127.67 140.12 52.28 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.562 -0.963 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.532 ' CE2' HD13 ' A' ' 77' ' ' LEU . 58.0 m95 -67.3 151.75 46.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -151.4 121.6 7.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -91.81 145.21 24.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.243 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -152.18 107.28 3.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.106 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.506 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -64.16 154.54 34.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.725 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.7 t -138.76 -33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.83 83.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -134.61 104.13 5.94 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.61 -0.936 . . . . 0.0 109.007 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.91 149.22 21.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.34 132.61 26.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -1.016 . . . . 0.0 108.99 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -87.14 19.64 3.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.53 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -57.66 -107.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.1 129.43 1.96 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.55 -30.3 2.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -30.86 22.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.3 t -79.54 -53.93 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 18.1 m -47.2 -19.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 164' ' ' SER . 65.9 m -74.49 -61.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.03 -15.13 45.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -57.19 -43.69 82.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 45.8 m-85 -71.84 -20.07 61.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.35 -34.38 29.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 93.1 mt -71.91 136.17 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -1.217 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -65.96 126.21 27.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.51 -12.25 59.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.408 -179.93 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.466 ' N ' ' SD ' ' A' ' 2' ' ' MET . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -156.53 156.38 33.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 57.0 mttp -126.98 -14.53 5.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.519 -0.738 . . . . 0.0 109.382 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 43.0 m-20 -146.31 128.63 15.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.208 -0.932 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 6' ' ' LEU . 69.2 t -127.17 158.56 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.567 -0.708 . . . . 0.0 109.307 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' N ' HG12 ' A' ' 5' ' ' VAL . 12.0 tp -145.64 109.45 4.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 109.061 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.78 150.84 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.905 . . . . 0.0 108.747 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.24 117.25 1.68 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.1 tp -115.36 124.21 50.67 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -144.03 150.56 22.59 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -159.95 152.12 20.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.396 -1.061 . . . . 0.0 109.893 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.18 129.61 34.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.575 -0.703 . . . . 0.0 109.643 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.4 170.18 16.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.386 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -132.72 107.07 8.15 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.522 -0.736 . . . . 0.0 109.314 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -85.35 123.91 31.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -145.74 -36.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.388 -0.82 . . . . 0.0 109.205 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -158.23 33.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.315 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.61 -0.28 84.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -78.28 165.89 23.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -1.18 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 12.3 p-10 -172.4 149.15 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.574 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.26 143.37 27.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -141.06 100.25 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.269 -0.894 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -83.28 135.51 34.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 108.748 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.51 117.59 30.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.51 130.98 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.66 167.75 25.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 109.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.27 144.98 42.91 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -101.94 151.81 21.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -118.87 143.34 47.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.562 -0.711 . . . . 0.0 109.282 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 133.2 22.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.069 -1.019 . . . . 0.0 110.136 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.5 176.5 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.741 -0.6 . . . . 0.0 109.487 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.93 -2.49 55.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 46.7 t30 -87.67 -1.43 57.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.741 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.54 -13.02 65.09 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -101.61 150.99 22.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.536 -0.979 . . . . 0.0 108.402 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 38' ' ' GLY . 27.4 t -69.05 137.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.24 -0.913 . . . . 0.0 109.121 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -71.62 8.68 1.04 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.74 170.95 35.35 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.1 m-20 -94.81 3.46 54.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.939 -1.33 . . . . 0.0 110.21 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.17 -42.13 5.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.056 -1.028 . . . . 0.0 110.584 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t0 49.63 9.93 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.955 -1.09 . . . . 0.0 109.496 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 8.2 t80 -138.13 100.22 4.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.323 -0.861 . . . . 0.0 109.803 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 29' ' ' LEU . 8.0 pt -96.75 139.6 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.208 -0.932 . . . . 0.0 108.608 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 35.4 p90 -151.23 -152.3 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 109.568 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.5 m-85 -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.644 -0.66 . . . . 0.0 110.013 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -57.27 -4.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -0.965 . . . . 0.0 108.639 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.0 t30 -151.32 102.03 2.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -48.72 -26.34 2.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.6 pttp -163.93 157.28 18.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 7.1 t -76.97 125.86 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.241 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.77 -45.81 67.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.922 . . . . 0.0 109.758 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.75 -12.23 19.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.494 -0.754 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.19 -13.51 68.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 p 60.45 12.19 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -1.212 . . . . 0.0 109.104 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' H ' ' HB3' ' A' ' 50' ' ' SER . 69.9 t -92.97 151.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.413 -0.804 . . . . 0.0 109.214 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.2 m -148.52 139.13 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.01 . . . . 0.0 109.921 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 73' ' ' LEU . 50.7 m80 -90.3 129.01 36.58 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -66.63 -53.02 38.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.4 114.09 0.54 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -79.37 110.98 15.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.94 -163.93 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 63' ' ' THR . 18.0 ptt180 -155.41 15.86 0.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.0 p -155.85 -39.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.22 24.79 46.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -58.34 135.78 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -1.15 . . . . 0.0 109.326 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.22 124.29 0.79 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.38 -163.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -1.145 . . . . 0.0 109.579 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 165.17 33.75 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.28 98.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -1.122 . . . . 0.0 109.486 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.21 -57.38 13.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.22 170.82 8.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 132.21 5.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.201 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -115.23 119.44 36.34 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.05 137.32 35.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 109.081 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -127.8 144.75 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.588 -0.695 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.35 97.27 3.34 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.7 mt -82.98 -14.96 53.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.087 -1.008 . . . . 0.0 109.557 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.43 -1.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.462 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.37 16.32 3.73 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.342 -0.849 . . . . 0.0 109.101 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.2 p -60.68 134.96 92.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.217 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.24 -177.95 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.814 1.676 . . . . 0.0 111.495 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.41 13.57 64.92 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -96.89 -59.78 1.73 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -1.14 . . . . 0.0 109.828 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.22 148.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.734 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -144.06 7.37 1.39 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.31 -0.869 . . . . 0.0 109.635 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -152.0 140.23 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 109.051 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 87' ' ' ILE . 6.1 mt -145.55 122.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.161 -0.962 . . . . 0.0 109.709 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.09 174.15 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.339 -0.851 . . . . 0.0 108.747 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -141.08 119.53 12.29 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.07 157.67 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.332 -0.855 . . . . 0.0 110.651 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.61 136.72 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 p -131.12 148.54 52.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.5 mm -75.57 147.87 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' ALA . 4.0 t60 -102.36 -68.48 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.249 -0.907 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.27 -18.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.48 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -54.25 -17.89 3.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -69.86 -59.63 2.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.939 -1.101 . . . . 0.0 109.964 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.77 -51.33 5.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.181 -0.949 . . . . 0.0 111.354 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -78.09 -16.84 57.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.96 -1.088 . . . . 0.0 110.991 -178.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' ARG . 35.6 ttp180 55.89 101.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.746 -1.221 . . . . 0.0 109.308 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -159.16 143.06 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -100.96 167.25 10.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -45.87 -35.35 4.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.686 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.15 -39.31 92.08 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -46.98 -16.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -1.174 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -86.08 168.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.149 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.518 ' N ' HG12 ' A' ' 106' ' ' VAL . 23.2 m -70.86 -22.23 62.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.819 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.61 79.39 0.03 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.5 23.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 109.748 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 42.8 p90 -152.34 163.32 39.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 54.3 mt -126.2 154.3 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.43 ' NH2' HG12 ' A' ' 122' ' ' VAL . 50.6 ttt85 -141.22 159.85 41.34 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.983 -1.073 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.2 tt -154.22 116.99 4.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 109.28 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.58 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -130.98 143.51 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 120' ' ' THR . 55.9 t30 -75.14 102.07 4.8 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.62 -1.32 2.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 25.3 t70 -83.01 -53.55 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.652 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.6 6.2 8.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.587 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 59.52 60.33 2.31 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 43.1 p -110.62 -70.12 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.925 -0.485 . . . . 0.0 110.298 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 122' ' ' VAL . 66.8 mt-10 -45.33 157.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.324 -0.86 . . . . 0.0 109.774 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 150.17 52.15 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.091 -1.006 . . . . 0.0 110.02 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -139.78 142.26 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.645 -0.659 . . . . 0.0 109.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.35 147.77 22.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.234 -0.916 . . . . 0.0 109.147 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -91.17 103.16 15.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.407 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 82.3 mt -79.24 -39.3 33.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.4 m -47.51 -30.29 3.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.971 -1.081 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.3 -54.74 3.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.403 -0.811 . . . . 0.0 109.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.5 -2.35 28.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.14 -0.975 . . . . 0.0 110.418 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.46 -45.27 69.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.217 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 t -70.91 3.08 3.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.491 -0.756 . . . . 0.0 109.868 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.1 m -83.11 -34.72 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.035 -1.04 . . . . 0.0 110.226 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -176.74 -162.42 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.022 . . . . 0.0 109.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.56 -15.31 7.58 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.41 138.67 36.71 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.3 ptm -165.45 157.99 15.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 0.0 109.916 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.07 134.64 37.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.347 -0.846 . . . . 0.0 109.664 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -76.71 -42.42 41.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.05 . . . . 0.0 109.431 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.44 -163.13 13.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.28 163.05 39.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -1.098 . . . . 0.0 109.015 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.5 tp -144.82 137.22 26.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.068 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -150.68 166.04 31.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 109.275 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -95.7 141.45 29.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.602 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER -99.18 -133.95 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.602 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 5.6 m120 -52.22 -50.48 61.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.984 -1.072 . . . . 0.0 108.269 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.04 16.94 0.13 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -129.87 154.43 47.3 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.228 -1.16 . . . . 0.0 109.683 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 1' ' ' SER . 71.9 m95 -72.35 151.86 42.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.395 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -147.28 121.63 9.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.233 -0.917 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -90.32 146.26 24.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -150.81 107.78 3.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.4 -0.812 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.44 154.7 40.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.835 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 -33.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.4 85.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.16 104.3 5.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.531 -0.982 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.89 150.66 26.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.67 135.07 41.79 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.604 -0.939 . . . . 0.0 108.837 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.51 2.7 54.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 109.519 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -58.68 -110.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.97 140.27 6.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.75 -35.22 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.848 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.49 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.79 -19.81 30.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.1 m -89.02 -52.44 5.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 12.7 m -54.54 -28.29 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.617 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 32.1 p -78.54 -54.59 5.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -71.98 -15.12 62.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.976 -1.077 . . . . 0.0 109.33 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -28.99 63.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 51.1 m-85 -71.78 -19.83 61.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 109.473 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.56 -49.0 4.29 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.3 158.87 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -1.136 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -69.51 122.69 19.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.459 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 91.21 5.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 149' ' ' TRP . 20.9 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.08 -170.99 2.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -153.25 -34.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -145.99 141.26 27.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.313 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG1' HD21 ' A' ' 113' ' ' LEU . 10.9 t -141.0 154.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.0 109.226 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.79 121.82 12.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 109.288 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -91.8 150.74 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 108.988 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.3 116.85 1.8 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -112.59 127.81 56.19 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.86 146.95 17.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -157.63 152.74 25.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -1.134 . . . . 0.0 109.872 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -92.53 126.51 37.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.737 . . . . 0.0 109.649 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.22 138.29 32.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.473 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -82.24 109.52 16.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -82.61 124.96 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 17' ' ' ASP . 10.2 t -152.96 -34.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 16' ' ' THR . 30.2 t70 -157.98 40.57 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.53 -22.14 4.88 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.59 171.46 7.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -1.167 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -176.03 173.39 2.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.474 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 95.2 m-85 -96.17 153.09 17.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -140.93 111.15 6.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.92 163.61 13.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -106.68 154.57 20.74 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 0.0 109.479 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -144.67 109.7 5.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.185 -0.947 . . . . 0.0 108.764 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 t -149.43 163.3 38.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 109.974 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 144.69 37.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 8.0 m-85 -104.04 129.07 51.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.447 -0.783 . . . . 0.0 108.909 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.004 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.53 155.56 17.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.41 -0.806 . . . . 0.0 109.204 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.23 137.3 25.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.69 176.35 8.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.445 -0.785 . . . . 0.0 109.266 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.5 -2.55 53.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.642 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -93.18 3.55 55.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.174 -0.954 . . . . 0.0 109.821 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 -19.6 53.83 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.3 mttp -106.26 172.45 6.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -101.27 141.81 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -59.69 -5.55 0.93 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -148.6 101.11 0.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 18.6 p-10 -45.23 -18.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.376 -1.073 . . . . 0.0 110.28 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.44 79.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 0.0 109.561 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.696 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 45.45 17.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' ALA . 52.5 t80 -137.8 100.02 4.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.533 -0.729 . . . . 0.0 109.858 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 29' ' ' LEU . 6.2 pt -106.3 139.65 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.315 -0.866 . . . . 0.0 109.072 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -152.92 -148.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 109.039 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' ASN . 25.9 p90 -44.46 -34.33 2.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.971 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.69 -5.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.166 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 54.0 t-20 -148.0 110.09 4.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -0.834 . . . . 0.0 108.956 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.24 -29.1 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 12.8 pttm -169.17 155.6 6.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.432 -0.793 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 5.1 t -73.51 117.51 15.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.189 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.22 78.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.663 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -93.42 -16.41 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.29 -0.881 . . . . 0.0 109.786 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.17 -13.69 61.58 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t 58.39 14.04 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.9 t -92.91 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.329 -0.857 . . . . 0.0 109.168 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.5 m -145.75 136.12 24.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 57.2 m80 -89.97 133.49 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.347 -0.846 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -71.75 -60.79 2.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.506 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.43 114.92 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 32.6 p-10 -82.21 110.94 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.0 t-20 -80.84 -163.48 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.358 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 36.1 ttp180 -151.91 14.23 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 109.243 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -154.11 -38.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.945 . . . . 0.0 109.25 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.83 -3.7 63.66 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.49 110.4 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -1.156 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.71 -122.11 1.13 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -169.85 160.02 8.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -1.11 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 166.58 31.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.24 124.13 9.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -1.165 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.93 -73.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -90.84 99.66 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 t -91.38 132.15 36.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.217 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -112.27 125.08 53.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -96.3 142.51 28.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 108.949 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -133.68 146.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.332 -0.855 . . . . 0.0 109.927 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -142.2 102.23 4.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 79' ' ' ALA . 5.6 mt -82.59 -27.69 31.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.862 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -63.63 4.65 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.29 19.08 4.01 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.81 125.81 45.19 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.117 -0.99 . . . . 0.0 108.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.06 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.818 1.679 . . . . 0.0 111.88 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.56 4.71 83.95 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -53.27 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -1.181 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.29 149.07 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.0 109.347 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 10.4 t0 -120.71 -13.79 8.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 109.482 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -158.02 134.18 9.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.013 . . . . 0.0 109.949 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -122.88 154.42 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -141.12 173.57 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.193 -0.942 . . . . 0.0 109.291 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -141.84 128.91 20.83 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.61 158.33 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 m -135.63 114.06 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -106.15 161.06 14.85 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.9 mm -73.01 140.58 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.12 -69.88 0.73 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.056 -1.028 . . . . 0.0 110.441 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -50.39 -17.92 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.146 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.598 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.35 -50.51 21.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -55.24 -28.02 50.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.904 -1.123 . . . . 0.0 109.801 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -54.14 4.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.114 -0.991 . . . . 0.0 111.173 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.45 -0.43 15.29 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.187 -0.945 . . . . 0.0 111.058 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.0 ttm-85 56.23 101.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.889 -1.132 . . . . 0.0 109.046 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -146.93 149.48 33.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.7 p -101.03 158.22 16.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.341 -0.849 . . . . 0.0 109.652 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -45.62 -34.46 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.397 -0.815 . . . . 0.0 109.743 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.684 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.7 -42.22 99.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 87.4 mm-40 -47.66 -15.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.251 . . . . 0.0 109.371 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -83.57 166.16 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.509 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.2 t -69.83 -20.48 63.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.725 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.83 79.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.06 162.76 26.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 109.734 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 20.7 p90 -156.3 149.96 24.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 56.7 mt -115.83 154.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -139.59 159.4 42.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.03 -1.043 . . . . 0.0 109.923 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -151.94 117.23 5.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -129.16 145.82 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HB3' ' H ' ' A' ' 120' ' ' THR . 56.9 t30 -76.42 102.05 5.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.93 -1.56 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.88 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -84.08 -53.17 5.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.713 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -123.11 4.67 9.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' ASN . 10.7 tt0 60.39 61.12 1.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.429 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 24.3 p -112.34 -68.97 0.89 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.903 -0.498 . . . . 0.0 110.221 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.3 mm-40 -45.4 157.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.851 . . . . 0.0 109.956 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.74 150.83 52.11 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.149 -0.969 . . . . 0.0 109.935 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptm180 -138.81 146.26 41.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.507 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.0 t80 -91.34 147.3 23.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.61 103.06 15.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.516 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.8 mt -81.38 -39.16 25.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.3 m -48.16 -31.87 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 0.0 109.152 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.18 -54.53 3.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.47 -0.769 . . . . 0.0 109.771 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 58.6 m-20 -72.75 -2.99 22.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.274 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.72 -44.35 66.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.244 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.5 p -72.39 3.17 5.03 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -82.79 -34.57 26.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.74 -162.6 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -127.37 -1.58 6.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.07 13.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.8 ptm -165.35 157.97 15.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.843 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -94.68 139.66 30.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 109.795 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 26.5 t80 -81.14 -42.82 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.629 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.62 -169.45 22.95 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.8 164.86 35.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.251 -1.147 . . . . 0.0 109.46 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 136.52 26.23 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 152' ' ' ARG . 9.5 p90 -146.95 166.27 27.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.019 -1.05 . . . . 0.0 110.25 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.98 145.32 24.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 4.7 t60 -122.77 -118.81 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.61 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 23.1 m120 -73.53 53.3 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.23 8.13 87.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.76 148.61 50.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.99 . . . . 0.0 109.312 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.4 m95 -75.08 151.79 38.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -147.74 127.11 13.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.112 -0.993 . . . . 0.0 109.603 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -89.63 148.23 23.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.484 -0.76 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 143' ' ' TYR . 2.6 ptp180 -153.87 107.52 2.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.06 154.55 37.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.44 -34.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.0 109.389 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 86.26 0.04 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -131.67 104.19 6.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.634 -0.921 . . . . 0.0 109.389 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.36 148.08 24.94 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -139.43 128.66 23.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -1.073 . . . . 0.0 109.321 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.8 12.16 13.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.06 -80.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 152.77 131.24 1.63 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.15 -13.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.56 -50.32 7.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.2 p -81.12 -37.72 28.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 161' ' ' GLY . 52.1 t -49.92 -24.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.434 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 93.4 m -79.55 -55.28 5.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.168 -0.957 . . . . 0.0 110.959 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.09 -15.21 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.957 -1.089 . . . . 0.0 110.355 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.3 -39.96 89.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.58 -19.62 62.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.683 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.96 -29.23 42.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.5 mt -80.13 139.56 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 172' ' ' ASN . 35.8 p-10 -66.03 112.58 3.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.41 -163.87 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.418 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 25.2 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.255 0.55 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.438 ' CE ' HD22 ' A' ' 115' ' ' ASN . 65.0 mtt -80.21 -174.64 4.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.536 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 62.2 mttm -153.21 -34.98 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 2.4 m120 -138.0 142.65 40.41 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.362 -0.837 . . . . 0.0 109.321 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 5.2 t -140.08 146.01 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.8 tt -136.25 111.9 9.37 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -86.42 150.97 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.26 117.08 1.56 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.8 tt -115.98 132.42 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -149.0 143.96 11.55 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.52 158.8 41.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -1.023 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -76.73 131.35 38.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.911 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -89.44 119.21 29.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 0.0 109.261 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -81.08 106.72 13.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -103.02 134.5 46.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -162.98 -34.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 26.5 t70 -159.68 41.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.97 -17.44 22.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 17' ' ' ASP . 2.0 mp0 -81.73 151.63 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.522 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -175.04 174.21 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.434 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.17 140.03 31.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.83 99.79 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.304 -0.872 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.69 153.29 24.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -108.44 109.06 20.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -0.761 . . . . 0.0 109.543 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.25 128.0 44.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.307 -0.87 . . . . 0.0 108.924 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -149.44 167.81 25.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.068 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.68 140.7 43.22 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -103.91 129.83 51.46 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.406 -0.809 . . . . 0.0 108.922 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.949 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.97 146.72 27.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 109.681 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.64 134.69 23.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.188 -0.945 . . . . 0.0 110.005 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.74 176.53 3.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.65 -6.4 58.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.711 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -86.57 1.49 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.86 59.16 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -99.48 152.26 20.2 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 38' ' ' GLY . 26.2 t -72.26 136.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.054 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -70.96 8.17 0.99 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.2 168.36 34.61 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.33 4.05 54.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.997 -1.296 . . . . 0.0 110.13 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -102.77 -42.05 6.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.158 -0.964 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 47.71 13.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.742 -1.224 . . . . 0.0 109.454 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ALA . 68.7 t80 -137.5 102.86 4.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.444 -0.785 . . . . 0.0 109.911 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 pt -103.08 131.04 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.813 . . . . 0.0 108.855 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 20.4 t80 -150.06 -146.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -50.65 -16.27 0.37 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 10.0 p-10 -78.92 4.88 12.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 108.799 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.1 t-20 -156.71 106.44 2.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.05 -25.57 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 11.9 pttm -172.86 158.53 3.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 t -69.64 141.38 53.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.66 -43.55 25.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.31 -1.58 12.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.694 -0.629 . . . . 0.0 109.553 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.8 -13.68 60.6 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 t 60.45 10.28 2.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -1.077 . . . . 0.0 109.426 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.13 147.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.99 138.2 25.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 109.721 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.438 ' NE2' HD11 ' A' ' 73' ' ' LEU . 36.0 m80 -89.82 130.17 36.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 108.785 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -69.49 -42.76 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.332 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.27 111.08 0.39 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -72.84 110.79 7.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.1 t-20 -86.3 -167.04 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.945 . . . . 0.0 109.341 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.466 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 15.5 ptt-85 -162.37 20.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 18.8 p -153.9 -43.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 109.352 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.57 30.35 12.06 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.23 150.49 48.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -1.172 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.02 144.33 2.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -79.73 -169.84 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.479 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.15 169.08 19.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -56.42 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -52.96 -61.07 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.65 165.31 13.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -154.89 132.15 11.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -116.15 124.48 50.43 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HZ2' ' HE3' ' A' ' 76' ' ' LYS . 36.9 tttm -95.91 139.83 31.55 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.51 146.8 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HE3' ' HZ2' ' A' ' 74' ' ' LYS . 88.7 mttt -139.57 99.35 3.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.18 -5.53 52.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -83.26 -26.89 30.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.93 5.87 50.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.42 124.44 85.53 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.13 -161.35 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.828 1.686 . . . . 0.0 112.057 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.32 1.38 79.5 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -68.9 -59.83 2.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 109.246 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 50.4 t -91.39 148.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.408 -0.807 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 2.4 m-20 -138.26 9.03 2.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -155.04 131.3 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 109.327 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.38 154.3 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.46 173.66 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.307 -0.87 . . . . 0.0 109.001 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.9 m-85 -140.95 120.48 13.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.21 158.11 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.714 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.63 136.34 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -125.55 143.88 50.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 109.695 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.7 mm -74.22 132.05 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 108.863 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -93.8 -60.14 1.83 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.33 -19.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.56 -43.88 72.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -55.79 -27.6 51.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.762 -1.212 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.67 -53.74 4.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.137 -0.977 . . . . 0.0 111.076 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -112.42 -3.9 14.37 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.244 -0.91 . . . . 0.0 110.9 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 48.0 ttp180 56.74 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.071 . . . . 0.0 109.321 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -157.88 153.65 26.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 83.0 p -101.85 158.47 16.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.01 -31.49 0.92 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.564 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.06 -33.51 22.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -57.53 -26.29 61.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -1.077 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -72.41 166.4 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.223 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.3 m -70.69 -28.89 65.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.4 75.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.62 25.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 108.938 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.9 p90 -153.24 169.86 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.297 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 41.8 mt -132.4 156.62 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.71 162.69 34.8 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.006 -1.059 . . . . 0.0 109.731 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.6 tt -157.52 116.66 3.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.587 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -132.92 141.88 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.318 -0.864 . . . . 0.0 109.651 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.438 HD22 ' CE ' ' A' ' 2' ' ' MET . 16.6 m-20 -77.79 102.1 7.03 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 6.1 p-10 -68.29 -3.67 11.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.9 t70 -72.96 -52.69 13.58 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.138 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -122.67 -12.02 8.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.766 -0.584 . . . . 0.0 109.617 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 115' ' ' ASN . 6.0 tt0 70.86 69.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -130.48 -45.71 1.09 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.738 -0.601 . . . . 0.0 109.979 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.0 mp0 -65.13 158.23 26.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 108.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 176.67 76.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.28 148.67 52.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.495 -0.753 . . . . 0.0 109.407 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 27.8 ptt180 -136.49 141.72 43.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.53 140.04 30.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 0.0 108.946 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -83.85 103.02 12.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 0.0 109.402 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 60.7 mt -78.22 -41.72 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 84.7 m -47.88 -29.58 3.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.933 -1.104 . . . . 0.0 109.274 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.05 -54.74 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 109.878 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.28 -4.74 37.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 110.355 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.21 -49.29 78.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.961 -1.087 . . . . 0.0 109.783 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.3 p -60.41 2.8 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.5 m -89.68 -33.31 16.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 110.4 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -172.68 -145.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.18 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.521 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -135.82 -52.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.77 143.64 30.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.2 ttt -166.2 158.08 13.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.043 . . . . 0.0 109.802 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -101.04 136.48 40.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.373 -0.83 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 25.9 t80 -81.65 -40.74 22.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.74 -170.79 26.95 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -150.96 163.62 38.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -1.12 . . . . 0.0 109.602 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.03 140.39 32.61 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -150.57 166.5 30.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.099 -1.001 . . . . 0.0 109.857 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -88.15 148.96 24.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.79 . . . . 0.0 109.709 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -152.5 123.78 7.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 63.7 t30 55.67 24.77 7.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.81 80.33 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -127.8 138.37 52.71 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.488 -1.007 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 76.8 m95 -67.69 150.7 48.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -151.35 126.19 9.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -89.23 147.02 24.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.465 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -152.76 108.09 3.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.048 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.54 154.74 41.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.0 t -139.31 -33.65 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -0.843 . . . . 0.0 109.293 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.09 86.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -138.25 104.46 5.2 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.928 . . . . 0.0 109.485 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.64 150.59 33.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -147.88 134.4 19.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.221 -1.164 . . . . 0.0 109.396 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.3 16.94 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.339 -0.851 . . . . 0.0 109.43 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.1 -64.55 2.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.64 127.04 0.97 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -47.22 -35.58 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.792 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.0 -22.2 27.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.423 ' C ' ' N ' ' A' ' 166' ' ' CYS . 26.0 m -79.18 -57.53 3.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.0 m -47.58 -20.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.423 ' N ' ' C ' ' A' ' 164' ' ' SER . 96.2 m -72.63 -61.94 1.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.68 -17.52 31.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.35 -43.51 88.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.24 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.92 -20.31 61.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.04 -53.28 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.9 mm -76.7 107.58 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -1.174 . . . . 0.0 109.373 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.52 114.17 19.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.57 24.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.461 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt -67.67 -178.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.436 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 81.8 mttt -153.62 -33.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.911 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.2 m120 -140.3 129.11 23.18 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -129.69 156.09 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.6 tp -142.02 110.0 5.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 108.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.22 150.5 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.209 -0.932 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.54 116.5 1.22 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.56 134.55 49.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.57 142.32 10.58 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -160.39 152.98 20.94 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -1.151 . . . . 0.0 109.914 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.08 99.32 11.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 109.403 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -79.31 163.37 24.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.428 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -132.81 106.86 7.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.487 -0.758 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 m -86.64 105.93 17.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p -79.53 -59.17 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.416 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 24.9 p-10 -158.51 18.01 0.21 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.68 -34.67 0.69 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -82.08 162.78 22.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -1.077 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -176.25 165.88 2.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.24 131.19 42.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 p-10 -141.03 100.8 3.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.18 146.3 28.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.78 121.4 44.3 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.33 -0.856 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.6 134.37 40.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.262 -0.899 . . . . 0.0 108.912 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.9 t -149.85 167.92 25.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.306 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.08 138.33 54.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.8 m-85 -104.06 128.03 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.317 -0.865 . . . . 0.0 109.332 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.011 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -103.03 155.84 18.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.42 137.49 25.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 109.35 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.14 176.78 9.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 109.501 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.35 59.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.98 4.66 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.119 -0.988 . . . . 0.0 109.839 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.89 -20.68 45.91 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 43.6 mtpt -103.32 172.49 6.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.689 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.6 t -101.29 142.63 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.406 -0.809 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 39.1 mmm-85 -59.74 -6.03 1.09 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -146.1 100.16 0.22 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -44.94 -21.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -1.091 . . . . 0.0 110.414 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.35 79.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 109.62 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.689 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER 47.77 13.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 109.369 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 84.9 t80 -138.28 99.46 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.366 -0.834 . . . . 0.0 109.654 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.83 136.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.8 p90 -144.94 -160.85 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.139 -0.976 . . . . 0.0 109.502 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.8 p90 -45.64 -29.96 1.39 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 15.8 t-20 -57.42 -6.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.855 -1.153 . . . . 0.0 108.989 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 48.6 t30 -140.17 110.07 6.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.458 -0.776 . . . . 0.0 109.022 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.03 -31.65 5.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 109.278 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 16.9 pttp -169.87 160.01 8.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -65.01 142.29 58.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.327 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.92 43.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.631 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -115.21 -3.79 12.49 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.643 -0.661 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -15.64 74.23 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.0 p 61.48 11.45 3.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.0 109.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 73' ' ' LEU . 54.9 m -147.68 133.85 19.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 109.746 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.55 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.8 m80 -91.42 139.17 30.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 m -74.43 -61.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.67 121.63 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 23.6 p-10 -81.28 112.11 18.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.146 . . . . 0.0 109.543 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.35 132.1 35.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -79.82 6.24 11.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.532 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.1 p -153.3 -34.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.92 15.78 10.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.51 110.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -1.068 . . . . 0.0 109.5 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.2 -135.57 2.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -160.31 69.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -1.166 . . . . 0.0 109.441 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.3 -175.67 33.17 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -49.2 106.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.04 -63.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -90.99 -179.69 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.562 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.9 m -161.85 135.43 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.18 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -121.41 120.5 35.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.13 138.8 33.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.096 -1.002 . . . . 0.0 109.304 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' CE1' ' A' ' 89' ' ' PHE . 79.8 mt -132.38 147.02 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.583 -0.698 . . . . 0.0 109.763 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' O ' ' OG ' ' A' ' 54' ' ' SER . 53.8 mttp -142.85 102.1 3.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.857 . . . . 0.0 108.722 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 79' ' ' ALA . 9.3 mt -77.11 -39.01 51.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.999 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -49.42 -17.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -100.17 -15.95 17.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.78 123.89 88.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.398 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.56 -160.74 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.967 1.778 . . . . 0.0 111.941 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.01 1.73 87.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' NH1' ' A' ' 37' ' ' ARG . 59.4 t0 -67.28 -55.64 13.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -1.143 . . . . 0.0 109.57 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -79.02 148.53 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 8.9 t0 -128.25 -7.13 5.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 109.564 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -158.21 135.84 10.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 109.614 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.75 154.12 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -146.51 173.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.262 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.447 ' CE1' HD13 ' A' ' 75' ' ' ILE . 9.3 m-85 -133.32 139.28 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.94 155.62 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.99 . . . . 0.0 111.212 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -147.57 113.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -121.14 171.62 8.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.449 -0.782 . . . . 0.0 110.606 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.8 mm -81.68 168.3 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.568 ' N ' HG22 ' A' ' 93' ' ' ILE . 27.0 t-80 -132.75 -64.8 0.74 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -49.91 -18.23 0.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.28 -39.44 79.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.579 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' NE2' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -52.9 -32.21 44.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.77 -1.206 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.84 4.22 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.135 -0.978 . . . . 0.0 111.296 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.23 1.75 16.31 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.127 -0.983 . . . . 0.0 111.091 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.4 ttm180 59.08 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.998 -1.064 . . . . 0.0 109.339 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.418 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 83.4 mt-30 -150.05 139.35 21.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 109.555 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 m -99.13 158.98 15.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.37 -0.831 . . . . 0.0 109.461 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -46.31 -30.21 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.325 -0.86 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.707 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -68.19 -37.53 86.91 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -47.71 -17.06 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.167 . . . . 0.0 109.138 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -85.0 167.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 108.969 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 106' ' ' VAL . 25.0 m -67.26 -20.47 65.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.0 80.48 0.03 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.76 164.68 23.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 109.832 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.8 p90 -154.07 150.45 28.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.129 -0.982 . . . . 0.0 110.024 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 36.2 mt -114.17 155.84 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -141.96 162.82 34.51 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.995 -1.065 . . . . 0.0 109.919 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.7 tt -157.07 118.14 3.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.6 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -130.77 144.56 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.331 -0.856 . . . . 0.0 110.049 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -75.24 101.97 4.85 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.92 -1.71 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 115' ' ' ASN . 22.3 t0 -84.75 -52.18 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.306 -0.871 . . . . 0.0 109.627 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -122.24 -0.48 9.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.65 -0.656 . . . . 0.0 109.988 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 60.67 63.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 21.9 p -118.13 -53.93 2.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.002 -0.436 . . . . 0.0 110.099 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.16 158.55 11.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 109.389 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER 178.31 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 148.01 52.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 109.791 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 41.1 ptt85 -134.82 145.68 48.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.408 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.8 t80 -91.36 147.59 22.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.15 -0.969 . . . . 0.0 109.186 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -86.11 102.99 14.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 109.285 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 66.9 mt -83.07 -40.66 19.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.458 ' H ' HG23 ' A' ' 128' ' ' THR . 5.9 p -48.13 -31.74 6.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.118 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -95.32 -54.62 3.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.823 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 47.1 m-20 -73.47 -3.82 29.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.161 -0.962 . . . . 0.0 110.416 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.707 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.27 -45.15 65.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.997 -1.065 . . . . 0.0 109.125 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.1 m -70.91 3.01 3.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.643 -0.66 . . . . 0.0 109.92 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -84.47 -34.26 23.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 110.17 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.64 -167.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -123.4 -8.05 8.1 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.05 135.52 24.26 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.94 157.65 14.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.014 -1.054 . . . . 0.0 110.048 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -92.6 138.37 31.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -81.51 -41.96 20.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.29 -169.95 20.97 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.406 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.9 tt0 -151.5 161.25 43.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -144.51 136.39 25.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.2 -0.937 . . . . 0.0 108.523 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.2 p90 -144.04 165.87 26.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.188 -0.945 . . . . 0.0 109.685 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.5 ptm180 -84.98 152.52 23.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -155.29 116.47 3.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 2.2 t30 56.25 24.99 8.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 -3.89 86.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 3.4 mp0 -109.64 135.09 51.16 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -69.14 151.64 46.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.192 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.85 129.42 15.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.119 -0.988 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 19.4 t80 -96.72 137.73 35.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.457 -0.777 . . . . 0.0 109.912 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -143.61 107.29 4.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.48 154.56 39.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -143.08 -34.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.264 -0.898 . . . . 0.0 109.322 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.04 85.24 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -132.65 104.23 6.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.663 -0.904 . . . . 0.0 109.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.76 149.71 25.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -140.24 133.44 29.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.468 -1.019 . . . . 0.0 109.117 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.16 7.66 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 0.0 109.439 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -69.6 0.91 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.89 125.39 0.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.21 -28.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.137 . . . . 0.0 109.928 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.75 -31.0 22.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.9 p -75.6 -50.48 15.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.4 m -48.13 -20.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.486 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.4 m -69.97 -58.94 3.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 110.326 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.71 -15.24 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -64.35 -44.2 92.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.293 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -71.23 -20.01 62.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.76 17.45 30.95 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.31 150.01 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -1.195 . . . . 0.0 109.344 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -65.87 119.23 10.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 99.78 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.447 -180.0 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 149' ' ' TRP . 53.0 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -77.61 148.8 34.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -129.64 -9.88 4.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 9.2 m120 -146.41 129.18 16.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.219 -0.926 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.9 t -135.88 147.98 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.066 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.7 tt -135.28 109.92 8.59 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.466 ' N ' HD23 ' A' ' 6' ' ' LEU . 15.4 t -86.16 143.87 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.47 117.15 2.18 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.7 tt -115.46 131.82 56.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -145.24 143.46 11.86 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' THR . 19.0 p90 -154.97 153.69 31.43 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.44 -1.035 . . . . 0.0 109.695 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.04 117.51 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.1 170.8 15.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.59 106.95 8.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -85.79 127.87 34.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -147.39 -34.64 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 17' ' ' ASP . 7.0 p30 -158.16 47.7 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 -41.11 2.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -60.49 159.28 10.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -170.12 171.91 6.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.391 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -140.9 99.65 3.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.39 -0.819 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.66 130.63 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -91.43 112.54 24.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 109.959 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 128.74 44.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.276 -0.89 . . . . 0.0 108.6 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -149.26 165.73 31.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.102 -0.999 . . . . 0.0 110.171 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 138.69 45.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.3 m-85 -104.45 129.41 52.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.472 -0.768 . . . . 0.0 109.007 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.02 153.42 19.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.377 -0.827 . . . . 0.0 109.949 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.02 135.36 22.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.822 . . . . 0.0 109.415 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.25 176.46 8.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.47 -10.49 59.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.973 . . . . 0.0 109.718 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -84.78 4.81 31.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.18 -19.61 51.21 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.0 mttt -103.71 172.05 7.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -103.03 140.94 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.458 -0.776 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' NH1' ' OD1' ' A' ' 83' ' ' ASP . 34.3 ttp180 -62.06 -3.54 1.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -143.54 101.29 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -45.54 -27.29 0.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 110.47 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.4 -42.34 82.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.912 -1.118 . . . . 0.0 109.623 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.8 t0 46.03 15.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 13.8 t80 -137.77 100.22 4.13 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.653 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 pt -101.55 137.92 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.3 p90 -141.14 -160.08 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 25.7 p90 -42.5 -36.06 1.23 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.607 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 9.1 t30 -49.27 -14.61 0.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.912 -1.118 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.479 ' N ' ' C ' ' A' ' 45' ' ' TYR . 40.7 t30 -153.88 112.85 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.94 -64.63 0.97 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.202 -0.937 . . . . 0.0 109.542 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -89.92 117.77 28.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.478 -0.764 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -57.21 134.77 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.89 75.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.826 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -116.39 -5.96 11.76 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.615 -0.678 . . . . 0.0 109.892 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.42 -19.27 64.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t 62.78 6.57 2.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -1.17 . . . . 0.0 109.238 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -92.97 152.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 108.932 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -143.45 142.13 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.111 -0.993 . . . . 0.0 110.468 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CE1' HD21 ' A' ' 73' ' ' LEU . 4.6 m80 -92.12 121.44 33.67 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 m -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.381 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 109.77 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -79.77 110.77 15.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -1.18 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -86.34 132.6 33.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -78.89 2.8 18.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 40.1 p -153.52 -35.01 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.78 21.26 76.49 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -58.53 115.46 3.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -1.185 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.86 -121.16 1.0 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -171.52 152.66 3.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.06 -163.92 47.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.2 94.69 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 109.557 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.17 -53.05 42.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.22 160.08 14.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 108.998 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 m -157.86 132.32 8.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.077 -1.014 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD21 ' CE1' ' A' ' 57' ' ' HIS . 2.3 mp -117.88 126.4 52.31 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -96.27 122.74 39.45 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 71.2 mt -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.434 -0.791 . . . . 0.0 110.199 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 103.52 4.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.12 -24.33 40.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.909 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.4 -21.99 66.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.67 -9.19 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.953 . . . . 0.0 109.773 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.13 125.06 90.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.98 -160.28 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.909 1.739 . . . . 0.0 111.909 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.26 3.22 75.91 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 16.4 t70 -69.12 -60.1 2.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.304 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 86' ' ' LYS . 7.3 p -91.36 148.75 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.508 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.7 m-20 -133.1 10.48 4.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.343 -0.848 . . . . 0.0 109.831 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' H ' HG22 ' A' ' 84' ' ' VAL . 75.7 tttt -158.14 131.73 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 109.235 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.9 mt -129.36 154.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.515 -0.741 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.03 173.17 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.426 -0.796 . . . . 0.0 109.014 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 6.9 m-85 -142.4 118.4 10.64 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.02 157.71 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.248 -0.907 . . . . 0.0 110.625 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -120.98 148.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -141.81 140.08 32.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -73.92 137.4 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.8 t-80 -94.17 -64.9 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -47.45 -18.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.852 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.94 -18.13 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.0 109.94 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -66.14 -60.44 2.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.889 -1.132 . . . . 0.0 109.484 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -43.6 9.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.364 -0.835 . . . . 0.0 111.151 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -83.88 -18.02 38.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 111.225 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 54.19 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.652 -1.28 . . . . 0.0 109.162 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -148.39 142.28 25.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.25 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -99.63 165.27 11.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.217 -0.927 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CG ' HD22 ' A' ' 127' ' ' LEU . 12.7 m-85 -46.29 -34.19 4.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.285 -0.885 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.685 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.26 -38.49 90.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -49.1 -18.85 0.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.981 -1.305 . . . . 0.0 109.338 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 107' ' ' SER . 23.2 t -82.54 166.22 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 109.161 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.496 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.3 m -70.28 -23.4 62.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.988 . . . . 0.0 109.758 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.35 77.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.2 163.48 23.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -1.176 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 30.6 p90 -154.23 169.88 22.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.5 mt -132.08 156.55 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -143.85 162.12 36.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.5 tt -157.77 118.1 3.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.079 -1.013 . . . . 0.0 109.658 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.91 143.8 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -79.85 102.01 8.87 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.01 -1.49 7.61 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 31.7 t0 -76.76 -52.44 9.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 8.2 m120 -122.48 -14.74 7.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.73 -0.606 . . . . 0.0 109.583 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 15.9 tt0 73.83 71.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -135.9 -45.13 0.65 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.644 -0.66 . . . . 0.0 109.975 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 49.9 mm-40 -65.37 158.44 26.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 108.931 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 173.4 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.79 149.45 52.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.501 -0.75 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.7 ptp180 -135.12 142.9 46.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.618 -0.676 . . . . 0.0 109.461 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -91.32 143.09 27.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.905 . . . . 0.0 108.925 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.16 102.87 14.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.585 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.3 mt -78.7 -41.0 32.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.204 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.9 p -47.78 -29.68 3.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 109.295 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -95.22 -54.68 3.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 109.804 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.93 -0.83 22.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.968 . . . . 0.0 110.275 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.0 -44.62 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 109.275 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 t -72.57 3.01 5.4 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.539 -0.725 . . . . 0.0 109.851 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.1 m -82.32 -34.35 28.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 110.124 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.76 -164.06 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 0.0 109.612 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.06 -14.34 8.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.6 140.12 36.94 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.8 ptm -165.47 158.05 15.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.008 -1.057 . . . . 0.0 109.871 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.19 137.58 35.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -82.87 -41.06 19.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.627 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.93 -170.1 25.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -151.21 164.24 37.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.216 -1.167 . . . . 0.0 109.558 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 139.02 29.04 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.16 166.45 29.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.065 -1.022 . . . . 0.0 109.894 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.508 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -89.19 146.18 24.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 109.506 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -128.23 -115.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 145' ' ' HIS . 88.4 m-20 -72.66 58.71 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.068 -1.02 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.73 8.09 62.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.02 149.47 50.35 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.963 . . . . 0.0 109.315 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.8 m95 -72.8 151.63 41.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.356 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -146.58 129.42 16.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -89.89 149.28 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.405 -0.81 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -155.46 113.52 3.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.195 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.96 154.53 31.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.56 -33.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -0.871 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.91 84.58 0.03 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -136.96 104.28 5.41 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.966 . . . . 0.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.36 152.12 37.38 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -141.95 129.46 21.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.24 9.31 31.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 109.444 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.36 -70.97 0.61 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.83 132.44 1.48 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.33 -33.33 3.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.63 -26.39 26.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 166' ' ' CYS . 12.6 t -74.69 -54.39 7.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.5 m -47.41 -20.71 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.504 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 60.0 m -71.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -15.4 39.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.35 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.28 -43.31 98.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.108 -0.995 . . . . 0.0 110.076 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -71.43 -19.7 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.95 -44.87 65.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 65.5 mt -80.09 129.71 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -79.62 111.7 16.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.66 86.49 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.504 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' TRP . 75.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 34.2 mtt -81.69 162.84 22.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -141.45 -33.73 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 13.1 m120 -146.11 128.46 15.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.7 t -128.84 149.0 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 73' ' ' LEU . 12.2 tp -132.63 108.24 8.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 108.985 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.55 150.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.94 117.0 1.25 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -106.05 132.45 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.07 138.41 7.26 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.946 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -156.46 155.19 31.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -75.5 125.53 29.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.45 121.51 29.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.263 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -132.71 123.96 27.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.458 -0.776 . . . . 0.0 109.459 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 98.5 p -95.73 132.74 40.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.865 . . . . 0.0 109.295 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -148.62 -84.25 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -71.17 3.0 3.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.22 -127.0 1.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -79.71 176.92 9.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.165 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -72.72 -164.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.32 104.9 16.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.184 -0.948 . . . . 0.0 109.338 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' ND1' ' A' ' 94' ' ' HIS . 24.4 p-10 -92.87 102.71 15.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 mt -83.4 138.04 33.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 109.15 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.07 106.69 18.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.05 119.05 38.08 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -149.04 168.37 23.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.04 . . . . 0.0 109.804 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.03 138.42 45.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.597 -0.689 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.0 m-85 -104.35 131.83 51.26 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.993 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.62 154.39 19.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.382 -0.823 . . . . 0.0 110.132 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 136.62 24.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.04 176.68 8.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.247 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -79.86 -11.23 59.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -86.55 5.65 34.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.069 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.46 52.16 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.7 mmtm -102.61 172.03 7.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.673 HG21 ' OD1' ' A' ' 41' ' ' ASP . 3.5 t -102.18 143.23 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 109.784 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -62.5 -3.24 1.34 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.82 102.57 0.25 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -45.18 -25.8 0.4 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -1.085 . . . . 0.0 110.751 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.819 -1.175 . . . . 0.0 109.687 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.673 ' OD1' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 48.4 12.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 109.444 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 40' ' ' ALA . 79.3 t80 -135.11 100.25 4.5 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HD11 ' A' ' 29' ' ' LEU . 4.6 pt -103.5 130.52 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.487 ' CZ ' ' OD2' ' A' ' 60' ' ' ASP . 33.4 t80 -170.99 -168.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.985 -1.072 . . . . 0.0 109.179 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.473 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 52.4 m-85 48.46 -113.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 48' ' ' LEU . 23.0 t30 -56.84 -7.65 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -67.49 68.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.945 -1.097 . . . . 0.0 109.648 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 46' ' ' ASN . 13.3 mt -52.98 -30.97 38.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 108.898 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 127.15 0.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.744 . . . . 0.0 109.124 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -55.86 111.9 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.67 -25.4 63.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.08 -16.12 11.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.545 -0.722 . . . . 0.0 109.658 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.53 -20.27 35.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.403 ' OG ' HG22 ' A' ' 80' ' ' VAL . 1.1 m 69.14 2.67 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.451 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.77 146.56 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.229 -0.92 . . . . 0.0 108.663 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -149.12 150.56 32.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.961 -1.087 . . . . 0.0 110.348 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -91.37 136.15 33.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.65 -0.657 . . . . 0.0 109.756 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 p -85.78 -30.35 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.27 104.1 0.24 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' CZ ' ' A' ' 44' ' ' PHE . 12.6 t70 -80.77 110.82 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.636 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -95.36 -167.85 1.69 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -161.47 19.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.8 p -154.29 -42.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.55 -6.65 7.5 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.48 110.43 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -1.09 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 177.54 155.41 13.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.64 88.66 3.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -1.142 . . . . 0.0 109.482 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 -116.21 5.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.87 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -71.93 -69.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.32 156.1 17.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.314 -0.866 . . . . 0.0 109.132 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -159.68 141.33 12.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 17.5 mt -112.19 131.81 55.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.067 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.47 110.16 22.26 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 26.6 mt -97.94 146.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 111.075 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -140.21 84.35 1.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 -5.19 11.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.9 -20.23 49.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.648 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.49 -13.89 21.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.217 -0.927 . . . . 0.0 109.781 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' A' ' 54' ' ' SER . 68.2 t -60.99 124.91 82.23 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 109.269 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.01 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.74 1.627 . . . . 0.0 111.866 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.56 1.86 79.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -71.41 -60.52 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.544 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 t -87.12 133.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 32' ' ' ALA . 16.6 m-20 -113.32 4.43 16.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.697 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -156.36 137.86 14.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.528 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 87' ' ' ILE . 10.4 mt -145.44 107.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -109.18 171.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 4.7 m-85 -129.84 134.4 47.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.1 158.16 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -131.28 134.75 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -138.04 164.62 28.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.8 mm -77.64 142.01 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 22' ' ' ASP . 20.6 t-160 -98.1 -68.35 0.81 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -51.33 -18.11 0.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.104 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -48.94 -42.93 38.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 109.772 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.19 -30.07 48.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.918 -1.114 . . . . 0.0 109.753 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -90.73 -54.01 4.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 111.297 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HE ' ' CB ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -112.52 -0.31 15.27 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.256 -0.903 . . . . 0.0 111.1 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 96' ' ' ALA . 43.1 ttt85 57.08 103.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.949 -1.095 . . . . 0.0 108.991 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -137.38 134.04 35.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.277 -0.889 . . . . 0.0 109.708 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -90.64 152.77 20.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -46.76 -30.89 2.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.197 -0.94 . . . . 0.0 109.583 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -57.96 -40.31 93.09 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -48.17 -17.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.241 . . . . 0.0 109.359 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.2 t -82.78 163.97 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 108.949 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 m -72.13 -25.55 61.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.14 78.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.11 164.71 25.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -1.109 . . . . 0.0 109.145 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 22.7 p90 -154.4 143.82 21.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.92 -1.113 . . . . 0.0 110.477 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 43.1 mt -108.43 154.16 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' NH2' HG12 ' A' ' 122' ' ' VAL . 52.0 ttt85 -139.94 160.8 39.1 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.999 -1.063 . . . . 0.0 109.731 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.9 tt -155.11 116.69 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.529 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.591 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -128.46 144.51 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 109.755 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 119' ' ' GLN . 53.8 t30 -76.37 102.12 5.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.22 -1.87 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.383 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 18.2 t70 -81.66 -53.23 6.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.22 4.22 9.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.771 -0.58 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 115' ' ' ASN . 20.0 tp60 59.5 60.41 2.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 53.9 m -113.46 -68.64 0.91 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.951 -0.468 . . . . 0.0 110.299 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.861 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.8 mm-40 -45.2 157.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 110.029 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -179.28 73.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.85 151.55 52.0 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.3 ptp180 -139.21 142.48 37.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -91.4 147.77 22.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.167 -0.958 . . . . 0.0 109.314 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -85.96 106.19 16.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -80.33 -46.78 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.5 m -47.83 -27.96 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.264 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -91.81 -54.57 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.59 0.84 9.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.96 -47.18 81.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 p -73.26 3.09 6.19 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.502 -0.749 . . . . 0.0 109.976 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.2 m -87.96 -34.61 18.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 0.0 110.478 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -175.65 -163.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.789 -1.194 . . . . 0.0 109.857 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.5 p -125.58 -8.73 6.82 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.14 27.81 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.5 ptm -165.46 157.9 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.04 -1.037 . . . . 0.0 109.951 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -96.76 137.29 36.07 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 109.436 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.0 t80 -79.69 -42.12 25.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.077 -1.015 . . . . 0.0 109.958 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.57 -166.29 15.48 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.532 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 10.1 tt0 -150.82 160.66 43.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -1.012 . . . . 0.0 109.292 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.422 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.0 mt -142.81 137.52 29.73 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.44 165.75 29.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -95.6 144.41 26.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.465 -0.772 . . . . 0.0 109.687 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 20.0 t-80 -125.49 -117.16 0.28 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.62 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 53.0 t30 -72.54 58.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.968 . . . . 0.0 109.407 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.31 10.49 66.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -127.74 141.46 51.59 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.933 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.0 m95 -71.37 152.03 43.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -148.52 131.39 16.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.561 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.1 t80 -89.7 149.64 22.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.509 -0.744 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 21.6 tpt85 -154.39 107.26 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 109.025 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.508 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -63.75 154.75 32.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.42 -33.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.435 -0.791 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.24 82.14 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -135.74 104.37 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.588 -0.948 . . . . 0.0 109.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.47 151.34 36.13 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -145.78 133.77 21.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.358 -1.084 . . . . 0.0 109.213 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.28 11.65 29.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.98 -27.47 6.68 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 83.6 139.5 3.86 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.63 -12.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -1.132 . . . . 0.0 109.719 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.664 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -77.81 -57.59 3.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 109.515 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 m -80.72 -41.83 22.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.01 -21.32 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -73.97 -60.37 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.616 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -26.42 23.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.195 -0.94 . . . . 0.0 110.443 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 169' ' ' TYR . 1.3 tm0? -51.32 -35.34 37.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 109.813 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 24.6 m-85 -85.73 13.26 7.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -150.73 27.87 1.04 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.9 pt -71.08 133.94 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.253 . . . . 0.0 109.173 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -78.37 137.04 37.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.533 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.41 36.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.479 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -80.24 115.88 20.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.89 -23.15 18.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -146.31 152.33 38.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.301 -0.874 . . . . 0.0 109.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 t -146.16 158.52 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.8 tp -147.69 107.65 4.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.851 . . . . 0.0 109.022 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.11 150.77 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.92 116.93 1.39 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -110.88 126.83 55.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -142.21 145.48 15.73 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -158.49 151.24 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 110.031 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -91.2 128.23 36.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 109.712 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.314 0.578 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 150.12 20.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.95 104.48 4.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.912 . . . . 0.0 109.64 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.36 151.38 25.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 108.783 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.36 106.56 17.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 109.879 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.5 125.68 45.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 108.757 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 5.7 t -149.43 167.62 25.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.941 -1.099 . . . . 0.0 109.913 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.38 136.53 49.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -104.02 127.96 51.58 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.77 142.0 30.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.373 -0.83 . . . . 0.0 109.998 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.57 131.62 20.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -0.935 . . . . 0.0 109.835 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.36 175.11 10.06 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.12 1.56 43.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.289 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -83.09 -9.84 59.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 109.504 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.7 -5.05 69.52 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -109.71 150.37 28.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.9 m -65.97 136.53 26.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -71.02 5.35 2.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ALA . . . -158.77 118.59 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -47.68 -10.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -1.113 . . . . 0.0 110.338 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLY . . . -95.7 -40.21 9.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.5 t0 47.57 14.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 109.294 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 62.6 t80 -137.2 100.39 4.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 109.654 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.9 pt -103.48 139.57 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.558 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.2 p90 -153.22 -153.98 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -0.879 . . . . 0.0 109.686 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.0 OUTLIER -43.43 -36.24 1.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.064 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.45 -1.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 108.946 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.3 t30 -149.57 103.97 3.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.137 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.21 -28.57 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttm -165.18 160.12 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 t -69.86 147.92 49.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.264 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.81 -48.52 14.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -116.2 1.64 13.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.661 -0.649 . . . . 0.0 109.587 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 -12.71 69.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 60.78 11.99 3.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.36 -1.082 . . . . 0.0 109.42 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.07 150.27 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.249 -0.907 . . . . 0.0 108.93 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.9 m -148.77 138.08 21.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.12 -0.987 . . . . 0.0 110.0 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.43 ' NE2' HD11 ' A' ' 73' ' ' LEU . 31.9 m80 -90.06 127.91 36.17 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -67.12 -56.91 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.57 111.11 0.47 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.4 110.88 12.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -81.92 -164.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -156.15 16.48 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -154.64 -37.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 109.325 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.63 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -1.169 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -73.28 -63.86 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.22 171.68 9.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.4 132.26 6.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.326 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -116.37 119.41 35.59 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -95.69 135.88 36.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 108.736 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.51 146.93 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 110.358 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.28 87.62 2.35 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 79' ' ' ALA . 21.9 mt -67.94 -34.52 76.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.869 . . . . 0.0 109.751 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -55.28 -5.71 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.582 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -119.27 20.65 12.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' PRO . 48.0 t -105.41 104.98 50.6 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.327 -0.858 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.25 -171.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.055 1.837 . . . . 0.0 112.353 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 1.08 89.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.02 -55.95 15.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -1.105 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 83.5 t -84.39 148.59 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 0.0 108.977 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 45.3 m-20 -136.61 -5.27 2.0 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.359 -0.838 . . . . 0.0 110.136 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -145.25 131.17 19.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.949 -1.094 . . . . 0.0 109.423 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -141.49 108.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 141' ' ' GLU . 10.8 pt -116.23 154.86 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 109.627 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -96.45 159.1 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 109.202 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 28' ' ' PHE . 60.3 t -147.23 152.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.746 0.784 . . . . 0.0 110.651 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.6 t -148.01 115.84 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 p -132.85 174.45 10.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.54 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 6.0 mm -86.53 143.25 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -100.4 -68.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.327 -0.858 . . . . 0.0 110.044 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -18.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.248 -0.908 . . . . 0.0 110.06 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.54 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -46.43 -26.96 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -53.98 -50.41 66.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 109.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.12 -39.48 12.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.42 -0.8 . . . . 0.0 110.984 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -96.99 -19.49 18.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.057 -1.027 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.6 mmt180 50.94 58.2 5.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.637 -1.289 . . . . 0.0 109.169 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.37 148.45 25.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.3 p -98.15 159.39 14.97 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.743 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -45.88 -33.94 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.658 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.16 -36.84 90.42 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -47.53 -19.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -1.21 . . . . 0.0 109.328 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 107' ' ' SER . 18.6 t -85.93 168.12 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.131 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -69.3 -23.91 63.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.21 79.98 0.03 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.75 25.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 109.817 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.8 p90 -153.33 143.51 22.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.099 -1.0 . . . . 0.0 110.257 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.8 mt -107.02 154.7 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.39 159.83 41.24 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.7 tt -154.23 116.54 4.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.097 -1.002 . . . . 0.0 109.482 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.572 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.0 p -129.65 143.3 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.436 ' HB2' ' H ' ' A' ' 120' ' ' THR . 78.8 m-20 -75.33 102.12 4.98 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -64.73 -1.85 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.561 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.1 -53.7 5.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 109.72 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.71 6.55 8.8 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.67 -0.644 . . . . 0.0 109.724 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 59.03 59.7 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 12.5 m -111.21 -69.91 0.84 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.866 -0.521 . . . . 0.0 110.309 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 51.0 mm-40 -45.26 157.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.0 109.893 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.58 72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.0 152.22 51.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.067 -1.021 . . . . 0.0 109.992 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 30.3 ptt180 -140.79 144.36 35.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -91.32 147.63 22.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 103.39 16.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.3 mt -80.44 -40.7 25.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.298 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.85 -29.58 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -95.26 -54.66 3.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.434 -0.791 . . . . 0.0 109.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.11 -1.35 25.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.85 -44.71 66.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.294 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -72.7 3.09 5.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.56 -0.713 . . . . 0.0 109.984 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.4 m -83.02 -34.39 26.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 0.0 110.283 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.75 -164.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.952 -1.093 . . . . 0.0 109.729 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 102' ' ' SER . 1.1 p -124.81 -5.71 7.46 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.76 135.31 23.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.36 150.67 9.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.8 pp -91.55 136.0 33.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.79 -49.4 46.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 109.938 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -153.35 -155.56 7.21 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.293 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 88' ' ' ILE . 14.7 tt0 -150.64 157.73 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -1.024 . . . . 0.0 109.347 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.74 135.74 28.23 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -150.82 166.8 29.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.931 -1.106 . . . . 0.0 110.275 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 11.5 ptm180 -86.95 147.07 25.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.779 . . . . 0.0 109.503 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.5 OUTLIER -129.54 -114.88 0.25 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.693 . . . . 0.0 109.259 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.537 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.2 m120 -72.67 58.42 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.963 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.44 7.25 63.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -127.92 154.18 45.84 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.668 -0.901 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -75.74 151.49 37.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -145.35 127.83 16.0 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -89.99 148.25 23.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -157.32 107.37 2.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.78 153.72 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.04 -32.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.78 85.92 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -139.14 104.48 5.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.559 -0.965 . . . . 0.0 109.548 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.0 154.79 35.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -150.08 124.17 9.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.404 -1.056 . . . . 0.0 109.123 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.69 15.09 6.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.32 -0.862 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.06 -76.56 0.15 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.21 126.18 0.82 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.481 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.01 -29.21 1.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -1.126 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.97 -32.6 21.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 166' ' ' CYS . 19.9 m -80.28 -50.35 10.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.73 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 m -45.76 -19.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.341 -0.849 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 78.0 m -70.94 -62.0 1.55 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.25 -15.38 38.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.108 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.68 -34.99 71.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.003 -1.06 . . . . 0.0 110.365 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -70.75 -19.59 62.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.153 . . . . 0.0 109.206 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.684 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.286 0.565 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.6 mtt -80.91 -173.67 4.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -153.15 -34.67 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.686 HD22 ' H ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -140.57 139.39 34.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.0 109.279 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.686 ' H ' HD22 ' A' ' 4' ' ' ASN . 3.8 t -144.46 130.64 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.21 109.76 17.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.71 144.73 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.145 -0.972 . . . . 0.0 108.727 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -129.98 129.94 6.11 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tt -134.87 126.81 29.49 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -144.01 151.11 23.12 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 27.5 p90 -155.73 154.7 31.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.367 -1.079 . . . . 0.0 109.738 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.8 99.62 11.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.28 134.43 39.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -141.11 100.06 3.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.0 109.712 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 136.48 34.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.888 . . . . 0.0 108.633 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.66 110.58 22.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.186 -0.947 . . . . 0.0 110.005 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 128.83 44.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.252 -0.905 . . . . 0.0 108.859 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 57' ' ' HIS . 58.5 m -150.25 167.8 25.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.046 -1.034 . . . . 0.0 110.37 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 136.62 48.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.8 m-85 -103.48 145.34 30.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -116.9 153.83 31.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.75 143.31 36.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -81.4 176.59 9.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.43 -13.24 52.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -0.906 . . . . 0.0 109.86 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -84.42 7.95 17.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 109.867 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 -14.8 61.88 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 37.6 mmtm -102.81 176.18 5.24 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 38' ' ' GLY . 21.4 t -101.11 137.07 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -62.76 1.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -151.04 124.38 1.69 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.51 3.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.156 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -97.78 -41.97 7.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.04 -1.037 . . . . 0.0 109.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 10.6 t0 46.92 14.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 109.442 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 14.0 t80 -136.9 99.07 3.92 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 0.0 109.368 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 pt -101.97 133.17 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.437 -0.79 . . . . 0.0 108.942 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.7 p90 -142.14 -161.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.259 -0.9 . . . . 0.0 109.278 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 21.7 p90 -44.65 -27.51 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.224 -0.923 . . . . 0.0 110.372 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.4 t30 -57.93 -8.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.999 -1.063 . . . . 0.0 108.96 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 45.0 t-20 -139.06 109.42 6.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.798 . . . . 0.0 108.966 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -47.37 -31.51 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.89 . . . . 0.0 109.183 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.8 pttt -168.52 155.01 7.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.442 -0.786 . . . . 0.0 109.39 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 33.3 t -60.82 147.88 41.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.38 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.36 -47.88 16.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -116.16 0.91 13.07 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.736 -0.602 . . . . 0.0 109.516 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.66 -12.01 65.1 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t 58.44 14.92 3.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.232 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.4 t -92.97 151.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.404 ' O ' HD23 ' A' ' 73' ' ' LEU . 76.1 m -148.84 134.62 18.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.0 109.811 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 73' ' ' LEU . 23.0 m80 -90.57 139.57 30.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.393 -0.817 . . . . 0.0 109.072 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 m -76.84 -55.55 5.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.44 117.28 0.66 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.91 113.62 18.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -1.148 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 132.95 35.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -81.75 7.97 11.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.69 -35.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.4 111.36 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -1.149 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.55 -63.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -87.92 159.29 18.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.6 m -152.51 132.4 13.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.214 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.557 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -117.15 123.95 47.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -95.87 136.19 36.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.275 -0.89 . . . . 0.0 108.853 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.52 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 87.4 mt -133.39 146.99 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.086 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.25 90.36 2.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 79' ' ' ALA . 13.8 mt -72.41 -25.27 61.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -66.4 4.74 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -137.08 24.91 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 81' ' ' PRO . 38.1 t -103.93 105.54 48.8 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.451 -0.78 . . . . 0.0 109.198 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . 73.2 Cg_exo -48.06 -175.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.026 1.817 . . . . 0.0 112.335 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.84 85.92 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.27 -50.81 72.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -1.204 . . . . 0.0 109.243 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 84' ' ' VAL . 5.2 m -95.55 139.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 109.076 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' A' ' 32' ' ' ALA . 3.4 m-20 -116.86 2.41 12.82 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.57 -0.706 . . . . 0.0 109.819 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -158.14 132.68 8.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.041 . . . . 0.0 109.777 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.7 mt -141.17 117.79 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.2 157.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 75' ' ' ILE . 4.6 m-85 -105.9 137.41 43.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 1.2 p -147.01 157.46 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.521 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 3.5 p -129.26 147.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 p -140.15 140.71 36.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -73.82 132.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.826 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 97' ' ' GLN . 83.8 t60 -89.95 -63.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.22 -18.22 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.92 -18.26 43.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 38.1 mt-30 -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.734 -1.229 . . . . 0.0 109.412 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.46 -44.42 9.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 0.0 111.047 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -81.72 -17.79 46.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.05 -1.031 . . . . 0.0 111.402 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 52.34 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.854 -1.154 . . . . 0.0 109.077 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -148.13 143.5 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.328 -0.857 . . . . 0.0 109.132 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -99.85 165.38 11.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.284 -0.885 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -46.22 -32.22 2.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.321 -0.862 . . . . 0.0 109.785 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -38.69 96.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -49.87 -17.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.3 . . . . 0.0 109.296 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 107' ' ' SER . 15.9 t -84.92 163.82 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 109.127 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -62.08 -26.79 68.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.597 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.1 79.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 164.37 25.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -1.146 . . . . 0.0 109.74 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 37.0 p90 -151.29 170.02 20.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.301 -0.875 . . . . 0.0 110.018 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 24.7 mt -132.66 154.93 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 72.6 ttt180 -143.38 162.48 35.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.968 -1.083 . . . . 0.0 109.718 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.3 tt -157.67 117.97 3.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 0.0 109.771 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.609 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.1 p -132.03 142.81 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.359 -0.838 . . . . 0.0 109.586 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.84 102.27 8.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 5.5 t70 -68.03 -1.78 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.5 -52.12 10.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 4.5 t-20 -122.02 -14.12 8.07 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.677 -0.639 . . . . 0.0 109.608 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 5.0 tt0 71.67 69.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.6 m -134.39 -43.71 0.77 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.722 -0.611 . . . . 0.0 109.807 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.876 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.7 mp0 -65.79 158.25 28.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 108.781 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 174.21 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.92 51.73 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.751 . . . . 0.0 109.201 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.0 ptt180 -134.08 142.07 47.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.607 -0.683 . . . . 0.0 109.474 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.8 t80 -91.43 147.35 23.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.371 -0.831 . . . . 0.0 108.916 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.77 102.83 15.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 109.394 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 50.5 mt -79.65 -39.19 31.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.6 p -47.56 -30.51 3.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.018 -1.051 . . . . 0.0 109.286 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -95.23 -54.59 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -0.825 . . . . 0.0 109.75 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 53.9 m-20 -74.77 -0.73 19.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.7 -46.5 74.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.085 -1.01 . . . . 0.0 109.321 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.2 t -69.23 2.99 2.42 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.548 -0.72 . . . . 0.0 109.882 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 m -82.96 -34.57 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.9 -162.91 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.001 -1.062 . . . . 0.0 109.582 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -15.25 7.56 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.35 137.37 35.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.6 ttp -164.89 152.05 11.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.872 -1.142 . . . . 0.0 110.144 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.596 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.7 pt? -87.96 135.43 33.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -77.81 -26.4 49.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.922 -1.111 . . . . 0.0 109.304 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.69 -164.23 21.91 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -150.53 154.22 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.988 . . . . 0.0 108.74 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 134.81 24.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.038 -1.039 . . . . 0.0 108.86 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -147.47 166.01 28.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 109.717 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.57 148.48 24.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -152.3 123.73 7.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER 55.72 24.8 7.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.18 80.05 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -127.82 137.48 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -1.015 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -67.69 151.19 47.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -148.61 121.98 9.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.148 -0.97 . . . . 0.0 109.726 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 17.6 t80 -89.94 143.77 26.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.497 -0.752 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.32 107.43 3.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 109.026 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.36 154.79 10.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.776 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -139.42 -34.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.373 -0.829 . . . . 0.0 109.05 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.41 81.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.551 ' H ' HD21 ' A' ' 138' ' ' LEU . 34.7 tt0 -141.35 104.14 4.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.057 . . . . 0.0 109.041 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.0 150.5 27.73 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.7 137.77 38.69 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.606 -0.937 . . . . 0.0 108.782 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.51 13.86 24.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.217 -0.927 . . . . 0.0 109.519 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.88 -68.35 1.34 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.06 131.59 1.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.7 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.23 -30.27 1.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -1.116 . . . . 0.0 109.87 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.7 -25.18 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' GLY . 53.6 p -77.34 -55.4 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.471 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.6 m -46.97 -20.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 80.0 m -71.47 -60.91 1.98 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.03 -19.64 28.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.28 -0.888 . . . . 0.0 110.141 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -55.21 -42.19 73.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 109.726 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -71.47 -19.86 62.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.355 -0.841 . . . . 0.0 109.178 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 149' ' ' TRP . 73.2 m . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -74.19 -169.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -153.9 -34.58 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 31.4 t30 -143.63 128.22 18.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 109.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.413 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.6 t -124.64 158.54 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.626 -0.671 . . . . 0.0 109.479 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.21 112.95 6.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.516 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -89.94 150.55 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 108.981 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.35 116.76 1.34 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.61 135.46 42.02 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.92 138.07 8.09 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -160.33 153.7 22.08 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.4 111.24 23.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.548 -0.72 . . . . 0.0 109.347 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 68.4 m-85 -96.31 150.9 20.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.07 99.67 3.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.865 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.63 132.78 35.56 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -95.85 111.06 23.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.096 -1.002 . . . . 0.0 110.092 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.36 125.34 43.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.414 -0.804 . . . . 0.0 108.893 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -149.81 167.77 25.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.844 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.0 142.25 41.66 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.5 m-85 -103.9 148.28 26.35 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -120.18 154.11 35.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.568 -0.708 . . . . 0.0 109.987 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 139.54 27.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.102 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.86 176.42 7.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.097 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.38 -9.44 58.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.179 -0.95 . . . . 0.0 109.763 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.39 8.29 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.136 -0.977 . . . . 0.0 109.919 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.18 70.1 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 66.7 mmtt -104.18 170.1 8.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.8 t -98.42 137.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.12 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.3 ttt-85 -64.69 1.94 0.76 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.93 125.21 1.7 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 4.42 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -1.148 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.59 -41.5 8.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.97 -1.081 . . . . 0.0 110.028 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 12.2 t0 47.72 13.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.857 -1.152 . . . . 0.0 109.43 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 72.4 t80 -136.89 99.39 4.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -0.8 . . . . 0.0 109.642 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.3 pt -99.7 139.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.6 p90 -154.22 -155.93 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 109.596 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 3.8 m-85 -43.54 -34.29 1.35 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.544 -0.723 . . . . 0.0 110.138 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -58.28 -2.16 0.17 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.096 -1.002 . . . . 0.0 108.827 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 43.5 t-20 -148.72 113.76 5.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 109.27 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -50.64 -38.49 46.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 108.945 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 36.0 pttt -161.87 157.67 24.31 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.372 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 t -63.21 144.57 56.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -47.12 17.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -116.31 2.02 13.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.715 -0.615 . . . . 0.0 109.67 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.7 -17.97 57.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 2.9 p 67.22 7.97 5.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -93.11 149.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 m -148.86 138.98 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.227 -0.92 . . . . 0.0 109.496 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 44.1 m80 -89.88 139.83 30.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -142.61 40.57 1.56 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 109.343 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.38 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.2 124.28 34.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -1.058 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.7 m120 -153.53 93.03 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -73.88 14.52 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 61' ' ' ASN . 52.6 p -147.59 -35.29 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.887 . . . . 0.0 109.303 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.73 122.01 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -82.01 -70.43 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.33 177.0 7.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.2 m -159.98 132.44 6.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -119.44 125.15 48.26 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -95.9 139.35 32.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 108.837 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.506 HD13 ' CE1' ' A' ' 89' ' ' PHE . 69.3 mt -132.22 146.61 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.5 mttm -141.22 101.32 3.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.68 -5.41 53.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.13 -20.46 32.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.569 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.74 7.99 43.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.15 123.95 84.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.203 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.923 1.749 . . . . 0.0 112.054 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.82 2.24 76.1 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -69.94 -60.63 2.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -1.199 . . . . 0.0 109.219 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.97 148.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.003 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.7 15.99 3.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.245 -0.909 . . . . 0.0 109.693 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' NZ ' ' OE2' ' A' ' 141' ' ' GLU . 50.6 tttp -158.37 135.21 9.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.589 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.2 mt -133.65 154.14 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.93 173.47 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 108.913 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.7 m-85 -142.1 123.38 14.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.71 157.9 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 110.352 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -131.24 115.53 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -107.11 153.24 22.93 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.39 -0.819 . . . . 0.0 110.242 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.7 mm -73.84 167.41 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.625 ' N ' HG22 ' A' ' 93' ' ' ILE . 46.7 t-80 -133.69 -60.81 0.82 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.385 -0.822 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -49.28 -18.27 0.34 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.972 . . . . 0.0 109.586 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.74 -40.02 90.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.81 -32.6 44.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.776 -1.202 . . . . 0.0 109.698 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.91 -54.03 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.124 -0.985 . . . . 0.0 111.352 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.49 4.09 17.21 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.294 -0.879 . . . . 0.0 111.16 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' ALA . 51.7 ttt180 57.56 106.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 109.301 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.44 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 34.7 mt-30 -151.34 145.34 25.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 109.671 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.8 p -104.95 163.59 12.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.447 -0.783 . . . . 0.0 109.55 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -46.15 -36.38 5.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 109.859 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.655 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.92 -41.43 96.23 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 57.8 mm-40 -49.43 -14.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.28 . . . . 0.0 109.267 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 107' ' ' SER . 21.9 t -83.59 165.4 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.049 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 t -69.0 -20.15 64.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.11 79.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.37 163.46 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.129 . . . . 0.0 109.821 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 18.3 p90 -157.85 158.75 35.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.8 mt -118.88 157.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -138.11 159.35 42.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.059 -1.026 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.9 tt -152.9 115.31 4.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.573 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.86 142.11 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.395 -0.816 . . . . 0.0 109.857 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLN . 57.9 t30 -79.49 101.82 8.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.53 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.7 t70 -69.34 -4.89 20.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.728 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.545 ' C ' HD22 ' A' ' 118' ' ' ASN . 13.7 t0 -70.91 -53.2 15.89 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.813 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.545 HD22 ' C ' ' A' ' 117' ' ' ASP . 1.4 m-80 -123.38 0.78 8.95 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 115' ' ' ASN . 26.1 tt0 62.93 64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.4 m -118.06 -69.9 0.82 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.924 -0.485 . . . . 0.0 110.304 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.854 ' O ' HG13 ' A' ' 122' ' ' VAL . 14.9 mm-40 -45.29 157.04 0.09 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.311 -0.868 . . . . 0.0 109.876 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.84 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.19 154.47 50.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.012 -1.055 . . . . 0.0 110.025 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.2 ptm180 -139.32 149.24 43.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 109.193 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.05 147.32 22.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.188 -0.945 . . . . 0.0 109.135 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.4 103.13 15.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 0.0 109.399 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 64.3 mt -80.94 -40.49 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 128' ' ' THR . 4.1 p -47.84 -31.06 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 109.189 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -95.2 -54.62 3.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -0.783 . . . . 0.0 109.753 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.96 -4.76 34.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.655 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.77 -45.95 67.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.132 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.5 p -69.14 3.01 2.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.647 -0.658 . . . . 0.0 109.845 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 m -83.18 -34.58 25.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 0.0 110.2 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 179.52 -163.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.93 -1.106 . . . . 0.0 109.592 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 -9.74 9.57 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.71 139.53 34.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.46 157.6 15.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.176 -0.953 . . . . 0.0 109.512 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.36 138.41 37.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 109.718 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 29.2 t80 -81.06 -43.98 18.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 109.611 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.82 -168.69 20.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.514 ' OE2' ' NZ ' ' A' ' 86' ' ' LYS . 29.2 tt0 -151.32 163.53 38.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -1.1 . . . . 0.0 109.408 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.92 140.73 29.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 0.0 108.661 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.45 ' OH ' ' CZ ' ' A' ' 152' ' ' ARG . 4.7 p90 -150.59 166.02 31.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.116 -0.99 . . . . 0.0 109.703 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -85.3 151.48 24.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.563 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -157.72 123.95 4.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 0.4 OUTLIER 55.97 24.15 7.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.366 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.12 10.55 83.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -127.8 138.98 52.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.598 -0.943 . . . . 0.0 109.339 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 1' ' ' SER . 83.5 m95 -67.67 151.6 47.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.519 ' NZ ' HH21 ' A' ' 152' ' ' ARG . 80.3 tttt -150.72 123.2 8.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -89.47 138.87 31.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.519 HH21 ' NZ ' ' A' ' 150' ' ' LYS . 86.0 mtt180 -143.67 107.35 4.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.26 154.68 39.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -139.8 -33.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.78 86.15 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -137.95 104.76 5.35 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.982 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 152.94 39.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' CE1' HG11 ' A' ' 165' ' ' VAL . 2.0 p90 -147.45 125.27 11.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -1.178 . . . . 0.0 109.33 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.36 11.7 25.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -65.75 2.23 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.37 126.99 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.77 -33.03 4.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 109.82 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.65 -26.03 26.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.335 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.9 t -74.37 -54.31 7.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.5 m -47.94 -20.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 109.438 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.9 m -71.44 -60.65 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.142 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -15.46 38.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.188 -0.945 . . . . 0.0 110.393 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.64 -44.23 87.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.941 -1.099 . . . . 0.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -71.49 -0.2 9.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.545 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.99 174.81 11.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -153.23 -34.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.472 HD22 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -145.94 143.49 29.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.093 -1.004 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -145.94 133.09 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.381 -0.824 . . . . 0.0 109.226 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 73' ' ' LEU . 13.8 tp -116.79 109.78 17.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.88 151.0 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.04 117.08 1.33 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -108.12 133.24 52.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.9 140.71 8.61 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -158.04 152.96 25.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -1.112 . . . . 0.0 109.984 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.72 130.55 39.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.0 109.597 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.314 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.14 151.17 19.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.325 -0.859 . . . . 0.0 109.282 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -141.02 99.77 3.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.285 -0.884 . . . . 0.0 109.676 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.28 142.64 30.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 108.625 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.52 112.71 25.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.376 -0.827 . . . . 0.0 109.563 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 130.12 44.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.1 m -149.58 163.06 38.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.089 -1.007 . . . . 0.0 109.937 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 146.08 36.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.5 m-85 -104.24 161.55 13.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.894 . . . . 0.0 109.415 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -129.06 139.16 52.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.661 -0.65 . . . . 0.0 109.478 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 133.46 22.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.05 176.41 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -81.21 -8.94 59.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.676 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -83.27 1.6 40.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.157 -0.965 . . . . 0.0 109.736 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.17 58.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -98.29 144.57 27.56 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 38' ' ' GLY . 22.4 t -66.39 136.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.067 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.02 13.44 0.68 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -159.89 173.15 36.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -94.52 -1.74 52.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.052 -1.264 . . . . 0.0 110.289 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.08 -42.08 5.89 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.196 -0.94 . . . . 0.0 110.059 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 26.9 t0 61.47 -1.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 110.094 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.59 124.31 19.74 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.166 -0.959 . . . . 0.0 110.009 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 pt -102.58 139.57 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.62 ' CE1' ' CZ ' ' A' ' 42' ' ' PHE . 1.3 p90 -138.11 -161.67 1.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 22.8 p90 -44.23 -30.49 0.8 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.162 -0.961 . . . . 0.0 110.437 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 2.4 t30 -51.1 -16.95 0.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 109.081 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.5 t-20 -135.03 104.06 5.8 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.525 -0.735 . . . . 0.0 109.071 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.98 -24.69 1.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.6 pttt -167.45 155.07 8.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.1 t -77.23 122.46 25.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.06 62.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.962 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -112.91 -19.0 12.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.57 -13.55 75.62 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.5 p 62.85 10.27 4.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -1.118 . . . . 0.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' A' ' 50' ' ' SER . 43.2 t -92.79 151.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -148.72 142.49 25.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.154 -0.966 . . . . 0.0 110.046 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 73' ' ' LEU . 7.4 m80 -91.83 126.41 36.9 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 25.5 m -74.48 -29.54 61.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.38 110.82 0.25 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.86 110.98 18.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -81.67 -163.56 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' THR . 28.6 ttm180 -152.16 14.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 109.268 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 62' ' ' ARG . 34.4 p -154.87 -37.73 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.99 101.97 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -1.155 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -55.25 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -89.27 167.5 13.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.346 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.418 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.5 p -160.48 132.86 6.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.6 mp -113.18 128.29 56.44 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.504 -0.747 . . . . 0.0 109.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HZ1' ' HE2' ' A' ' 76' ' ' LYS . 1.8 tmtp? -96.36 110.51 22.83 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.93 146.88 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.596 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HE2' ' HZ1' ' A' ' 74' ' ' LYS . 86.3 mttt -136.49 94.42 3.01 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.52 -11.57 59.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.93 . . . . 0.0 109.616 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.41 4.7 23.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.35 10.73 7.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.449 -0.782 . . . . 0.0 109.322 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.4 t -81.3 125.77 78.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.022 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.14 -162.23 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.841 1.694 . . . . 0.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.38 -0.12 82.75 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.86 -60.69 2.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -1.172 . . . . 0.0 109.44 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.6 t -89.93 148.65 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 41.3 m-20 -139.35 1.96 2.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 109.659 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -150.92 131.48 13.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.186 -0.946 . . . . 0.0 109.006 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.99 154.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.503 -0.748 . . . . 0.0 109.31 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -139.86 173.93 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 17.1 m-85 -141.55 122.06 14.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.63 157.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.4 p -134.14 114.31 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -107.82 151.95 25.05 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.331 -0.855 . . . . 0.0 109.924 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.36 140.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 108.799 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -62.34 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.076 -1.015 . . . . 0.0 109.877 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -47.6 -20.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 109.569 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.6 -18.28 28.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 109.777 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -64.75 -60.79 2.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.687 -1.258 . . . . 0.0 109.255 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.44 11.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 111.024 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -86.16 -19.58 29.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.944 -1.097 . . . . 0.0 111.379 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 55.33 96.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.759 -1.213 . . . . 0.0 109.275 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -158.74 152.54 23.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.491 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 m -105.15 154.65 19.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.457 -0.777 . . . . 0.0 109.241 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.6 -29.89 0.81 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.429 -0.794 . . . . 0.0 109.727 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.67 -37.39 50.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -58.96 -14.18 8.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 109.345 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 107' ' ' SER . 27.9 t -80.32 165.81 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.131 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.506 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.7 t -68.15 -25.89 65.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.94 . . . . 0.0 109.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.12 79.89 0.03 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.45 26.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 13.5 p90 -152.69 142.92 22.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.07 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 48.0 mt -107.49 156.73 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -140.46 161.1 38.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.966 -1.083 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.4 tt -157.35 117.52 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.055 -1.028 . . . . 0.0 109.756 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.605 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -129.54 143.98 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.366 -0.833 . . . . 0.0 109.522 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -74.78 101.69 4.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.93 -1.83 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.056 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.472 ' CB ' HD22 ' A' ' 4' ' ' ASN . 29.0 t0 -82.57 -52.74 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -122.52 -5.97 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.652 . . . . 0.0 109.851 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 65.81 65.77 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.5 p -123.81 -49.1 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.931 -0.481 . . . . 0.0 109.998 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 54.6 mm-40 -62.94 159.05 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.288 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 177.53 75.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.92 52.28 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.424 -0.798 . . . . 0.0 109.508 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 32.4 ptt180 -136.16 141.16 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.693 . . . . 0.0 109.226 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -92.1 143.61 26.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.0 109.163 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -87.64 103.64 15.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.5 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.6 mt -80.57 -38.31 29.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.4 m -48.25 -33.62 8.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.863 -1.148 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -95.21 -51.12 4.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.406 -0.809 . . . . 0.0 109.747 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.55 -7.44 50.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.251 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.22 -49.99 75.45 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.009 -1.057 . . . . 0.0 109.825 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 p -55.88 0.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.78 . . . . 0.0 110.509 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 131' ' ' ALA . 38.0 p -87.42 -33.12 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.746 -1.221 . . . . 0.0 110.081 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -172.34 -145.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.785 -1.197 . . . . 0.0 109.712 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 21.1 m -126.61 -40.23 1.94 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.18 155.97 26.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 ttt -166.81 157.59 12.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.16 -0.963 . . . . 0.0 109.829 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.81 126.8 50.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.328 -0.857 . . . . 0.0 109.337 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -70.07 -37.13 75.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.932 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.1 -163.39 24.06 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.851 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -151.54 164.09 37.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -1.069 . . . . 0.0 109.519 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.72 140.04 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.244 -0.91 . . . . 0.0 108.571 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.447 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.8 p90 -150.61 166.31 30.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.913 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 17.4 ptm180 -85.34 152.7 23.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.514 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 2.1 t60 -153.9 119.9 5.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.267 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 29.0 m-20 52.46 29.39 6.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 109.501 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.52 81.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -127.87 134.91 49.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.48 -1.012 . . . . 0.0 109.396 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.43 149.34 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -148.86 125.98 11.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.208 -0.932 . . . . 0.0 109.538 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -93.37 140.99 28.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 109.971 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -144.06 107.54 4.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.422 -0.799 . . . . 0.0 109.09 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.13 154.65 41.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.098 -1.001 . . . . 0.0 109.72 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.24 -33.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.81 85.82 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.308 -1.113 . . . . 0.0 109.572 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.56 154.03 46.75 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 165' ' ' VAL . 12.7 p90 -137.88 124.04 20.39 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.377 -1.072 . . . . 0.0 109.436 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.63 3.08 34.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.45 -75.09 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 156.39 136.59 2.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.7 pp -47.38 -36.97 10.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -1.172 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.86 -16.83 37.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.3 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 161' ' ' GLY . 34.5 m -78.82 -56.0 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 158' ' ' TYR . 14.4 m -51.62 -19.94 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 109.11 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 70.8 m -73.67 -63.02 1.29 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.469 -0.769 . . . . 0.0 110.352 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.28 35.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.849 . . . . 0.0 110.583 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -61.37 -48.74 79.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.064 -1.022 . . . . 0.0 110.26 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -71.74 -20.33 61.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 109.464 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.448 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 20.3 mmt -79.95 -176.29 5.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 82.7 mttt -151.73 -35.77 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 51.8 m-20 -145.09 143.77 30.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -140.81 158.14 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.6 tp -145.34 109.75 4.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.03 145.7 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.36 117.21 2.89 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.93 124.92 50.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.15 150.47 22.68 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.535 -1.317 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -157.04 153.98 28.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.412 -1.052 . . . . 0.0 109.804 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.69 130.05 34.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.762 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.288 0.566 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 60.9 m-85 -96.41 146.79 24.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 12.1 m-20 -141.03 99.62 3.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -85.28 140.64 30.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 108.524 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -103.17 119.7 39.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.29 131.71 43.73 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.292 -0.88 . . . . 0.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -150.19 168.18 24.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.63 147.47 45.19 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 90' ' ' VAL . 4.3 m-85 -103.6 123.15 46.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.0 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.02 135.72 37.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 108.725 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.01 128.33 17.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.964 -1.085 . . . . 0.0 110.388 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 176.26 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.71 1.13 44.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -84.62 -7.44 59.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 -10.78 73.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -105.07 148.09 27.17 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 38' ' ' GLY . 44.3 t -66.39 137.25 25.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.91 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -70.79 7.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.691 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -154.04 172.66 32.7 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.94 -2.88 49.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.842 -1.387 . . . . 0.0 110.321 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.19 -40.85 6.27 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.09 -1.006 . . . . 0.0 110.982 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' HG11 ' A' ' 36' ' ' VAL . 35.7 t0 50.44 10.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.74 -1.225 . . . . 0.0 109.329 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ALA . 81.8 t80 -138.12 100.22 4.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.0 109.533 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.8 pt -101.41 137.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.22 -0.925 . . . . 0.0 109.086 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.8 p90 -142.81 -162.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.3 p90 -45.23 -32.37 1.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -0.942 . . . . 0.0 110.512 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 17.9 t-20 -51.83 -11.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.886 -1.134 . . . . 0.0 109.036 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.0 t-20 -135.6 107.8 7.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.9 tp -47.52 -29.71 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 35.3 pttt -168.85 156.96 7.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -65.95 144.25 56.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.92 -46.98 32.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -116.07 -2.78 12.17 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.05 -15.68 76.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.46 9.41 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.07 149.82 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.154 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.51 137.75 25.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.164 -0.96 . . . . 0.0 109.869 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -89.42 135.25 33.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.773 . . . . 0.0 108.931 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -73.38 -44.44 58.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.09 110.11 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.59 110.89 12.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -1.142 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.96 -164.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 63' ' ' THR . 10.2 ptm180 -158.18 17.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 62' ' ' ARG . 33.3 p -155.71 -40.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.332 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.81 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 42.8 p-10 -48.66 98.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -1.153 . . . . 0.0 109.564 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 68' ' ' GLY . 68.0 m-20 -74.8 -46.18 38.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.46 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' CG ' ' N ' ' A' ' 72' ' ' SER . 68.0 tt0 -115.82 162.7 16.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.685 . . . . 0.0 109.176 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 m -153.53 143.09 21.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -121.73 123.1 41.05 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.603 -0.685 . . . . 0.0 109.24 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -95.61 138.63 33.01 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.27 146.82 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.434 -0.791 . . . . 0.0 110.182 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -139.12 106.42 5.51 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 79' ' ' ALA . 9.0 mt -78.98 -42.52 26.49 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -52.55 -8.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.977 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.68 19.5 16.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.55 -0.719 . . . . 0.0 109.67 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 81' ' ' PRO . 47.2 t -104.63 105.17 49.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.319 -0.863 . . . . 0.0 109.246 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.2 Cg_exo -48.97 -173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.039 1.826 . . . . 0.0 112.355 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.25 0.33 87.22 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.77 -58.51 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -1.198 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.35 145.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -135.93 -5.74 2.15 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.082 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -142.46 130.67 22.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.997 -1.064 . . . . 0.0 109.214 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.1 mt -139.99 113.99 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.67 173.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.316 -0.865 . . . . 0.0 109.121 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.94 142.2 51.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 91' ' ' VAL . 58.7 t -146.9 156.53 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.857 -1.152 . . . . 0.0 111.713 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.3 p -146.58 113.65 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -120.57 161.67 20.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.295 -0.878 . . . . 0.0 110.828 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.542 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -77.56 161.87 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.482 ' N ' HG22 ' A' ' 93' ' ' ILE . 1.3 t60 -111.19 -76.05 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.344 -0.848 . . . . 0.0 109.934 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' GLN . 1.4 m-20 -47.82 -18.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.772 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.77 -19.07 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 49.7 tt0 -71.45 -62.22 1.49 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.95 -1.094 . . . . 0.0 109.319 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.52 -43.82 9.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.339 -0.85 . . . . 0.0 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 101' ' ' GLN . 40.9 ttt85 -79.23 -20.18 48.87 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 99' ' ' ARG . 59.5 ttt-85 54.59 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.745 -1.222 . . . . 0.0 109.474 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.475 ' CD ' ' HE ' ' A' ' 99' ' ' ARG . 18.8 mt-30 -157.8 141.47 15.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -102.2 163.89 11.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -46.73 -33.01 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.844 . . . . 0.0 109.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.5 -42.28 98.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 66.1 mm-40 -51.21 -12.04 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.156 -1.202 . . . . 0.0 109.225 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.4 t -82.74 165.29 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.852 . . . . 0.0 109.204 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.2 m -69.39 -18.51 63.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.195 -0.941 . . . . 0.0 109.657 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.76 79.46 0.03 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.19 157.51 22.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -1.18 . . . . 0.0 109.706 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 26.5 p90 -150.24 169.71 20.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 109.969 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -135.87 151.56 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -138.17 161.59 36.43 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.022 -1.049 . . . . 0.0 109.984 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.14 116.32 4.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.177 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -128.69 144.94 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.317 -0.864 . . . . 0.0 109.957 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.448 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 57.8 t30 -76.13 102.03 5.58 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.91 -1.57 3.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.668 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.64 -53.78 5.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.49 ' CG ' ' HG1' ' A' ' 120' ' ' THR . 13.7 p30 -123.82 6.81 8.73 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.737 -0.602 . . . . 0.0 109.638 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' ASN . 8.1 mt-30 59.55 60.52 2.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 118' ' ' ASN . 86.0 m -110.82 -70.41 0.81 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.896 -0.502 . . . . 0.0 110.342 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.858 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.9 mm-40 -45.3 157.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.18 156.01 48.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.168 -0.958 . . . . 0.0 109.923 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptp180 -142.49 143.31 32.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.545 -0.722 . . . . 0.0 109.243 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.429 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.4 t80 -91.22 142.04 28.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 108.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -85.26 102.86 13.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.065 -1.022 . . . . 0.0 109.432 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 54.1 mt -79.0 -39.21 34.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.166 -0.959 . . . . 0.0 109.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.2 t -47.79 -31.07 4.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.992 -1.067 . . . . 0.0 109.209 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.18 -54.6 3.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.773 . . . . 0.0 109.711 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.429 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 46.8 m-20 -73.23 -2.68 22.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.283 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.1 -47.15 72.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.087 -1.008 . . . . 0.0 109.238 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 t -68.1 3.12 1.73 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.549 -0.719 . . . . 0.0 109.819 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 m -84.3 -34.93 23.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.985 . . . . 0.0 110.169 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -177.53 -166.31 0.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.931 -1.105 . . . . 0.0 109.66 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.69 -10.72 9.14 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.79 26.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.68 158.14 15.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.41 134.16 37.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.1 t80 -73.33 -45.44 55.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.892 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.74 -162.5 11.26 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 22.2 tt0 -151.97 164.29 37.47 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.106 -1.232 . . . . 0.0 109.839 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 13.3 tp -144.16 133.35 23.0 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -148.64 166.22 28.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.0 109.639 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 14.5 ptm180 -94.47 141.24 28.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.377 -0.827 . . . . 0.0 110.095 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.575 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 10.2 t-160 -100.03 -132.88 0.26 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.575 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.3 m120 -51.85 -51.45 56.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.887 -1.133 . . . . 0.0 108.322 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.48 16.93 0.14 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.83 159.51 36.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -77.73 151.81 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -148.21 124.99 11.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -89.69 147.65 23.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.377 -0.827 . . . . 0.0 109.391 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -153.9 109.35 3.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.69 154.68 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.526 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.58 -34.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.14 84.22 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.32 104.41 7.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.68 -0.894 . . . . 0.0 109.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 149.96 29.32 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.63 127.47 19.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.46 12.15 21.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.6 -67.18 1.76 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.77 126.89 1.13 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -44.68 -32.5 1.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.363 -1.08 . . . . 0.0 110.099 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.74 -27.19 25.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 161' ' ' GLY . 23.3 t -77.71 -50.51 12.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.426 -0.796 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -48.68 -20.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.483 ' SG ' ' CB ' ' A' ' 42' ' ' PHE . 56.7 m -72.35 -61.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.57 -15.36 37.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.165 -0.959 . . . . 0.0 110.537 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.88 -42.14 99.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.033 . . . . 0.0 110.476 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.62 -20.62 61.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.513 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.567 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.1 mpt? -73.06 171.46 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -153.98 -34.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.71 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.06 128.31 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.245 -0.91 . . . . 0.0 109.233 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.71 ' N ' HD22 ' A' ' 4' ' ' ASN . 5.2 t -127.69 156.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.613 -0.679 . . . . 0.0 109.178 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.1 tp -142.4 107.18 4.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.78 150.6 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.83 116.94 1.32 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.71 135.18 45.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.9 135.46 5.9 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -157.04 153.2 27.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -1.103 . . . . 0.0 109.816 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.09 108.02 20.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.262 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.34 141.66 29.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.239 -0.913 . . . . 0.0 109.402 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.4 p30 -141.07 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.155 -0.966 . . . . 0.0 109.595 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.69 134.87 34.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 108.877 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -92.4 107.13 18.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.034 -1.042 . . . . 0.0 109.83 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.41 123.46 42.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.74 167.59 26.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.101 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.49 46.2 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.6 m-85 -104.37 128.37 52.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.338 -0.851 . . . . 0.0 108.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.76 155.62 17.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 110.088 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.53 137.28 25.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.349 -0.845 . . . . 0.0 109.362 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -80.16 176.67 9.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.16 -8.56 59.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.966 . . . . 0.0 109.805 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -85.67 2.91 43.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.139 -0.975 . . . . 0.0 109.808 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.03 -18.31 57.6 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.6 mttt -106.61 173.23 6.41 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -101.3 142.18 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.405 -0.809 . . . . 0.0 109.675 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -60.11 -5.55 1.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -144.33 102.32 0.27 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 31.8 p-10 -45.28 -25.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -1.101 . . . . 0.0 110.356 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -58.76 -42.06 88.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.067 -1.02 . . . . 0.0 109.822 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 38.8 t0 46.27 15.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 81.5 t80 -137.35 99.58 4.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 109.419 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.0 pt -102.86 137.92 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.7 p90 -140.85 -160.78 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.18 -0.95 . . . . 0.0 109.344 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.4 p90 -44.68 -31.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 0.0 110.495 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.6 t-20 -51.05 -14.27 0.22 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.903 -1.123 . . . . 0.0 109.01 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.4 t-20 -135.77 107.38 6.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -47.78 -26.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.372 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 14.4 pttm -170.52 159.14 6.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 8.1 t -73.22 129.99 39.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.388 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.24 -30.36 54.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.66 -15.97 11.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 -12.58 75.28 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 60.68 10.75 2.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 50' ' ' SER . 59.7 t -92.75 151.9 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 108.963 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -145.37 145.0 31.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -90.94 119.59 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 m -67.24 -46.98 72.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.27 117.61 0.77 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -78.46 158.9 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -1.178 . . . . 0.0 109.543 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -157.55 109.98 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.59 17.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.897 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -152.56 -35.05 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.255 -0.903 . . . . 0.0 109.372 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.16 99.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -1.135 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -69.11 -73.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -98.67 164.45 12.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -160.81 139.33 10.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.338 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 mp -117.94 127.32 53.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.524 -0.735 . . . . 0.0 109.382 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HG2' ' HZ2' ' A' ' 76' ' ' LYS . 52.4 tttp -96.19 114.79 26.52 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.531 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 64.5 mt -104.18 147.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.388 -0.82 . . . . 0.0 110.571 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HZ2' ' HG2' ' A' ' 74' ' ' LYS . 64.4 mttp -138.71 105.65 5.42 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.27 -38.61 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.15 -22.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.71 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.06 -24.03 17.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.279 -0.888 . . . . 0.0 109.75 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.99 124.24 79.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 109.334 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.23 -160.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.939 1.759 . . . . 0.0 111.826 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.25 0.89 88.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -66.98 -56.37 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.15 148.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 11.7 t0 -125.53 -19.58 4.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.572 -0.705 . . . . 0.0 109.567 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -149.43 143.42 25.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.118 -0.989 . . . . 0.0 109.784 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 89.6 mt -135.21 154.35 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -145.21 172.77 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 2.9 m-85 -142.47 118.76 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.16 158.01 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.308 -0.87 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.0 p -133.41 113.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 p -110.44 156.29 21.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 0.0 110.347 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.536 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.16 144.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.405 ' C ' ' N ' ' A' ' 96' ' ' ALA . 74.6 t60 -99.46 -69.1 0.78 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' NE2' ' A' ' 101' ' ' GLN . 2.9 p30 -49.14 -18.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.849 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.48 -50.37 59.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.712 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 -30.25 41.38 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.799 -1.188 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.85 -53.71 4.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.066 -1.021 . . . . 0.0 111.471 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 100' ' ' ARG . 5.1 ptp180 -112.14 3.5 17.3 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.153 -0.967 . . . . 0.0 111.101 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 85.9 mtt-85 53.42 104.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OD1' ' A' ' 95' ' ' ASP . 25.3 mt-30 -147.93 137.85 22.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.4 p -94.71 160.54 14.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -46.66 -37.03 7.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.739 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.25 -37.73 87.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -47.7 -16.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -1.226 . . . . 0.0 109.322 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 107' ' ' SER . 33.6 t -87.58 166.75 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 109.121 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -67.92 -21.68 65.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 109.707 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.96 79.4 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.03 162.17 25.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 109.75 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 17.8 p90 -155.8 161.44 40.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.8 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 49.7 mt -123.25 157.97 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.401 ' N ' HG22 ' A' ' 111' ' ' ILE . 73.9 ttt180 -141.18 159.71 41.63 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.045 -1.034 . . . . 0.0 109.614 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -154.67 117.42 4.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.953 -1.092 . . . . 0.0 109.499 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.3 p -129.5 144.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 119' ' ' GLN . 55.7 t30 -76.76 102.06 6.09 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 4' ' ' ASN . 23.0 t70 -67.2 -1.61 4.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.318 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.3 t0 -80.65 -53.35 6.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.223 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -123.33 3.97 9.13 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 115' ' ' ASN . 11.9 mt-30 59.75 61.18 2.0 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 89.8 m -113.54 -68.49 0.92 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.956 -0.465 . . . . 0.0 110.363 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 36.4 mm-40 -45.25 157.65 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.907 . . . . 0.0 109.907 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.83 73.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.84 150.3 52.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.044 -1.035 . . . . 0.0 110.084 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.3 ptm180 -140.28 142.66 35.7 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.27 146.39 23.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.062 -1.024 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.39 103.4 16.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 109.389 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 97.6 mt -79.55 -36.52 38.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m -48.08 -32.4 6.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.048 . . . . 0.0 109.213 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.23 -53.88 3.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.76 -4.15 32.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.96 -42.91 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.0 t -74.38 2.95 8.22 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.979 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -83.39 -34.2 25.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.167 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -176.43 -167.41 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.928 -1.107 . . . . 0.0 109.654 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.09 -15.75 8.68 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.22 140.48 41.73 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 45.7 ttp -165.8 158.0 14.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 109.749 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -99.91 135.71 40.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.388 -0.82 . . . . 0.0 109.152 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.99 -43.75 33.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 0.0 109.628 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.29 -172.48 31.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.56 166.65 29.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.238 . . . . 0.0 109.943 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.89 143.56 45.07 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -148.1 166.05 28.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.045 . . . . 0.0 109.667 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 9.1 ptm180 -95.02 146.05 24.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.682 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.454 ' CE1' ' ND2' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -122.49 -120.63 0.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 145' ' ' HIS . 17.4 m-80 -73.61 52.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.24 9.61 86.38 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.82 138.22 52.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.526 -0.985 . . . . 0.0 109.387 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -67.42 151.67 47.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -149.78 128.61 12.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.456 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -89.8 151.01 22.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 109.779 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -156.12 107.19 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.68 39.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.686 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.33 -34.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.66 87.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -132.37 104.45 6.73 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.62 150.88 35.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.463 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.8 p90 -144.32 126.36 15.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -1.099 . . . . 0.0 109.268 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.5 11.91 20.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.25 -77.74 0.11 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 158.3 138.29 2.45 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.71 -34.94 20.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.187 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -81.64 -15.56 54.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.6 m -90.15 -53.99 4.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.8 m -54.5 -21.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 15.0 p -75.85 -51.96 11.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.041 -1.037 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.625 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.82 -25.39 23.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.905 -1.122 . . . . 0.0 110.492 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -57.59 -39.56 77.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.046 -1.034 . . . . 0.0 110.469 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -71.0 -19.53 62.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 149' ' ' TRP . 21.0 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.275 0.559 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 46.5 mtt -152.55 90.98 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.21 -21.97 49.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 6.7 m120 -146.36 139.58 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.7 t -145.67 129.62 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.9 113.71 25.9 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.11 150.68 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -134.7 116.85 1.66 Allowed Glycine 0 N--CA 1.499 2.851 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -115.57 126.22 53.95 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.52 151.99 24.18 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.563 -1.303 . . . . 0.0 109.964 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -161.58 152.45 18.06 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.369 -1.077 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.27 127.54 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 109.591 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.895 . . . . 0.0 109.382 179.823 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.298 0.571 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -96.28 143.45 27.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -141.09 100.33 3.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 109.863 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.09 138.55 33.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' CE2' ' A' ' 44' ' ' PHE . 58.7 t0 -98.81 119.78 38.14 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.161 -0.962 . . . . 0.0 110.383 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -100.53 133.79 44.45 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.2 t -150.0 167.7 25.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.051 -1.03 . . . . 0.0 109.801 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.77 148.82 39.41 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 87' ' ' ILE . 3.9 m-85 -103.19 162.11 13.24 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -139.17 148.91 43.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.87 . . . . 0.0 109.683 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.03 141.05 28.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.925 . . . . 0.0 109.076 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.97 176.33 7.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.6 -1.0 52.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.9 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -95.95 4.17 52.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.181 -0.949 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.02 -13.4 66.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.7 mttp -105.03 163.83 12.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.5 t -90.06 136.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.229 -0.92 . . . . 0.0 109.045 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -66.46 4.09 0.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.14 127.1 1.82 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.6 5.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -1.185 . . . . 0.0 110.523 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -92.14 -42.57 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.847 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 48.0 12.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.653 -1.28 . . . . 0.0 109.468 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ALA . 13.0 t80 -137.68 99.48 3.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.456 -0.778 . . . . 0.0 109.094 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 4.0 pt -97.08 120.96 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.269 -0.894 . . . . 0.0 109.367 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 25' ' ' ALA . 27.0 t80 -171.48 -166.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 67.9 m-85 54.2 -112.89 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.825 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.17 -21.53 65.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 24.0 t-20 -81.39 68.9 7.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.29 -19.61 5.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.152 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 14.8 pttm -163.37 156.65 19.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.474 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 69.5 m -74.54 148.11 41.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.87 -46.41 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.197 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -116.47 -0.4 12.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.725 -0.609 . . . . 0.0 109.647 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.02 -9.74 76.59 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 t 60.52 12.31 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -1.082 . . . . 0.0 109.633 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 38.5 t -93.01 147.97 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.441 ' O ' HD23 ' A' ' 73' ' ' LEU . 31.9 m -149.2 137.61 20.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.047 -1.033 . . . . 0.0 109.887 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.0 m80 -91.7 132.11 36.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.375 -0.828 . . . . 0.0 108.906 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.54 -57.57 5.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.94 124.25 1.11 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.5 112.24 19.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.146 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.11 121.38 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -79.49 13.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.441 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -153.76 -35.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -49.8 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -1.21 . . . . 0.0 109.435 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' GLY . 28.5 m-20 -69.81 -67.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -93.09 102.8 15.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.1 m -91.88 133.4 35.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -112.17 126.52 55.3 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.49 140.16 30.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.269 -0.894 . . . . 0.0 109.33 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 54.3 mt -133.79 146.74 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -145.42 99.86 3.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 79' ' ' ALA . 6.4 mt -81.62 -25.23 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.97 . . . . 0.0 109.865 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.27 4.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.91 22.72 3.56 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 81' ' ' PRO . 55.3 t -104.01 105.7 49.78 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.261 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' VAL . 71.4 Cg_exo -48.39 -174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.02 1.813 . . . . 0.0 112.275 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 1.54 88.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -55.11 20.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -1.112 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.86 121.45 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.381 -0.824 . . . . 0.0 109.121 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.73 -1.6 32.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.325 -0.859 . . . . 0.0 110.289 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -158.17 144.64 17.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.123 . . . . 0.0 110.106 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 28' ' ' PHE . 9.3 mt -146.11 118.56 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 173.34 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 0.0 109.737 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 96.5 m-85 -140.3 118.13 11.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.11 158.01 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.471 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.3 p -126.42 117.56 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -112.69 149.91 32.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.15 149.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.755 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 96' ' ' ALA . 66.9 t60 -103.91 -68.85 0.82 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -46.9 -19.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 109.614 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -57.91 -18.5 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.82 -60.6 2.89 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.716 -1.24 . . . . 0.0 109.315 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.53 -33.3 15.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 111.127 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt-85 -95.57 -18.88 20.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.895 -1.128 . . . . 0.0 111.503 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttt85 56.9 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.796 -1.19 . . . . 0.0 108.984 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -146.09 138.45 25.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.37 -0.831 . . . . 0.0 109.246 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.6 p -96.08 164.27 12.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 135' ' ' THR . 46.8 m-85 -48.17 -35.71 12.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.766 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.75 -37.84 94.24 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -47.27 -16.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -1.189 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 21.6 t -86.74 168.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.044 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 20.8 m -68.19 -20.96 64.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.77 80.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.26 164.11 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.9 p90 -154.23 155.32 35.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 50.0 mt -120.08 153.66 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 8' ' ' GLY . 62.5 ttt180 -140.18 159.57 41.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.966 -1.084 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -153.57 116.34 4.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 109.467 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.4 p -129.38 143.12 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.467 -0.771 . . . . 0.0 109.749 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 119' ' ' GLN . 60.7 t-20 -78.24 101.88 7.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.48 -1.96 4.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 0.0 109.301 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 115' ' ' ASN . 21.1 t0 -77.56 -53.34 7.71 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.032 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.44 3.12 9.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 115' ' ' ASN . 24.6 mt-30 60.01 61.74 1.8 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.6 p -115.17 -67.93 0.96 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.903 -0.498 . . . . 0.0 110.379 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 47.9 mm-40 -45.37 157.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 109.973 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.98 73.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.54 152.55 51.54 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.123 -0.985 . . . . 0.0 109.841 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.5 ptt180 -140.16 145.82 37.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.552 -0.718 . . . . 0.0 109.377 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -91.32 147.82 22.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 108.975 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.73 101.94 14.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.243 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 26.5 mt -81.43 -31.66 33.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.524 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.7 m -48.48 -36.82 15.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 108.82 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -95.4 -49.94 5.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.477 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.62 -11.63 58.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.766 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.35 -43.8 61.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 109.246 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.0 m -74.46 2.89 8.51 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.639 -0.663 . . . . 0.0 109.978 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -89.74 -33.94 16.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.056 . . . . 0.0 110.376 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -175.48 -176.48 0.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.772 -1.205 . . . . 0.0 109.844 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -112.84 -16.37 12.74 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.01 138.65 40.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.8 ttp -164.99 157.78 16.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 109.703 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.61 139.23 33.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.253 -0.904 . . . . 0.0 109.636 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.7 t80 -82.51 -44.07 16.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.082 -1.011 . . . . 0.0 109.605 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.31 -171.41 29.52 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -150.82 166.77 29.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.293 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mt -138.94 131.8 29.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.2 p90 -138.86 166.15 25.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.302 -0.873 . . . . 0.0 109.707 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.7 ptm180 -85.79 149.37 25.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.827 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.524 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 80.4 t60 -155.01 124.54 6.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 0.0 109.217 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.524 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 6.2 m120 54.11 26.04 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.55 11.62 82.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.88 140.4 52.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.508 -0.995 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' SER . 78.2 m95 -68.11 151.51 46.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.221 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -150.73 135.65 17.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 17.5 t80 -93.81 150.46 20.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.741 . . . . 0.0 109.701 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 15.2 tpt85 -156.16 107.1 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.099 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.19 154.6 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.704 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.28 -32.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.497 -0.752 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.79 83.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -139.18 104.28 4.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.981 . . . . 0.0 109.377 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.76 151.07 31.76 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -143.78 123.26 13.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.391 -1.064 . . . . 0.0 109.245 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.93 10.45 21.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 109.503 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -73.94 0.29 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.1 135.21 1.89 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.95 -24.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -1.177 . . . . 0.0 109.807 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.85 -33.86 21.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.9 t -75.19 -51.93 12.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.701 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 158' ' ' TYR . 33.3 m -46.6 -19.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 85.0 m -73.32 -61.23 1.9 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.063 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.99 -15.39 38.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.244 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -59.38 -40.62 87.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.65 -15.83 62.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.21 -0.932 . . . . 0.0 109.398 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.86 173.39 12.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -153.41 -35.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 3.9 m120 -146.14 140.18 26.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.9 t -141.74 146.0 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.35 -0.844 . . . . 0.0 109.245 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.0 tp -130.7 109.39 10.59 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.63 147.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 108.514 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.89 116.8 1.38 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.48 136.64 41.94 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.49 137.35 6.74 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -157.37 152.52 25.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -1.137 . . . . 0.0 109.759 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.46 109.59 22.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.678 -0.639 . . . . 0.0 109.544 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.0 m-85 -96.26 145.29 25.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.416 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.92 140.74 34.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CD2' HD13 ' A' ' 93' ' ' ILE . 15.2 mt -128.52 128.61 44.64 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -91.97 108.55 20.01 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.168 -0.957 . . . . 0.0 110.176 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 44' ' ' PHE . . . -100.6 125.97 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.284 -0.885 . . . . 0.0 108.936 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p -149.46 168.04 24.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 0.0 109.937 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.44 139.75 44.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.46 125.75 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.2 152.97 18.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.343 -0.848 . . . . 0.0 109.605 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.42 138.25 27.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.1 176.41 8.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.563 -0.711 . . . . 0.0 109.232 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.48 -8.41 58.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.784 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 3.51 39.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.927 . . . . 0.0 109.947 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.47 61.53 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.5 mmtp -104.2 168.56 9.03 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 38' ' ' GLY . 18.9 t -93.18 137.05 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.173 -0.955 . . . . 0.0 108.993 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 32.3 ttp180 -63.84 2.09 0.55 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -153.36 128.22 2.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -65.07 4.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -1.189 . . . . 0.0 110.234 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -94.35 -41.87 9.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.0 -1.062 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 t0 45.78 17.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.0 109.477 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 40' ' ' ALA . 31.8 t80 -136.97 106.59 6.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 109.627 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 29' ' ' LEU . 6.9 pt -112.64 139.69 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.581 -0.699 . . . . 0.0 109.132 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -161.01 -145.23 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 46.8 p90 -43.76 -31.1 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 109.944 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.09 3.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.3 t-20 -158.65 116.28 2.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.154 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -50.66 -36.04 33.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttp -165.78 157.43 14.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 109.361 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.4 t -70.54 120.1 15.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.58 87.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.178 -0.951 . . . . 0.0 109.547 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 43.4 p-10 -103.27 -17.61 15.24 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.516 -0.74 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . -84.36 -15.34 69.18 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.1 p 61.86 11.19 3.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -1.104 . . . . 0.0 109.491 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' H ' ' HB3' ' A' ' 50' ' ' SER . 55.2 t -93.02 151.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.311 -0.868 . . . . 0.0 109.175 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 m -148.05 136.26 21.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 0.0 110.078 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.409 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.8 m80 -90.41 129.75 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -68.59 -56.62 7.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 109.335 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.17 123.41 1.22 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -81.72 110.89 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -81.72 -169.63 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 63' ' ' THR . 15.6 ptt180 -150.82 12.28 0.68 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 109.544 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.8 p -156.64 -35.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -50.04 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.174 . . . . 0.0 109.456 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -70.8 -68.93 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -86.9 175.64 8.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 109.533 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -159.25 132.43 7.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.314 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -119.41 123.43 44.09 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -95.18 137.61 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 52.1 mt -128.75 147.07 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.547 -0.721 . . . . 0.0 110.348 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.8 mttm -140.51 97.16 3.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.54 -5.31 49.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.99 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.98 -22.97 31.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.095 -1.003 . . . . 0.0 109.777 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.34 -11.61 27.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.183 -0.948 . . . . 0.0 109.891 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.98 123.99 77.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.22 -161.33 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.795 1.663 . . . . 0.0 112.098 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.05 -0.17 83.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.2 m-20 -70.06 -60.35 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 86' ' ' LYS . 46.5 t -91.11 144.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.66 10.95 5.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.393 -0.817 . . . . 0.0 109.532 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 141' ' ' GLU . 81.7 tttt -158.48 144.13 16.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.225 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.39 115.75 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.081 -1.012 . . . . 0.0 109.369 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -104.1 173.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 95.0 m-85 -142.29 129.55 21.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.55 157.76 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 0.0 110.649 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -132.42 113.62 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -110.22 154.64 23.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.393 -0.817 . . . . 0.0 110.778 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.22 151.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 96' ' ' ALA . 9.3 t60 -101.93 -74.23 0.63 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.372 -0.83 . . . . 0.0 110.271 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.09 -17.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 109.798 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.589 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -49.98 -19.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.448 -0.782 . . . . 0.0 109.504 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -71.61 -62.58 1.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.971 -1.08 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -39.27 12.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.33 -0.856 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.613 ' NE ' ' NE2' ' A' ' 101' ' ' GLN . 49.4 ttt180 -83.89 -20.2 33.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.934 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 ttp85 53.33 96.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.766 -1.209 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.613 ' NE2' ' NE ' ' A' ' 99' ' ' ARG . 60.7 mt-30 -155.85 143.5 19.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.453 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -100.7 166.27 10.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.468 -0.77 . . . . 0.0 109.627 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -49.12 -29.7 5.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.705 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.03 -40.34 97.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 29.5 mm-40 -51.03 -11.7 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.315 . . . . 0.0 109.326 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.47 ' N ' ' C ' ' A' ' 104' ' ' GLY . 11.3 t -86.7 162.63 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.845 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.402 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -64.29 -23.35 67.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.83 79.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.37 162.28 25.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 109.686 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 20.5 p90 -156.21 158.39 37.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 110.004 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 32.0 mt -120.55 156.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -143.42 159.09 43.02 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.926 -1.109 . . . . 0.0 109.912 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 tt -152.43 124.39 8.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.209 -0.932 . . . . 0.0 109.185 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.07 144.87 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.429 -0.795 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -74.45 101.83 4.26 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.84 -1.84 2.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.677 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.37 -53.85 5.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.912 . . . . 0.0 109.919 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -123.75 7.6 8.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.628 -0.67 . . . . 0.0 109.996 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 59.66 60.2 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.449 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 28.0 m -109.98 -70.52 0.81 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.825 -0.547 . . . . 0.0 110.3 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.855 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -45.27 157.43 0.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.49 72.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.05 150.54 52.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.088 -1.007 . . . . 0.0 110.13 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.2 ptt180 -143.27 140.21 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.707 . . . . 0.0 109.136 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -91.26 147.86 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 109.016 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.56 102.04 14.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.075 -1.016 . . . . 0.0 108.942 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.5 mt -76.37 -26.57 55.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.6 m -49.57 -33.61 15.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.969 -1.082 . . . . 0.0 108.385 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.44 -52.05 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 109.286 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.458 ' OD2' ' SD ' ' A' ' 137' ' ' MET . 15.7 t70 -67.1 -10.71 52.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.199 -0.938 . . . . 0.0 109.987 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.41 -46.33 62.88 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.8 t -71.46 3.47 3.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.761 -0.587 . . . . 0.0 110.022 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.2 m -92.12 -34.23 14.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.949 -1.094 . . . . 0.0 110.49 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -175.51 -174.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.676 -1.265 . . . . 0.0 110.011 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.29 -8.94 12.27 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.81 137.2 26.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.458 ' SD ' ' OD2' ' A' ' 130' ' ' ASP . 12.4 ptp -165.41 158.21 15.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.86 141.92 27.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.196 -0.94 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -85.5 -44.61 12.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.99 -176.02 24.27 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 86' ' ' LYS . 29.4 tt0 -151.22 122.2 7.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 142' ' ' LEU . 9.7 mp -99.34 142.74 30.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 109.001 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.48 166.23 31.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.017 -1.052 . . . . 0.0 109.695 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.54 142.83 26.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.256 -0.902 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.614 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 17.6 t-160 -115.63 -120.16 0.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.614 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.1 m120 -73.56 52.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.84 9.39 85.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.79 142.89 51.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.593 -0.946 . . . . 0.0 109.365 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -67.86 151.66 46.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -153.66 133.12 12.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.978 . . . . 0.0 109.434 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 21.8 t80 -89.58 153.7 20.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 109.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.534 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 17.5 tpt180 -160.42 107.26 1.55 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.126 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.08 149.11 50.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.56 -30.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.553 -0.717 . . . . 0.0 109.068 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.2 83.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -139.37 104.44 4.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.959 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.07 152.84 35.19 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.441 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -146.37 127.67 14.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.27 -1.136 . . . . 0.0 109.244 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.3 9.05 33.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.41 -69.0 0.99 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 154.45 129.29 1.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.48 -28.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 109.8 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.69 -26.41 25.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' GLY . 43.9 t -78.06 -54.65 6.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.1 m -46.98 -20.49 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 73.2 m -70.53 -60.72 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.393 -0.817 . . . . 0.0 110.103 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -17.34 33.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.38 -45.51 91.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.959 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -71.85 -19.93 61.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.638 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 149' ' ' TRP . 7.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.48 ' SD ' ' OD1' ' A' ' 115' ' ' ASN . 62.7 mtm -147.55 -170.89 3.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.934 . . . . 0.0 109.332 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -152.46 -33.52 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.278 -0.889 . . . . 0.0 109.7 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.415 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 71.5 m-80 -142.66 128.3 19.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -130.82 150.88 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.69 115.34 9.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -86.22 151.03 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.14 117.29 1.51 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.02 133.98 49.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -150.33 145.22 13.02 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.054 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -158.13 151.55 23.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.493 -1.004 . . . . 0.0 109.674 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -80.24 121.73 25.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.388 179.773 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.34 0.59 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -96.21 150.6 20.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 109.3 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -140.95 99.93 3.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.0 109.726 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.39 138.55 33.46 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' ' CE2' ' A' ' 44' ' ' PHE . 8.2 t70 -92.17 117.24 29.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 109.829 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.63 48.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.421 -0.8 . . . . 0.0 109.016 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.34 167.66 25.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.092 -1.005 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.93 137.04 52.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -104.22 159.46 15.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.399 -0.813 . . . . 0.0 109.282 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.54 144.93 51.01 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.546 -0.721 . . . . 0.0 109.765 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.47 134.84 24.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.082 -1.011 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.96 176.59 3.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.5 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.89 -8.24 59.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -83.28 1.31 41.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.05 -13.42 59.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -101.03 153.4 19.58 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.673 HG12 ' H ' ' A' ' 38' ' ' GLY . 35.6 t -73.7 137.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.893 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.83 7.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -156.95 172.83 34.57 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.39 2.69 55.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.287 . . . . 0.0 109.969 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.04 -41.84 5.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.269 -0.895 . . . . 0.0 109.834 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.0 t0 53.25 6.46 0.07 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.945 -1.097 . . . . 0.0 109.71 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.5 p90 -138.45 123.49 19.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.289 -0.882 . . . . 0.0 110.264 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 pt -110.17 122.68 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 33.3 t80 -170.56 -170.95 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.933 -1.104 . . . . 0.0 109.722 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 53.4 m-85 51.03 -112.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.949 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -55.42 -16.78 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.562 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 49' ' ' LYS . 1.6 t30 -95.14 82.37 3.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.561 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.83 -22.1 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' C ' HD21 ' A' ' 47' ' ' ASN . 37.8 pttt -166.54 156.97 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' SER . 4.5 p -84.93 113.49 21.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.48 69.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.268 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -104.64 -19.2 14.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.556 -0.715 . . . . 0.0 109.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.28 -13.98 75.36 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.8 p 70.16 2.05 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.92 146.85 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 p -147.0 152.59 38.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.077 -1.014 . . . . 0.0 110.567 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' CE1' HD21 ' A' ' 73' ' ' LEU . 6.1 m80 -92.03 130.23 37.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -78.33 -38.91 41.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.15 100.94 0.15 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.07 110.89 14.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.462 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.95 -164.37 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -156.02 16.12 0.35 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.4 p -154.71 -35.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.873 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -48.41 111.32 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -1.146 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -80.85 -67.18 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -105.22 162.92 12.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.815 . . . . 0.0 109.394 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.4 p -162.31 138.52 7.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.426 HD21 ' CE1' ' A' ' 57' ' ' HIS . 4.9 mp -112.2 131.41 55.49 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.15 120.67 36.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 46.7 mt -108.36 146.57 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 110.58 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -143.77 97.65 3.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.4 mt -82.32 -15.98 50.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.982 -1.074 . . . . 0.0 109.48 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.81 -0.87 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -131.82 15.99 4.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.55 -0.718 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.3 p -60.34 134.75 91.13 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.855 . . . . 0.0 109.193 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.26 -161.78 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.902 1.734 . . . . 0.0 111.736 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.95 5.06 53.09 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -90.57 -72.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.163 -1.198 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.3 p -70.14 149.06 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.55 -30.02 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 109.451 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -114.88 157.54 23.18 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 87' ' ' ILE . 14.7 mt -142.38 150.37 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -141.34 162.03 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.369 -0.832 . . . . 0.0 108.882 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 88' ' ' ILE . 57.4 m-85 -141.69 125.31 16.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.22 157.92 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.386 -0.822 . . . . 0.0 110.191 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.1 p -131.0 121.6 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 p -117.44 153.47 33.04 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.45 -0.782 . . . . 0.0 110.438 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.7 mm -74.2 145.0 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.416 ' C ' ' N ' ' A' ' 96' ' ' ALA . 24.5 t60 -100.64 -69.67 0.76 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLN . 5.4 m-20 -48.25 -18.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -45.9 -18.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' ASP . 65.2 mt-30 -69.58 -58.24 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.917 -1.114 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.66 -52.68 4.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.169 -0.957 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -75.43 -20.74 58.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.967 -1.083 . . . . 0.0 110.917 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 53.94 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.01 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -150.69 149.85 30.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 135' ' ' THR . 43.9 m -104.42 167.28 9.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' ' CE ' ' A' ' 137' ' ' MET . 57.9 m-85 -46.12 -38.19 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.441 -0.787 . . . . 0.0 109.881 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.1 -38.02 88.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -47.14 -18.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.237 . . . . 0.0 109.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 107' ' ' SER . 17.3 t -84.35 168.63 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.079 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.5 t -71.46 -19.56 62.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.77 79.52 0.03 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.6 164.59 22.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.127 . . . . 0.0 109.735 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.8 p90 -156.74 161.15 39.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.054 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 59.1 mt -120.95 156.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -140.94 160.42 40.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.998 -1.064 . . . . 0.0 109.915 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.4 tt -154.37 117.62 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.122 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.3 p -132.2 142.97 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.305 -0.872 . . . . 0.0 110.322 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' OD1' ' SD ' ' A' ' 2' ' ' MET . 76.8 m-20 -74.97 102.13 4.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.21 -1.53 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.474 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 16.7 t70 -81.58 -53.47 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -123.49 7.0 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.783 -0.573 . . . . 0.0 109.676 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 58.61 59.69 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.8 m -109.74 -71.02 0.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.927 -0.483 . . . . 0.0 110.386 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.846 ' O ' HG13 ' A' ' 122' ' ' VAL . 32.3 mt-10 -45.38 157.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.0 109.803 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.18 73.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.67 155.02 49.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.196 -0.94 . . . . 0.0 109.836 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.8 ptm180 -142.59 147.34 35.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 109.18 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -91.32 146.95 23.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -87.97 103.18 15.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.14 -0.975 . . . . 0.0 109.421 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 57.6 mt -81.03 -42.11 21.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.429 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.8 p -47.56 -30.18 3.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 109.245 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -95.31 -54.6 3.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.341 -0.849 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -74.87 -3.44 31.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.965 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.87 -45.85 71.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 109.26 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.2 p -70.83 3.17 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.541 -0.725 . . . . 0.0 109.976 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -82.77 -35.1 26.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.979 -1.075 . . . . 0.0 110.353 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -177.29 -161.94 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.661 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -123.56 -1.71 8.5 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.61 137.63 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.42 ' CE ' ' CE1' ' A' ' 103' ' ' PHE . 10.6 ptp -165.04 157.56 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.342 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -97.87 128.9 44.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.219 -0.925 . . . . 0.0 109.737 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 24.6 t80 -65.57 -43.82 88.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.153 -0.967 . . . . 0.0 109.342 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.57 31.22 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.213 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 167.01 29.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.264 -1.139 . . . . 0.0 110.667 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.9 mt -132.31 136.95 47.25 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 6.4 p90 -140.36 160.91 38.95 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.003 -1.061 . . . . 0.0 109.733 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 9.0 ptm180 -84.96 148.66 26.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.042 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.523 ' NE2' ' OD1' ' A' ' 146' ' ' ASN . 29.8 t-80 -148.92 121.58 8.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.062 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.523 ' OD1' ' NE2' ' A' ' 145' ' ' HIS . 3.6 m120 52.32 27.18 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.26 75.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.9 136.22 51.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.981 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.472 ' CD2' HD13 ' A' ' 77' ' ' LEU . 70.4 m95 -67.31 151.47 47.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.549 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -150.9 143.89 24.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -99.58 142.08 31.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.363 -0.835 . . . . 0.0 110.154 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -134.47 114.82 13.26 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.6 150.03 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 109.639 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.0 t -147.41 -36.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 109.084 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.75 79.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -122.45 106.03 10.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.782 -0.834 . . . . 0.0 109.537 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.01 149.08 32.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -149.99 139.85 21.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -1.173 . . . . 0.0 109.465 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.18 6.87 47.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.35 -37.45 25.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 82.88 150.59 9.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -48.07 -13.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 0.0 109.618 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -72.55 -56.89 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.086 -1.009 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.0 t -90.57 -37.87 13.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.16 -0.963 . . . . 0.0 109.73 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.39 -20.68 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.522 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 29.9 p -83.41 -55.77 4.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.111 -0.993 . . . . 0.0 110.823 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.91 -24.63 23.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 110.531 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' SER . 51.4 tt0 -51.68 -37.59 51.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.974 . . . . 0.0 109.74 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.66 -20.35 58.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.661 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.7 mmt -78.77 178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -154.39 -35.32 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.703 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.25 128.14 15.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 109.135 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.703 ' N ' HD22 ' A' ' 4' ' ' ASN . 6.2 t -127.78 158.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.8 tp -144.46 106.7 4.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.958 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.29 150.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.11 116.98 1.24 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.85 129.53 54.68 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.95 142.78 11.16 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.45 ' CE2' ' CA ' ' A' ' 64' ' ' GLY . 25.1 p90 -157.22 153.43 27.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.405 -1.056 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -77.51 128.81 34.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.505 -0.747 . . . . 0.0 109.809 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.27 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.363 0.601 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.32 150.43 20.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 15.3 p-10 -141.04 99.74 3.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.258 -0.901 . . . . 0.0 109.712 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.62 130.91 34.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 108.631 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -87.24 111.44 21.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.966 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.32 125.86 46.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 108.803 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 m -149.76 168.06 24.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 109.769 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 136.09 49.48 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -103.79 119.59 39.23 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.796 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.19 152.63 21.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.525 -0.735 . . . . 0.0 109.906 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 134.94 22.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -75.67 176.32 7.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 108.979 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.69 -10.85 59.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.681 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 33' ' ' ASN . 3.0 m120 -84.32 4.55 30.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.29 56.75 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 48.9 mtpt -104.45 171.95 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.729 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -103.45 143.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -61.83 -4.09 1.39 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.75 101.22 0.23 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -45.12 -20.97 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.401 -1.058 . . . . 0.0 110.601 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.26 -41.81 80.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.597 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.729 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 48.12 12.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.978 -1.076 . . . . 0.0 109.517 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 23.8 t80 -137.46 105.8 5.77 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.842 . . . . 0.0 110.214 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 pt -110.52 134.92 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.3 p90 -151.99 -152.89 0.45 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.04 . . . . 0.0 109.766 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.7 m-85 -43.81 -36.0 2.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.576 -0.703 . . . . 0.0 110.028 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -58.65 -1.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 108.73 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 45' ' ' TYR . 51.1 t-20 -148.11 108.71 4.16 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.23 -27.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 109.407 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.5 pttt -172.8 160.55 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.287 -0.883 . . . . 0.0 109.322 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 54' ' ' SER . 10.2 p -65.12 135.24 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.286 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.39 -45.35 55.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.1 1.49 13.23 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.657 -0.652 . . . . 0.0 109.604 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 -14.33 61.3 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.4 m 64.13 4.17 1.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -1.054 . . . . 0.0 109.314 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.14 146.75 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.919 . . . . 0.0 109.105 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -149.21 152.11 35.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.464 ' CE1' HD21 ' A' ' 73' ' ' LEU . 9.2 m80 -91.75 132.58 36.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 109.392 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 m -82.94 -38.85 22.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.55 107.55 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 33.2 p-10 -80.58 159.15 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.49 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -155.29 -173.01 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 109.418 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -161.82 30.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.9 p -151.81 -34.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' CA ' ' CE2' ' A' ' 11' ' ' TRP . . . . . . . . 0 N--CA 1.497 2.761 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.6 p-10 -48.68 111.14 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.599 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.12 -67.45 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.405 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -98.4 158.27 15.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.266 -0.896 . . . . 0.0 109.134 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.475 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -159.69 138.89 11.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.464 HD21 ' CE1' ' A' ' 57' ' ' HIS . 8.9 mp -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.518 -0.739 . . . . 0.0 109.548 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -96.39 112.68 24.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.1 mp -100.66 146.87 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 110.898 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -135.54 88.92 2.45 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.38 -13.54 61.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.306 -0.871 . . . . 0.0 109.794 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -78.29 4.82 11.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.66 10.99 6.15 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.435 -0.791 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -82.01 125.86 76.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.947 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.52 -161.76 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.74 -0.17 84.1 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -69.44 -59.73 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -1.178 . . . . 0.0 109.321 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.89 148.78 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.89 . . . . 0.0 109.252 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -135.98 0.82 2.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 141' ' ' GLU . 43.3 tttp -150.09 131.5 14.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.877 . . . . 0.0 109.055 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 90.4 mt -136.35 132.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 0.0 109.003 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.95 154.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.814 . . . . 0.0 109.671 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -107.1 137.95 44.2 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 91' ' ' VAL . 2.7 p -146.73 158.16 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.115 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 7.5 p -132.36 147.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -143.09 145.26 32.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.125 -0.985 . . . . 0.0 109.727 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.35 137.5 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 50.9 t-80 -95.49 -63.44 1.16 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.161 -0.962 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 12.0 m-20 -47.4 -18.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 0.0 109.578 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.24 -18.18 34.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.835 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -65.94 -60.82 2.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.85 -1.156 . . . . 0.0 109.437 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.14 -41.22 11.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.082 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' NH1' ' OD2' ' A' ' 95' ' ' ASP . 54.5 mtt180 -85.66 -19.58 30.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.973 -1.079 . . . . 0.0 111.352 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 55.19 92.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.687 -1.258 . . . . 0.0 109.035 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -148.46 142.54 25.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 109.256 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -98.75 165.15 11.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -47.37 -35.48 8.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 109.624 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.737 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.89 -38.38 74.09 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -47.42 -19.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.361 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 107' ' ' SER . 19.3 t -83.97 167.03 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.005 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -72.61 -24.51 61.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 0.0 109.712 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.38 78.1 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.13 164.8 24.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.36 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.4 p90 -154.0 143.7 21.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.0 110.573 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.6 mt -106.94 153.86 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.38 160.21 40.36 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.987 -1.07 . . . . 0.0 109.84 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.31 116.07 4.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 0.0 109.386 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.559 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -129.3 143.75 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.298 -0.876 . . . . 0.0 109.95 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.54 102.04 5.9 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -67.26 -1.36 4.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.539 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.04 -52.97 6.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -123.1 3.59 9.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.721 -0.612 . . . . 0.0 109.479 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ASN . 21.0 tp60 60.41 61.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 40.9 m -113.27 -69.15 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.883 -0.51 . . . . 0.0 110.256 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 33.1 mm-40 -45.24 157.55 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.344 -0.848 . . . . 0.0 109.984 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.73 72.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.53 52.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 110.038 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.4 ptm180 -138.5 145.65 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -91.33 145.16 24.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.994 . . . . 0.0 109.082 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.28 103.16 15.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.023 . . . . 0.0 109.51 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 92.1 mt -82.11 -37.84 25.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.3 p -48.35 -35.06 11.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.906 -1.121 . . . . 0.0 109.091 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -95.39 -49.24 5.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -76.45 -4.16 41.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.737 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.33 -43.71 67.87 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.954 -1.091 . . . . 0.0 109.695 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.3 p -68.97 3.17 2.15 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 110.978 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 p -86.15 -34.51 20.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.544 -1.348 . . . . 0.0 110.526 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.2 -161.44 0.08 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.766 -1.209 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.91 -12.98 7.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.48 133.78 24.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.8 ptp -165.41 141.44 5.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.4 pp -76.47 141.11 41.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -0.952 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.5 t80 -79.41 -46.2 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.411 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.493 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -150.88 -163.52 11.37 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.466 ' CD ' ' NZ ' ' A' ' 86' ' ' LYS . 11.5 tt0 -150.7 158.29 43.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.382 -1.069 . . . . 0.0 109.061 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 136.19 25.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -150.73 166.51 30.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.882 -1.136 . . . . 0.0 110.122 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 15.5 ptm180 -90.59 143.43 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -117.95 -120.12 0.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.605 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 34.9 m120 -73.56 51.25 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.05 -1.031 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 9.1 85.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.77 142.13 51.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.997 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -68.53 151.48 46.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -148.91 131.8 16.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.112 -0.993 . . . . 0.0 109.69 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -89.76 150.61 22.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -149.75 124.19 9.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 0.0 109.065 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.75 147.91 27.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.1 t -150.15 -36.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 109.09 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.26 76.54 0.15 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -108.6 104.38 13.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.754 -0.85 . . . . 0.0 109.125 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.03 143.35 20.39 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.484 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -142.15 141.7 32.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.299 -1.118 . . . . 0.0 109.086 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.14 9.55 43.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.32 -0.863 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -68.01 1.33 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.51 132.5 1.51 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.9 -30.55 2.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -1.123 . . . . 0.0 109.607 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.74 24.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 69.2 m -73.4 -53.28 11.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.5 m -47.74 -20.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 57.7 m -71.55 -60.84 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 110.163 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.4 38.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 110.402 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -65.78 -43.79 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.95 -1.094 . . . . 0.0 110.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -71.34 -19.62 62.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.5 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.5 mtt -86.8 147.43 25.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 94.0 mttt -116.9 -21.8 8.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.565 -0.709 . . . . 0.0 109.274 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 51.3 m-20 -146.23 142.34 28.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.3 t -140.8 158.52 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -0.77 . . . . 0.0 109.211 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.5 tp -146.29 107.32 4.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.937 . . . . 0.0 109.09 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.78 150.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.25 116.84 1.15 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.0 137.05 42.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.82 139.19 7.81 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -156.49 152.35 27.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.201 -1.176 . . . . 0.0 109.971 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -90.74 126.99 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.608 -0.682 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.356 179.865 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.251 0.548 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.8 m-85 -96.25 142.8 27.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 14.6 m-20 -141.03 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.26 -0.9 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.77 149.69 25.1 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -108.11 118.17 36.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.322 -0.861 . . . . 0.0 109.633 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.91 133.11 42.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.388 -0.82 . . . . 0.0 108.993 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -149.95 167.85 25.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 110.201 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.3 137.65 54.6 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 9.0 m-85 -104.15 126.66 51.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.967 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.96 153.69 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.345 -0.847 . . . . 0.0 109.918 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -145.3 135.74 24.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 109.111 179.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.67 176.54 8.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.094 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.59 -7.51 59.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -85.24 1.82 46.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 109.906 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.66 -17.99 58.25 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 57.5 mttm -107.48 171.02 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 38' ' ' GLY . 5.7 t -99.64 137.36 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -62.31 -0.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -136.61 114.42 1.15 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.52 3.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -1.177 . . . . 0.0 110.6 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -99.34 -42.07 7.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.917 -1.114 . . . . 0.0 109.82 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' HG21 ' A' ' 36' ' ' VAL . 46.5 t0 46.81 14.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.994 -1.066 . . . . 0.0 109.594 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 36.2 t80 -137.3 99.44 3.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.815 . . . . 0.0 109.724 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.0 pt -105.2 135.13 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.1 p90 -139.3 -163.05 1.41 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.0 109.368 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 26.6 p90 -43.79 -36.92 2.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 110.551 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.586 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.8 t-20 -50.5 -11.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 109.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.1 t30 -135.29 104.7 5.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.468 -0.77 . . . . 0.0 109.067 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 mt -49.13 -28.92 4.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.473 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.1 pttp -164.85 157.67 16.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.331 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.479 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 3.6 m -68.7 143.5 54.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.458 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 -48.16 36.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.165 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.29 1.73 13.13 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.747 -0.596 . . . . 0.0 109.548 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.42 -14.15 74.57 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t 62.42 6.29 1.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -1.107 . . . . 0.0 109.799 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.15 151.62 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.115 -0.99 . . . . 0.0 108.986 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 p -145.21 139.74 27.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.075 -1.016 . . . . 0.0 110.251 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.419 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.0 m80 -90.27 132.87 35.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -72.25 -40.4 67.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.348 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.93 111.44 0.33 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.27 110.95 13.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.87 -164.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 63' ' ' THR . 12.7 ptt-85 -156.23 16.34 0.34 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 62' ' ' ARG . 23.0 p -155.84 -36.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.278 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.92 108.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -1.153 . . . . 0.0 109.433 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -61.37 -69.62 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.41 173.11 10.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -159.51 132.6 6.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.258 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -118.21 122.14 42.24 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -96.01 137.3 35.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 0.0 109.067 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.7 mt -129.33 143.35 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.634 -0.666 . . . . 0.0 110.018 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -141.22 98.84 3.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' VAL . 7.3 mt -80.79 -17.78 49.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -51.04 -36.73 41.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.27 27.28 7.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 80' ' ' VAL . 6.2 p -60.56 115.34 13.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 81.4 Cg_exo -46.55 -178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.812 1.674 . . . . 0.0 112.264 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.18 59.71 0.63 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -154.71 -54.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -1.177 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.45 148.53 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 1.0 OUTLIER -143.43 11.95 1.72 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.179 -0.951 . . . . 0.0 109.858 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -157.02 133.52 9.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 88' ' ' ILE . 87.9 mt -129.39 154.24 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.548 -0.72 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 87' ' ' ILE . 1.2 mt -144.68 173.44 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 108.904 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.62 141.95 49.76 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.1 t -147.23 151.94 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.942 -1.099 . . . . 0.0 110.953 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.7 p -147.53 113.92 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -122.28 174.6 6.89 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.741 0.781 . . . . 0.0 110.222 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.4 mm -83.86 166.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.546 ' N ' HG22 ' A' ' 93' ' ' ILE . 53.6 t60 -133.26 -66.58 0.65 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -48.12 -18.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.25 -38.42 52.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -54.53 -31.95 57.25 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 109.214 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -52.83 4.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -0.83 . . . . 0.0 111.008 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 10.9 ptp180 -110.51 -4.71 15.37 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.282 -0.886 . . . . 0.0 111.166 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.1 ttm180 57.07 102.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.858 -1.151 . . . . 0.0 109.205 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -147.69 148.97 31.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 m -104.2 161.93 13.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.43 -0.794 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -47.15 -35.31 7.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.734 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -42.38 99.75 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 23.4 mm100 -48.5 -14.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 109.403 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.4 t -83.76 164.59 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.1 t -64.87 -23.73 67.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.06 -1.025 . . . . 0.0 109.552 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.89 79.94 0.03 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.7 164.54 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 109.958 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.4 p90 -154.81 152.35 29.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.889 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -115.53 157.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.27 160.73 39.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.897 -1.127 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.8 tt -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.6 p -129.03 144.25 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 4.2 t-20 -76.07 102.14 5.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -65.79 -1.69 3.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HA ' HD22 ' A' ' 4' ' ' ASN . 23.5 t0 -82.29 -53.72 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.58 6.33 8.89 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' ASN . 19.5 tt0 59.61 60.52 2.22 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 42.2 p -111.07 -69.8 0.85 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.879 -0.513 . . . . 0.0 110.334 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 45.1 mt-10 -45.26 157.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.77 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.52 52.15 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.134 -0.979 . . . . 0.0 110.218 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.5 ptt180 -140.18 142.4 35.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -91.34 147.65 22.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.089 -1.007 . . . . 0.0 109.12 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 18.5 p-10 -91.54 103.29 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.145 -0.972 . . . . 0.0 109.358 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.3 mt -80.89 -32.75 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.295 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 m -48.98 -37.52 20.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.909 -1.119 . . . . 0.0 108.963 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.37 -45.78 6.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.695 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.32 -4.54 42.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 110.535 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.4 -46.12 76.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.798 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -65.33 3.29 0.68 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 111.013 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -86.14 -34.93 20.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.596 -1.315 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.9 -161.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.907 -1.12 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.05 -3.83 6.94 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -146.79 135.4 22.07 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.4 ttp -165.83 158.08 14.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.941 -1.1 . . . . 0.0 110.335 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.69 139.41 31.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.341 -0.849 . . . . 0.0 109.471 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -78.62 -47.62 16.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 109.782 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.72 -164.29 14.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -151.45 163.19 39.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.168 -1.195 . . . . 0.0 109.739 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.65 134.75 24.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -146.05 165.84 27.86 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 109.781 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.507 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.1 ptm180 -90.34 143.7 26.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.859 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-80 -119.81 -116.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.606 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 18.8 m-20 -76.02 53.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.45 8.02 87.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -127.88 145.39 50.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.989 . . . . 0.0 109.314 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.1 m95 -70.58 151.59 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.424 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -145.97 126.85 14.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -89.72 147.92 23.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -153.03 107.37 3.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.305 -0.872 . . . . 0.0 109.046 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.91 154.64 40.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.6 t -143.41 -33.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.72 83.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -132.26 104.32 6.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.647 -0.913 . . . . 0.0 109.31 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.38 152.7 38.14 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.45 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -143.2 124.4 14.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.355 -1.085 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.06 6.22 37.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.44 -68.58 1.13 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.41 129.08 1.18 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.696 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.62 -26.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.165 . . . . 0.0 109.891 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.32 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.897 . . . . 0.0 109.457 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -50.98 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.45 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.3 m -47.83 -20.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 39.9 m -69.33 -59.93 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.817 . . . . 0.0 110.191 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -18.89 29.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.17 -43.74 87.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.017 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -71.48 -19.81 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -67.66 -170.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 58.6 mttp -153.78 -34.64 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 59.7 m-20 -145.96 152.57 39.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' LEU . 77.2 t -147.62 155.8 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 109.291 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.4 tp -143.79 108.53 4.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 108.949 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.28 148.76 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 108.661 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.23 116.85 1.28 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.87 136.25 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.74 141.19 9.02 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.556 -1.307 . . . . 0.0 109.856 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -158.42 156.59 30.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.421 -1.047 . . . . 0.0 109.707 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -81.36 126.19 31.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.856 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.828 . . . . 0.0 109.118 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.19 138.31 33.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.85 99.81 3.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 109.677 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -83.37 141.01 32.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -98.97 109.97 22.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.23 125.61 43.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.212 -0.93 . . . . 0.0 108.9 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 t -149.76 168.13 24.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 109.993 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.53 138.87 45.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -104.02 127.72 51.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.958 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.39 155.99 16.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.28 -0.888 . . . . 0.0 110.055 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.77 139.99 32.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.084 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.84 176.59 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.34 -5.46 59.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.75 4.04 50.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.0 109.905 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.96 -11.02 73.23 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.4 mttt -109.89 169.12 8.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 20.2 t -93.09 136.57 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 109.171 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -64.01 1.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -150.01 122.07 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -61.96 3.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 110.076 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.05 -42.24 8.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.889 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 31.8 t0 46.17 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 109.599 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 75.7 t80 -137.49 99.59 3.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.456 -0.777 . . . . 0.0 109.52 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.2 pt -103.69 137.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.4 p90 -143.52 -160.76 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 18.0 p90 -45.17 -31.89 1.63 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 7.9 t-20 -52.59 -11.22 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.873 -1.142 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.0 t30 -135.75 108.25 7.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -47.43 -28.93 2.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.835 . . . . 0.0 109.266 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.2 pttt -171.81 157.51 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 67.3 m -62.69 149.57 43.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.65 -48.75 14.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -116.45 0.84 12.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.651 -0.656 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.94 -12.84 67.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m 58.71 13.92 2.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 109.401 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 99.5 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.304 -0.872 . . . . 0.0 109.027 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.6 m -148.6 135.06 19.58 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.019 -1.051 . . . . 0.0 110.212 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' NE2' HD11 ' A' ' 73' ' ' LEU . 26.2 m80 -90.17 129.06 36.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -69.8 -43.84 71.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.3 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.11 115.18 0.44 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.08 110.95 17.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -1.133 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.92 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.381 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 63' ' ' THR . 76.2 mtm180 -150.69 12.38 0.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 62' ' ' ARG . 28.3 p -156.28 -38.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 0.0 109.273 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.868 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 p-10 -48.73 115.7 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 109.595 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.32 -64.9 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -88.39 173.43 8.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.95 132.24 6.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.362 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 ' NE2' ' A' ' 57' ' ' HIS . 1.0 OUTLIER -117.79 121.66 41.36 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -95.4 138.16 33.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 108.533 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.04 146.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.484 -0.76 . . . . 0.0 110.502 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 9.5 mtpm? -138.55 94.1 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.69 -5.36 40.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.47 -29.67 37.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 0.0 109.791 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.74 10.37 37.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.0 109.905 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.24 125.59 69.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.984 . . . . 0.0 109.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.95 -161.11 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.894 1.729 . . . . 0.0 111.868 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.84 4.52 78.76 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 2.5 m-20 -64.41 -54.52 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -1.189 . . . . 0.0 109.44 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.99 149.07 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 9.3 t0 -123.91 -9.05 7.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.767 . . . . 0.0 109.46 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -158.06 131.34 7.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 110.029 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.9 mt -121.13 154.18 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -142.57 173.16 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.093 -1.004 . . . . 0.0 109.304 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 11.0 m-85 -142.31 118.56 10.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.89 157.73 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.7 p -130.92 114.35 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -110.21 148.16 32.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.1 mm -74.3 138.97 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 21.3 t-160 -96.27 -65.11 0.99 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.005 . . . . 0.0 109.805 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -47.31 -18.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.08 -18.23 23.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 109.734 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.25 -61.49 1.82 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.85 -1.156 . . . . 0.0 109.545 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.18 -40.47 11.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -0.84 . . . . 0.0 111.086 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.4 mpt_? -85.19 -19.13 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.897 -1.127 . . . . 0.0 110.955 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 99' ' ' ARG . 50.1 ttp85 55.62 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.806 -1.184 . . . . 0.0 109.255 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.9 144.67 14.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -102.03 166.82 10.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.52 -32.14 3.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.847 . . . . 0.0 109.76 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.66 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.5 -37.05 93.51 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -46.88 -19.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -1.192 . . . . 0.0 109.244 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 107' ' ' SER . 19.2 t -86.48 166.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 0.0 108.986 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 p -66.99 -26.6 66.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.639 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.2 78.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.03 164.67 25.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 22.6 p90 -152.37 151.98 31.5 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 110.263 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.0 mt -114.49 154.46 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -144.13 157.5 44.27 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 tt -150.63 125.77 9.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 0.0 109.266 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.25 143.57 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.699 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 120' ' ' THR . 61.4 m-20 -75.19 102.08 4.85 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 35.5 t0 -66.1 -1.67 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 109.851 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 1.1 p30 -83.53 -52.65 6.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -0.928 . . . . 0.0 109.494 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 22.1 m120 -122.87 5.69 9.37 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 0.0 109.819 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.1 mt-30 58.97 60.06 2.58 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.456 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.0 m -112.03 -69.72 0.85 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.946 -0.471 . . . . 0.0 110.471 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 53.6 mm-40 -45.25 157.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.97 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.95 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.78 151.21 52.05 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -140.74 143.54 35.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.708 . . . . 0.0 109.143 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.73 147.82 22.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.6 103.31 15.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.971 . . . . 0.0 109.326 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.2 mt -81.03 -38.19 27.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.5 m -47.61 -32.1 5.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.147 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.47 -54.23 3.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.533 -0.729 . . . . 0.0 109.94 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.49 -2.95 27.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.99 . . . . 0.0 110.612 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.66 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.05 -45.99 68.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 109.193 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -69.36 3.19 2.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.0 109.873 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.2 m -82.78 -34.5 27.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 110.346 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -176.76 -162.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.958 -1.089 . . . . 0.0 109.729 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.47 -7.92 6.91 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.48 136.04 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 ptm -165.46 157.75 15.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -92.27 141.43 28.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -86.54 -22.42 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.19 -171.29 40.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.31 163.41 38.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -1.156 . . . . 0.0 109.496 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.67 138.88 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.55 166.15 31.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.145 -0.972 . . . . 0.0 109.718 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -93.35 143.9 25.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.671 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.3 t60 -118.79 -118.55 0.31 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.626 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 30.8 t30 -75.41 51.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.05 8.84 86.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -127.81 139.99 52.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.987 . . . . 0.0 109.353 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -68.05 151.79 46.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -148.69 125.74 11.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -89.3 146.82 24.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.442 -0.786 . . . . 0.0 109.459 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -151.22 111.23 4.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.041 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.99 154.68 40.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.766 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.17 -33.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.39 0.04 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.561 ' H ' HD21 ' A' ' 138' ' ' LEU . 32.7 tt0 -143.72 104.31 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.443 -1.034 . . . . 0.0 109.157 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.73 34.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -134.6 138.44 44.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.618 -0.931 . . . . 0.0 108.919 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.39 9.06 39.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.76 -73.88 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 155.53 129.84 1.26 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.27 -24.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 109.879 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.0 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 166' ' ' CYS . 52.8 p -78.99 -54.43 6.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.652 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.472 HG11 ' CE1' ' A' ' 158' ' ' TYR . 29.6 m -45.37 -19.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.328 -0.857 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 164' ' ' SER . 89.3 m -72.54 -62.15 1.55 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.1 -14.88 40.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.381 -0.825 . . . . 0.0 110.133 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -56.33 -45.65 80.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -78.79 -19.71 51.54 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.529 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.4 mpt? -79.63 175.98 10.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.428 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -154.09 -34.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 4.4 m120 -146.13 128.44 15.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -127.0 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.63 110.84 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.446 -0.783 . . . . 0.0 109.057 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.99 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 108.699 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.83 117.15 1.61 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -112.44 127.23 55.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.28 150.0 22.2 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -159.42 151.45 20.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.355 -1.085 . . . . 0.0 109.944 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -90.51 122.87 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.677 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.839 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 62.9 m-85 -96.21 136.39 36.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.8 p-10 -140.92 99.79 3.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 23' ' ' LEU . 7.5 mp -83.45 130.49 35.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -90.67 123.36 34.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.76 131.03 44.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 p -150.1 168.24 24.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.021 -1.049 . . . . 0.0 109.939 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -139.75 136.81 34.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -103.32 138.26 40.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.149 -0.969 . . . . 0.0 109.796 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.931 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -90.36 163.22 14.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 mt -144.92 141.7 29.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.059 -1.026 . . . . 0.0 109.867 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.12 176.71 9.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.583 -0.698 . . . . 0.0 109.219 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.04 -3.78 55.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.29 2.45 55.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -22.36 40.1 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 mttp -104.97 173.15 6.43 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -93.99 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -68.9 4.07 1.69 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -127.88 150.16 18.26 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.37 1.2 57.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.254 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.41 -42.34 5.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.221 -0.924 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 45.43 21.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.311 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 66.6 t80 -136.2 99.64 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.554 -0.716 . . . . 0.0 110.275 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 pt -103.34 134.85 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.0 p90 -146.11 -161.18 1.26 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.03 -1.044 . . . . 0.0 109.735 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.3 p90 -45.92 -30.67 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.116 -0.99 . . . . 0.0 110.434 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 8.3 t30 -61.97 -1.17 0.61 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.895 -1.128 . . . . 0.0 108.972 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.3 t30 -141.48 100.12 3.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.448 -0.783 . . . . 0.0 109.039 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.12 -24.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.305 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.3 pttt -166.78 154.87 9.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.41 ' OG ' HD21 ' A' ' 29' ' ' LEU . 23.1 t -62.67 137.85 58.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.51 92.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -116.13 -17.14 10.92 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.648 -0.658 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.67 76.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m 54.47 20.72 2.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 109.288 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB3' ' A' ' 50' ' ' SER . 89.2 t -92.85 151.54 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.886 . . . . 0.0 109.076 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -133.91 125.48 28.38 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.512 -0.742 . . . . 0.0 109.515 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -92.46 124.19 36.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.339 -0.851 . . . . 0.0 109.367 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.8 m -58.58 -46.59 86.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.92 143.72 3.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.3 112.51 24.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -1.119 . . . . 0.0 109.395 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 64' ' ' GLY . 3.1 m-20 -82.08 128.78 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.63 5.65 17.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.9 p -153.55 -35.03 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 38.4 p-10 -52.65 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.106 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.418 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.4 m-20 -57.95 -64.45 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 72' ' ' SER . 60.0 mt-10 -102.69 170.97 7.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.363 -0.835 . . . . 0.0 108.989 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.1 m -165.85 164.65 18.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -135.06 124.04 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -95.69 109.68 21.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.729 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.29 146.81 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -142.29 92.7 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' ALA . 10.5 mt -71.09 -41.95 69.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.111 -0.993 . . . . 0.0 110.322 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -48.15 -13.96 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.544 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -104.97 -19.3 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.459 -0.776 . . . . 0.0 109.858 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 77' ' ' LEU . 37.9 t -60.81 126.37 85.26 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.268 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 -160.11 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.983 1.789 . . . . 0.0 111.895 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.49 3.7 63.66 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.64 -60.95 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -1.218 . . . . 0.0 109.347 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 30' ' ' LEU . 11.7 p -84.46 148.06 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.468 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.1 m-20 -125.71 -3.14 7.22 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.378 -0.826 . . . . 0.0 110.046 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.48 136.67 15.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.952 -1.093 . . . . 0.0 109.436 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.41 154.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.602 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -138.38 172.89 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.146 -0.971 . . . . 0.0 110.103 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -137.53 129.2 28.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG21 ' CE2' ' A' ' 28' ' ' PHE . 25.1 t -140.57 151.32 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.953 . . . . 0.0 111.344 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.0 p -132.7 131.63 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -132.4 155.37 48.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.64 HD12 ' NE2' ' A' ' 101' ' ' GLN . 6.1 mm -73.9 162.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -128.34 -60.24 1.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.522 -0.736 . . . . 0.0 109.465 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -49.88 -18.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.25 -42.4 86.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -54.13 -32.07 54.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.739 -1.226 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.86 -53.23 4.48 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.256 -0.903 . . . . 0.0 111.311 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' ARG . 3.1 ptp85 -111.85 1.72 16.69 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.181 -0.949 . . . . 0.0 111.237 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 96' ' ' ALA . 46.2 ttp180 56.19 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.788 -1.195 . . . . 0.0 109.24 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.64 ' NE2' HD12 ' A' ' 93' ' ' ILE . 1.3 pp0? -153.16 147.77 26.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.154 -0.966 . . . . 0.0 109.437 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 101' ' ' GLN . 20.8 m -105.01 163.41 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.831 . . . . 0.0 110.01 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -43.85 -28.61 0.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 0.0 110.161 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.641 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.1 -44.1 96.26 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.409 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 7.5 tp-100 -47.64 -17.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 107' ' ' SER . 16.1 t -82.25 165.88 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -67.86 -21.72 65.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.671 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.41 79.98 0.03 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.23 162.48 27.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 109.623 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.5 p90 -155.38 151.69 28.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 45.9 mt -117.02 153.61 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -139.98 154.72 47.25 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.058 -1.026 . . . . 0.0 109.739 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -148.59 117.51 6.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.7 p -129.16 145.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.38 -0.825 . . . . 0.0 109.838 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.12 101.87 5.51 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.46 -1.58 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.847 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -83.62 -52.99 5.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 109.661 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -122.97 4.37 9.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 60.29 60.61 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 35.8 m -113.07 -69.09 0.88 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.817 -0.552 . . . . 0.0 110.227 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.2 mt-10 -45.29 157.83 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.91 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.57 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.53 148.86 52.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 109.902 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.7 ptm180 -138.61 145.2 40.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.405 ' CE2' ' HE1' ' A' ' 137' ' ' MET . 8.0 t80 -91.32 147.59 22.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.235 -0.916 . . . . 0.0 109.061 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -91.05 103.37 16.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 83.9 mt -80.77 -37.71 29.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.482 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 128' ' ' THR . 2.5 p -47.8 -32.37 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.151 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.29 -53.89 3.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 -2.2 23.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.224 -0.922 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -53.25 -46.8 69.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.2 t -69.49 3.2 2.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.603 -0.686 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -83.4 -34.7 25.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 110.354 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -176.61 -161.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.4 -2.49 5.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.65 134.09 13.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.405 ' HE1' ' CE2' ' A' ' 125' ' ' TYR . 20.5 ptm -165.49 152.58 10.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.058 -1.026 . . . . 0.0 109.911 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -87.47 138.43 31.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 27.6 t80 -80.25 -43.57 21.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.31 -173.85 35.11 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.858 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -150.77 166.59 30.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.143 -1.21 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 139.8 44.14 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -144.88 166.2 25.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.03 -1.044 . . . . 0.0 109.84 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.468 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.3 ptm180 -90.15 145.77 24.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.51 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 1.1 t60 -123.57 -120.29 0.28 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.598 -0.689 . . . . 0.0 109.166 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.51 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 10.1 m120 -73.37 52.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.64 88.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.84 142.0 51.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.582 -0.952 . . . . 0.0 109.406 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.458 ' CG ' HD13 ' A' ' 77' ' ' LEU . 74.6 m95 -67.48 151.64 47.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.358 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -149.96 132.82 16.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.076 -1.015 . . . . 0.0 109.632 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -89.91 153.16 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 107.32 1.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.1 154.74 41.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.724 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.69 -33.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.859 . . . . 0.0 109.268 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.57 86.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -134.8 104.36 5.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.574 -0.956 . . . . 0.0 109.214 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.64 146.09 18.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.551 ' CD1' HG11 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -147.4 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -1.08 . . . . 0.0 108.971 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.88 40.6 3.24 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.539 -0.726 . . . . 0.0 109.471 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.95 -54.45 3.4 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.0 122.13 0.71 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -45.53 -35.74 4.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.12 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.45 -28.36 23.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 109.59 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.8 p -80.88 -50.68 9.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.989 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.551 HG11 ' CD1' ' A' ' 158' ' ' TYR . 17.8 m -49.15 -21.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.008 . . . . 0.0 109.533 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 28' ' ' PHE . 57.9 m -79.39 -59.98 2.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.912 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.5 63.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.465 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -71.05 -28.41 64.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.969 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.85 -19.57 61.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.4 mtt -81.31 162.51 23.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -130.95 -31.3 1.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.499 -0.75 . . . . 0.0 109.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.23 128.17 15.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 109.089 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.707 ' N ' HD22 ' A' ' 4' ' ' ASN . 94.3 t -128.13 144.45 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 73' ' ' LEU . 15.5 tp -130.64 114.29 15.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 89' ' ' PHE . 61.9 t -86.0 151.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 108.777 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.43 121.65 2.34 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.7 tt -132.49 126.17 32.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.608 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -146.32 152.99 25.04 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -155.04 154.57 32.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -1.044 . . . . 0.0 109.7 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -90.45 120.97 32.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.171 -0.955 . . . . 0.0 109.303 179.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -96.32 145.73 25.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 25.1 p-10 -140.97 99.68 3.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.371 -0.831 . . . . 0.0 109.574 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -85.51 130.53 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 108.758 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.72 106.0 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -98.28 124.93 43.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -149.47 168.23 24.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.973 -1.079 . . . . 0.0 110.115 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.58 137.38 46.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m-85 -102.99 130.55 50.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.0 109.178 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.73 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.66 145.54 28.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.86 136.46 25.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.026 . . . . 0.0 110.109 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.16 176.48 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.699 . . . . 0.0 109.519 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -7.47 59.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.2 m-80 -83.03 -0.16 47.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.31 -12.01 61.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.74 148.68 24.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 38' ' ' GLY . 29.0 t -66.39 136.89 25.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.934 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.94 9.25 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.0 170.09 34.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.14 3.83 54.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.986 -1.302 . . . . 0.0 109.902 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.16 -41.78 5.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.243 -0.91 . . . . 0.0 110.309 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 23.2 t0 51.04 9.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 0.0 109.313 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.2 p90 -138.29 118.75 13.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.316 -0.865 . . . . 0.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 29' ' ' LEU . 6.3 pt -114.22 134.14 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -154.74 -148.21 0.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.959 . . . . 0.0 108.888 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 47' ' ' ASN . 37.3 p90 -44.89 -32.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.826 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 18.2 p-10 -65.4 4.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.177 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.1 t30 -155.53 100.29 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.804 . . . . 0.0 109.155 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -48.09 -18.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 28.4 pttt -175.38 155.23 1.81 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.398 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 54' ' ' SER . 53.2 p -66.71 130.51 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.83 -48.72 44.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.826 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -116.39 23.36 12.14 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 109.929 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.33 -15.11 7.24 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.6 t 63.48 4.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -1.116 . . . . 0.0 109.458 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 50' ' ' SER . 69.7 t -92.9 146.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.914 . . . . 0.0 108.916 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.9 m -149.78 153.78 37.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.057 . . . . 0.0 110.35 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.6 m80 -90.58 131.74 36.12 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.2 m -81.78 -34.71 30.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.506 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 113.76 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.74 159.09 25.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -1.122 . . . . 0.0 109.492 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.82 118.59 7.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -84.17 10.77 9.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.7 p -154.41 -35.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.85 99.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -1.198 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.53 -68.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.33 146.73 23.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.267 -0.896 . . . . 0.0 109.279 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -159.84 141.56 12.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.37 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 57' ' ' HIS . 8.0 mp -115.4 130.36 56.87 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.0 109.554 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -96.73 109.94 22.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.408 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.3 mp -98.8 146.75 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.204 -0.935 . . . . 0.0 110.465 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -141.98 90.62 2.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 149' ' ' TRP . 11.3 mt -78.86 -10.76 59.9 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.13 -0.84 0.82 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.009 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -135.83 18.12 3.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.0 p -60.2 134.99 90.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.329 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.5 -161.36 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.939 1.759 . . . . 0.0 111.682 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.08 39.7 2.79 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -126.19 -59.16 1.33 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.477 -1.014 . . . . 0.0 109.688 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.82 145.67 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.11 -0.994 . . . . 0.0 109.686 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -138.97 1.5 2.06 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.399 -0.813 . . . . 0.0 109.581 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -149.06 131.35 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 108.963 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -137.38 130.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 141' ' ' GLU . 9.3 pt -137.22 152.89 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.933 . . . . 0.0 109.619 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 7' ' ' VAL . 28.3 m-85 -101.59 141.18 34.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.377 -0.827 . . . . 0.0 109.08 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.89 153.02 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.922 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -133.15 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -138.29 145.17 40.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.904 . . . . 0.0 109.861 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.26 148.01 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -0.862 . . . . 0.0 108.822 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' ALA . 56.6 t-80 -101.32 -70.66 0.74 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -47.51 -18.1 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 109.694 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -53.5 -18.76 3.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.81 -62.19 1.49 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.905 -1.122 . . . . 0.0 109.244 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.45 -38.45 12.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 110.813 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.517 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 6.2 mpt_? -85.14 -18.0 35.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.042 -1.036 . . . . 0.0 111.109 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 99' ' ' ARG . 16.1 tpt180 52.1 94.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.811 -1.18 . . . . 0.0 108.763 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -152.46 140.68 20.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 109.435 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 t -99.62 164.14 12.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.44 -30.9 2.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.397 -0.814 . . . . 0.0 109.934 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.39 -39.73 98.08 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -49.78 -15.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.502 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 107' ' ' SER . 17.7 t -83.13 163.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 109.088 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -62.66 -22.7 66.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.74 80.02 0.03 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.3 164.33 24.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.129 . . . . 0.0 109.667 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.0 p90 -150.04 169.82 20.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.194 -0.942 . . . . 0.0 110.185 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 18.1 mt -136.13 152.11 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 67.0 ttt-85 -143.55 163.62 32.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.1 tt -156.58 117.19 3.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.568 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.0 p -132.13 145.32 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.309 -0.87 . . . . 0.0 110.212 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 119' ' ' GLN . 2.2 m120 -78.6 102.35 7.91 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -68.0 -1.76 6.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.104 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.15 -53.13 7.29 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.993 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -123.27 3.03 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.2 mt-30 59.95 61.28 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 32.6 m -114.33 -66.31 1.1 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.901 -0.499 . . . . 0.0 110.247 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 122' ' ' VAL . 1.4 mp0 -45.3 156.91 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.563 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.4 73.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.23 143.83 50.2 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.087 -1.008 . . . . 0.0 110.154 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.1 ptp180 -138.0 139.33 39.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.508 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 6.4 t80 -91.02 142.78 27.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 108.97 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -85.72 102.85 13.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.438 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 95.0 mt -79.42 -36.71 38.61 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 0.0 109.308 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 128' ' ' THR . 4.9 p -48.06 -33.2 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.139 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -95.3 -53.59 3.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.487 -0.758 . . . . 0.0 109.721 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 65.8 m-20 -71.9 -5.46 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.96 -46.06 68.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.18 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 65.4 p -68.84 3.18 2.08 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.916 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.0 m -83.32 -34.78 25.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.252 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -177.06 -162.77 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.971 -1.081 . . . . 0.0 109.677 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.52 -13.29 7.59 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.39 135.36 32.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.2 ttp -165.33 151.34 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.024 -1.047 . . . . 0.0 110.189 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.36 137.21 32.53 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.429 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -75.84 -47.43 25.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.902 -1.124 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.96 -158.91 9.06 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 88' ' ' ILE . 13.2 tt0 -150.98 158.65 44.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -1.085 . . . . 0.0 109.266 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 143' ' ' TYR . 1.8 tt -143.28 131.92 22.49 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.562 ' N ' HD23 ' A' ' 142' ' ' LEU . 12.1 p90 -150.66 166.34 30.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.5 ptm180 -94.68 142.53 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.449 -0.782 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -114.15 -120.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.593 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 20.0 t-20 -73.66 51.35 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.129 -0.982 . . . . 0.0 109.146 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.64 82.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -127.67 140.12 52.28 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.562 -0.963 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.532 ' CE2' HD13 ' A' ' 77' ' ' LEU . 58.0 m95 -67.3 151.75 46.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -151.4 121.6 7.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -91.81 145.21 24.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.243 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -152.18 107.28 3.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.106 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.506 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -64.16 154.54 34.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.725 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.7 t -138.76 -33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.83 83.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -134.61 104.13 5.94 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.61 -0.936 . . . . 0.0 109.007 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.91 149.22 21.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.34 132.61 26.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -1.016 . . . . 0.0 108.99 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -87.14 19.64 3.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.53 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -57.66 -107.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.1 129.43 1.96 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.55 -30.3 2.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -30.86 22.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.3 t -79.54 -53.93 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 18.1 m -47.2 -19.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 164' ' ' SER . 65.9 m -74.49 -61.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.03 -15.13 45.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -57.19 -43.69 82.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 45.8 m-85 -71.84 -20.07 61.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.466 ' N ' ' SD ' ' A' ' 2' ' ' MET . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -156.53 156.38 33.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 57.0 mttp -126.98 -14.53 5.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.519 -0.738 . . . . 0.0 109.382 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 43.0 m-20 -146.31 128.63 15.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.208 -0.932 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 6' ' ' LEU . 69.2 t -127.17 158.56 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.567 -0.708 . . . . 0.0 109.307 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' N ' HG12 ' A' ' 5' ' ' VAL . 12.0 tp -145.64 109.45 4.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 109.061 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.78 150.84 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.905 . . . . 0.0 108.747 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.24 117.25 1.68 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.1 tp -115.36 124.21 50.67 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -144.03 150.56 22.59 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -159.95 152.12 20.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.396 -1.061 . . . . 0.0 109.893 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.18 129.61 34.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.575 -0.703 . . . . 0.0 109.643 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.386 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 12.3 p-10 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.211 0.529 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.26 143.37 27.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -141.06 100.25 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.269 -0.894 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -83.28 135.51 34.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 108.748 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.51 117.59 30.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.51 130.98 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.66 167.75 25.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 109.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.27 144.98 42.91 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -101.94 151.81 21.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -118.87 143.34 47.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.562 -0.711 . . . . 0.0 109.282 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 133.2 22.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.069 -1.019 . . . . 0.0 110.136 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.5 176.5 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.741 -0.6 . . . . 0.0 109.487 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.93 -2.49 55.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 46.7 t30 -87.67 -1.43 57.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.741 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.54 -13.02 65.09 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -101.61 150.99 22.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.536 -0.979 . . . . 0.0 108.402 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 38' ' ' GLY . 27.4 t -69.05 137.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.24 -0.913 . . . . 0.0 109.121 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -71.62 8.68 1.04 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.74 170.95 35.35 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.1 m-20 -94.81 3.46 54.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.939 -1.33 . . . . 0.0 110.21 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.17 -42.13 5.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.056 -1.028 . . . . 0.0 110.584 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t0 49.63 9.93 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.955 -1.09 . . . . 0.0 109.496 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 8.2 t80 -138.13 100.22 4.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.323 -0.861 . . . . 0.0 109.803 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 29' ' ' LEU . 8.0 pt -96.75 139.6 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.208 -0.932 . . . . 0.0 108.608 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 35.4 p90 -151.23 -152.3 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 109.568 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.5 m-85 -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.644 -0.66 . . . . 0.0 110.013 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -57.27 -4.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -0.965 . . . . 0.0 108.639 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.0 t30 -151.32 102.03 2.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -48.72 -26.34 2.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.6 pttp -163.93 157.28 18.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 7.1 t -76.97 125.86 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.241 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.77 -45.81 67.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.922 . . . . 0.0 109.758 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.75 -12.23 19.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.494 -0.754 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.19 -13.51 68.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 p 60.45 12.19 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -1.212 . . . . 0.0 109.104 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' H ' ' HB3' ' A' ' 50' ' ' SER . 69.9 t -92.97 151.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.413 -0.804 . . . . 0.0 109.214 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.2 m -148.52 139.13 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.01 . . . . 0.0 109.921 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 73' ' ' LEU . 50.7 m80 -90.3 129.01 36.58 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -66.63 -53.02 38.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.4 114.09 0.54 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -79.37 110.98 15.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.94 -163.93 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 63' ' ' THR . 18.0 ptt180 -155.41 15.86 0.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.0 p -155.85 -39.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.28 98.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -1.122 . . . . 0.0 109.486 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.21 -57.38 13.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.22 170.82 8.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 132.21 5.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.201 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -115.23 119.44 36.34 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.05 137.32 35.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 109.081 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -127.8 144.75 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.588 -0.695 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.35 97.27 3.34 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.7 mt -82.98 -14.96 53.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.087 -1.008 . . . . 0.0 109.557 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.43 -1.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.462 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.37 16.32 3.73 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.342 -0.849 . . . . 0.0 109.101 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.2 p -60.68 134.96 92.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.217 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.24 -177.95 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.814 1.676 . . . . 0.0 111.495 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.41 13.57 64.92 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -96.89 -59.78 1.73 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -1.14 . . . . 0.0 109.828 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.22 148.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.734 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -144.06 7.37 1.39 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.31 -0.869 . . . . 0.0 109.635 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -152.0 140.23 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 109.051 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 87' ' ' ILE . 6.1 mt -145.55 122.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.161 -0.962 . . . . 0.0 109.709 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.09 174.15 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.339 -0.851 . . . . 0.0 108.747 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -141.08 119.53 12.29 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.07 157.67 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.332 -0.855 . . . . 0.0 110.651 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.61 136.72 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 p -131.12 148.54 52.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.5 mm -75.57 147.87 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' ALA . 4.0 t60 -102.36 -68.48 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.249 -0.907 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.27 -18.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.48 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -54.25 -17.89 3.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -69.86 -59.63 2.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.939 -1.101 . . . . 0.0 109.964 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.77 -51.33 5.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.181 -0.949 . . . . 0.0 111.354 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -78.09 -16.84 57.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.96 -1.088 . . . . 0.0 110.991 -178.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' ARG . 35.6 ttp180 55.89 101.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.746 -1.221 . . . . 0.0 109.308 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -159.16 143.06 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -100.96 167.25 10.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -45.87 -35.35 4.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.686 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.15 -39.31 92.08 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -46.98 -16.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -1.174 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -86.08 168.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.149 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.518 ' N ' HG12 ' A' ' 106' ' ' VAL . 23.2 m -70.86 -22.23 62.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.819 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.61 79.39 0.03 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.5 23.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 109.748 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 42.8 p90 -152.34 163.32 39.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 54.3 mt -126.2 154.3 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.43 ' NH2' HG12 ' A' ' 122' ' ' VAL . 50.6 ttt85 -141.22 159.85 41.34 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.983 -1.073 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.2 tt -154.22 116.99 4.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 109.28 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.58 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -130.98 143.51 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 120' ' ' THR . 55.9 t30 -75.14 102.07 4.8 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.62 -1.32 2.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 25.3 t70 -83.01 -53.55 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.652 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.6 6.2 8.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.587 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 59.52 60.33 2.31 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 43.1 p -110.62 -70.12 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.925 -0.485 . . . . 0.0 110.298 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 122' ' ' VAL . 66.8 mt-10 -45.33 157.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.324 -0.86 . . . . 0.0 109.774 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 150.17 52.15 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.091 -1.006 . . . . 0.0 110.02 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -139.78 142.26 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.645 -0.659 . . . . 0.0 109.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.35 147.77 22.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.234 -0.916 . . . . 0.0 109.147 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -91.17 103.16 15.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.407 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 82.3 mt -79.24 -39.3 33.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.4 m -47.51 -30.29 3.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.971 -1.081 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.3 -54.74 3.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.403 -0.811 . . . . 0.0 109.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.5 -2.35 28.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.14 -0.975 . . . . 0.0 110.418 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.46 -45.27 69.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.217 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 t -70.91 3.08 3.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.491 -0.756 . . . . 0.0 109.868 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.1 m -83.11 -34.72 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.035 -1.04 . . . . 0.0 110.226 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -176.74 -162.42 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.022 . . . . 0.0 109.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.56 -15.31 7.58 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.41 138.67 36.71 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.3 ptm -165.45 157.99 15.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 0.0 109.916 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.07 134.64 37.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.347 -0.846 . . . . 0.0 109.664 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -76.71 -42.42 41.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.05 . . . . 0.0 109.431 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.44 -163.13 13.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.28 163.05 39.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -1.098 . . . . 0.0 109.015 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.5 tp -144.82 137.22 26.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.068 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -150.68 166.04 31.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 109.275 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -95.7 141.45 29.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.602 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 9.5 t-160 -99.18 -133.95 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.602 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 5.6 m120 -52.22 -50.48 61.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.984 -1.072 . . . . 0.0 108.269 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.04 16.94 0.13 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -129.87 154.43 47.3 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.228 -1.16 . . . . 0.0 109.683 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 1' ' ' SER . 71.9 m95 -72.35 151.86 42.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.395 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -147.28 121.63 9.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.233 -0.917 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -90.32 146.26 24.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -150.81 107.78 3.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.4 -0.812 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.44 154.7 40.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.835 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 -33.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.4 85.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.16 104.3 5.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.531 -0.982 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.89 150.66 26.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.67 135.07 41.79 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.604 -0.939 . . . . 0.0 108.837 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.51 2.7 54.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 109.519 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -58.68 -110.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.97 140.27 6.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.75 -35.22 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.848 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.49 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.79 -19.81 30.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.1 m -89.02 -52.44 5.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 12.7 m -54.54 -28.29 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.617 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 32.1 p -78.54 -54.59 5.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -71.98 -15.12 62.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.976 -1.077 . . . . 0.0 109.33 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -28.99 63.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 51.1 m-85 -71.78 -19.83 61.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 109.473 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.439 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.774 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 149' ' ' TRP . 20.9 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.08 -170.99 2.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -153.25 -34.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 15.5 m120 -145.99 141.26 27.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG1' HD21 ' A' ' 113' ' ' LEU . 10.9 t -141.0 154.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.0 109.226 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.79 121.82 12.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 109.288 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -91.8 150.74 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 108.988 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.3 116.85 1.8 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -112.59 127.81 56.19 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.86 146.95 17.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -157.63 152.74 25.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -1.134 . . . . 0.0 109.872 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -92.53 126.51 37.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.737 . . . . 0.0 109.649 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.473 179.789 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 95.2 m-85 -96.17 153.09 17.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -140.93 111.15 6.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.92 163.61 13.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -106.68 154.57 20.74 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 0.0 109.479 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -144.67 109.7 5.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.185 -0.947 . . . . 0.0 108.764 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 t -149.43 163.3 38.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 109.974 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 144.69 37.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 8.0 m-85 -104.04 129.07 51.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.447 -0.783 . . . . 0.0 108.909 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.004 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.53 155.56 17.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.41 -0.806 . . . . 0.0 109.204 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.23 137.3 25.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.69 176.35 8.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.445 -0.785 . . . . 0.0 109.266 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.5 -2.55 53.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.642 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -93.18 3.55 55.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.174 -0.954 . . . . 0.0 109.821 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 -19.6 53.83 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.3 mttp -106.26 172.45 6.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -101.27 141.81 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -59.69 -5.55 0.93 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -148.6 101.11 0.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 18.6 p-10 -45.23 -18.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.376 -1.073 . . . . 0.0 110.28 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.44 79.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 0.0 109.561 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.696 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 45.45 17.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' ALA . 52.5 t80 -137.8 100.02 4.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.533 -0.729 . . . . 0.0 109.858 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 29' ' ' LEU . 6.2 pt -106.3 139.65 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.315 -0.866 . . . . 0.0 109.072 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -152.92 -148.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 109.039 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' ASN . 25.9 p90 -44.46 -34.33 2.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.971 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.69 -5.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.166 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 54.0 t-20 -148.0 110.09 4.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -0.834 . . . . 0.0 108.956 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.24 -29.1 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 12.8 pttm -169.17 155.6 6.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.432 -0.793 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 5.1 t -73.51 117.51 15.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.189 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.22 78.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.663 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -93.42 -16.41 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.29 -0.881 . . . . 0.0 109.786 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.17 -13.69 61.58 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t 58.39 14.04 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.9 t -92.91 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.329 -0.857 . . . . 0.0 109.168 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.5 m -145.75 136.12 24.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 57.2 m80 -89.97 133.49 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.347 -0.846 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -71.75 -60.79 2.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.506 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.43 114.92 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 32.6 p-10 -82.21 110.94 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.0 t-20 -80.84 -163.48 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.358 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 36.1 ttp180 -151.91 14.23 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 109.243 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -154.11 -38.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.945 . . . . 0.0 109.25 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.24 124.13 9.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -1.165 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.93 -73.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -90.84 99.66 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 t -91.38 132.15 36.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.217 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -112.27 125.08 53.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -96.3 142.51 28.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 108.949 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -133.68 146.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.332 -0.855 . . . . 0.0 109.927 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -142.2 102.23 4.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 79' ' ' ALA . 5.6 mt -82.59 -27.69 31.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.862 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -63.63 4.65 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.29 19.08 4.01 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.81 125.81 45.19 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.117 -0.99 . . . . 0.0 108.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.06 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.818 1.679 . . . . 0.0 111.88 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.56 4.71 83.95 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -53.27 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -1.181 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.29 149.07 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.0 109.347 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 10.4 t0 -120.71 -13.79 8.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 109.482 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -158.02 134.18 9.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.013 . . . . 0.0 109.949 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -122.88 154.42 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -141.12 173.57 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.193 -0.942 . . . . 0.0 109.291 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -141.84 128.91 20.83 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.61 158.33 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 m -135.63 114.06 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -106.15 161.06 14.85 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.9 mm -73.01 140.58 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.12 -69.88 0.73 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.056 -1.028 . . . . 0.0 110.441 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -50.39 -17.92 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.146 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.598 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.35 -50.51 21.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -55.24 -28.02 50.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.904 -1.123 . . . . 0.0 109.801 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -54.14 4.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.114 -0.991 . . . . 0.0 111.173 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.45 -0.43 15.29 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.187 -0.945 . . . . 0.0 111.058 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.0 ttm-85 56.23 101.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.889 -1.132 . . . . 0.0 109.046 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -146.93 149.48 33.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.7 p -101.03 158.22 16.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.341 -0.849 . . . . 0.0 109.652 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -45.62 -34.46 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.397 -0.815 . . . . 0.0 109.743 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.684 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.7 -42.22 99.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 87.4 mm-40 -47.66 -15.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.251 . . . . 0.0 109.371 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -83.57 166.16 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.509 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.2 t -69.83 -20.48 63.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.725 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.83 79.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.06 162.76 26.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 109.734 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 20.7 p90 -156.3 149.96 24.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 56.7 mt -115.83 154.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -139.59 159.4 42.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.03 -1.043 . . . . 0.0 109.923 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -151.94 117.23 5.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -129.16 145.82 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.2 t-20 -76.42 102.05 5.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.93 -1.56 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.88 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -84.08 -53.17 5.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.713 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -123.11 4.67 9.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' ASN . 10.7 tt0 60.39 61.12 1.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.429 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 24.3 p -112.34 -68.97 0.89 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.903 -0.498 . . . . 0.0 110.221 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.3 mm-40 -45.4 157.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.851 . . . . 0.0 109.956 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.74 150.83 52.11 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.149 -0.969 . . . . 0.0 109.935 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptm180 -138.81 146.26 41.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.507 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.0 t80 -91.34 147.3 23.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.61 103.06 15.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.516 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.8 mt -81.38 -39.16 25.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.3 m -48.16 -31.87 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 0.0 109.152 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.18 -54.53 3.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.47 -0.769 . . . . 0.0 109.771 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 58.6 m-20 -72.75 -2.99 22.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.274 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.72 -44.35 66.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.244 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.5 p -72.39 3.17 5.03 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -82.79 -34.57 26.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.74 -162.6 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -127.37 -1.58 6.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.07 13.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.8 ptm -165.35 157.97 15.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.843 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -94.68 139.66 30.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 109.795 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 26.5 t80 -81.14 -42.82 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.629 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.62 -169.45 22.95 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.8 164.86 35.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.251 -1.147 . . . . 0.0 109.46 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 136.52 26.23 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 152' ' ' ARG . 9.5 p90 -146.95 166.27 27.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.019 -1.05 . . . . 0.0 110.25 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.98 145.32 24.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 4.7 t60 -122.77 -118.81 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.61 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 73.6 m-20 -73.53 53.3 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.23 8.13 87.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.76 148.61 50.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.99 . . . . 0.0 109.312 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.4 m95 -75.08 151.79 38.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -147.74 127.11 13.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.112 -0.993 . . . . 0.0 109.603 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -89.63 148.23 23.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.484 -0.76 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 143' ' ' TYR . 2.6 ptp180 -153.87 107.52 2.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.06 154.55 37.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.44 -34.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.0 109.389 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 86.26 0.04 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -131.67 104.19 6.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.634 -0.921 . . . . 0.0 109.389 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.36 148.08 24.94 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -139.43 128.66 23.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -1.073 . . . . 0.0 109.321 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.8 12.16 13.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.06 -80.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 152.77 131.24 1.63 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.15 -13.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.56 -50.32 7.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.2 p -81.12 -37.72 28.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 161' ' ' GLY . 52.1 t -49.92 -24.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.434 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 93.4 m -79.55 -55.28 5.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.168 -0.957 . . . . 0.0 110.959 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.09 -15.21 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.957 -1.089 . . . . 0.0 110.355 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -66.3 -39.96 89.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.58 -19.62 62.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.683 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.734 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 25.2 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.255 0.55 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -80.21 -174.64 4.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -153.21 -34.98 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.428 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 6.2 m-20 -138.0 142.65 40.41 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.362 -0.837 . . . . 0.0 109.321 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 5.2 t -140.08 146.01 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.8 tt -136.25 111.9 9.37 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -86.42 150.97 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.26 117.08 1.56 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.8 tt -115.98 132.42 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -149.0 143.96 11.55 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.52 158.8 41.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -1.023 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -76.73 131.35 38.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.911 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 0.0 109.261 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 p30 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.17 140.03 31.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.83 99.79 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.304 -0.872 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.69 153.29 24.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -108.44 109.06 20.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -0.761 . . . . 0.0 109.543 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.25 128.0 44.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.307 -0.87 . . . . 0.0 108.924 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -149.44 167.81 25.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.068 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.68 140.7 43.22 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -103.91 129.83 51.46 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.406 -0.809 . . . . 0.0 108.922 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.949 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.97 146.72 27.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 109.681 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.64 134.69 23.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.188 -0.945 . . . . 0.0 110.005 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.74 176.53 3.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.65 -6.4 58.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.711 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -86.57 1.49 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.86 59.16 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -99.48 152.26 20.2 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 38' ' ' GLY . 26.2 t -72.26 136.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.054 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -70.96 8.17 0.99 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.2 168.36 34.61 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.33 4.05 54.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.997 -1.296 . . . . 0.0 110.13 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -102.77 -42.05 6.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.158 -0.964 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 47.71 13.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.742 -1.224 . . . . 0.0 109.454 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ALA . 68.7 t80 -137.5 102.86 4.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.444 -0.785 . . . . 0.0 109.911 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 pt -103.08 131.04 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.813 . . . . 0.0 108.855 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 20.4 t80 -150.06 -146.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -50.65 -16.27 0.37 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 10.0 p-10 -78.92 4.88 12.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 108.799 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.1 t-20 -156.71 106.44 2.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.05 -25.57 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 11.9 pttm -172.86 158.53 3.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 t -69.64 141.38 53.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.66 -43.55 25.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.31 -1.58 12.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.694 -0.629 . . . . 0.0 109.553 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.8 -13.68 60.6 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 t 60.45 10.28 2.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -1.077 . . . . 0.0 109.426 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.13 147.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.99 138.2 25.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 109.721 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.438 ' NE2' HD11 ' A' ' 73' ' ' LEU . 36.0 m80 -89.82 130.17 36.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 108.785 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -69.49 -42.76 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.332 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.27 111.08 0.39 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -72.84 110.79 7.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.1 t-20 -86.3 -167.04 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.945 . . . . 0.0 109.341 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.466 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 15.5 ptt-85 -162.37 20.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 18.8 p -153.9 -43.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 109.352 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -56.42 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -52.96 -61.07 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.65 165.31 13.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -154.89 132.15 11.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -116.15 124.48 50.43 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HZ2' ' HE3' ' A' ' 76' ' ' LYS . 36.9 tttm -95.91 139.83 31.55 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.51 146.8 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HE3' ' HZ2' ' A' ' 74' ' ' LYS . 88.7 mttt -139.57 99.35 3.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.18 -5.53 52.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -83.26 -26.89 30.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.93 5.87 50.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.42 124.44 85.53 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.13 -161.35 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.828 1.686 . . . . 0.0 112.057 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.32 1.38 79.5 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -68.9 -59.83 2.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 109.246 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 50.4 t -91.39 148.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.408 -0.807 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 2.4 m-20 -138.26 9.03 2.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -155.04 131.3 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 109.327 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.38 154.3 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.46 173.66 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.307 -0.87 . . . . 0.0 109.001 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.9 m-85 -140.95 120.48 13.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.21 158.11 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.714 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.63 136.34 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -125.55 143.88 50.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 109.695 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.7 mm -74.22 132.05 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 108.863 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -93.8 -60.14 1.83 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.33 -19.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.56 -43.88 72.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -55.79 -27.6 51.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.762 -1.212 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.67 -53.74 4.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.137 -0.977 . . . . 0.0 111.076 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.439 ' CZ ' HE22 ' A' ' 101' ' ' GLN . 12.3 ptm180 -112.42 -3.9 14.37 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.244 -0.91 . . . . 0.0 110.9 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 48.0 ttp180 56.74 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.071 . . . . 0.0 109.321 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.439 HE22 ' CZ ' ' A' ' 99' ' ' ARG . 3.8 pt20 -157.88 153.65 26.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 83.0 p -101.85 158.47 16.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.01 -31.49 0.92 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.564 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.06 -33.51 22.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -57.53 -26.29 61.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -1.077 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -72.41 166.4 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.223 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.3 m -70.69 -28.89 65.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.4 75.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.62 25.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 108.938 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.9 p90 -153.24 169.86 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.297 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 41.8 mt -132.4 156.62 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.71 162.69 34.8 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.006 -1.059 . . . . 0.0 109.731 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.6 tt -157.52 116.66 3.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.587 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -132.92 141.88 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.318 -0.864 . . . . 0.0 109.651 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' GLN . 1.4 m120 -77.79 102.1 7.03 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 6.1 p-10 -68.29 -3.67 11.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.9 t70 -72.96 -52.69 13.58 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.138 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -122.67 -12.02 8.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.766 -0.584 . . . . 0.0 109.617 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 115' ' ' ASN . 6.0 tt0 70.86 69.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -130.48 -45.71 1.09 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.738 -0.601 . . . . 0.0 109.979 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.0 mp0 -65.13 158.23 26.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 108.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 176.67 76.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.28 148.67 52.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.495 -0.753 . . . . 0.0 109.407 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 27.8 ptt180 -136.49 141.72 43.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.53 140.04 30.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 0.0 108.946 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -83.85 103.02 12.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 0.0 109.402 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 60.7 mt -78.22 -41.72 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 84.7 m -47.88 -29.58 3.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.933 -1.104 . . . . 0.0 109.274 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.05 -54.74 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 109.878 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.28 -4.74 37.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 110.355 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.21 -49.29 78.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.961 -1.087 . . . . 0.0 109.783 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.3 p -60.41 2.8 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.5 m -89.68 -33.31 16.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 110.4 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -172.68 -145.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.18 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.521 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -135.82 -52.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.77 143.64 30.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.2 ttt -166.2 158.08 13.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.043 . . . . 0.0 109.802 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -101.04 136.48 40.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.373 -0.83 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 25.9 t80 -81.65 -40.74 22.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.74 -170.79 26.95 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -150.96 163.62 38.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -1.12 . . . . 0.0 109.602 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.03 140.39 32.61 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -150.57 166.5 30.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.099 -1.001 . . . . 0.0 109.857 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -88.15 148.96 24.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.79 . . . . 0.0 109.709 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -152.5 123.78 7.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 55.67 24.77 7.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.81 80.33 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -127.8 138.37 52.71 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.488 -1.007 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 76.8 m95 -67.69 150.7 48.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -151.35 126.19 9.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -89.23 147.02 24.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.465 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -152.76 108.09 3.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.048 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.54 154.74 41.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.0 t -139.31 -33.65 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -0.843 . . . . 0.0 109.293 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.09 86.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -138.25 104.46 5.2 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.928 . . . . 0.0 109.485 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.64 150.59 33.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -147.88 134.4 19.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.221 -1.164 . . . . 0.0 109.396 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.3 16.94 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.339 -0.851 . . . . 0.0 109.43 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.1 -64.55 2.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.64 127.04 0.97 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -47.22 -35.58 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.792 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.0 -22.2 27.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.423 ' C ' ' N ' ' A' ' 166' ' ' CYS . 26.0 m -79.18 -57.53 3.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.0 m -47.58 -20.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.423 ' N ' ' C ' ' A' ' 164' ' ' SER . 96.2 m -72.63 -61.94 1.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.68 -17.52 31.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.35 -43.51 88.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.24 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.92 -20.31 61.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt -67.67 -178.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.436 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 81.8 mttt -153.62 -33.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.911 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 26.7 m-20 -140.3 129.11 23.18 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -129.69 156.09 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.6 tp -142.02 110.0 5.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 108.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.22 150.5 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.209 -0.932 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.54 116.5 1.22 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.56 134.55 49.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.57 142.32 10.58 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -160.39 152.98 20.94 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -1.151 . . . . 0.0 109.914 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.08 99.32 11.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 109.403 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.428 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.24 131.19 42.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 p-10 -141.03 100.8 3.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.18 146.3 28.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.78 121.4 44.3 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.33 -0.856 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.6 134.37 40.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.262 -0.899 . . . . 0.0 108.912 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.9 t -149.85 167.92 25.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.306 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.08 138.33 54.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.8 m-85 -104.06 128.03 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.317 -0.865 . . . . 0.0 109.332 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.011 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -103.03 155.84 18.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.42 137.49 25.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 109.35 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.14 176.78 9.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 109.501 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.35 59.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.98 4.66 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.119 -0.988 . . . . 0.0 109.839 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.89 -20.68 45.91 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 43.6 mtpt -103.32 172.49 6.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.689 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.6 t -101.29 142.63 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.406 -0.809 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 39.1 mmm-85 -59.74 -6.03 1.09 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -146.1 100.16 0.22 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -44.94 -21.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -1.091 . . . . 0.0 110.414 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.35 79.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 109.62 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.689 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER 47.77 13.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 109.369 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 84.9 t80 -138.28 99.46 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.366 -0.834 . . . . 0.0 109.654 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.83 136.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.8 p90 -144.94 -160.85 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.139 -0.976 . . . . 0.0 109.502 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.8 p90 -45.64 -29.96 1.39 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.433 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.8 t30 -57.42 -6.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.855 -1.153 . . . . 0.0 108.989 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 48.6 t30 -140.17 110.07 6.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.458 -0.776 . . . . 0.0 109.022 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.03 -31.65 5.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 109.278 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 16.9 pttp -169.87 160.01 8.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -65.01 142.29 58.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.327 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.92 43.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.631 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -115.21 -3.79 12.49 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.643 -0.661 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -15.64 74.23 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.0 p 61.48 11.45 3.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.0 109.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 73' ' ' LEU . 54.9 m -147.68 133.85 19.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 109.746 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.55 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.8 m80 -91.42 139.17 30.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 m -74.43 -61.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.67 121.63 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 23.6 p-10 -81.28 112.11 18.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.146 . . . . 0.0 109.543 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.35 132.1 35.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -79.82 6.24 11.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.532 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.1 p -153.3 -34.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -49.2 106.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.04 -63.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -90.99 -179.69 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.562 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.9 m -161.85 135.43 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.18 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.55 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -121.41 120.5 35.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.13 138.8 33.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.096 -1.002 . . . . 0.0 109.304 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' CE1' ' A' ' 89' ' ' PHE . 79.8 mt -132.38 147.02 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.583 -0.698 . . . . 0.0 109.763 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' O ' ' OG ' ' A' ' 54' ' ' SER . 53.8 mttp -142.85 102.1 3.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.857 . . . . 0.0 108.722 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 79' ' ' ALA . 9.3 mt -77.11 -39.01 51.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.999 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -49.42 -17.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -100.17 -15.95 17.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.78 123.89 88.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.398 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.56 -160.74 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.967 1.778 . . . . 0.0 111.941 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.01 1.73 87.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' NH1' ' A' ' 37' ' ' ARG . 59.4 t0 -67.28 -55.64 13.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -1.143 . . . . 0.0 109.57 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -79.02 148.53 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 8.9 t0 -128.25 -7.13 5.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 109.564 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -158.21 135.84 10.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 109.614 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.75 154.12 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -146.51 173.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.262 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.447 ' CE1' HD13 ' A' ' 75' ' ' ILE . 9.3 m-85 -133.32 139.28 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.94 155.62 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.99 . . . . 0.0 111.212 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -147.57 113.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -121.14 171.62 8.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.449 -0.782 . . . . 0.0 110.606 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.8 mm -81.68 168.3 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.568 ' N ' HG22 ' A' ' 93' ' ' ILE . 27.0 t-80 -132.75 -64.8 0.74 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -49.91 -18.23 0.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.28 -39.44 79.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.579 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' NE2' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -52.9 -32.21 44.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.77 -1.206 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.84 4.22 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.135 -0.978 . . . . 0.0 111.296 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.23 1.75 16.31 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.127 -0.983 . . . . 0.0 111.091 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.4 ttm180 59.08 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.998 -1.064 . . . . 0.0 109.339 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.418 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 83.4 mt-30 -150.05 139.35 21.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 109.555 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 m -99.13 158.98 15.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.37 -0.831 . . . . 0.0 109.461 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -46.31 -30.21 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.325 -0.86 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.707 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -68.19 -37.53 86.91 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -47.71 -17.06 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.167 . . . . 0.0 109.138 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -85.0 167.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 108.969 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 106' ' ' VAL . 25.0 m -67.26 -20.47 65.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.0 80.48 0.03 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.76 164.68 23.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 109.832 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.8 p90 -154.07 150.45 28.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.129 -0.982 . . . . 0.0 110.024 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 36.2 mt -114.17 155.84 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -141.96 162.82 34.51 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.995 -1.065 . . . . 0.0 109.919 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.7 tt -157.07 118.14 3.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.6 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -130.77 144.56 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.331 -0.856 . . . . 0.0 110.049 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -75.24 101.97 4.85 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.92 -1.71 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 115' ' ' ASN . 22.3 t0 -84.75 -52.18 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.306 -0.871 . . . . 0.0 109.627 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -122.24 -0.48 9.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.65 -0.656 . . . . 0.0 109.988 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 60.67 63.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 21.9 p -118.13 -53.93 2.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.002 -0.436 . . . . 0.0 110.099 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.16 158.55 11.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 109.389 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER 178.31 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 148.01 52.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 109.791 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 41.1 ptt85 -134.82 145.68 48.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.408 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.8 t80 -91.36 147.59 22.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.15 -0.969 . . . . 0.0 109.186 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -86.11 102.99 14.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 109.285 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 66.9 mt -83.07 -40.66 19.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.458 ' H ' HG23 ' A' ' 128' ' ' THR . 5.9 p -48.13 -31.74 6.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.118 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -95.32 -54.62 3.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.823 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 47.1 m-20 -73.47 -3.82 29.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.161 -0.962 . . . . 0.0 110.416 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.707 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.27 -45.15 65.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.997 -1.065 . . . . 0.0 109.125 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.1 m -70.91 3.01 3.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.643 -0.66 . . . . 0.0 109.92 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -84.47 -34.26 23.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 110.17 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.64 -167.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -123.4 -8.05 8.1 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.05 135.52 24.26 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.94 157.65 14.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.014 -1.054 . . . . 0.0 110.048 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -92.6 138.37 31.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -81.51 -41.96 20.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.29 -169.95 20.97 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.406 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.9 tt0 -151.5 161.25 43.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -144.51 136.39 25.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.2 -0.937 . . . . 0.0 108.523 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.2 p90 -144.04 165.87 26.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.188 -0.945 . . . . 0.0 109.685 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.5 ptm180 -84.98 152.52 23.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -155.29 116.47 3.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.411 ' O ' ' OE1' ' A' ' 148' ' ' GLU . 14.6 t-20 56.25 24.99 8.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 -3.89 86.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 3.4 mp0 -109.64 135.09 51.16 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -69.14 151.64 46.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.192 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.85 129.42 15.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.119 -0.988 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 19.4 t80 -96.72 137.73 35.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.457 -0.777 . . . . 0.0 109.912 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -143.61 107.29 4.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.48 154.56 39.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -143.08 -34.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.264 -0.898 . . . . 0.0 109.322 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.04 85.24 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -132.65 104.23 6.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.663 -0.904 . . . . 0.0 109.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.76 149.71 25.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -140.24 133.44 29.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.468 -1.019 . . . . 0.0 109.117 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.16 7.66 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 0.0 109.439 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -69.6 0.91 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.89 125.39 0.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.21 -28.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.137 . . . . 0.0 109.928 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.75 -31.0 22.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.9 p -75.6 -50.48 15.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.4 m -48.13 -20.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.486 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.4 m -69.97 -58.94 3.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 110.326 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.71 -15.24 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.35 -44.2 92.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.293 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -71.23 -20.01 62.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 149' ' ' TRP . 53.0 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -77.61 148.8 34.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -129.64 -9.88 4.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.453 ' ND2' ' OD1' ' A' ' 117' ' ' ASP . 11.7 m-80 -146.41 129.18 16.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.219 -0.926 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.462 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.9 t -135.88 147.98 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.066 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.7 tt -135.28 109.92 8.59 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.466 ' N ' HD23 ' A' ' 6' ' ' LEU . 15.4 t -86.16 143.87 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.47 117.15 2.18 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.7 tt -115.46 131.82 56.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -145.24 143.46 11.86 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' THR . 19.0 p90 -154.97 153.69 31.43 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.44 -1.035 . . . . 0.0 109.695 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.04 117.51 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -140.9 99.65 3.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.39 -0.819 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.66 130.63 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -91.43 112.54 24.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 109.959 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 128.74 44.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.276 -0.89 . . . . 0.0 108.6 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -149.26 165.73 31.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.102 -0.999 . . . . 0.0 110.171 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 138.69 45.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.3 m-85 -104.45 129.41 52.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.472 -0.768 . . . . 0.0 109.007 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.02 153.42 19.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.377 -0.827 . . . . 0.0 109.949 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.02 135.36 22.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.822 . . . . 0.0 109.415 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.25 176.46 8.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.47 -10.49 59.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.973 . . . . 0.0 109.718 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -84.78 4.81 31.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.18 -19.61 51.21 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.0 mttt -103.71 172.05 7.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -103.03 140.94 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.458 -0.776 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' NH1' ' OD1' ' A' ' 83' ' ' ASP . 34.3 ttp180 -62.06 -3.54 1.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -143.54 101.29 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -45.54 -27.29 0.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 110.47 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.4 -42.34 82.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.912 -1.118 . . . . 0.0 109.623 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.8 t0 46.03 15.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 13.8 t80 -137.77 100.22 4.13 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.653 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 pt -101.55 137.92 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.3 p90 -141.14 -160.08 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 25.7 p90 -42.5 -36.06 1.23 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.607 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 9.1 t30 -49.27 -14.61 0.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.912 -1.118 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.479 ' N ' ' C ' ' A' ' 45' ' ' TYR . 40.7 t30 -153.88 112.85 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.94 -64.63 0.97 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.202 -0.937 . . . . 0.0 109.542 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -89.92 117.77 28.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.478 -0.764 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -57.21 134.77 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.89 75.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.826 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -116.39 -5.96 11.76 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.615 -0.678 . . . . 0.0 109.892 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.42 -19.27 64.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t 62.78 6.57 2.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -1.17 . . . . 0.0 109.238 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -92.97 152.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 108.932 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -143.45 142.13 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.111 -0.993 . . . . 0.0 110.468 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CE1' HD21 ' A' ' 73' ' ' LEU . 4.6 m80 -92.12 121.44 33.67 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 m -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.381 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 109.77 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -79.77 110.77 15.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -1.18 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -86.34 132.6 33.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -78.89 2.8 18.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 40.1 p -153.52 -35.01 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.2 94.69 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 109.557 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.17 -53.05 42.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.22 160.08 14.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 108.998 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 m -157.86 132.32 8.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.077 -1.014 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD21 ' CE1' ' A' ' 57' ' ' HIS . 2.3 mp -117.88 126.4 52.31 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -96.27 122.74 39.45 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 71.2 mt -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.434 -0.791 . . . . 0.0 110.199 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 103.52 4.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.12 -24.33 40.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.909 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.4 -21.99 66.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.67 -9.19 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.953 . . . . 0.0 109.773 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.13 125.06 90.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.98 -160.28 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.909 1.739 . . . . 0.0 111.909 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.26 3.22 75.91 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 16.4 t70 -69.12 -60.1 2.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.304 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 86' ' ' LYS . 7.3 p -91.36 148.75 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.508 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.7 m-20 -133.1 10.48 4.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.343 -0.848 . . . . 0.0 109.831 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' H ' HG22 ' A' ' 84' ' ' VAL . 75.7 tttt -158.14 131.73 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 109.235 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.9 mt -129.36 154.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.515 -0.741 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.03 173.17 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.426 -0.796 . . . . 0.0 109.014 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 6.9 m-85 -142.4 118.4 10.64 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.02 157.71 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.248 -0.907 . . . . 0.0 110.625 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -120.98 148.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -141.81 140.08 32.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -73.92 137.4 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.8 t-80 -94.17 -64.9 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -47.45 -18.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.852 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.94 -18.13 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.0 109.94 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -66.14 -60.44 2.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.889 -1.132 . . . . 0.0 109.484 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -43.6 9.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.364 -0.835 . . . . 0.0 111.151 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -83.88 -18.02 38.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 111.225 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 54.19 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.652 -1.28 . . . . 0.0 109.162 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -148.39 142.28 25.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.25 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -99.63 165.27 11.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.217 -0.927 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CG ' HD22 ' A' ' 127' ' ' LEU . 12.7 m-85 -46.29 -34.19 4.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.285 -0.885 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.685 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.26 -38.49 90.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -49.1 -18.85 0.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.981 -1.305 . . . . 0.0 109.338 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 107' ' ' SER . 23.2 t -82.54 166.22 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 109.161 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.496 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.3 m -70.28 -23.4 62.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.988 . . . . 0.0 109.758 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.35 77.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.2 163.48 23.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -1.176 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 30.6 p90 -154.23 169.88 22.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.5 mt -132.08 156.55 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -143.85 162.12 36.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.5 tt -157.77 118.1 3.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.079 -1.013 . . . . 0.0 109.658 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.91 143.8 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -79.85 102.01 8.87 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.01 -1.49 7.61 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 31.7 t0 -76.76 -52.44 9.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 5.4 m-80 -122.48 -14.74 7.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.73 -0.606 . . . . 0.0 109.583 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 15.9 tt0 73.83 71.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -135.9 -45.13 0.65 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.644 -0.66 . . . . 0.0 109.975 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 49.9 mm-40 -65.37 158.44 26.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 108.931 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 173.4 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.79 149.45 52.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.501 -0.75 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.7 ptp180 -135.12 142.9 46.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.618 -0.676 . . . . 0.0 109.461 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -91.32 143.09 27.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.905 . . . . 0.0 108.925 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.16 102.87 14.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.585 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.3 mt -78.7 -41.0 32.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.204 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.9 p -47.78 -29.68 3.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 109.295 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -95.22 -54.68 3.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 109.804 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.93 -0.83 22.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.968 . . . . 0.0 110.275 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.0 -44.62 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 109.275 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 t -72.57 3.01 5.4 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.539 -0.725 . . . . 0.0 109.851 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.1 m -82.32 -34.35 28.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 110.124 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.76 -164.06 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 0.0 109.612 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.06 -14.34 8.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.6 140.12 36.94 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.8 ptm -165.47 158.05 15.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.008 -1.057 . . . . 0.0 109.871 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.19 137.58 35.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -82.87 -41.06 19.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.627 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.93 -170.1 25.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -151.21 164.24 37.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.216 -1.167 . . . . 0.0 109.558 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 139.02 29.04 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.16 166.45 29.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.065 -1.022 . . . . 0.0 109.894 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.508 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -89.19 146.18 24.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 109.506 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 146' ' ' ASN . 19.9 t-160 -128.23 -115.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 145' ' ' HIS . 21.9 m120 -72.66 58.71 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.068 -1.02 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.73 8.09 62.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.02 149.47 50.35 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.963 . . . . 0.0 109.315 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.8 m95 -72.8 151.63 41.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.356 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -146.58 129.42 16.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -89.89 149.28 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.405 -0.81 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -155.46 113.52 3.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.195 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.96 154.53 31.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.56 -33.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -0.871 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.91 84.58 0.03 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -136.96 104.28 5.41 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.966 . . . . 0.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.36 152.12 37.38 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -141.95 129.46 21.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.24 9.31 31.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 109.444 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.36 -70.97 0.61 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.83 132.44 1.48 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.33 -33.33 3.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.63 -26.39 26.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 166' ' ' CYS . 12.6 t -74.69 -54.39 7.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.5 m -47.41 -20.71 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.504 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 60.0 m -71.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -15.4 39.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.35 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.28 -43.31 98.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.108 -0.995 . . . . 0.0 110.076 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -71.43 -19.7 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' TRP . 75.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 34.2 mtt -81.69 162.84 22.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -141.45 -33.73 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 13.1 m120 -146.11 128.46 15.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.7 t -128.84 149.0 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 73' ' ' LEU . 12.2 tp -132.63 108.24 8.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 108.985 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.55 150.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.94 117.0 1.25 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -106.05 132.45 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.07 138.41 7.26 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.946 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -156.46 155.19 31.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -75.5 125.53 29.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.263 179.686 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.281 0.562 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.32 104.9 16.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.184 -0.948 . . . . 0.0 109.338 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' ND1' ' A' ' 94' ' ' HIS . 24.4 p-10 -92.87 102.71 15.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 mt -83.4 138.04 33.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 109.15 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.07 106.69 18.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.05 119.05 38.08 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -149.04 168.37 23.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.04 . . . . 0.0 109.804 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.03 138.42 45.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.597 -0.689 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.0 m-85 -104.35 131.83 51.26 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.993 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.62 154.39 19.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.382 -0.823 . . . . 0.0 110.132 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 136.62 24.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.04 176.68 8.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.247 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -79.86 -11.23 59.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.5 m120 -86.55 5.65 34.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.069 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.46 52.16 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.7 mmtm -102.61 172.03 7.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.673 HG21 ' OD1' ' A' ' 41' ' ' ASP . 3.5 t -102.18 143.23 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 109.784 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -62.5 -3.24 1.34 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.82 102.57 0.25 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -45.18 -25.8 0.4 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -1.085 . . . . 0.0 110.751 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.819 -1.175 . . . . 0.0 109.687 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.673 ' OD1' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 48.4 12.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 109.444 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 40' ' ' ALA . 79.3 t80 -135.11 100.25 4.5 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HD11 ' A' ' 29' ' ' LEU . 4.6 pt -103.5 130.52 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.487 ' CZ ' ' OD2' ' A' ' 60' ' ' ASP . 33.4 t80 -170.99 -168.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.985 -1.072 . . . . 0.0 109.179 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.473 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 52.4 m-85 48.46 -113.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 48' ' ' LEU . 23.0 t30 -56.84 -7.65 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -67.49 68.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.945 -1.097 . . . . 0.0 109.648 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 46' ' ' ASN . 13.3 mt -52.98 -30.97 38.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 108.898 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 127.15 0.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.744 . . . . 0.0 109.124 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -55.86 111.9 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.67 -25.4 63.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.08 -16.12 11.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.545 -0.722 . . . . 0.0 109.658 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.53 -20.27 35.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.403 ' OG ' HG22 ' A' ' 80' ' ' VAL . 1.1 m 69.14 2.67 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.451 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.77 146.56 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.229 -0.92 . . . . 0.0 108.663 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -149.12 150.56 32.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.961 -1.087 . . . . 0.0 110.348 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -91.37 136.15 33.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.65 -0.657 . . . . 0.0 109.756 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 p -85.78 -30.35 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.27 104.1 0.24 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' CZ ' ' A' ' 44' ' ' PHE . 12.6 t70 -80.77 110.82 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.636 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -95.36 -167.85 1.69 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -161.47 19.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.8 p -154.29 -42.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.856 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.927 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.87 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -71.93 -69.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.32 156.1 17.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.314 -0.866 . . . . 0.0 109.132 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -159.68 141.33 12.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 17.5 mt -112.19 131.81 55.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.067 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.47 110.16 22.26 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 26.6 mt -97.94 146.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 111.075 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -140.21 84.35 1.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 -5.19 11.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.9 -20.23 49.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.648 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.49 -13.89 21.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.217 -0.927 . . . . 0.0 109.781 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' A' ' 54' ' ' SER . 68.2 t -60.99 124.91 82.23 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 109.269 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.01 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.74 1.627 . . . . 0.0 111.866 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.56 1.86 79.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -71.41 -60.52 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.544 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 t -87.12 133.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 32' ' ' ALA . 16.6 m-20 -113.32 4.43 16.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.697 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -156.36 137.86 14.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.528 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 87' ' ' ILE . 10.4 mt -145.44 107.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -109.18 171.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 4.7 m-85 -129.84 134.4 47.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.1 158.16 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -131.28 134.75 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -138.04 164.62 28.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.8 mm -77.64 142.01 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 22' ' ' ASP . 20.6 t-160 -98.1 -68.35 0.81 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -51.33 -18.11 0.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.104 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -48.94 -42.93 38.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 109.772 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.19 -30.07 48.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.918 -1.114 . . . . 0.0 109.753 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -90.73 -54.01 4.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 111.297 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HE ' ' CB ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -112.52 -0.31 15.27 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.256 -0.903 . . . . 0.0 111.1 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 96' ' ' ALA . 43.1 ttt85 57.08 103.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.949 -1.095 . . . . 0.0 108.991 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.435 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 70.1 mt-30 -137.38 134.04 35.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.277 -0.889 . . . . 0.0 109.708 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -90.64 152.77 20.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -46.76 -30.89 2.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.197 -0.94 . . . . 0.0 109.583 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -57.96 -40.31 93.09 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.435 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 51.0 mt-30 -48.17 -17.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.241 . . . . 0.0 109.359 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.2 t -82.78 163.97 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 108.949 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 m -72.13 -25.55 61.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.14 78.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.11 164.71 25.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -1.109 . . . . 0.0 109.145 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 22.7 p90 -154.4 143.82 21.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.92 -1.113 . . . . 0.0 110.477 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 43.1 mt -108.43 154.16 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' NH2' HG12 ' A' ' 122' ' ' VAL . 52.0 ttt85 -139.94 160.8 39.1 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.999 -1.063 . . . . 0.0 109.731 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.9 tt -155.11 116.69 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.529 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.591 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -128.46 144.51 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 109.755 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 119' ' ' GLN . 53.8 t30 -76.37 102.12 5.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.22 -1.87 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.383 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 18.2 t70 -81.66 -53.23 6.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.22 4.22 9.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.771 -0.58 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 115' ' ' ASN . 20.0 tp60 59.5 60.41 2.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 53.9 m -113.46 -68.64 0.91 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.951 -0.468 . . . . 0.0 110.299 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.861 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.8 mm-40 -45.2 157.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 110.029 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -179.28 73.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.85 151.55 52.0 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.3 ptp180 -139.21 142.48 37.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -91.4 147.77 22.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.167 -0.958 . . . . 0.0 109.314 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -85.96 106.19 16.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -80.33 -46.78 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.5 m -47.83 -27.96 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.264 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -91.81 -54.57 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.59 0.84 9.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.96 -47.18 81.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 p -73.26 3.09 6.19 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.502 -0.749 . . . . 0.0 109.976 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.2 m -87.96 -34.61 18.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 0.0 110.478 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -175.65 -163.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.789 -1.194 . . . . 0.0 109.857 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.5 p -125.58 -8.73 6.82 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.14 27.81 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.5 ptm -165.46 157.9 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.04 -1.037 . . . . 0.0 109.951 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -96.76 137.29 36.07 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 109.436 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.0 t80 -79.69 -42.12 25.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.077 -1.015 . . . . 0.0 109.958 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.57 -166.29 15.48 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.532 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 10.1 tt0 -150.82 160.66 43.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -1.012 . . . . 0.0 109.292 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.422 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.0 mt -142.81 137.52 29.73 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.44 165.75 29.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -95.6 144.41 26.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.465 -0.772 . . . . 0.0 109.687 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 20.0 t-80 -125.49 -117.16 0.28 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.62 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 53.0 t30 -72.54 58.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.968 . . . . 0.0 109.407 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.31 10.49 66.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -127.74 141.46 51.59 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.933 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.0 m95 -71.37 152.03 43.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -148.52 131.39 16.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.561 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.1 t80 -89.7 149.64 22.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.509 -0.744 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 21.6 tpt85 -154.39 107.26 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 109.025 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.508 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -63.75 154.75 32.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.42 -33.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.435 -0.791 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.24 82.14 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -135.74 104.37 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.588 -0.948 . . . . 0.0 109.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.47 151.34 36.13 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -145.78 133.77 21.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.358 -1.084 . . . . 0.0 109.213 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.28 11.65 29.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.98 -27.47 6.68 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 83.6 139.5 3.86 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.63 -12.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -1.132 . . . . 0.0 109.719 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.664 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -77.81 -57.59 3.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 109.515 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 m -80.72 -41.83 22.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.01 -21.32 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -73.97 -60.37 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.616 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -26.42 23.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.195 -0.94 . . . . 0.0 110.443 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 169' ' ' TYR . 1.3 tm0? -51.32 -35.34 37.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 109.813 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 24.6 m-85 -85.73 13.26 7.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.504 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -80.24 115.88 20.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.89 -23.15 18.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -146.31 152.33 38.97 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.301 -0.874 . . . . 0.0 109.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 t -146.16 158.52 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.8 tp -147.69 107.65 4.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.851 . . . . 0.0 109.022 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -86.11 150.77 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.92 116.93 1.39 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.9 tp -110.88 126.83 55.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -142.21 145.48 15.73 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -158.49 151.24 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 110.031 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -91.2 128.23 36.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.635 -0.666 . . . . 0.0 109.712 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.18 31.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -79.65 106.96 12.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 p -84.91 124.62 31.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -155.93 -39.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.265 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.51 25.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.0 109.073 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.65 6.69 63.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -77.54 163.99 25.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -170.31 146.82 2.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -96.24 150.12 20.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.95 104.48 4.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.912 . . . . 0.0 109.64 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.36 151.38 25.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 108.783 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.36 106.56 17.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 109.879 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.5 125.68 45.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 108.757 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 43' ' ' ILE . 5.7 t -149.43 167.62 25.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.941 -1.099 . . . . 0.0 109.913 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.38 136.53 49.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -104.02 127.96 51.58 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.77 142.0 30.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.373 -0.83 . . . . 0.0 109.998 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.57 131.62 20.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -0.935 . . . . 0.0 109.835 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.36 175.11 10.06 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.12 1.56 43.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.289 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -83.09 -9.84 59.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 109.504 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.7 -5.05 69.52 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -109.71 150.37 28.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' GLY . 26.9 m -65.97 136.53 26.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -71.02 5.35 2.09 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ALA . . . -158.77 118.59 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -47.68 -10.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -1.113 . . . . 0.0 110.338 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLY . . . -95.7 -40.21 9.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.012 . . . . 0.0 109.82 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.5 t0 47.57 14.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 109.294 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 62.6 t80 -137.2 100.39 4.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 109.654 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 26' ' ' SER . 8.9 pt -103.48 139.57 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.558 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.2 p90 -153.22 -153.98 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.294 -0.879 . . . . 0.0 109.686 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.0 OUTLIER -43.43 -36.24 1.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.064 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.45 -1.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 108.946 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 47.3 t30 -149.57 103.97 3.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.137 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.21 -28.57 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttm -165.18 160.12 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 t -69.86 147.92 49.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.264 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.81 -48.52 14.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -116.2 1.64 13.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.661 -0.649 . . . . 0.0 109.587 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 -12.71 69.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 60.78 11.99 3.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.36 -1.082 . . . . 0.0 109.42 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.07 150.27 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.249 -0.907 . . . . 0.0 108.93 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.9 m -148.77 138.08 21.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.12 -0.987 . . . . 0.0 110.0 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.43 ' NE2' HD11 ' A' ' 73' ' ' LEU . 31.9 m80 -90.06 127.91 36.17 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -67.12 -56.91 7.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.57 111.11 0.47 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.4 110.88 12.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -81.92 -164.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -156.15 16.48 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 p -154.64 -37.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 109.325 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 16.43 79.41 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -58.47 111.14 1.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -1.136 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.21 -145.19 10.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -160.01 57.56 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -1.142 . . . . 0.0 109.391 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.12 -176.3 48.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.63 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -1.169 . . . . 0.0 109.495 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -73.28 -63.86 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.22 171.68 9.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.4 132.26 6.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.326 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -116.37 119.41 35.59 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -95.69 135.88 36.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 108.736 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.51 146.93 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.75 . . . . 0.0 110.358 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.28 87.62 2.35 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 79' ' ' ALA . 21.9 mt -67.94 -34.52 76.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.869 . . . . 0.0 109.751 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -55.28 -5.71 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.582 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -119.27 20.65 12.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' PRO . 48.0 t -105.41 104.98 50.6 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.327 -0.858 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.25 -171.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.055 1.837 . . . . 0.0 112.353 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 1.08 89.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.02 -55.95 15.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -1.105 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 83.5 t -84.39 148.59 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 0.0 108.977 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 45.3 m-20 -136.61 -5.27 2.0 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.359 -0.838 . . . . 0.0 110.136 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -145.25 131.17 19.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.949 -1.094 . . . . 0.0 109.423 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.1 mt -141.49 108.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 141' ' ' GLU . 10.8 pt -116.23 154.86 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 109.627 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -96.45 159.1 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 109.202 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 28' ' ' PHE . 60.3 t -147.23 152.28 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.746 0.784 . . . . 0.0 110.651 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.6 t -148.01 115.84 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 p -132.85 174.45 10.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.54 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 6.0 mm -86.53 143.25 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -100.4 -68.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.327 -0.858 . . . . 0.0 110.044 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -18.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.248 -0.908 . . . . 0.0 110.06 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.54 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -46.43 -26.96 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -53.98 -50.41 66.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 109.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.12 -39.48 12.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.42 -0.8 . . . . 0.0 110.984 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -96.99 -19.49 18.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.057 -1.027 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.6 mmt180 50.94 58.2 5.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.637 -1.289 . . . . 0.0 109.169 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.37 148.45 25.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.3 p -98.15 159.39 14.97 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.743 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -45.88 -33.94 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.658 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.16 -36.84 90.42 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -47.53 -19.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -1.21 . . . . 0.0 109.328 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 107' ' ' SER . 18.6 t -85.93 168.12 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.131 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -69.3 -23.91 63.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.21 79.98 0.03 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.75 25.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 109.817 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.8 p90 -153.33 143.51 22.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.099 -1.0 . . . . 0.0 110.257 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.8 mt -107.02 154.7 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.39 159.83 41.24 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.7 tt -154.23 116.54 4.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.097 -1.002 . . . . 0.0 109.482 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.572 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.0 p -129.65 143.3 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.436 ' HB2' ' H ' ' A' ' 120' ' ' THR . 78.8 m-20 -75.33 102.12 4.98 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -64.73 -1.85 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.561 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.1 -53.7 5.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 109.72 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.71 6.55 8.8 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.67 -0.644 . . . . 0.0 109.724 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 59.03 59.7 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 12.5 m -111.21 -69.91 0.84 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.866 -0.521 . . . . 0.0 110.309 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 51.0 mm-40 -45.26 157.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.0 109.893 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.58 72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.0 152.22 51.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.067 -1.021 . . . . 0.0 109.992 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 30.3 ptt180 -140.79 144.36 35.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -91.32 147.63 22.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 103.39 16.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.3 mt -80.44 -40.7 25.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.298 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.85 -29.58 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -95.26 -54.66 3.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.434 -0.791 . . . . 0.0 109.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.11 -1.35 25.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.85 -44.71 66.98 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.294 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -72.7 3.09 5.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.56 -0.713 . . . . 0.0 109.984 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.4 m -83.02 -34.39 26.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 0.0 110.283 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.75 -164.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.952 -1.093 . . . . 0.0 109.729 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 102' ' ' SER . 1.1 p -124.81 -5.71 7.46 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.76 135.31 23.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.36 150.67 9.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.8 pp -91.55 136.0 33.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.79 -49.4 46.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.035 -1.041 . . . . 0.0 109.938 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -153.35 -155.56 7.21 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.293 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 88' ' ' ILE . 14.7 tt0 -150.64 157.73 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.459 -1.024 . . . . 0.0 109.347 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.74 135.74 28.23 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -150.82 166.8 29.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.931 -1.106 . . . . 0.0 110.275 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 11.5 ptm180 -86.95 147.07 25.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.779 . . . . 0.0 109.503 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.5 OUTLIER -129.54 -114.88 0.25 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.693 . . . . 0.0 109.259 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.537 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.2 m120 -72.67 58.42 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.963 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 71.44 7.25 63.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -127.92 154.18 45.84 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.668 -0.901 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -75.74 151.49 37.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -145.35 127.83 16.0 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.16 -0.962 . . . . 0.0 109.712 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -89.99 148.25 23.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.54 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -157.32 107.37 2.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.78 153.72 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.04 -32.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.78 85.92 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -139.14 104.48 5.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.559 -0.965 . . . . 0.0 109.548 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.0 154.79 35.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -150.08 124.17 9.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.404 -1.056 . . . . 0.0 109.123 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.69 15.09 6.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.32 -0.862 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.06 -76.56 0.15 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.21 126.18 0.82 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.481 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.01 -29.21 1.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -1.126 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.97 -32.6 21.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 166' ' ' CYS . 19.9 m -80.28 -50.35 10.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.73 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 m -45.76 -19.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.341 -0.849 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 78.0 m -70.94 -62.0 1.55 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.25 -15.38 38.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.108 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.68 -34.99 71.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.003 -1.06 . . . . 0.0 110.365 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -70.75 -19.59 62.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.153 . . . . 0.0 109.206 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -92.49 -47.94 3.12 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.88 94.47 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -1.148 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.501 ' H ' HD22 ' A' ' 172' ' ' ASN . 2.4 p30 -78.11 116.24 18.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.39 110.25 15.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.459 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.286 0.565 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.6 mtt -80.91 -173.67 4.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -153.15 -34.67 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.686 HD22 ' H ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -140.57 139.39 34.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.0 109.279 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.686 ' H ' HD22 ' A' ' 4' ' ' ASN . 3.8 t -144.46 130.64 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.21 109.76 17.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.71 144.73 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.145 -0.972 . . . . 0.0 108.727 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -129.98 129.94 6.11 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tt -134.87 126.81 29.49 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -144.01 151.11 23.12 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 27.5 p90 -155.73 154.7 31.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.367 -1.079 . . . . 0.0 109.738 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.8 99.62 11.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 165.96 24.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -132.88 106.85 7.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.442 -0.786 . . . . 0.0 109.217 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -86.96 105.61 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 p -88.16 -61.74 1.65 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 109.179 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -158.12 17.74 0.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 109.476 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.73 -26.55 0.94 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -82.31 142.65 31.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 109.601 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -157.71 153.66 26.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 109.353 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.28 134.43 39.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -141.11 100.06 3.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.0 109.712 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 136.48 34.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.888 . . . . 0.0 108.633 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.66 110.58 22.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.186 -0.947 . . . . 0.0 110.005 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 128.83 44.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.252 -0.905 . . . . 0.0 108.859 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 57' ' ' HIS . 58.5 m -150.25 167.8 25.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.046 -1.034 . . . . 0.0 110.37 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 136.62 48.81 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.8 m-85 -103.48 145.34 30.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -116.9 153.83 31.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.75 143.31 36.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -81.4 176.59 9.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB2' ' CG ' ' A' ' 85' ' ' ASP . . . -84.43 -13.24 52.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -0.906 . . . . 0.0 109.86 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -84.42 7.95 17.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 109.867 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 -14.8 61.88 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 37.6 mmtm -102.81 176.18 5.24 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 38' ' ' GLY . 21.4 t -101.11 137.07 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -62.76 1.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -151.04 124.38 1.69 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.51 3.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -1.167 . . . . 0.0 110.156 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -97.78 -41.97 7.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.04 -1.037 . . . . 0.0 109.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 10.6 t0 46.92 14.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 109.442 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 14.0 t80 -136.9 99.07 3.92 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 0.0 109.368 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 pt -101.97 133.17 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.437 -0.79 . . . . 0.0 108.942 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.7 p90 -142.14 -161.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.259 -0.9 . . . . 0.0 109.278 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 21.7 p90 -44.65 -27.51 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.224 -0.923 . . . . 0.0 110.372 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.4 t30 -57.93 -8.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.999 -1.063 . . . . 0.0 108.96 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 45.0 t-20 -139.06 109.42 6.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.798 . . . . 0.0 108.966 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -47.37 -31.51 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.89 . . . . 0.0 109.183 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.8 pttt -168.52 155.01 7.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.442 -0.786 . . . . 0.0 109.39 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 33.3 t -60.82 147.88 41.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.38 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.36 -47.88 16.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -116.16 0.91 13.07 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.736 -0.602 . . . . 0.0 109.516 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.66 -12.01 65.1 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t 58.44 14.92 3.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.232 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.4 t -92.97 151.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.404 ' O ' HD23 ' A' ' 73' ' ' LEU . 76.1 m -148.84 134.62 18.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.0 109.811 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 73' ' ' LEU . 23.0 m80 -90.57 139.57 30.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.393 -0.817 . . . . 0.0 109.072 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 m -76.84 -55.55 5.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.44 117.28 0.66 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.91 113.62 18.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -1.148 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.03 132.95 35.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -81.75 7.97 11.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.69 -35.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.17 16.16 57.44 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.5 110.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -1.124 . . . . 0.0 109.344 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.21 156.78 7.22 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.6 p30 -85.14 -171.97 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -1.17 . . . . 0.0 109.477 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.14 -175.44 19.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.4 111.36 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -1.149 . . . . 0.0 109.515 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.55 -63.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -87.92 159.29 18.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.344 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.6 m -152.51 132.4 13.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.214 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -117.15 123.95 47.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -95.87 136.19 36.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.275 -0.89 . . . . 0.0 108.853 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.52 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 87.4 mt -133.39 146.99 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.086 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.25 90.36 2.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 79' ' ' ALA . 13.8 mt -72.41 -25.27 61.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -66.4 4.74 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -137.08 24.91 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 81' ' ' PRO . 38.1 t -103.93 105.54 48.8 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.451 -0.78 . . . . 0.0 109.198 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . 73.2 Cg_exo -48.06 -175.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.026 1.817 . . . . 0.0 112.335 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.84 85.92 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.27 -50.81 72.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -1.204 . . . . 0.0 109.243 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 84' ' ' VAL . 5.2 m -95.55 139.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 109.076 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' A' ' 32' ' ' ALA . 3.4 m-20 -116.86 2.41 12.82 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.57 -0.706 . . . . 0.0 109.819 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -158.14 132.68 8.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.041 . . . . 0.0 109.777 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.7 mt -141.17 117.79 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.2 157.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 109.596 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 75' ' ' ILE . 4.6 m-85 -105.9 137.41 43.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 28' ' ' PHE . 1.2 p -147.01 157.46 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.521 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 3.5 p -129.26 147.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 p -140.15 140.71 36.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -73.82 132.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.826 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 97' ' ' GLN . 83.8 t60 -89.95 -63.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.136 -0.977 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.22 -18.22 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.92 -18.26 43.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 38.1 mt-30 -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.734 -1.229 . . . . 0.0 109.412 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.46 -44.42 9.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 0.0 111.047 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -81.72 -17.79 46.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.05 -1.031 . . . . 0.0 111.402 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 52.34 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.854 -1.154 . . . . 0.0 109.077 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -148.13 143.5 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.328 -0.857 . . . . 0.0 109.132 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -99.85 165.38 11.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.284 -0.885 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -46.22 -32.22 2.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.321 -0.862 . . . . 0.0 109.785 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -38.69 96.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -49.87 -17.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.3 . . . . 0.0 109.296 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 107' ' ' SER . 15.9 t -84.92 163.82 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 109.127 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -62.08 -26.79 68.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.597 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.1 79.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 164.37 25.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -1.146 . . . . 0.0 109.74 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 37.0 p90 -151.29 170.02 20.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.301 -0.875 . . . . 0.0 110.018 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 24.7 mt -132.66 154.93 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 72.6 ttt180 -143.38 162.48 35.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.968 -1.083 . . . . 0.0 109.718 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.3 tt -157.67 117.97 3.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 0.0 109.771 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.609 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.1 p -132.03 142.81 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.359 -0.838 . . . . 0.0 109.586 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.84 102.27 8.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 5.5 t70 -68.03 -1.78 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -76.5 -52.12 10.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 4.5 t-20 -122.02 -14.12 8.07 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.677 -0.639 . . . . 0.0 109.608 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 5.0 tt0 71.67 69.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.6 m -134.39 -43.71 0.77 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.722 -0.611 . . . . 0.0 109.807 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.876 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.7 mp0 -65.79 158.25 28.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 108.781 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 174.21 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.92 51.73 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.751 . . . . 0.0 109.201 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.0 ptt180 -134.08 142.07 47.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.607 -0.683 . . . . 0.0 109.474 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.8 t80 -91.43 147.35 23.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.371 -0.831 . . . . 0.0 108.916 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.77 102.83 15.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 109.394 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 50.5 mt -79.65 -39.19 31.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.6 p -47.56 -30.51 3.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.018 -1.051 . . . . 0.0 109.286 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -95.23 -54.59 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -0.825 . . . . 0.0 109.75 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 53.9 m-20 -74.77 -0.73 19.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.7 -46.5 74.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.085 -1.01 . . . . 0.0 109.321 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.2 t -69.23 2.99 2.42 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.548 -0.72 . . . . 0.0 109.882 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 m -82.96 -34.57 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.9 -162.91 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.001 -1.062 . . . . 0.0 109.582 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -15.25 7.56 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.35 137.37 35.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.6 ttp -164.89 152.05 11.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.872 -1.142 . . . . 0.0 110.144 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.596 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.7 pt? -87.96 135.43 33.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -77.81 -26.4 49.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.922 -1.111 . . . . 0.0 109.304 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.69 -164.23 21.91 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -150.53 154.22 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.988 . . . . 0.0 108.74 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 134.81 24.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.038 -1.039 . . . . 0.0 108.86 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -147.47 166.01 28.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 109.717 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.57 148.48 24.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -152.3 123.73 7.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER 55.72 24.8 7.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.91 13.18 80.05 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -127.82 137.48 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -1.015 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -67.69 151.19 47.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -148.61 121.98 9.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.148 -0.97 . . . . 0.0 109.726 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 17.6 t80 -89.94 143.77 26.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.497 -0.752 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.32 107.43 3.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 109.026 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.36 154.79 10.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.0 109.776 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.8 t -139.42 -34.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.373 -0.829 . . . . 0.0 109.05 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.41 81.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.551 ' H ' HD21 ' A' ' 138' ' ' LEU . 34.7 tt0 -141.35 104.14 4.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.057 . . . . 0.0 109.041 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.0 150.5 27.73 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.7 137.77 38.69 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.606 -0.937 . . . . 0.0 108.782 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.51 13.86 24.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.217 -0.927 . . . . 0.0 109.519 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.88 -68.35 1.34 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.06 131.59 1.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.7 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.23 -30.27 1.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -1.116 . . . . 0.0 109.87 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.7 -25.18 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' GLY . 53.6 p -77.34 -55.4 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.471 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.6 m -46.97 -20.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 80.0 m -71.47 -60.91 1.98 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.03 -19.64 28.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.28 -0.888 . . . . 0.0 110.141 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -55.21 -42.19 73.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 109.726 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -71.47 -19.86 62.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.355 -0.841 . . . . 0.0 109.178 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.31 -53.71 3.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.08 90.34 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -1.154 . . . . 0.0 109.281 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.24 106.12 8.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 109.455 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 10.02 5.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.51 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 149' ' ' TRP . 73.2 m . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -74.19 -169.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -153.9 -34.58 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.193 -0.942 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' OD1' ' A' ' 116' ' ' ASP . 31.4 t30 -143.63 128.22 18.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.944 . . . . 0.0 109.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.413 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.6 t -124.64 158.54 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.626 -0.671 . . . . 0.0 109.479 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.21 112.95 6.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -89.94 150.55 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 108.981 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.35 116.76 1.34 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.61 135.46 42.02 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.92 138.07 8.09 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -160.33 153.7 22.08 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.4 111.24 23.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.548 -0.72 . . . . 0.0 109.347 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.07 43.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.33 106.81 17.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 p -93.9 128.96 40.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -156.2 -76.19 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 108.855 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.8 21.5 3.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.04 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.19 0.67 80.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -84.85 178.37 7.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.118 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.14 165.44 2.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 68.4 m-85 -96.31 150.9 20.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -141.07 99.67 3.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.865 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.63 132.78 35.56 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -95.85 111.06 23.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.096 -1.002 . . . . 0.0 110.092 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.36 125.34 43.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.414 -0.804 . . . . 0.0 108.893 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -149.81 167.77 25.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.05 . . . . 0.0 109.844 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.0 142.25 41.66 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.5 m-85 -103.9 148.28 26.35 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -120.18 154.11 35.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.568 -0.708 . . . . 0.0 109.987 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 139.54 27.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.102 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.86 176.42 7.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.097 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.38 -9.44 58.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.179 -0.95 . . . . 0.0 109.763 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.39 8.29 31.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.136 -0.977 . . . . 0.0 109.919 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.01 -11.18 70.1 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 66.7 mmtt -104.18 170.1 8.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.8 t -98.42 137.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.12 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.3 ttt-85 -64.69 1.94 0.76 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -153.93 125.21 1.7 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 4.42 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -1.148 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.59 -41.5 8.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.97 -1.081 . . . . 0.0 110.028 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 12.2 t0 47.72 13.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.857 -1.152 . . . . 0.0 109.43 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 72.4 t80 -136.89 99.39 4.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -0.8 . . . . 0.0 109.642 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.3 pt -99.7 139.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.6 p90 -154.22 -155.93 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.843 . . . . 0.0 109.596 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' ASN . 3.8 m-85 -43.54 -34.29 1.35 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.544 -0.723 . . . . 0.0 110.138 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -58.28 -2.16 0.17 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.096 -1.002 . . . . 0.0 108.827 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 45' ' ' TYR . 43.5 t-20 -148.72 113.76 5.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 109.27 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -50.64 -38.49 46.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 108.945 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 36.0 pttt -161.87 157.67 24.31 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.334 -0.854 . . . . 0.0 109.372 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 t -63.21 144.57 56.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -47.12 17.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -116.31 2.02 13.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.715 -0.615 . . . . 0.0 109.67 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.7 -17.97 57.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 2.9 p 67.22 7.97 5.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.366 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -93.11 149.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 m -148.86 138.98 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.227 -0.92 . . . . 0.0 109.496 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 44.1 m80 -89.88 139.83 30.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -142.61 40.57 1.56 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 109.343 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.38 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.2 124.28 34.72 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -1.058 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.7 m120 -153.53 93.03 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -73.88 14.52 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 61' ' ' ASN . 52.6 p -147.59 -35.29 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.887 . . . . 0.0 109.303 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.45 13.25 29.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.46 110.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -1.113 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.07 -126.35 1.65 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -159.29 170.57 21.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.48 172.29 2.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.73 122.01 5.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -82.01 -70.43 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.33 177.0 7.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.2 m -159.98 132.44 6.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -119.44 125.15 48.26 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -95.9 139.35 32.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 108.837 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.506 HD13 ' CE1' ' A' ' 89' ' ' PHE . 69.3 mt -132.22 146.61 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.5 mttm -141.22 101.32 3.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.68 -5.41 53.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.13 -20.46 32.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.569 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.74 7.99 43.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.15 123.95 84.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.203 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.51 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.923 1.749 . . . . 0.0 112.054 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.82 2.24 76.1 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -69.94 -60.63 2.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -1.199 . . . . 0.0 109.219 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.97 148.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.003 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.7 15.99 3.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.245 -0.909 . . . . 0.0 109.693 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' NZ ' ' OE2' ' A' ' 141' ' ' GLU . 50.6 tttp -158.37 135.21 9.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.995 . . . . 0.0 109.589 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.2 mt -133.65 154.14 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.93 173.47 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 108.913 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.7 m-85 -142.1 123.38 14.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.71 157.9 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.257 -0.902 . . . . 0.0 110.352 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -131.24 115.53 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -107.11 153.24 22.93 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.39 -0.819 . . . . 0.0 110.242 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.7 mm -73.84 167.41 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.625 ' N ' HG22 ' A' ' 93' ' ' ILE . 46.7 t-80 -133.69 -60.81 0.82 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.385 -0.822 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -49.28 -18.27 0.34 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.972 . . . . 0.0 109.586 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.74 -40.02 90.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.81 -32.6 44.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.776 -1.202 . . . . 0.0 109.698 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.91 -54.03 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.124 -0.985 . . . . 0.0 111.352 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.49 4.09 17.21 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.294 -0.879 . . . . 0.0 111.16 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' ALA . 51.7 ttt180 57.56 106.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 109.301 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.44 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 34.7 mt-30 -151.34 145.34 25.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 109.671 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.8 p -104.95 163.59 12.42 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.447 -0.783 . . . . 0.0 109.55 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -46.15 -36.38 5.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 109.859 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.655 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.92 -41.43 96.23 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 57.8 mm-40 -49.43 -14.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.28 . . . . 0.0 109.267 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 107' ' ' SER . 21.9 t -83.59 165.4 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.049 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 t -69.0 -20.15 64.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.11 79.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.37 163.46 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.129 . . . . 0.0 109.821 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 18.3 p90 -157.85 158.75 35.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.872 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.8 mt -118.88 157.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -138.11 159.35 42.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.059 -1.026 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.9 tt -152.9 115.31 4.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.573 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.86 142.11 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.395 -0.816 . . . . 0.0 109.857 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLN . 57.9 t30 -79.49 101.82 8.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.53 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 5.7 t70 -69.34 -4.89 20.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.728 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.545 ' C ' HD22 ' A' ' 118' ' ' ASN . 13.7 t0 -70.91 -53.2 15.89 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.813 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.545 HD22 ' C ' ' A' ' 117' ' ' ASP . 1.4 m-80 -123.38 0.78 8.95 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 115' ' ' ASN . 26.1 tt0 62.93 64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.4 m -118.06 -69.9 0.82 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.924 -0.485 . . . . 0.0 110.304 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.854 ' O ' HG13 ' A' ' 122' ' ' VAL . 14.9 mm-40 -45.29 157.04 0.09 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.311 -0.868 . . . . 0.0 109.876 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.84 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.19 154.47 50.6 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.012 -1.055 . . . . 0.0 110.025 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.2 ptm180 -139.32 149.24 43.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 109.193 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.05 147.32 22.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.188 -0.945 . . . . 0.0 109.135 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.4 103.13 15.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 0.0 109.399 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 64.3 mt -80.94 -40.49 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.935 . . . . 0.0 109.333 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 128' ' ' THR . 4.1 p -47.84 -31.06 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 109.189 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -95.2 -54.62 3.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -0.783 . . . . 0.0 109.753 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.96 -4.76 34.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.655 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.77 -45.95 67.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.132 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.5 p -69.14 3.01 2.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.647 -0.658 . . . . 0.0 109.845 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 m -83.18 -34.58 25.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 0.0 110.2 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 179.52 -163.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.93 -1.106 . . . . 0.0 109.592 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 -9.74 9.57 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.71 139.53 34.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.3 ttt -165.46 157.6 15.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.176 -0.953 . . . . 0.0 109.512 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.36 138.41 37.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 109.718 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 29.2 t80 -81.06 -43.98 18.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 109.611 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.82 -168.69 20.55 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.514 ' OE2' ' NZ ' ' A' ' 86' ' ' LYS . 29.2 tt0 -151.32 163.53 38.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -1.1 . . . . 0.0 109.408 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.92 140.73 29.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.17 -0.956 . . . . 0.0 108.661 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.45 ' OH ' ' CZ ' ' A' ' 152' ' ' ARG . 4.7 p90 -150.59 166.02 31.56 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.116 -0.99 . . . . 0.0 109.703 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -85.3 151.48 24.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.563 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -157.72 123.95 4.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 0.4 OUTLIER 55.97 24.15 7.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.366 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.12 10.55 83.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -127.8 138.98 52.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.598 -0.943 . . . . 0.0 109.339 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.454 ' O ' ' N ' ' A' ' 1' ' ' SER . 83.5 m95 -67.67 151.6 47.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.519 ' NZ ' HH21 ' A' ' 152' ' ' ARG . 80.3 tttt -150.72 123.2 8.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -89.47 138.87 31.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.519 HH21 ' NZ ' ' A' ' 150' ' ' LYS . 86.0 mtt180 -143.67 107.35 4.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.26 154.68 39.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.1 t -139.8 -33.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.78 86.15 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -137.95 104.76 5.35 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.982 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 152.94 39.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' CE1' HG11 ' A' ' 165' ' ' VAL . 2.0 p90 -147.45 125.27 11.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.197 -1.178 . . . . 0.0 109.33 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.36 11.7 25.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.196 -0.94 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -65.75 2.23 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.37 126.99 0.94 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.77 -33.03 4.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 109.82 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.65 -26.03 26.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 109.335 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.9 t -74.37 -54.31 7.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.5 m -47.94 -20.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 109.438 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.9 m -71.44 -60.65 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.142 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -15.46 38.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.188 -0.945 . . . . 0.0 110.393 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.64 -44.23 87.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.941 -1.099 . . . . 0.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -71.49 -0.2 9.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -149.41 34.09 1.08 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 tt -75.17 159.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.47 127.88 33.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 74.27 7.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.482 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.6 p . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.484 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.99 174.81 11.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -153.23 -34.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.472 HD22 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -145.94 143.49 29.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.093 -1.004 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -145.94 133.09 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.381 -0.824 . . . . 0.0 109.226 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 73' ' ' LEU . 13.8 tp -116.79 109.78 17.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.88 151.0 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.04 117.08 1.33 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -108.12 133.24 52.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.9 140.71 8.61 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -158.04 152.96 25.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -1.112 . . . . 0.0 109.984 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.72 130.55 39.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.735 . . . . 0.0 109.597 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.29 133.88 35.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.314 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -79.12 106.85 11.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -90.34 127.57 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -156.24 -36.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.07 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -149.85 22.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 108.977 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.93 2.76 62.46 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -80.63 151.81 28.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -1.144 . . . . 0.0 109.384 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -157.45 151.65 24.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.14 151.17 19.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.325 -0.859 . . . . 0.0 109.282 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -141.02 99.77 3.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.285 -0.884 . . . . 0.0 109.676 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.28 142.64 30.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 108.625 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.52 112.71 25.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.376 -0.827 . . . . 0.0 109.563 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 130.12 44.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.1 m -149.58 163.06 38.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.089 -1.007 . . . . 0.0 109.937 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 146.08 36.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.5 m-85 -104.24 161.55 13.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.894 . . . . 0.0 109.415 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -129.06 139.16 52.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.661 -0.65 . . . . 0.0 109.478 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 133.46 22.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.05 176.41 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -81.21 -8.94 59.85 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.676 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -83.27 1.6 40.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.157 -0.965 . . . . 0.0 109.736 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.17 58.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -98.29 144.57 27.56 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 38' ' ' GLY . 22.4 t -66.39 136.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.067 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.02 13.44 0.68 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -159.89 173.15 36.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -94.52 -1.74 52.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.052 -1.264 . . . . 0.0 110.289 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.08 -42.08 5.89 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.196 -0.94 . . . . 0.0 110.059 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 26.9 t0 61.47 -1.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 110.094 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -138.59 124.31 19.74 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.166 -0.959 . . . . 0.0 110.009 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 pt -102.58 139.57 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.62 ' CE1' ' CZ ' ' A' ' 42' ' ' PHE . 1.3 p90 -138.11 -161.67 1.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.258 -0.901 . . . . 0.0 109.386 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 22.8 p90 -44.23 -30.49 0.8 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.162 -0.961 . . . . 0.0 110.437 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 2.4 t30 -51.1 -16.95 0.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 109.081 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.5 t-20 -135.03 104.06 5.8 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.525 -0.735 . . . . 0.0 109.071 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.98 -24.69 1.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.6 pttt -167.45 155.07 8.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.345 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.1 t -77.23 122.46 25.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.06 62.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.962 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -112.91 -19.0 12.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.57 -13.55 75.62 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.5 p 62.85 10.27 4.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -1.118 . . . . 0.0 109.393 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' A' ' 50' ' ' SER . 43.2 t -92.79 151.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -148.72 142.49 25.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.154 -0.966 . . . . 0.0 110.046 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 73' ' ' LEU . 7.4 m80 -91.83 126.41 36.9 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 25.5 m -74.48 -29.54 61.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.38 110.82 0.25 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.86 110.98 18.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -81.67 -163.56 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' THR . 28.6 ttm180 -152.16 14.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 109.268 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 62' ' ' ARG . 34.4 p -154.87 -37.73 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.86 4.1 65.79 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.57 110.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.421 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.15 -125.63 1.57 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -165.48 160.6 18.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.05 177.59 47.91 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.99 101.97 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -1.155 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -55.25 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -89.27 167.5 13.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.19 -0.944 . . . . 0.0 109.346 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.418 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.5 p -160.48 132.86 6.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.6 mp -113.18 128.29 56.44 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.504 -0.747 . . . . 0.0 109.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HZ1' ' HE2' ' A' ' 76' ' ' LYS . 1.8 tmtp? -96.36 110.51 22.83 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.93 146.88 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.349 -0.844 . . . . 0.0 110.596 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HE2' ' HZ1' ' A' ' 74' ' ' LYS . 86.3 mttt -136.49 94.42 3.01 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.52 -11.57 59.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.93 . . . . 0.0 109.616 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.41 4.7 23.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.35 10.73 7.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.449 -0.782 . . . . 0.0 109.322 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.4 t -81.3 125.77 78.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 109.022 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.14 -162.23 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.841 1.694 . . . . 0.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.38 -0.12 82.75 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.86 -60.69 2.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -1.172 . . . . 0.0 109.44 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.6 t -89.93 148.65 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 144' ' ' ARG . 41.3 m-20 -139.35 1.96 2.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 109.659 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -150.92 131.48 13.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.186 -0.946 . . . . 0.0 109.006 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.8 mt -130.99 154.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.503 -0.748 . . . . 0.0 109.31 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -139.86 173.93 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 17.1 m-85 -141.55 122.06 14.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.63 157.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.4 p -134.14 114.31 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -107.82 151.95 25.05 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.331 -0.855 . . . . 0.0 109.924 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.36 140.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 108.799 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -62.34 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.076 -1.015 . . . . 0.0 109.877 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -47.6 -20.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 109.569 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.6 -18.28 28.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 109.777 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -64.75 -60.79 2.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.687 -1.258 . . . . 0.0 109.255 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.44 11.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.46 -0.775 . . . . 0.0 111.024 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -86.16 -19.58 29.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.944 -1.097 . . . . 0.0 111.379 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 55.33 96.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.759 -1.213 . . . . 0.0 109.275 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -158.74 152.54 23.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.491 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 m -105.15 154.65 19.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.457 -0.777 . . . . 0.0 109.241 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.6 -29.89 0.81 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.429 -0.794 . . . . 0.0 109.727 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.67 -37.39 50.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -58.96 -14.18 8.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 109.345 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 107' ' ' SER . 27.9 t -80.32 165.81 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.866 . . . . 0.0 109.131 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.506 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.7 t -68.15 -25.89 65.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.94 . . . . 0.0 109.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.12 79.89 0.03 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.45 26.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 13.5 p90 -152.69 142.92 22.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.07 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 48.0 mt -107.49 156.73 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -140.46 161.1 38.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.966 -1.083 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.4 tt -157.35 117.52 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.055 -1.028 . . . . 0.0 109.756 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.605 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -129.54 143.98 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.366 -0.833 . . . . 0.0 109.522 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -74.78 101.69 4.42 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.93 -1.83 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.056 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.472 ' CB ' HD22 ' A' ' 4' ' ' ASN . 29.0 t0 -82.57 -52.74 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -122.52 -5.97 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.652 . . . . 0.0 109.851 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 65.81 65.77 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.5 p -123.81 -49.1 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.931 -0.481 . . . . 0.0 109.998 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 54.6 mm-40 -62.94 159.05 17.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.288 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 177.53 75.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.92 52.28 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.424 -0.798 . . . . 0.0 109.508 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 32.4 ptt180 -136.16 141.16 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.693 . . . . 0.0 109.226 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -92.1 143.61 26.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.0 109.163 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -87.64 103.64 15.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.173 -0.955 . . . . 0.0 109.5 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.6 mt -80.57 -38.31 29.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.593 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.4 m -48.25 -33.62 8.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.863 -1.148 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -95.21 -51.12 4.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.406 -0.809 . . . . 0.0 109.747 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.55 -7.44 50.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.251 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.22 -49.99 75.45 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.009 -1.057 . . . . 0.0 109.825 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 p -55.88 0.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.451 -0.78 . . . . 0.0 110.509 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 131' ' ' ALA . 38.0 p -87.42 -33.12 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.746 -1.221 . . . . 0.0 110.081 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -172.34 -145.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.785 -1.197 . . . . 0.0 109.712 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 21.1 m -126.61 -40.23 1.94 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.18 155.97 26.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 ttt -166.81 157.59 12.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.16 -0.963 . . . . 0.0 109.829 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.81 126.8 50.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.328 -0.857 . . . . 0.0 109.337 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -70.07 -37.13 75.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.932 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.1 -163.39 24.06 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.851 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -151.54 164.09 37.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -1.069 . . . . 0.0 109.519 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.72 140.04 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.244 -0.91 . . . . 0.0 108.571 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.447 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.8 p90 -150.61 166.31 30.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.913 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 17.4 ptm180 -85.34 152.7 23.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.644 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.514 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 2.1 t60 -153.9 119.9 5.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.267 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 29.0 m-20 52.46 29.39 6.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 109.501 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.52 81.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -127.87 134.91 49.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.48 -1.012 . . . . 0.0 109.396 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.43 149.34 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -148.86 125.98 11.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.208 -0.932 . . . . 0.0 109.538 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -93.37 140.99 28.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 109.971 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -144.06 107.54 4.6 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.422 -0.799 . . . . 0.0 109.09 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.13 154.65 41.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.098 -1.001 . . . . 0.0 109.72 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.24 -33.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.81 85.82 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.308 -1.113 . . . . 0.0 109.572 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.56 154.03 46.75 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 165' ' ' VAL . 12.7 p90 -137.88 124.04 20.39 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.377 -1.072 . . . . 0.0 109.436 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.63 3.08 34.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.45 -75.09 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 156.39 136.59 2.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.7 pp -47.38 -36.97 10.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -1.172 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.86 -16.83 37.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.3 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 161' ' ' GLY . 34.5 m -78.82 -56.0 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 158' ' ' TYR . 14.4 m -51.62 -19.94 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 109.11 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 70.8 m -73.67 -63.02 1.29 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.469 -0.769 . . . . 0.0 110.352 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.28 35.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.849 . . . . 0.0 110.583 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -61.37 -48.74 79.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.064 -1.022 . . . . 0.0 110.26 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -71.74 -20.33 61.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.952 . . . . 0.0 109.464 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.62 -46.46 5.74 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.95 139.3 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.545 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -72.6 112.92 9.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.434 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.41 50.23 1.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.425 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.448 ' SD ' ' ND2' ' A' ' 115' ' ' ASN . 20.3 mmt -79.95 -176.29 5.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 82.7 mttt -151.73 -35.77 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 51.8 m-20 -145.09 143.77 30.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -140.81 158.14 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.343 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.6 tp -145.34 109.75 4.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.03 145.7 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.36 117.21 2.89 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.93 124.92 50.61 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.15 150.47 22.68 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.535 -1.317 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -157.04 153.98 28.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.412 -1.052 . . . . 0.0 109.804 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.69 130.05 34.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.762 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.85 133.38 33.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -86.33 109.26 18.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.532 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -82.85 124.46 30.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.456 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.6 m -154.19 -41.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.835 . . . . 0.0 109.301 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -149.44 28.13 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 109.047 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.2 -30.32 5.61 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -62.98 158.4 19.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.407 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -165.91 176.09 8.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 109.558 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 60.9 m-85 -96.41 146.79 24.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 12.1 m-20 -141.03 99.62 3.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -85.28 140.64 30.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 108.524 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -103.17 119.7 39.34 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.29 131.71 43.73 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.292 -0.88 . . . . 0.0 109.27 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -150.19 168.18 24.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.63 147.47 45.19 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 90' ' ' VAL . 4.3 m-85 -103.6 123.15 46.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.0 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.02 135.72 37.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 108.725 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.01 128.33 17.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.964 -1.085 . . . . 0.0 110.388 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 176.26 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.71 1.13 44.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -84.62 -7.44 59.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 -10.78 73.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -105.07 148.09 27.17 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 38' ' ' GLY . 44.3 t -66.39 137.25 25.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.91 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -70.79 7.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.691 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -154.04 172.66 32.7 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.94 -2.88 49.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.842 -1.387 . . . . 0.0 110.321 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.19 -40.85 6.27 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.09 -1.006 . . . . 0.0 110.982 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' HG11 ' A' ' 36' ' ' VAL . 35.7 t0 50.44 10.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.74 -1.225 . . . . 0.0 109.329 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ALA . 81.8 t80 -138.12 100.22 4.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.0 109.533 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.8 pt -101.41 137.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.22 -0.925 . . . . 0.0 109.086 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.8 p90 -142.81 -162.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.3 p90 -45.23 -32.37 1.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -0.942 . . . . 0.0 110.512 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 17.9 t-20 -51.83 -11.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.886 -1.134 . . . . 0.0 109.036 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.0 t-20 -135.6 107.8 7.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.9 tp -47.52 -29.71 2.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 35.3 pttt -168.85 156.96 7.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -65.95 144.25 56.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.92 -46.98 32.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -116.07 -2.78 12.17 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.05 -15.68 76.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.46 9.41 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.07 149.82 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.154 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.51 137.75 25.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.164 -0.96 . . . . 0.0 109.869 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -89.42 135.25 33.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.773 . . . . 0.0 108.931 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -73.38 -44.44 58.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.09 110.11 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.59 110.89 12.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -1.142 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.96 -164.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 63' ' ' THR . 10.2 ptm180 -158.18 17.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 62' ' ' ARG . 33.3 p -155.71 -40.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.332 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.74 69.72 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.48 110.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -1.152 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.4 -140.72 6.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 68' ' ' GLY . 22.7 t0 -80.0 -169.95 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -1.109 . . . . 0.0 109.516 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 67' ' ' ASP . . . -60.8 -93.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 42.8 p-10 -48.66 98.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -1.153 . . . . 0.0 109.564 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 68' ' ' GLY . 68.0 m-20 -74.8 -46.18 38.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.46 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' CG ' ' N ' ' A' ' 72' ' ' SER . 68.0 tt0 -115.82 162.7 16.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.685 . . . . 0.0 109.176 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 m -153.53 143.09 21.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -121.73 123.1 41.05 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.603 -0.685 . . . . 0.0 109.24 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -95.61 138.63 33.01 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.27 146.82 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.434 -0.791 . . . . 0.0 110.182 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -139.12 106.42 5.51 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 79' ' ' ALA . 9.0 mt -78.98 -42.52 26.49 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -52.55 -8.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.977 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.68 19.5 16.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.55 -0.719 . . . . 0.0 109.67 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 81' ' ' PRO . 47.2 t -104.63 105.17 49.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.319 -0.863 . . . . 0.0 109.246 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.2 Cg_exo -48.97 -173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.039 1.826 . . . . 0.0 112.355 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.25 0.33 87.22 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.77 -58.51 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -1.198 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.35 145.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -135.93 -5.74 2.15 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.082 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -142.46 130.67 22.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.997 -1.064 . . . . 0.0 109.214 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.1 mt -139.99 113.99 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.67 173.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.316 -0.865 . . . . 0.0 109.121 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.94 142.2 51.63 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 91' ' ' VAL . 58.7 t -146.9 156.53 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.857 -1.152 . . . . 0.0 111.713 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.3 p -146.58 113.65 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -120.57 161.67 20.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.295 -0.878 . . . . 0.0 110.828 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.542 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -77.56 161.87 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.482 ' N ' HG22 ' A' ' 93' ' ' ILE . 1.3 t60 -111.19 -76.05 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.344 -0.848 . . . . 0.0 109.934 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' GLN . 1.4 m-20 -47.82 -18.07 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.772 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.77 -19.07 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 49.7 tt0 -71.45 -62.22 1.49 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.95 -1.094 . . . . 0.0 109.319 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.52 -43.82 9.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.339 -0.85 . . . . 0.0 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 101' ' ' GLN . 40.9 ttt85 -79.23 -20.18 48.87 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 99' ' ' ARG . 59.5 ttt-85 54.59 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.745 -1.222 . . . . 0.0 109.474 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.475 ' CD ' ' HE ' ' A' ' 99' ' ' ARG . 18.8 mt-30 -157.8 141.47 15.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -102.2 163.89 11.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -46.73 -33.01 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.844 . . . . 0.0 109.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.5 -42.28 98.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 66.1 mm-40 -51.21 -12.04 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.156 -1.202 . . . . 0.0 109.225 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.4 t -82.74 165.29 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.852 . . . . 0.0 109.204 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.2 m -69.39 -18.51 63.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.195 -0.941 . . . . 0.0 109.657 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.76 79.46 0.03 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.19 157.51 22.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -1.18 . . . . 0.0 109.706 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 26.5 p90 -150.24 169.71 20.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 109.969 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -135.87 151.56 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -138.17 161.59 36.43 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.022 -1.049 . . . . 0.0 109.984 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.14 116.32 4.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.177 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -128.69 144.94 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.317 -0.864 . . . . 0.0 109.957 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.448 ' ND2' ' SD ' ' A' ' 2' ' ' MET . 57.8 t30 -76.13 102.03 5.58 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.91 -1.57 3.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.668 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.64 -53.78 5.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.49 ' CG ' ' HG1' ' A' ' 120' ' ' THR . 13.7 p30 -123.82 6.81 8.73 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.737 -0.602 . . . . 0.0 109.638 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' ASN . 8.1 mt-30 59.55 60.52 2.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 118' ' ' ASN . 86.0 m -110.82 -70.41 0.81 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.896 -0.502 . . . . 0.0 110.342 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.858 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.9 mm-40 -45.3 157.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.18 156.01 48.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.168 -0.958 . . . . 0.0 109.923 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptp180 -142.49 143.31 32.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.545 -0.722 . . . . 0.0 109.243 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.429 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 8.4 t80 -91.22 142.04 28.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 108.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -85.26 102.86 13.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.065 -1.022 . . . . 0.0 109.432 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 54.1 mt -79.0 -39.21 34.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.166 -0.959 . . . . 0.0 109.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.2 t -47.79 -31.07 4.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.992 -1.067 . . . . 0.0 109.209 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.18 -54.6 3.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.773 . . . . 0.0 109.711 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.429 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 46.8 m-20 -73.23 -2.68 22.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.283 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -54.1 -47.15 72.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.087 -1.008 . . . . 0.0 109.238 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.0 t -68.1 3.12 1.73 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.549 -0.719 . . . . 0.0 109.819 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 m -84.3 -34.93 23.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.985 . . . . 0.0 110.169 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -177.53 -166.31 0.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.931 -1.105 . . . . 0.0 109.66 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.69 -10.72 9.14 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.79 26.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.68 158.14 15.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -94.41 134.16 37.22 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.1 t80 -73.33 -45.44 55.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.892 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.74 -162.5 11.26 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 22.2 tt0 -151.97 164.29 37.47 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.106 -1.232 . . . . 0.0 109.839 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 13.3 tp -144.16 133.35 23.0 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -148.64 166.22 28.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.0 109.639 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 14.5 ptm180 -94.47 141.24 28.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.377 -0.827 . . . . 0.0 110.095 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.575 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 10.2 t-160 -100.03 -132.88 0.26 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.575 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 17.3 m120 -51.85 -51.45 56.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.887 -1.133 . . . . 0.0 108.322 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.48 16.93 0.14 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.83 159.51 36.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -77.73 151.81 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -148.21 124.99 11.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -89.69 147.65 23.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.377 -0.827 . . . . 0.0 109.391 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -153.9 109.35 3.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.69 154.68 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.526 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.58 -34.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.14 84.22 0.04 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -130.32 104.41 7.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.68 -0.894 . . . . 0.0 109.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 149.96 29.32 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.63 127.47 19.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.46 12.15 21.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.585 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.6 -67.18 1.76 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 153.77 126.89 1.13 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -44.68 -32.5 1.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.363 -1.08 . . . . 0.0 110.099 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.74 -27.19 25.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.096 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 161' ' ' GLY . 23.3 t -77.71 -50.51 12.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.426 -0.796 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -48.68 -20.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.483 ' SG ' ' CB ' ' A' ' 42' ' ' PHE . 56.7 m -72.35 -61.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.173 -0.955 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.57 -15.36 37.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.165 -0.959 . . . . 0.0 110.537 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.88 -42.14 99.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.033 . . . . 0.0 110.476 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.62 -20.62 61.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.513 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.04 -49.56 5.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 52.4 mt -81.02 132.17 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.475 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.39 146.06 45.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 -178.45 6.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.536 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.1 mpt? -73.06 171.46 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -153.98 -34.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.71 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.06 128.31 15.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.245 -0.91 . . . . 0.0 109.233 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 ' N ' HD22 ' A' ' 4' ' ' ASN . 5.2 t -127.69 156.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.613 -0.679 . . . . 0.0 109.178 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.1 tp -142.4 107.18 4.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.78 150.6 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.83 116.94 1.32 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -103.71 135.18 45.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.9 135.46 5.9 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -157.04 153.2 27.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -1.103 . . . . 0.0 109.816 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.09 108.02 20.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.532 -0.73 . . . . 0.0 109.675 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.09 162.36 24.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -132.84 106.77 7.92 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.452 -0.78 . . . . 0.0 109.246 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.9 p -89.97 105.71 17.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 p -85.29 -100.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.318 -0.864 . . . . 0.0 109.199 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -83.42 -10.6 58.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.285 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.37 -17.14 0.36 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.89 176.36 2.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 109.664 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -176.75 162.38 2.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.34 141.66 29.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.239 -0.913 . . . . 0.0 109.402 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.4 p30 -141.07 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.155 -0.966 . . . . 0.0 109.595 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.69 134.87 34.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 108.877 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -92.4 107.13 18.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.034 -1.042 . . . . 0.0 109.83 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.41 123.46 42.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.74 167.59 26.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.101 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.49 46.2 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 6.6 m-85 -104.37 128.37 52.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.338 -0.851 . . . . 0.0 108.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.76 155.62 17.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 110.088 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.53 137.28 25.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.349 -0.845 . . . . 0.0 109.362 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -80.16 176.67 9.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.16 -8.56 59.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -0.966 . . . . 0.0 109.805 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -85.67 2.91 43.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.139 -0.975 . . . . 0.0 109.808 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.03 -18.31 57.6 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.6 mttt -106.61 173.23 6.41 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -101.3 142.18 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.405 -0.809 . . . . 0.0 109.675 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -60.11 -5.55 1.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -144.33 102.32 0.27 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 31.8 p-10 -45.28 -25.31 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -1.101 . . . . 0.0 110.356 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -58.76 -42.06 88.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.067 -1.02 . . . . 0.0 109.822 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 38.8 t0 46.27 15.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.985 -1.072 . . . . 0.0 109.626 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 81.5 t80 -137.35 99.58 4.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.511 -0.743 . . . . 0.0 109.419 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.0 pt -102.86 137.92 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 1.7 p90 -140.85 -160.78 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.18 -0.95 . . . . 0.0 109.344 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 20.4 p90 -44.68 -31.88 1.32 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.925 . . . . 0.0 110.495 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.6 t-20 -51.05 -14.27 0.22 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.903 -1.123 . . . . 0.0 109.01 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.4 t-20 -135.77 107.38 6.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -47.78 -26.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.372 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 14.4 pttm -170.52 159.14 6.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 8.1 t -73.22 129.99 39.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.388 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.24 -30.36 54.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.66 -15.97 11.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.0 109.46 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 -12.58 75.28 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t 60.68 10.75 2.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -1.145 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 50' ' ' SER . 59.7 t -92.75 151.9 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 108.963 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -145.37 145.0 31.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -90.94 119.59 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 m -67.24 -46.98 72.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.27 117.61 0.77 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -78.46 158.9 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -1.178 . . . . 0.0 109.543 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -157.55 109.98 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -79.59 17.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.897 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -152.56 -35.05 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.255 -0.903 . . . . 0.0 109.372 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.46 18.7 59.01 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -58.44 110.4 0.97 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -1.13 . . . . 0.0 109.399 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 177.06 -134.87 2.63 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -166.04 69.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -1.144 . . . . 0.0 109.442 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.55 -166.57 33.33 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -51.16 99.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -1.135 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -69.11 -73.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -98.67 164.45 12.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -160.81 139.33 10.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.338 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 mp -117.94 127.32 53.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.524 -0.735 . . . . 0.0 109.382 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HG2' ' HZ2' ' A' ' 76' ' ' LYS . 52.4 tttp -96.19 114.79 26.52 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.531 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 64.5 mt -104.18 147.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.388 -0.82 . . . . 0.0 110.571 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HZ2' ' HG2' ' A' ' 74' ' ' LYS . 64.4 mttp -138.71 105.65 5.42 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.27 -38.61 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.15 -22.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.71 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.06 -24.03 17.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.279 -0.888 . . . . 0.0 109.75 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.99 124.24 79.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 109.334 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.23 -160.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.939 1.759 . . . . 0.0 111.826 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.25 0.89 88.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -66.98 -56.37 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.15 148.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 11.7 t0 -125.53 -19.58 4.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.572 -0.705 . . . . 0.0 109.567 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -149.43 143.42 25.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.118 -0.989 . . . . 0.0 109.784 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 89.6 mt -135.21 154.35 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -145.21 172.77 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 2.9 m-85 -142.47 118.76 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.16 158.01 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.308 -0.87 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.0 p -133.41 113.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 p -110.44 156.29 21.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 0.0 110.347 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.536 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.16 144.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.405 ' C ' ' N ' ' A' ' 96' ' ' ALA . 74.6 t60 -99.46 -69.1 0.78 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' NE2' ' A' ' 101' ' ' GLN . 2.9 p30 -49.14 -18.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.849 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.48 -50.37 59.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.712 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 -30.25 41.38 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.799 -1.188 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.85 -53.71 4.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.066 -1.021 . . . . 0.0 111.471 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 100' ' ' ARG . 5.1 ptp180 -112.14 3.5 17.3 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.153 -0.967 . . . . 0.0 111.101 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 85.9 mtt-85 53.42 104.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OD1' ' A' ' 95' ' ' ASP . 25.3 mt-30 -147.93 137.85 22.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.4 p -94.71 160.54 14.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -46.66 -37.03 7.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.739 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.25 -37.73 87.88 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -47.7 -16.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -1.226 . . . . 0.0 109.322 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 107' ' ' SER . 33.6 t -87.58 166.75 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 109.121 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -67.92 -21.68 65.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 109.707 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.96 79.4 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.03 162.17 25.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 109.75 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 17.8 p90 -155.8 161.44 40.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.8 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 49.7 mt -123.25 157.97 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.401 ' N ' HG22 ' A' ' 111' ' ' ILE . 73.9 ttt180 -141.18 159.71 41.63 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.045 -1.034 . . . . 0.0 109.614 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -154.67 117.42 4.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.953 -1.092 . . . . 0.0 109.499 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.3 p -129.5 144.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 119' ' ' GLN . 55.7 t30 -76.76 102.06 6.09 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 4' ' ' ASN . 23.0 t70 -67.2 -1.61 4.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.318 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.3 t0 -80.65 -53.35 6.61 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.223 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -123.33 3.97 9.13 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 115' ' ' ASN . 11.9 mt-30 59.75 61.18 2.0 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 89.8 m -113.54 -68.49 0.92 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.956 -0.465 . . . . 0.0 110.363 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 36.4 mm-40 -45.25 157.65 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.907 . . . . 0.0 109.907 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.83 73.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.84 150.3 52.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.044 -1.035 . . . . 0.0 110.084 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.3 ptm180 -140.28 142.66 35.7 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.27 146.39 23.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.062 -1.024 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.39 103.4 16.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 109.389 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 97.6 mt -79.55 -36.52 38.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.6 m -48.08 -32.4 6.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.048 . . . . 0.0 109.213 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.23 -53.88 3.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.79 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.76 -4.15 32.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.96 -42.91 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.0 t -74.38 2.95 8.22 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.979 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -83.39 -34.2 25.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.167 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -176.43 -167.41 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.928 -1.107 . . . . 0.0 109.654 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.09 -15.75 8.68 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.22 140.48 41.73 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 45.7 ttp -165.8 158.0 14.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 109.749 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -99.91 135.71 40.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.388 -0.82 . . . . 0.0 109.152 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.99 -43.75 33.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.999 -1.063 . . . . 0.0 109.628 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.29 -172.48 31.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.56 166.65 29.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.238 . . . . 0.0 109.943 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.89 143.56 45.07 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -148.1 166.05 28.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.045 . . . . 0.0 109.667 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 9.1 ptm180 -95.02 146.05 24.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.682 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.454 ' CE1' ' ND2' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -122.49 -120.63 0.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 145' ' ' HIS . 17.4 m-80 -73.61 52.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.24 9.61 86.38 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.82 138.22 52.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.526 -0.985 . . . . 0.0 109.387 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -67.42 151.67 47.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -149.78 128.61 12.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.456 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -89.8 151.01 22.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 109.779 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -156.12 107.19 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.68 39.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.686 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.8 t -143.33 -34.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.66 87.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -132.37 104.45 6.73 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.62 150.88 35.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.463 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.8 p90 -144.32 126.36 15.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -1.099 . . . . 0.0 109.268 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.5 11.91 20.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.899 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.25 -77.74 0.11 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 158.3 138.29 2.45 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.71 -34.94 20.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.187 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -81.64 -15.56 54.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.6 m -90.15 -53.99 4.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 158' ' ' TYR . 32.8 m -54.5 -21.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 15.0 p -75.85 -51.96 11.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.041 -1.037 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.625 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.82 -25.39 23.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.905 -1.122 . . . . 0.0 110.492 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -57.59 -39.56 77.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.046 -1.034 . . . . 0.0 110.469 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -71.0 -19.53 62.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.89 -49.44 7.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 172' ' ' ASN . 87.2 mt -80.49 157.13 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.127 . . . . 0.0 109.5 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.433 ' N ' HG22 ' A' ' 171' ' ' ILE . 79.2 m-20 -75.79 136.27 40.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 -178.47 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.445 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 149' ' ' TRP . 21.0 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.275 0.559 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 46.5 mtt -152.55 90.98 1.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.21 -21.97 49.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 6.7 m120 -146.36 139.58 25.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.7 t -145.67 129.62 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.9 113.71 25.9 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.11 150.68 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -134.7 116.85 1.66 Allowed Glycine 0 N--CA 1.499 2.851 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -115.57 126.22 53.95 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.52 151.99 24.18 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.563 -1.303 . . . . 0.0 109.964 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -161.58 152.45 18.06 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.369 -1.077 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.27 127.54 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.51 -0.744 . . . . 0.0 109.591 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.5 170.73 14.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -0.895 . . . . 0.0 109.382 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -128.64 126.89 41.12 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.562 -0.711 . . . . 0.0 109.297 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -84.74 127.64 34.21 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.3 m -149.56 -45.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.88 . . . . 0.0 109.373 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -152.69 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.21 -24.98 9.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.638 HE22 ' NH2' ' A' ' 99' ' ' ARG . 18.2 mt-30 -71.91 177.85 4.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -1.155 . . . . 0.0 109.423 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -173.2 178.31 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.578 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -96.28 143.45 27.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -141.09 100.33 3.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.297 -0.877 . . . . 0.0 109.863 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.09 138.55 33.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' CE2' ' A' ' 44' ' ' PHE . 58.7 t0 -98.81 119.78 38.14 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.161 -0.962 . . . . 0.0 110.383 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -100.53 133.79 44.45 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.2 t -150.0 167.7 25.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.051 -1.03 . . . . 0.0 109.801 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.77 148.82 39.41 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 87' ' ' ILE . 3.9 m-85 -103.19 162.11 13.24 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -139.17 148.91 43.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.87 . . . . 0.0 109.683 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.03 141.05 28.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.925 . . . . 0.0 109.076 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -74.97 176.33 7.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.6 -1.0 52.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.9 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -95.95 4.17 52.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.181 -0.949 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.02 -13.4 66.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.7 mttp -105.03 163.83 12.25 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.5 t -90.06 136.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.229 -0.92 . . . . 0.0 109.045 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -66.46 4.09 0.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -158.14 127.1 1.82 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.6 5.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -1.185 . . . . 0.0 110.523 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -92.14 -42.57 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.735 -1.228 . . . . 0.0 110.847 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 48.0 12.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.653 -1.28 . . . . 0.0 109.468 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' ALA . 13.0 t80 -137.68 99.48 3.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.456 -0.778 . . . . 0.0 109.094 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 4.0 pt -97.08 120.96 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.269 -0.894 . . . . 0.0 109.367 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 25' ' ' ALA . 27.0 t80 -171.48 -166.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 109.29 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 67.9 m-85 54.2 -112.89 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.825 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.17 -21.53 65.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 24.0 t-20 -81.39 68.9 7.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.29 -19.61 5.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.152 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 14.8 pttm -163.37 156.65 19.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.474 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 69.5 m -74.54 148.11 41.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.87 -46.41 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.197 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -116.47 -0.4 12.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.725 -0.609 . . . . 0.0 109.647 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.02 -9.74 76.59 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 t 60.52 12.31 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -1.082 . . . . 0.0 109.633 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 38.5 t -93.01 147.97 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 108.953 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.441 ' O ' HD23 ' A' ' 73' ' ' LEU . 31.9 m -149.2 137.61 20.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.047 -1.033 . . . . 0.0 109.887 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.547 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.0 m80 -91.7 132.11 36.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.375 -0.828 . . . . 0.0 108.906 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.54 -57.57 5.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.94 124.25 1.11 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.5 112.24 19.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.146 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.11 121.38 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -79.49 13.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.441 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -153.76 -35.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.32 12.12 57.59 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -59.92 114.92 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.2 -143.69 9.14 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -160.59 67.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' ASP . . . 170.96 176.46 40.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -49.8 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -1.21 . . . . 0.0 109.435 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' GLY . 28.5 m-20 -69.81 -67.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -93.09 102.8 15.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.1 m -91.88 133.4 35.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -112.17 126.52 55.3 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -95.49 140.16 30.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.269 -0.894 . . . . 0.0 109.33 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 54.3 mt -133.79 146.74 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.611 -0.68 . . . . 0.0 109.486 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -145.42 99.86 3.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 79' ' ' ALA . 6.4 mt -81.62 -25.23 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.97 . . . . 0.0 109.865 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.27 4.92 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.91 22.72 3.56 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 81' ' ' PRO . 55.3 t -104.01 105.7 49.78 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.261 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' VAL . 71.4 Cg_exo -48.39 -174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.02 1.813 . . . . 0.0 112.275 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 1.54 88.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -55.11 20.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -1.112 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.86 121.45 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.381 -0.824 . . . . 0.0 109.121 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.73 -1.6 32.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.325 -0.859 . . . . 0.0 110.289 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -158.17 144.64 17.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.123 . . . . 0.0 110.106 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 28' ' ' PHE . 9.3 mt -146.11 118.56 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 173.34 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 0.0 109.737 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 96.5 m-85 -140.3 118.13 11.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.11 158.01 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.471 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.3 p -126.42 117.56 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -112.69 149.91 32.25 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.15 149.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.755 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 96' ' ' ALA . 66.9 t60 -103.91 -68.85 0.82 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -46.9 -19.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 109.614 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.457 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -57.91 -18.5 23.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.82 -60.6 2.89 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.716 -1.24 . . . . 0.0 109.315 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.53 -33.3 15.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 111.127 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.638 ' NH2' HE22 ' A' ' 19' ' ' GLN . 22.5 mtt-85 -95.57 -18.88 20.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.895 -1.128 . . . . 0.0 111.503 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.3 ttt85 56.9 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.796 -1.19 . . . . 0.0 108.984 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -146.09 138.45 25.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.37 -0.831 . . . . 0.0 109.246 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.6 p -96.08 164.27 12.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 135' ' ' THR . 46.8 m-85 -48.17 -35.71 12.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.766 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.75 -37.84 94.24 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -47.27 -16.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.179 -1.189 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 21.6 t -86.74 168.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.044 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 20.8 m -68.19 -20.96 64.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.77 80.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.26 164.11 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.9 p90 -154.23 155.32 35.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 50.0 mt -120.08 153.66 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 8' ' ' GLY . 62.5 ttt180 -140.18 159.57 41.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.966 -1.084 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -153.57 116.34 4.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 109.467 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.4 p -129.38 143.12 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.467 -0.771 . . . . 0.0 109.749 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 119' ' ' GLN . 60.7 t-20 -78.24 101.88 7.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.48 -1.96 4.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 0.0 109.301 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 115' ' ' ASN . 21.1 t0 -77.56 -53.34 7.71 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.032 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.44 3.12 9.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 115' ' ' ASN . 24.6 mt-30 60.01 61.74 1.8 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.6 p -115.17 -67.93 0.96 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.903 -0.498 . . . . 0.0 110.379 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 47.9 mm-40 -45.37 157.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 109.973 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.98 73.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.54 152.55 51.54 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.123 -0.985 . . . . 0.0 109.841 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.5 ptt180 -140.16 145.82 37.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.552 -0.718 . . . . 0.0 109.377 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -91.32 147.82 22.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 108.975 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.73 101.94 14.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.243 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 26.5 mt -81.43 -31.66 33.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.524 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.7 m -48.48 -36.82 15.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 108.82 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -95.4 -49.94 5.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.454 -0.779 . . . . 0.0 109.477 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -67.62 -11.63 58.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.766 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.35 -43.8 61.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 109.246 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.0 m -74.46 2.89 8.51 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.639 -0.663 . . . . 0.0 109.978 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -89.74 -33.94 16.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.056 . . . . 0.0 110.376 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -175.48 -176.48 0.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.772 -1.205 . . . . 0.0 109.844 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -112.84 -16.37 12.74 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.01 138.65 40.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.8 ttp -164.99 157.78 16.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 109.703 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.61 139.23 33.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.253 -0.904 . . . . 0.0 109.636 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.7 t80 -82.51 -44.07 16.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.082 -1.011 . . . . 0.0 109.605 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.31 -171.41 29.52 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -150.82 166.77 29.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.293 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mt -138.94 131.8 29.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.2 p90 -138.86 166.15 25.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.302 -0.873 . . . . 0.0 109.707 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.7 ptm180 -85.79 149.37 25.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.827 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.524 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 80.4 t60 -155.01 124.54 6.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 0.0 109.217 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.524 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 6.2 m120 54.11 26.04 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.55 11.62 82.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.88 140.4 52.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.508 -0.995 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' SER . 78.2 m95 -68.11 151.51 46.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.221 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -150.73 135.65 17.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 17.5 t80 -93.81 150.46 20.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.741 . . . . 0.0 109.701 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 15.2 tpt85 -156.16 107.1 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.099 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.19 154.6 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.704 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.28 -32.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.497 -0.752 . . . . 0.0 109.199 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.79 83.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -139.18 104.28 4.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.981 . . . . 0.0 109.377 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.76 151.07 31.76 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -143.78 123.26 13.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.391 -1.064 . . . . 0.0 109.245 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.93 10.45 21.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 109.503 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -73.94 0.29 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.1 135.21 1.89 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.692 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.95 -24.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -1.177 . . . . 0.0 109.807 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.85 -33.86 21.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.9 t -75.19 -51.93 12.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.701 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 158' ' ' TYR . 33.3 m -46.6 -19.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 85.0 m -73.32 -61.23 1.9 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.063 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.99 -15.39 38.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.244 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -59.38 -40.62 87.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.006 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 171' ' ' ILE . 15.2 m-85 -71.65 -15.83 62.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.21 -0.932 . . . . 0.0 109.398 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -52.6 -7.73 0.45 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 169' ' ' TYR . 21.3 pt -71.69 156.4 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -1.23 . . . . 0.0 109.505 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.421 ' ND2' ' HZ1' ' A' ' 35' ' ' LYS . 3.0 m-20 -73.06 108.29 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.67 144.44 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 109.457 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.487 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.86 173.39 12.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -153.41 -35.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 3.9 m120 -146.14 140.18 26.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.9 t -141.74 146.0 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.35 -0.844 . . . . 0.0 109.245 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.0 tp -130.7 109.39 10.59 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.63 147.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 108.514 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.89 116.8 1.38 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.48 136.64 41.94 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.49 137.35 6.74 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -157.37 152.52 25.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -1.137 . . . . 0.0 109.759 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.46 109.59 22.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.678 -0.639 . . . . 0.0 109.544 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -81.78 168.13 18.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -132.74 106.68 7.91 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.468 -0.77 . . . . 0.0 109.29 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -92.29 105.81 17.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.213 -0.929 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 p -82.54 -29.76 30.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.241 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -158.38 -34.71 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.0 109.37 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.97 -32.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.579 ' CD ' ' H ' ' A' ' 19' ' ' GLN . 1.8 mp0 -70.14 174.34 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -1.143 . . . . 0.0 109.608 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -175.84 177.12 1.72 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.42 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.0 m-85 -96.26 145.29 25.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.416 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.92 140.74 34.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.365 -0.834 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CD2' HD13 ' A' ' 93' ' ' ILE . 15.2 mt -128.52 128.61 44.64 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -91.97 108.55 20.01 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.168 -0.957 . . . . 0.0 110.176 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 44' ' ' PHE . . . -100.6 125.97 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.284 -0.885 . . . . 0.0 108.936 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p -149.46 168.04 24.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 0.0 109.937 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.44 139.75 44.04 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.46 125.75 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.2 152.97 18.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.343 -0.848 . . . . 0.0 109.605 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.42 138.25 27.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.1 176.41 8.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.563 -0.711 . . . . 0.0 109.232 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.48 -8.41 58.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.784 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 3.51 39.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.927 . . . . 0.0 109.947 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.47 61.53 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.5 mmtp -104.2 168.56 9.03 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 38' ' ' GLY . 18.9 t -93.18 137.05 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.173 -0.955 . . . . 0.0 108.993 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 32.3 ttp180 -63.84 2.09 0.55 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -153.36 128.22 2.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -65.07 4.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -1.189 . . . . 0.0 110.234 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -94.35 -41.87 9.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.0 -1.062 . . . . 0.0 110.059 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 t0 45.78 17.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.0 109.477 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 40' ' ' ALA . 31.8 t80 -136.97 106.59 6.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 109.627 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 29' ' ' LEU . 6.9 pt -112.64 139.69 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.581 -0.699 . . . . 0.0 109.132 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -161.01 -145.23 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 46.8 p90 -43.76 -31.1 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 109.944 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.09 3.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.3 t-20 -158.65 116.28 2.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.154 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -50.66 -36.04 33.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 17.9 pttp -165.78 157.43 14.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 109.361 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 3.4 t -70.54 120.1 15.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.167 -0.958 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.58 87.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.178 -0.951 . . . . 0.0 109.547 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 43.4 p-10 -103.27 -17.61 15.24 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.516 -0.74 . . . . 0.0 109.637 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . -84.36 -15.34 69.18 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.1 p 61.86 11.19 3.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -1.104 . . . . 0.0 109.491 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' H ' ' HB3' ' A' ' 50' ' ' SER . 55.2 t -93.02 151.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.311 -0.868 . . . . 0.0 109.175 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 m -148.05 136.26 21.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.116 -0.99 . . . . 0.0 110.078 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.409 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.8 m80 -90.41 129.75 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -68.59 -56.62 7.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 109.335 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.17 123.41 1.22 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -81.72 110.89 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -81.72 -169.63 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 63' ' ' THR . 15.6 ptt180 -150.82 12.28 0.68 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 109.544 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.8 p -156.64 -35.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.94 11.71 25.91 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.42 110.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -1.118 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.05 -130.35 2.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -170.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -1.168 . . . . 0.0 109.542 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.63 178.1 33.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -50.04 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.174 . . . . 0.0 109.456 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -70.8 -68.93 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -86.9 175.64 8.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 109.533 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -159.25 132.43 7.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.314 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -119.41 123.43 44.09 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -95.18 137.61 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 52.1 mt -128.75 147.07 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.547 -0.721 . . . . 0.0 110.348 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 54' ' ' SER . 65.8 mttm -140.51 97.16 3.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.54 -5.31 49.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.99 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.98 -22.97 31.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.095 -1.003 . . . . 0.0 109.777 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.34 -11.61 27.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.183 -0.948 . . . . 0.0 109.891 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.98 123.99 77.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.22 -161.33 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.795 1.663 . . . . 0.0 112.098 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.05 -0.17 83.44 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.2 m-20 -70.06 -60.35 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 86' ' ' LYS . 46.5 t -91.11 144.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.66 10.95 5.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.393 -0.817 . . . . 0.0 109.532 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 141' ' ' GLU . 81.7 tttt -158.48 144.13 16.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.225 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.39 115.75 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.081 -1.012 . . . . 0.0 109.369 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -104.1 173.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 75' ' ' ILE . 95.0 m-85 -142.29 129.55 21.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.55 157.76 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 0.0 110.649 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -132.42 113.62 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -110.22 154.64 23.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.393 -0.817 . . . . 0.0 110.778 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.0 mm -74.22 151.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 96' ' ' ALA . 9.3 t60 -101.93 -74.23 0.63 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.372 -0.83 . . . . 0.0 110.271 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.09 -17.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 109.798 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.589 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -49.98 -19.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.448 -0.782 . . . . 0.0 109.504 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -71.61 -62.58 1.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.971 -1.08 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -39.27 12.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.33 -0.856 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.613 ' NE ' ' NE2' ' A' ' 101' ' ' GLN . 49.4 ttt180 -83.89 -20.2 33.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.934 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 ttp85 53.33 96.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.766 -1.209 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.613 ' NE2' ' NE ' ' A' ' 99' ' ' ARG . 60.7 mt-30 -155.85 143.5 19.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.453 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -100.7 166.27 10.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.468 -0.77 . . . . 0.0 109.627 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -49.12 -29.7 5.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.705 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.03 -40.34 97.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 29.5 mm-40 -51.03 -11.7 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.315 . . . . 0.0 109.326 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.47 ' N ' ' C ' ' A' ' 104' ' ' GLY . 11.3 t -86.7 162.63 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.845 . . . . 0.0 108.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.402 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.1 t -64.29 -23.35 67.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.83 79.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.37 162.28 25.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 109.686 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 20.5 p90 -156.21 158.39 37.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 110.004 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 32.0 mt -120.55 156.25 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -143.42 159.09 43.02 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.926 -1.109 . . . . 0.0 109.912 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 tt -152.43 124.39 8.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.209 -0.932 . . . . 0.0 109.185 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.07 144.87 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.429 -0.795 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -74.45 101.83 4.26 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.84 -1.84 2.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.677 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.37 -53.85 5.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.912 . . . . 0.0 109.919 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -123.75 7.6 8.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.628 -0.67 . . . . 0.0 109.996 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 59.66 60.2 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.449 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 28.0 m -109.98 -70.52 0.81 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.825 -0.547 . . . . 0.0 110.3 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.855 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -45.27 157.43 0.09 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.49 72.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.05 150.54 52.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.088 -1.007 . . . . 0.0 110.13 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 28.2 ptt180 -143.27 140.21 30.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.707 . . . . 0.0 109.136 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -91.26 147.86 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 109.016 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.56 102.04 14.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.075 -1.016 . . . . 0.0 108.942 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.5 mt -76.37 -26.57 55.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.6 m -49.57 -33.61 15.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.969 -1.082 . . . . 0.0 108.385 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -95.44 -52.05 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 109.286 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.458 ' OD2' ' SD ' ' A' ' 137' ' ' MET . 15.7 t70 -67.1 -10.71 52.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.199 -0.938 . . . . 0.0 109.987 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -51.41 -46.33 62.88 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.8 t -71.46 3.47 3.8 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.761 -0.587 . . . . 0.0 110.022 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.2 m -92.12 -34.23 14.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.949 -1.094 . . . . 0.0 110.49 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -175.51 -174.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.676 -1.265 . . . . 0.0 110.011 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.29 -8.94 12.27 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.81 137.2 26.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.458 ' SD ' ' OD2' ' A' ' 130' ' ' ASP . 12.4 ptp -165.41 158.21 15.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.86 141.92 27.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.196 -0.94 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -85.5 -44.61 12.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.99 -176.02 24.27 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 86' ' ' LYS . 29.4 tt0 -151.22 122.2 7.64 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 142' ' ' LEU . 9.7 mp -99.34 142.74 30.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 109.001 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -151.48 166.23 31.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.017 -1.052 . . . . 0.0 109.695 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.54 142.83 26.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.256 -0.902 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.614 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 17.6 t-160 -115.63 -120.16 0.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.614 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.1 m120 -73.56 52.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.84 9.39 85.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.79 142.89 51.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.593 -0.946 . . . . 0.0 109.365 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -67.86 151.66 46.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -153.66 133.12 12.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.978 . . . . 0.0 109.434 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 21.8 t80 -89.58 153.7 20.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 109.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.534 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 17.5 tpt180 -160.42 107.26 1.55 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.126 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -65.08 149.11 50.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.56 -30.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.553 -0.717 . . . . 0.0 109.068 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.2 83.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -139.37 104.44 4.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.959 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.07 152.84 35.19 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.441 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.1 p90 -146.37 127.67 14.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.27 -1.136 . . . . 0.0 109.244 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.3 9.05 33.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.41 -69.0 0.99 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 154.45 129.29 1.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.48 -28.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 109.8 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.69 -26.41 25.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' GLY . 43.9 t -78.06 -54.65 6.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.1 m -46.98 -20.49 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 73.2 m -70.53 -60.72 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.393 -0.817 . . . . 0.0 110.103 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -17.34 33.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.38 -45.51 91.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.959 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -71.85 -19.93 61.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.4 -40.29 19.73 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.33 155.82 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -1.106 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.96 134.07 41.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 134.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.451 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 149' ' ' TRP . 7.8 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.48 ' SD ' ' OD1' ' A' ' 115' ' ' ASN . 62.7 mtm -147.55 -170.89 3.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.934 . . . . 0.0 109.332 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -152.46 -33.52 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.278 -0.889 . . . . 0.0 109.7 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.415 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 71.5 m-80 -142.66 128.3 19.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -130.82 150.88 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.69 115.34 9.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 t -86.22 151.03 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.14 117.29 1.51 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.02 133.98 49.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -150.33 145.22 13.02 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.054 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -158.13 151.55 23.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.493 -1.004 . . . . 0.0 109.674 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -80.24 121.73 25.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.28 123.37 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.388 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -75.66 106.83 7.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.539 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -91.28 127.4 36.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' ' OD1' ' A' ' 17' ' ' ASP . 6.6 t -157.93 -35.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.282 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 16' ' ' THR . 26.4 m-20 -157.24 37.24 0.29 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -10.86 49.85 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -79.11 139.93 37.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -1.135 . . . . 0.0 109.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -157.16 169.08 25.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -96.21 150.6 20.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 109.3 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -140.95 99.93 3.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.292 -0.88 . . . . 0.0 109.726 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.39 138.55 33.46 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' ' CE2' ' A' ' 44' ' ' PHE . 8.2 t70 -92.17 117.24 29.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 109.829 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.63 48.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.421 -0.8 . . . . 0.0 109.016 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.34 167.66 25.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.092 -1.005 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.93 137.04 52.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -104.22 159.46 15.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.399 -0.813 . . . . 0.0 109.282 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.54 144.93 51.01 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.546 -0.721 . . . . 0.0 109.765 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.47 134.84 24.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.082 -1.011 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.96 176.59 3.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.5 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.89 -8.24 59.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -83.28 1.31 41.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.05 -13.42 59.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -101.03 153.4 19.58 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.673 HG12 ' H ' ' A' ' 38' ' ' GLY . 35.6 t -73.7 137.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.893 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.83 7.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -156.95 172.83 34.57 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.39 2.69 55.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.287 . . . . 0.0 109.969 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -103.04 -41.84 5.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.269 -0.895 . . . . 0.0 109.834 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.0 t0 53.25 6.46 0.07 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.945 -1.097 . . . . 0.0 109.71 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.5 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.5 p90 -138.45 123.49 19.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.289 -0.882 . . . . 0.0 110.264 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 pt -110.17 122.68 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 33.3 t80 -170.56 -170.95 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.933 -1.104 . . . . 0.0 109.722 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 53.4 m-85 51.03 -112.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.949 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -55.42 -16.78 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.562 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 49' ' ' LYS . 1.6 t30 -95.14 82.37 3.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.561 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -61.83 -22.1 65.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' C ' HD21 ' A' ' 47' ' ' ASN . 37.8 pttt -166.54 156.97 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 54' ' ' SER . 4.5 p -84.93 113.49 21.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.7 -32.48 69.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 0.0 109.268 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -104.64 -19.2 14.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.556 -0.715 . . . . 0.0 109.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -83.28 -13.98 75.36 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.8 p 70.16 2.05 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.92 146.85 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 p -147.0 152.59 38.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.077 -1.014 . . . . 0.0 110.567 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' CE1' HD21 ' A' ' 73' ' ' LEU . 6.1 m80 -92.03 130.23 37.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -78.33 -38.91 41.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.15 100.94 0.15 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.07 110.89 14.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.462 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.95 -164.37 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -156.02 16.12 0.35 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.4 p -154.71 -35.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.58 -0.08 26.18 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -68.63 110.27 4.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.32 -1.106 . . . . 0.0 109.324 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 178.69 173.94 44.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.8 OUTLIER -82.24 96.96 8.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 109.537 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 -108.32 1.45 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -48.41 111.32 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -1.146 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -80.85 -67.18 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -105.22 162.92 12.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.815 . . . . 0.0 109.394 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.4 p -162.31 138.52 7.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD21 ' CE1' ' A' ' 57' ' ' HIS . 4.9 mp -112.2 131.41 55.49 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -96.15 120.67 36.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 89' ' ' PHE . 46.7 mt -108.36 146.57 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 110.58 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -143.77 97.65 3.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.4 mt -82.32 -15.98 50.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.982 -1.074 . . . . 0.0 109.48 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.81 -0.87 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -131.82 15.99 4.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.55 -0.718 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.3 p -60.34 134.75 91.13 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.855 . . . . 0.0 109.193 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.26 -161.78 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.902 1.734 . . . . 0.0 111.736 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.95 5.06 53.09 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -90.57 -72.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.163 -1.198 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.3 p -70.14 149.06 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.55 -30.02 1.31 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 109.451 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -114.88 157.54 23.18 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 87' ' ' ILE . 14.7 mt -142.38 150.37 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -141.34 162.03 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.369 -0.832 . . . . 0.0 108.882 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 88' ' ' ILE . 57.4 m-85 -141.69 125.31 16.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.22 157.92 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.386 -0.822 . . . . 0.0 110.191 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.1 p -131.0 121.6 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 p -117.44 153.47 33.04 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.45 -0.782 . . . . 0.0 110.438 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.7 mm -74.2 145.0 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.416 ' C ' ' N ' ' A' ' 96' ' ' ALA . 24.5 t60 -100.64 -69.67 0.76 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.184 -0.947 . . . . 0.0 110.249 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLN . 5.4 m-20 -48.25 -18.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -45.9 -18.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' ASP . 65.2 mt-30 -69.58 -58.24 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.917 -1.114 . . . . 0.0 109.816 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.66 -52.68 4.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.169 -0.957 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -75.43 -20.74 58.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.967 -1.083 . . . . 0.0 110.917 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 53.94 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.01 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -150.69 149.85 30.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 135' ' ' THR . 43.9 m -104.42 167.28 9.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 109.531 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' ' CE ' ' A' ' 137' ' ' MET . 57.9 m-85 -46.12 -38.19 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.441 -0.787 . . . . 0.0 109.881 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.1 -38.02 88.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -47.14 -18.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.237 . . . . 0.0 109.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 107' ' ' SER . 17.3 t -84.35 168.63 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.079 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.5 t -71.46 -19.56 62.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.77 79.52 0.03 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.6 164.59 22.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.127 . . . . 0.0 109.735 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.8 p90 -156.74 161.15 39.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.054 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 59.1 mt -120.95 156.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -140.94 160.42 40.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.998 -1.064 . . . . 0.0 109.915 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.4 tt -154.37 117.62 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.122 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.3 p -132.2 142.97 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.305 -0.872 . . . . 0.0 110.322 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' OD1' ' SD ' ' A' ' 2' ' ' MET . 76.8 m-20 -74.97 102.13 4.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.21 -1.53 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.474 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 16.7 t70 -81.58 -53.47 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -123.49 7.0 8.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.783 -0.573 . . . . 0.0 109.676 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 58.61 59.69 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.8 m -109.74 -71.02 0.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.927 -0.483 . . . . 0.0 110.386 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.846 ' O ' HG13 ' A' ' 122' ' ' VAL . 32.3 mt-10 -45.38 157.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.0 109.803 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.18 73.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.67 155.02 49.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.196 -0.94 . . . . 0.0 109.836 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.8 ptm180 -142.59 147.34 35.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 109.18 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -91.32 146.95 23.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -87.97 103.18 15.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.14 -0.975 . . . . 0.0 109.421 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 57.6 mt -81.03 -42.11 21.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.429 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.8 p -47.56 -30.18 3.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 109.245 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -95.31 -54.6 3.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.341 -0.849 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -74.87 -3.44 31.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.965 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.87 -45.85 71.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 109.26 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 97.2 p -70.83 3.17 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.541 -0.725 . . . . 0.0 109.976 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -82.77 -35.1 26.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.979 -1.075 . . . . 0.0 110.353 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -177.29 -161.94 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.661 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -123.56 -1.71 8.5 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.61 137.63 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.42 ' CE ' ' CE1' ' A' ' 103' ' ' PHE . 10.6 ptp -165.04 157.56 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.108 -0.995 . . . . 0.0 109.342 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -97.87 128.9 44.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.219 -0.925 . . . . 0.0 109.737 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 24.6 t80 -65.57 -43.82 88.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.153 -0.967 . . . . 0.0 109.342 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.57 31.22 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.213 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 167.01 29.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.264 -1.139 . . . . 0.0 110.667 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.9 mt -132.31 136.95 47.25 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 6.4 p90 -140.36 160.91 38.95 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.003 -1.061 . . . . 0.0 109.733 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.441 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 9.0 ptm180 -84.96 148.66 26.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.042 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.523 ' NE2' ' OD1' ' A' ' 146' ' ' ASN . 29.8 t-80 -148.92 121.58 8.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.062 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.523 ' OD1' ' NE2' ' A' ' 145' ' ' HIS . 3.6 m120 52.32 27.18 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.26 75.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.9 136.22 51.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.981 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.472 ' CD2' HD13 ' A' ' 77' ' ' LEU . 70.4 m95 -67.31 151.47 47.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.549 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -150.9 143.89 24.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -99.58 142.08 31.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.363 -0.835 . . . . 0.0 110.154 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -134.47 114.82 13.26 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.6 150.03 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 109.639 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.0 t -147.41 -36.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 109.084 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.75 79.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -122.45 106.03 10.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.782 -0.834 . . . . 0.0 109.537 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.01 149.08 32.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -149.99 139.85 21.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -1.173 . . . . 0.0 109.465 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.18 6.87 47.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.35 -37.45 25.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 82.88 150.59 9.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -48.07 -13.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 0.0 109.618 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -72.55 -56.89 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.086 -1.009 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.0 t -90.57 -37.87 13.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.16 -0.963 . . . . 0.0 109.73 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.39 -20.68 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.522 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 29.9 p -83.41 -55.77 4.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.111 -0.993 . . . . 0.0 110.823 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.591 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -87.91 -24.63 23.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 110.531 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' SER . 51.4 tt0 -51.68 -37.59 51.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.974 . . . . 0.0 109.74 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.66 -20.35 58.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.17 -27.83 47.52 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.28 129.9 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -1.153 . . . . 0.0 109.473 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -65.85 104.51 1.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 109.509 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.42 -74.2 0.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.471 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.7 mmt -78.77 178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -154.39 -35.32 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.703 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.25 128.14 15.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 109.135 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.703 ' N ' HD22 ' A' ' 4' ' ' ASN . 6.2 t -127.78 158.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD11 ' OG ' ' A' ' 72' ' ' SER . 12.8 tp -144.46 106.7 4.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.958 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.29 150.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.11 116.98 1.24 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.85 129.53 54.68 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -144.95 142.78 11.16 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.45 ' CE2' ' CA ' ' A' ' 64' ' ' GLY . 25.1 p90 -157.22 153.43 27.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.405 -1.056 . . . . 0.0 109.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -77.51 128.81 34.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.505 -0.747 . . . . 0.0 109.809 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -85.53 123.36 30.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -132.92 119.34 20.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.0 m -90.2 128.67 36.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.4 m -150.29 -80.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.915 . . . . 0.0 109.386 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -3.55 7.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.86 -124.57 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.657 ' H ' HH22 ' A' ' 99' ' ' ARG . 98.3 mm-40 -74.03 163.55 27.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -1.189 . . . . 0.0 109.268 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.44 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.32 150.43 20.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 15.3 p-10 -141.04 99.74 3.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.258 -0.901 . . . . 0.0 109.712 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.62 130.91 34.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 108.631 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -87.24 111.44 21.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.966 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.32 125.86 46.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 108.803 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 m -149.76 168.06 24.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 109.769 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 136.09 49.48 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 5.4 m-85 -103.79 119.59 39.23 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.796 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.19 152.63 21.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.525 -0.735 . . . . 0.0 109.906 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 134.94 22.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -75.67 176.32 7.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 108.979 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.69 -10.85 59.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.681 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 33' ' ' ASN . 3.0 m120 -84.32 4.55 30.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.29 56.75 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 48.9 mtpt -104.45 171.95 7.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.729 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -103.45 143.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -61.83 -4.09 1.39 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.75 101.22 0.23 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -45.12 -20.97 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.401 -1.058 . . . . 0.0 110.601 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.26 -41.81 80.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.597 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.729 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 48.12 12.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.978 -1.076 . . . . 0.0 109.517 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 23.8 t80 -137.46 105.8 5.77 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.842 . . . . 0.0 110.214 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 pt -110.52 134.92 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 15.3 p90 -151.99 -152.89 0.45 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.04 . . . . 0.0 109.766 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.7 m-85 -43.81 -36.0 2.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.576 -0.703 . . . . 0.0 110.028 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -58.65 -1.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 108.73 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 45' ' ' TYR . 51.1 t-20 -148.11 108.71 4.16 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.23 -27.25 2.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 109.407 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.5 pttt -172.8 160.55 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.287 -0.883 . . . . 0.0 109.322 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 54' ' ' SER . 10.2 p -65.12 135.24 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.286 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.39 -45.35 55.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.1 1.49 13.23 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.657 -0.652 . . . . 0.0 109.604 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.78 -14.33 61.3 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.4 m 64.13 4.17 1.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -1.054 . . . . 0.0 109.314 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.14 146.75 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.919 . . . . 0.0 109.105 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -149.21 152.11 35.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.464 ' CE1' HD21 ' A' ' 73' ' ' LEU . 9.2 m80 -91.75 132.58 36.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 109.392 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 m -82.94 -38.85 22.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -159.55 107.55 0.32 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 33.2 p-10 -80.58 159.15 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.49 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -155.29 -173.01 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 109.418 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -161.82 30.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 14.9 p -151.81 -34.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' CA ' ' CE2' ' A' ' 11' ' ' TRP . . . 106.45 3.79 37.75 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -67.37 110.25 3.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -1.085 . . . . 0.0 109.368 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 173.36 154.01 10.14 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.57 102.62 13.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.6 -140.82 21.43 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.6 p-10 -48.68 111.14 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.599 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -70.12 -67.45 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.405 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -98.4 158.27 15.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.266 -0.896 . . . . 0.0 109.134 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.475 ' OG ' HD11 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -159.69 138.89 11.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.464 HD21 ' CE1' ' A' ' 57' ' ' HIS . 8.9 mp -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.518 -0.739 . . . . 0.0 109.548 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -96.39 112.68 24.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.1 mp -100.66 146.87 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 110.898 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -135.54 88.92 2.45 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.38 -13.54 61.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.306 -0.871 . . . . 0.0 109.794 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -78.29 4.82 11.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.66 10.99 6.15 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.435 -0.791 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -82.01 125.86 76.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.947 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.52 -161.76 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.74 -0.17 84.1 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -69.44 -59.73 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -1.178 . . . . 0.0 109.321 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.89 148.78 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.89 . . . . 0.0 109.252 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -135.98 0.82 2.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' NZ ' ' CD ' ' A' ' 141' ' ' GLU . 43.3 tttp -150.09 131.5 14.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.877 . . . . 0.0 109.055 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 90.4 mt -136.35 132.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 0.0 109.003 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.95 154.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.814 . . . . 0.0 109.671 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -107.1 137.95 44.2 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 91' ' ' VAL . 2.7 p -146.73 158.16 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.019 . . . . 0.0 110.115 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 90' ' ' VAL . 7.5 p -132.36 147.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -143.09 145.26 32.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.125 -0.985 . . . . 0.0 109.727 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.35 137.5 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 50.9 t-80 -95.49 -63.44 1.16 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.161 -0.962 . . . . 0.0 109.602 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 12.0 m-20 -47.4 -18.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 0.0 109.578 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.24 -18.18 34.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.835 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -65.94 -60.82 2.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.85 -1.156 . . . . 0.0 109.437 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.14 -41.22 11.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.082 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.657 HH22 ' H ' ' A' ' 19' ' ' GLN . 54.5 mtt180 -85.66 -19.58 30.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.973 -1.079 . . . . 0.0 111.352 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 55.19 92.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.687 -1.258 . . . . 0.0 109.035 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -148.46 142.54 25.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 109.256 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -98.75 165.15 11.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -47.37 -35.48 8.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 109.624 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.737 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.89 -38.38 74.09 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -47.42 -19.16 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.361 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 107' ' ' SER . 19.3 t -83.97 167.03 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.381 -0.824 . . . . 0.0 109.005 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -72.61 -24.51 61.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 0.0 109.712 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.38 78.1 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.13 164.8 24.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -1.111 . . . . 0.0 109.36 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.4 p90 -154.0 143.7 21.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.053 -1.029 . . . . 0.0 110.573 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 44.6 mt -106.94 153.86 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -139.38 160.21 40.36 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.987 -1.07 . . . . 0.0 109.84 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.1 tt -154.31 116.07 4.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 0.0 109.386 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.559 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -129.3 143.75 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.298 -0.876 . . . . 0.0 109.95 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.54 102.04 5.9 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -67.26 -1.36 4.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.539 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.04 -52.97 6.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -123.1 3.59 9.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.721 -0.612 . . . . 0.0 109.479 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ASN . 21.0 tp60 60.41 61.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 40.9 m -113.27 -69.15 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.883 -0.51 . . . . 0.0 110.256 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 33.1 mm-40 -45.24 157.55 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.344 -0.848 . . . . 0.0 109.984 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.73 72.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.53 52.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.141 -0.974 . . . . 0.0 110.038 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.4 ptm180 -138.5 145.65 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -91.33 145.16 24.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.994 . . . . 0.0 109.082 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.28 103.16 15.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.023 . . . . 0.0 109.51 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 92.1 mt -82.11 -37.84 25.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.3 p -48.35 -35.06 11.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.906 -1.121 . . . . 0.0 109.091 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -95.39 -49.24 5.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -76.45 -4.16 41.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.737 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.33 -43.71 67.87 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.954 -1.091 . . . . 0.0 109.695 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.3 p -68.97 3.17 2.15 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 110.978 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 p -86.15 -34.51 20.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.544 -1.348 . . . . 0.0 110.526 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.2 -161.44 0.08 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.766 -1.209 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.91 -12.98 7.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.48 133.78 24.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.8 ptp -165.41 141.44 5.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 140' ' ' GLY . 2.4 pp -76.47 141.11 41.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -0.952 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 21.5 t80 -79.41 -46.2 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.411 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.493 ' O ' HD13 ' A' ' 138' ' ' LEU . . . -150.88 -163.52 11.37 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.466 ' CD ' ' NZ ' ' A' ' 86' ' ' LYS . 11.5 tt0 -150.7 158.29 43.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.382 -1.069 . . . . 0.0 109.061 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 136.19 25.68 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -150.73 166.51 30.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.882 -1.136 . . . . 0.0 110.122 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 15.5 ptm180 -90.59 143.43 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -117.95 -120.12 0.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.605 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 34.9 m120 -73.56 51.25 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.05 -1.031 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 9.1 85.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.77 142.13 51.39 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.997 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -68.53 151.48 46.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -148.91 131.8 16.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.112 -0.993 . . . . 0.0 109.69 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -89.76 150.61 22.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -149.75 124.19 9.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 0.0 109.065 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.75 147.91 27.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.1 t -150.15 -36.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 109.09 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 48.26 76.54 0.15 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -108.6 104.38 13.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.754 -0.85 . . . . 0.0 109.125 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.03 143.35 20.39 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.484 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -142.15 141.7 32.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.299 -1.118 . . . . 0.0 109.086 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.14 9.55 43.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.32 -0.863 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.51 -68.01 1.33 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.51 132.5 1.51 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 166' ' ' CYS . 2.6 pp -46.9 -30.55 2.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -1.123 . . . . 0.0 109.607 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -28.74 24.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 69.2 m -73.4 -53.28 11.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.5 m -47.74 -20.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 57.7 m -71.55 -60.84 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 110.163 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.06 -15.4 38.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 110.402 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -65.78 -43.79 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.95 -1.094 . . . . 0.0 110.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -71.34 -19.62 62.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.944 . . . . 0.0 109.416 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.89 -44.57 36.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 22.7 pt -72.04 158.35 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -77.06 146.85 37.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 45.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.467 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 149' ' ' TRP . 8.5 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 45.5 mtt -86.8 147.43 25.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 94.0 mttt -116.9 -21.8 8.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.565 -0.709 . . . . 0.0 109.274 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 51.3 m-20 -146.23 142.34 28.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.3 t -140.8 158.52 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.469 -0.77 . . . . 0.0 109.211 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 73' ' ' LEU . 11.5 tp -146.29 107.32 4.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.937 . . . . 0.0 109.09 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.78 150.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.25 116.84 1.15 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.0 137.05 42.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.82 139.19 7.81 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -156.49 152.35 27.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.201 -1.176 . . . . 0.0 109.971 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -90.74 126.99 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.608 -0.682 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.73 138.31 34.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.356 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -132.76 106.85 8.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 109.29 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.1 m -86.16 106.1 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 p -59.36 -30.48 68.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -160.91 -34.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.431 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.61 60.62 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.533 ' CB ' HH22 ' A' ' 99' ' ' ARG . 3.1 pt20 -163.4 -165.97 1.16 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -1.189 . . . . 0.0 109.521 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -173.23 165.05 4.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 85.8 m-85 -96.25 142.8 27.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' PHE . 14.6 m-20 -141.03 99.92 3.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.26 -0.9 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.77 149.69 25.1 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -108.11 118.17 36.04 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.322 -0.861 . . . . 0.0 109.633 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.91 133.11 42.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.388 -0.82 . . . . 0.0 108.993 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -149.95 167.85 25.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 110.201 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.3 137.65 54.6 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 9.0 m-85 -104.15 126.66 51.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.967 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -96.96 153.69 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.345 -0.847 . . . . 0.0 109.918 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -145.3 135.74 24.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 109.111 179.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.67 176.54 8.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.094 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.59 -7.51 59.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 109.796 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -85.24 1.82 46.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 109.906 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.66 -17.99 58.25 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 57.5 mttm -107.48 171.02 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 38' ' ' GLY . 5.7 t -99.64 137.36 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -62.31 -0.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -136.61 114.42 1.15 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -58.52 3.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -1.177 . . . . 0.0 110.6 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 38' ' ' GLY . . . -99.34 -42.07 7.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.917 -1.114 . . . . 0.0 109.82 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' HG21 ' A' ' 36' ' ' VAL . 46.5 t0 46.81 14.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.994 -1.066 . . . . 0.0 109.594 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 36.2 t80 -137.3 99.44 3.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.815 . . . . 0.0 109.724 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.0 pt -105.2 135.13 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.1 p90 -139.3 -163.05 1.41 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.0 109.368 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 26.6 p90 -43.79 -36.92 2.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 110.551 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.586 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 22.8 t-20 -50.5 -11.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 109.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.1 t30 -135.29 104.7 5.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.468 -0.77 . . . . 0.0 109.067 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 mt -49.13 -28.92 4.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.473 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.1 pttp -164.85 157.67 16.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.331 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.479 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 3.6 m -68.7 143.5 54.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.458 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 -48.16 36.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.165 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.29 1.73 13.13 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.747 -0.596 . . . . 0.0 109.548 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.42 -14.15 74.57 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t 62.42 6.29 1.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -1.107 . . . . 0.0 109.799 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.15 151.62 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.115 -0.99 . . . . 0.0 108.986 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 p -145.21 139.74 27.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.075 -1.016 . . . . 0.0 110.251 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.419 ' NE2' HD11 ' A' ' 73' ' ' LEU . 41.0 m80 -90.27 132.87 35.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -72.25 -40.4 67.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.348 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.93 111.44 0.33 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.27 110.95 13.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.87 -164.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 63' ' ' THR . 12.7 ptt-85 -156.23 16.34 0.34 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 62' ' ' ARG . 23.0 p -155.84 -36.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.278 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.19 7.49 88.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.11 110.54 1.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -1.12 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.86 -127.1 1.79 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -164.96 163.3 20.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -1.092 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.24 -172.12 34.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.92 108.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -1.153 . . . . 0.0 109.433 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -61.37 -69.62 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.41 173.11 10.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -159.51 132.6 6.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.258 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -118.21 122.14 42.24 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -96.01 137.3 35.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 0.0 109.067 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.7 mt -129.33 143.35 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.634 -0.666 . . . . 0.0 110.018 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -141.22 98.84 3.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' VAL . 7.3 mt -80.79 -17.78 49.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -51.04 -36.73 41.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.27 27.28 7.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 80' ' ' VAL . 6.2 p -60.56 115.34 13.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 81.4 Cg_exo -46.55 -178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.812 1.674 . . . . 0.0 112.264 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.18 59.71 0.63 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -154.71 -54.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -1.177 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.45 148.53 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 1.0 OUTLIER -143.43 11.95 1.72 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.179 -0.951 . . . . 0.0 109.858 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -157.02 133.52 9.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 88' ' ' ILE . 87.9 mt -129.39 154.24 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.548 -0.72 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 87' ' ' ILE . 1.2 mt -144.68 173.44 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 108.904 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.62 141.95 49.76 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.1 t -147.23 151.94 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.942 -1.099 . . . . 0.0 110.953 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.7 p -147.53 113.92 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -122.28 174.6 6.89 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.741 0.781 . . . . 0.0 110.222 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.4 mm -83.86 166.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.546 ' N ' HG22 ' A' ' 93' ' ' ILE . 53.6 t60 -133.26 -66.58 0.65 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -48.12 -18.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -51.25 -38.42 52.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -54.53 -31.95 57.25 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 109.214 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -52.83 4.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.373 -0.83 . . . . 0.0 111.008 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.533 HH22 ' CB ' ' A' ' 19' ' ' GLN . 10.9 ptp180 -110.51 -4.71 15.37 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.282 -0.886 . . . . 0.0 111.166 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.1 ttm180 57.07 102.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.858 -1.151 . . . . 0.0 109.205 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -147.69 148.97 31.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 m -104.2 161.93 13.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.43 -0.794 . . . . 0.0 109.646 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -47.15 -35.31 7.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 109.681 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.734 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.61 -42.38 99.75 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 23.4 mm100 -48.5 -14.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 109.403 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 104' ' ' GLY . 19.4 t -83.76 164.59 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.1 t -64.87 -23.73 67.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.06 -1.025 . . . . 0.0 109.552 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.89 79.94 0.03 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.7 164.54 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -1.088 . . . . 0.0 109.958 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.4 p90 -154.81 152.35 29.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.889 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 35.2 mt -115.53 157.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.27 160.73 39.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.897 -1.127 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.8 tt -155.41 117.06 4.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.6 p -129.03 144.25 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 4.2 t-20 -76.07 102.14 5.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -65.79 -1.69 3.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HA ' HD22 ' A' ' 4' ' ' ASN . 23.5 t0 -82.29 -53.72 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.58 6.33 8.89 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' ASN . 19.5 tt0 59.61 60.52 2.22 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 42.2 p -111.07 -69.8 0.85 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.879 -0.513 . . . . 0.0 110.334 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.857 ' O ' HG13 ' A' ' 122' ' ' VAL . 45.1 mt-10 -45.26 157.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.77 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.52 52.15 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.134 -0.979 . . . . 0.0 110.218 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 33.5 ptt180 -140.18 142.4 35.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -91.34 147.65 22.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.089 -1.007 . . . . 0.0 109.12 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 18.5 p-10 -91.54 103.29 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.145 -0.972 . . . . 0.0 109.358 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.3 mt -80.89 -32.75 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.295 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 m -48.98 -37.52 20.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.909 -1.119 . . . . 0.0 108.963 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.37 -45.78 6.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.695 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.32 -4.54 42.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 110.535 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.4 -46.12 76.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 109.798 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -65.33 3.29 0.68 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 111.013 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -86.14 -34.93 20.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.596 -1.315 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.9 -161.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.907 -1.12 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.05 -3.83 6.94 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -146.79 135.4 22.07 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.4 ttp -165.83 158.08 14.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.941 -1.1 . . . . 0.0 110.335 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.69 139.41 31.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.341 -0.849 . . . . 0.0 109.471 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -78.62 -47.62 16.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 109.782 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.72 -164.29 14.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -151.45 163.19 39.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.168 -1.195 . . . . 0.0 109.739 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.65 134.75 24.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -146.05 165.84 27.86 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.969 -1.082 . . . . 0.0 109.781 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.1 ptm180 -90.34 143.7 26.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.859 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-80 -119.81 -116.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.606 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 18.8 m-20 -76.02 53.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.45 8.02 87.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -127.88 145.39 50.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.989 . . . . 0.0 109.314 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 1' ' ' SER . 74.1 m95 -70.58 151.59 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.424 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -145.97 126.85 14.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -89.72 147.92 23.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -153.03 107.37 3.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.305 -0.872 . . . . 0.0 109.046 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.91 154.64 40.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.6 t -143.41 -33.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.72 83.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -132.26 104.32 6.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.647 -0.913 . . . . 0.0 109.31 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.38 152.7 38.14 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.45 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -143.2 124.4 14.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.355 -1.085 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.06 6.22 37.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.44 -68.58 1.13 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.41 129.08 1.18 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.696 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.62 -26.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.165 . . . . 0.0 109.891 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.32 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.897 . . . . 0.0 109.457 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -50.98 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 109.638 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.45 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.3 m -47.83 -20.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 39.9 m -69.33 -59.93 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.817 . . . . 0.0 110.191 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.94 -18.89 29.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.17 -43.74 87.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.017 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -71.48 -19.81 62.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.56 -2.37 89.62 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.41 159.42 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -79.03 135.59 36.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.42 81.84 6.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.513 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.446 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.3 mpt? -67.66 -170.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 58.6 mttp -153.78 -34.64 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 59.7 m-20 -145.96 152.57 39.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' LEU . 77.2 t -147.62 155.8 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 109.291 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.4 tp -143.79 108.53 4.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 108.949 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.28 148.76 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 108.661 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.23 116.85 1.28 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.87 136.25 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.74 141.19 9.02 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.556 -1.307 . . . . 0.0 109.856 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -158.42 156.59 30.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.421 -1.047 . . . . 0.0 109.707 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -81.36 126.19 31.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.856 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.74 136.32 33.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.828 . . . . 0.0 109.118 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -132.99 116.44 16.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -120.7 106.53 11.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 m -65.27 -61.23 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.392 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.18 18.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.78 51.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -166.77 165.3 16.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -177.92 156.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.256 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.19 138.31 33.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.85 99.81 3.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 109.677 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -83.37 141.01 32.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -98.97 109.97 22.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.23 125.61 43.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.212 -0.93 . . . . 0.0 108.9 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 t -149.76 168.13 24.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 109.993 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.53 138.87 45.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -104.02 127.72 51.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.958 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -98.39 155.99 16.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.28 -0.888 . . . . 0.0 110.055 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.77 139.99 32.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.084 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.84 176.59 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.34 -5.46 59.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.75 4.04 50.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.0 109.905 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.96 -11.02 73.23 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.4 mttt -109.89 169.12 8.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 20.2 t -93.09 136.57 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 109.171 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -64.01 1.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -150.01 122.07 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -61.96 3.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 110.076 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -95.05 -42.24 8.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.024 -1.047 . . . . 0.0 109.889 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' LEU . 31.8 t0 46.17 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 109.599 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 75.7 t80 -137.49 99.59 3.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.456 -0.777 . . . . 0.0 109.52 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 50' ' ' SER . 7.2 pt -103.69 137.5 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.4 p90 -143.52 -160.76 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 18.0 p90 -45.17 -31.89 1.63 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 7.9 t-20 -52.59 -11.22 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.873 -1.142 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 49.0 t30 -135.75 108.25 7.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -47.43 -28.93 2.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.835 . . . . 0.0 109.266 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 30.2 pttt -171.81 157.51 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 67.3 m -62.69 149.57 43.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.65 -48.75 14.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -116.45 0.84 12.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.651 -0.656 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.94 -12.84 67.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m 58.71 13.92 2.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 109.401 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 50' ' ' SER . 99.5 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.304 -0.872 . . . . 0.0 109.027 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.6 m -148.6 135.06 19.58 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.019 -1.051 . . . . 0.0 110.212 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' NE2' HD11 ' A' ' 73' ' ' LEU . 26.2 m80 -90.17 129.06 36.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 m -69.8 -43.84 71.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.3 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.11 115.18 0.44 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.08 110.95 17.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -1.133 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.92 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.381 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 63' ' ' THR . 76.2 mtm180 -150.69 12.38 0.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 62' ' ' ARG . 28.3 p -156.28 -38.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.164 -0.96 . . . . 0.0 109.273 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.63 -1.28 13.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.54 110.26 0.95 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.276 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 172.93 150.42 7.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.3 120.3 25.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.23 -138.41 41.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 p-10 -48.73 115.7 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 109.595 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.32 -64.9 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -88.39 173.43 8.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.0 m -159.95 132.24 6.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.362 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 ' NE2' ' A' ' 57' ' ' HIS . 1.0 OUTLIER -117.79 121.66 41.36 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -95.4 138.16 33.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 108.533 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.04 146.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.484 -0.76 . . . . 0.0 110.502 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' NZ ' ' CB ' ' A' ' 76' ' ' LYS . 9.5 mtpm? -138.55 94.1 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.69 -5.36 40.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.47 -29.67 37.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 0.0 109.791 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.74 10.37 37.19 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.0 109.905 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -85.24 125.59 69.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.984 . . . . 0.0 109.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.95 -161.11 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.894 1.729 . . . . 0.0 111.868 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.84 4.52 78.76 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 2.5 m-20 -64.41 -54.52 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -1.189 . . . . 0.0 109.44 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.99 149.07 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 9.3 t0 -123.91 -9.05 7.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.767 . . . . 0.0 109.46 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -158.06 131.34 7.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 110.029 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 77.9 mt -121.13 154.18 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -142.57 173.16 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.093 -1.004 . . . . 0.0 109.304 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 11.0 m-85 -142.31 118.56 10.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.89 157.73 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 3.7 p -130.92 114.35 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -110.21 148.16 32.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.1 mm -74.3 138.97 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 21.3 t-160 -96.27 -65.11 0.99 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.005 . . . . 0.0 109.805 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -47.31 -18.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.08 -18.23 23.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 109.734 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.25 -61.49 1.82 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.85 -1.156 . . . . 0.0 109.545 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.18 -40.47 11.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.356 -0.84 . . . . 0.0 111.086 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.4 mpt_? -85.19 -19.13 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.897 -1.127 . . . . 0.0 110.955 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 99' ' ' ARG . 50.1 ttp85 55.62 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.806 -1.184 . . . . 0.0 109.255 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -159.9 144.67 14.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -102.03 166.82 10.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.52 -32.14 3.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.847 . . . . 0.0 109.76 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.66 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -61.5 -37.05 93.51 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -46.88 -19.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.174 -1.192 . . . . 0.0 109.244 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 107' ' ' SER . 19.2 t -86.48 166.97 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 0.0 108.986 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 p -66.99 -26.6 66.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.639 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.2 78.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.03 164.67 25.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 22.6 p90 -152.37 151.98 31.5 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 110.263 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.0 mt -114.49 154.46 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -144.13 157.5 44.27 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 tt -150.63 125.77 9.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 0.0 109.266 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.25 143.57 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.699 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 120' ' ' THR . 61.4 m-20 -75.19 102.08 4.85 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 35.5 t0 -66.1 -1.67 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 109.851 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 1.1 p30 -83.53 -52.65 6.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -0.928 . . . . 0.0 109.494 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 22.1 m120 -122.87 5.69 9.37 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 0.0 109.819 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.1 mt-30 58.97 60.06 2.58 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.456 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 20.0 m -112.03 -69.72 0.85 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.946 -0.471 . . . . 0.0 110.471 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 53.6 mm-40 -45.25 157.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.0 109.97 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.95 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.78 151.21 52.05 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -140.74 143.54 35.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.708 . . . . 0.0 109.143 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.73 147.82 22.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.6 103.31 15.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.147 -0.971 . . . . 0.0 109.326 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 94.2 mt -81.03 -38.19 27.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.5 m -47.61 -32.1 5.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.147 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.47 -54.23 3.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.533 -0.729 . . . . 0.0 109.94 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.49 -2.95 27.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.99 . . . . 0.0 110.612 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.66 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.05 -45.99 68.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 109.193 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -69.36 3.19 2.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.0 109.873 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.2 m -82.78 -34.5 27.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 110.346 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -176.76 -162.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.958 -1.089 . . . . 0.0 109.729 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.47 -7.92 6.91 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.48 136.04 21.81 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 ptm -165.46 157.75 15.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -92.27 141.43 28.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -86.54 -22.42 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.19 -171.29 40.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.31 163.41 38.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -1.156 . . . . 0.0 109.496 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.67 138.88 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.55 166.15 31.1 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.145 -0.972 . . . . 0.0 109.718 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -93.35 143.9 25.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.671 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.3 t60 -118.79 -118.55 0.31 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.626 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 30.8 t30 -75.41 51.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.05 8.84 86.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -127.81 139.99 52.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.987 . . . . 0.0 109.353 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -68.05 151.79 46.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.878 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -148.69 125.74 11.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -89.3 146.82 24.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.442 -0.786 . . . . 0.0 109.459 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -151.22 111.23 4.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 109.041 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.99 154.68 40.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.766 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.17 -33.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.39 0.04 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.561 ' H ' HD21 ' A' ' 138' ' ' LEU . 32.7 tt0 -143.72 104.31 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.443 -1.034 . . . . 0.0 109.157 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.73 34.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -134.6 138.44 44.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.618 -0.931 . . . . 0.0 108.919 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.39 9.06 39.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.76 -73.88 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 164' ' ' SER . . . 155.53 129.84 1.26 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -46.27 -24.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 109.879 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.0 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 166' ' ' CYS . 52.8 p -78.99 -54.43 6.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.652 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.472 HG11 ' CE1' ' A' ' 158' ' ' TYR . 29.6 m -45.37 -19.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.328 -0.857 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 164' ' ' SER . 89.3 m -72.54 -62.15 1.55 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.476 -0.765 . . . . 0.0 110.019 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.1 -14.88 40.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.381 -0.825 . . . . 0.0 110.133 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -56.33 -45.65 80.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -78.79 -19.71 51.54 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.529 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . -75.04 -41.24 32.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.9 pt -78.9 159.53 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.13 147.06 53.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.933 . . . . 0.0 109.421 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.4 98.69 7.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.446 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.4 mpt? -79.63 175.98 10.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.428 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -154.09 -34.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.942 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 4.4 m120 -146.13 128.44 15.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.3 t -127.0 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.63 110.84 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.446 -0.783 . . . . 0.0 109.057 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.99 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 108.699 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.83 117.15 1.61 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -112.44 127.23 55.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.28 150.0 22.2 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -159.42 151.45 20.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.355 -1.085 . . . . 0.0 109.944 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -90.51 122.87 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.677 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.67 167.08 17.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -132.85 106.99 8.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.437 -0.789 . . . . 0.0 109.401 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 m -87.99 125.4 34.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 109.279 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -157.93 -36.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.42 26.67 2.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.395 -0.815 . . . . 0.0 109.002 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.7 -23.93 6.24 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -64.0 155.72 30.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -1.166 . . . . 0.0 109.361 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -157.67 156.1 31.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 62.9 m-85 -96.21 136.39 36.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.286 -0.884 . . . . 0.0 109.266 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.8 p-10 -140.92 99.79 3.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 23' ' ' LEU . 7.5 mp -83.45 130.49 35.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -90.67 123.36 34.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.76 131.03 44.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 p -150.1 168.24 24.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.021 -1.049 . . . . 0.0 109.939 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -139.75 136.81 34.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -103.32 138.26 40.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.149 -0.969 . . . . 0.0 109.796 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.931 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -90.36 163.22 14.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 mt -144.92 141.7 29.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.059 -1.026 . . . . 0.0 109.867 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.12 176.71 9.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.583 -0.698 . . . . 0.0 109.219 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.04 -3.78 55.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.29 2.45 55.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -22.36 40.1 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 mttp -104.97 173.15 6.43 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.5 t -93.99 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -68.9 4.07 1.69 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -127.88 150.16 18.26 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.37 1.2 57.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.254 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.41 -42.34 5.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.221 -0.924 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 45.43 21.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.311 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 66.6 t80 -136.2 99.64 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.554 -0.716 . . . . 0.0 110.275 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 pt -103.34 134.85 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.0 p90 -146.11 -161.18 1.26 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.03 -1.044 . . . . 0.0 109.735 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.3 p90 -45.92 -30.67 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.116 -0.99 . . . . 0.0 110.434 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 8.3 t30 -61.97 -1.17 0.61 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.895 -1.128 . . . . 0.0 108.972 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.3 t30 -141.48 100.12 3.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.448 -0.783 . . . . 0.0 109.039 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.12 -24.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.305 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 33.3 pttt -166.78 154.87 9.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.41 ' OG ' HD21 ' A' ' 29' ' ' LEU . 23.1 t -62.67 137.85 58.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.325 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.51 92.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -116.13 -17.14 10.92 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.648 -0.658 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.67 76.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m 54.47 20.72 2.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 109.288 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB3' ' A' ' 50' ' ' SER . 89.2 t -92.85 151.54 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.886 . . . . 0.0 109.076 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -133.91 125.48 28.38 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.512 -0.742 . . . . 0.0 109.515 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -92.46 124.19 36.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.339 -0.851 . . . . 0.0 109.367 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.8 m -58.58 -46.59 86.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.92 143.72 3.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.3 112.51 24.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -1.119 . . . . 0.0 109.395 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 64' ' ' GLY . 3.1 m-20 -82.08 128.78 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.63 5.65 17.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.9 p -153.55 -35.03 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . 63.39 16.63 58.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -58.34 110.42 0.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -1.145 . . . . 0.0 109.532 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.35 -126.26 1.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -170.33 69.41 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -1.139 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.74 -176.03 37.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 38.4 p-10 -52.65 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.106 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.418 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.4 m-20 -57.95 -64.45 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.497 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 72' ' ' SER . 60.0 mt-10 -102.69 170.97 7.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.363 -0.835 . . . . 0.0 108.989 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 3.1 m -165.85 164.65 18.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -135.06 124.04 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -95.69 109.68 21.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.729 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.29 146.81 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -142.29 92.7 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 79' ' ' ALA . 10.5 mt -71.09 -41.95 69.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.111 -0.993 . . . . 0.0 110.322 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -48.15 -13.96 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.544 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -104.97 -19.3 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.459 -0.776 . . . . 0.0 109.858 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 77' ' ' LEU . 37.9 t -60.81 126.37 85.26 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.268 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 -160.11 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.983 1.789 . . . . 0.0 111.895 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.49 3.7 63.66 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.64 -60.95 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -1.218 . . . . 0.0 109.347 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 30' ' ' LEU . 11.7 p -84.46 148.06 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.468 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.1 m-20 -125.71 -3.14 7.22 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.378 -0.826 . . . . 0.0 110.046 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.48 136.67 15.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.952 -1.093 . . . . 0.0 109.436 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.41 154.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.602 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -138.38 172.89 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.146 -0.971 . . . . 0.0 110.103 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -137.53 129.2 28.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG21 ' CE2' ' A' ' 28' ' ' PHE . 25.1 t -140.57 151.32 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.953 . . . . 0.0 111.344 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.0 p -132.7 131.63 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -132.4 155.37 48.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.64 HD12 ' NE2' ' A' ' 101' ' ' GLN . 6.1 mm -73.9 162.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -128.34 -60.24 1.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.522 -0.736 . . . . 0.0 109.465 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -49.88 -18.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.203 -0.935 . . . . 0.0 109.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.25 -42.4 86.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -54.13 -32.07 54.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.739 -1.226 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.86 -53.23 4.48 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.256 -0.903 . . . . 0.0 111.311 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' ARG . 3.1 ptp85 -111.85 1.72 16.69 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.181 -0.949 . . . . 0.0 111.237 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 96' ' ' ALA . 46.2 ttp180 56.19 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.788 -1.195 . . . . 0.0 109.24 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.64 ' NE2' HD12 ' A' ' 93' ' ' ILE . 1.3 pp0? -153.16 147.77 26.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.154 -0.966 . . . . 0.0 109.437 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 101' ' ' GLN . 20.8 m -105.01 163.41 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.831 . . . . 0.0 110.01 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -43.85 -28.61 0.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 0.0 110.161 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.641 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.1 -44.1 96.26 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 7.5 tp-100 -47.64 -17.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 107' ' ' SER . 16.1 t -82.25 165.88 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -67.86 -21.72 65.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.671 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.41 79.98 0.03 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.23 162.48 27.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 109.623 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 33.5 p90 -155.38 151.69 28.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 45.9 mt -117.02 153.61 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -139.98 154.72 47.25 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.058 -1.026 . . . . 0.0 109.739 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -148.59 117.51 6.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.594 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.7 p -129.16 145.14 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.38 -0.825 . . . . 0.0 109.838 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 2.3 t-20 -76.12 101.87 5.51 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -65.46 -1.58 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.847 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -83.62 -52.99 5.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 109.661 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -122.97 4.37 9.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 109.786 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 60.29 60.61 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 35.8 m -113.07 -69.09 0.88 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.817 -0.552 . . . . 0.0 110.227 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.2 mt-10 -45.29 157.83 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.91 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -178.57 73.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.53 148.86 52.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 109.902 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 15.7 ptm180 -138.61 145.2 40.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.405 ' CE2' ' HE1' ' A' ' 137' ' ' MET . 8.0 t80 -91.32 147.59 22.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.235 -0.916 . . . . 0.0 109.061 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -91.05 103.37 16.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 83.9 mt -80.77 -37.71 29.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.482 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 128' ' ' THR . 2.5 p -47.8 -32.37 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.151 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.29 -53.89 3.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 -2.2 23.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.224 -0.922 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.641 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -53.25 -46.8 69.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.2 t -69.49 3.2 2.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.603 -0.686 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -83.4 -34.7 25.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 110.354 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -176.61 -161.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.4 -2.49 5.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.65 134.09 13.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.405 ' HE1' ' CE2' ' A' ' 125' ' ' TYR . 20.5 ptm -165.49 152.58 10.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.058 -1.026 . . . . 0.0 109.911 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 pp -87.47 138.43 31.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 27.6 t80 -80.25 -43.57 21.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.31 -173.85 35.11 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.858 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -150.77 166.59 30.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.143 -1.21 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 139.8 44.14 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -144.88 166.2 25.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.03 -1.044 . . . . 0.0 109.84 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.468 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.3 ptm180 -90.15 145.77 24.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.51 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 1.1 t60 -123.57 -120.29 0.28 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.598 -0.689 . . . . 0.0 109.166 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.51 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 10.1 m120 -73.37 52.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.64 88.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -127.84 142.0 51.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.582 -0.952 . . . . 0.0 109.406 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.458 ' CG ' HD13 ' A' ' 77' ' ' LEU . 74.6 m95 -67.48 151.64 47.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.358 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -149.96 132.82 16.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.076 -1.015 . . . . 0.0 109.632 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -89.91 153.16 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 107.32 1.52 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.1 154.74 41.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.724 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.69 -33.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.859 . . . . 0.0 109.268 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.57 86.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -134.8 104.36 5.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.574 -0.956 . . . . 0.0 109.214 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.64 146.09 18.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.551 ' CD1' HG11 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -147.4 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -1.08 . . . . 0.0 108.971 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.88 40.6 3.24 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.539 -0.726 . . . . 0.0 109.471 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.95 -54.45 3.4 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.0 122.13 0.71 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -45.53 -35.74 4.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.12 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.45 -28.36 23.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 109.59 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.8 p -80.88 -50.68 9.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.989 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.551 HG11 ' CD1' ' A' ' 158' ' ' TYR . 17.8 m -49.15 -21.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.008 . . . . 0.0 109.533 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 28' ' ' PHE . 57.9 m -79.39 -59.98 2.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.912 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.09 -15.5 63.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.465 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -71.05 -28.41 64.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.969 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.85 -19.57 61.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . -80.55 -51.71 4.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.85 159.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.33 -1.1 . . . . 0.0 109.403 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -69.59 140.02 53.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 -160.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.48 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.4 mtt -81.31 162.51 23.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -130.95 -31.3 1.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.499 -0.75 . . . . 0.0 109.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.23 128.17 15.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 109.089 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.707 ' N ' HD22 ' A' ' 4' ' ' ASN . 94.3 t -128.13 144.45 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 73' ' ' LEU . 15.5 tp -130.64 114.29 15.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 89' ' ' PHE . 61.9 t -86.0 151.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 108.777 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.43 121.65 2.34 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 10' ' ' GLY . 3.7 tt -132.49 126.17 32.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.608 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -146.32 152.99 25.04 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -155.04 154.57 32.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -1.044 . . . . 0.0 109.7 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -90.45 120.97 32.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 137.31 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.171 -0.955 . . . . 0.0 109.303 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -87.1 113.26 22.69 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.447 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -84.44 123.42 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -145.46 -41.75 0.22 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.308 -0.87 . . . . 0.0 109.274 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.28 37.72 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.25 -20.71 24.72 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -74.65 149.77 39.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.168 . . . . 0.0 109.313 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -160.14 175.31 13.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.521 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -96.32 145.73 25.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 25.1 p-10 -140.97 99.68 3.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.371 -0.831 . . . . 0.0 109.574 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mp -85.51 130.53 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 108.758 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.72 106.0 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -98.28 124.93 43.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -149.47 168.23 24.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.973 -1.079 . . . . 0.0 110.115 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.58 137.38 46.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m-85 -102.99 130.55 50.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.358 -0.839 . . . . 0.0 109.178 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.73 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.66 145.54 28.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.86 136.46 25.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.026 . . . . 0.0 110.109 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.16 176.48 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.699 . . . . 0.0 109.519 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -7.47 59.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.2 m-80 -83.03 -0.16 47.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.31 -12.01 61.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.74 148.68 24.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 38' ' ' GLY . 29.0 t -66.39 136.89 25.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.934 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.94 9.25 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.0 170.09 34.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -94.14 3.83 54.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.986 -1.302 . . . . 0.0 109.902 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.16 -41.78 5.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.243 -0.91 . . . . 0.0 110.309 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 23.2 t0 51.04 9.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.649 -1.282 . . . . 0.0 109.313 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 1.2 p90 -138.29 118.75 13.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.316 -0.865 . . . . 0.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 29' ' ' LEU . 6.3 pt -114.22 134.14 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -154.74 -148.21 0.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.959 . . . . 0.0 108.888 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 47' ' ' ASN . 37.3 p90 -44.89 -32.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.586 -0.696 . . . . 0.0 109.826 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 18.2 p-10 -65.4 4.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.177 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 47.1 t30 -155.53 100.29 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.804 . . . . 0.0 109.155 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -48.09 -18.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 28.4 pttt -175.38 155.23 1.81 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.398 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 54' ' ' SER . 53.2 p -66.71 130.51 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.83 -48.72 44.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.826 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -116.39 23.36 12.14 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 109.929 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.33 -15.11 7.24 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.6 t 63.48 4.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -1.116 . . . . 0.0 109.458 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 50' ' ' SER . 69.7 t -92.9 146.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.914 . . . . 0.0 108.916 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.9 m -149.78 153.78 37.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.057 . . . . 0.0 110.35 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.6 m80 -90.58 131.74 36.12 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.2 m -81.78 -34.71 30.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.506 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.24 113.76 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.74 159.09 25.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -1.122 . . . . 0.0 109.492 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.82 118.59 7.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -84.17 10.77 9.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.7 p -154.41 -35.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.886 . . . . 0.0 109.403 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.62 13.03 58.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.57 110.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.478 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.25 -115.61 0.67 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.03 166.12 4.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.451 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.63 177.98 49.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.85 99.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.163 -1.198 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.53 -68.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.33 146.73 23.83 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.267 -0.896 . . . . 0.0 109.279 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -159.84 141.56 12.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.37 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' CD2' ' A' ' 57' ' ' HIS . 8.0 mp -115.4 130.36 56.87 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.0 109.554 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -96.73 109.94 22.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.408 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 5.3 mp -98.8 146.75 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.204 -0.935 . . . . 0.0 110.465 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -141.98 90.62 2.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 149' ' ' TRP . 11.3 mt -78.86 -10.76 59.9 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.13 -0.84 0.82 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.009 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -135.83 18.12 3.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.0 p -60.2 134.99 90.81 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.329 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.5 -161.36 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.939 1.759 . . . . 0.0 111.682 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.08 39.7 2.79 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -126.19 -59.16 1.33 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.477 -1.014 . . . . 0.0 109.688 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.82 145.67 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.11 -0.994 . . . . 0.0 109.686 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.458 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 0.9 OUTLIER -138.97 1.5 2.06 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.399 -0.813 . . . . 0.0 109.581 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -149.06 131.35 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 108.963 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -137.38 130.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 141' ' ' GLU . 9.3 pt -137.22 152.89 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.933 . . . . 0.0 109.619 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 7' ' ' VAL . 28.3 m-85 -101.59 141.18 34.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.377 -0.827 . . . . 0.0 109.08 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.89 153.02 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.922 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -133.15 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -138.29 145.17 40.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.904 . . . . 0.0 109.861 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -74.26 148.01 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -0.862 . . . . 0.0 108.822 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' ALA . 56.6 t-80 -101.32 -70.66 0.74 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -47.51 -18.1 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 109.694 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -53.5 -18.76 3.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.81 -62.19 1.49 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.905 -1.122 . . . . 0.0 109.244 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.45 -38.45 12.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 110.813 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.517 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 6.2 mpt_? -85.14 -18.0 35.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.042 -1.036 . . . . 0.0 111.109 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 99' ' ' ARG . 16.1 tpt180 52.1 94.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.811 -1.18 . . . . 0.0 108.763 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -152.46 140.68 20.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 109.435 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 t -99.62 164.14 12.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.278 -0.889 . . . . 0.0 109.64 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -46.44 -30.9 2.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.397 -0.814 . . . . 0.0 109.934 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.637 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -63.39 -39.73 98.08 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -49.78 -15.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.502 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 107' ' ' SER . 17.7 t -83.13 163.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 109.088 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.6 t -62.66 -22.7 66.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.74 80.02 0.03 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.3 164.33 24.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.129 . . . . 0.0 109.667 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 34.0 p90 -150.04 169.82 20.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.194 -0.942 . . . . 0.0 110.185 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 18.1 mt -136.13 152.11 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 67.0 ttt-85 -143.55 163.62 32.67 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.1 tt -156.58 117.19 3.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.568 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.0 p -132.13 145.32 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.309 -0.87 . . . . 0.0 110.212 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 119' ' ' GLN . 2.2 m120 -78.6 102.35 7.91 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -68.0 -1.76 6.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.104 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.15 -53.13 7.29 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.993 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -123.27 3.03 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' ASN . 28.2 mt-30 59.95 61.28 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 115' ' ' ASN . 32.6 m -114.33 -66.31 1.1 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.901 -0.499 . . . . 0.0 110.247 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.83 ' O ' HG13 ' A' ' 122' ' ' VAL . 1.4 mp0 -45.3 156.91 0.1 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.563 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.4 73.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.23 143.83 50.2 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.087 -1.008 . . . . 0.0 110.154 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.1 ptp180 -138.0 139.33 39.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.508 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 6.4 t80 -91.02 142.78 27.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 108.97 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -85.72 102.85 13.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.438 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 95.0 mt -79.42 -36.71 38.61 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.244 -0.91 . . . . 0.0 109.308 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 128' ' ' THR . 4.9 p -48.06 -33.2 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.139 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -95.3 -53.59 3.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.487 -0.758 . . . . 0.0 109.721 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 65.8 m-20 -71.9 -5.46 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.96 -46.06 68.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.18 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 65.4 p -68.84 3.18 2.08 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.916 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.0 m -83.32 -34.78 25.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.252 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -177.06 -162.77 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.971 -1.081 . . . . 0.0 109.677 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.52 -13.29 7.59 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.39 135.36 32.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.2 ttp -165.33 151.34 9.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.024 -1.047 . . . . 0.0 110.189 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.36 137.21 32.53 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.429 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -75.84 -47.43 25.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.902 -1.124 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.96 -158.91 9.06 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 88' ' ' ILE . 13.2 tt0 -150.98 158.65 44.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -1.085 . . . . 0.0 109.266 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 143' ' ' TYR . 1.8 tt -143.28 131.92 22.49 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.562 ' N ' HD23 ' A' ' 142' ' ' LEU . 12.1 p90 -150.66 166.34 30.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.701 -1.249 . . . . 0.0 110.115 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 15.5 ptm180 -94.68 142.53 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.449 -0.782 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -114.15 -120.24 0.3 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.593 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 20.0 t-20 -73.66 51.35 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.129 -0.982 . . . . 0.0 109.146 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.64 82.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -127.67 140.12 52.28 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.562 -0.963 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.532 ' CE2' HD13 ' A' ' 77' ' ' LEU . 58.0 m95 -67.3 151.75 46.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -151.4 121.6 7.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -91.81 145.21 24.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.243 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -152.18 107.28 3.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.106 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.506 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -64.16 154.54 34.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.725 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.7 t -138.76 -33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.83 83.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -134.61 104.13 5.94 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.61 -0.936 . . . . 0.0 109.007 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.91 149.22 21.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.34 132.61 26.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -1.016 . . . . 0.0 108.99 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -87.14 19.64 3.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.53 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -57.66 -107.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.1 129.43 1.96 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.55 -30.3 2.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.61 -30.86 22.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 166' ' ' CYS . 32.3 t -79.54 -53.93 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 18.1 m -47.2 -19.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 164' ' ' SER . 65.9 m -74.49 -61.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.03 -15.13 45.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -57.19 -43.69 82.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 45.8 m-85 -71.84 -20.07 61.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.35 -34.38 29.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 93.1 mt -71.91 136.17 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -1.217 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -65.96 126.21 27.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.51 -12.25 59.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.408 -179.93 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.466 ' N ' ' SD ' ' A' ' 2' ' ' MET . 48.3 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -156.53 156.38 33.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 57.0 mttp -126.98 -14.53 5.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.519 -0.738 . . . . 0.0 109.382 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 43.0 m-20 -146.31 128.63 15.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.208 -0.932 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 6' ' ' LEU . 69.2 t -127.17 158.56 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.567 -0.708 . . . . 0.0 109.307 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' N ' HG12 ' A' ' 5' ' ' VAL . 12.0 tp -145.64 109.45 4.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 109.061 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.78 150.84 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.905 . . . . 0.0 108.747 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.24 117.25 1.68 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.1 tp -115.36 124.21 50.67 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -144.03 150.56 22.59 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 28.9 p90 -159.95 152.12 20.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.396 -1.061 . . . . 0.0 109.893 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.18 129.61 34.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.575 -0.703 . . . . 0.0 109.643 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.4 170.18 16.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.386 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -132.72 107.07 8.15 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.522 -0.736 . . . . 0.0 109.314 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -85.35 123.91 31.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -145.74 -36.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.388 -0.82 . . . . 0.0 109.205 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -158.23 33.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.315 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.61 -0.28 84.8 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -78.28 165.89 23.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -1.18 . . . . 0.0 109.42 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 12.3 p-10 -172.4 149.15 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.574 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.26 143.37 27.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -141.06 100.25 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.269 -0.894 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.7 mp -83.28 135.51 34.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 108.748 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.51 117.59 30.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.51 130.98 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.1 p -149.66 167.75 25.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.09 -1.006 . . . . 0.0 109.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.27 144.98 42.91 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -101.94 151.81 21.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -118.87 143.34 47.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.562 -0.711 . . . . 0.0 109.282 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 133.2 22.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.069 -1.019 . . . . 0.0 110.136 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.5 176.5 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.741 -0.6 . . . . 0.0 109.487 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.93 -2.49 55.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 46.7 t30 -87.67 -1.43 57.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.217 -0.927 . . . . 0.0 109.741 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.54 -13.02 65.09 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -101.61 150.99 22.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.536 -0.979 . . . . 0.0 108.402 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 38' ' ' GLY . 27.4 t -69.05 137.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.24 -0.913 . . . . 0.0 109.121 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -71.62 8.68 1.04 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.74 170.95 35.35 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.1 m-20 -94.81 3.46 54.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.939 -1.33 . . . . 0.0 110.21 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -103.17 -42.13 5.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.056 -1.028 . . . . 0.0 110.584 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t0 49.63 9.93 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.955 -1.09 . . . . 0.0 109.496 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 8.2 t80 -138.13 100.22 4.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.323 -0.861 . . . . 0.0 109.803 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 29' ' ' LEU . 8.0 pt -96.75 139.6 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.208 -0.932 . . . . 0.0 108.608 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 35.4 p90 -151.23 -152.3 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.319 -0.863 . . . . 0.0 109.568 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.5 m-85 -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.644 -0.66 . . . . 0.0 110.013 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -57.27 -4.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -0.965 . . . . 0.0 108.639 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 44.0 t30 -151.32 102.03 2.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -48.72 -26.34 2.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 18.6 pttp -163.93 157.28 18.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 7.1 t -76.97 125.86 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.241 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.77 -45.81 67.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.922 . . . . 0.0 109.758 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.75 -12.23 19.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.494 -0.754 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.19 -13.51 68.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 p 60.45 12.19 3.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -1.212 . . . . 0.0 109.104 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' H ' ' HB3' ' A' ' 50' ' ' SER . 69.9 t -92.97 151.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.413 -0.804 . . . . 0.0 109.214 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.2 m -148.52 139.13 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.01 . . . . 0.0 109.921 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 73' ' ' LEU . 50.7 m80 -90.3 129.01 36.58 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -66.63 -53.02 38.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.4 114.09 0.54 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -79.37 110.98 15.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.94 -163.93 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 63' ' ' THR . 18.0 ptt180 -155.41 15.86 0.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.0 p -155.85 -39.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.22 24.79 46.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -58.34 135.78 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -1.15 . . . . 0.0 109.326 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.22 124.29 0.79 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.38 -163.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -1.145 . . . . 0.0 109.579 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 165.17 33.75 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.28 98.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -1.122 . . . . 0.0 109.486 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.21 -57.38 13.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.22 170.82 8.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 132.21 5.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.201 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -115.23 119.44 36.34 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.05 137.32 35.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 109.081 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -127.8 144.75 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.588 -0.695 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.35 97.27 3.34 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 79' ' ' ALA . 7.7 mt -82.98 -14.96 53.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.087 -1.008 . . . . 0.0 109.557 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.43 -1.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.462 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -134.37 16.32 3.73 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.342 -0.849 . . . . 0.0 109.101 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.2 p -60.68 134.96 92.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.217 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.24 -177.95 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.814 1.676 . . . . 0.0 111.495 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.41 13.57 64.92 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -96.89 -59.78 1.73 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -1.14 . . . . 0.0 109.828 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.22 148.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.734 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -144.06 7.37 1.39 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.31 -0.869 . . . . 0.0 109.635 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -152.0 140.23 20.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 109.051 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 87' ' ' ILE . 6.1 mt -145.55 122.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.161 -0.962 . . . . 0.0 109.709 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.09 174.15 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.339 -0.851 . . . . 0.0 108.747 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -141.08 119.53 12.29 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.07 157.67 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.332 -0.855 . . . . 0.0 110.651 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.61 136.72 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 p -131.12 148.54 52.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.5 mm -75.57 147.87 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' ALA . 4.0 t60 -102.36 -68.48 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.249 -0.907 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.27 -18.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.48 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -54.25 -17.89 3.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -69.86 -59.63 2.81 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.939 -1.101 . . . . 0.0 109.964 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.77 -51.33 5.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.181 -0.949 . . . . 0.0 111.354 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -78.09 -16.84 57.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.96 -1.088 . . . . 0.0 110.991 -178.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' ARG . 35.6 ttp180 55.89 101.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.746 -1.221 . . . . 0.0 109.308 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -159.16 143.06 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -100.96 167.25 10.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.361 -0.837 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -45.87 -35.35 4.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.686 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.15 -39.31 92.08 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -46.98 -16.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.204 -1.174 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -86.08 168.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.149 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.518 ' N ' HG12 ' A' ' 106' ' ' VAL . 23.2 m -70.86 -22.23 62.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.819 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.61 79.39 0.03 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.99 164.5 23.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 109.748 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 42.8 p90 -152.34 163.32 39.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.326 -0.859 . . . . 0.0 109.906 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 54.3 mt -126.2 154.3 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.43 ' NH2' HG12 ' A' ' 122' ' ' VAL . 50.6 ttt85 -141.22 159.85 41.34 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.983 -1.073 . . . . 0.0 109.862 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 114' ' ' VAL . 2.2 tt -154.22 116.99 4.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 109.28 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.58 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -130.98 143.51 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 120' ' ' THR . 55.9 t30 -75.14 102.07 4.8 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.62 -1.32 2.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 25.3 t70 -83.01 -53.55 5.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.652 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -123.6 6.2 8.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.587 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 59.52 60.33 2.31 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 43.1 p -110.62 -70.12 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.925 -0.485 . . . . 0.0 110.298 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 122' ' ' VAL . 66.8 mt-10 -45.33 157.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.324 -0.86 . . . . 0.0 109.774 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 72.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 150.17 52.15 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.091 -1.006 . . . . 0.0 110.02 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 31.7 ptt180 -139.78 142.26 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.645 -0.659 . . . . 0.0 109.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.35 147.77 22.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.234 -0.916 . . . . 0.0 109.147 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -91.17 103.16 15.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.407 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 82.3 mt -79.24 -39.3 33.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.4 m -47.51 -30.29 3.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.971 -1.081 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -95.3 -54.74 3.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.403 -0.811 . . . . 0.0 109.864 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.5 -2.35 28.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.14 -0.975 . . . . 0.0 110.418 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.46 -45.27 69.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.217 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 t -70.91 3.08 3.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.491 -0.756 . . . . 0.0 109.868 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.1 m -83.11 -34.72 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.035 -1.04 . . . . 0.0 110.226 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -176.74 -162.42 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.022 . . . . 0.0 109.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.56 -15.31 7.58 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.41 138.67 36.71 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.3 ptm -165.45 157.99 15.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 0.0 109.916 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.07 134.64 37.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.347 -0.846 . . . . 0.0 109.664 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -76.71 -42.42 41.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.05 . . . . 0.0 109.431 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.44 -163.13 13.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.28 163.05 39.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -1.098 . . . . 0.0 109.015 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.5 tp -144.82 137.22 26.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.068 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -150.68 166.04 31.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 109.275 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -95.7 141.45 29.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.602 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 9.5 t-160 -99.18 -133.95 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.602 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 5.6 m120 -52.22 -50.48 61.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.984 -1.072 . . . . 0.0 108.269 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.04 16.94 0.13 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -129.87 154.43 47.3 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.228 -1.16 . . . . 0.0 109.683 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 1' ' ' SER . 71.9 m95 -72.35 151.86 42.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.395 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -147.28 121.63 9.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.233 -0.917 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -90.32 146.26 24.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -150.81 107.78 3.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.4 -0.812 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.44 154.7 40.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.835 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 -33.38 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.4 85.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -135.16 104.3 5.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.531 -0.982 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.89 150.66 26.71 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.67 135.07 41.79 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.604 -0.939 . . . . 0.0 108.837 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.51 2.7 54.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 109.519 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -58.68 -110.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.97 140.27 6.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.75 -35.22 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.848 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.49 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.79 -19.81 30.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.1 m -89.02 -52.44 5.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 12.7 m -54.54 -28.29 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.617 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 32.1 p -78.54 -54.59 5.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -71.98 -15.12 62.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.976 -1.077 . . . . 0.0 109.33 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -72.21 -28.99 63.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 51.1 m-85 -71.78 -19.83 61.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 109.473 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.56 -49.0 4.29 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.3 158.87 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -1.136 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -69.51 122.69 19.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.938 . . . . 0.0 109.459 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 91.21 5.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 149' ' ' TRP . 20.9 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.5 OUTLIER -79.08 -170.99 2.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -153.25 -34.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 15.5 m120 -145.99 141.26 27.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG1' HD21 ' A' ' 113' ' ' LEU . 10.9 t -141.0 154.78 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.0 109.226 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.79 121.82 12.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 109.288 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -91.8 150.74 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 108.988 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.3 116.85 1.8 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -112.59 127.81 56.19 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -146.86 146.95 17.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -157.63 152.74 25.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -1.134 . . . . 0.0 109.872 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -92.53 126.51 37.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.737 . . . . 0.0 109.649 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.22 138.29 32.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.473 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -82.24 109.52 16.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -82.61 124.96 30.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 17' ' ' ASP . 10.2 t -152.96 -34.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 16' ' ' THR . 30.2 t70 -157.98 40.57 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.53 -22.14 4.88 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.59 171.46 7.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -1.167 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -176.03 173.39 2.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.474 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 95.2 m-85 -96.17 153.09 17.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -140.93 111.15 6.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.92 163.61 13.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -106.68 154.57 20.74 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 0.0 109.479 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . . . -144.67 109.7 5.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.185 -0.947 . . . . 0.0 108.764 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 t -149.43 163.3 38.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 109.974 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 144.69 37.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 8.0 m-85 -104.04 129.07 51.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.447 -0.783 . . . . 0.0 108.909 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.004 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.53 155.56 17.78 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.41 -0.806 . . . . 0.0 109.204 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.23 137.3 25.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.69 176.35 8.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.445 -0.785 . . . . 0.0 109.266 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.5 -2.55 53.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 109.642 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -93.18 3.55 55.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.174 -0.954 . . . . 0.0 109.821 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 -19.6 53.83 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.3 mttp -106.26 172.45 6.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.8 t -101.27 141.81 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -59.69 -5.55 0.93 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -148.6 101.11 0.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 18.6 p-10 -45.23 -18.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.376 -1.073 . . . . 0.0 110.28 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.44 79.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 0.0 109.561 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.696 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 45.45 17.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 109.539 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' ALA . 52.5 t80 -137.8 100.02 4.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.533 -0.729 . . . . 0.0 109.858 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 29' ' ' LEU . 6.2 pt -106.3 139.65 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.315 -0.866 . . . . 0.0 109.072 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -152.92 -148.68 0.26 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 109.039 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' ASN . 25.9 p90 -44.46 -34.33 2.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.602 -0.686 . . . . 0.0 109.971 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.69 -5.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.166 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 54.0 t-20 -148.0 110.09 4.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -0.834 . . . . 0.0 108.956 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.24 -29.1 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.369 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 12.8 pttm -169.17 155.6 6.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.432 -0.793 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 5.1 t -73.51 117.51 15.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.189 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.22 78.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 109.663 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -93.42 -16.41 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.29 -0.881 . . . . 0.0 109.786 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.17 -13.69 61.58 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t 58.39 14.04 2.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' H ' ' HB3' ' A' ' 50' ' ' SER . 86.9 t -92.91 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.329 -0.857 . . . . 0.0 109.168 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.5 m -145.75 136.12 24.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' NE2' HD11 ' A' ' 73' ' ' LEU . 57.2 m80 -89.97 133.49 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.347 -0.846 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -71.75 -60.79 2.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.506 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.43 114.92 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 32.6 p-10 -82.21 110.94 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.0 t-20 -80.84 -163.48 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.358 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 36.1 ttp180 -151.91 14.23 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 109.243 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -154.11 -38.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.945 . . . . 0.0 109.25 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.83 -3.7 63.66 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.49 110.4 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -1.156 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.71 -122.11 1.13 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -169.85 160.02 8.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -1.11 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 166.58 31.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.24 124.13 9.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -1.165 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.93 -73.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -90.84 99.66 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 t -91.38 132.15 36.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 109.217 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -112.27 125.08 53.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -96.3 142.51 28.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 108.949 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -133.68 146.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.332 -0.855 . . . . 0.0 109.927 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -142.2 102.23 4.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 79' ' ' ALA . 5.6 mt -82.59 -27.69 31.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.862 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -63.63 4.65 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.29 19.08 4.01 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.81 125.81 45.19 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.117 -0.99 . . . . 0.0 108.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.06 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.818 1.679 . . . . 0.0 111.88 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.56 4.71 83.95 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -53.27 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.192 -1.181 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.29 149.07 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.0 109.347 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 10.4 t0 -120.71 -13.79 8.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 109.482 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -158.02 134.18 9.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.013 . . . . 0.0 109.949 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -122.88 154.42 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -141.12 173.57 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.193 -0.942 . . . . 0.0 109.291 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -141.84 128.91 20.83 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.61 158.33 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 m -135.63 114.06 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -106.15 161.06 14.85 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.9 mm -73.01 140.58 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.12 -69.88 0.73 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.056 -1.028 . . . . 0.0 110.441 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -50.39 -17.92 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.146 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.598 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -47.35 -50.51 21.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -55.24 -28.02 50.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.904 -1.123 . . . . 0.0 109.801 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -54.14 4.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.114 -0.991 . . . . 0.0 111.173 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.45 -0.43 15.29 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.187 -0.945 . . . . 0.0 111.058 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.0 ttm-85 56.23 101.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.889 -1.132 . . . . 0.0 109.046 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -146.93 149.48 33.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.7 p -101.03 158.22 16.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.341 -0.849 . . . . 0.0 109.652 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -45.62 -34.46 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.397 -0.815 . . . . 0.0 109.743 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.684 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -60.7 -42.22 99.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 87.4 mm-40 -47.66 -15.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.251 . . . . 0.0 109.371 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -83.57 166.16 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.509 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.2 t -69.83 -20.48 63.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.725 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.83 79.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.06 162.76 26.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 109.734 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 20.7 p90 -156.3 149.96 24.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.098 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 56.7 mt -115.83 154.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -139.59 159.4 42.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.03 -1.043 . . . . 0.0 109.923 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.3 tt -151.94 117.23 5.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 113' ' ' LEU . 9.2 p -129.16 145.82 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.353 -0.842 . . . . 0.0 110.164 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.2 t-20 -76.42 102.05 5.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.93 -1.56 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.88 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -84.08 -53.17 5.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.713 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -123.11 4.67 9.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' ASN . 10.7 tt0 60.39 61.12 1.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.429 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 24.3 p -112.34 -68.97 0.89 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.903 -0.498 . . . . 0.0 110.221 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 122' ' ' VAL . 22.3 mm-40 -45.4 157.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.851 . . . . 0.0 109.956 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.1 m -178.52 73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.74 150.83 52.11 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.149 -0.969 . . . . 0.0 109.935 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 7.5 ptm180 -138.81 146.26 41.1 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.507 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.0 t80 -91.34 147.3 23.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.61 103.06 15.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.516 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 46.8 mt -81.38 -39.16 25.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.3 m -48.16 -31.87 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 0.0 109.152 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -95.18 -54.53 3.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.47 -0.769 . . . . 0.0 109.771 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 58.6 m-20 -72.75 -2.99 22.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.274 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.72 -44.35 66.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.244 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.5 p -72.39 3.17 5.03 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -82.79 -34.57 26.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.992 -1.068 . . . . 0.0 110.331 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.74 -162.6 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.96 -1.088 . . . . 0.0 109.852 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -127.37 -1.58 6.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.07 13.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.8 ptm -165.35 157.97 15.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.843 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -94.68 139.66 30.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 109.795 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 26.5 t80 -81.14 -42.82 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.629 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.62 -169.45 22.95 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.8 164.86 35.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.251 -1.147 . . . . 0.0 109.46 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 136.52 26.23 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 152' ' ' ARG . 9.5 p90 -146.95 166.27 27.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.019 -1.05 . . . . 0.0 110.25 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.98 145.32 24.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 4.7 t60 -122.77 -118.81 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.61 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 73.6 m-20 -73.53 53.3 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.23 8.13 87.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.76 148.61 50.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.99 . . . . 0.0 109.312 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.4 m95 -75.08 151.79 38.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -147.74 127.11 13.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.112 -0.993 . . . . 0.0 109.603 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -89.63 148.23 23.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.484 -0.76 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 143' ' ' TYR . 2.6 ptp180 -153.87 107.52 2.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.06 154.55 37.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.44 -34.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.272 -0.893 . . . . 0.0 109.389 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 86.26 0.04 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -131.67 104.19 6.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.634 -0.921 . . . . 0.0 109.389 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.36 148.08 24.94 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -139.43 128.66 23.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -1.073 . . . . 0.0 109.321 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.8 12.16 13.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.06 -80.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 152.77 131.24 1.63 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.15 -13.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.56 -50.32 7.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 80.2 p -81.12 -37.72 28.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 161' ' ' GLY . 52.1 t -49.92 -24.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.434 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 93.4 m -79.55 -55.28 5.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.168 -0.957 . . . . 0.0 110.959 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.09 -15.21 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.957 -1.089 . . . . 0.0 110.355 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -66.3 -39.96 89.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.58 -19.62 62.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.683 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.96 -29.23 42.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.5 mt -80.13 139.56 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 172' ' ' ASN . 35.8 p-10 -66.03 112.58 3.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.41 -163.87 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.418 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 149' ' ' TRP . 25.2 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.255 0.55 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -80.21 -174.64 4.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -153.21 -34.98 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.428 ' H ' ' HB2' ' A' ' 117' ' ' ASP . 6.2 m-20 -138.0 142.65 40.41 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.362 -0.837 . . . . 0.0 109.321 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 5.2 t -140.08 146.01 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.349 -0.844 . . . . 0.0 109.382 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.8 tt -136.25 111.9 9.37 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' HD23 ' A' ' 6' ' ' LEU . 6.5 t -86.42 150.97 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.26 117.08 1.56 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.8 tt -115.98 132.42 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -149.0 143.96 11.55 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.52 158.8 41.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -1.023 . . . . 0.0 109.512 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -76.73 131.35 38.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.911 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -89.44 119.21 29.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.341 -0.849 . . . . 0.0 109.261 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -81.08 106.72 13.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.2 p -103.02 134.5 46.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -162.98 -34.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 26.5 t70 -159.68 41.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 109.363 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.97 -17.44 22.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.554 ' NE2' ' N ' ' A' ' 19' ' ' GLN . 1.4 mp0 -81.73 151.63 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.522 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -175.04 174.21 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.434 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.17 140.03 31.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.83 99.79 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.304 -0.872 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.69 153.29 24.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -108.44 109.06 20.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -0.761 . . . . 0.0 109.543 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.25 128.0 44.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.307 -0.87 . . . . 0.0 108.924 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -149.44 167.81 25.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.068 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.68 140.7 43.22 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -103.91 129.83 51.46 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.406 -0.809 . . . . 0.0 108.922 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.949 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.97 146.72 27.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 109.681 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.64 134.69 23.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.188 -0.945 . . . . 0.0 110.005 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.74 176.53 3.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.65 -6.4 58.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.711 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -86.57 1.49 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.86 59.16 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -99.48 152.26 20.2 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 38' ' ' GLY . 26.2 t -72.26 136.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.054 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -70.96 8.17 0.99 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -158.2 168.36 34.61 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.33 4.05 54.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.997 -1.296 . . . . 0.0 110.13 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -102.77 -42.05 6.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.158 -0.964 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 47.71 13.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.742 -1.224 . . . . 0.0 109.454 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ALA . 68.7 t80 -137.5 102.86 4.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.444 -0.785 . . . . 0.0 109.911 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 pt -103.08 131.04 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.813 . . . . 0.0 108.855 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 20.4 t80 -150.06 -146.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -50.65 -16.27 0.37 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 46' ' ' ASN . 10.0 p-10 -78.92 4.88 12.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 108.799 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 50.1 t-20 -156.71 106.44 2.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.056 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -48.05 -25.57 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 109.316 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 11.9 pttm -172.86 158.53 3.91 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 t -69.64 141.38 53.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.66 -43.55 25.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.31 -1.58 12.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.694 -0.629 . . . . 0.0 109.553 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.8 -13.68 60.6 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 t 60.45 10.28 2.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -1.077 . . . . 0.0 109.426 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.13 147.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.99 138.2 25.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 109.721 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.438 ' NE2' HD11 ' A' ' 73' ' ' LEU . 36.0 m80 -89.82 130.17 36.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 108.785 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 m -69.49 -42.76 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.332 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.27 111.08 0.39 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -72.84 110.79 7.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 109.441 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 5.1 t-20 -86.3 -167.04 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.945 . . . . 0.0 109.341 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.466 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 15.5 ptt-85 -162.37 20.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 18.8 p -153.9 -43.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 109.352 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.57 30.35 12.06 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.23 150.49 48.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -1.172 . . . . 0.0 109.432 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.02 144.33 2.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -79.73 -169.84 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.479 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.15 169.08 19.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -56.42 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -52.96 -61.07 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.65 165.31 13.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -154.89 132.15 11.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -116.15 124.48 50.43 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HZ2' ' HE3' ' A' ' 76' ' ' LYS . 36.9 tttm -95.91 139.83 31.55 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.51 146.8 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HE3' ' HZ2' ' A' ' 74' ' ' LYS . 88.7 mttt -139.57 99.35 3.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.18 -5.53 52.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.839 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -83.26 -26.89 30.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.93 5.87 50.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.42 124.44 85.53 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.13 -161.35 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.828 1.686 . . . . 0.0 112.057 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.32 1.38 79.5 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -68.9 -59.83 2.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 109.246 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 50.4 t -91.39 148.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.408 -0.807 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 2.4 m-20 -138.26 9.03 2.71 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -155.04 131.3 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 109.327 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.38 154.3 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.46 173.66 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.307 -0.87 . . . . 0.0 109.001 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 7.9 m-85 -140.95 120.48 13.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.21 158.11 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.714 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.63 136.34 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 p -125.55 143.88 50.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 109.695 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.7 mm -74.22 132.05 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 108.863 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -93.8 -60.14 1.83 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.33 -19.87 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.56 -43.88 72.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -55.79 -27.6 51.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.762 -1.212 . . . . 0.0 109.673 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.67 -53.74 4.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.137 -0.977 . . . . 0.0 111.076 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.439 ' CZ ' HE22 ' A' ' 101' ' ' GLN . 12.3 ptm180 -112.42 -3.9 14.37 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.244 -0.91 . . . . 0.0 110.9 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 48.0 ttp180 56.74 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.071 . . . . 0.0 109.321 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.439 HE22 ' CZ ' ' A' ' 99' ' ' ARG . 3.8 pt20 -157.88 153.65 26.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 83.0 p -101.85 158.47 16.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.01 -31.49 0.92 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.564 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.06 -33.51 22.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -57.53 -26.29 61.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -1.077 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -72.41 166.4 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.223 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.3 m -70.69 -28.89 65.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.4 75.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.62 25.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 108.938 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 28.9 p90 -153.24 169.86 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.297 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 41.8 mt -132.4 156.62 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.71 162.69 34.8 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.006 -1.059 . . . . 0.0 109.731 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.6 tt -157.52 116.66 3.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.587 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -132.92 141.88 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.318 -0.864 . . . . 0.0 109.651 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' GLN . 1.4 m120 -77.79 102.1 7.03 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 6.1 p-10 -68.29 -3.67 11.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 20.9 t70 -72.96 -52.69 13.58 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.138 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -122.67 -12.02 8.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.766 -0.584 . . . . 0.0 109.617 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 115' ' ' ASN . 6.0 tt0 70.86 69.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -130.48 -45.71 1.09 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.738 -0.601 . . . . 0.0 109.979 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 122' ' ' VAL . 5.0 mp0 -65.13 158.23 26.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 108.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER 176.67 76.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.28 148.67 52.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.495 -0.753 . . . . 0.0 109.407 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 27.8 ptt180 -136.49 141.72 43.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -91.53 140.04 30.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 0.0 108.946 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -83.85 103.02 12.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.075 -1.016 . . . . 0.0 109.402 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 60.7 mt -78.22 -41.72 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 84.7 m -47.88 -29.58 3.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.933 -1.104 . . . . 0.0 109.274 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.05 -54.74 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.41 -0.806 . . . . 0.0 109.878 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.28 -4.74 37.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 110.355 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -60.21 -49.29 78.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.961 -1.087 . . . . 0.0 109.783 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.3 p -60.41 2.8 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.5 m -89.68 -33.31 16.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 110.4 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -172.68 -145.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.18 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.521 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -135.82 -52.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.77 143.64 30.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.2 ttt -166.2 158.08 13.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.043 . . . . 0.0 109.802 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 pp -101.04 136.48 40.82 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.373 -0.83 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 25.9 t80 -81.65 -40.74 22.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.74 -170.79 26.95 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -150.96 163.62 38.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -1.12 . . . . 0.0 109.602 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.03 140.39 32.61 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -150.57 166.5 30.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.099 -1.001 . . . . 0.0 109.857 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -88.15 148.96 24.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.79 . . . . 0.0 109.709 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -152.5 123.78 7.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 55.67 24.77 7.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.33 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.81 80.33 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -127.8 138.37 52.71 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.488 -1.007 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' O ' ' N ' ' A' ' 1' ' ' SER . 76.8 m95 -67.69 150.7 48.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -151.35 126.19 9.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -89.23 147.02 24.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.465 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -152.76 108.09 3.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 109.048 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.54 154.74 41.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.0 t -139.31 -33.65 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -0.843 . . . . 0.0 109.293 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.09 86.23 0.03 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -138.25 104.46 5.2 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.928 . . . . 0.0 109.485 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.64 150.59 33.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -147.88 134.4 19.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.221 -1.164 . . . . 0.0 109.396 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.3 16.94 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.339 -0.851 . . . . 0.0 109.43 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.1 -64.55 2.97 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.64 127.04 0.97 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -47.22 -35.58 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.792 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.0 -22.2 27.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.423 ' C ' ' N ' ' A' ' 166' ' ' CYS . 26.0 m -79.18 -57.53 3.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.0 m -47.58 -20.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.423 ' N ' ' C ' ' A' ' 164' ' ' SER . 96.2 m -72.63 -61.94 1.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.68 -17.52 31.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.35 -43.51 88.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.24 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.92 -20.31 61.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.04 -53.28 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.9 mm -76.7 107.58 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -1.174 . . . . 0.0 109.373 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.52 114.17 19.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.57 24.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.461 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.7 mtt -67.67 -178.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.436 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 81.8 mttt -153.62 -33.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.911 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 26.7 m-20 -140.3 129.11 23.18 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' HD21 ' A' ' 113' ' ' LEU . 5.9 t -129.69 156.09 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.6 tp -142.02 110.0 5.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 108.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.22 150.5 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.209 -0.932 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.54 116.5 1.22 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.56 134.55 49.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.57 142.32 10.58 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -160.39 152.98 20.94 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -1.151 . . . . 0.0 109.914 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.08 99.32 11.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 109.403 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -79.31 163.37 24.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.428 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -132.81 106.86 7.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.487 -0.758 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 m -86.64 105.93 17.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p -79.53 -59.17 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.416 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 24.9 p-10 -158.51 18.01 0.21 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.68 -34.67 0.69 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -82.08 162.78 22.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -1.077 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -176.25 165.88 2.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.24 131.19 42.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 p-10 -141.03 100.8 3.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.342 -0.849 . . . . 0.0 109.796 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.18 146.3 28.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.78 121.4 44.3 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.33 -0.856 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.6 134.37 40.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.262 -0.899 . . . . 0.0 108.912 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.9 t -149.85 167.92 25.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.306 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.08 138.33 54.7 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.8 m-85 -104.06 128.03 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.317 -0.865 . . . . 0.0 109.332 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.011 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -103.03 155.84 18.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.42 137.49 25.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 109.35 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -79.14 176.78 9.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 109.501 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.35 59.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -86.98 4.66 40.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.119 -0.988 . . . . 0.0 109.839 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.89 -20.68 45.91 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 43.6 mtpt -103.32 172.49 6.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.689 HG21 ' CG ' ' A' ' 41' ' ' ASP . 3.6 t -101.29 142.63 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.406 -0.809 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' NH1' ' OD2' ' A' ' 83' ' ' ASP . 39.1 mmm-85 -59.74 -6.03 1.09 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -146.1 100.16 0.22 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -44.94 -21.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -1.091 . . . . 0.0 110.414 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.21 -41.35 79.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 109.62 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.689 ' CG ' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER 47.77 13.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 109.369 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 84.9 t80 -138.28 99.46 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.366 -0.834 . . . . 0.0 109.654 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.83 136.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.343 -0.848 . . . . 0.0 108.834 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.8 p90 -144.94 -160.85 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.139 -0.976 . . . . 0.0 109.502 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' C ' ' H ' ' A' ' 47' ' ' ASN . 16.8 p90 -45.64 -29.96 1.39 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.151 -0.968 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.8 t30 -57.42 -6.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.855 -1.153 . . . . 0.0 108.989 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 48.6 t30 -140.17 110.07 6.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.458 -0.776 . . . . 0.0 109.022 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.9 mt -48.03 -31.65 5.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 109.278 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 16.9 pttp -169.87 160.01 8.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -65.01 142.29 58.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.327 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.92 43.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.631 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -115.21 -3.79 12.49 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.643 -0.661 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.07 -15.64 74.23 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 76' ' ' LYS . 5.0 p 61.48 11.45 3.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -92.92 151.72 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.0 109.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 73' ' ' LEU . 54.9 m -147.68 133.85 19.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 109.746 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.55 ' NE2' HD11 ' A' ' 73' ' ' LEU . 34.8 m80 -91.42 139.17 30.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 m -74.43 -61.74 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.67 121.63 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 23.6 p-10 -81.28 112.11 18.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -1.146 . . . . 0.0 109.543 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -80.35 132.1 35.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -79.82 6.24 11.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.532 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.1 p -153.3 -34.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -0.914 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.92 15.78 10.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.51 110.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -1.068 . . . . 0.0 109.5 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.2 -135.57 2.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -160.31 69.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -1.166 . . . . 0.0 109.441 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.3 -175.67 33.17 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -49.2 106.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.414 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.04 -63.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -90.99 -179.69 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.562 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.9 m -161.85 135.43 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.18 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD11 ' NE2' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -121.41 120.5 35.17 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.13 138.8 33.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.096 -1.002 . . . . 0.0 109.304 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' CE1' ' A' ' 89' ' ' PHE . 79.8 mt -132.38 147.02 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.583 -0.698 . . . . 0.0 109.763 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' O ' ' OG ' ' A' ' 54' ' ' SER . 53.8 mttp -142.85 102.1 3.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.857 . . . . 0.0 108.722 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 79' ' ' ALA . 9.3 mt -77.11 -39.01 51.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.999 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -49.42 -17.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -100.17 -15.95 17.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.78 123.89 88.95 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.398 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.56 -160.74 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.967 1.778 . . . . 0.0 111.941 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.01 1.73 87.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' NH1' ' A' ' 37' ' ' ARG . 59.4 t0 -67.28 -55.64 13.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -1.143 . . . . 0.0 109.57 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -79.02 148.53 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 8.9 t0 -128.25 -7.13 5.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 109.564 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -158.21 135.84 10.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 0.0 109.614 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -129.75 154.12 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -146.51 173.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 109.262 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.447 ' CE1' HD13 ' A' ' 75' ' ' ILE . 9.3 m-85 -133.32 139.28 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.94 155.62 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.99 . . . . 0.0 111.212 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -147.57 113.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -121.14 171.62 8.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.449 -0.782 . . . . 0.0 110.606 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 94' ' ' HIS . 5.8 mm -81.68 168.3 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.568 ' N ' HG22 ' A' ' 93' ' ' ILE . 27.0 t-80 -132.75 -64.8 0.74 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -49.91 -18.23 0.49 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -58.28 -39.44 79.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.579 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' NE2' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -52.9 -32.21 44.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.77 -1.206 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.84 4.22 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.135 -0.978 . . . . 0.0 111.296 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -112.23 1.75 16.31 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.127 -0.983 . . . . 0.0 111.091 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.4 ttm180 59.08 110.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.998 -1.064 . . . . 0.0 109.339 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.418 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 83.4 mt-30 -150.05 139.35 21.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 109.555 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 m -99.13 158.98 15.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.37 -0.831 . . . . 0.0 109.461 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -46.31 -30.21 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.325 -0.86 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.707 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -68.19 -37.53 86.91 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -47.71 -17.06 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.167 . . . . 0.0 109.138 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 107' ' ' SER . 23.0 t -85.0 167.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 108.969 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 106' ' ' VAL . 25.0 m -67.26 -20.47 65.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.0 80.48 0.03 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.76 164.68 23.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -1.175 . . . . 0.0 109.832 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 11.8 p90 -154.07 150.45 28.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.129 -0.982 . . . . 0.0 110.024 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 36.2 mt -114.17 155.84 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -141.96 162.82 34.51 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.995 -1.065 . . . . 0.0 109.919 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.7 tt -157.07 118.14 3.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.6 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.9 p -130.77 144.56 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.331 -0.856 . . . . 0.0 110.049 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 3.9 t-20 -75.24 101.97 4.85 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.92 -1.71 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 115' ' ' ASN . 22.3 t0 -84.75 -52.18 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.306 -0.871 . . . . 0.0 109.627 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -122.24 -0.48 9.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.65 -0.656 . . . . 0.0 109.988 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 60.67 63.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 115' ' ' ASN . 21.9 p -118.13 -53.93 2.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.002 -0.436 . . . . 0.0 110.099 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.86 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.16 158.55 11.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 109.389 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.86 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.5 OUTLIER 178.31 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.03 148.01 52.24 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 109.791 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 41.1 ptt85 -134.82 145.68 48.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.408 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 9.8 t80 -91.36 147.59 22.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.15 -0.969 . . . . 0.0 109.186 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -86.11 102.99 14.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 109.285 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 66.9 mt -83.07 -40.66 19.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.458 ' H ' HG23 ' A' ' 128' ' ' THR . 5.9 p -48.13 -31.74 6.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.118 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -95.32 -54.62 3.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.823 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 47.1 m-20 -73.47 -3.82 29.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.161 -0.962 . . . . 0.0 110.416 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.707 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -52.27 -45.15 65.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.997 -1.065 . . . . 0.0 109.125 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.1 m -70.91 3.01 3.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.643 -0.66 . . . . 0.0 109.92 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -84.47 -34.26 23.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 110.17 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -176.64 -167.35 0.19 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -123.4 -8.05 8.1 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.05 135.52 24.26 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.94 157.65 14.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.014 -1.054 . . . . 0.0 110.048 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -92.6 138.37 31.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -81.51 -41.96 20.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.29 -169.95 20.97 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.406 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.9 tt0 -151.5 161.25 43.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -144.51 136.39 25.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.2 -0.937 . . . . 0.0 108.523 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.2 p90 -144.04 165.87 26.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.188 -0.945 . . . . 0.0 109.685 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 8.5 ptm180 -84.98 152.52 23.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -155.29 116.47 3.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.411 ' O ' ' OE1' ' A' ' 148' ' ' GLU . 14.6 t-20 56.25 24.99 8.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 -3.89 86.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 3.4 mp0 -109.64 135.09 51.16 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -69.14 151.64 46.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.192 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.85 129.42 15.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.119 -0.988 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 19.4 t80 -96.72 137.73 35.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.457 -0.777 . . . . 0.0 109.912 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -143.61 107.29 4.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 109.041 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.48 154.56 39.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -143.08 -34.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.264 -0.898 . . . . 0.0 109.322 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.04 85.24 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -132.65 104.23 6.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.663 -0.904 . . . . 0.0 109.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.76 149.71 25.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -140.24 133.44 29.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.468 -1.019 . . . . 0.0 109.117 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.16 7.66 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 0.0 109.439 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.08 -69.6 0.91 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.89 125.39 0.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.21 -28.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.137 . . . . 0.0 109.928 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.75 -31.0 22.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.9 p -75.6 -50.48 15.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.4 m -48.13 -20.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.486 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 59.4 m -69.97 -58.94 3.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.835 . . . . 0.0 110.326 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.71 -15.24 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.35 -44.2 92.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.293 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -71.23 -20.01 62.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.76 17.45 30.95 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.31 150.01 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -1.195 . . . . 0.0 109.344 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -65.87 119.23 10.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 99.78 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.447 -180.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 149' ' ' TRP . 53.0 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 2' ' ' MET . 2.0 mpt? -77.61 148.8 34.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -129.64 -9.88 4.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.453 ' ND2' ' OD1' ' A' ' 117' ' ' ASP . 11.7 m-80 -146.41 129.18 16.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.219 -0.926 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.462 ' CG1' HD21 ' A' ' 113' ' ' LEU . 4.9 t -135.88 147.98 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.48 -0.762 . . . . 0.0 109.066 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.7 tt -135.28 109.92 8.59 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.466 ' N ' HD23 ' A' ' 6' ' ' LEU . 15.4 t -86.16 143.87 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.47 117.15 2.18 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 10' ' ' GLY . 2.7 tt -115.46 131.82 56.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 9' ' ' LEU . . . -145.24 143.46 11.86 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' THR . 19.0 p90 -154.97 153.69 31.43 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.44 -1.035 . . . . 0.0 109.695 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.04 117.51 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.1 170.8 15.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.59 106.95 8.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 m -85.79 127.87 34.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -147.39 -34.64 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 17' ' ' ASP . 7.0 p30 -158.16 47.7 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 -41.11 2.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -60.49 159.28 10.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -170.12 171.91 6.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.391 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -96.2 136.63 36.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 109.442 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -140.9 99.65 3.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.39 -0.819 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.66 130.63 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -91.43 112.54 24.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 109.959 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 128.74 44.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.276 -0.89 . . . . 0.0 108.6 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -149.26 165.73 31.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.102 -0.999 . . . . 0.0 110.171 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.88 138.69 45.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 7.3 m-85 -104.45 129.41 52.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.472 -0.768 . . . . 0.0 109.007 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.95 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -100.02 153.42 19.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.377 -0.827 . . . . 0.0 109.949 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.02 135.36 22.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.822 . . . . 0.0 109.415 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -76.25 176.46 8.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.47 -10.49 59.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.973 . . . . 0.0 109.718 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -84.78 4.81 31.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 109.695 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.18 -19.61 51.21 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.0 mttt -103.71 172.05 7.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -103.03 140.94 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.458 -0.776 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' NH1' ' OD1' ' A' ' 83' ' ' ASP . 34.3 ttp180 -62.06 -3.54 1.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -143.54 101.29 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -45.54 -27.29 0.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 110.47 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -57.4 -42.34 82.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.912 -1.118 . . . . 0.0 109.623 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 41.8 t0 46.03 15.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 13.8 t80 -137.77 100.22 4.13 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.653 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 pt -101.55 137.92 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.3 p90 -141.14 -160.08 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 25.7 p90 -42.5 -36.06 1.23 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.607 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 9.1 t30 -49.27 -14.61 0.1 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.912 -1.118 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.479 ' N ' ' C ' ' A' ' 45' ' ' TYR . 40.7 t30 -153.88 112.85 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.94 -64.63 0.97 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.202 -0.937 . . . . 0.0 109.542 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -89.92 117.77 28.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.478 -0.764 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -57.21 134.77 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.89 75.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.826 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -116.39 -5.96 11.76 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.615 -0.678 . . . . 0.0 109.892 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.42 -19.27 64.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t 62.78 6.57 2.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -1.17 . . . . 0.0 109.238 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -92.97 152.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 108.932 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -143.45 142.13 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.111 -0.993 . . . . 0.0 110.468 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CE1' HD21 ' A' ' 73' ' ' LEU . 4.6 m80 -92.12 121.44 33.67 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 m -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.381 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 109.77 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -79.77 110.77 15.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -1.18 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -86.34 132.6 33.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -78.89 2.8 18.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 40.1 p -153.52 -35.01 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.78 21.26 76.49 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -58.53 115.46 3.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -1.185 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.86 -121.16 1.0 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -171.52 152.66 3.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.06 -163.92 47.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.2 94.69 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -1.122 . . . . 0.0 109.557 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.17 -53.05 42.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.22 160.08 14.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 108.998 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.4 m -157.86 132.32 8.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.077 -1.014 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD21 ' CE1' ' A' ' 57' ' ' HIS . 2.3 mp -117.88 126.4 52.31 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -96.27 122.74 39.45 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 71.2 mt -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.434 -0.791 . . . . 0.0 110.199 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 103.52 4.63 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.12 -24.33 40.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.909 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.4 -21.99 66.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.67 -9.19 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.953 . . . . 0.0 109.773 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.13 125.06 90.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.98 -160.28 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.909 1.739 . . . . 0.0 111.909 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.26 3.22 75.91 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 16.4 t70 -69.12 -60.1 2.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.304 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 86' ' ' LYS . 7.3 p -91.36 148.75 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.508 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.7 m-20 -133.1 10.48 4.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.343 -0.848 . . . . 0.0 109.831 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' H ' HG22 ' A' ' 84' ' ' VAL . 75.7 tttt -158.14 131.73 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 109.235 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.9 mt -129.36 154.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.515 -0.741 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -144.03 173.17 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.426 -0.796 . . . . 0.0 109.014 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 88' ' ' ILE . 6.9 m-85 -142.4 118.4 10.64 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.02 157.71 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.248 -0.907 . . . . 0.0 110.625 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -120.98 148.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 p -141.81 140.08 32.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.242 -0.911 . . . . 0.0 109.719 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.2 mm -73.92 137.4 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.8 t-80 -94.17 -64.9 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -47.45 -18.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.852 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -58.94 -18.13 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.0 109.94 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -66.14 -60.44 2.8 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.889 -1.132 . . . . 0.0 109.484 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -43.6 9.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.364 -0.835 . . . . 0.0 111.151 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -83.88 -18.02 38.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 111.225 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 54.19 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.652 -1.28 . . . . 0.0 109.162 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -148.39 142.28 25.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.25 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -99.63 165.27 11.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.217 -0.927 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CG ' HD22 ' A' ' 127' ' ' LEU . 12.7 m-85 -46.29 -34.19 4.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.285 -0.885 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.685 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -58.26 -38.49 90.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -49.1 -18.85 0.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.981 -1.305 . . . . 0.0 109.338 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 107' ' ' SER . 23.2 t -82.54 166.22 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 109.161 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.496 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.3 m -70.28 -23.4 62.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.988 . . . . 0.0 109.758 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.35 77.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.2 163.48 23.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -1.176 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 30.6 p90 -154.23 169.88 22.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 37.5 mt -132.08 156.55 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -143.85 162.12 36.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.5 tt -157.77 118.1 3.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.079 -1.013 . . . . 0.0 109.658 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.5 p -130.91 143.8 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -79.85 102.01 8.87 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.01 -1.49 7.61 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD1' ' ND2' ' A' ' 4' ' ' ASN . 31.7 t0 -76.76 -52.44 9.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 119' ' ' GLN . 5.4 m-80 -122.48 -14.74 7.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.73 -0.606 . . . . 0.0 109.583 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' A' ' 118' ' ' ASN . 15.9 tt0 73.83 71.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -135.9 -45.13 0.65 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.644 -0.66 . . . . 0.0 109.975 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 122' ' ' VAL . 49.9 mm-40 -65.37 158.44 26.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.0 108.931 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 173.4 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.79 149.45 52.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.501 -0.75 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 11.7 ptp180 -135.12 142.9 46.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.618 -0.676 . . . . 0.0 109.461 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -91.32 143.09 27.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.905 . . . . 0.0 108.925 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.16 102.87 14.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.585 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.3 mt -78.7 -41.0 32.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.204 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.9 p -47.78 -29.68 3.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 109.295 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -95.22 -54.68 3.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 109.804 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.93 -0.83 22.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.968 . . . . 0.0 110.275 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -53.0 -44.62 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 109.275 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 t -72.57 3.01 5.4 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.539 -0.725 . . . . 0.0 109.851 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.1 m -82.32 -34.35 28.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.005 -1.06 . . . . 0.0 110.124 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -176.76 -164.06 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 0.0 109.612 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.06 -14.34 8.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.6 140.12 36.94 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.8 ptm -165.47 158.05 15.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.008 -1.057 . . . . 0.0 109.871 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.19 137.58 35.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -82.87 -41.06 19.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.627 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.93 -170.1 25.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -151.21 164.24 37.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.216 -1.167 . . . . 0.0 109.558 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 139.02 29.04 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -150.16 166.45 29.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.065 -1.022 . . . . 0.0 109.894 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.508 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -89.19 146.18 24.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 109.506 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 146' ' ' ASN . 19.9 t-160 -128.23 -115.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 145' ' ' HIS . 21.9 m120 -72.66 58.71 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.068 -1.02 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.73 8.09 62.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -128.02 149.47 50.35 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.963 . . . . 0.0 109.315 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 1' ' ' SER . 81.8 m95 -72.8 151.63 41.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.356 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -146.58 129.42 16.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -89.89 149.28 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.405 -0.81 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -155.46 113.52 3.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.195 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.96 154.53 31.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.56 -33.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -0.871 . . . . 0.0 109.287 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 53.91 84.58 0.03 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -136.96 104.28 5.41 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.966 . . . . 0.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.36 152.12 37.38 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CE1' HG11 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -141.95 129.46 21.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.24 9.31 31.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.264 -0.898 . . . . 0.0 109.444 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -47.36 -70.97 0.61 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.83 132.44 1.48 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.8 pt? -46.33 -33.33 3.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.63 -26.39 26.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 166' ' ' CYS . 12.6 t -74.69 -54.39 7.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 158' ' ' TYR . 35.5 m -47.41 -20.71 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.504 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 60.0 m -71.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -15.4 39.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.35 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.28 -43.31 98.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.108 -0.995 . . . . 0.0 110.076 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -71.43 -19.7 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.95 -44.87 65.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 65.5 mt -80.09 129.71 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -1.145 . . . . 0.0 109.432 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.407 HD22 ' N ' ' A' ' 173' ' ' ALA . 0.9 OUTLIER -79.62 111.7 16.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.407 ' N ' HD22 ' A' ' 172' ' ' ASN . . . -80.66 86.49 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.504 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 149' ' ' TRP . 75.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 34.2 mtt -81.69 162.84 22.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -141.45 -33.73 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 13.1 m120 -146.11 128.46 15.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 113' ' ' LEU . 6.7 t -128.84 149.0 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 73' ' ' LEU . 12.2 tp -132.63 108.24 8.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 108.985 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.55 150.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.94 117.0 1.25 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -106.05 132.45 52.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.07 138.41 7.26 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.481 -1.342 . . . . 0.0 109.946 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -156.46 155.19 31.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -75.5 125.53 29.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.517 -0.739 . . . . 0.0 109.886 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.45 121.51 29.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.263 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -132.71 123.96 27.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.458 -0.776 . . . . 0.0 109.459 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 98.5 p -95.73 132.74 40.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.865 . . . . 0.0 109.295 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -148.62 -84.25 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -71.17 3.0 3.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.345 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.22 -127.0 1.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -79.71 176.92 9.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.165 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -72.72 -164.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.32 104.9 16.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.184 -0.948 . . . . 0.0 109.338 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' ND1' ' A' ' 94' ' ' HIS . 24.4 p-10 -92.87 102.71 15.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 mt -83.4 138.04 33.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 109.15 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.07 106.69 18.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.05 119.05 38.08 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -149.04 168.37 23.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.04 . . . . 0.0 109.804 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.03 138.42 45.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.597 -0.689 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.0 m-85 -104.35 131.83 51.26 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.993 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -102.62 154.39 19.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.382 -0.823 . . . . 0.0 110.132 -178.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 136.62 24.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -77.04 176.68 8.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.247 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . . . -79.86 -11.23 59.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.5 m120 -86.55 5.65 34.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.069 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.16 -19.46 52.16 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.7 mmtm -102.61 172.03 7.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.673 HG21 ' OD1' ' A' ' 41' ' ' ASP . 3.5 t -102.18 143.23 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 109.784 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -62.5 -3.24 1.34 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . -147.82 102.57 0.25 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -45.18 -25.8 0.4 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -1.085 . . . . 0.0 110.751 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 42' ' ' PHE . . . -56.52 -40.72 75.51 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.819 -1.175 . . . . 0.0 109.687 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.673 ' OD1' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 48.4 12.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 109.444 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 40' ' ' ALA . 79.3 t80 -135.11 100.25 4.5 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HD11 ' A' ' 29' ' ' LEU . 4.6 pt -103.5 130.52 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.487 ' CZ ' ' OD2' ' A' ' 60' ' ' ASP . 33.4 t80 -170.99 -168.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.985 -1.072 . . . . 0.0 109.179 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.473 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 52.4 m-85 48.46 -113.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 48' ' ' LEU . 23.0 t30 -56.84 -7.65 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -67.49 68.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.945 -1.097 . . . . 0.0 109.648 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 46' ' ' ASN . 13.3 mt -52.98 -30.97 38.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 108.898 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 127.15 0.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.509 -0.744 . . . . 0.0 109.124 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -55.86 111.9 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.67 -25.4 63.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.08 -16.12 11.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.545 -0.722 . . . . 0.0 109.658 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.53 -20.27 35.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.403 ' OG ' HG22 ' A' ' 80' ' ' VAL . 1.1 m 69.14 2.67 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.978 . . . . 0.0 109.451 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.77 146.56 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.229 -0.92 . . . . 0.0 108.663 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -149.12 150.56 32.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.961 -1.087 . . . . 0.0 110.348 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -91.37 136.15 33.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.65 -0.657 . . . . 0.0 109.756 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 p -85.78 -30.35 23.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.27 104.1 0.24 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.487 ' OD2' ' CZ ' ' A' ' 44' ' ' PHE . 12.6 t70 -80.77 110.82 16.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.636 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -95.36 -167.85 1.69 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -161.47 19.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.8 p -154.29 -42.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.55 -6.65 7.5 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.48 110.43 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -1.09 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 177.54 155.41 13.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.64 88.66 3.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -1.142 . . . . 0.0 109.482 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 -116.21 5.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.87 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -71.93 -69.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -99.32 156.1 17.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.314 -0.866 . . . . 0.0 109.132 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -159.68 141.33 12.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 6' ' ' LEU . 17.5 mt -112.19 131.81 55.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.067 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.47 110.16 22.26 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 26.6 mt -97.94 146.95 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 0.0 111.075 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -140.21 84.35 1.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 -5.19 11.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.9 -20.23 49.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.648 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.49 -13.89 21.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.217 -0.927 . . . . 0.0 109.781 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' A' ' 54' ' ' SER . 68.2 t -60.99 124.91 82.23 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.142 -0.974 . . . . 0.0 109.269 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.01 -160.98 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.74 1.627 . . . . 0.0 111.866 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.56 1.86 79.59 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -71.41 -60.52 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.544 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 t -87.12 133.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 32' ' ' ALA . 16.6 m-20 -113.32 4.43 16.39 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.697 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -156.36 137.86 14.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.528 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 87' ' ' ILE . 10.4 mt -145.44 107.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -109.18 171.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CZ ' HD13 ' A' ' 75' ' ' ILE . 4.7 m-85 -129.84 134.4 47.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.1 158.16 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -131.28 134.75 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 p -138.04 164.62 28.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 4.8 mm -77.64 142.01 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 22' ' ' ASP . 20.6 t-160 -98.1 -68.35 0.81 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -51.33 -18.11 0.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.104 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -48.94 -42.93 38.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 109.772 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.19 -30.07 48.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.918 -1.114 . . . . 0.0 109.753 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -90.73 -54.01 4.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 111.297 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HE ' ' CB ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -112.52 -0.31 15.27 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.256 -0.903 . . . . 0.0 111.1 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 96' ' ' ALA . 43.1 ttt85 57.08 103.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.949 -1.095 . . . . 0.0 108.991 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.435 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 70.1 mt-30 -137.38 134.04 35.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.277 -0.889 . . . . 0.0 109.708 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -90.64 152.77 20.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -46.76 -30.89 2.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.197 -0.94 . . . . 0.0 109.583 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.648 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -57.96 -40.31 93.09 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.435 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 51.0 mt-30 -48.17 -17.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.241 . . . . 0.0 109.359 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' GLY . 17.2 t -82.78 163.97 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 108.949 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 m -72.13 -25.55 61.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.14 78.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.11 164.71 25.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -1.109 . . . . 0.0 109.145 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 22.7 p90 -154.4 143.82 21.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.92 -1.113 . . . . 0.0 110.477 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 43.1 mt -108.43 154.16 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' NH2' HG12 ' A' ' 122' ' ' VAL . 52.0 ttt85 -139.94 160.8 39.1 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.999 -1.063 . . . . 0.0 109.731 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.9 tt -155.11 116.69 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.529 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.591 ' N ' HD23 ' A' ' 113' ' ' LEU . 8.8 p -128.46 144.51 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 109.755 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 119' ' ' GLN . 53.8 t30 -76.37 102.12 5.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.22 -1.87 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.383 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 4' ' ' ASN . 18.2 t70 -81.66 -53.23 6.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.22 4.22 9.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.771 -0.58 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 115' ' ' ASN . 20.0 tp60 59.5 60.41 2.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 53.9 m -113.46 -68.64 0.91 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.951 -0.468 . . . . 0.0 110.299 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.861 ' O ' HG13 ' A' ' 122' ' ' VAL . 57.8 mm-40 -45.2 157.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 110.029 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -179.28 73.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.85 151.55 52.0 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 14.3 ptp180 -139.21 142.48 37.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -91.4 147.77 22.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.167 -0.958 . . . . 0.0 109.314 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -85.96 106.19 16.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -80.33 -46.78 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.5 m -47.83 -27.96 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -0.966 . . . . 0.0 109.264 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -91.81 -54.57 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.59 0.84 9.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.96 -47.18 81.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 p -73.26 3.09 6.19 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.502 -0.749 . . . . 0.0 109.976 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.2 m -87.96 -34.61 18.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.007 -1.058 . . . . 0.0 110.478 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -175.65 -163.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.789 -1.194 . . . . 0.0 109.857 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.5 p -125.58 -8.73 6.82 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.14 27.81 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.5 ptm -165.46 157.9 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.04 -1.037 . . . . 0.0 109.951 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 pp -96.76 137.29 36.07 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 109.436 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 139' ' ' PHE . 32.0 t80 -79.69 -42.12 25.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.077 -1.015 . . . . 0.0 109.958 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.57 -166.29 15.48 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.532 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 10.1 tt0 -150.82 160.66 43.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -1.012 . . . . 0.0 109.292 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.422 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.0 mt -142.81 137.52 29.73 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.44 165.75 29.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -95.6 144.41 26.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.465 -0.772 . . . . 0.0 109.687 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 20.0 t-80 -125.49 -117.16 0.28 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.62 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 53.0 t30 -72.54 58.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.968 . . . . 0.0 109.407 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.31 10.49 66.16 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -127.74 141.46 51.59 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.933 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' SER . 84.0 m95 -71.37 152.03 43.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -148.52 131.39 16.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.561 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.1 t80 -89.7 149.64 22.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.509 -0.744 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 21.6 tpt85 -154.39 107.26 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.439 -0.788 . . . . 0.0 109.025 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.508 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -63.75 154.75 32.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.42 -33.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.435 -0.791 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.24 82.14 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -135.74 104.37 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.588 -0.948 . . . . 0.0 109.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.47 151.34 36.13 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -145.78 133.77 21.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.358 -1.084 . . . . 0.0 109.213 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.28 11.65 29.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.98 -27.47 6.68 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 83.6 139.5 3.86 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.63 -12.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -1.132 . . . . 0.0 109.719 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.664 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -77.81 -57.59 3.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 109.515 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 m -80.72 -41.83 22.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.01 -21.32 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.687 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 13.5 t -73.97 -60.37 2.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.616 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.16 -26.42 23.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.195 -0.94 . . . . 0.0 110.443 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 169' ' ' TYR . 1.3 tm0? -51.32 -35.34 37.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 109.813 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 24.6 m-85 -85.73 13.26 7.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -150.73 27.87 1.04 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.9 pt -71.08 133.94 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.253 . . . . 0.0 109.173 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -78.37 137.04 37.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.533 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.41 36.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.479 -179.933 . . . . . . . . 0 0 . 1 stop_ save_